according national public health data <NUMBER> million scorpion envenomings resulting <NUMBER> deaths recorded annually worldwide <NUMBER> <NUMBER> large regions northern hemisphere united states canada europe russia well australia southern hemisphere associated severe scorpionism <NUMBER> two billion people living northern saharan africa african sahel south africa near middle east southern india eastern andes mexico south america risk stung scorpions <NUMBER> climate change together urban expansion poor city sanitation management many areas increased likelihood encountering scorpions instance brazil alone malign incidences scorpions nearly doubled <NUMBER> <NUMBER> annual envenoming cases since <NUMBER> <NUMBER> b cn<NUMBER> centruroides noxius venom classical βnatx c cn<NUMBER> also c noxius venom shows structural resemblance βnatxs exhibits αnatx function agitoxin <NUMBER> leiurus hebraeus previously l quinquestriatus hebraeus αktx toxin protein database accession numbers <NUMBER>ptx ahhii <NUMBER>cn<NUMBER> cn<NUMBER> <NUMBER>pe<NUMBER> cn<NUMBER> <NUMBER>agt agitoxin <NUMBER> ktx potassium channel toxins natx sodium channel toxins peptides long scorpion toxin superfamily <NUMBER> residuelong molecules generally four disulfide bridges <NUMBER> due mode action also called sodium channel toxins natxs main targets sodium ion channels <NUMBER> family divided two groups α βnatxs depending specific interaction voltagegated na channels figure <NUMBER>a b αnatxs block site <NUMBER> sodium ion channels therefore inhibit inactivation channels prolong action potential contrast βnatxs interact site <NUMBER> na channels shift activation voltage channels negative potential results channel inactivation opposite effects site <NUMBER> toxins <NUMBER> noteworthy natxs assigned two groups example cn<NUMBER> centruroides noxius ts<NUMBER> tityus serrulatus venom structurally resemble βnatx exhibit αnatx effect figure <NUMBER>c <NUMBER> <NUMBER> addition aah it<NUMBER> toxin androctonus australis hector displays α βnatx effects <NUMBER> short scorpion toxin family composed peptides <NUMBER> residues length three four disulfide bridges peptides also known potassium channel toxins ktxs mainly act potassium ion channel blockers figure <NUMBER>d <NUMBER> considering sequences cysteine pairs ktxs divided α β γ κ δ λ εktx groups <NUMBER> <NUMBER> αktx group considered largest subgroup short scorpion toxin family contains <NUMBER> residuelong peptides three four disulfide bridges <NUMBER> βktx group comprises longer chain peptides <NUMBER> residues length <NUMBER> γktx group found genera centruroides mesobuthus buthus mainly blocks human etheràgogorelated gene herg channels <NUMBER> instead cs αβ structure similar α β γktx subfamilies toxins κktx group predictable structurefunction relationship <NUMBER> peptides cationic molecules display notable structural flexibility aqueous solutions peptides exhibit random coil conformation however membranemimicking environments <NUMBER> aqueous trifluoroethanol readily adopt amphipathic αhelical structure <NUMBER> characteristic enables interact broad spectrum biological targets however known specific molecular targets <NUMBER> <NUMBER> enzymes found scorpion venoms part recently interest focused small proteins peptides however past years hyaluronidases phospholipases metalloproteases among enzymes detected venoms different scorpion species different hyaluronidases identified different families scorpions including buthidae bothriuridae urodacidae <NUMBER> known enzymes potentiate toxicity venom disrupting integrity extracellular matrix connective tissues surrounding blood vessels sting point thereby ease systemic diffusion relevant scorpion toxins <NUMBER> recently demonstrated hyaluronidases also play essential role venom distribution bloodstream target organs <NUMBER> study also indicated neutralization hyaluronidases could considered firstaid strategy scorpion envenoming treatment phospholipases known potent hemolytic agents disrupt cell membranes hydrolyzing phospholipids also cause tissue necrosis hemorrhages phospholipase activity detected several scorpion species including opisthacanthus cayaporum <NUMBER> heterometrus laoticus <NUMBER> generally venoms tityus species exhibit significant proteolytic activity first scorpion metalloprotease discovered venom serrulatus <NUMBER> metalloproteases serine proteases also detected discrepans venom <NUMBER> apart tityus species venom hemiscorpius lepturus <NUMBER> believed proteases play key role activating toxin precursors posttranslational modifications <NUMBER> addition enzymes inhibit platelet aggregation modulate cytokine production activate complement system <NUMBER> <NUMBER> altogether effects facilitate diffusion scorpion venom toxins via degradation matrix proteins limited number studies nonpeptidic scorpion venom compounds reported however shown venoms scorpions including tamulus contain serotonin monoamine may cause vomiting considerable local pain scorpion envenomings <NUMBER> metal salt composition scorpion species also evaluated alasmari et al <NUMBER> study found copper zinc calcium magnesium iron lead manganese arsenic nickel ions venom bicolor crassicauda leiurus quinquestriatus suggested components associated enzyme activity probably act enzyme cofactors addition two <NUMBER>benzoquinone compounds antimicrobial activity recently isolated venom diplocentrus melici scorpion species endemic mexico <NUMBER> see table <NUMBER> moreover reported one lowmolecularweight compounds anticoagulant activity isolated heterometrus laoticus venom adenosine wellknown inhibitor platelet aggregation <NUMBER> <NUMBER> scorpion envenomings cause severe pathological effects even death humans intensity envenoming usually depends victims sensitivity body mass anatomical location sting amount injected venom scorpion species commonly based severity symptoms scorpion envenomings classified three levels mild moderate severe figure <NUMBER> <NUMBER> <NUMBER> mild envenomings result local inflammatory reactions whereas moderate severe envenomings may provoke lethal systemic responses clinical manifestations symptoms mild moderate severe scorpion envenomings typical symptoms mild stings last minutes hours include great local pain reddened swollen site sting erythema edema numbness sweating body tremors agitation intense stings scorpions venom containing cytolytic toxins may result blood blisters hemorrhages necrosis surrounding tissue moderate envenoming cases body additionally reacts fever abdominal joint pain hyperglycemia abnormally rapid breathing increased heart rate nausea vomiting symptoms reside days mostly caused neurotoxins na k ca <NUMBER> ion channel modulators neurotoxins also cause severe envenomings lead cardiovascular neurological pulmonary andor gastrointestinal complications pulmonary edema myocardial failure arrhythmia congestive heart failure extreme muscular convulsion hypertensive encephalopathy acute peptic ulcers pancreatitis lethal multiple organ failure mental confusion coma several days victims lethal scorpion stings die cardiac respiratory failure generally first treatment strategies undertaken envenoming event focus pain relief possibly intravenous hydration decrease negative effects strong salivation sweating order relieve acute pain scorpion sting either cooling ice intravenous injection paracetamol nonsteroidal antiinflammatory drugs diclofenac indomethacin topical administration lidocaine cream site sting used <NUMBER> however surprising analgesic effect lidocaine might superior former treatments <NUMBER> substances considered application envenoming cases prazosin counteracts catecholamineinduced hypertension <NUMBER> antihistamines steroids reduce inflammatory responses <NUMBER> sodium phenobarbital prevents convulsions lung edema <NUMBER> <NUMBER> calcium gluconate eases muscle spasms <NUMBER> partially used practice seem general consensus efficacy possible adverse effects treatment options yet case prazosin shown mortality mean residence time hospital could significantly reduced administration two doses drug one immediate one three hours envenoming incident <NUMBER> additionally small molecules heparin ethylenediaminetetraacetic acid edta aristolochic acid shown neutralize scorpion venom enzymes hyaluronidases phospholipases <NUMBER> metalloproteases thus molecules might considered starting point development future treatments <NUMBER> severe envenoming cases antivenoms employed neutralize venom diminish morbidity mortality scorpion stings figure <NUMBER> conventional plasmaderived antivenoms produced purification digestion polyclonal immunoglobulin g igg molecules harvested plasma hyperimmunized animals horses sheep polyclonal antivenoms cause severe adverse reactions due heterologous origin <NUMBER> known field snakebite envenoming generally possess low percentages venomneutralizing antibodies <NUMBER> <NUMBER> moreover conventional antivenoms may limited efficacy medically important toxins small neurotoxins toxins often weakly immunogenic therefore fail raise strong antibody response production animal <NUMBER> nonetheless administration types antivenoms effective clinical use lifesaving since <NUMBER>s thus plasmaderived antivenoms still standard treatment systemic scorpion envenomings <NUMBER> recently pursuit finding alternatives equine iggs scorpion envenoming treatment strategies involving avian eggyolkderived immunoglobulin ys igys developed <NUMBER> contrast equine iggs avian igy antibodies obtained noninvasively egg yolks laying hens immunized scorpion venom igy molecules argued activate mammalian complement system much less animalderived iggs interact rheumatoid factors produced amounts comparable found plasma large mammals argued affordable previous studies igybased antivenoms snake scorpion venoms demonstrated neutralizing antibodies raised method albeit lower neutralizing capacity antibodies present plasmaderived antivenoms <NUMBER> nevertheless slightly increased interest use eggyolkderived igy antibodies antivenom manufacture <NUMBER> <NUMBER> <NUMBER> <NUMBER> example recent study demonstrated using rescue assay involving mice lethality australis hector aah venom could neutralized igy antibodies however addition drawbacks equine iggs terms polyclonality batchtobatch variation avianderived igys phylogenetically even distantly related mammals <NUMBER> still require use production animals manufacture therefore seems likely development nextgeneration antivenoms based recombinant monoclonal antibodies antibody fragments may promising research avenue developing effective safe costcompetitive antivenoms defined therapeutic composition future envenoming therapy field nextgeneration antivenoms development phage display technology recent advances toxicovenomics enabled researchers pursue new therapeutic strategies purpose creating better envenoming therapies <NUMBER> technologydriven approaches made possible identify toxic thus medically relevant components given venom efficiently systematically discover human monoclonal antibodies components turn paved way developing recombinant antivenoms anticipated improved safety profiles compared conventional antivenoms example using phage display technology discovery human monoclonal singlechain variable fragment scfv antibody serrulatus toxins serrumab reported <NUMBER> <NUMBER> monoclonal antibody demonstrated high neutralizing capacity βtoxins serrulatus also capable crossneutralizing toxins c suffusus suffusus l quinquestriatus recently <NUMBER> field recombinant scorpion antivenoms took another step forward discovery broadlyneutralizing monoclonal scfv antibody scfv <NUMBER>fg<NUMBER> capable neutralizing estimated <NUMBER> different neurotoxins different scorpion species belonging centruroides genus reported <NUMBER> using rescue assay study demonstrated scfv <NUMBER>fg<NUMBER> capable neutralizing <NUMBER> ld <NUMBER> freshly obtained whole venoms five different scorpion species belonging centruroides genus <NUMBER> <NUMBER> molar ratios venom antibody implementation broadlyneutralizing antibodies formulation recombinant antivenoms significant simplification pharmaceutical composition since inclusion broadlyneutralizing antibodies may sufficient neutralize entire venoms several different species reducing product complexity recombinant antivenoms important challenge solve enable costcompetitive manufacture medicines <NUMBER> <NUMBER> next scfvs singledomain v h h antibodies also known nanobodies nb intensively explored utility relation recombinant antivenoms nbs native immune system camelids sharks constitute smallest natural antibody fragments known date <NUMBER> low molecular mass nbs allows distribution deep tissues throughout body <NUMBER> <NUMBER> property addition high ex vivo stability low immunogenicity makes interesting format development nextgeneration scorpion antivenoms <NUMBER> <NUMBER> example utility preclinical study bispecific nb targeting aahi aahii toxins australis venom demonstrated nb able provide vivo protection <NUMBER> ld <NUMBER> intracerebroventricularly administered aahi toxin nb molar ratio <NUMBER> <NUMBER> ld <NUMBER> subcutaneously administered whole venom results significantly better controls equimolar amounts traditional equine antibody fragments unable neutralize <NUMBER> ld <NUMBER> subcutaneously administered whole venom <NUMBER> finally using murine model demonstrated low molecular mass toxinnb complexes seemed quickly cleared glomerular filtration uptake liver remained low <NUMBER> thus studies demonstrated nbs may possess promising pharmacokinetic pharmacodynamic characteristics similar studies h lepturus hottentotta saulcyi comparable results also support notion nbs may find utility developing novel treatments scorpion envenomings <NUMBER> <NUMBER> finally monoclonal iggs another recombinant antibody format investigated ability neutralize animal toxins example vivo lethality studies assessing neutralization capacity several murine monoclonal iggs shown positive results neutralization australis c noxius toxins <NUMBER> future however likely research area focus human monoclonal iggs rather nonhuman iggs human iggs range benefits heterologous iggs overview benefits drawbacks different antibody formats found elsewhere <NUMBER> widely reported literature scorpion venom rich source bioactive compounds toxins interest pharmaceutical biotech industries <NUMBER> however despite fact substantial research efforts ongoing prospects scorpionderived therapeutic peptides promising chlorotoxin toxin scorpion venom taken clinical trials <NUMBER> moreover scorpion toxinbased drug currently found market <NUMBER> section potential applications scorpion venom compounds subject therapeutic research presented figure <NUMBER> focus results recently reported scientific literature comprehensive overview compounds including older research reports found elsewhere <NUMBER> past century antimicrobial drugs revolutionized control diseases caused microorganisms bacteria fungi viruses parasites however due global problem antimicrobial resistance amr development new antimicrobial agents crucially needed <NUMBER>st century agents must discovered rate sufficiently fast combat evolving rate multidrug resistance mdr microorganisms <NUMBER> natural product research holds promise providing new molecules basis novel antimicrobial drug development <NUMBER> reported folding pattern charybdotoxin ktx isolated l quinquestriatus hebraeus venom strikingly similar insect antibacterial component defensin <NUMBER> discovery set stage studies scorpionderived antimicrobial peptides amps led large number discoveries may relevance therapeutic applications comprehensive reviews different classes amps found venom several scorpion species found elsewhere <NUMBER> <NUMBER> focus directed recent discoveries overview amps bactericidal activity reported last five years summarized table <NUMBER> compounds mentioned table <NUMBER> scorpion venom unless otherwise specified whenever data number disulfide bridges available compound question mark used nonpeptidic compounds marked star recently spotlight put general intrinsic multifunctionality scorpion venom components including amps <NUMBER> instance native scorpion amps uyct<NUMBER> uyct<NUMBER> u yaschenkoi enhanced uyct peptide designated d<NUMBER> demonstrated potential bioinsecticides promising candidates engineering aphidresistant crops pea aphids acyrthosiphon pisum known severe agricultural pests fed amps amps displayed activity aphid bacterial symbionts reduced number symbionts leading reduction pest survival delay pest reproduction <NUMBER> meucin<NUMBER> eupeus also showed insecticidal activity addition broadspectrum activity grampositive gramnegative bacteria <NUMBER> red blue benzoquinones melici multifunctional components besides showing antibacterial activity also exert cytotoxic effects neoplastic cell lines mouse models mdr tuberculosis infection blue benzoquinone showed comparable activity commercially available antibiotics cause adverse side effects healthy mice <NUMBER> similarly low molecular mass chitosan obtained gibbosus strong inhibitory effect bacterium l monocytogenes yeast c albicans addition antibacterial activity b subtilis enteritidis higher antibiotic gentamicin <NUMBER> despite multifunctionality desirable potent action microbes natural scorpion amps generally cytotoxic effects eukaryotic cells obstacle must overcome end protein engineering techniques used improve potency spectra antimicrobial activity natural scorpion amps <NUMBER> <NUMBER> <NUMBER> employing techniques demonstrated scorpion amps effectively used scaffolds design specific less harmful antibiotics <NUMBER> <NUMBER> addition combining low concentrations fastkilling scorpion amps classical antibiotics another approach pursued order circumvent cytotoxic effects eukaryotic cells <NUMBER> using natural scorpion amps scaffolds rational design novel antimicrobial agents mixed formulations antibiotics opens new window research pursued future important opportunistic fungal pathogens responsible high mortality especially hospitalized immunocompromisedcritically ill patients belong candida aspergillus cryptococcus pneumocystis genera <NUMBER> reported prevalence invasive fungal infections increased <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> among aforementioned genera candida common cause fungal infections worldwide invasive candidiasis occurs <NUMBER> patients every year <NUMBER> antifungal drug resistance among candida species increasingly reported emergence mdr c glabrata acquire resistance following exposure antifungal agents presents significant challenges many medical centers <NUMBER> moreover three drug classes licensed monotherapy candida infections including azoles polyenes echinocandins <NUMBER> therefore new antifungal drug candidates additional drug classes sought summary scorpionderived antifungal agents reported last five years found table <NUMBER> <NUMBER> niger c albicans <NUMBER> compounds mentioned table <NUMBER> scorpion venom unless otherwise specified whenever data molecular weight andor number disulfide bridges available compound question mark used stigmurin selected synthesized based transcriptomic analysis stigmurus venom gland exhibits antibacterial antifungal activity effective grampositive bacterial species aureus including methicillinresistant strains stigmurin also demonstrated effective fungi c albicans c krusei c glabrata low toxicity healthy human erythrocytes <NUMBER> data suggested stigmurin could considered treatment candidiasis recently two analog peptides stiga<NUMBER> stiga<NUMBER> designed original peptide demonstrated improved antimicrobial antifungal activity peptides could inhibit growth grampositive gramnegative bacteria well c albicans c krusei c glabrata lower minimal inhibitory doses compared stigmurin <NUMBER> stiga<NUMBER> stiga<NUMBER> also showed high antiparasitic activity trypanosoma cruzi see section <NUMBER> study demonstrated rational design using scorpion toxins scaffolds may useful obtaining leads improved therapeutic features wide range pathogens including fungi antiviral vaccines drugs commercially available <NUMBER> viruses known infect humans <NUMBER> situation highlighted current sarscov<NUMBER> pandemic puts emphasis importance discovery development new antiviral agents end venomous animals considered many researchers promising sources discoveries <NUMBER> <NUMBER> scorpion toxins show specific antiviral effects one type virus toxins active several different viruses mucroporinm<NUMBER> derivative mucroporin lychas mucronatus venom presents antiviral activities three rna viruses measles mev severe acute respiratory syndromerelated coronavirus sarscov influenza h<NUMBER>n<NUMBER> binding assays demonstrated significant specific interaction immobilized mucroporinm<NUMBER> cm<NUMBER> biosensor chips mev following mixing <NUMBER> × <NUMBER> <NUMBER> plaqueforming units per milliliter pfuml mev different concentrations mucroporinm<NUMBER> incubating mixture <NUMBER> h <NUMBER> • c two probable mechanisms action assessed assessments included measurements direct effects mucroporinm<NUMBER> virus inhibition mev plaque formation evaluation compounds ability compromise infectivity virus suppression mev replication results showed mev infectivity could inhibited almost completely <NUMBER> µgml mucroporinm<NUMBER> within <NUMBER> min similar way mucroporinm<NUMBER> showed inhibitory effects sarscov h<NUMBER>n<NUMBER> pseudoviruses <NUMBER> later demonstrated mucroporinm<NUMBER> inhibit replication hepatitis b virus activation mitogenactivated protein kinase mapk pathway downregulation hnf<NUMBER>α vitro vivo <NUMBER> given dual inhibitory activities viruses bacteria mucroporinm<NUMBER> may considered lead compound treating viral bacterial coinfections mucroporinm<NUMBER> also serves example demonstrating potential peptides scorpion venoms used scaffolds designing multifunctional antiviral agents another example recombinant peptide rev<NUMBER> scorpion euscorpiops validus demonstrated possess inhibitory effects dengue virus type <NUMBER> denv<NUMBER> hepatitis c virus hcv zika virus zikv herpes simplex virus type <NUMBER> infections noncytotoxic concentrations inhibitory effects rev<NUMBER> denv<NUMBER> hcv zikv infections determined hepatoma cell line huh<NUMBER> via realtime fluorescent quantitative pcr mrna infected cells rev<NUMBER> able reduce level denv<NUMBER> hcv zikv infection mrna level concentration <NUMBER> µm <NUMBER> <NUMBER> <NUMBER> respectively since cellular entry processes four viruses similar suggested specific molecular mechanism rev<NUMBER> peptide alkalizes acidic organelles prevent low phdependent fusion viral membrane endosomal membrane blocks release viral genome endosome cytoplasm thus restricts viral late entry <NUMBER> propensity cause adverse reactions lack low efficacy high price vaccines therapeutics available aforementioned viruses <NUMBER> <NUMBER> emphasize rev<NUMBER> may relevant lead possibly could developed antiviral drug smp<NUMBER> scorpinelike peptide venom maurus palmatus another recent example scorpionderived agent effective different viruses recombinantly expressed peptide rsmp<NUMBER> inhibit rna replication protein synthesis denv<NUMBER> zikv primary mouse macrophages human lung adenocarcinoma cell line a<NUMBER> huh<NUMBER> cell line human monocytic cell line thp<NUMBER> dosedependent manner concentration <NUMBER> mm inhibitory effects rsmp<NUMBER> <NUMBER> infections caused denv<NUMBER> tsv<NUMBER> virulent strain ngc zikv infection inhibition evaluated <NUMBER> although detailed molecular mechanisms rsmp<NUMBER>induced inhibitory effects need elucidated seems mechanism inhibition include direct inactivation viral particles suggested rsmp<NUMBER> suppresses established viral infection upregulating interferonβ expression phosphorylation interferon regulatory factor <NUMBER> enhances typei ifn responses thus inhibits viral infection <NUMBER> since achievement viral clearance difficult antiviral agents rsmp<NUMBER> suppress established viral infections considered efficient traditional antiviral therapeutics exert antiviral effects direct inactivation viral particles inhibition viral cell entry <NUMBER> enhancing protective effects host innate immunity interferon ifn activation antiviral agents rsmp<NUMBER> may potentially circumvent development drug resistance effects genetic variability viral genome <NUMBER> examples selected dozens ongoing studies demonstrate potential scorpionderived peptides developed antiviral therapeutics parasitic diseases considered health problem particularly developing countries people frequently infected parasites belonging genera plasmodium trypanosoma leishmania among others <NUMBER> <NUMBER> since antiparasitic therapeutic agents available clinical use often toxic <NUMBER> urgent need discovery development novel therapeutics <NUMBER> scorpion toxins demonstrated possess inhibitory effects number parasites scorpine purified pandinus imperator venom first isolated scorpion toxin demonstrated antiprotozoan effects plasmodium berghei <NUMBER> later recombinantly expressed scorpine produced <NUMBER> mortality sexual stage p berghei <NUMBER> reduction p falciparum parasitemia <NUMBER> similarly meucin<NUMBER> meucin<NUMBER> two linear ndbps synthesized cdna library eupeus venom gland demonstrated antimalarial activity peptides inhibited development p berghei killed intraerythrocytic p falciparum parasites micromolar concentrations without harming mammalian cells <NUMBER> making potential candidates antimalarial therapies scorpionderived agents effective parasites well taenia solium pork tapeworm parasite responsible taeniasis intestinal infection cysticercosis tissue infection humans <NUMBER> <NUMBER> solium cysticercosis added list major neglected tropical diseases world health organization <NUMBER> crassiceps another species taeniidae family tapeworms due extensive antigen similarity solium functions experimental model test screen promising antigens testing pigs <NUMBER> demonstrated using vitro assays hge<NUMBER> naturally occurring truncated form scorpinelike peptide hoffmannihadrurus gertschi venom reduce viability crassiceps larval cysts submicromolar concentrations minimal effect human lymphocytes <NUMBER> study demonstrated scorpionderived agents may hold potential therapeutic agents human cysticercosis disease human african trypanosomiasis sleeping sickness american trypanosomiasis chagas disease induced upon infection protozoan parasites brucei cruzi respectively considered endemic latin america chagas disease potentially lifethreatening illness affects <NUMBER> million lives according <NUMBER> vitro assay recently demonstrated stigmurin analogs stiga<NUMBER> stiga<NUMBER> stiga<NUMBER> stiga<NUMBER> show high antiparasitic activity epimastigote forms cruzi form naturally found gut infected insect vectors <NUMBER> <NUMBER> stiga<NUMBER> stiga<NUMBER> also shown activity trypomastigote forms cruzi mainly found blood patients acute phase chagas disease addition peptides demonstrate higher antiparasitic activity lower concentration compared benznidazole together nifurtimox currently available chagas disease medicines <NUMBER> therefore stiga<NUMBER> stiga<NUMBER> may utilized development therapeutics chagas disease demonstrated leishmania parasites sensitive peptides antimicrobial ion channel inhibitory activity since scorpion venoms rich sources peptides borges et al demonstrated discrepans crude venom main fractions tdi ii iii could inhibit growth promastigote forms motile longelongated flagellated infective form leishmania parasite develops midgut sandfly l mexicana l braziliensis l chagasi eventually led parasite death vitro <NUMBER> unfortunately best knowledge leishmanicidal activity compounds venoms scorpion speciesfamilies reported investigated whether leshmanicidal effects restricted genus tityus bradykinin potent endotheliumdependent vasodilator peptide hypotensive properties belongs kinin group proteins angiotensinconverting enzyme ace inactivates bradykinin degrading <NUMBER> <NUMBER> inhibition ace via bradykininpotentiating peptides bpps captopril derived peptide found venom lancehead viper bothrops jararaca established clinically approved strategy preventing hypertension <NUMBER> multifunctionality scorpion toxins limelight regarding bradykininpotentiating effects scorpion venoms demonstrated cterminal fragment bmkbpp amp martensii venom antibacterial antifungal activities shows significant sequence similarity peptide k<NUMBER> known ace inhibitor b occitanus venom vitro assay using guinea pig ileum segments nearly <NUMBER> cm length bmkbpp whole peptide cterminal fragment bmkbppc demonstrated bradykininpotentiating activity concentration <NUMBER> nm however bmkbpp whole peptide bmkbppc less potent peptide k<NUMBER> bmkbppc active whole peptide <NUMBER> sequence similarity fragment toxin bpps also observed serrulatus venom peptides nterminal ts<NUMBER> αtoxin acting voltagegated sodium channels demonstrated striking sequence similarity ts<NUMBER> former peptide known bpp <NUMBER> ts<NUMBER> originally reported ace inhibitor since could inhibit acecatalyzed hydrolysis bradykinin <NUMBER> later using male wistar rats aortic rings vitro vivo assays demonstrated nterminal ts<NUMBER> ts<NUMBER> <NUMBER>c<NUMBER>s ts<NUMBER> able directly inhibit ace activity instead induced strong vasodilatory effect could reversed presence nitric oxide synthase inhibitor nωnitrolarginine methyl ester lname suggests ts<NUMBER> ts<NUMBER> <NUMBER>c<NUMBER>s play role activating molecular targets vascular endothelium leads production eventually vasodilation <NUMBER> addition reported serrulatus hypotensins tshpti ii iii iv tisth stigmurus also potentiate bradykinin improvement endothelial function release rats <NUMBER> <NUMBER> cases show scorpion peptides potentiate bradykinin mechanisms ace inhibition besides vasodilation hypotension scorpionderived bpps play important roles physiological processes estimated considerable number cancer patients receive radiation therapy course illness <NUMBER> however radiation therapy might lead side effects including radiationinduced heart disease rihd patients lymphoma breast lung esophageal cancer <NUMBER> <NUMBER> demonstrated bpps obtained l quinquestriatus improved cardiomyopathy induced γradiation rats probably acting scavenger free radicals protect heart negative effects derived radiation exposure <NUMBER> several scorpion toxins modulate immune system <NUMBER> indeed contribution released inflammatory mediators eg cytokines eicosanoids reactive oxygen species activation complement system well explored envenoming pathophysiology following scorpion stings <NUMBER> <NUMBER> <NUMBER> instance increase regulatory cytokines interleukin il<NUMBER> il<NUMBER> observed experimental envenomings australis hector c noxius well real human envenomings serrulatus <NUMBER> <NUMBER> <NUMBER> <NUMBER> although studied scorpion toxins exhibit proinflammatory effects activate immune system <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> demonstrate potential therapeutic applications controlling immune responses acting immunosuppressive agents studied class immunosuppressive scorpion toxins blockers voltagegated potassium channel type <NUMBER> k v <NUMBER> although many cells express k v <NUMBER> studies focused effector memory cells em due high expression profiles k v <NUMBER> em cells subpopulation cells regarded attractive pharmacological target role development autoimmune diseases <NUMBER> recent review covering structure function channels well therapeutic implications blocking k v <NUMBER> using toxins derived scorpion venom summarized studies <NUMBER> scorpion toxins androctonus buthus mesobuthus lychas parabuthus leiurus centruroides tityus genera <NUMBER> beside k v <NUMBER> channels ion channels k v <NUMBER> k v <NUMBER> also demonstrated important tcell activation function <NUMBER> <NUMBER> pucca et al described ts<NUMBER> ts<NUMBER> serrulatus block k v <NUMBER> inhibit proliferation function different tcell subpopulations vitro study also showed ts<NUMBER> capable inhibiting delayedtype hypersensitivity dth response vivo indicating potential peptide developed treatment autoimmune diseases <NUMBER> another study performed xiao et al described immunosuppressive antiinflammatory properties st<NUMBER> disulfidebridged αktx found venom scorpiops tibetanus vitro functional studies showed peptide able inhibit expression cell surface marker cd<NUMBER> well secretion il<NUMBER> tumor necrosis factor tnfα ifnγ activated human cells vivo experiments using rat autoimmune disease model showed dth ameliorated presence st<NUMBER> <NUMBER> thus new immunosuppressive therapeutic drugs may derived scorpion venom toxins optimized regard structure function possibly facilitating future use agents clinical settings generally scorpion stings reported painful events known scorpion toxins known modulate voltagegated ion channels mainly sodium potassium channels <NUMBER> voltagegated sodium na v channels play key role nociception pain <NUMBER> na v channels comprise family nine homologous αsubunits na v <NUMBER>na v <NUMBER> together βunits β<NUMBER>β<NUMBER> generate ionconducting pore <NUMBER> however four na v channel subtypes involved pain na v <NUMBER> na v <NUMBER> na v <NUMBER> na v <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> throughout last decades scorpion toxins capable inducing pain mediated channels widely explored <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently two peptides hj<NUMBER>a hj<NUMBER>a isolated hottentotta jayakari venom potent agonists na v <NUMBER> demonstrating dual αβ activity modifying activation inactivation properties channel hj<NUMBER>a hj<NUMBER>a may used alternative tools developing selective na v <NUMBER> modulators treatment epileptic diseases dravet syndrome <NUMBER> addition scorpion toxins induce pain mediated different ion channels voltagegated potassium channel <NUMBER> k v <NUMBER> <NUMBER> trpv<NUMBER> <NUMBER> <NUMBER> also encountered moreover scorpion toxins capable controlling pain ie analgesics reported literature many analgesic toxins toxic mammals belong group insectspecific neurotoxic α βtoxins interact na v k v andor ca v pathways <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> last two decades <NUMBER> scorpion venomderived peptides proteins reported exert antinociceptive effects vitro vivo due absence toxicity mammals comparable effects standard care medications carbamazepine scorpionderived proteins intriguing agents could used future development analgesics scorpion martensii previously known b martensii karsch thoroughly studied source <NUMBER> analgesic peptides <NUMBER> <NUMBER> analgesic properties also reported mauretanicus mauretanicus ammviii αanatoxin l quinquestriatus quinquestriatus lqqit<NUMBER> βtoxin h laoticus hetlaxin αtoxin b occitanus tunetanus botaf βtoxin serrulatus tsntxp table <NUMBER> however still much unexplored venom territory future discovery field analgesic venom components <NUMBER> rigo et al reported presence antinociceptive effects nontoxic protein serrulatus tsntxp <NUMBER> protein described structurally similar na v modulating neurotoxins ts<NUMBER> however tsntxp nontoxic animals effects tsntxp studied <NUMBER> adult male female swiss mice regard acute neuropathic pain results demonstrated tsntxp potent antinociceptive properties models potentially due substantial reduction glutamate release results combined lack acute adverse effects suggest tsntxp may possibly utilized future pain treatment table <NUMBER> summary known antinociceptive scorpion toxins bmk martensii <NUMBER> da <NUMBER> ttxr na v <NUMBER> <NUMBER> ttxs na v <NUMBER> reduction neural excitability skeletal muscle ryr <NUMBER> <NUMBER> <NUMBER> <NUMBER> bmk it<NUMBER> martensii <NUMBER> da <NUMBER> ttxr ttxs na v <NUMBER> <NUMBER> discovery specific selective anticancer drugs directly act tumors display synergistic effect existing chemotherapeutics function cargoes drugs low bioavailability significantly rise <NUMBER> chlorotoxin ctx l quinquestriatus venom molecule interacts chloride channels ctx first scorpionderived agent demonstrated inhibitory effects glioma cell migration invasion also exhibited advantage able penetrate deep tumor tissue <NUMBER> <NUMBER> since discovery ctx list scorpion crude venoms isolated toxins anticancer activity growing rapidly hence comprehensive review reported compounds exceeds scope review found elsewhere <NUMBER> <NUMBER> <NUMBER> <NUMBER> present cherrypicked recent studies significant findings serrulatus crude venom tested <NUMBER> possible anticancer effects siha hela cervical cancer cell lines venom shown induce apoptosis hela cells <NUMBER> wang et al previously obtained similar results crude venoms h liangi martensii two venoms tested potential anticancer effects toward hela cells venoms showed dosedependent antiproliferative apoptosisinducing effects upregulation cdkinhibitor p<NUMBER> however neither venoms showed significant effects noncancer huvec<NUMBER> cells suggesting specificity toward cancer cells <NUMBER> additionally venoms crassicauda l quinquestriatus examined using breast mdamb<NUMBER> colorectal hct<NUMBER> cancer cell lines <NUMBER> examination revealed venoms exhibited significant time dosedependent cytotoxicity caused increase number apoptotic cells reactive oxygen species cancer cell lines cell lines subjected venoms observed arrests cell cycle could indication tumor suppressor p<NUMBER> upregulation could hence suggest selectivity toward cancer cells anticancer properties recently associated crude venom rhopalurus junceus mix five peptides venom <NUMBER> <NUMBER> despite generating promising results investigations aforementioned scorpion crude venoms needed characterize effective anticancer constituents among venom components <NUMBER> li et al constructed scorpion venom library australis mauretanicus led discovery highly potent novel anticancer peptide mauretanicus named gonearrestide peptide subsequently tested several colorectal cancer cell lines dld<NUMBER> hke<NUMBER> dks<NUMBER> hct<NUMBER> glioma cell line u<NUMBER> extensive vitro vivo ex vivo studies hct<NUMBER> cells demonstrated peptide possessed high specificity toward cancer cells could significantly arrest cell cycle g<NUMBER> phase could thus strongly inhibit tumor growth additionally proliferation cytotoxicity studies noncancer human epithelial cell lines fhc colon mcf<NUMBER>a breast human erythrocytes identified negligible offtarget effects gonearrestide <NUMBER> another study benaissa et al investigated activity negatively charged fractions australis venom du<NUMBER> prostate cancer cells successfully identified strong antiproliferative effects mediated na v <NUMBER>directed peptide aahiv <NUMBER> however regardless potent antiproliferative effects peptide able inhibit cell migration another study agap agapsypu<NUMBER> martensii venom see section <NUMBER> analgesic effects demonstrated two peptides possessed vivo antitumor properties mouse ehrlich ascites tumor models mouse s<NUMBER> fibrosarcoma models <NUMBER> <NUMBER> furthermore agap showed strong anticancer effects including inhibition stemness epithelialmesenchymal transition migration invasion toward mcf<NUMBER> mdamb<NUMBER> breast cancer cells <NUMBER> also inhibited voltagegated proton channel hv<NUMBER> <NUMBER> investigated possible target cancer therapy extensively reviewed elsewhere <NUMBER> two studies third martensii peptide bmkn<NUMBER> indicated peptide could selectively induce apoptosis cancerous human oral cells normal cells affected much lesser extent <NUMBER> <NUMBER> another interesting study highlights newly discovered short <NUMBER> residues peptide b occitanus tunetanus rk<NUMBER> potent anticancer effects toward glioblastoma u<NUMBER> melanoma igr<NUMBER> cancers <NUMBER> showing apparent vivo neurotoxicity toward intracerebroventricularly injected mice rk<NUMBER> demonstrated possess cytotoxicity u<NUMBER> igr<NUMBER> cells vitro able inhibit cell proliferation migration two cancer cell lines rk<NUMBER> also inhibited angiogenesis chicken chorioallantoic membrane model cellpenetrating peptide cpp serrulatus venom named cppts final promising member long list scorpionderived agents anticancer effects discussed using cpptsderived peptide subpeptide study demonstrated peptide selective internalization properties specific cancer cell lines skmel<NUMBER> hep g<NUMBER> caco<NUMBER> mdamb<NUMBER> a<NUMBER> du <NUMBER> make potential intranuclear delivery tool cancer cell targeting <NUMBER> handful studies growing body recently published papers indicate potential utilizing scorpion venoms source discovering new cancer therapeutics large diversity scorpion venom components fueled wide range studies molecules toxicology antivenom development therapeutic applications particular therapeutic applications scorpion venom compounds attracted lot attention due urgent need either finding improving treatments broad spectrum diseases emergence spread superbugs amr microorganisms represent increasingly serious threat global public health projected get much worse years ahead therefore exploration utility novel bioactive molecules scaffolds mechanisms action represents potentially powerful approach develop new antimicrobial therapeutics diagnostic tools current future diseases dozens scorpionderived bioactive molecules shown possess promising pharmacological properties around <NUMBER> mentioned review pharmacological properties scorpionderived bioactive molecules include antimicrobial immunosuppressive bradykininpotentiating analgesic anticancer effects among others addition chlorotoxin already entered clinical trials cppts peptide potential intranuclear delivery tool targeting cancer cells likely molecule receiving significant scientific interest future however venomderived biotherapeutics introduced market number technological issues must overcome including obtaining access material venoms toxins characterizing isolated venom components establishing manufacturing approaches novel compounds reducing potential propensity cause adverse effects especially longterm therapy nevertheless scientific literature reviewed shows several examples promising scorpion venomderived proteins peptides may used leads development new biotherapeutics thus data observed vitro preclinical models translates well clinical setting may indeed great promise exploiting benefits scorpion toxins funding thank villum foundation grant <NUMBER> financial support authors declare conflicts interest advancements next generation sequencing technologies <NUMBER> <NUMBER> solexa <NUMBER> led increased interest deep sequencing samples mixed populations sequences interest largely similar salient differences exist within populations difficult quantify identify important trends existing tools msa useful visual aid analyzing small set sequences within sample identify important trends within large number sequences among multiple sets deeply sequenced samples quantitative approach necessary existing tools bioperl <NUMBER> biopython <NUMBER> samtools <NUMBER> useful efficiently generating manipulating storing msas statistical metrics visualizations comparison samples msas represent exist applications implemented andes allow investigator identify compare variations within sample among multiple samples three independent projects used andes described results discussion section first project involved quantifying whole genome level mutation rates locations novel variations coronavirus passaged <NUMBER> consecutive times cell culture depth sequencing derived single solexa run <NUMBER> selected passages exemplifies andes used compare temporally separated samples analyze genomewide mutation trends identify specific variations analyses second project andes used differentiate strains human influenza h<NUMBER>n<NUMBER> sequences deposited genbank majority human h<NUMBER>n<NUMBER> sequences generated circulating seasonal strain little consistent annotations genbank records differentiate collected sequences <NUMBER> swineorigin influenza pandemic case sequencing depth accumulated across data deposited community influenza researchers clustering analyses dataset made possible design strainoptimized degenerate pcr primers purpose sequencing seasonal swine origin h<NUMBER>n<NUMBER> genomes final project described application andes toolset assess sequencing accuracy identify locispecific sequencing errors <NUMBER> titanium sequencing run performed subregion <NUMBER>s rrna gene <NUMBER>s rdna deep sequencing clonal copies <NUMBER>s sequence provided data empirically determine actual pcr sequencing error rates played critical role characterizing nature sequencing errors downstream analyses fundamental data structure andes suite tools position profile data structure contains number nucleotides support position analyzed region interest andes currently supports conversion output clustalw <NUMBER> ie aln files however format position profile relatively trivial therefore encoding output alternative alignment application readily supported alignments generated razers <NUMBER> muscle <NUMBER> amoscmp <NUMBER> tools also successfully converted position profiles analyzed figure <NUMBER> shows input msa resultant position profile figure <NUMBER> created column position profile calculated summing number nucleotides gap contributions position line position profile essentially probability mass function pmf support g c gap values normalized sum <NUMBER> gaps introduced beginning end msa assumed caused read termination gaps considered nucleotide variations therefore ignored bases iupac ambiguity codes <NUMBER> alignment given equal weight nucleotide represent example iupac code represents c <NUMBER> contributed c position counts major allele also stored profile visual convenience number lines position profile gapped length consensus sequence msa alignment two profiles important comparing merging contents new composite profile profile merging may used pool multiple sample profiles together accumulate sequencing results previously partitioned sample figure <NUMBER> column <NUMBER> contains common allele multiple alleles share value greatest frequency one alleles arbitrarily chosen represent position columns <NUMBER> represent frequency nucleotide position sample represented position profile since compute time allversusall msa tool clustalw exponential growth rate <NUMBER> function number sequences run n recommended reduce n take advantage parallel computation resources accomplished dividing n across independent runs smaller input sizes ns performing final merge across profiles profile alignment andes involves computing major allele position based underlying nucleotide composition common allele position gap frequent allele caused gap open used major allele representative major alleles profile aligned clustalw results clustalw alignment used proxy underlying nucleotide distributions since quality profile alignment good algorithms used align major alleles andes also allows integration alternative msa tools muscle also produce clustalwlike output complete profile merge new position frequencies summed column using major allele positions proxies similarly profile comparison corresponding positional frequencies two aligned profiles compared root mean square deviation rmsd plot visualization differences nucleotide distributions along alignment two samples rmsd plot alignment two sequences represented along xaxis computed rmsd value nucleotide position two aligned samples represented along yaxis figure <NUMBER> compute rmsd nucleotide position standard rmsd formula <NUMBER> modified compare nucleotide distributions sample py ip probabilities nucleotide p position sample x respectively nucleotide p element nucleotide set g c character represents gap necessary align two profiles position ranges <NUMBER> length gapped alignment l number insertions deletions indels necessary align sequences msa also included position denominator within square root operator <NUMBER> number symbols nucleotide set used minimum rmsd value <NUMBER> occurs distributions nucleotides identical two alignments specific position maximum value <NUMBER> generated allele one sample completely different second sample example sample x consisted <NUMBER> ts sample consisted <NUMBER> gs another important rmsd value <NUMBER> value occurs one sample biallelic example sample partially similar single allelic representation see figure <NUMBER> <NUMBER> sample calculations two cases summary rmsd values two samples computed taking arithmetic mean rmsd value every position along length alignment l summary values used generate distance matrix among samples see table <NUMBER> shannon entropy se measure uncertainty information content random variable applied distribution nucleotides single position represents amount variation position normalized shannon entropy nse computed using logarithm base <NUMBER> number supports distribution calculation nse range <NUMBER> <NUMBER> <NUMBER> represents variation single allele represented sample <NUMBER> represents maximum variation uniform existence g c gaps px ip probability nucleotide p position sample x nucleotide p element g c character represents gap necessary align sequences within sample position ranges <NUMBER> length gapped alignment l number insertions deletions indels necessary align sequences msa also included position se plot generated plotting alignment single sample along xaxis versus se yaxis example figure <NUMBER> summary se value single sample computed taking arithmetic mean se every position along length alignment l since se calculated within single sample useful quickly identifying regions positions variability without necessity choosing ideal reference sequence base conversion probabilities two samples within single sample computed aligned profiles given alignment sequences samples following formula based definition conditional probability utilized  formula computes probability base q aligned position sample converting base p aligned position sample x summed aligned positions p q nucleotide set g c nucleotide position range <NUMBER> figure <NUMBER> example calculation rmsd value two monoallelic samples x case maximum rmsd value <NUMBER> achieved allelic distributions two sample positions agree figure <NUMBER> example calculation rmsd value biallelic sample x monoallelic sample case intermediate rmsd value <NUMBER> generated sample x biallelic sample monoallelic partial agreement length gapped alignment l computing base conversion frequencies useful determining unexpected pressures mutation rates towards particular nucleotides sequencing error biases one typically see significantly higher base conversion rate transitions a↔g c↔t transversions remaining combinations intersample cluster analyses performed first computing distance matrix among samples rmsd formula matrix loaded statistics package r <NUMBER> multidimensional scaling mds plot dendrogram may computed plotted mds statistical technique used convert n dimensional description relationship samples eg distance matrix lower dimensional plot eg <NUMBER>d result samples similar characteristics reflected plot close spatial proximity sample r code provided andes tool set perform cluster analyses based generated distance matrices detection polymorphisms generation representative consensus sequence depend investigators threshold determining significance underlying variations example threshold may rate sequencing errors prevalence minor allele investigator would like eliminate consensus sequence common automatically assign iupac ambiguity codes certain base positions even existence alternative base bases low frequency eg <NUMBER> representative alternatively consensus sequences may manually edited entire sequences may eliminated set representative input sequences effort reduce dominance ambiguity codes final consensus sequence workarounds tedious elimination specific sequences set sequences analysis leaves final consensus sequence potentially skewed towards representation common variants downstream processes degenerate primer design forced compute nonrepresentative consensus generate representative consensus sequence preferable use largest sample possible since represent population interest accurately minimize effects random errors profile consensus generation automatically converts position profile consensus sequence using standard iupac ambiguity codes benefit using position profile generate consensus sequence ability perform filtering priori using either nominal percent cutoff nominal thresholdbased filter applied nucleotide frequencies table represents subset rmsdbased distances calculated partitions human influenza h<NUMBER>n<NUMBER> collection dates value average positional rmsd along lengths <NUMBER> compared ha segments complete rmsd distance matrix used input r compute dendrogram seen figure <NUMBER> position exceed specified threshold set zero changing values nucleotide frequencies exceed threshold relative proportions still maintained applying percent cutoff filter positional nucleotide frequencies first normalized positional probability mass functions pmfs application thresholdbased filtering remove low levels nucleotide representations result sequencing errors prioritize depth variation allowed consensus sequence example effect filtering based nucleotide probability shown figure <NUMBER> example ambiguity code assigned position position required representation existence c sample sequencing error upper bound rate <NUMBER> determined used threshold filtering low prevalence nucleotide representations necessity c representation removed allowing new ambiguity code become w representing assuming representation c result sequencing error w ambiguity code accurate representation allelic composition position sample deep sequencing performed homogenous clonal population possible estimate average quality value qv assigned position independent quality values assigned sequencing technologys base caller useful comparing actual error rate base callers quality value example properly calibrate sequencing qv set alternative thresholds sequence quality based actual acceptable error rates standard formula qv probability error perr estimated position probability error defined probability attaining common allele empirically determined error rate <NUMBER> qv set <NUMBER> ie <NUMBER> errors per base coverage depth allows determination error rates less <NUMBER> qv greater <NUMBER> optionally permitted base callers limit maximum qv <NUMBER> although theoretical limit compare merge positional nucleotide distributions across multiple profiles necessary first perform global profile alignment homologous nucleotide positions determined demonstrate profile alignment strategy based using major allele proxy <NUMBER> sequences sample size divisible <NUMBER> <NUMBER> <NUMBER> randomly sampled <NUMBER> avian influenza mp segments available genbank multiple degrees partitioning merging compared reference profile generated without partitioning merging results experiment show effect partition size count profile generation accuracy compute time accuracy partition merge strategy measured illustrated rmsd plot split merge <NUMBER> <NUMBER> <NUMBER> partitions plotted reference seen figure <NUMBER> nucleotide distributions merged profiles identical reference rmsd value <NUMBER> exceptions occurred around <NUMBER> bp dinucleotide repeat <NUMBER> <NUMBER> ends even reference msa questionable due improper gapping combination lower sequencing quality towards <NUMBER> end sequences mismatching sequence lengths short tandem repeats typically contribute poor end msas overall merging profiles accurate even across <NUMBER> partitions figure <NUMBER> example effect percentage filtering used reduce coverage ambiguity codes original nucleotide distribution specific position ambiguity code represents g called c likely result sequencing error preferable exclude designing degenerate primers applying <NUMBER> filter assigned ambiguity code position reduced w accurately represents target population timing statistics measuring reduction serial parallel compute times using partition merge strategy laid table <NUMBER> parallel compute times estimated sum parallel times sequence alignment profile generation profile merge serial compute times used sum serial times <NUMBER> steps parallel compute time step estimated longest running job among partition compute times serial compute time estimated sum partition compute times input sequences split <NUMBER> partitions serial parallel speedup factors <NUMBER>x <NUMBER>x observed respectively little degradation profile generation accuracy deep sequencing platforms <NUMBER> solexa solid provide opportunities explore genetic diversity populations much greater resolution sanger sequencing development quantitative visual analyses genomewide variations critical identifying trends assessing biological significance figure <NUMBER> example root mean square deviation rmsd plot applied study viral diversity using deep sequencing data generated series coronavirus cov passages coronavirus utilized study engineered produce rapidly mutating phenotype viral rna <NUMBER> st <NUMBER> th <NUMBER> th passages subjected rtpcr amplicons deeply sequenced solexa <NUMBER> reads mapped onto sanger sequenced reference cov sequence genbank accession ay<NUMBER> using razers position profile generated sequenced passages approximate coverage depth base positions ranged <NUMBER>x <NUMBER>x significantly greater sequencing depth positions covered overlapping amplicons rmsd plot generated based positional rmsd values computed position profiles passages reference blue green red glyphs represent variations <NUMBER> st <NUMBER> th <NUMBER> th passages respectively base position rmsd plot one determine positional distributions nucleotides increasingly deviated reference association annotation presented investigator quickly determine genes may impacted focus analyses shannon entropy se plot generated investigate variation within sample cov population sequenced <NUMBER> th passage figure <NUMBER> se plot facilitates distinguishing positions sequenced genomes higher background levels variation positions analyzed region <NUMBER> <NUMBER> bp se close zero would indicate single allele dominant se analysis time may show se values specific positions increase viral population began adapt growth cell culture decrease advantageous variation increasingly dominates population positions consistently high se values time may experiencing little selective pressure example figure <NUMBER> variation seen se plot higher background region <NUMBER> <NUMBER> region encompasses envelope protein membrane protein orfs cov data may suggest researchers experiment could designed investigate role particular proteins covs adaptation growth cell culture nucleotide conversion table computed <NUMBER> st <NUMBER> th passage region cov genome analyzed rmsd se plots table <NUMBER> nucleotide conversion table summarizes probability base <NUMBER> st passage change another base <NUMBER> th passage <NUMBER> st passage nucleotides labeled row left table <NUMBER> th passage nucleotides labeled column top table example <NUMBER> probability g <NUMBER> st passage become <NUMBER> th passage transition probabilities a↔g c↔t highlighted bold tend greater transversion probabilities table probability transition g®a <NUMBER> greater transversion probabilities g®t <NUMBER> g®c <NUMBER> however a®t <NUMBER> t®g <NUMBER> transversions higher rates a®g <NUMBER> t®c <NUMBER> transitions contributes additional evidence may selective pressure acting upon region genome especially probabilities depart significantly computed entire length genome using sequencing technology establishing baseline sequencing technology specific systematic sequencing errors especially important nucleotide conversion analyses since computed values absolute rather relative another samples positional nucleotide distribution since every read contributes overall analysis rather vote towards consensus sequence impact sequencing errors individual reads must considered sequencing technologies either include step amplify target dna require quantities dna required investigator perform dna amplification priori estimated pcr amplification introduce upper bound sequence quality dependent fidelity polymerase excluding pcr slippage mispriming taq dna polymerase demonstrated produce error rates least <NUMBER> <NUMBER> base substitutions <NUMBER> <NUMBER> frameshift errors <NUMBER> application <NUMBER> avian mp segments randomly selected without replacement available <NUMBER> segments genbank sequences partitioned <NUMBER> <NUMBER> <NUMBER> subsets demonstrate effect partitioning profile generation time accuracy individual compute times sequence alignment profile generation profile merge recorded job parallel serial compute times sequence alignment profile generation computed finding maximum sum respectively across individual job times total parallel serial compute times partition calculated summing parallel serial compute times respectively across sequence alignment profile generation profile merge partitioned <NUMBER> subsets serial parallel speedup factors <NUMBER> <NUMBER> observed respectively source nucleotide represented along rows destination nucleotide represented along columns interpret measure <NUMBER> st passage g<NUMBER> th passage one could say <NUMBER> probability g first passage become <NUMBER> th passage pa <NUMBER> th passage g <NUMBER> st passage <NUMBER> transition frequencies highlighted bold table contains conditional probabilities ie marginal probabilities percentages row sum <NUMBER> percentages column may nucleotide distributionbased filtering tools integral part andes allows user define threshold differentiating base conversions may significant versus attributed sequencing pcr errors important capability andes ability compute summary distances deep sequencing results produce n × n distance matrix large group sequences partitioned example temporally andes used quantify differences among partition help statistical cluster analyses tools partitions contain variations interest identified example hemagglutinin ha coding segments human influenza h<NUMBER>n<NUMBER> sequences downloaded ncbi grouped according collection date annotated respective genbank records sequences grouped biweekly partitions possible collection day available sequence assigned partition month null day example collection date sample june <NUMBER> samples sequence would assigned <NUMBER> partition collection year information recorded sequence would assigned partition null month null day example <NUMBER> partition clustalw used align sequences within partition position profile generated distance matrix generated computing summary rmsd value every position profile r statistical software package used produce dendrogram hclust function figure <NUMBER> apparent dendrogram human h<NUMBER>n<NUMBER> samples collected march june <NUMBER> much greater sequence similarity collected june <NUMBER> january <NUMBER> may attributed sudden focus h<NUMBER>n<NUMBER> sequencing performed potential swine origin viral samples collected starting march <NUMBER> many applications imagined comparing position profiles across partitions example investigating influenza diversity among different avian species association viral clades geographic location ability analyze groups similar sequences objectively partitioned either spatially temporally allows individual partitions interest identified underlying position profiles partitions merged together generate new cumulative position profile consensus sequence generated downstream applications degenerate primer design example suppose determined mutation rate circulating virus caused percentage previously designed primers fail unacceptable level high throughput sequencing period <NUMBER> months downloading sequences genbank building partitions new sequences weekly basis incrementally merged profile consisting arbitrarily defined time period extending past quickly generated merged profile converted consensus sequence appropriate threshold set achieve desired sensitivity currently used primers figure <NUMBER> example dendrogram clustering using rmsdbased distance matrix leaf dendrogram represents biweekly partition collection dates cluster leaves lefthand side likely attributed swine origin h<NUMBER>n<NUMBER> virus outbreak whereas sequences collected righthand side based circulating seasonal h<NUMBER>n<NUMBER> virus tested silico new consensus sequence determine regions minimum required coverage depth due predicted primer failure new primers designed regions based new consensus sequences included cumulative position profile manual intervention necessary decimate redundant sequences result possible generate consensus sequence closely represents genotypes viral variants circulation accurately timely manner identify nature sequencing artifacts may impact analyses <NUMBER>s metagenomic sample andes applied compute empiricallydetermined quality values set <NUMBER> titanium sequencing runs actual quality values compared assigned <NUMBER> base caller associated sequence features homopolymer runs briefly mock community consisting <NUMBER> known microbial organisms phyla actinobacteria bacteroidetes deinococcusthermus firmicutes proteobacteria established pcr amplification targeted <NUMBER> variable regions ribosomal <NUMBER>s gene approximately <NUMBER> bp length pcr products sequenced using <NUMBER> titanium resultant sequences analyzed using blast algorithm <NUMBER> <NUMBER>s reference database consisting mock community order associate sequence organism <NUMBER>s copy highest similarity organism <NUMBER>s copy variable region combination partition sequences created amoscmp used align partitioned sequences specific organism <NUMBER>s copy variable region reference sequence position profile generated based amoscmp results figure <NUMBER> example estimated quality values along one organism <NUMBER>s copy variable region combination partitions average coverage depth <NUMBER> majority positions error rates less <NUMBER> <NUMBER> qv <NUMBER> average qvs compared average qvs position assigned <NUMBER> base caller order determine well <NUMBER> assigned quality values correlated actual error rates correlation analyses also performed aggregating nucleotide type length homopolymer runs shown results studies indicate little correlation empirically determined quality values <NUMBER> assigned quality values suggests many sequencing errors unpredictable current error models consensus sequences <NUMBER> assemblies generally high quality availability coverage depth ameliorates impact random errors systematic errors caused homopolymer runs cannot addressed additional sequencing depth known accepted source error needs addressed downstream processing however level individual error rates cannot dismissed intended downstream cluster analyses important step prior establishing operational taxonomic units otus example frequency errors along figure <NUMBER> example plot empirically determined quality values qv subregion <NUMBER>s gene deeply sequenced <NUMBER> titanium transformed position profile average empirically determined qv plotted yaxis along length genome xaxis length organism <NUMBER>s copy variable region combination shown figure <NUMBER> pattern random error along entire length alignment consistent difficulties observed using individual <NUMBER> sequences establish otus order estimate population diversity <NUMBER> contrary initial supposition addressing errors homopolymer runs alone sufficient solving problem accurately establishing otus tools andes allow investigator produce accurate local global view deep sequencing results serves make identification trends visible may eventually addressed correctly discussed merging comparing profiles subsection alignment two profiles uses major allele positional distribution proxy alignment works well datasets analyzed would preferable use rmsd distances positions actual mismatch penalties would make full nucleotide distribution position available optimally determining whether introducing gap substitution suitable increasing cost efficiency deep sequencing provides us great opportunity asking questions exploring potentially complex structure variations within evolving nearly homogeneous population shared biomarker explored application andes tool sets toward understanding mutation rates coronavirus aiding cluster analyses seasonal versus swine origin h<NUMBER>n<NUMBER> flu partitions exploring quality deep sequencing technology andes provides useful tool set basis comparison complex samples level positional nucleotide distributions visually statistically tools help reveal important biological information hidden mountains deep sequencing data project name andes project home page httpandestoolssourceforgenet download web site httpssourceforgenetprojects andestools operating system tested production linux programming language perl r license gnu gpl v<NUMBER> restrictions use nonacademics none coronaviruses known medicine time <NUMBER> course recently coronavirus sarscov<NUMBER> covid<NUMBER> virus new dangerous humans identified believed related initial cluster pneumonia cases associated seafood fresh meat market wuhan china <NUMBER> current case rates time writing close one million close <NUMBER> deaths genomic relationships coronaviruses quickly examined lu et al shed light origins epidemiology receptor binding virus <NUMBER> january <NUMBER>th <NUMBER> wuhan isolate genbank entry mn<NUMBER> replaced mn<NUMBER> mn<NUMBER> probably represents adequate stable description sequence research strain isolate immediately investigated present author <NUMBER> <NUMBER> originally seen authorities coronavirus outbreak sars severe acute respiratory syndrome however genomic relationships examined refs <NUMBER> <NUMBER> also showed many fairly close correlations genomes sarscov previous human pandemic outbreaks pigs bats civets emphasis finding subsequences well conserved across coronavirus strains species earliest patients suffering called covid<NUMBER> overall <NUMBER>·<NUMBER> genome sequence identity wuhan isolate one may reasonably say origin covid<NUMBER> virus sarscov<NUMBER> <NUMBER> earlier wuhan isolates also related <NUMBER> identity two batderived severe acute respiratory syndrome sarslike coronaviruses collected <NUMBER> zhoushan china differed sarscov <NUMBER> merscov <NUMBER> <NUMBER> wuhan related isolates revealed coronavirus resides subgenus sarbecovirus genus betacoronavirus <NUMBER> although genetically distinct predecessor sarscov appeared similar external binding proteins meaning spike glycoprotein discussed extensively present paper see section <NUMBER> introduction protein also discusses early identified genomic correlations addition rest present paper discusses many genomic relationships relevant design synthetic vaccines therapeutic antagonists againstcovid<NUMBER> one problem covid<NUMBER> new pathogen posing global threat presents new challenges primary prevention vaccine required secondary prevention therapeutic compound ideally pill required treat patients infected might also present challenges tertiary prevention seeks remedy persistent level infection prevent recurrence even essentially strain discussed section <NUMBER> main problem concern point present paper likely appearance new strains resistance vaccines therapeutic agents time writing confirmed cases double globally every <NUMBER> days undetected cases expected much higher current plateauing reported cases china offers glimpse attenuate soon estimates varied significant portion humanity already infected enhanced probability successful escape mutations genome virus development vaccines perhaps particularly therapeutics could take account targeting less variable protein regions could huge waste resource dangerous delay covid<NUMBER> course far serious first sars outbreak concern humans coronaviruses decades veterinary concern <NUMBER> however still remains true zoonotic coronaviruses rather recently seriously impacted humans far known include sarscov <NUMBER> betacoronavirus subgenus sarbecovirus merscov <NUMBER> betacoronavirus subgenus merbecovirus although idea sarscov<NUMBER> distinct sarscov originally discouraged distinction matter degree usual criteria fairly closely related genetically clustering within betacoronavirus subgenus sarbecovirus recently sarscov effectively sarscov<NUMBER> primary reference point model regarding molecular functional details remains important shortly appearance genbank apparently final version wuhan seafood market isolate mn<NUMBER> <NUMBER> present author compared variety coronavirus genomes <NUMBER> <NUMBER> krsfiedllfnkv protein subsequence seen potential achilles heel exposed potentially exposable required proteolytic activation cleavage importantly also wellconserved feature surface virus <NUMBER> <NUMBER> well conserved suggests mutations much less easily accepted meaning virus less likely survive one two generations discussed conservation region protein virus surface concerned least one step lung cell entry interesting coronaviruses seem able readily adjust alternative means entry possibly hinting additional roles subsequence whether case motif seems likely primary target synthetic vaccines basis drug discovery proposed <NUMBER> <NUMBER> motif found quite well conserved even distantly related coronaviruses <NUMBER> <NUMBER> present paper also explores far seems extend includes common cold coronaviruses another potential subsequence interest popular researchers also examined ace<NUMBER> binding domain discussed remains popular present author relatively high degree conservation present authors opinion however relates specter recently haunted covid<NUMBER> vaccine research might still cause concerns question significant immunity acquired body prevent recurrence common cold roughly <NUMBER> cases believed due coronaviruses fortunately time final writing paper news reports indicate neutralizing antibodies found patients covid<NUMBER> however risks escape mutations virus mind remains worthwhile considering whether subsequence krsfiedllfnkv found well conserved <NUMBER> <NUMBER> across many coronaviruses <NUMBER> <NUMBER> still present common cold coronavirus order force better immune response targeting using synthetic cloned vaccines epitope common cold strains fall one two coronavirus serotypes oc<NUMBER>like <NUMBER>elike main examples discussed common cold generally considered mainly upper respiratory tract infection mundane inconvenience common human coronaviruses betacoronavirus hcovoc<NUMBER> hcovhku<NUMBER> well alphacoronavirus hcov<NUMBER>e also cause severe lower respiratory tract infections children elderly discussion also given hcovhku<NUMBER> paper motif krsfiedllfnkv occurs spike glycoprotein <NUMBER> responsible initial binding previous sars coronaviruses lung cells activation spike protein proteolytic cleavage <NUMBER> <NUMBER> <NUMBER> spike glycoprotein spike protein familiar spike studs surface coronavirus giving appearance crown electron microscopy hence corona latin crown completion first version previous paper <NUMBER> bat virus <NUMBER> identity amino acid sequence spike protein discussed extensively present paper entered genbank entry qhr<NUMBER> time final writing april <NUMBER> nd <NUMBER> <NUMBER> match protein entry yp<NUMBER> appears similar wuhan isolate top hundred nonredundant matching entries found using mn<NUMBER> blastp httpsblastncbinlmnihgovblastcgi see mn<NUMBER> spike protein used vary <NUMBER> match <NUMBER> <NUMBER> aau<NUMBER> civet isolate viruses proteins similar protruding nature eg hemagglutinin influenza primary targets vaccine development important targets development therapeutic drugs seek block virus infecting host cells time current project three dimensional structures sarscov spike proteins earlier sars outbreak known eg ref <NUMBER> <NUMBER> sequence match sarscov<NUMBER> <NUMBER> note customary write sarscov rather sarscov<NUMBER> rna viruses mutate high frequency far differences spike proteins emergent sarscov<NUMBER> variants much less time study late february early march <NUMBER> amino acid residue sequences spike proteins covid<NUMBER> isolates different states countries california brazil taiwan india remain identical almost example respect original wuhan isolate <NUMBER> phenylalanine f replaced cysteine c residue <NUMBER> swedish isolate alanine replaced valine v residue <NUMBER> indian isolate <NUMBER> st march <NUMBER> largest variants sarscov<NUMBER> genome whole show <NUMBER> nucleotide sequence match genome <NUMBER> rna bases suggests approximately <NUMBER> base changes order <NUMBER> spike glycoprotein gene <NUMBER> nucleotides suggests roughly <NUMBER> <NUMBER> amino acid differences spike protein current march <NUMBER> sarscov<NUMBER> variants consistent specific observations isolates california etc single amino acid change course sometimes significant effect eg aggressive character coronavirus considered creating new strain new strains reported time writing authors knowledge none spike protein variations specifically none yet krsfiedllfnkv subsequence left hand side fig <NUMBER> shows sarscov previous sars s<NUMBER> spike glycoprotein within trimer makes spike right hand side shows sarscov<NUMBER> sars current concern human sars coronaviruses indeed spike proteins many related coronaviruses appear similar overall conformation variations seen experimental structures probably crystallization preparation methods particularly regarding solvent details ligands sarscov left well studied still serves reference model order fuse infect cells spike protein needs open state presumably closed state makes less vulnerable antibodies left fig <NUMBER> also shows approximate positions cleavage points superimposed protein data bank pdb entry <NUMBER>xlr sarscov reading nterminus s<NUMBER> important functional elements sars coronaviruses deduced sarscov studies <NUMBER> <NUMBER> applicable sarscov<NUMBER> s<NUMBER> nterminal domain s<NUMBER>ntd s<NUMBER> cterminal domain s<NUMBER>ctd s<NUMBER>s<NUMBER> site first protease cleavage site loop pleated sheet ahelix fusion peptide fp associated highly disordered loop two ahelices contains second cleavage site s<NUMBER> heptad repeat hr arginine r conserved motif krsfiedllfnkv interest previous study <NUMBER> cleavage point s<NUMBER> recall krsfiedllfnkv subsequence associated s<NUMBER> potentially important least must exposed exposable permits proteolytic cleavage therefore site cannot well shielded experimental three dimensional structures coronavirus spike proteins part reveal large amount glycosylation protects spike protein surface possibly major problem however much selection accessible surface regions basis design entry inhibitor vaccine design <NUMBER> <NUMBER> coronavirus readily escapes agents mutation including spike protein <NUMBER> <NUMBER> importance highly conserved motif ie subsequence readily change strain strain except conservative sidechain replacement remote strains course one carries study forward distantly related viruses one expects motif differ stage investigated later contrast nonetheless pigag motif associate s<NUMBER>s<NUMBER> cleavage site disappears coronaviruses distantly related <NUMBER> <NUMBER> noted high degree conservation krsfiedllfnkv face genetic indicates way important virus presumably proteolytic activation cleavage andor initial binding lung cells could interactions proteins ie reduce inflammatory response discussed later agents modern computerdriven strategies kind chemical products help produce differ substantially earlier familiar approaches computer played little role large part due invention automatable peptide synthesis merrifield <NUMBER> used solid phase peptide synthesis based crosslinked polystyrene beads <NUMBER> traditional vaccines purely biological composed dead attenuated strains pathogen meaning mainly viruses bacteria contrast synthetic vaccine vaccine consisting mainly synthetic peptides also sometimes carbohydrates often linked carrier protein render immunogenic vaccines produced via chemical synthesis safer involve cellderived material biological processes production purity controlled case classical drugs worlds first synthetic vaccine created <NUMBER> diphtheria toxin louis chedid scientist pasteur institute michael sela weizmann institute <NUMBER> manuel elkin patarroyo created spf<NUMBER> first version synthetic vaccine malaria primarily applications far veterinary many early vaccines used dead samples foot mouth disease virus inoculate animals caused real outbreaks scientists discovered vaccine could made using single key protein virus later also found loops surface proteins could cloned used cloned synthetic constructs novartis vaccine diagnostics among companies developed synthetic approach rapidly generates vaccine viruses amino acid sequence data order able administer vaccinations early pandemic outbreak traditional vaccines far remained popular choice h<NUMBER>n<NUMBER> outbreak <NUMBER> became available large quantities peak human infections learning experience vaccine companies creating vaccines synthetically would currently expensive ability increase speed production retune fine tune solution combat new variations pathogens especially important event pandemic synthetic vaccines also considered safer researchers vaccines grown eg eggs bacterial cultures latter case may even viruses present cloned proteins however reflect desirable principles regions pathogen amino acid sequence acting epitopes see presented loops surface cloned protein general idea synthetic vaccines freer contaminants focus essential features required immune response also developed logical step step approach example sometimes diagnostics considered useful early step way vaccine since required raise antibodies animals sheep diagnostic kit production safe humans also raise immune system memory cellular well antibody response synthetic vaccines also advantage seen cartridge vaccines meaning contain bits pieces readily replaced others update vaccine order combat new strains pathogen synthetic vaccine thus several functional components looking somewhat like swiss army knife electron microscope key component reproduces essential features pathogen protein immune system sees epitope typically means patch <NUMBER> <NUMBER> amino acid residues reproduced short peptide epitopes considered haptens haptens substances low molecular weight peptides small proteins drug molecules generally immunogenic require aid carrier protein stimulate response immune system form antibody production two main types epitope b discussed theory section <NUMBER> synthetic vaccine consists tepitopes haptens cell response immune system memory molecular adjuvant eg muramyl dipeptide possibly excitatory antiinhibitory peptides bepitopes good raising antibodies eg sheep use diagnosticsbiosensors attached cloned carrier protein latter must safe time sufficiently different human protein avoid autoimmune disease used extensively carrier protein production antibodies research biotechnology therapeutic applications keyhole limpet hemocyanin klh widely employed carrier protein least studies using laboratory animals humans food drug authorities may preferences carrier protein klh illustrates desired features large size numerous epitopes generate substantial immune response abundance lysine residues coupling haptens allows high haptencarrier protein ratio increasing likelihood generating haptenspecific antibodies klh derived limpet gastropod phylogenetically distant mammalian proteins thus reducing false positives immunologicallybased research techniques mammalian model organisms clinically avoiding autoimmune effects far food drug authorities seem favored synthetic vaccines human use may peptides carrier proteins available earlier methods peptide synthesis achieve high levels purity however changed quite elaborate peptides well proteins made facilitated making peptide synthesizers run fast avoid slower side reactions methods join shorter synthetic peptides longer chains <NUMBER> <NUMBER> <NUMBER> <NUMBER> one original motivations present study capture experience design strategies vaccine diagnostic antagonist design <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> methods author colleagues ranged expert system approach automated bioinformatics protein modeling <NUMBER> <NUMBER> <NUMBER> automated drug design eg refs <NUMBER> <NUMBER> <NUMBER> <NUMBER> see also ref <NUMBER> recently automated approach based proposed quel language <NUMBER> <NUMBER> <NUMBER> <NUMBER> finegrained principles design synthetic peptide vaccines antagonist peptides made damino acids discussed detail previous paper <NUMBER> variety bioinformatics techniques available help development solutions eg ref <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> well computational eg refs <NUMBER> synthetic techniques eg ref <NUMBER> quel language <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> used preceding work <NUMBER> also means gathering relevant information world wide web efficiently encountering new problem epidemic caused new virus least problem new researcher <NUMBER> <NUMBER> <NUMBER> also enables automated interaction websites publically available bioinformatics tools motivation stronger popular highly integrated approach bioinformatics called biology workbench university san diego supercomputer center longer available time <NUMBER> however standard bioinformatics tools eg refs <NUMBER> <NUMBER> <NUMBER> used present study course used readily researchers reasonably experienced bioinformatics although peptidomimetics containing amino acids would occur normal ribosomebased biosynthesis considered authors basis haptens synthetic vaccines authors opinion probably best considered potential therapeutic antagonists present study specific aims include design molecules impede binding activation spike glycoprotein surface lung cells <NUMBER> <NUMBER> <NUMBER> synthetic peptides copied subsequences spike protein could used directly clinical purposes important design step would render resistant biodegradation human proteases typically inclusion damino acid residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously authors personal opinion peptides peptidiomimetics currently best considered first steps research development small organic pill molecules traditional kind favored pharmaceutical industry role nonetheless powerful one linking amino acid sequences seen nature conveniently already designed millions years evolution typically smaller novel organic molecules designed vanderwaals electrostatic features binding site however authors reticence largely based cost including cost changing traditional production strategy reservations food drug authorities fairly recently appears changing thpdb httpcrddosddnetraghavathpdb includes example manually curated repository peptides related molecules approved us food drug administration fda <NUMBER> peptide drugs approved us major markets pipelines approaching clinical trials may exceeding <NUMBER> entries natural compounds peptide drugs typically less toxic traditional chemical candidates although damino acids natural features ribosomal production peptides proteins human metabolism handle occur gut microbes ingested material human proteins form spontaneously kind aging process amino acids situ protein sequences eg l daspartate diverse damino acids dserine daspartate dalanine dcysteine found free amino acids small peptides well proteins quite commonly mammals often found playing important roles nervous system example nmethyldaspartate nmda receptors associated learning memory dserine daspartate dalanine bind receptors hydrogen sulfide generated dcysteine reduces disulfide bonds receptors potentiates activity peptides made damino acids resist normal proteolytic degradation also resist immune response unless attached carry protein <NUMBER> <NUMBER> persist <NUMBER> days body ideal time period pharmaceutical action ultimately degraded safe products probably mainly peroxisomes enzymes kidneys <NUMBER> <NUMBER> negative aspect higher entropy overcome many drugs traditional form practice appears barrier computer simulation binding real molecule extensively discussed studying binding synthetic peptides small organic molecules human proteins benefits computer simulations solutesolvent system early found ideally include water molecules detailed way hydrogen bonding options water molecules amino acid residues particularly intuitive <NUMBER> <NUMBER> cases spatial locations hydrogen atoms deduced rather seen experimental protein peptide three dimensional structures likely impact considerations docking ligands protein targets present authors opinion provides beneficial possibility retroinverso designs <NUMBER> made reversing sequence using damino acids unfortunate complicating effect interchanging co nh groups backbone synthetic peptide <NUMBER> beneficial possibility example repulsive co…oc electrostatic interaction synthetic peptide spike protein could ameliorated manner co…h…oc h water serine threonine hydrogen atom co…hoh…oc albeit practice water molecule likely lies side oo interaction vector somewhat similar considerations apply nh…hn interactions ameliorated lone pair orbitals oxygen atom could also involve tautomerization andor rearrangement internal hydrogen bonding networks eg manner …oh…oh… …hoho… today take care matters researchers consider docking ligand protein high grade molecular dynamics simulations overall solutesolvent system molecular dynamics least final refinement step <NUMBER> even awareness compensations others take place make worthwhile synthesize test proposal somewhat similarly design peptide synthetic vaccines diagnostics make direct use peptides duplicating sequence motifs pathogen protein found bioinformatics relatively simple computational tools researchers often go straight synthesis experimental immunological testing constructs rather using complex simulations <NUMBER> <NUMBER> <NUMBER> epitope predictions sarscov<NUMBER> simply meaning choice amino acid residue subsequences synthesize synthetic vaccines also peptidomimetic antagonists made several authors eg ref <NUMBER> typically made use extensive historical experimental data amino acid residue sequences epitopes epitope database analysis resource iedb virus pathogen resource vipr eg ref <NUMBER> immune system nature make adjustments recognize pathogens vaccines designing kind therapeutic antagonist virus binding lung cells requires rather consideration human protein spike protein binding bioinformatics study biosequences powerful tool well known detailed three dimensional structure human protein target potential new pharmaceutical agent virus attaches great benefit rational computeraided design studies specifically investigating human protein binding activation previously known sars viruses years carried several groups eg <NUMBER> <NUMBER> <NUMBER> <NUMBER> seems reasonably well agreed angiotensin converting enzyme type <NUMBER> ace<NUMBER> responsible binding sars associated <NUMBER> outbreak combined proteolytic cleavage activate spike protein type ii transmembrane serine protease tmprss<NUMBER> current popular candidate <NUMBER> several three dimensional structures known ace<NUMBER> complexed sars spike protein eg protein data bank pdb entry <NUMBER>acg variants latter eg tmprss<NUMBER> protein data bank entry <NUMBER>oq<NUMBER> however full story involving human cell surface proteins sarscov<NUMBER> interacts order infect replicate possibly quite firmly established time present study summaries would suggest origin general problem detailed conformational chemistry approach diversity genome means infecting cells readily generated nature case different virus hosts virus strains species jumps long established binding shows variation receptors used correspond viral groups alternative proposed candidates initial binding receptors eg carcinoembryonic antigenrelated cell adhesion molecule <NUMBER> ceacam<NUMBER> various dipeptidyl peptidases highly virulent coronaviruses form syncytia cells even spread receptorindependent fashion even initial binding receptor ace<NUMBER> identified coronavirus initial uncertainty enduring complexity rest entry process may norm many human proteases present lung seem capable cleaving various sites spike protein could cause activation example variety proteases trypsin tryptase clara miniplasmin human airway trypsinlike protease hat tmprss<NUMBER> transmembrane protease serine <NUMBER> known cleave glycoprotein hemagglutinin ha influenza viruses prerequisite fusion viral host cell membranes viral cell entry human airway trypsin like protease hat tmprss<NUMBER> tmprss<NUMBER> tmprss<NUMBER> also considered sars researchers various stages human proteins might similar involvement sarscov<NUMBER> case also affected antagonists sarscov<NUMBER> targets preceding paragraph also attracted attention researchers trypsinlike serine protease hepsin fairly broad action significantly inhibited diverse set ligands particular example one binding represented protein data bank entry <NUMBER>ce<NUMBER> even intracellular proteases could released cell damage resulting first wave lung infection disease tissue trauma variants strains may use yet unknown proteins sugars assist entry also plausible spike protein might activated proteases exit epithelial lung cells allowing efficiently infect cells spike glycoprotein sarscov<NUMBER> also socalled furin cleavage sequence prrars prrars extension socalled pigag motif ref <NUMBER> consistent present authors preferred choice krsfiedllfnkv motif coronaviruses high sequence homology isolated bat yunnan <NUMBER> lack furin cleavage sequence nonetheless furin proteases abundant respiratory tract sarscov<NUMBER> spike glycoprotein might cleaved exit cells even means binding activation entry well established viral strain recall single rna base difference resulting single amino acid residue difference could alter also appear several possibilities virus exploit parallel indeed somewhat similarly potential inhibitors sars entry andor activation proposed researchers eg refs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> may work several routes parallel significantly least three mechanisms reported one relevant study <NUMBER> target protein relevant binding site clearly understood methods available screening available ligands binding molecules bind sites potential antagonists even growing evolving antagonist molecules sites whether smaller organic molecules <NUMBER> <NUMBER> <NUMBER> peptides <NUMBER> pharmaceutical chemists long used evidence hunches deduce pharmacophore ie abstract description recurrent molecular features necessary molecular recognition ligand protein <NUMBER> pharmacophore ultimately implies least schematic model interfacial surface ligand protein practice pharmacophore tends either considered perception ligand one compares similar inhibitors etc perception binding site one compares positions key residues binding site choice depends quality kind data could involve historically drug design frequently based indirect deduction binding site features using chemical features ligands successfully inhibit instances excite response essentially use quantitative structure activity relationships qsar effect perception binding site indirect typically based chemists expertise hunches often extremely fuzzy subsequent elucidation many protein structures clear pictures binding sites led crisper physical perspective exemplified study <NUMBER> included many ligand molecules present investigation faced similar issues approach may considered traditional docking calculations fast using grid maps consist three dimensional lattice regularly spaced points centered region interest protein target study discussed ace<NUMBER> tmprss<NUMBER> likely correct targets necessarily targets even cell entry current sarscov<NUMBER> mechanisms used new coronavirus strain differ result even single amino acid residue change circumstances conservation krsfiedllfnkv motif might considered suspicious activation cleavage arginine r workers tend conclude site essential action s<NUMBER>s<NUMBER> mutation arginine r specifically inhibits trypsindependent fusion cellcell fusion laboratory assays also arginine retained many proteases active spike protein others laboratory conditions conservation one might therefore hold seemingly reasonable hypothesis site also susceptible cleavage activation extracellular proteolytic enzymes also something else whether complexity makes detailed interaction models spike protein binding activation difficult best bet ranking choices target protein may currently seem obvious making reasonable currently conventional choice actually incorrect assumption delay productive research therapeutic agents case hunt prevention cure virus diseases particularly covid<NUMBER> seems increased justification fuzzier settheoretic picture pharmacophore ensemble different binding sites ligands ligandoriented perspective follows many perhaps suggest even one using incorrect picture mechanisms entry replication even using wrong less important protein target one might achieve success brief summary justifications ensemble pharmacophore coronavirus case ie contributions fuzziness include parsimony proteins parts proteins sometimes one function <NUMBER> encouraged limited numbers accessible sites due eg glycosylation exemplified parallel alternative mechanisms cell entry multiple methods drug action escape scientific defense measures virus mutation polymorphism human proteins involved different expression levels human proteins involved potential problem specter vaccine development concerns missing appropriate region virus allows common cold viruses escape appropriate immune response may course added fact even experimental researcher convinced value specific protein appropriate target picture computational chemist fuzzy one system real simulated seen statistical mechanical ensemble multiple states sampled population molecules across conformational behavior time least protein binding sites often partially disordered binding case may several binding modes picking right one difficult fine balance solvent conformational entropy entropy notoriously hard compute <NUMBER> given argued uncertainty nature target protein binding site broader initial net ensemble pharmacophore help docking approaches continually improved researchers recently include ways combining features could ultimately relate different protein binding sites many authors studies include word ensemble discussion pharmacophores appeared significantly different particular means combining multiple pharmacophores explored however present author attention drawn rather similar approach kumar <NUMBER> appears particularly akin especially regard distributions expected values use weighting kumars description <NUMBER> thus suffices briefly stated explores ability ensemble selected proteinligand complexes populate pharmacophore space ligand binding site assesses importance pharmacophore features using poisson statistical informationtheoretic entropy calculations generates pharmacophore models high probabilities scoring function combines resultant highscoring pharmacophore models one significant operational difference kumars approach used recall traditional docking approach ligand candidate drug typically seen variable constantly changing many studies evolving ligand chemistry pharmacophore basis drug design <NUMBER> <NUMBER> <NUMBER> <NUMBER> ref <NUMBER> related present study aspects applied different way kumars approach however combine perspective pharmacophore ligand conceptual variables despite present authors approach used present overall project considers one candidate ligand time seems less efficient point view designing candidates even smart older single nonprobabilistic pharmacophore approaches <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonetheless single simpler oneligandatatime strategy adequate appropriate present case already data collection candidate antagonists build <NUMBER> discussed section <NUMBER> approaches ensemble pharmacophore kind currently highly recommended investigation sarscov<NUMBER> spike protein particular uncertainties likely multiple functions spike protein features however yet significant impact present study approach actually taken remains consistent sense inclusion one particular source pharmacophore enzyme considered author evidently going dominate ensemble certain similarities antagonists sars virus entry inhibitors enzyme <NUMBER> given knowledge available time choice however obvious follows pharmacophore may controversial case representative choice protein obviously relevant target protein simply radar coronavirus researchers makes candidate necessarily relevant viral infection necessarily evolutionary relationship proteins considered relevant although question addressed briefly paper rather may simply based pragmatic notion may ligands potential binding molecules antagonists common popular choices human target proteins less obvious candidate small organic molecule emodin found inhibit sars coronavirus entry <NUMBER> <NUMBER> also compounds emodinlike features <NUMBER> <NUMBER> similar molecules importantly emodin also inhibitors <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> example steroid binding enzyme <NUMBER> normally anchored within endoplasmic reticulum nterminal transmembrane domain involvement protein target based chemical justification biological justification might enzyme involved inflammation response coronavirus might also benefit inhibiting goal course help virus inhibiting target would also gain inhibiting rather inhibit protein targets crucial ie cell entry possibly replication even crucial virus inhibition <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> might even desirable thing excessive prolonged inflammation including response pathogens well known potentially damaging host excessive inappropriate immune response may also include basis allergic reactions even autoimmune diseases pragmatic reason choice protein pharmacophore also one proteinligand interaction systems well studied present author collaborators <NUMBER> studies pursued idea using rigid molecular framework including steroid framework fragments rigid scaffold active drug groups <NUMBER> importantly study subsequent work already established data base compounds bind <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> includes many molecules including discussed paper features emodin also includes many weak binders could also much stronger binders turns obviously relevant protein target issues addressed quickly laboratory certainly seem worthy investigation addressing popular targets implication previous paper <NUMBER> though requirement main arguments peptides designed basis krsfiedllfnkv motif bind krsfiedllfnkv site emodinlike molecules seems currently even less reliable assumption assumption steroid dehydrogenase enzyme relevant coronavirus biology course assumption even matters either peptidomimetic andor small organic molecule found effective however keeping mind limited number accessible conserved sites spike protein may involved multiple mechanisms discussed common targets action peptides smaller organics like emodin seems plausible partially problem extensive glycosylation well known glycosylation plays important role receptorligand recognition also structural influence receptorligand recognition bulky shape caused branched side chains reasons may krsfiedllfnkv site little variation almost site spike protein persistently recognizable coronavirus strains presumably carrying important function accessible also discussed paper angiotensin converting enzyme <NUMBER> ace<NUMBER> binding however also considered paper number ideas principles borrowed established recent design synthetic vaccines petidomimetics used see ref <NUMBER> discussion eg refs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> well ideas lie behind popular zinc data base <NUMBER> discussed refs <NUMBER> <NUMBER> present investigation started use case hyperbolic dirac net hdn particularly associated quel language automated inference <NUMBER> <NUMBER> <NUMBER> <NUMBER> theory discussed elsewhere eg refs <NUMBER> <NUMBER> <NUMBER> <NUMBER> relate practical general uses quel considerations less important present studies reproduced standard bioinformatics molecular modeling means nonetheless doubtful research refs <NUMBER> <NUMBER> could done written rapidly without aid quel interact websites world wide web gather knowledge facilitate use publically available bioinformatics tools <NUMBER> challenge ultimately one molecular recognition practice many key principles hapten design relate distinguishing types naturally occurring epitope term epitope paper meant continuous epitope though several smaller epitopes may joined represent discontinuous epitope conformation relative position space sometimes important synthetic construct implies use synthetic chemistry typically combined judicious carrier protein peptide linked chemically constructs also obtained cloning using protein engineering principles <NUMBER> terms bepitope tepitope relate traditional picture bone marrow b thymus response b cell epitopes occur surface protein immune system response required recognized b cell receptors antibodies native structure concerned bone marrow response antibody production epitopes may buried inside protein structures released proteolysis traditionally considered concerned cellular response immune system memory ie active immunity continuous b cell epitope prediction similar cell epitope prediction focus bepitopes though bepitope also overlap tepitope especially significant content hydrophobic residues prediction traditionally based mainly based amino acid properties hydrophilicity charge exposed surface area secondary structure many predictive algorithms available present author prefers expert system kind approach incudes experimental data though biophysical considerations certainly still play strong role see infection previous paper <NUMBER> focused primarily design synthetic peptides infection antagonists however partly reason greater conformational flexibility discussed smaller less flexible organic molecules ie fewer rotatable bonds traditional province synthetic chemist rather use automated peptide synthesizer preferred pharmaceutical application consideration peptides often considered merely useful intermediate step traditional pharmaceutical compound design biodegradability per se peptides main concern since including damino acids design prevents proteolysis preliminary docking simulation studies peptides bind <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> less strongly several binding modes <NUMBER> weaker binding contraindication idea peptides bind site rigid nonpeptide molecules expected consequence much greater flexibility peptides compared molecules example multiple aromatic ring scaffolds conventional wisdom eg ref <NUMBER> frequently uses ruleofthumb total change intramolecular bond rotational entropy peptide ligand roughly t∆s total <NUMBER> kcal⋅mol −<NUMBER> per residue <NUMBER> k corresponding approximately <NUMBER>fold reduction conformational freedom per residue binding van der walls hydrogen bonding tend roughly equivalent peptides water well bound forms water entropy effects known hydrophobic effects along electrostatic forces play important role determining balance energies final outcome krsfiedllfnkv would thus cost <NUMBER> kcalmole entropic contribution bind rigidly primarily compensated hydrophobic contacts <NUMBER> kcalmole going aqueous nonpolar environment ie <NUMBER> kcalmole <NUMBER> residue peptide analogue krsfiedllfnkv example would favor binding proper calculation details show balance favors good binding found case experimentally despite comments flexibility peptides provide opportunities fit specific binding site ie show accommodation tolerant imperfections design process however also argument importance intermediate step design conventional pharmaceutical agents main methods essentially standard bioinformatics approaches used refs <NUMBER> <NUMBER> methods eg rules epitope prediction best discussed context results section <NUMBER> quel methods specifically bioinformatics discussed <NUMBER> computational chemistry docking compounds using krunch described ref <NUMBER> appendix ref <NUMBER> somewhat unorthodox focusing heuristics handle multiple energy minimum problem end effect probably similar long runs using high grade molecular dynamics calculations given opportunities calibration <NUMBER> epitope predictions lie traditional one dimensional bioinformatics paper previous paper depended predictions using gor<NUMBER> secondary structure prediction αhelix h extended chain βsheet e coil loop c reason particular use gor<NUMBER> discussed ref <NUMBER> briefly part sections predicted runs c tend immunogenic even incorrect structure predictions <NUMBER> however charged residues αhelices βsheets believed occasionally bepitopes short sections extended chain effectively imply loops core initial rules bepitope prediction used present study consider surface exposure three dimension structure known allowing conformational adjustment expose residue likely disordered flexible loop scores <NUMBER> ii known exposure based kind experiment also recognizes possibility partially buried site criteria brought surface binding notably proteolytic cleavage <NUMBER> iii runs amino acid set stnqy score <NUMBER> set dekhr score <NUMBER> set livfcm score <NUMBER> iv runs secondary structure prediction coil loop c though runs three less e first last three helix h considered c purpose score <NUMBER> v motif nxstx asparagine n serine threonine x means proline p scores <NUMBER> however permit corresponding peptidomimetic vaccine without considering glycopeptide synthesis technology see discussion would justify negative score depending technology available addition may combined predictions based significant homology proven epitopes data bases already done several groups sarscov<NUMBER> eg ref <NUMBER> sources data concerning covid<NUMBER> virus spike proteins genbank protein data bank main sources use inhouse collections data eg typical bepitopes tepitopes although publically available collections would probably serve function also use also data base nonpeptide ligand molecules potential interest already generated since work described ref <NUMBER> used appropriate many molecules including emodin also found public zinc data base <NUMBER> indicated results section <NUMBER> several including derivatives carbenoxelone derivatives interest potential coronavirus antagonists look entry zinc data base codes used papers one go httpzinc<NUMBER>dockingorg substances enter zinc<NUMBER> automated approach favored quel variable perl variable mol zinc<NUMBER> set quel application goes httpzinc<NUMBER>dockingorgsubstancessearchqmol references experimental binding results concern data cited papers see example ref <NUMBER> typical methods used natural herbal compounds discussed ref <NUMBER> quel helped gather form quel knowledge representation tags become part growing knowledge representation store regard peptides proteins table <NUMBER> used ref <NUMBER> shows standard iupac oneletter codes used amino acid residues sequences throughout paper table <NUMBER> one letter amino acid codes used text conservative replacements common substitutions peptide design perspective example phenylalanine f isoleucine alanine seen natural substitutions appear discussion spike protein sequence motifs later amino acid residues hydrophobic sidechains conservative replacements rather substantially different size reasonable explanation course sidechain size conservation matters less sidechains exposed surface protein similar notions underlie idea readily replace always equal probability direction respect table <NUMBER> tends reflect changes used present project design starting epitopes previous paper <NUMBER> give impression specific motifs discussed particularly krsfiedllfnkv sections likely sarscov<NUMBER> spike protein interest respect preference one choice based conservation across many strains suggesting site important function likely spike surface b avoiding shielding spike protein extensive glycosylation dramatic effect relaxing restrictions major point section large number candidates found overprediction necessarily bad thing laboratory peptide synthesizer tools constructing testing designs relatively easy cheap test reject ideas problematic miss opportunities intention also cover possibilities enable index numbers assigned according order sequence putative epitope <NUMBER> etc consequently future one may readily refer index number speak new proposal experimental epitope extending overlapping even lying two epitopes primarily seen bepitope predictions though favored tepitopic character also expected initial step based adding weights described methods section <NUMBER> practice also judicious use expertise epitope data base attempt refine assignments recall trimeric sars coronavirus sarscov spike glycoprotein consists three s<NUMBER>s<NUMBER> heterodimers shielded configuration life cycle virus necessarily every protein monomer also shielded glycosylation higher scoring predicted epitopes sequence underlined bold primarily considered bepitopes extension include tepitope character possible also included predictions using immune epitope database analysis resource iedb virus pathogen resource vipr already made <NUMBER> see later shown underlined bold italics following since contiguous sections look like single long representation following also stated separately apparent focus krsfiedllfnkv strain variation glycosylation ignored much spike protein sequence contains epitope candidates <NUMBER> <NUMBER> many epitopes predicted present study overlap prediction made using immune epitope database analysis resource iedb virus pathogen resource vipr <NUMBER> comprised following recall one reasons original single preferred candidate krsfiedllfnkv many predicted epitopes contain evidence glycosylation reflecting last rules v methods section <NUMBER> rule however special status present author tended consider undesirable synthetic vaccine diagnostic development indicates likely glycosylation protein bulky oligosaccharides attached immunogenic rather difficult work synthetically traditionally expected make bulk production expensive may variable structure cannot typically seen detail experimental three dimensional protein structures typically obtained xray crystallography high grade electron microscopy antibodies raised glycosylated surface patch protein corresponding synthetic glycopeptides may specific carbohydrate units recognized irrespective peptides context adjacent amino acid residues conformation exposure bpeptide epitopes glycoproteins may modulated glycosylation intramolecular carbohydrateprotein interactions beneficial versus undesirable effects glycosylation synthetic vaccines also complex matter glycosylation may essential reactivity antibody conversely may effect inactivate capabilities section amino acid sequence function bepitope seems good reason giving glycosylation motif strong negative rather positive score unfortunately depend structure antigenic site antibody fine specificity recognition mechanisms involved fully clear usually positive aspect however current view similar effects glycosylation apply tcelldependent cellular immune igg antibody responses glycosylated peptides elicit glycopeptidespecific cell clones bound presented mhc class ii molecules course positive aspect intended effect obtained synthetic construct overall spike glycoprotein protein sequence shown changes across coronaviruses krsfiedllfnkv subsequence notable amongst exceptions extends common cold coronaviruses minor variation may imply better targeted approach stimulate immunity common colds caused rhinovirus recent research suggests misdirection antibody responses nonprotective epitope mechanism virus escapes immunity permits recurrent infections <NUMBER> clearer understanding conserved subsequences coronaviruses may also help tune action tolllike receptors initiate appropriate response class proteins play key role innate immune system singlepass membranespanning receptors usually expressed sentinel cells eg macrophages dendritic cells recognize structurally conserved molecular features pathogens <NUMBER> despite concerns two strains covid<NUMBER> virus appearing big changes present purposes sufficient consider sequence original wuhan isolate reference comparisons present purposes ie comparing spike protein sequences coronaviruses recall discussed introduction section <NUMBER> time study late february early march <NUMBER> sequences spike proteins covid<NUMBER> isolates different states countries california brazil taiwan india remain identical almost example respect original wuhan isolate <NUMBER> phenylalanine f replaced cysteine c residue <NUMBER> swedish isolate alanine replaced valine v residue <NUMBER> indian isolate neither relate sequence motif krsfiedllfnkv particular interest initial studies <NUMBER> <NUMBER> genome common cold coronavirus particularly sequence spike protein considered sufficiently far covid<NUMBER> virus less relevant problem looking differing sequences essential detection conserved motifs different less relevant pathogens unlikely preserve except perhaps pattern matches involving quite complex substitution rules however appearance covid<NUMBER> krsfiedllfnkv motif appear common cold coronaviruses typically two relatively conservative substitutions sense preserving hydrophobic sidechain discussed methods section <NUMBER> conservative aspartate asparagine n replacement also fairly common motif sequences examined example shown clustal omega alignment covid<NUMBER> virus spike protein original wuhan seafood market isolate genbank entry mn<NUMBER> spike proteins representatives members two major common cold coronaviruses strains <NUMBER>e oc<NUMBER> genbank entries np<NUMBER> aiv<NUMBER> despite radical sequence differences spike protein sequences overall <NUMBER> identity well within range random match underlined sequence motif krsfiedllfnkv covid<NUMBER> virus essentially retained sequence except alanine replaces phenylalanine f common cold coronavirus moderately conservative surface protein conservative leucine valine substation one case sequence shown hcovhku<NUMBER> often associated serious cases coldlike diseases motif still noticeable rsffedllfdkv isoleucine replaced phenylalanine f f modified motif rsaiedllfdkv also found coronaviruses dogs cats rodents pigs rabbits camels ferret badgers raccoon dogs amongst others might eaten humans certain countries notably part species live close proximity humans pigag motif show alignment also case many distantly related coronaviruses <NUMBER> <NUMBER> however subsequence pigtnyrscestt hcovhku<NUMBER> spike protein appears relate pigagicasyqtq covid<NUMBER> virus recall hcovhku<NUMBER> common cold virus albeit usually associated severe lower respiratory tract cases contrast krsfiedllfnkv motif stand potentially important covid<NUMBER> virus virtue comparisons also match motif almost continuous stretch amino acid residues alignments like subsequence kwpwyiwl exception interest characteristic feature many sars coronaviruses however considered present paper except note appear associated covid<NUMBER> virus spike protein proteolytic cleavage site sites prominently trypsin s<NUMBER>s<NUMBER> htvsllrstsqksivaytmsl s<NUMBER> lpdplkptkrsfiedllfnkv cathepsin s<NUMBER>s<NUMBER> htvsllrstsqksivaytmsl elastase s<NUMBER> lpdplkptkrsfiedllfnkv plasmin s<NUMBER>s<NUMBER> htvsllrstsqksivaytmsl s<NUMBER> lpdplkptkrsfiedllfnkv tmprss<NUMBER> s<NUMBER>s<NUMBER> htvsllrstsqksivaytmsl tmprss<NUMBER> multiple sites tmprss<NUMBER>a s<NUMBER>s<NUMBER> htvsllrstsqksivaytmsl s<NUMBER> lpdplkptkrsfiedllfnkv one looks distant relatives number variations krsfiedllfnkv motif despite large variations spike protein sequence whole still recognizable spike proteins coronaviruses diverse various host species shown examples table <NUMBER> noticeable variation occasional substitution cleavage point arginine r g rather disrupt possibility cleavage however seemingly displacing role arginine r lysine k lies nterminal left side motif interesting commonly retains firmly iedllf core motif notion krsfiedllfnkv motif overall plays important role presumably common similar function across least large number known coronaviruses still seems reasonable one important course least case sarscov<NUMBER> virus near relatives time match coronavirus genebank detected author blastp using queries phenylalanine f eg rsaiedllldkv rsaiedllidkv rsaiedlladkv rsaiedllmdkv rsaiedllwdkv rsaiedllydkv queries search exhaustive would contradictory current hypotheses found group inserted glycine g replacement initial argine r similar positively charged lysine k common however long motif significantly recognizable histidine h opposed initial arginine r found motif cannot extend strains indefinitely recognizable point evolutionary tree bring virus hosts subject quite different selective pressures motif definition coronaviruses however still persists recognizable birds duck eg genbank kx<NUMBER> kc<NUMBER> whiteeye bird cov hku nc<NUMBER> magpierobin shama cov hku<NUMBER> nc<NUMBER> strains selction spans large range coronavirus genome sizes see alignments compared wuhan seafood market isolate genbank mn<NUMBER> showing motif underlined bold eeyihklnatlvdldwlnrvetyikwpwwvwllitlaivafvvilvtiflctgccggcfg <NUMBER>  indication limit survival motif rsfiedllfnkv researcher departs sarscov<NUMBER> might given nidoviruses coronaviruses somewhat coronaviruslike nidoviruses common eg reptile viruses order nidovirales contains enveloped positivestrand rna viruses largest known rna genomes nidoviruses identified snakes appear closely related coronavirus subfamily torovirinae might best represented genus subfamily sequences suggestive rsfiedllfnkv eg knfidlllagf occur genomes ball python genome really lie beyond limit serious detection example clustal omega gives <NUMBER> exact match wuhan isolate spike protein nidovirus <NUMBER> reptile shingleback motif barely recognizable including fish nidovirus pacific salmon genbank qeg<NUMBER> notable supports alignment preserved gtlywldy salmon nidovirus far krsfiedl nearest preceding plausible cleavage point arginine r <NUMBER> residues nterminal direction left however similar occurs mammalian coronaviruses residue may still play similar role activation cleavage looking similar motifs human proteins somewhat different motive makes sense significant match subsequences might represent features proteins spike protein human proteins may bind irrespective justification commonality even coincidental epitopes similar proposed synthetic vaccine always possible interest assessing risk crossreaction inducing autoimmunity synthetic vaccine designs certain occasion peptidomimetics induce immune response perhaps binding strongly human protein designer intend discussed ref <NUMBER> motif match <NUMBER> identity <NUMBER> coverage tumor protein d<NUMBER> isoform <NUMBER> homo sapiens id np<NUMBER> similarly tumor protein d<NUMBER>like <NUMBER> homo sapiens id aah<NUMBER> next match regard neprilsyn entries <NUMBER> match <NUMBER> coverage none sufficient close concern regarding induction autoimmune response fairly close matches krsfiedllfnkv f modified motif rsaiedllfdkv come light might plausibly biological significance supported biological relevance likely random matches selecting human proteins hits vary <NUMBER> cover <NUMBER> identity <NUMBER> cover <NUMBER> identity hits cannot considered significant peptides length isolation evidence however seem worth recording future reference regard potential biological function virus already noted <NUMBER> rrsfidelafgrg section human semaphorin genbank np<NUMBER> produced response lung disorders running rsaiedllfdkv blastp generates <NUMBER> coronavirus hits rnareellfd found human mhc class ii antigen genbank axn<NUMBER> rnareellfd found human immunoglobulin heavy chain junction region genbank mcg<NUMBER> dllfekv found human tubulin gamma complex associated protein <NUMBER> isoform crad genbank eaw<NUMBER> e<NUMBER> interest <NUMBER> identity <NUMBER> matches sfleellfin khksfleellf ubiquitin cellular e<NUMBER> ubiquitin ligase ringfinger chy zincfinger domaincontaining <NUMBER> rchy<NUMBER> identified interacting partners viral sarsunique domain sud papainlike protease pl pro involvement cellular p<NUMBER> antagonist coronaviral replication downregulation p<NUMBER> major player antiviral innate immunity <NUMBER> however matches remain tenuous genbank order <NUMBER> billion nucleic acid sequences <NUMBER> residue peptide <NUMBER> billion sequences krsfiedllfnkv motif remains favored author target time identifying amino acid residues ace<NUMBER> spike protein important may example involve conserved residues together continuous sequence conserved run amino acid residues sufficient list candidates important site important sites necessarily conserved runs amino acid residues shown conservation significant variation compared rsfiedllfnkv subsequences rsfiedllfnkv pigagicasy…r discussed ref <NUMBER> motifs associated activation cleavage sites lie receptor ace<NUMBER> binding domain sarscov<NUMBER> spike glycoprotein relationships whole spike protein receptor binding domains pdb entries <NUMBER>m<NUMBER> pdb <NUMBER>vw<NUMBER> shown alignment note receptor binding domain precedes motifs sequence three dimensional perspective required appreciation important sequence features fig <NUMBER> pdb <NUMBER>vw<NUMBER> binding domain right bound ace<NUMBER> left fig <NUMBER> course receptor binding domain interacting intimately ace<NUMBER> sections receptor binding domain interact ace<NUMBER> also shown underlined facilitate deeper analysis loops spike protein receptor binding domain initially classified loops abcde f order visual perspective joined three subsequences <NUMBER> <NUMBER> <NUMBER> contain loops part spike glycoprotein sequence represents receptor ace<NUMBER> binding domain shown considering proteins used two structural determinations <NUMBER>m<NUMBER> <NUMBER>vw<NUMBER> protein data bank shown alignment made using clustal omega alignment note receptor binding domain precedes motifs sequence amino acids residues bold underlined font subsequences ace<NUMBER> interact spike protein ace<NUMBER> binding domain loops indicated subsequence include longer range electrostatic interactions potential solvent effects also italics dkfnheaedlfy dkfnheaedlfy kgdfr particularly strong interactions reference perspective full sequence ace<NUMBER> angiotensinconverting enzyme <NUMBER> isoform x<NUMBER> homo sapiens genbank entry xp<NUMBER> follows part three dimensional structure bold underlined font note least particular experimental structures involvement glycosylationlike molecules example <NUMBER>vw<NUMBER> well localized nacetyldglucosamine βdmannose <NUMBER>ethanediol molecules make significant interactions gluelike manner essentially glue around edges however obvious indication involvement glycosylation main interior interaction face complex intimate interactions proteinprotein ie amino acid residues primarily solely ace<NUMBER> spike glycoprotein association involves interaction bent αhelix residues <NUMBER> stiee…nyntn ace<NUMBER> extended chain configuration effectively stretched loop runs residue <NUMBER> gfncy…ygqpt spike glycoprotein involves ends loops <NUMBER>a <NUMBER>b <NUMBER>f case ace<NUMBER> interacting ace<NUMBER> binding domain spike glycoprotein one could principle imagine blocking ace<NUMBER> receptor mimic spike protein surface blocking receptor binding site spike glycoprotein protein mimic ace<NUMBER> receptor surface kinds infection former usually considered plausible latter would interfere normal function ace<NUMBER> course essentially way immune system notably antibodies work possibly main argument second choice essentially equivalent using antibodies raised spike protein ie effect passive immunization time final writing various news articles drawing attention potential use upper sequence parts αhelix ace<NUMBER> example httpsscitechdailycommitchemistshavedevelopedapeptidethatcouldblockcovid<NUMBER> alignment helix contains <NUMBER> residues extended chain contains <NUMBER> similar length expected structures αhelix rise <NUMBER> å per residue along axis typical protein helices turn variations imply <NUMBER> å βstrand similar extended chain spike glycoprotein interacts rise circa <NUMBER> å per residue general geometry naturally puts two sequences roughly onetoone spatial correspondence shown note intended sequence match representation chains interact respect lack charged residues acidic basic sidechains extended chain spike glycoprotein structure <NUMBER>vw<NUMBER> although aspartic acid replaces serine strains arginine r replaces asparagine n others eg see blastp alignments later detailed backbone view confusingly cluttered one may identify residues interact boundary ace<NUMBER> spike protein sidechains spike protein subsequence gfncyfplqsygfqpt either make close contact likely influence interface perhaps useful initial mental picture roughly speaking planes peptide groups tangential αhelix surface rather constituting extended chain makes edgeon approach even fig <NUMBER> suffice makes clear however extended chain like socalled extended chain proteins practice essentially visible helix larger pitch resembling stretchedout αhelix slightly supercoiled wrap around ace<NUMBER> αhelix case tends follow elbow bend αhelix staying roughly parallel local axis αhelix make intimate contact overall gfncyfplqsygfqpt use epitope analogue cysteine c may tested convenient linker carrier protein otherwise replaced serine close analogue far peptide antagonists concerned difficulty using sequences stiee… gfncy… readily degraded host proteases would occur peptide made entirely daminoacid restudies retroinverso peptide <NUMBER> <NUMBER> made damino acids reversed sequence subsequence seeks mimic extended conformation assumes side chain topology similar original native peptide backbone nh carbonyl co groups interchanged peptidomimetics subsequences sequences stiee… ace<NUMBER> gfncy… spike glycoprotein respectively cysteine c …cnfg second molecule may convenient linker epitope vaccine replaced serine antagonist recall problem backbone amide nh carbonyl co groups interchanged original section backbone mimicked nh co groups form hydrogen bond recipient donor groups protein hydrogen bonds disrupted intended competitive antagonsist eg would unstable nh…hn co…oc interactions would thus seem significant advantage using ace<NUMBER> mimic essentially αhelix uses backbone amide carbonyl groups however retroinverso αhelices typically found areas shown degree success <NUMBER> antigenic mimicry would nonetheless seem value test retroinverso peptides laboratory studies developing basis synthetic vaccine peptidomimetic worth extending studies small organic drug molecules everything depends extent gfncyfplqsygfqpt produce escape mutations might soon rend solutions useless previous paper relate variations sequence bother closer much distant relatives following shows using blastp go far sarscov<NUMBER> find matches part sequence coverage differences within area partial match original wuhan seafood market pneumonia virus isolate wuhanhu<NUMBER> genbank id mn<NUMBER> subsequence regions fncyfplqsygf following examples coverage found blastp last blastp httpsblastncbinlmnihgovblastcgi match results differs total alignment clustal omega httpswwwebiacuktoolsmsaclustalo follows course illustrates high degree variation occurs one proceeds coronaviruses less related wuhan seafood market isolate believed associated origin covid<NUMBER> phenylalanine f commonly immediately precedes many matching subsequences ncyfp… ncywp… etc conservative substitution tryptophan w substitution second phenylalanine f also common may worth noting fnctwp subsequence mammalian vomeronasal type<NUMBER> receptor <NUMBER> sensory cells within main nasal chamber detects heavy moistureborne odor particles fnctwp also found dynein many viruses require minusenddirected dynein motor complex transport microtubules cell surface toward nucleus dynein addition kinesins transport toward plasma membrane however direct connection viral infection tempting far obvious mechanistic evolutionary explanation also dynein nuclear shuttle transport may less relevant coronavirus rna virus certainly rna viruses rely dynein system eg hanta virus uses endoplasmic reticulumgolgi intermediate compartment least illustrates kinds perhaps immediately less obvious functions ace<NUMBER> binding domain spike glycoprotein motif might within coronaviruses degree conservation suggests ncywplndygf segment virus conserve hint fnctwpgf key part soon clearly significant variations across coronaviruses different hosts depart wuhan seafood market isolate compared rsfiedllfnkv motif s<NUMBER> cleavage regions <NUMBER> small organic drugs design mimic section simply designed designed antagonize ace<NUMBER> binding thus potentially susceptible escape mutations ie rapid appearance drug resistance binding studies <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> model pharmacaphore <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> inhibited emodin interim model pharmacophore choice <NUMBER> point development argument optimal targets vaccines therapeutic antagonists target fits follows regarding ace<NUMBER> binding must kept mind antagonist development noted motif well conserved could prone development escape mutations ie acquired resistance vaccines therapeutic antagonists dominant theme ace<NUMBER> αhelix interacting extended chain loop spike glycoprotein structure interaction region fairly easy deduce various sars strains yet obvious strongly recurrent theme significant conserved residues discontinuous ie together subsequence could interacting closely ace<NUMBER> time emodin appears act ace<NUMBER> binding site <NUMBER> remains interest complexities <NUMBER> <NUMBER> discussed introduction section <NUMBER> notably ace<NUMBER> binding domain spike protein binding sequence discussed might bind human proteins might functions emodin related compounds related sense least consistent pharmacophore features might inhibit priori binding properties emodin choice <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> model pharmacophore could equally relate rsfiedllfnkv site site mix several case interaction vomeronasal type<NUMBER> receptor <NUMBER> dynein discussed best marginal examples illustrated diversity kinds functions important virus might apply event relations emodin similar potentially related molecules remains interest impeding sarscov<NUMBER> entry worse casualty would continuity story developed intended illustrate flow reasoning using standard tools bioinformatics <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> interesting accommodating great variety ligands steroid binding site without degree specificity general features ligands far resemble potential sarscov<NUMBER> therapeutics keeping mind refutation principle <NUMBER> pharmacophore contribution pharmacophore ensemble dehydrogenase worthy use new ligand information proves otherwise far pharmacophore validation ie demonstration suitable pharmacophore model proven otherwise based circumstantially emodin compounds looking chemically similar known practice argued theoretically interact sars virus entry way bind least weakly experimentally computationally <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> <NUMBER> review compounds known experimentally inhibit dehydrogenase known experimentally inhibit coronavirus entry replication maturation prepared however validation also extensively based weaker larger body preliminary binding studies involving variety antagonists coronavirus infection often kinds virus infection also bind least weakly dehydrogenase see discussion weakly emodinlike otherwise first found quel knowledge gathering tools used initial coronavirus study <NUMBER> combined early candidate selection rules based estimates mean binding strength groups binding well note hydrogen bond worth <NUMBER> kcalmole nonetheless effectively zero binding well relative binding water contrast aromatic large aliphatic worth circa <NUMBER> kcalmole due hydrophobic interactions depend considered relative water complex electrostatic intramolecular entropic considerations beyond present scope noting least preliminary study interaction <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> arbitrator weak weak candidates also considered may multiple binding modes take great deal computer time explore could yield lower binding fre energies produces fairly mixed bag compounds based argument viruses coronavirus particular may use limited number exposed exposable sites several purposes coronavirus seems able readily adjust new mechanisms selective pressure drugs vaccines details molecules studies subject paper also discuss interesting unifying themes briefly include many names hopedfor drugs coronavirus appear news internet discussion convenient see dividing three classes quinonelike quinone class aromatic compounds two carbonyl ketone co functional groups sixmembered ring though quinonelike author includes include many compounds resembling steroid fragments may many one carbonyl groups several rings group includes <NUMBER>anthraquinone derivatives relate many important drugs suggestive laxative antiinflammatory functions collectively called anthracenediones include ubiquinone coenzyme q various shorter aliphatic chain forms hydroxyldecylubiquinone shorter aliphatic chain forms laxatives dantron emodin aloe emodin senna glycosides antimalarials rufigallol antineoplastics used treatment cancer mitoxantrone pixantrone anthracyclines caution reuired reading list list potential therapeutics anthraquinone derivatives rhein aloe emodin anthrone lacks methyl group parietin physcion extent emodin chrysophanol extracted cassia occidentalis toxic known cause hepatomyoencephalopathy children medical term effectively defined cover lethargy jaundice altered senses children india consumption cassia seeds ii steroidlike group includes plant steroidlike compounds carbenoxolone liquorish licorice others found soy sprouts<NUMBER>βestradiol endogenous ligand responsible growth development many tissues diethylstilbestrol synthetic estrogen <NUMBER>methylbenzaanthracene<NUMBER>diol possible natural product common polyaromatic hydrocarbon also interest group resembles group concern group ii molecules like emodin known antagonize viral infections generally smaller possible relevant pharmacophore would sterically exclude large steroidlike ring iii quininelike confused quinonelike quinine alkaloid derived cinchona bark used treat malaria ingredient tonic water common feature nonetheless abundance aromatic rings quininelike case include nitrogen variously resembling pyrimidines purines histidine tryptophan group current considerable interest potential thereputics covid<NUMBER> particular interest chloroquine theophylline tavipiravir baloxavir marboxil ace ace<NUMBER> inhibitors classified group weak weak binders discussed later camostat serine protease inhibitor considered potential therapeutic covi<NUMBER> convenient place class analogues include nitrogen atom within ring several possible intriguing biological connections discussed elsewhere one might briefly mentioned considering combined therapeutic use member set ubiquinonelike compounds inhibit ubiquinone sites work concert nadh nadph cofactor sites latter turn often inhibited quininelike members many compounds generally bind weakly though steroidlike compounds strong binders many quininelike compounds medium binders discussed binding strength course matter degree rt r gas constant absolute temperature <NUMBER> <NUMBER> k ie circa <NUMBER> biological temperatures <NUMBER> kcalmole significant thermal noise free energies <NUMBER> <NUMBER> <NUMBER> <NUMBER> correspond binding association constants <NUMBER> <NUMBER> <NUMBER> <NUMBER> free energies usually expressed negative perspective associated system considering absolute values much less reliable relative values field one might conservatively consider binding energy <NUMBER> kcalmole worthy justification keeping compound list one wish reject prematurely seems reasonable one still mind refutation principle includes mental picture model pharmacophore <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> fairly large cavity provide strong steric inhibition candidate ligands new evidence might show large ligand steroid might big fit real target experimental data describing words deficiencies pharmacophore model start show considering larger potential drugs also benefit using <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> model pharmacophore present author data base experimental computational studies compounds bind stated nonetheless case common evolutionary relationship dehydrogenase spike protein binding receptor ace<NUMBER> would best marginal <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> <NUMBER> residues ace<NUMBER> <NUMBER> <NUMBER> identity match amino acid residues region best possible match dehydrogenase also <NUMBER> conservative substitution clustal ie conservation groups strongly similar properties score greater <NUMBER> pam <NUMBER> matrix taken alone would provide basis exploring relationship admittedly conventional rule thumb two sequences considered homologous <NUMBER> exact amino acid residue matches strictly speaking apply entire lengths discussed chapter <NUMBER> ref <NUMBER> brief review standard tools given refs <NUMBER> <NUMBER> nonetheless caution required <NUMBER> exact match criterion well known miss many easily detected homologs <NUMBER> sometime found supported evidence evolutionary functional relationship example alignments common cold sarscov<NUMBER> spike proteins already discussed range every good reason believe common ancestry overall conformational similarity essential features sequence motifs preserved sense comparable fold motifs ace<NUMBER> comprising two <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> folds dehydrogenase bundle <NUMBER> well defined roughly parallel antiparallel αhelices <NUMBER> residues interspersed <NUMBER> short βpleated sheet strands ace<NUMBER> <NUMBER> well defined predominantly roughly parallel antiparallel αhelices <NUMBER> residues interspersed <NUMBER> short βpleated sheet strands common evolutionary origin <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> ace<NUMBER> domains distant remains marginally possible extensive conformational analysis underway even less evidence homology <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> tmprss<NUMBER> although serine residue highly conserved catalytic site cases arguably makes worthy initial exploration tmprss<NUMBER> comprises distinct cystine rich scavenger domain residues <NUMBER> serine protease domain residues <NUMBER> clustal o<NUMBER> multiple sequence alignment gives exact match amino acid <NUMBER> grounds investigation future also <NUMBER> conservative substitution clustal see tmprss<NUMBER> suggestive short section matches order appearance eg aqyyys ayyyys vvshc vvshc lyhsd lfhdd gilrqs galrqe arguments slightly increase statistical significance significant conformational homology apparent even likely chance match argument similarity proteins would basis kind convergent evolution based certain common ligands recalling coronavirus might benefit inhibiting inflammatory response preliminary studies panel ligands discussed suggest degree binding <NUMBER> kcalmole better ie negative <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> studies still fully complete low energies may yet obtained substantial data base results reasonably considered final large part original studies <NUMBER> carbenoxolone automatically evolved automatic editing chemical structure combined selective pressure improve binding <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> avoiding significant match compounds covered us patents <NUMBER> subsequent docking high grade molecular dynamic simulations carried ibms blue gene <NUMBER> many subsequent studies however carried using krunch personal computer initial study predicted well blue gene results providing krunch binding energies obtained corrected refined fit blue gene results linear regression formula <NUMBER> recall basis similarities compounds antagonize sars virus entry bind steroid dehydrogenase plus notable commonality case emodin ie binds model pharmacophore chosen since emodin many compounds interest contain two three aromatic rings reasonable least initial tactic one may regard pieces steroid ring system start steroid binding cavity plane steroid ring case involving minor variations sidechains original steroid core way make initial fit using carbenoxolone guide obvious however flat view steroid misleading steroid ring system buckle various cistrans combinations bonds rings longer sidechain conformations preferred basis intramolecular energy perhaps obvious although rotation barriers transitions clearly thermal energy kt energy conformations <NUMBER> kcalmole associated energy demands buckling parts steroid ring system variously roughly <NUMBER> <NUMBER> kcalmole less ligandreceptor binding associated energy demands gain energy ligandreceptor binding protein target shown high grade quantum mechanical hartreefock gamess calculations blue gene original study <NUMBER> described literature minimized energy conformers steroidlike compounds considered shown fig <NUMBER> calculations calculations vacuo less reliable charged species one may obtain qualitative assessment relative values comparative uncharged species compounds also shown clearly chemists perspective two dimensional formula format later fig <NUMBER> shows one early analogues carbenoxolone thioketone derivative cbos<NUMBER> discussed later <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> steroid binding site particular interest compound follows since original study <NUMBER> krunch judged strongest binder <NUMBER> kcalmole compound frequently used starting template initial docking configurations using krunch even though probably unlikely choice chemist use practice likely oligimerization thioketone groups even though b corphos also known cortisol <NUMBER>phosphate cortisol phosphate hydrocortisone<NUMBER>phosphate <NUMBER>hydrocortisonephosphoric acid strongest <NUMBER> kcal mole using instead amber force field molecular dynamics ibms blue gene <NUMBER> thioketone still retained reasonable binding energy <NUMBER> kcalmole latter study however ie effectively binding strength within state art fig <NUMBER> give details ligandprotein interactions see discussion refs <NUMBER> <NUMBER> although illustrate tightest fit except lower right thioketone ring ligand appear relate genuine opportunities additional groups added carbenoxolone position carbenoxolone initial closely related derivatives derived study <NUMBER> shown fig <NUMBER> binding range <NUMBER> <NUMBER> kcalmole accuracy limited realism methods really justify precise statements binding energy classification binding strong medium weak see ref <NUMBER> detail compounds authors variously consider binding energies <NUMBER> <NUMBER> safe requirement significant binding subject considerations accuracy almost agree relative values significant note often interpreteted estimates binding free energy entropy component particularly aqueous solvent solutesolvent intercations difficult estimate experimental binding values ligands general biological systems typically range <NUMBER> <NUMBER> kcalmole though <NUMBER> lie range <NUMBER> <NUMBER> kcalmole thiioketone derivatives theoretical interest binding studies practice may cause oligmerization organic compounds binding pharmacophore strong binders original study <NUMBER> estimated binding energy range <NUMBER> <NUMBER> kcalmole deigned carbenoxolone intent stronger comparable strong binding <NUMBER> kcalmole corphos cbonring cbos<NUMBER> bind <NUMBER> kcalmole recall two peptide analogues features spike protein interest <NUMBER> follows far simulations show binding relatively weakly <NUMBER> <NUMBER> kcalmole respectively compounds highly flexible theoretical internal vacuo conformational entropy corresponding <NUMBER> kcalmole discussed theory section <NUMBER> show multiple binding modes conformers binding may yet complete high performance computer like ibms blue gene used earlier drug design study <NUMBER> would certainly help fig <NUMBER> shown set compounds zinc data base <NUMBER> identified original <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> study <NUMBER> subsequent studies bind significantly usual criteria weakly range found synthetic peptides interest much less conformational freedom small shown appear original higher grade studies reasonable binding energies could reproduced reasons yet clear organic compounds binding pharmacophore medium binders zinc data base estimated binding energy range <NUMBER> <NUMBER> kcalmole fig <NUMBER> shows weaker binding results using krunch <NUMBER> great caution required drawing conclusions compounds fig <NUMBER> camostat definitely interest inhibitor ace<NUMBER> protein spike protein initially binds cell entry seem effective blocking entry <NUMBER> similarly hepsin results related interest eg potential alternative entry point ace inhibitors also looked initially interesting virtue certain similarities potential ligands course binding theoretical study traditional ace inhibitors commonly viewed inhibiting ace <NUMBER> taking drug valsartan acts ace might upregulate ace<NUMBER> facilitating virus entry <NUMBER> emerging information revealing complicated picture see discussion conclusions possible explanations would still allow competing spike protein binding seem somewhat unlikely probably binding sufficiently weak normal substrate also spike protein displace aromatic group interactions may important <NUMBER> organic compounds binding pharmacophore weak binders selected known drugs proposals caution use ace inhibitors might counterproductive see text estimated binding energy range <NUMBER> <NUMBER> kcalmole consideration given prediction ligand binding site motifs far proven essentially negative regards interesting results might shed light although clues may well missed binding sites often comprised conserved residues contiguous continuous sequence require detailed study although subsequences <NUMBER> <NUMBER> amino acid residues length worthy quick preliminary study commonly involved ligand interactions matches involved judged blastp clustal omega statistically significant one might think weak matches ligand binding site predictions much way one thinks epitope predictions much present paper structure emodin carbenoxolone related compounds involved discussion aromatic rings hence phenylananine f tyrosine tryptophan w generally amino acid residues hydrophobic character polar subsequences also strong binders charged ligands role charged molecules inorganic ions way far subsequences coronavirus spike protein concerned polar chargepattern motifs drets dreds common ligand binding molecules may interest antagonizing sars entry activation replication way present authors experience specifically motifs like initial interest present project sarscov nonstructural proteins zinc finger motifs ret especially red common prosite motifs httpsprositeexpasyorgcgibinprositeprositesearchfullpl including zincfinger motifs considered directly relevant spike protein example respectively genbank entry aia<NUMBER> dreds drets align srldkv threeway clustal omega alignment srldk original wuhan spike protein sequence mn<NUMBER> drldt np<NUMBER> spike protein however many similar alignments also illustrate considerable sequence variation weak matches close sequence subsequences interest neither coronavirus spike protein human proteins potential discussed far ace<NUMBER> concerned closes match drets dregs drkkps weak match lays well away regions current interest eg sequence region interacts spike glycoprotein dteta drfin occur cterminal half human <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> expected coincidental matches like first vaccines <NUMBER> therapeutics course drawn directly almost directly nature late <NUMBER> th century chemical synthesis became science <NUMBER>s use begin made computers rational drug design advantages still seriously considering herbal remedies tend tolerated cells produced cells already subjected hundreds years human trial often economic solutions bulk production leads drug development discovery principal nonpeptide compounds considered possible therapeutics convenient herbal sources reviewed previously <NUMBER> herbal extract emodin convenient product extracted rhubarb buckthorn japanese knotweed several fungi previous paper <NUMBER> also noted emodin certain molecular similarities antiinflammatory drugs carbenoxolone derived extract glycyrrhizic acid liquorish licorice variously inhibit believed inhibit human<NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> guarantee efficacy emodin carbenoxolone sarscov<NUMBER> least even emodin studies concerned sarscov sarscov<NUMBER> case dehydrogenase circumstantial related substances worthy investigation indeed paper described number compounds bind dehydrogenase importantly however recall weak binders also ace inhibitors may dangerous promote infection upregulate ace<NUMBER> <NUMBER> nonetheless situation resolved follows considerations action possible usefulness empirical observations largely independent bioinformatics molecular computation even independent whether correct human protein targets discussed correct relevant however would valuable know might relate ace<NUMBER> <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> ideally also understand enzymes might benefit coronavirus interaction also paper could provide evidence evolutionary relationship proteins despite certain similarities tmprss<NUMBER> far obvious relationship dehydrogenase studies author transmembrane serine proteases yet suggest relationship without connections dehydrogenase considered rather arbitrary model pharmacophore possibly meritorious correctly representing ensemble multiple targets may fortuitous hence used refuted evidence nonetheless possible clues mutual relevance human protein targets might come noting tissue distribution considering may relate biological role regards ace<NUMBER> mrna known present virtually organs studying sars entry human cells hamming et al <NUMBER> considered remarkable finding substantial surface expression ace<NUMBER> protein lung alveolar epithelial cells also enterocytes small intestine arterial venous endothelial cells arterial smooth muscle cells organ studied oral nasal mucosa nasopharynx lung stomach small intestine colon skin lymph nodes thymus bone marrow spleen liver kidney brain attractive prospect several many herbal remedies considered laxatives interact ace<NUMBER> inhibit sarscovid<NUMBER> entry recall emodin antagonist ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> <NUMBER> past <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> considered distributed mainly human liver detectable levels intestine kidney mostly membranebound retained liver microsomal fraction <NUMBER> however finding bruley et al <NUMBER> found highly expressed glucocorticoid target tissues including liver notably lung modest levels brain also found modest levels adipose tissue medical interest selective increase expression occurs obese humans rodents likely pathogenic importance metabolic syndrome <NUMBER> lung expression appears managed differently new promotor authors discovered called p<NUMBER> predominated lung previously known promotor predominated liver adipose tissue brain <NUMBER> researchers therefore need sort intriguing web information possible complex web laxative antiinflammatory effect may provide clues somehow relating bodys attempts reject eject viruses kind viruss attempts resist well known covid<NUMBER> patients complain stomach upsets diarrhea recapitulate essential themes terms action alimentary tract recall emodin earlier shown several groups researchers eg ref <NUMBER> inhibit sarscov entry cells apparently initially binding ace<NUMBER> emodin taken herbal laxative licorice conversely sometimes taken soother alimentary disorders carbenoxolone used commercially past specifically treat peptic ulcers intriguingly carbenoxolone also known influence reninangiotensin system involving ace<NUMBER> least appears connection terms networks physiological control noted traditionally <NUMBER>βhydroxysteroid dehydrogenase type <NUMBER> thought liver enzyme many researchers indicated ace<NUMBER> dehydrogenase available lung intestinal tract eg refs <NUMBER> <NUMBER> <NUMBER> hints also laxatives work similar stimulatory way might block viral entry ace<NUMBER> perhaps targets explored course absolutely nothing done patients without physician direction dosages difficult matters least herbal products potentially serious side effects salt balance blood pressure might cause birth defects potentially worse covid<NUMBER> would people worryingly still situation settled physicians patients could take action wrong direction gurwitz <NUMBER> emphasized picture even complex examined reports china suggesting mechanism production lung injury viral infection may due excess free angiotensinii might displaced ace<NUMBER> sars virus particles increasing amount ace<NUMBER> could desirable administering angiotensin receptor antagonists could beneficially upregulate production ace<NUMBER> becomes important examine medical records patients infected sarscov<NUMBER> particular eye taking ace inhibitors noted section <NUMBER> merrifield developed first solid phase peptide synthesis crosslinked polystyrene beads <NUMBER> <NUMBER> somewhat like natural compounds discussed peptides petidomimetics potentially important first steps detailed rational design small organic molecules convenient traditional pill drugs however present paper ability propose specific peptides peptidomimetics depend bioinformatics benefits computational chemistry note case one thinking largely screening natural products considering truly novel molecules using theoretical methods yet exist variations krsfiedllfnkv motif might appropriate synthetic vaccine peptidomimetic antagonist design suggest following amino acid residues square brackets represent alternatives g means optional glycine insertion also valid regular expression ie match query operating systems software generally colloquially positive chargeoptional glycineserinehydrophobichydrophobicglutamateaspartatehydrophobicleucinephenylalaninehydrophilic alaninelysinevaline considerations nterminus cterminus design synthetic vaccine retroinverso approach peptidomimetic agonist described ref <NUMBER> variations appear strain becomes distant universal clear indication sharp point departure although glycine g insertion evidence significant jump happen one may therefore ask variations included emphasis sarscov<NUMBER> closely medium distance relatives interest purpose prevent mutations escape vaccines antagonists elude diagnostics far sarscov<NUMBER> concerned krsfiedllfnkv satisfactory basis large number coronaviruses significantly different sarscov<NUMBER> preserve cases conservative substitutions may well fact residues example hydrophobic positively charged sufficient approach applicable mammalian coronavirus diseases successful basic motif form attempting tackle common cold priority words may well immune response krsfiedllfnkv also illicit response motif variants providing course krsfiedllfnkv elicits response remains motif one subsequences still recognizable moving rather distantly related coronaviruses common cold one feature figs <NUMBER> <NUMBER> course constant appearance aromatic rings also noticeable many studies antagonists sars virus binding activation course aromatic ie benzene ring makes copious appearance many pharmaceutical agents event provide rigid scaffolds added groups supported many longestablished recipes synthesis compounds figs <NUMBER> <NUMBER> distinguished lopinavar ritonar promazine particularly niclosamide explored sars viruses past targeted drug designers sars virus protease required maturation assembling virus nonetheless visual similarity compounds fig <NUMBER> particularly niclosamide normally medication used treat tapeworm infestation also present case prevalence aromatic rings figs <NUMBER> <NUMBER> hardly surprising since carbenoxolone derivatives shown fig <NUMBER> starting point evolution selection zinc data base nonetheless principle nothing constrain evolution aromatic chemistry <NUMBER> later unpublished studies produce molecules departing aromatic chemistry however bound relatively weakly possible importance aromatic rings avoidance escape mutations coronavirus mind question whether occasional loss phenylalanine f krsfiedllfnkv motif discussed contests tentative hypothesis peptidomimetic candidates derived krsfiedllfnkv bind similar site smaller organic ligands considered two phenylalanine residues f original motif tendency several benzene rings case organic ligands answer perhaps seems need one aromatic ring present motif match coronavirus genebank detected author blastp using queries phenylalanine f eg rsaiedllldkv rsaiedllidkv rsaiedlladkv rsaiedllmdkv rsaiedllwdkv rsaiedllydkv queries though also noted search exhaustive would contradictory current main hypotheses examples found fact tyrosine seem readily substitute phenylalanine f differs hydroxyl oh ie phenolic group suggests important hydrophobic feature pharmacophore point course many druglike molecules contain least one aromatic ring almost certainly form especially strong stacking interactions binding site one relevant report month writing present paper emphasizes use protein fragments characterize binding pocket determine strengths ligandprotein interactions common computational experimental approach aromatic interactions strong need special attention <NUMBER> resonance special nature π orbitals strength stacking best calculated using high level quantum mechanical approaches empirical force fields <NUMBER> however calculations performed vacuum solvation properties neglected led proposal grid inhomogeneous solvation theory gist describe properties individual heteroaromatics complexes gave good correlation estimated desolvation penalty experimental binding free energy prediction binding sites <NUMBER> main conclusion peptide krsfiedllfnkv remains special interest well conserved across coronaviruses sites proteins virus may course emerge solutions formidable problem aspects virus must considered however even ace<NUMBER> binding domain significantly prone accepted mutations recurrence core features krsfiedllfnkv motif many diverse species reminds us zoonotic origins might recalled jenner inventor vaccination consider many perhaps plagues mankind might ultimately animal origin <NUMBER> <NUMBER> april <NUMBER> <NUMBER> confirmed cases novel coronavirus disease <NUMBER> covid <NUMBER> reported worldwide <NUMBER> examination fulllength genome revealed coronavirus responsible covid<NUMBER> namely severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> βcoronavirus subgenus severe acute respiratory syndrome sars virus different clade <NUMBER> structure receptorbinding gene region similar sars coronavirus employ angiotensinconverting enzyme <NUMBER> ace<NUMBER> cell entry <NUMBER> ace<NUMBER> negative regulator reninangiotensin system ras homolog ace expression identified principally heart kidney airway epithelial cells <NUMBER> functions carboxypeptidase converting angiotensin ii angiotensin<NUMBER> thereby opposing vasoconstrictive effect angiotensin ii <NUMBER> currently available epidemiological studies reported increased prevalence cardiovascular disease cvd including hypertension among patients developed severe subtype covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> example study guan et al <NUMBER> one earliest analyses characteristics chinese patients covid<NUMBER> reported prevalence coronary heart disease fourfold higher among patients developed combined primary endpoint admission intensive care unit mechanical ventilation death relative patients less severe outcomes addition recent studies <NUMBER> <NUMBER> evaluated covid<NUMBER>associated cardiac injury observed high prevalence hypertension <NUMBER> coronary heart disease <NUMBER> cardiomyopathy <NUMBER> chronic heart failure <NUMBER> among covid<NUMBER> patients complicated cardiac injury independently associated mortality covid<NUMBER> since researchers tend favor association cvd severity covid<NUMBER> <NUMBER> <NUMBER> nevertheless interpreting association done caution since validity association hampered unclear definition cvd including hypertension adopted studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> without knowing baseline cvd status patients hard suggest cvd added risk factor developing severe covid<NUMBER> infection moreover available studies originated china therefore generalizability association global population limited patients underlying cvd likely experience excessive morbidity cause diminished circulatory reserve meet excessive demands cardiovascular system furthermore since prevalence cvd increased age age may act confounding factor available studies also reported older patients covid<NUMBER> tend develop severe course disease including development cardiac injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> future studies agestratified analysis could shed light association cvd severity covid<NUMBER> infection hand researchers called consider safety ras inhibitors including ace inhibitors angiotensin ii type receptor blockers arbs among patients covid<NUMBER> <NUMBER> <NUMBER> speculation patients covid<NUMBER> receiving agents may increased risk adverse outcomes given ace<NUMBER> functional receptor sarscov<NUMBER> ras inhibitors increase ace<NUMBER> levels <NUMBER> <NUMBER> however increased level ace<NUMBER> upon exposure ras inhibitors universal finding animal studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> noticed increased expression ace<NUMBER> upon exposure ace inhibitors arbs studies reported otherwise <NUMBER> <NUMBER> findings human studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> discredited association levels ace<NUMBER> use ace inhibitors arbs although one study <NUMBER> notice increased urinary secretion ace<NUMBER> hypertensive patients treated arb olmesartan ace inhibitors arbs furthermore another study <NUMBER> demonstrated increased gene expression ace<NUMBER> small intestine patients ace inhibitorarb treatment compared untreated controls addition elevation serum ace<NUMBER> found patients unsatisfactory blood pressure control utilizing ace inhibitor therapy reported study among hypertensive subjects <NUMBER> therefore effect ras inhibitors ace<NUMBER> among human subjects mainly due expression ace<NUMBER> plasma kidney gastrointestinal system known effect ras inhibitors expression ace<NUMBER> human airway epithelial cells furthermore increased expression ace<NUMBER> correspond increased ace<NUMBER> activity animal study <NUMBER> known biological effect ace<NUMBER> would wane immediately upon discontinuation ace inhibitors arbs role ace<NUMBER> coronavirus infection still controversial although ace<NUMBER> prerequisite infectivity sarscov presence cofactors seems important efficient cellular infection since sarscov also identified cell types lacking ace<NUMBER> expression <NUMBER> addition upregulation ace<NUMBER> entirely harmful since paradoxically increased level ace<NUMBER> might protect coronavirusinduced lung injury <NUMBER> binding coronavirus spike protein ace<NUMBER> leads ace<NUMBER> downregulation turn results excessive production angiotensin ii <NUMBER> angiotensin ii increases pulmonary vascular permeability could produce lung injury impair lung function <NUMBER> <NUMBER> coincidentally study investigated clinical biochemical parameters patients covid<NUMBER> observed levels angiotensin ii higher compared healthy controls <NUMBER> moreover angiotensin ii levels linearly associated lung injury supporting hypothesis angiotensin ii responsible lung injury covid<NUMBER> previously mentioned clinical course covid<NUMBER> complicated cardiac injury manifested increased biomarkers portends worse prognosis ace<NUMBER> plays significant role myocardial recovery response <NUMBER> <NUMBER> <NUMBER> indeed heart samples patients died sars presence viral rna identified associated reduced ace<NUMBER> protein expression <NUMBER> safety issue ace inhibitors arbs since created great concerns social media sites emerging data reassuring retrospective observational study <NUMBER> published chinese language reported use ace inhibitors arbs differ significantly patients recovered patients died covid<NUMBER> suggesting use ras inhibitors may result worse prognosis although conclusion safe use ras inhibitors could firmly drawn study due limited number patients receiving ras inhibitors n <NUMBER> however another recent retrospective study <NUMBER> reported covid<NUMBER> patients underlying hypertension taking ace inhibitorsarbs much lower proportion critical disease <NUMBER> vs <NUMBER> p <NUMBER> lower mortality rate <NUMBER> vs <NUMBER> p <NUMBER> hypertensive counterparts receiving ace inhibitorarb furthermore patients taking ace inhibitorsarbs significantly lower levels creactive protein procalcitonin compared patients receiving ace inhibitorarb suggesting potential antiinflammatory function covid<NUMBER> ras inhibitors could indicated chronic heart failure chronic kidney disease selfdiscontinuation agents without prior consultation physicians may lead decompensation within days weeks compromising cardiopulmonary reserve patients risk covid<NUMBER> <NUMBER> <NUMBER> benefits specific ace inhibitorsarbs may recapitulated antihypertensive agents diseases data reported effect temporary discontinuation ras inhibitors mortality among patients covid<NUMBER> shreds evidence extrapolated patient settings suggest harm studies veterans affairs healthcare system showed nonresumption arbs table <NUMBER> position statements selected major cardiovascular societies use reninangiotensin system inhibitors context covid<NUMBER> american heart association heart failure society america american college cardiology … recommend continuation raas antagonists patients currently prescribed agents indications agents known beneficial heart failure hypertension ischemic heart disease <NUMBER> march <NUMBER> https wwwaccorglates tincardi ology artic les<NUMBER>hfsaaccahastate mentaddre ssesconce rnsreusing raasantag onist sincovid <NUMBER> within <NUMBER> days ace inhibitors within <NUMBER> days surgery associated higher <NUMBER>day mortality rates <NUMBER> <NUMBER> risk fall elderly population abruptly stopping longterm medication eg ace inhibitors could result significant adverse consequences increasing risk fractures bleeding conclusion although cvd reported one common comorbidities among patients severe covid<NUMBER> association cvd severity covid<NUMBER> yet confirmed since thus far biological connection cvd viral replication addition established benefits ace inhibitors arbs cvd outweigh uncertain risks among patients risk covid<NUMBER> since available evidence demonstrated direct pathological relationship ras blockade covid<NUMBER> therefore echo position statements table <NUMBER> major cardiovascular societies <NUMBER> discourage discontinuation ace inhibitors arbs patients covid<NUMBER> statements provide reassurance clinicians would like continue using ace inhibitors arbs among patients risk covid<NUMBER> furthermore ongoing clinical trial covid<NUMBER>infected patients receiving ace inhibitorarb randomized either alternative antihypertensive medication continuation ace inhibitorarb therapy may provide definitive answer debate <NUMBER> funding external funding used preparation manuscript clinical outcomes observed raas inhibitors covid<NUMBER> patients human covs hcovs belong coronavirinae subfamily classified <NUMBER> phylogenic clusters α β γ δ covs f zhang et al <NUMBER> among covs <NUMBER> prominant strains α β subgroups infect humans madjid safavinaeini solomon vardeny <NUMBER> <NUMBER> humaninfectious covs <NUMBER> hcovnl<NUMBER> hcovhku<NUMBER> hcovoc<NUMBER> hcov<NUMBER>e cause selfresolving upper respiratory tract infections secondmost common cause <NUMBER> common cold killerby et al <NUMBER> su et al <NUMBER> clinical manifestation vary different strains covs hcovnl<NUMBER> hcovhku<NUMBER> hcovoc<NUMBER> hcov<NUMBER>e mainly cause mild symptoms cause organ damage individuals example giacomo et al reported hcovoc<NUMBER> triggered fulminant myocarditis <NUMBER>yearold woman veronese et al <NUMBER> van doremalen falzarano munster <NUMBER> three viruses induce respriratory distress distinctive properties table <NUMBER> sarscov<NUMBER> infectious reproductive number r <NUMBER> estimated <NUMBER> comparison sarscov merscov respective r <NUMBER> estimates <NUMBER> <NUMBER> respectively petrosillo sarscov<NUMBER> binds surface protein ace<NUMBER> merscov enters host cells via binding dipeptidyl peptidase <NUMBER> dpp<NUMBER> petrosillo et al <NUMBER> relative sarscov spike protein sarscov<NUMBER> spike protein contains several amino acid changes increase salt bridge formation hydrophobic interactions strengthen ace<NUMBER> binding gheblawi et al <NUMBER> changes may contribute virulence considerably larger global spread sarscov<NUMBER> compared sarscov gheblawi et al <NUMBER> ace<NUMBER> transmembrane protein plays central role downregulation raas gheblawi et al <NUMBER> coexpressed transmembrane protease serine <NUMBER> tmprss<NUMBER> ace<NUMBER> acts receptor sarscov<NUMBER> cell entry guzik et al <NUMBER> ace<NUMBER> expression considerably reduced sarscov sarscov<NUMBER> infection jung choi kim <NUMBER> interaction ace<NUMBER> receptor binding domain rbd s<NUMBER> subunit viral spike protein facilitates virus entrance endocytosis sarscov<NUMBER> along ace<NUMBER> endosomes reduces surface ace<NUMBER> expression k wang gheblawi oudit <NUMBER> viral entry sarscov<NUMBER> subsequently upregulates adam metallopeptidase domain <NUMBER> adam<NUMBER> mediates ectodomain shedding ace<NUMBER> patel et al <NUMBER> adam<NUMBER> activation also mediates liberation membrane bound cytokine precursors including il<NUMBER> ifnγ repress ace<NUMBER> mrna expression k sarscov<NUMBER> activation raas combined reduced ace<NUMBER>mediated conversion angiotensin ii ang ii ang<NUMBER> results increased angii accumulation ang ii activates angiotensin receptor type <NUMBER> j u r n l p r e p r f receptor at<NUMBER>r trigger signaling cascade whereby activation erkp<NUMBER> map kinase signaling results upregulation adam<NUMBER> initiate positive feedback loop limits ace<NUMBER> expression patel et al <NUMBER> addition inflammationinduced lung injury leads apoptosis clara cells type ii alveolar epithelial cells major ace<NUMBER>expressing cell subsets reduced survival cells also contributes downregulation ace<NUMBER> figure <NUMBER> wiener cao hinds ramirez williams <NUMBER> clinical outcomes covid<NUMBER> patients strongly associated preexisting health status infected patients cvd comorbidities increase mortality patients covid<NUMBER> shahid et al <NUMBER> cvd comorbidities direct consequences upon sarscov<NUMBER> infection example patients abnormally high blood pressure may exhibit increased apoptosis heart also kidney may exacerbated additional stress sarscov<NUMBER> infection gonzalez et al <NUMBER> hamet et al <NUMBER> course severe covid<NUMBER> biomarkers indicating heart injury become elevated mehta et al <NUMBER> washington state case series <NUMBER> critically ill covid<NUMBER> patients <NUMBER> patients <NUMBER> developed cardiomyopathy <NUMBER> <NUMBER> developed acute renal injury arentz et al <NUMBER> ace<NUMBER> expression human heart might one potential mechanism underlying heart injury infection sarscov<NUMBER> however sarscov<NUMBER> infectioninduced cytokine storm may also contribute cardiovascular injury l chen li chen feng xiong <NUMBER> tissue kallikrein produces kinin bradykinin peptides cleaving j u r n l p r e p r f substrate kininogen addition role production angiotensin ii ace mediates bradykinin degradation thus kinin bradykinin increased use ace inhibitors figure <NUMBER> increased bradykinin levels believed responsible dry cough adverse effect observed patients ace inhibitors moreover kinin bradykinin peptides also participate shock respiratory allergy thus wellknown side effects suggest ace inhibitors may aggravate lung inflammation cause lung dysfunction covid<NUMBER> despite potential adverse effect dry cough respiratory tract kallikreinkinin system kks many positive functions may ameliorate cvd figure <NUMBER> experimental models expression human tissue kallikrein caused significant reduction blood pressure fructoseinduced hypertension rats affect blood pressure nonfructosefed normal rats yao yin shen chao chao <NUMBER> accumulating evidence indicates kks capable exerting organ protection apart blood pressurelowing effect vivo study showed infusion kinin improved renal function hypertensive rats lowered corresponding increase capase<NUMBER> activity recombinant adenoassociated virus raav mediated human tissue kallikrein exerted protective effect myocardial apoptosis spontaneous hypertensive rats shrs specifically modulating activity caspase<NUMBER> b<NUMBER> receptor yan wang wang <NUMBER> tissue kallikrein reduced blood pressure also attenuated remodeling myocardium large blood vessels kidney wang et al <NUMBER> addition tissue kallikrein efficiently protected diabetic nephropathy chronic renal j u r n l p r e p r f failure tu et al <NUMBER> yuan et al <NUMBER> zhao et al <NUMBER> also suggested tissue kallikrein prevents apoptosis ventricular remodeling myocardial infarction yao et al <NUMBER> summary bradykinin may improve blood pressure regulation provide organ protection hypertensive patients since organ injury often determines mortality hypertensive patients infected sarscov<NUMBER> hypothesize product increased bradykinin levels induced ace inhibition may provide benefit harm cvdcomorbid covid<NUMBER> patients many studies demonstrated ang iiinduced hypertension accompanying vascular inflammation result organ damage chen et al <NUMBER> f chen et al <NUMBER> g e gonzalez et al <NUMBER> yang et al <NUMBER> il<NUMBER> markedly attenuates cardiac injury inflammation induced ang ii suggests il<NUMBER> acts downstream ang ii effector chen et al <NUMBER> f chen et al <NUMBER> g e gonzalez et al <NUMBER> yang et al <NUMBER> ang ii also induces production proinflammatory cytokines tnfα il<NUMBER>β guo et al <NUMBER> several studies suggest ang ii acts vasoactive peptide regulates blood pressure also works inflammatory cytokine causing cardiovascular remodeling gibbons pratt dzau <NUMBER> griendling minieri ollerenshaw alexander <NUMBER> sadoshima izumo <NUMBER> immune response activated sarscov<NUMBER> cytokine storm often observed severe cases serum j u r n l p r e p r f levels proinflammatory cytokines including il<NUMBER> il<NUMBER>r il<NUMBER>β elevated qin et al <NUMBER> xu et al <NUMBER> increased markers cytokine storm serum il<NUMBER> predict poor outcome patients severe covid<NUMBER> cao <NUMBER> covid<NUMBER> patients also elevated ang ii levels positively associated viral load lung injury thus sarscov<NUMBER> infection dysregulates ang ii overactivates immune response augments cytokine storm causes organ damage inhibition blockage raas may helpful attenuate inflammatory storm prevent endorgan damage ace<NUMBER> plays important role regulation angiotensin signaling generation ang ii well understood liverderived angiotensinogen atg cleaved renin ang processed ace ang ii converted ace<NUMBER> ang<NUMBER> ang<NUMBER> generally considered cvdprotective counters action ang ii g proteincoupled sarscov<NUMBER> uses ace<NUMBER> abundantly expressed pulmonary epithelium kidney heart intracellular entry figure <NUMBER> infection sarscov<NUMBER> ace<NUMBER> expression reduced crackower et al <NUMBER> kuba et al <NUMBER> animal models infection sarscov showed ace<NUMBER> downregulation resulted proinflammatory responses including lung injury cardiac contractility impairment crackower et al <NUMBER> imai et al <NUMBER> kuba et al <NUMBER> sarscov<NUMBER> infections progress similarly sarscov virus may deteriorate patients condition via two production contribute tissue damage covid<NUMBER> although ace inhibitors arbs directly affect ace<NUMBER> indirectly lead increased ace<NUMBER> activity ang<NUMBER> expression hanff harhay brown cohen mohareb <NUMBER> study ferrario coworkers showed ace inhibitor caused <NUMBER>fold rise plasma ang<NUMBER> concentrations approximately <NUMBER> increase ace<NUMBER> expression left ventricle ferrario et al <NUMBER> thus usage ace inhibitors arbs may potential benefit preventing covid<NUMBER>triggered organ damage via upregulation ang<NUMBER> depletion ang ii conclusion dysregulation raas due increased ang ii decreased ace<NUMBER> lead harmful inflammatory response worsening j u r n l p r e p r f elevated blood pressure ace inhibitors arbs may potential role preventing harmful effects directly countering ang ii upregulating ace<NUMBER> acute respiratory distress syndrome ards common devastating orfanos et al <NUMBER> ace activity considerably elevated bronchoalveolar lavage fluid balf j u r n l p r e p r f patients ards idell et al <NUMBER> polymorphic insert reduces ace expression activity associated reduced ards severity marshall et al <NUMBER> ace expression activates macrophage function stimulates interleukin il formation covid<NUMBER> associated increased proportion mononuclear phagocytes regulated raas merad martin <NUMBER> addition alveolar macrophages associated tissue repair fibrosis generation covid<NUMBER> patients ramachandran et al <NUMBER> lastly ace inhibitors decrease oxygen free radical production generated lung alveolar macrophages suzuki et al <NUMBER> yamamoto et al <NUMBER> ang ii also induce endothelial expression il<NUMBER> eselectin pselectin ccchemokine ligand<NUMBER> ccl<NUMBER> ccl<NUMBER> increase pulmonary leukocyte recruitment retention bernstein et al <NUMBER> moreover ang ii induces nicotinamide adenine dinucleotide phosphate nadph oxidase vascular smooth muscle cells endothelial cells increase reactive oxygen species ros cause vascular injury bernstein et al <NUMBER> addition ang ii reduces alveolar epithelial cell survival accelerating cellular j u r n l p r e p r f apoptosis ec <NUMBER> <NUMBER> nm r wang et al <NUMBER> epithelial apoptosis linked subsequent fibrotic responses shetty et al <NUMBER> uhal et al <NUMBER> finally severe ards covid<NUMBER> patients often suffer septic shock prolonged ang ii signaling induces at<NUMBER>r phosphorylation desensitization major cause vascular hyporesponsiveness leads pulmonary vasoplegia levy et al <NUMBER> together data suggests ang ii may potential therapeutic target treatement many vascular pathophysiologies covid<NUMBER> ang ii lower ace<NUMBER> deleterious cardiovascular consequences also worsens lung functional decline compared wt mice ace<NUMBER>deficient mice impaired lung function higher mortality sepsisinduced lung injury severe lung failure ace<NUMBER>deficient mice could rescued j u r n l p r e p r f inactivation ace at<NUMBER>r blockage arbs prevent downregulation ace<NUMBER> lpsinduced ards suggesting raas inhibitors may also protect lung damage patients sars wostenvan asperen et al <NUMBER> furthermore downregulation ace<NUMBER> lead elevated activation ace ang ii li et al <NUMBER> simoes e silva et al <NUMBER> exacerbate physiological progression ards covid<NUMBER> thus despite acting receptor sarscov<NUMBER> ace<NUMBER> activity likely protective covid<NUMBER> disease progression conclusion elevation ace ang ii downregulation ace<NUMBER> exacerbate sarscov<NUMBER> induced ards drugs target ace ang ii ace inhibitors arbs may play important role abrogating inflammatory response vasoconstriction vq mismatching causes clinical deterioration patients covid<NUMBER> animal models clinical experience suggest beneficial deleterious effects ace inhibitors arbs patients suffering covid<NUMBER> uncertainty raises concerns regarding overall effect raas inhibitors sarscov<NUMBER> infection sriram insel <NUMBER> concerns ignored examination clinical outcomes raas inhibitor application covid<NUMBER> patients top priority g l zhou et al <NUMBER> accumulated clinical data demonstrates hypertension associated higher mortality patients covid<NUMBER> sars middle east respiratory syndrome mers inhibitors covid<NUMBER>related outcomes south korea jung et al <NUMBER> among <NUMBER> confirmed sarscov<NUMBER> patients raas inhibitor use alter mortality adjusted <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> jung et al <NUMBER> among hospitalized covid<NUMBER> patients hypertension inhospital mortality lower <NUMBER> patients given raas inhibitors treated raas inhibitors <NUMBER> although difference statisticaly significant p<NUMBER> jung et al <NUMBER> multivariate analysis adjusted baseline comorbidities revealed independent association raas inhibitor use risk mortality among hypertensive covid<NUMBER> patients adjusted <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> jung et al <NUMBER> mancia et al <NUMBER> data suggest treatment ace inhibitorsarbs increase inhibitortreated subjects may seek routine intensive medical care heightened awareness leads diligent hygiene andor social distancing addition findings may replicate populations geographically ethnically diverse cohorts randomized controlled clinical trials needed better understand specific effect raas inhibitors covid<NUMBER> patients two recent studies suggest interesting finding ace inhibitors might reduce covid<NUMBER> morbidity arbs less pronounced effect khera et al reported <NUMBER> hypertensive sarscov<NUMBER> patients treated ace inhibitors <NUMBER> less likely hospitalized treated ace inhibitors reduction hospitalization patients treated arbs khera et al <NUMBER> milne et al j u r n l p r e p r f analyzed gene expression <NUMBER> lung tissue samples discovered ace inhibitor treatment associated significantly lower expression ace<NUMBER> coreceptor tmprss<NUMBER> contrast tmprss<NUMBER> expression altered patients treated arbs milne yang timens bosse sin <NUMBER> data provide potential mechanistic explanation protective role ace inhibitors arbs covid<NUMBER> treatment review recent literature suggests potential protective effects continued treatment cvd covid<NUMBER> subjects ace inhibitors andor authors declared competing interests exist arb angiotensinreceptor blocker recent severe acute respiratory syndrome sars due coronavirus <NUMBER> cov<NUMBER> infection pandemic subsequent spread disease called covid<NUMBER> brought back discussion topic already highlighted sarscov<NUMBER> coronavirusrelated sars known middle east respiratory distress syndrome mers <NUMBER> <NUMBER> outbreaks observed particularly elevated incidence cardiovascular disease among patients also characterized elderly particular mers prevalently male <NUMBER> <NUMBER> another main topic discussion role angiotensinconverting enzyme ace <NUMBER> indeed carboxypeptidase identified functional receptor spike protein coronaviruses outer membrane including sarscov<NUMBER> <NUMBER> ace<NUMBER> strongly expressed epithelium different organs kidney heart lungs ace<NUMBER> shares large affinity amino peptidase ace target ace inhibitors class antihypertensive drugs ace inhibitors represent used class cardiovascular agents world treatment epidemic cardiovascular conditions hypertension heart failure although directly inhibited ace inhibitors ace<NUMBER> affected chronic treatment class drugs leads increase ace<NUMBER> expression several tissues <NUMBER> interestingly feature also shared another class drugs angiotensin receptor<NUMBER> blockers arbs whose chronic administration well able increase level expression ace<NUMBER> also activity assessed circulating levels ace<NUMBER> product angiotensin <NUMBER> <NUMBER> findings support concern treatment reninangiotensin system ras inhibitors could make covid<NUMBER> symptoms severe due increased expression ace<NUMBER> remarkably issues reproposed occurrence present epidemic covid<NUMBER> particular issue prevalence cardiovascular diseases among covid<NUMBER> patients proposed observational data obtained chinese <NUMBER> italian patients <NUMBER> context still lack analysis confounding effects age apparent association cardiovascular disease covid<NUMBER> infection clinical severity indeed observed prevalence male elderly patients observed especially italian covid<NUMBER> population confounding factor needs corrected conclusive association drawn concern expressed many <NUMBER> <NUMBER> <NUMBER> similarly ace<NUMBER> upregulation argument never demonstrated humans indeed conflicting evidence animal studies arbs probably ace inhibitors may upregulate membranebound ace<NUMBER> tissuespecific manners eg heart kidney data cannot extrapolated humans sufficient support facilitation sarscov<NUMBER> entry <NUMBER> particular never demonstrated ace<NUMBER> upregulation human lung occurs upon ras inhibition even less causes worsening covid<NUMBER> disease furthermore also speculated ace<NUMBER> upregulation protective indeed shown binding coronavirus ace<NUMBER> leads downregulation ace<NUMBER> <NUMBER> turn causes aceace<NUMBER> imbalance excessive production angiotensin ii related ace enzyme excess angiotensin ii stimulates angiotensin ii receptor type <NUMBER> at<NUMBER>r might cause increase pulmonary vascular permeability lung damage <NUMBER> therefore according hypothesis upregulation ace<NUMBER> caused chronic intake at<NUMBER>r ace inhibitors could protective two mechanisms first blocking increased production angiotensin <NUMBER> advocated possible mechanism protection lung second reducing production angiotensin ii removes cause lung damage <NUMBER> context uncertainty advocates within scientific community raising voices cessation ace inhibitors arbs among patients taking drugs claimed prevention infection attenuation symptoms case infection speculative claims taken laical press starting word mouth sustains panic behaviors among general population italian society hypertension siia therefore takes clear firm position line statements international societies see table <NUMBER> furthermore siia reiterates subsequent points acute suspension without medical control cardiovascular therapy specifically antihypertensive treatment increases occurrence acute events including hypertensive emergencies heart failure decompensation heart attacks stroke b favorable effects ace inhibitors arbs control progression cvds general particular hypertensive patients confirmed many years reason ras inhibitors represent central agents management cardiovascular conditions cannot easily substituted <NUMBER> c hypertensive patients covid<NUMBER> risk covid<NUMBER> infection ace inhibitors arbs treatment maintained according recommendations contained <NUMBER> escesh guidelines <NUMBER> similarly patients currently therapy ace inhibitors arbs case patients heart failure also arnis drugs must suspended e patients covid<NUMBER> severe symptoms sepsis ace inhibitors arbs like antihypertensive drugs used discontinued case case basis taking account current guidelines siia hopes promotes research analyzes constantly increasing data impact hypertension antihypertensive drugs particular ace inhibitors arbs clinical course covid<NUMBER> infections order update positions new evidence becomes available particular clarify mechanism prevalent role clinical manifestation covid<NUMBER> siia launched factfinding investigation verify impact therapy inhibitors reninangiotensin system onset clinical manifestation disease covid<NUMBER> observational research based online questionnaire made <NUMBER> questions collect information medical history evolution disease covid<NUMBER> patients id nct<NUMBER> clinicaltrialsgov conflict interest behalf authors corresponding author states conflict interest open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holderto view copy licence visit httpcreat iveco mmons orglicen sesbync<NUMBER> recent severe acute respiratory syndrome sars due coronavirus <NUMBER> cov<NUMBER> infection pandemic subsequent spread disease called covid<NUMBER> brought back discussion topic already highlighted sarscov<NUMBER> coronavirusrelated sars known middle east respiratory distress syndrome mers <NUMBER> <NUMBER> outbreaks observed particularly elevated incidence cardiovascular disease among patients also characterized elderly particular mers prevalently male <NUMBER> <NUMBER> another main topic discussion role angiotensinconverting enzyme ace <NUMBER> indeed carboxypeptidase identified functional receptor spike protein coronaviruses outer membrane including sarscov<NUMBER> <NUMBER> ace<NUMBER> strongly expressed epithelium different organs kidney heart lungs ace<NUMBER> shares large affinity amino peptidase ace target ace inhibitors class antihypertensive drugs ace inhibitors represent used class cardiovascular agents world treatment epidemic cardiovascular conditions hypertension heart failure although directly inhibited ace inhibitors ace<NUMBER> affected chronic treatment class drugs leads increase ace<NUMBER> expression several tissues <NUMBER> interestingly feature also shared another class drugs angiotensin receptor<NUMBER> blockers arbs whose chronic administration well able increase level expression ace<NUMBER> also activity assessed circulating levels ace<NUMBER> product angiotensin <NUMBER> <NUMBER> findings support concern treatment reninangiotensin system ras inhibitors could make covid<NUMBER> symptoms severe due increased expression ace<NUMBER> remarkably issues reproposed occurrence present epidemic covid<NUMBER> particular issue prevalence cardiovascular diseases among covid<NUMBER> patients proposed observational data obtained chinese <NUMBER> italian patients <NUMBER> context still lack analysis confounding effects age apparent association cardiovascular disease covid<NUMBER> infection clinical severity indeed observed prevalence male elderly patients observed especially italian covid<NUMBER> population confounding factor needs corrected conclusive association drawn concern expressed many <NUMBER> <NUMBER> <NUMBER> similarly ace<NUMBER> upregulation argument never demonstrated humans indeed conflicting evidence animal studies arbs probably ace inhibitors may upregulate membranebound ace<NUMBER> tissuespecific manners eg heart kidney data cannot extrapolated humans sufficient support facilitation sarscov<NUMBER> entry <NUMBER> particular never demonstrated ace<NUMBER> upregulation human lung occurs upon ras inhibition even less causes worsening covid<NUMBER> disease furthermore also speculated ace<NUMBER> upregulation protective indeed shown binding coronavirus ace<NUMBER> leads downregulation ace<NUMBER> <NUMBER> turn causes aceace<NUMBER> imbalance excessive production angiotensin ii related ace enzyme excess angiotensin ii stimulates angiotensin ii receptor type <NUMBER> at<NUMBER>r might cause increase pulmonary vascular permeability lung damage <NUMBER> therefore according hypothesis upregulation ace<NUMBER> caused chronic intake at<NUMBER>r ace inhibitors could protective two mechanisms first blocking increased production angiotensin <NUMBER> advocated possible mechanism protection lung second reducing production angiotensin ii removes cause lung damage <NUMBER> context uncertainty advocates within scientific community raising voices cessation ace inhibitors arbs among patients taking drugs claimed prevention infection attenuation symptoms case infection speculative claims taken laical press starting word mouth sustains panic behaviors among general population italian society hypertension siia therefore takes clear firm position line statements international societies see table <NUMBER> furthermore siia reiterates subsequent points acute suspension without medical control cardiovascular therapy specifically antihypertensive treatment increases occurrence acute events including hypertensive emergencies heart failure decompensation heart attacks stroke b favorable effects ace inhibitors arbs control progression cvds general particular hypertensive patients confirmed many years reason ras inhibitors represent central agents management cardiovascular conditions cannot easily substituted <NUMBER> c hypertensive patients covid<NUMBER> risk covid<NUMBER> infection ace inhibitors arbs treatment maintained according recommendations contained <NUMBER> escesh guidelines <NUMBER> similarly patients currently therapy ace inhibitors arbs case patients heart failure also arnis drugs must suspended e patients covid<NUMBER> severe symptoms sepsis ace inhibitors arbs like antihypertensive drugs used discontinued case case basis taking account current guidelines siia hopes promotes research analyzes constantly increasing data impact hypertension antihypertensive drugs particular ace inhibitors arbs clinical course covid<NUMBER> infections order update positions new evidence becomes available particular clarify mechanism prevalent role clinical manifestation covid<NUMBER> siia launched factfinding investigation verify impact therapy inhibitors reninangiotensin system onset clinical manifestation disease covid<NUMBER> observational research based online questionnaire made <NUMBER> questions collect information medical history evolution disease covid<NUMBER> patients id nct<NUMBER> clinicaltrialsgov conflict interest behalf authors corresponding author states conflict interest open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holderto view copy licence visit httpcreat iveco mmons orglicen sesbync<NUMBER> <NUMBER> may <NUMBER> <NUMBER> millions people world confirmed <NUMBER> novel coronavirus disease infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> initially called <NUMBER>ncov <NUMBER> february <NUMBER> part coronaviridae family positivesense singlestranded rna viruses includes sarscov merscov middle east respiratory syndrome coronavirus also cause severe respiratory infections death count china far <NUMBER> number expected go higher increasing article open access article distributed terms conditions creative commons attribution cc license httpcreativecommonsorglicensesby<NUMBER> number confirmed nonconfirmed cases medical research community vigorously seeking treatment control infection save lives severely infected patients weeks covid<NUMBER> outbreak complete genome sarscov<NUMBER> determined reported genbank accession mn<NUMBER> viruses also isolated patients understand genomic characteristics mechanism viral infection revealed analysis sarscov<NUMBER> shared <NUMBER> sequence identity sarscov one study sarscov<NUMBER> found closely related two batderived severe acute respiratory syndrome sarslike coronaviruses <NUMBER> <NUMBER> shared identity <NUMBER> another study sarscov<NUMBER> <NUMBER> identical wholegenome level bat coronavirus <NUMBER> despite high sequence identity sarscov<NUMBER> sarscov open reading frame regions envelop spike protein sprotein <NUMBER> mediates infection sarscov via human host protein ace<NUMBER> <NUMBER> shared sequence identity sarscov sarscov<NUMBER> <NUMBER> within sprotein receptor docking domain higher divergence four five critical ace<NUMBER> interacting amino acid residues replaced sars cov<NUMBER> however structural modeling indicated four residues sarscov<NUMBER> retain structural conformation similar sarscov sarscov<NUMBER> sprotein able bind ace<NUMBER> reasonable affinity <NUMBER> indeed studies zhou et al using cells expressing human ace<NUMBER> confirmed sarscov<NUMBER> could infect cells via protein ace<NUMBER> sarscov <NUMBER> thus one option treat infection search inhibitor prevent interaction sarscov<NUMBER> sprotein human ace<NUMBER> availability genome sequence sarscov<NUMBER> allows us establish structural models sprotein <NUMBER> rna coronaviruses encodes polyproteins processed viral proteases yield mature proteins mechanism shared picornaviruses retroviruses patients treated protease inhibitors appeared much better clinical outcomes without using inhibitors sars death <NUMBER> vs <NUMBER> <NUMBER> molecular dynamics simulations revealed molecular docking active site main protease <NUMBER>cl sarscov lopinavir ritonavir could induce conformation changes potentially interfere infection sars virus <NUMBER> expect apply sarscov<NUMBER> crystal structure sarscov<NUMBER> protease <NUMBER>cl pro recently reported liu et al <NUMBER> thus another option treat sarscov<NUMBER> infection search inhibitors sarscov<NUMBER> <NUMBER>cl pro models crystal data performed silico studies potential inhibitors sarscov<NUMBER> sprotein <NUMBER>cl pro calculations operated dell poweredge c<NUMBER> servers chemical structures prepared autodocktools<NUMBER> <NUMBER> chimera <NUMBER> <NUMBER> avogadro <NUMBER> docking studies performed autodock <NUMBER> autodock<NUMBER> autodocktools<NUMBER> <NUMBER> autodock vina <NUMBER> <NUMBER> <NUMBER>cl proteases threedimensional crystal structure retrieved protein data bank pdb id <NUMBER>lu<NUMBER> applied receptor molecular docking cleaning chimera ligands observed ie fdaapproved drugs <NUMBER> structures total retrieved bindingdb httpswwwbindingdborg structures ligands optimized avogadro force field applied geometry optimization mmff<NUMBER> sarscov<NUMBER>ace<NUMBER> structure retrieved using function comparative modeling chimera interface modeler version <NUMBER> <NUMBER> preparation sarscov<NUMBER>ace<NUMBER> structure target template sequence retrieved zhang et als work sarscovace<NUMBER> pdb id <NUMBER>acd served template also top candidate basic local alignment search tool blast results sarscov sarscov<NUMBER> <NUMBER> similarity <NUMBER>d structure predicted high accuracy next sequence alignments performed using sarscov template model built followed refining loops side chain optimization model optimization homology model generated validated using whatcheckprocheck program <NUMBER> basic parameters like torsion angle rotational angle bond length etc finally model used receptor docking purposes loop refinement side chain optimization performed using chimera <NUMBER> selecting active region parameters default version noteworthy calculated work performed crystal structure covid<NUMBER> sprotein released <NUMBER>lzg <NUMBER>vw<NUMBER> etc crystal structures released structures compared structures overlaid well figure <NUMBER> <NUMBER> residues allowed region minor difference top right loop site interacts ace<NUMBER> recalculation conducted using new crystal structures sarscov<NUMBER> <NUMBER> cl inhibition calculation input files autodock vina prepared receptors original file pdb format ligands files sdf format using autodocktools<NUMBER> minimizing grid box set <NUMBER> å × <NUMBER> å ×<NUMBER> å along x z axis respectively docking site defined <NUMBER> å using autodock vina grid box set docking site h<NUMBER> c<NUMBER> e<NUMBER> regions according docking site coronavirus main proteinase <NUMBER> cl severe acute respiratory syndrome sars receptor file pdbqt format docking purposes prepared addition polar hydrogen atoms removal water molecules calculation gasteiger charge instructed command prompts used docking process docking output file includes docking energy kcalmol indication binding affinityefficiency one specific ligand receptor molecule interaction ligands receptor hydrogen bond pipi stacking etc sarscov<NUMBER> sprotein inhibition calculation pdb files sarscov<NUMBER> sprotein generated using homology modeling method chimera template used sarscov sprotein minimization input file prepared using autodocktools<NUMBER> grid box rectangular shaped area covered possible docking sites sarscov<NUMBER> sprotein receptor ace<NUMBER> chosen <NUMBER> å × <NUMBER> å ×<NUMBER> å along x z axis respectively docking site defined <NUMBER> å using autodock vina receptor file pdbqt format docking purposes prepared addition polar hydrogen atoms removal water molecules calculation gasteiger charge docking results ranked order high low different modes according docking scores docking energy kcalmol ligands negative docking scoresie highest affinitieswere selected visualization docked complexes using chimera <NUMBER> docking energies sarscov<NUMBER> sprotein human ace<NUMBER> calculated using bioluminate <NUMBER> <NUMBER> <NUMBER> compared docking energies sarscov sprotein human ace<NUMBER> verify whether ligands used blocking interaction sprotein human ace<NUMBER> docking energies sarscov<NUMBER> sproteinligands human ace<NUMBER> also calculated solvation model used vsgb <NUMBER> force field chosen opls<NUMBER> <NUMBER> docking energy predictions table <NUMBER> shows binding affinity several ligands sarscov<NUMBER> <NUMBER> cl protease sorted according docking scores binding affinities calculated autodock vina figure <NUMBER> shows docking high docking scorestadalafil dasatinib saquinavirwith protease docking sites protease modeled ligands may bind large docking area top sprotein interacts ace<NUMBER> red cycle figure <NUMBER>a table <NUMBER> shows binding affinities several ligands highest docking scores toward top docking side sprotein figure <NUMBER>b shows dockings several ligands sarscov<NUMBER> sprotein understand whether ligands reasonably good inhibitors block interaction sarscov<NUMBER> sprotein ace<NUMBER> docking energy sproteinligand complex ace<NUMBER> calculated results listed table <NUMBER> comparison docking energy sarscov sprotein ace<NUMBER> also calculated score −<NUMBER> kcalmol close −<NUMBER> kcalmol reported xu et als work <NUMBER> docking energy sarscov<NUMBER> sprotein ace<NUMBER> calculated −<NUMBER> kcalmol suggesting slightly weaker interaction sarscov sprotein ace<NUMBER> observation similar reported xu et als work <NUMBER> table <NUMBER> shows half ligands docking onto sarscov<NUMBER> sprotein significantly change interaction sarscov<NUMBER> sprotein ace<NUMBER>ie inhibitors block interaction sarscov<NUMBER> sprotein ace<NUMBER> however ergotamine amphotericin b vancomycin zafirlukast lanicor showed bound sprotein interactions complex ace<NUMBER> longer energetically favored interactionsie ligands acted desired inhibitors efficiently block interaction sarscov sprotein ace<NUMBER> among ergotamine amphotericin b promising since demonstrate highest docking energy sarscov<NUMBER> sprotein table <NUMBER> thus strongly suggested core drugs clinical trials treat covid<NUMBER> patients considering severe potentially lethal side effects amphotericin b <NUMBER> ergotamine vancomycin seem top choices disulfiram lopinavir ritonavir three approved active protease inhibitors sars mers indeed lopinavir ritonavir successfully used treat patient thailand jan <NUMBER> results show among ligands saquinavir tadalafil rivaroxaban sildenafil dasatinib vardenafil montelukast promising due higher docking scores −<NUMBER> kcalmol coresponds <NUMBER> μm ic<NUMBER> others scores appear better antiviral drug lopinavir −<NUMBER> kcal mol comparison docking scores reported lopinavir viral rna polymerase −<NUMBER> kcalmol <NUMBER> remarkable observation sarscov<NUMBER> inhibitors indinavir could block interaction sarscov<NUMBER> sprotein ace<NUMBER> inhibitors ergotamine amphotericin b effectively inhibit interaction somewhat confusing since three compounds dock docking site marked red circles figure <NUMBER> grove extended insertion contains β<NUMBER>β<NUMBER> strands receptorbinding motif rbm loop <NUMBER> comprehend caused significant difference overlaid structures three docked compounds ace<NUMBER> sarscov<NUMBER> spike protein figure <NUMBER> comparison clearly shows ergotamine red amphotericin b blue extend toward ace<NUMBER> thus effectively block interaction sarscov<NUMBER> spike protein ace<NUMBER> indinavir green clings sarscov<NUMBER> spike protein leaving room ace<NUMBER> interact spike protein inhibition sarscov<NUMBER> <NUMBER> cl protease saquinavir tadalafil rivaroxaban sildenafil dasatinib vardenafil montelukast promising due high docking scores − <NUMBER> kcalmol negative ligands among showed excellent inhibiting property block interaction sarscov<NUMBER> sprotein ace<NUMBER> table <NUMBER> ergotamine amphotericin b vancomycin promising since also among highest bind sarscov<NUMBER> sprotein shown table <NUMBER> active results combination <NUMBER> cl protease inhibitors ergotamine may considered comparison crystal structures sars<NUMBER> spike protein <NUMBER>vw<NUMBER> pink color homology modeling light brown color using sars<NUMBER> template overlay modeled structures amphotericin ergotamin indinavir ace<NUMBER> sarscov<NUMBER> spike protein reninangiotensin system ras plays key role maintaining blood pressure homeostasis well fluid salt balance angiotensin ii key effector peptide system causes vasoconstriction exerts multiple biological functions angiotensinconverting enzyme ace plays central role generating angiotensin ii angiotensin capillary blood vessels lung one major sites ace expression angiotensin ii production human body ras implicated pathogenesis pulmonary hypertension pulmonary fibrosis commonly seen chronic lung diseases chronic obstructive lung disease recent studies indicate ras also plays critical role acute lung diseases especially acute respiratory distress syndrome ards ace<NUMBER> close homologue ace functions negative regulator angiotensin system identified key receptor sars severe acute respiratory syndrome coronavirus infections lung ace<NUMBER> protects acute lung injury several animal models ards thus ras appears play critical role pathogenesis acute lung injury indeed increasing ace<NUMBER> activity might novel approach treatment acute lung failure several diseases many decades roles reninangiotensin system ras studied physiology multiple disorders particular cardiovascular diseases <NUMBER> <NUMBER> angiotensin ii ang ii key effector peptide ras exerts multiple biological functions including vasoconstriction sodium balance involved blood pressure homeostasis angiotensinconverting enzyme ace plays central role generating ang ii angiotensin ang <NUMBER> <NUMBER> figure <NUMBER> ace inhibitors ang ii receptor blockers exhibit beneficial effects cardiovascular diseases capillary blood vessels lung major site highlevel expression ace <NUMBER> thus lung important organ generating circulating ang ii acting classical circulationborne endocrine system contrast endocrine ras model numerous studies highlighted importance local rass <NUMBER> example increase endothelial ace expression muscularized intraacinar arteries lungs shown patients pulmonary hypertension <NUMBER> rats hypoxiainduced pulmonary hypertension <NUMBER> addition ace components ras expressed lungs including renin <NUMBER> angiotensinogen <NUMBER> ang ii receptors <NUMBER> <NUMBER> ace<NUMBER> homologue ace identified discovery instantaneously added new complexity ras <NUMBER> <NUMBER> although ace<NUMBER> functions similarly ace carboxypeptidase ace<NUMBER> different substrate specificity <NUMBER> <NUMBER> <NUMBER> shown vitro analyses using recombinant ace<NUMBER> protein whereas ace removes dipeptides cterminus peptide substrates generating octapeptide ang ii decapeptide ang <NUMBER> <NUMBER> ace<NUMBER> cleaves single residue ang ii generating angiotensin<NUMBER> <NUMBER> <NUMBER> single residue ang ii generate angiotensin<NUMBER> <NUMBER> genetic inactivation ace using homologous recombination results phenotype characterized spontaneous hypotension reduced male fertility kidney malformation <NUMBER> contrast targeted disruption murine ace<NUMBER> resulted increased systemic ang ii levels impaired cardiac contractility aged mice <NUMBER> loss ace ace<NUMBER> background reversed cardiac phenotype <NUMBER> thus ace<NUMBER> appears negative regulator ras counterbalances function ace figure <NUMBER> importance ras lung diseases recently reemerged since identification ace<NUMBER> severe acute respiratory syndrome sars coronavirus receptor several months <NUMBER> sars newly identified illness spread rapidly china throughout world causing <NUMBER> deaths <NUMBER> <NUMBER> novel coronavirus identified sars pathogen triggered atypical pneumonia characterized high fever severe dyspnea <NUMBER> <NUMBER> death rate following sars coronavirus exposure approached almost <NUMBER> infected people owing development acute respiratory distress syndrome ards ards severe form acute lung injury characterized pulmonary oedema accumulation inflammatory cells severe hypoxia <NUMBER> <NUMBER> clinical well experimental animal studies implicated ace pathogenesis ards <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> expressed lungs healthy diseased humans <NUMBER> recent ards sars studies shown ace<NUMBER> protects murine lungs severe acute injury <NUMBER> <NUMBER> importantly experiments also revealed ace<NUMBER> essential receptor sars infections vitro vivo <NUMBER> <NUMBER> review review role ras particular sars receptor ace<NUMBER> lung diseases focusing pulmonary hypertension pulmonary fibrosis acute lung injury possible applications blocking ras andor modulating ace<NUMBER> treatment lung diseases discussed pulmonary hypertension characterized elevations pulmonary artery pressure pulmonary vascular resistance caused multiple etiologies including primary pulmonary hypertension chronic obstructive pulmonary disease copd high altitude pulmonary embolism abnormal pulmonary vasoconstriction pulmonary vascular remodeling major pathological features seen forms pulmonary hypertension <NUMBER> <NUMBER> although ang ii well known potent vasopressor peptide pathogenesis pulmonary hypertension ang ii seems play role pulmonary vascular remodeling rather pulmonary vasoconstriction vitro cell culture models ang ii shown directly cause growthproliferation pulmonary artery smooth muscle cells largely ang ii type <NUMBER> rather type ii <NUMBER> receptors <NUMBER> figure <NUMBER> pulmonary hypertension vivo expression ace increased endothelial layer small well elastic pulmonary arteries <NUMBER> <NUMBER> addition hypoxic monocrotalinetreated <NUMBER> pulmonary hypertensive rats ang ii binding number <NUMBER> receptors increased <NUMBER> <NUMBER> human patients association ace insertiondeletion polymorphism allele human ace gene confers increased ace activity plasma pulmonary hypertension reported association however controversial instance one study showed ace dd genotype associated less right ventricular hypertrophy <NUMBER> whereas another reported correlation ace dd genotype severity symptoms <NUMBER> pharmacologic treatment animals either ace blocker ang ii receptor antagonist inhibited pulmonary vascular remodeling associated development pulmonary hypertension chronically hypoxic rats mice <NUMBER> <NUMBER> monocrotalinetreated rats <NUMBER> contrast tissue acedeficient mice exhibit undetectable lung ace activity retain <NUMBER> ace activity plasma show remodeling pulmonary arterioles wildtype mice <NUMBER> addition despite earlier studies acute ace inhibition <NUMBER> <NUMBER> <NUMBER> recent pilot study patients pulmonary hypertension secondary copd showed treatment <NUMBER> receptor blocker losartan <NUMBER> mg showed statistically significant beneficial effect terms pulmonary artery pressure exercise capacity breathlessness score <NUMBER> discrepancy hypoxic rat studies human trial might caused differences pathogenesis hypoxic rats versus patients copdrelated pulmonary hypertension studies required solve important issues pulmonary fibrosis frequent response insults injuries lung etiologies include idiopathic pulmonary fibrosis sarcoidosis irradiationinduced pneumonitis ards excess deposition extracellular matrix proteins key feature interstitial fibrosis lung pathogenesis pulmonary fibrosis includes endothelial epithelial cell injury influx inflammatory cells production chemical mediators leading proliferation activation fibroblasts <NUMBER> <NUMBER> although various initiating mechanisms etiologies terminal phases fibrosis commonly characterized proliferation progressive <NUMBER> respiratory figure <NUMBER> current view ras pulmonary hypertension pulmonary fibrosis ang serves substrate ace ace<NUMBER> ang ii known act vasoconstrictor well mitogen smooth muscle cells fibroblasts mainly <NUMBER> receptor function angiotensin<NUMBER> well understood ace ace<NUMBER> involved production vasodilator peptide angiotensin<NUMBER> accumulation connective tissue replacing normal functional parenchyma ang ii immunoreactivity also significantly increased within lung fibroblasts macrophages bronchiolar alveolar epithelium irradiation <NUMBER> addition angiotensinogen produced fibroblasts fibrotic normal human lung ang ii upregulates expression profibrotic cytokine transforming growth factorb<NUMBER> involved conversion fibroblasts myofibroblasts accumulation collagen <NUMBER> figure <NUMBER> vivo role ang ii pulmonary fibrosis implied animal models bleomycinor irradiationmediated lung injury bleomycininduced pulmonary fibrosis rats mice ace inhibitors <NUMBER> receptor blockers attenuate epithelial apoptosis interstitial fibrosis collagen deposition <NUMBER> <NUMBER> <NUMBER> irradiationinduced lung fibrosis ace inhibitors attenuate endothelial dysfunction fibrosis rats <NUMBER> conversely retrospective comparison incidence irradiationinduced lung injury subjects took ace inhibitors failed reveal protective effect <NUMBER> however serum concentrations ace inhibitors used subjects human study would expected considerably less achieved animal models cited published prospective retrospective studies regarding use ace inhibitors <NUMBER> receptor blockers human pulmonary fibrosis induced factors irradiation therefore still unclear inhibition ras would indeed beneficial effects lung fibrosis ards severe form acute lung injury affects approximately one million individuals worldwide year mortality rate least <NUMBER> <NUMBER> <NUMBER> ards triggered multiple diseases sepsis aspiration trauma acute pancreatitis pneumonias following infections sars coronavirus avian human influenza viruses recent cohort studies ards showed significant association ace insertiondeletion polymorphism susceptibility outcome ards <NUMBER> <NUMBER> dd genotype frequency increased patients ards compared control cohort <NUMBER> addition ace dd allele significantly associated mortality ards group <NUMBER> another study showed patients carrying ace ii genotype significantly increased survival rate <NUMBER> thus results inhibitor experiments rodents <NUMBER> ace allelic correlation studies humans <NUMBER> <NUMBER> suggested ras could play role acute lung failure group investigated role ace<NUMBER> ards using ace<NUMBER> knockout mice acidaspirationinduced ards endotoxininduced ards peritoneal sepsisinduced ards ace<NUMBER> knockout mice exhibited severe disease compared control mice express ace<NUMBER> <NUMBER> loss ace<NUMBER> expression mutant mice resulted enhanced vascular permeability increased lung edema neutrophil accumulation worsened lung function importantly treatment catalytically active enzymatically inactive recombinant ace<NUMBER> protein improved symptoms acute lung injury wildtype mice well ace<NUMBER> knockout mice <NUMBER> thus ace<NUMBER> plays protective role acute lung injury mechanistically negative regulation ang ii levels ace<NUMBER> accounts part protective function ace<NUMBER> ards example <NUMBER> receptor inhibitor treatment additional ace gene deficiency ace<NUMBER> knockout background rescues severe phenotype ace<NUMBER> single mutant mice acute lung injury <NUMBER> addition ace knockout mice <NUMBER>a receptor knockout mice showed improved symptoms acute lung injury <NUMBER> therefore acute lung injury ace ang ii <NUMBER> receptors function lung injurypromoting factors <NUMBER> <NUMBER> whereas ace<NUMBER> protects lung injury <NUMBER> figure <NUMBER> findings suggest beneficial effects ace inhibitors <NUMBER> receptor blockers lung injury models induced bleomycin irradiation observed earlier studies derive largely effects acute phase injuries within months following publication sarscov genome <NUMBER> <NUMBER> ace<NUMBER> identified potential receptor cell line studies vitro <NUMBER> ace<NUMBER> demonstrated bind sarscov spike support syncytia formation fusion spikeproteinexpressing cells large multinucleated cells also seen real sars infections using mouse sars infection model ace<NUMBER> knockout mice group provided evidence ace<NUMBER> indeed essential sars infections vivo <NUMBER> ace<NUMBER> knockout mice infected sars coronavirus become resistant virus infection <NUMBER> virus titers lung tissues infected ace<NUMBER> knockout mice <NUMBER> <NUMBER> fold lower isolated lung sarscovinfected wildtype mice <NUMBER> lung histology ace<NUMBER> knockout mice challenged sars coronavirus showed signs inflammation <NUMBER> whereas sarsinfected wildtype mice displayed mild inflammation leukocyte infiltration <NUMBER> <NUMBER> thus ace<NUMBER> essential receptor sars infections vivo despite many studies sarscov reasons sarscov infections trigger severe lung disease high mortality contrast coronaviruses remain mystery accumulating evidence indicates severe sars infections dependent upon burden viral replication well immunopathologic consequences host response review see <NUMBER> <NUMBER> addition aberrant activation immune systems studies implicated involvement ras sars pathogenesis firstly ace<NUMBER> critical sars receptor vivo secondly ace<NUMBER> components ras play central role controlling severity acute lung failure disease process initiated <NUMBER> figure <NUMBER> intriguingly wildtype mice infected sarscov showed markedly downregulated ace<NUMBER> expression lungs <NUMBER> similarly treatment recombinant sarsspike protein absence virus components downregulates ace<NUMBER> expression vitro vivo <NUMBER> thus sarscovinfected spike proteintreated wildtype mice resemble ace<NUMBER> knockout mice similar ace<NUMBER> mutant mice spiketreated wildtype mice show markedly severe pathology acute lung injury additionally spiketreated mice ang ii peptide levels increased worsened ards symptoms could partially reversed <NUMBER> receptor blocker treatment <NUMBER> contrast spike affect ards symptoms ace<NUMBER> knockout mice <NUMBER> thus downregulation ace<NUMBER> expression sarscov infections might play causal role sars pathogenesis especially disease progression ards ang ii plays roles tissue remodeling fibrotic changes acting fibroblasts smooth muscle cells thereby contributing pathogenesis progression pulmonary fibrosis pulmonary hypertension notion strongly supported successful treatment disease conditions using ace inhibitors <NUMBER> receptor blockers animal models however pilot clinical trials failed observe significant beneficial effects ace inhibitors radiationinduced pulmonary fibrosis positive effects <NUMBER> receptor blockers copdrelated pulmonary hypertension recently critical importance ras pathogenesis acute lung disease ie ardsacute lung injury emerged hypothetically ras appears contribute initial severity lung diseases rather later stages define chronic fibrosis tissue remodeling line notion dd polymorphism ace gene associated incidence pneumonias japanese elderly patients <NUMBER> mortality ards patients <NUMBER> <NUMBER> importantly ace<NUMBER> identified key sars receptor ace<NUMBER> protects murine lungs acute lung injury induced acid aspiration endotoxin shock peritoneal sepsis sars spike challenge findings might provide opportunity develop ace<NUMBER> novel drug ards develops emerging lung infectious diseases avian influenza h<NUMBER>n<NUMBER> <NUMBER> diseases affect lung function <NUMBER> ace<NUMBER> nonspecific protease would also interesting investigate role ace<NUMBER> metabolites including angiotensin<NUMBER> desarg<NUMBER>bradykinin apelin dynorphin ards <NUMBER> look forward use angiotensin systemmodulating agentsmolecules particular ace<NUMBER> schematic diagram proposed role ras development severe ards acute lung injury sarscov infections acid aspiration pneumonias sepsis generation ang ii ang enhanced ace ang ii contributes acute lung failure stimulation <NUMBER> receptor whereas ace<NUMBER> <NUMBER> receptor negatively regulate pathway protect acute lung failure however additional ace<NUMBER>regulated ang iiindependent pathways seem also contribute ards novel therapeutic agents treat severe acute lung failure syndrome currently affects millions people without effective drug treatment novel coronavirus outbreak covid<NUMBER> caused sarscov<NUMBER> originated wuhan hubei providence central china december <NUMBER> declared pandemic march <NUMBER> th <NUMBER> <NUMBER> compared sarscov caused <NUMBER> <NUMBER> outbreak sarscov<NUMBER> appears stronger rate transmission whereas sars infection exhibits prolonged clinical course predominantly involving respiratory manifestations clinical course novel coronavirus unclear clinical insights wuhan suggest patients covid<NUMBER> exhibit severe cardiovascular damage underlying cardiovascular disease appear increased risk death <NUMBER> <NUMBER> sarscov cov<NUMBER> belong betacoronavirus phylogeny <NUMBER> although bats may natural reservoirs sarslike coronavirus <NUMBER> interspecies transfer sarscov sarscov<NUMBER> could occurred civets <NUMBER> pangolins <NUMBER> respectively sarscov strains identified use angiotensin converting enzyme ii ace<NUMBER> receptor portal entry affected cell <NUMBER> <NUMBER> ace<NUMBER> key modulator reninangiotensin system ras signaling pathway involved regulation vascular function including regulation blood pressure natriuresis blood volume control <NUMBER> normally ras system involves formation angiotensin ii ang ii ace contributes multiple cardiovascular physiological pathophysiological functions including hypertension myocardial hypertrophy cardiac fibrosis inflammation vascular remodeling atherosclerosis <NUMBER> <NUMBER> <NUMBER> given adverse cardiovascular effects ras system upregulation inhibition ace inhibitors angiotensin ii receptor blockers arbs mineralocorticoid receptor antagonists mras critical management various cardiovascular diseases last two decades identification ace<NUMBER> involvement counter regulation classic ras system offered potentially new therapeutic target <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> exists membranebound soluble form former mediates sarscov<NUMBER> infection via protein binding <NUMBER> <NUMBER> unclear whether sarscov<NUMBER> interferes ace<NUMBER> manner contributes pathogenesis sars cardiovascular damage observed <NUMBER> <NUMBER> raises question whether ras inhibition cardiovascular patients reassessed setting novel coronavirus classically ras system involves conversion angiotensinogen renin angiotensin ang ang metabolized angiotensin ii ang ii via dipeptide carboxypeptidase angiotensinconverting enzyme ace proinflammatory effects ang ii <NUMBER> <NUMBER> <NUMBER> mediated ang ii type at<NUMBER> receptors recently ace<NUMBER> receptor signaling pathway identified important counter regulatory mechanism classic ras system ace<NUMBER> type integral membrane glycoprotein <NUMBER> expressed predominantly bronchus lung parenchyma heart endothelium kidneys duodenum small intestine <NUMBER> ace<NUMBER> monocarboxypeptidase unlike homolog ace dipeptidase ace<NUMBER> antagonized ace inhibitors <NUMBER> whereas ace contains two active catalytic domains ace<NUMBER> single catalytic domain <NUMBER> identical residues <NUMBER> <NUMBER> major substrate ace<NUMBER> ang ii upon cterminus cleavage produces angiotensin <NUMBER> ang<NUMBER> lphenylalanine <NUMBER> substrates ace<NUMBER> include ang apelin<NUMBER> dynorphin<NUMBER> catalyzed much lower affinities <NUMBER> noncatalytic cterminal domain ace<NUMBER> shares <NUMBER> sequence homology collectrin protein involved neutral amino acid reabsorption intestine kidney <NUMBER> <NUMBER> presence disintegrin metalloproteinase <NUMBER> adam<NUMBER> also known tnfαconverting enzyme tace ace<NUMBER> exhibits ectodomain shedding <NUMBER> resulting formation soluble enzyme ace<NUMBER> also contains calmodulin domain cytoplasmic tail influences ectodomain shedding <NUMBER> ang decapeptide converted octapeptide ang ii ace unlike ace ang converted ang<NUMBER> ace<NUMBER> importantly ang ii converted ang <NUMBER> ace<NUMBER> <NUMBER> ang<NUMBER> range antiinflammatory antioxidant vasodilatory natriuretic effects mediated gpcr mas receptor <NUMBER> <NUMBER> <NUMBER> ang<NUMBER> may produced directly ang alternative pathways involving zinc metallopeptidase neprilysin nep conversion ang<NUMBER> ang <NUMBER> via ace though significantly lower efficiency <NUMBER> genetic deletion studies established ace<NUMBER> essential regulator cardiovascular function <NUMBER> studies focused regulation ace<NUMBER> cardiac myocytes cardiac fibroblasts demonstrated whereas ang ii significantly reduced ace<NUMBER> activity downregulated ace<NUMBER> mrna cardiac myocytes reduced ace<NUMBER> activity fibroblasts <NUMBER> myocytes endothelin<NUMBER> et<NUMBER> also significantly decreased ace<NUMBER> mrna production reduction ace<NUMBER> mrna ang ii et<NUMBER> blocked inhibitors mitogenactivated protein kinase kinase <NUMBER> mapk<NUMBER> suggesting ang ii et<NUMBER> activate extracellular signalregulated kinase erk<NUMBER>erk<NUMBER> reduce ace<NUMBER> <NUMBER> vivo murine studies showed ang ii mediated loss membranebound cardiomyocyte ace<NUMBER> correlated upregulation taceadam<NUMBER> activity prevented at<NUMBER> receptor blockade <NUMBER> cardiac fibroblasts coronary endothelial cells also express ace<NUMBER> tace reciprocal relationship extends cell types well <NUMBER> <NUMBER> ang ii activates several signaling cascades pkc jak<NUMBER>stat<NUMBER> signaling pathways results myocardial hypertrophy increased fibrosis <NUMBER> binding ang<NUMBER> cterminal domain also inhibits proteolytic function ace enzyme promotes bradykinin function <NUMBER> studies human vascular cardiac tissue plasma show ang<NUMBER> higher affinity ace ang suggesting ang<NUMBER>s inhibitory effects ace may contribute protective effects <NUMBER> treatment ace<NUMBER> knock mice ang ii infusion recombinant ace<NUMBER> rhace<NUMBER> eliminated erk<NUMBER> jak<NUMBER>stat<NUMBER> pkc signaling rhace<NUMBER> least partially responsible attenuation ang ii induced myocardial hypertrophy fibrosis improvement diastolic dysfunction <NUMBER> studies highlighted role ace<NUMBER>ang<NUMBER>mas axis modulating expression proinflammatory cytokines tnfα il<NUMBER>β il<NUMBER> mcp<NUMBER> tgfβ cardiaclung fibrosis pulmonary hypertension vascular remodeling <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> given importance ras system cardiovascular disease regulation via ace inhibitors arbs mras played essential role management cardiovascular diseases central illustration several studies elucidated role drug classes modulation ace<NUMBER>ang<NUMBER>mas axis mouse peritoneal macrophages mpms treated vitro aldosterone demonstrated significantly increased ace activity well ace mrna significantly reduced ace<NUMBER> however mpms treated nadph oxidase inhibitor aldosterone could increase ace decrease ace<NUMBER> suggesting effects mediated part nadph oxidase <NUMBER> effects also attenuated treatment mraeplerenone <NUMBER> human monocytederived macrophages obtained patients heart failure one month treatment another mraspironolactone <NUMBER> mgd showed <NUMBER> reduction ace activity <NUMBER> reduction ace mrna expression time ace<NUMBER> activity increased <NUMBER> ace<NUMBER> mrna expression increased <NUMBER> <NUMBER> mice treated two weeks eplerenone cardiac ace<NUMBER> activity increased twofold paralleled increased ace<NUMBER> activity macrophages <NUMBER> study demonstrated mra reduced oxidative stress decreased ace activity increased ace<NUMBER> activityexpression suggesting protective role played increased generation ang <NUMBER> decreased formation ang ii overall aldosterone decreased ace<NUMBER> transcription nicotinamide adenine dinucleotide phosphate oxidasemediated pathway <NUMBER> vascular smooth muscle cells potentiated ang ii signaling increased phosphorylation extracellular signalregulated kinase erk<NUMBER> cjun kinase jnk also dependent reactive oxygen species generation <NUMBER> thus beneficial effects mras likely associated reduction oxidative stress differential control angiotensinases mras appeared promote membrane ace<NUMBER> expression suppress peripheral effects ang ii however effect mras soluble ace<NUMBER> remains unclear similar upregulation ace<NUMBER> observed studies focused effects arb treatment spontaneously hypertensive rats shr treated olmesartan demonstrated <NUMBER>fold greater expression ace<NUMBER> mrna increased ang<NUMBER> thoracic aorta treated atenolol hydralazine exhibited change ace<NUMBER> expression ang<NUMBER> <NUMBER> comparison vessel wall dimensions showed olmesartan selectively reduced thoracic aorta mediatolumen ratio vascular hypertrophy unchanged shr given atenolol hydralazine <NUMBER> change ace<NUMBER>ang<NUMBER> expressionactivity carotid arteries treated animals possibility effects olmesartan vascular ace<NUMBER> gene protein expression result reduced arterial blood pressure ruled given comparative effect observed mice treated atenolol hydralazine <NUMBER> spraguedawley rats treated <NUMBER>week course ang ii infusion showed ang ii upregulated at<NUMBER> receptor downregulated at<NUMBER> receptor ace<NUMBER> activity enos expression increased cd<NUMBER> expression hyaluronidase <NUMBER> however rats treated telmisartan exhibited significantly increased ace<NUMBER> activity enos expression intracardiac vessels intermyocardium well downregulated local expression at<NUMBER> receptor treatment telmisartan also inhibited membrane cd<NUMBER> expression reduced tgfβ smad expression <NUMBER> studies normotensive rats post coronary artery ligation left ventricular remodeling dysfunction exhibited partial resolution following losartan olmesartan treatment augmenting plasma concentrations angiotensins <NUMBER> associated recovery cardiac at<NUMBER> receptor mrna increased ace<NUMBER> mrna post myocardial infarction implying beneficial effects arbs cardiac remodeling accompanied direct blockade at<NUMBER> receptors increased ace<NUMBER> expressionactivity <NUMBER> literature offers conflicting results pertaining arb use level ace<NUMBER> expression myocardium controversy arises difference ace<NUMBER> cell surface expression plasma ace<NUMBER> levels spraguedawley rats left coronary artery ligation myocardial infarction plasma ang ii ang <NUMBER> elevated plasma ace<NUMBER> elevated along enhanced cardiac ace<NUMBER> at<NUMBER> receptor mrna infarct border <NUMBER> receptor upregulation observed remote myocardium <NUMBER> treatment ramipril valsartan resulted increased plasma ang ang ii suppression plasma ace ace<NUMBER> activity however neither monotherapy combination therapy affected ace<NUMBER> at<NUMBER> receptor expression remained levels comparable nonmyocardial infarction control <NUMBER> however prior study murine model showed ace ace<NUMBER> upregulation border infarct zones viable myocardium myocardial infarction treatment ramipril reduced ace expression ace<NUMBER> remained elevated compared noninfarcted control <NUMBER> recent study murine model demonstrated treatment olmesartan telmisartan increased cardiac ace<NUMBER> mrna protein expression augmenting plasma ang <NUMBER>ang ii ratios resulting improved cardiac function alleviated collagen disposition <NUMBER> experiments suggest ace inhibitors arbs variably upregulated ace<NUMBER> expression <NUMBER> arbs inhibit binding ang ii at<NUMBER> receptor permitting circulating ang ii shunted ace<NUMBER> conversion ang<NUMBER> studies suggest ace<NUMBER>ang<NUMBER> axis collaborates regulated at<NUMBER> receptor may important mediating vascular cardiac remodeling effects ang ii mechanisms ace inhibitors act complex although ace<NUMBER> inhibited ace inhibitors <NUMBER> increase ang <NUMBER> suggests clinical effects partly mediated angiotensinases ace inhibitors inhibit conversion ang ang ii inhibit hydrolysis bradykinin ace inhibition promotes vasodilatory effects bradykinin improved endotheliumdependent vasodilation increased prostaglandin nitric oxide production regulation at<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> studies elucidating effect ace inhibition ace<NUMBER> gene shown inhibition ang ii synthesis regulated ace<NUMBER> mrna ace<NUMBER> activity <NUMBER> however ace inhibition alone combination losartan demonstrated increase plasma ang<NUMBER> reducing plasma ang ii <NUMBER> compared degree ace<NUMBER> mrna upregulation seen post losartan monotherapy combination losartan lisinopril resulted suppressed upregulation ace<NUMBER> mrna suggesting ace inhibitors may override signal regulates ace<NUMBER> transcription <NUMBER> although ang ii predominant substrate ace<NUMBER> also convert ang ang <NUMBER> turn could converted ang <NUMBER> via ace ang directly converted ang <NUMBER> via nep <NUMBER> though less favorable kinetics baseline thus one assume ace inhibitors disrupt balance catalytically active ace ace<NUMBER> resulting favored activation ace<NUMBER>ang<NUMBER>mas axis overall given demonstrated antiinflammatory antifibrotic antithrombotic effects associated ace<NUMBER>ang<NUMBER>mas axis upregulation could serve valuable therapeutic target multiple murine studies demonstrated rhace<NUMBER> modulates ras pathway though unclear effects translate humans clinical study nct<NUMBER> assessing pharmacokinetics pharmacodynamics soluble rhace<NUMBER> treatment healthy volunteers known comorbidities showed decrease plasma ang <NUMBER> increased ang <NUMBER> ang <NUMBER> effect blood pressure heart rate <NUMBER> common side effects included diarrhea headache antibodies rhace<NUMBER> developed suggesting elicit immune response single repeated dosing <NUMBER> however studies investigating immunogenicity rhace required patients ards sepsis serum levels ace ang ii elevated <NUMBER> <NUMBER> studies focused microvascular dysfunction sepsis showed degree elevation plasma renin ang ii correlated extent organ failure degree microvascular dysfunction especially patients receiving exogenous vasoconstrictors <NUMBER> also negative correlation reoxygenation rates concentrations plasma renin ang ii <NUMBER> pilot clinical trial nct<NUMBER> patients ards treated rhace<NUMBER> exhibited decreased plasma ang ii elevated plasma ang <NUMBER> surfactant proteind involved innate immunity <NUMBER> il<NUMBER> concentrations treated patients also reduced albeit statistically insignificantly owed intrasubject variability baseline imbalance although rhace<NUMBER> attenuated ras mediators infusions medication show improvement physiological clinical measures ards study <NUMBER> additional pilot study nct<NUMBER> investigated effects rhace<NUMBER> human pulmonary arterial hypertension characterized reduced ace<NUMBER> activity <NUMBER> treatment rhace<NUMBER> showed improved cardiac output coincided maximum suppression plasma cytokines reduction nitrotyrosine levels improved peripheral vascular resistance well improved renal perfusion <NUMBER> ongoing clinical studies assessing modulation ras axis include <NUMBER> assessment relative activity ace ace<NUMBER> diabetic patients following treatment candesartan nct<NUMBER> <NUMBER> overexpression ace<NUMBER>ang <NUMBER> cardiac progenitor cells assesses enhancement reparative function potential attenuate myocardial ischemiainduced cardiac damage nct<NUMBER> evident targeting ace<NUMBER>ang<NUMBER>mas axis going interesting clinical settings given observed cardioprotective effects vivo murine vitro cell culture models however investigation required demonstrate whether favorable experimental effects could translated clinical benefit several reports noted covid<NUMBER> associated cardiac involvement cohort studies hospitalized patients confirmed covid<NUMBER> several patients presented elevated troponin creactive protein ntprobnp suggestive myocardial injury <NUMBER> <NUMBER> <NUMBER> anecdotal studies reported patients presenting cardiac magnetic resonance imaginingverified acute myopericarditis systolic dysfunction masquerading diffuse stelevation myocardial infarction elevated cardiac markers absence obstructive coronary disease <NUMBER> cohort study <NUMBER> covid<NUMBER> confirmed hospitalized patients wuhan china <NUMBER> acute myocardial injury <NUMBER> shock <NUMBER> arrhythmia <NUMBER> observed patients cardiac injury found high risk death time symptom onset time admission <NUMBER> epidemiological studies emerge china italy affected areas data available elucidate clinical presentation patients cardiovascular damage associated novel coronavirus regard covid<NUMBER> currently several clinical studies investigating effects ras inhibition ace<NUMBER> regulation ongoing study assess impact ace inhibitor arb treatment severity prognosis patients covid<NUMBER> nct<NUMBER> nct<NUMBER> along lines two recently launched trials testing effects losartan among patients hospitalized covid<NUMBER> nct<NUMBER> ambulatory nct<NUMBER> studies launched evaluate effect continuation verses replacement nct<NUMBER> withdrawal nct<NUMBER> ras inhibitors clinical outcomes patients cardiovascular disease covid<NUMBER> also ongoing pilot study assessing effects rhace<NUMBER> treatment patients covid<NUMBER> nct<NUMBER> currently data support conclusive effects use ras inhibitors patients covid<NUMBER> sarscov emerged guangdong province china sarscov<NUMBER> emerged wuhan china closely related betacoronaviruses whose affected receptor ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> time unknown approximate <NUMBER> sequence similarity strains viruses translates similar biological properties <NUMBER> recent studies confirmed covid<NUMBER> exploits ace<NUMBER> entry thus may target similar spectrum cells sarscov <NUMBER> sarscov<NUMBER> binds ace<NUMBER> via spike protein <NUMBER> <NUMBER> surface unit s<NUMBER> protein binds ace<NUMBER> facilitates viral attachment target cells following receptor binding virus must gain access host cytosol accomplished aciddependent proteolytic cleavage protein cellular serine protease tmprss<NUMBER> similar protein priming sarscov <NUMBER> figure <NUMBER> given sequence similarity sarscov sarscov<NUMBER> affected receptor recently confirmed tmprss<NUMBER>mediated viral entry reasonable hypothesize sarscov<NUMBER> may act similarly respect utilizing host endocytosis machinery subsequent virus propagation infection upon binding ace<NUMBER> cleavage protein s<NUMBER>s<NUMBER> sites s<NUMBER> allows fusion viral cellular membranes sarscov internalized penetrates early endosomes clathrindependent manner <NUMBER> viral binding ace<NUMBER> appears affect tnfα activity presence calmodulin inhibitors promotes ectodomain cleavage <NUMBER> case sarscov<NUMBER> possible shedding also mediated tnfα given one clinical features noted covid<NUMBER> patients presence cytokine storm increased plasma concentrations il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα <NUMBER> also possible ace<NUMBER> shedding may mediated cytokines dysregulated covid<NUMBER> shedding contributes downregulation membranebound ace<NUMBER> observed severe acute lung injury <NUMBER> ectodomain shedding increases concentration plasma ace<NUMBER> remains catalytically active though function soluble ace<NUMBER> remains unclear patients advanced heart failure plasma ace<NUMBER> activity increased direct proportion worsening clinical status reduction ejection fraction correlates adverse clinical outcomes <NUMBER> since downregulation bound ace<NUMBER> observed severe acute lung injury <NUMBER> post myocardial infarction <NUMBER> concentrations soluble ace<NUMBER> appears correlate clinical outcomes heart failure patients <NUMBER> possible suggest concentrations soluble ace<NUMBER> may correlate extent tissue damage sustained may correlate degree systemic inflammatory pathways upregulated evidence suggest soluble ace<NUMBER> able regulate systemic ang ii clinical trials shown rhace<NUMBER> could convert systemic ang ii ang <NUMBER> <NUMBER> <NUMBER> play pathological compensatory counter regulatory roles sarscov<NUMBER> induce ace<NUMBER> ectodomain shedding resulting reduction ace<NUMBER> entry sites infected cell possible following transcription proteins fuse directly host cell membrane directly promote infection neighboring cells resulting formation multinucleated syncytia <NUMBER> formation multinucleated cells would allow virus spread without detected neutralized virusspecific antibodies <NUMBER> otherwise following replication transcription complete virion assembly golgi would result transportation virus vesicles release exocytosis <NUMBER> setting full virion assembly exocytosis unclear ace<NUMBER> ectodomain shedding would favorable propagation infection regardless sarscov<NUMBER> completes virion assembly clear membranebound ace<NUMBER> would play physiological role replication novel virus question remains whether use ace inhibitors arbs mras avoided setting sarscov infection given agent <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> upregulates ace<NUMBER> expression activity lipopolysaccharide lpsinduced acute lung injury ali mouse models exhibited decreased expression ace<NUMBER> lung inflammatory injury however ameliorated injection cells transfected ace<NUMBER> results improvement lung function lung injury treatment mice ace inhibitors arbs also alleviated lpsinduced pneumonic injury <NUMBER> prior studies shown sarscov protein exaggerate acute lung failure deregulation reninangiotensin system however sarscov spikemediated lung failure could rescued inhibition at<NUMBER> receptor <NUMBER> adequate data effects ras inhibition covid<NUMBER> patients available ongoing clinicalobservations studies conducted nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> sarscov<NUMBER> downregulates membranebound ace<NUMBER> promoting adam<NUMBER> mediated ectodomain shedding resulting increased concentrations soluble ace<NUMBER> without compromising viral propagation hypothesize would result overall downregulation ace<NUMBER>ang<NUMBER>mas pathway would contribute severity inflammation systemic dysregulation observed sarscov<NUMBER> thus patients cardiovascular disease sarscov<NUMBER> use ace inhibitors arbs mras may favorable method endogenously upregulate ace<NUMBER> compensatory mechanism provides antiinflammatory antifibrotic antithrombotic support well reduction progression vascularcardiac remodeling heart failure several societies including american college cardiology american heart association heart failure society america <NUMBER> european society cardiology <NUMBER> recommended continuing ras system antagonists given lack conclusive data link upregulation systemic tissue ace<NUMBER> increased susceptibility covid<NUMBER> patients cardiovascular disease based review hypothesize cardiovascular patients covid<NUMBER> remain ras system inhibitors given protective effects ace<NUMBER> pathway ras blockade proven increase risk covid<NUMBER> • covid<NUMBER> associated cardiac involvement sarscov<NUMBER> requires binding ace<NUMBER> ras system • ace<NUMBER>ang<NUMBER>mas pathway counterbalances ras system resulting activation antiinflammatory pathways • ace inhibitors arbs mras upregulate ace<NUMBER> activity expression • data required determine regulation ace<NUMBER> patients cardiovascular disease covid<NUMBER> would help improve clinical outcomes central illustration ras system interaction covid<NUMBER> normally ang converted ang ii via ace could inhibited ace inhibitors proinflammatory effects ang ii mediated at<NUMBER>r several ways <NUMBER> zona glomerulosa adrenal medulla stimulates aldosterone secretion binding mineralocorticoid receptors promote water reabsorption increase salt retention inhibited mras <NUMBER> posterior pituitary ang ii stimulates antidiuretic hormone secretion promote water retention <NUMBER> median age <NUMBER> years men <NUMBER> years women strongest predictor elevated concentrations ace<NUMBER> cohorts male sex estimate <NUMBER> p <NUMBER> <NUMBER> p <NUMBER> respectively index cohort use ace inhibitors angiotensin receptor blockers arbs mineralocorticoid receptor antagonists mras independent predictor plasma ace<NUMBER> validation cohort ace inhibitor estimate <NUMBER> p <NUMBER> arb use estimate <NUMBER> <NUMBER> p <NUMBER> independent predictors lower plasma ace<NUMBER> use mra estimate <NUMBER> p <NUMBER> independent predictor higher plasma ace<NUMBER> concentrations two independent cohorts patients heart failure plasma concentrations ace<NUMBER> higher men women use neither ace inhibitor arb associated higher plasma ace<NUMBER> concentrations data might explain higher incidence fatality rate covid<NUMBER> men support world currently faced outbreak new severe acute respiratory syndrome coronavirus sarscov new virus sarscov<NUMBER> emerged december <NUMBER> city wuhan china causative agent respiratory syndrome known coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> efforts aimed curbing spread sarscov<NUMBER> finding effective treatments ongoing early epidemiological observations indicate sarscov<NUMBER> infects age groups older men chronic illnesses may severely affected preponderance men <NUMBER> compared women <NUMBER> testing positive covid<NUMBER> <NUMBER> previous sarscov epidemic <NUMBER> men higher mortality women <NUMBER> vs <NUMBER> <NUMBER> p <NUMBER> <NUMBER> whether men current sarscov<NUMBER> virus also worse mortality outcome becoming apparent recent report indicate <NUMBER> patients died covid<NUMBER> italy men <NUMBER> mainly elderly increased vulnerability older people cardiovascular disease comorbid conditions could related increased concentrations angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> known increased heart failure <NUMBER> ace<NUMBER> enzyme also functional receptor cell surfaces sarscov sarscov<NUMBER> highly expressed heart testis kidneys lungs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> shed plasma reports suggested inhibitors reninangiotensinaldosterone system raas increase plasma ace<NUMBER> concentrations <NUMBER> <NUMBER> although speculations supported substantial body research therefore investigated plasma concentrations ace<NUMBER> two large independent cohorts men women heart failure according use raas inhibitors biology study tailored treatment chronic heart failure biostatchf <NUMBER> measured ace<NUMBER> concentrations <NUMBER> men <NUMBER> women heart failure <NUMBER> european countries results validated another independent biostatchf cohort consisting <NUMBER> men <NUMBER> women heart failure enrolled scotland participants sufficient plasma samples used research design baseline characteristics cohorts biostatchf published elsewhere <NUMBER> inclusion criteria index validation cohorts exception left ventricular ejection fraction lvef <NUMBER> patients btype natriuretic peptide bnp <NUMBER> ngl nterminal probnp ntprobnp <NUMBER> ngl index cohort validation cohort study complied declaration helsinki approved medical ethics committees participating centres <NUMBER> ace<NUMBER> measured using olink proseek analysis service olink proteomics uppsala sweden olink platform <NUMBER> utilizes highthroughput multiplex immunoassay based proprietary proximity extension assay pea technology biomarker addressed matched pair antibodies coupled unique partially complementary oligonucleotides measured quantitative realtime pcr results expressed form relative quantification normalized protein expression npx logarithmically related protein concentration cannot converted absolute protein concentrations interpretations therefore relative absolute analytical validation sensitivity specificity olink assay study achieved comparing available routine laboratory measurements two protein biomarkers growth differentiation factor <NUMBER> gdf<NUMBER> pg ml ntprobnp pgml measured using olink npx ntprobnp canonical biomarker cardiovascular disease biology <NUMBER> statistical analyses performed using r <NUMBER> version <NUMBER> group comparisons categorical variables depicted numbers percentages normally distributed variables depicted means ± sd nonnormally distributed variables median interquartile range iqr defined first third quartile q<NUMBER>q<NUMBER> means continuous variables compared oneway analysis variance anova kruskalwallis test categorical variables compared v <NUMBER> test multivariate models based backward stepwise regression baseline tables made using rbased comparegroups <NUMBER> package general twotailed pvalue <NUMBER> considered statistically significant diabetes higher heart rate lower systolic blood pressure supplementary material online table s<NUMBER> index cohort <NUMBER> <NUMBER> patients received ace inhibitor angiotensin receptor blocker arb validation cohort <NUMBER> <NUMBER> received ace inhibitor arb among patients treated raas inhibitors men predominant uppermost quartile ace<NUMBER> supplementary material online table s<NUMBER> s<NUMBER> ace<NUMBER> concentrations higher men women <NUMBER> <NUMBER> countries similar ace inhibitorarb use supplementary material online figures s<NUMBER> s<NUMBER> study cohorts routine lab concentrations two golden standard biomarkers gdf<NUMBER> ntprobnp showed strong correlation measured using olink spearmans rho <NUMBER> p <NUMBER> supplementary material online figure s<NUMBER> ace<NUMBER>raascovid<NUMBER> axis summarized figure <NUMBER> cohorts plasma ace<NUMBER> concentrations npx units higher men women index cohort mean plasma concentration <NUMBER> men compared <NUMBER> women p <NUMBER> validation cohort mean plasma concentration <NUMBER> men compared <NUMBER> women p <NUMBER> figure <NUMBER> shows plasma ace<NUMBER> concentrations treated without blockers raas index cohort mean plasma concentration <NUMBER> patients used ace inhibitor <NUMBER> p <NUMBER> validation cohort mean plasma concentration <NUMBER> used ace inhibitor vs <NUMBER> p <NUMBER> index cohort mean plasma concentration <NUMBER> patients used arb compared <NUMBER> p <NUMBER> validation cohort mean plasma concentration <NUMBER> used arb vs <NUMBER> <NUMBER> p <NUMBER> index cohort mean plasma concentration <NUMBER> patients used mra compared <NUMBER> p <NUMBER> validation cohort mean plasma concentration figure <NUMBER> summary raas pathway <NUMBER> used mra vs <NUMBER> p <NUMBER> age sex interaction analyses indicated men used mra increased ace<NUMBER> concentration p <NUMBER> unadjusted models adjusted ace inhibitor use arb use age diabetes atrial fibrillation statistically significant index cohort validation cohort men used ace inhibitor lower ace<NUMBER> concentrations p <NUMBER> unadjusted models adjusted ace inhibitor use arb use age diabetes atrial fibrillation similar interaction tests statistically significant strongest predictor elevated plasma concentrations ace<NUMBER> index validation cohort male sex estimate <NUMBER> p <NUMBER> <NUMBER> p <NUMBER> respectively index cohort neither ace inhibitors arbs mras associated plasma ace<NUMBER> concentrations table <NUMBER> validation cohort ace inhibitors estimate <NUMBER> p <NUMBER> arbs estimate <NUMBER> p <NUMBER> associated lower plasma ace<NUMBER> concentrations mras estimate <NUMBER> p <NUMBER> associated higher concentrations supplementary material online table s<NUMBER> two large independent cohorts patients heart failure found plasma ace<NUMBER> concentrations higher men women addition receiving ace inhibitors arbs higher concentrations ace<NUMBER> increase taking mra validation cohort confirmed index cohort increased susceptibility elderly people chronic comorbidities sars coronaviruses men appear especially vulnerable sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> given typical heart failure patient belongs highrisk group sought uncover factors could explain sexbased susceptibility sarscov<NUMBER> vulnerable population baseline characteristics two cohorts presented typical patients heart failure confirm elderly patients often comorbidities including diabetes hypertension renal disease copd spectrum comorbidities involves organs affected covid<NUMBER> including heart lungs kidneys liver <NUMBER> covid<NUMBER> patients patients underlying diseases hyperinflammatory state might well patients various kidney diseases high endothelial ace<NUMBER> <NUMBER> making ace<NUMBER> damage marker furthermore plasma ace<NUMBER> activity increased patients heart failure <NUMBER> posttranscriptional events ace<NUMBER> testis ace<NUMBER> widely distributed tissues including lung alveolar epithelial cells vascular endothelium heart kidney testis <NUMBER> <NUMBER> <NUMBER> <NUMBER> readers convenience provide supplementary material online figures s<NUMBER> s<NUMBER> showing gene structure ace<NUMBER> isoforms tissue distribution ace<NUMBER> protein interestingly also noncoding isoforms highly expressed testis <NUMBER> take home figure supplementary material online figure s<NUMBER> isoform transcription could possibly affect protein translation malespecific tissue eg via microrna mirna competition previous studies indicate ace<NUMBER> may subject posttranscriptional regulation via mir<NUMBER> <NUMBER> could exploited novel potential therapeutic target modulate ace<NUMBER> expression disease testisexpressed ace<NUMBER> protein expressed organs enters circulation largely unknown tissuespecific transcriptional regulation ace<NUMBER> could partially explain higher ace<NUMBER> protein concentrations coronavirus would flourish men recently suggested higher prevalence fatality rate patients cardiac diseases hypertension diabetes related concomitant use ace inhibitors arbs suggested increase ace<NUMBER> concentrations authors speculated might due increased expression ace<NUMBER> offered evidence <NUMBER> <NUMBER> <NUMBER> <NUMBER> animal models selective blockade either angiotensin ii synthesis activity induced increases cardiac ace<NUMBER> gene expression cardiac ace<NUMBER> activity <NUMBER> whether translates humans needs validated best knowledge first substantial study examine association plasma ace<NUMBER> concentrations use raas blockers patients cardiovascular disease contrast previous reports <NUMBER> ace inhibitors arbs associated increased plasma concentrations ace<NUMBER> present study indeed anything use ace inhibitors arbs predicted lower concentrations ace<NUMBER> validation cohort although findings replicated index cohort taken together data support withholding ace inhibitors arbs patients risk sarscov<NUMBER> infection validation cohort mra use associated weak statistically significant increase plasma ace<NUMBER> concentrations univariate multivariateadjusted analyses indicated significant sexbased interaction men mra higher ace<NUMBER> concentrations similar association found index cohort effect mra plasma ace<NUMBER> therefore clear one study found trend p <NUMBER> towards increased plasma ace<NUMBER> activity patients treated mra <NUMBER> addition one mechanistic study using macrophages reported increase ace<NUMBER> activity mra <NUMBER> data available clearly findings suggest mras discontinued patients heart failure sarscov<NUMBER> infection found moreover even mras consistently found increase plasma ace<NUMBER> concentrations still needs established whether use associated higher vulnerability severe consequences sarscov<NUMBER> infection mras effective treatment heart failure hypothetical effects viral infection weighed carefully proven benefits equilibrium soluble membranebound ace<NUMBER> might influence covid<NUMBER> pathogenesis treatment options previous studies indicate adam<NUMBER>mediated ace<NUMBER> shedding <NUMBER> <NUMBER> would affect coronavirus infectivity concomitant use raas inhibitors warrants separate research study dogs heart disease indicated ace<NUMBER> shedding important factor total extent tissuebound ace<NUMBER> activity rather loss tissue ace<NUMBER> circulation would tend decrease overall compensatory potential ace<NUMBER> <NUMBER> work required show whether translates humans two large cohorts patients heart failure plasma ace<NUMBER> concentrations higher men women possibly reflecting higher tissue expression receptor sars coronavirus infections could explain men might susceptible infection consequences sarscov<NUMBER> patients receiving ace inhibitors arbs higher plasma concentrations ace<NUMBER> effect mras small inconsistent supporting continued use agents patients heart failure current sarscov<NUMBER> pandemic conclusions drawn analysis mainly restricted heart failure albeit group patients high risk covid<NUMBER> secondly since patients coronavirus infected cannot provide direct link course covid<NUMBER> disease patients low vs high plasma ace<NUMBER> concentrations influence age raas blockers course disease thirdly measured plasma ace<NUMBER> concentrations membranebound ace<NUMBER> speculate circulating concentrations associated tissue concentration since compelling evidence supplementary material available europeaan heart journal online work supported grant european commission fp<NUMBER>biostatchf conflict interest bts reports grants dutch heart foundation <NUMBER>t<NUMBER> conduct study jgfc reports grants personal fees amgen novartis pharmacosmos vifor personal fees servier outside submitted work sda reports personal fees bayer boehringer ingelheim cardiac dimension impulse dynamics novartis servier st jude medical vifor pharma grant support abbott vascular vifor pharma outside submitted work gf reports committee member trials sponsored medtronic vifor servier novartis bi outside submitted work mm reports personal fees consulting honoraria participation trials committees advisory boards abbott vascular amgen astrazeneca bayer vifor pharma last <NUMBER> years personal fees fees public speeches sponsored symposia abbott vascular edwards therapeutics outside submitted work authors conflicts declare coronavirus disease <NUMBER> caused novel coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> abruptly reached pandemic proportions sarscov<NUMBER> member betacoronavirus family well sarscov severe acute respiratory syndrome coronavirus merscov middle east respiratory syndromerelated coronavirus since beginning <NUMBER> number confirmed cases covid<NUMBER> dramatically increased worldwide leaping million march <NUMBER> <NUMBER> although majority covid<NUMBER> patients develop mild moderate clinical features <NUMBER> severe pneumonia acute respiratory distress syndrome ards multiorgan failure leading high death rate may develop notably marked sex differences emerged covid<NUMBER> prevalence prognosis particular agespecific risk disease reported significantly higher males females except age <NUMBER> years moreover agespecific risks death hospitalization least two fold higher males females among age ranges <NUMBER> furthermore patients advanced age underlying pathologies mainly hypertension diabetes cardiovascular disease cvd prone experience severe form disease <NUMBER> even though overall mortality considerably varies among countries fatalityrate age groups displays similar patterns rising consistently <NUMBER>year age group <NUMBER> importantly presence comorbidities increases mortality sample <NUMBER> patients died covid<NUMBER> italy prevalence diabetes <NUMBER> <NUMBER> differently covid<NUMBER> spread diabetes known boundaries number affected people reached nearly half billion worldwide <NUMBER> number deaths attributed diabetes complications around <NUMBER> million <NUMBER> <NUMBER> notably <NUMBER> diabetic patients <NUMBER> years old <NUMBER> thus although extremely different connotations covid<NUMBER> diabetes two pandemics share burden wide diffusion elderly population dramatic impact global mortality economic health resources short review focused open questions emerging effort fully understand link covid<NUMBER> diabetes mainly context possible harmful beneficial effects commonly used drugs patients diabetes course covid<NUMBER> infection diabetes reportedly major cause mortality morbidity worldwide conceivable link diabetes infectious diseases postulated particular lower respiratory tract infections known rather common severe elderly type <NUMBER> diabetes t<NUMBER>d <NUMBER> although evidence suggests diabetes unlikely significantly increase susceptibility sarscov<NUMBER> infection higher risk worse covid<NUMBER> progression outcomes observed <NUMBER> mechanisms underlying association completely clear yet exacerbated proinflammatory cascade impaired immune response diabetic patients covid<NUMBER> suspected crucially involved particular increased levels proinflammatory markers leukocyte neutrophil count procalcitonin creactive protein ferritin circulating cytokines trigger cytokine storm namely il<NUMBER> il<NUMBER> il<NUMBER> receptor tnfα detected diabetic patients severe covid<NUMBER> compared patients without diabetes <NUMBER> furthermore altered immune response diabetic patients possibly due impaired lymphocyte neutrophil monocytemacrophage function long hypothesised especially presence poorly controlled glycaemia <NUMBER> <NUMBER> higher concentrations ddimer fibrinogen hallmarks severe forms covid<NUMBER> also reported patients diabetes compared patients without diabetes suggesting patients might prone develop coagulation abnormalities course infection known significantly associated worse prognosis <NUMBER> <NUMBER> recent retrospective study involving chinese patients n <NUMBER> moderate severe critical disease major risk factors mortality poor outcomes evaluated among enrolled patients <NUMBER> n <NUMBER> diabetes including t<NUMBER>d type <NUMBER> diabetes gestational diabetes overall diabetes increased odds inhospital death poor prognosis diabetic patients older significant alterations several laboratory parameters associated poor prognosis compared patients without diabetes particular higher levels ddimer female diabetic patients increased ldh neutrophil count compared nondiabetic patients cvd common men diabetes nondiabetic men notably multivariable regression analysis insulin therapy independently associated poor prognosis creactive protein independent risk factor either mortality poor prognosis patients covid<NUMBER> diabetes <NUMBER> besides research also needed clarify whether hypoglycaemia might also contribute adverse outcomes increased mortality covid<NUMBER> patients diabetes <NUMBER> patients diabetes high prevalence high blood pressure increased risk cvd <NUMBER> hence treatment hypertension largely includes drug classes demonstrated reduce cardiovascular events angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs <NUMBER> since ace converts angiotensin angiotensin ii potent vasoconstrictor sodiumretentive agent blockage reninangiotensinaldosterone system raas leads effective reduction blood pressure ace shows homology angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor transmembrane spike glycoprotein surface sarscov sarscov<NUMBER> binds allowing internalization virus alveolar cells cell types <NUMBER> ace<NUMBER> clearly direct target ace inhibitors ubiquitous monocarboxypeptidase converts angiotensin ii antiinflammatory antifibrotic angiotensin<NUMBER> contrasting potent vasoconstrictor sodiumretentive proinflammatory profibrotic effects indeed angiotensin<NUMBER> binding mas receptor induces nitric oxide release protecting tissue injury <NUMBER> another known substrate ace<NUMBER> angiotensin converted angiotensin<NUMBER> <NUMBER> <NUMBER> latter turn converted angiotensin<NUMBER> ace therefore competing angiotensin ii binding <NUMBER> limited animal vitro studies reported upregulation ace<NUMBER> induced arbs far lesser extent ace inhibitors predominantly heart kidney effect partly explained increase local levels angiotensin ii induced arbs ace inhibitors <NUMBER> indeed arbs block angiotensin ii type <NUMBER> at<NUMBER> receptors consequently increase availability substrate angiotensin ii upregulates ace<NUMBER> <NUMBER> based assumption speculated treatment arbs ace inhibitors might favour entry sarscov<NUMBER> lung cells therefore increasing risk adverse outcomes severe forms covid<NUMBER> infection conversely beneficial effect background therapy arb course disease supposed two complex mechanisms might support hypothesis firstly angiotensin ii binding receptor at<NUMBER> might enhance shedding transmembrane ace<NUMBER> promoted adam<NUMBER> disintegrin metalloprotease therefore releasing soluble ace<NUMBER> locally soluble form ace<NUMBER> unable mediate sarscov<NUMBER> internalization longer annexed cell membrane <NUMBER> secondly upregulation ace<NUMBER> probably induced arbs might necessarily negative effects sarscov<NUMBER> internalization lung cells inevitably induces downregulation ace<NUMBER> increase substrate angiotensin ii potent vasoconstrictor proinflammatory agent might contribute exacerbation lung injury indeed animal models lung injury clear association activation angiotensin iiat<NUMBER> signalling severity lung damage observed detrimental effects cascade counterbalanced activation ace<NUMBER>angiotensin<NUMBER>mas receptor axis <NUMBER> specifically models sepsis acid aspiration frequently cause acute lung injury ards ace<NUMBER> knockout mice experienced severe tissue damage characterized marked inflammatory cell infiltration increased vascular permeability lung oedema bleeding compared wildtype mice similarly angiotensin ii type <NUMBER> at<NUMBER> receptors knockout mice marked lung damage models injection recombinant human ace<NUMBER> protein ace<NUMBER> knockout mice considerably decreased severity lung injury <NUMBER> line findings pretreatment recombinant human ace<NUMBER> able reduce inflammatory cell infiltration tissue injury mouse model respiratory syncytial virus infection <NUMBER> evidence clinical studies still rather limited patients ards recombinant human ace<NUMBER> increased angiotensin<NUMBER> decreased angiotensinii concentrations even though study prematurely discontinued lack clinical improvement <NUMBER> overall evidence animal models suggests conceivable pneumoprotective role ace<NUMBER> at<NUMBER> receptor context lung injury loss pulmonary ace<NUMBER> might therefore harmful effects exacerbating inflammation promoting respiratory distress fibrosis way activation ace angiotensin ii at<NUMBER> receptor axis might exert detrimental effects worsening lung damage rationale raas inhibition therefore counterbalancing effects reducing angiotensin ii increasing ace<NUMBER> notably arb ace inhibitors attenuated lpsinduced lung injury several preclinical studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently milne et al analysed gene expression ace<NUMBER> ace agtr<NUMBER> encoding at<NUMBER> tmprss<NUMBER> transmembrane protease serine <NUMBER> requested cofactor internalization sarscov<NUMBER> adam<NUMBER> large number healthy lung tissue samples collected patients undergoing lung resection cancer significant association use ace inhibitors reduced ace<NUMBER> gene expression observed differently use arbs linked relevant changes ace<NUMBER> expression significantly correlated increased ace decreased agtr<NUMBER> expression <NUMBER> although findings quite contrast data animal studies highlighted gene expression rather protein concentration analysed collected tissue samples exhibit lung injury ards covid<NUMBER> results severe lung damage imbalance raas system context cannot excluded recently pilot study covid<NUMBER> patients found higher levels circulating angiotensin ii compared healthy subjects correlation angiotensin ii concentration severity disease observed well <NUMBER> thus effects ace inhibitors arbs might different extremely damaged context therefore explored animal models covid<NUMBER> mounting evidence recent clinical studies suggests raas inhibitor use related increased risk covid<NUMBER> infection poor outcomes retrospective cohort study <NUMBER> patients screened covid<NUMBER> test positivity significantly associated ace inhibitor arb therapy <NUMBER> similarly us study relationship emerged prior ace inhibitor arb use increased likelihood positive sarscov<NUMBER> test result adjusting relevant confounding factors <NUMBER> italian communitybased casecontrol study association found ace inhibitor arb treatment covid<NUMBER> infection although use drugs rather frequent due high prevalence cvd <NUMBER> overall findings excluded increased risk covid<NUMBER> infection patients already treated raas inhibitors studies evaluated link covid<NUMBER> progression raas inhibitor therapy recent korean populationbased cohort study involving <NUMBER> covid<NUMBER> patients use ace inhibitors arbs associated higher mortality risk adjustment confounders <NUMBER> recent systematic review including total n <NUMBER> covid<NUMBER> patients different countries ace inhibitor arb use associated increased severity covid<NUMBER> illness <NUMBER> interestingly metaanalysis <NUMBER> covid<NUMBER> patients seven cohort studies five casecontrol studies use raas inhibitors linked higher risk covid<NUMBER> infection severity mortality whereas mortality risk significantly lower patients treated ace inhibitors arbs compared treated antihypertensive drugs <NUMBER> taking together data observational studies indicates raas inhibitor therapy unlikely negative impact course infection however whether patients covid<NUMBER> might take advantage initiating drugs terms disease progression outcomes explored clinical trials still ongoing cvd wellknown major complications diabetes risk developing cvd <NUMBER>to fivefold higher patients t<NUMBER>d nondiabetic patients mainly due diabetesrelated coronary atherosclerosis <NUMBER> addition diabetic cardiomyopathy may occur independently coronary artery disease likely developing helper <NUMBER> driven responses within cardiomyocyte <NUMBER> <NUMBER> besides common clinical features covid<NUMBER> cardiovascular damage may occur nearly <NUMBER> patients <NUMBER> cause major concern due high related mortality mechanisms underlying complication largely unknown direct viral damage destabilization coronary plaques reportedly suspected play consistent role notably sample <NUMBER> patients covid<NUMBER> guo et al observed presence background coronary heart disease cardiomyopathy associated frequent occurrence myocardial damage highlighted marked increase serum troponin course disease <NUMBER> accordingly mortality considerably higher among patients myocardial injury concomitant cvd <NUMBER> patients without cvd <NUMBER> remarkably considerable percentage patients displaying myocardial injury diabetes <NUMBER> compared patients without myocardial injury <NUMBER> myocardial injury may therefore contribute poorer outcomes observed diabetic patients covid<NUMBER> <NUMBER> note patients myocardial injury prone develop malignant arrhythmias ards coagulopathy acute kidney injury explained high mortality <NUMBER> importantly ace inhibitors arbs broadly used patients myocardial injury mortality significantly differ treated nontreated patients although consistent evidence excluding harms suggesting benefits raas inhibitors covid<NUMBER> patients hearth injury lacking arbs able increase ace<NUMBER> expression hearts animal models arterial hypertension <NUMBER> even pathological context possible effects drugs elucidated downregulation ace<NUMBER> cardiomyocytes blood vessels induced sarscov<NUMBER> internalization might exacerbate myocardial injury endothelial dysfunction compromising heart function patients diabetes underlying cvd <NUMBER> <NUMBER> addition patients t<NUMBER>d high rate lipid alterations statins first line therapy dyslipidaemia remarkably evidence preclinical studies suggests statins might modulate ace<NUMBER> expression several tissues including heart observed atorvastatin increased ace<NUMBER> protein expression heart kidney rabbits atherosclerosis <NUMBER> another study diabetic rats displayed significantly lower expression ace<NUMBER> impaired systolic diastolic function compared control rats combined treatment insulin fluvastatin associated higher levels ace<NUMBER> compared nontreated diabetic rats <NUMBER> ace<NUMBER> multisubstrate enzyme targeted several molecules although extremely limited evidence animal studies peroxisome proliferatoractivated receptor gamma pparγ agonists insulinsensitizer drugs treatment type <NUMBER> diabetes t<NUMBER>d might increase expression ace<NUMBER> different tissues animal model hypertension insulinsensitizer rosiglitazone modulated ace<NUMBER>angiotensin<NUMBER>angiotensin ii axis aortic tissue lowered blood pressure increasing expression ace<NUMBER> <NUMBER> similarly high fat diet fed rats animal model obesity pioglitazone increased expression ace<NUMBER> insulinsensitive tissues liver adipose tissue skeletal muscle likely modulation reninangiotensin system <NUMBER> ace<NUMBER> widely distributed human tissues remarkably expression found even lower lung sites <NUMBER> hence mediators thought play role facilitating sarscov<NUMBER> infection priming serine protease tmprss<NUMBER> requested binding ace<NUMBER> internalization sarscov<NUMBER> tmprss<NUMBER> cleaves protein s<NUMBER> s<NUMBER> subunits necessary step membrane fusion viral internalization contextually drags ace<NUMBER> alveolar cells <NUMBER> light antibodies targeting sprotein tmprss<NUMBER> inhibitors might prevent sarscov<NUMBER> entry lung cell <NUMBER> individuating possible candidate coreceptors therefore great importance development new therapeutic strategies contrast infection dpp<NUMBER> ubiquitously expressed cell surface exopeptidase important metabolic functions mainly regulates bioactivity gutderived hormones glucagonlike peptide<NUMBER> glp<NUMBER> glucosedependent insulinotropic polypeptide gip stimulate insulin secretion response oral glucose administration known incretin effect <NUMBER> dpp<NUMBER> inhibitors dpp<NUMBER>i commonly used drugs treatment t<NUMBER>d prevent degradation incretins inhibiting catalytic activity dpp<NUMBER> result ßcell insulin secretion potentiated glycaemia significantly reduced independently catalytic function dpp<NUMBER> displays inflammatory immune functions <NUMBER> indeed expressed mainly tlymphocytes involved activation proliferation <NUMBER> interestingly proinflammatory factors significantly increase dpp<NUMBER> expression circulating immune cells <NUMBER> unlike sarscov sarscov<NUMBER> binds ace<NUMBER> entry lung cells dpp<NUMBER> functional receptor merscov <NUMBER> hence several mouse human monoclonal antibodies preventing protein binding dpp<NUMBER> given promising results treatment mers <NUMBER> note recently reported dpp<NUMBER> shares patterns expression ace<NUMBER> lung precisely alveolar type <NUMBER> cells main target sarscov<NUMBER> <NUMBER> vankadari et al recently set docking model dpp<NUMBER> sarscov<NUMBER> spike glycoprotein <NUMBER> predicted several dpp<NUMBER> residues might involved interaction sarscov<NUMBER> s<NUMBER> domain spike protein also targeted coronaviruses enter host cells functional receptor dpp<NUMBER> however validation needed draw conclusions establish whether possible adhesion dpp<NUMBER> spike protein may play role sarscov<NUMBER> infection consequently important issues addressed claiming possible beneficial effects dpp<NUMBER> modulation covid <NUMBER> <NUMBER> according data chen et al patients diabetes moderatesevere covid<NUMBER> use dpp<NUMBER>i significantly impact mortality clinical outcomes <NUMBER> presence diabetes considerably influences course covid<NUMBER> infection risk factor poor outcomes limited preclinical studies ace<NUMBER> expression found modulated several players different tissues largely employed treatment diabetes antihypertensive considerably lesser extent insulinsensitizers statins light potential harmful protective effects treatments covid<NUMBER> infection might interesting soil research date data supporting drugs clearly interfere sarscov<NUMBER> access lung cells tissues completely lacking stressed absence evidence consistent clinical studies discontinuation adoption therapies attempt influence course infection strongly discouraged hypertension could active comparator antihypertensive agents also provide information association inpatients conducted study association ace inhibitors arbs mortality among people hypertension hospitalized covid<NUMBER> stratified assessments insurance groups due substantial differences two populations conducted <NUMBER> studies patients hypertensionthe first study included individuals tested positive sarscov<NUMBER> outpatient second included patients hospitalized covid <NUMBER> addition diagnosis hypertension prespecified study population include individuals receiving least <NUMBER> antihypertensive agent account medical comorbidities created robust propensity score matched cohorts patients treated ace inhibitors arbs antihypertensive agents evaluated success matching algorithms explicit assessments covariate balance across comparisons evaluation exposure groups falsification endpoints due systematic differences among enrollees medicare advantage commercial insurance programs enhanced risk adverse outcomes covid<NUMBER> among older individuals overrepresented medicare <NUMBER> <NUMBER> <NUMBER> <NUMBER> evaluated association drugs outcomes analyses stratified insurance groups ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint used deidentified administrative claims medicare advantage commercially insured members research database single large us health insurance provider database contains medical emergency inpatient outpatient pharmacy claims services submitted third party reimbursement available international classification diseases tenth revision clinical modification icd<NUMBER>cm national drug codes ndc claims respectively claims aggregated completion care encounters submission claims reimbursement two additional data sources included information covid<NUMBER> could linked claims first limited outpatient testing dataset included information sarscov<NUMBER> test results members underwent outpatient testing sarscov<NUMBER> <NUMBER> hospitalbased freestanding outpatient thirdparty labs states across united states <NUMBER> tests submitted thirdparty lab vendors second inpatient covid<NUMBER> dataset included dailyupdated record covid<NUMBER> inpatient admissions insurance enrollees claims information representing admitted hospital primary secondary diagnosis covid<NUMBER> etable <NUMBER> along current disposition admitted discharged transferred expired unknown ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint constructed cohorts patients two studies first outpatient study identified outpatients tested positive sarscov<NUMBER> included individuals least <NUMBER> years age least <NUMBER> months enrollment medicare advantage commercial insurance january december <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents tested positive sarscov<NUMBER> positive outpatient setting march <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> database satisfied inclusion criteria evaluated association ace inhibitors arbs respectively risk hospitalization outpatient cohort compared patients antihypertensive medications second second inpatient study identified inpatient cohort adults hospitalized covid <NUMBER> included patients age ≥<NUMBER> years least <NUMBER> months health insurance enrollment <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents hospitalized principal secondary diagnosis covid<NUMBER> january <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> evaluated association ace inhibitors arbs respectively mortality hospitalized individuals cohort compared patients antihypertensive medications studies diagnosis hypertension based icd<NUMBER> codes etable <NUMBER> drug treatment hypertension defined receipt one agents included <NUMBER> american heart association hypertension ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint guidelines <NUMBER> include firstline agents ace inhibitors arbs thiazide thiazidelike diuretics dihydropyridine nondihydropyridine calcium channel blockers well secondline agents betaadrenergic antagonists alpha blockers centrally acting alpha agonists loop diuretics potassium sparing diuretics mineralocorticoid receptor antagonists direct vasodilators individual drugs listed etable <NUMBER> information latter derived pharmacy claims defined cumulative supply greater <NUMBER> days july <NUMBER> <NUMBER> december <NUMBER> <NUMBER> identified <NUMBER> mutually exclusive exposure groups <NUMBER> patients receiving ace inhibitors <NUMBER> receiving arb without agents used active comparator analyses included remaining patients diagnosis hypertension received one antihypertensive agents drug classes ace inhibitor arb agents include first second line antihypertensive agents based <NUMBER> aha guidelines hypertension <NUMBER> use individual agents defined one pharmacy claims least <NUMBER> days medication supply agent july december <NUMBER> sensitivity analyses restricted control group individuals receiving least one first line antihypertensive agent drug classes ace inhibitor arb ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> combined information inpatient outpatient claims <NUMBER> identify potential confounders association ace inhibitors arb use patient outcomes included patient age sex race conditions would represent potential indications selective use ace inhibitors arbs diabetes myocardial infarction heart failure chronic kidney disease additional comorbidities included charlson comorbidity index peripheral vascular disease cerebrovascular disease hemior paraplegia dementia chronic pulmonary disease rheumatologic disease diabetes chronic complications malignancy metastatic solid tumor mild liver disease moderatetosevere liver disease acquired immunodeficiency syndrome human immunodeficiency virus icd<NUMBER> codes corresponding variables included etable <NUMBER> appendix race available medicare advantage members included information total number antihypertensive agents prescribed patients using pharmacy claims finally regional clustering cases identified using location sites submitting claims laboratory testing sarscov<NUMBER> hospital site inhospital outcomes outpatient study primary outcome inpatient hospitalization covid<NUMBER> defined hospitalization principal secondary diagnosis covid<NUMBER> linked inpatient dataset etable <NUMBER> assessed mortality inpatient hospitalization secondary outcome ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint inpatient study primary outcome inhospital mortality addition evaluated secondary composite outcome death discharge hospice hospital length stay outpatient inpatient studies created propensity scorematched cohorts patients hypertension treated ace inhibitors arbs antihypertensive medications constructed nonparsimonious multivariable logistic regression model receipt ace inhibitors arb antihypertensive dependent variable example modeled receipt ace inhibitor another antihypertensive excluding arb determine patients likelihood receiving agents based measured clinical characteristics applied strategy different pairs treatment comparisons ace inhibitor vs others arb vs others ace inhibitor vs arb briefly performed <NUMBER> matching recipients based propensity scores caliper width onetenth standard deviation logit propensity score <NUMBER> pursued <NUMBER> iterations find lowest mean absolute standardized difference among matched variables matched cohorts age gender race insurance type conditions may lead selective use ace inhibitors arbs ie diabetes myocardial infarction heart failure chronic kidney disease comorbidities charlson comorbidity index number antihypertensive agents used patient account regional clustering care practices response covid<NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint pandemic explicitly accounted census region lab testing site inpatient facility models evaluated performance propensity score matching using several strategies first assessed propensity score distributions unmatched matched cohorts calculated equipoise metric summarize degree overlap characteristics patients receiving drugs <NUMBER> <NUMBER> represents proportion individuals unmatched groups propensity score <NUMBER> <NUMBER> representing state equipoise two drugs value greater <NUMBER> implies two drugs empirical equipoise higher value indicating lower likelihood confounding indication <NUMBER> next evaluated standardized difference matched covariates propensity score matching specifically evaluated whether matching algorithm achieved standardized difference <NUMBER> matched cohort suggestive adequately matched groups <NUMBER> second evaluated success matching algorithm using priori defined negative control outcomes chose two negative control falsification endpointsclaims gastroesophageal reflux disease ingrown nail unlikely affected treatment assignment directional effect would represent covariate imbalance <NUMBER> third evaluated whether propensity matched cohort also adequately matched therapeutic classes nonantihypertensive agents directly included matching algorithm strategies designed evaluate potential residual confounding creating propensity score matched cohorts finally evaluated observations robustness assessing treatment effects <NUMBER> iterations propensity score ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint matching algorithm evaluating whether findings consistent across iterations varied degree matching individual covariates describe differences patients treated ace inhibitors arbs compared antihypertensive agents treated ace inhibitors using chi square test categorical variables ttest continuous variables duration follow expected vary across individuals outpatient inpatient covid<NUMBER> cohorts evaluated effects timetoevent analyses coxproportional hazards models unadjusted propensity scorematched cohorts reduce bias residual differences matched covariates evaluation patient outcomes included covariates included propensity score matching algorithm independent variables models <NUMBER> repeated analyses without additional covariate adjustment outpatient study index date represented day positive covid<NUMBER> test outpatient period study measured days positive covid<NUMBER> outcome interest hospitalization inpatient study index date represented first day hospitalization covid<NUMBER> period study measured days admission outcome interest death since hospitalization could end either patients death discharged alive created causespecific cox proportional hazards model competing risk analysis <NUMBER> <NUMBER> <NUMBER> analyses censored end observation period may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint given systematic differences patients enrolled medicare advantage commercial insurance particularly older age higher comorbidity burden higher risk covid<NUMBER> complications among medicare advantage enrollees evaluated quantitative qualitative interactions insurance type treatment groups assessment outcomes also created propensity scorematched cohorts within two insurance subgroups analyses performed using open source r <NUMBER> cran python <NUMBER> hypothesis tests <NUMBER>sided level significance set <NUMBER> except interaction tests level significance set <NUMBER> given exploratory nature study statistical tests adjusted multiple testing yale affairs exempted study review activities limited retrospective analysis deidentified data accessed accordance health insurance portability accountability act regulations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint median age individuals <NUMBER> years <NUMBER> women medicare advantage patients <NUMBER> african american patients receiving ace inhibitors arbs likely men diabetes without chronic complications receiving <NUMBER> antihypertensive drugs table <NUMBER> less likely chronic heart failure moderatetosevere renal disease compared patients receiving antihypertensive treatments patients receiving ace inhibitors similar receiving arbs higher rate dementia peripheral vascular disease table <NUMBER> matched <NUMBER> patients receiving ace inhibitors <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> achieving <NUMBER> standardized differences covariates figure <NUMBER> similarly matched <NUMBER> patients receiving arb <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> among <NUMBER> patients hospitalized covid<NUMBER> linked claims data <NUMBER> diagnosis hypertension outpatient prescription least one antihypertensive drug efigure <NUMBER> inpatient cohort included patients <NUMBER> states us efigure <NUMBER> included patients <NUMBER> medicare advantage enrollees median age hospitalized individuals <NUMBER> years <NUMBER> women <NUMBER> medicare advantage enrollees african american differences hospitalized patients treated ace inhibitors arbs agents included table <NUMBER> inpatient cohort <NUMBER> patients receiving ace ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inhibitors <NUMBER> patients receiving arbs propensity scorematched patients receiving antihypertensive agents efigure <NUMBER> covariate standardized differences <NUMBER> matching figure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> outpatient cohort median <NUMBER> iqr <NUMBER> <NUMBER> days sarscov<NUMBER> testing patients receiving ace inhibitors less frequently hospitalized receiving antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> significant association arb therapy hospitalization rates <NUMBER> vs <NUMBER> individuals insurance p <NUMBER> propensity scorematched cohorts efigure table <NUMBER> differences priori chosen falsification endpoints propensity scorematched populations etable <NUMBER> differences association ace inhibitors hospitalization risk across insurance groups p interaction <NUMBER> lower risk hospitalization medicare advantage patients hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> observed commercially insured individuals hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint propensity scorematched analyses arb use associated significantly lower hospitalization risk individuals receiving antihypertensive agents hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> significant differences hospitalization rates propensity score matched cohorts patients receiving ace inhibitor compared arb hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant interactions insurancetype association arb outcomes pinteraction <NUMBER> among individuals outpatient cohort hospitalized association ace inhibitor arb use subsequent inhospital mortality etable <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> <NUMBER> died hospitalization <NUMBER> <NUMBER> discharged alive <NUMBER> <NUMBER> still hospitalized end observation period majority deaths <NUMBER> among medicare advantage population median length stay including patients died well discharged alive covid<NUMBER> hospitalizations <NUMBER> iqr <NUMBER> <NUMBER> days similar across patients died <NUMBER> iqr <NUMBER> <NUMBER> days discharged alive <NUMBER> iqr <NUMBER> <NUMBER> days observation period overall proportion covid<NUMBER> patients died differ significantly ace inhibitor therapy hospitalization compared antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> propensity matchedcohort patients receiving ace inhibitors hospitalization inhospital mortality ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity table <NUMBER> similarly arb significantly different risk mortality compared antihypertensive agents <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant differences mortality patients receiving ace inhibitors arbs overall population without significant interaction insurance group treatment assignment patient outcome figure <NUMBER> table <NUMBER> findings consistent secondary outcome inhospital death discharge hospice etable <NUMBER> also association treatment ace inhibitor arb hospital length stay etable <NUMBER> sensitivity analyses focused individuals receiving least one first line antihypertensive agent control group varied covariate adjustment strategies consistent primary analysis etables <NUMBER> <NUMBER> iterations propensity score matching algorithm found lower risk hospitalization ace inhibitors across iterations pvalue less <NUMBER> <NUMBER> <NUMBER> iterations medicare advantage population first national study ace inhibitors arbs outpatients testing positive sarscov<NUMBER> found overall drugs confer additional risk benefit however among medicare advantage ace inhibitors associated almost <NUMBER> significantly lower risk hospitalization covid<NUMBER> effect observed arbs among hospitalized covid<NUMBER> find benefit harm medications collectively findings support change current use medications given lack effective therapies mitigate ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint harm virus study provide rationale testing use ace inhibitors older patients reduce risk severe sarscov<NUMBER> infection design several attributes provide confidence findings even though observational study restricted people hypertension receiving least one antihypertensive agent thereby limiting assessment individuals receiving treatment chronic illness therefore equally likely seek care healthcare needs covid<NUMBER> analyses explicitly compared individuals equipoise receiving either drug treatment moreover find evidence confounding disease severity choice therapy assessment priori defined falsification endpoints study included individuals across united states thereby limiting effect hospital regional care practices may bias evaluation treatment effects observations extends prior evidence supporting safety ace inhibitor treatment covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> show safety agents outpatient sarscov<NUMBER> infected individuals complements studies hospitalized <NUMBER> <NUMBER> <NUMBER> also national study complements single center single region studies <NUMBER> study intriguing finding subgroup individuals enrolled medicare advantage find ace inhibitors associated significantly lower risk hospitalization following infection sarscov<NUMBER> outpatient setting patients older frequently comorbidities vulnerable severe covid<NUMBER> disease <NUMBER> <NUMBER> findings particularly relevant medicare advantage group represented <NUMBER> covid<NUMBER> hospitalizations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inpatient cohort also interestingly find association arbs despite clinical equipoise use drugs findings consistent prior evidence randomized clinical trials reduced risk pneumonia ace inhibitors observed arb <NUMBER> study inhospital outcomes adds literature studies reached contrasting conclusions regarding role ace inhibitor therapy inhospital mortality among hospitalized covid<NUMBER> patients find significant association mortality consistent others found association <NUMBER> <NUMBER> <NUMBER> however findings contrast certain studies found lower mortality hospitalized covid<NUMBER> patients treated ace inhibitors <NUMBER> <NUMBER> notably studies evaluated mortality risk covid<NUMBER> consistently designed detect potential causal association drug therapy outcomes <NUMBER> relied case control designs <NUMBER> pursued potentially biased assessment using comparators receiving therapy <NUMBER> <NUMBER> based data single health centers <NUMBER> moreover studied ace inhibitors arbs together despite potentially different mechanisms effects patient outcomes <NUMBER> rationale may specific ace inhibitor effect preclinical evidence suggests possible protective role ace inhibitors covid<NUMBER> ace inhibitors arbs associated upregulation ace<NUMBER> receptors <NUMBER> <NUMBER> receptors modulate local reninangiotensinaldosterone system interactions lung tissue <NUMBER> presence ace<NUMBER> receptors therefore exerts protective effect development acute lung injury infections sars coronaviruses lead dysregulation mechanisms endothelial ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> study important implications <NUMBER> ongoing randomized trials none align observations study <NUMBER> <NUMBER> trials <NUMBER> testing use ace inhibitors arbs treatment hospitalized covid<NUMBER> patients <NUMBER> using <NUMBER>day course arbs positive sarscov<NUMBER> test prevent hospitalization <NUMBER> however study suggests appropriate strategy test trial would prophylactic use ace inhibitor prevent hospitalization tested current study findings study interpreted light following limitations first study observational despite robust methods explicit assessments residual confounding understanding potential protective role ace inhibitors covid<NUMBER> requires dedicated randomized controlled trial second know proportion patients receiving antihypertensive agents continued treated drugs illness association continued use cessation patient outcomes third included data elements contingent upon individuals seeking care ailment filling medication using insurance provider would captured chose selfpay however expect sizeable proportion insured individuals would defer insurance coverage care fourth cannot account differences timing ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint presentation patients relative symptom onset however limited effect differential presentation patients across exposure groups focusing patients receiving treatment medical comorbidity ie hypertension varying class drugs moreover included patients across us accounted clustering patients thereby limiting effect local practice patterns may affect hospitalization thresholds therefore unlikely patients care seeking ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ant ihypert ensi e agent use roups propensit score ching roups aft er propensit score ching ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inclusion criteria icd<NUMBER> codes hypertension i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> h<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> g<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> i<NUMBER> hypertension could active comparator antihypertensive agents also provide information association inpatients conducted study association ace inhibitors arbs mortality among people hypertension hospitalized covid<NUMBER> stratified assessments insurance groups due substantial differences two populations conducted <NUMBER> studies patients hypertensionthe first study included individuals tested positive sarscov<NUMBER> outpatient second included patients hospitalized covid <NUMBER> addition diagnosis hypertension prespecified study population include individuals receiving least <NUMBER> antihypertensive agent account medical comorbidities created robust propensity score matched cohorts patients treated ace inhibitors arbs antihypertensive agents evaluated success matching algorithms explicit assessments covariate balance across comparisons evaluation exposure groups falsification endpoints due systematic differences among enrollees medicare advantage commercial insurance programs enhanced risk adverse outcomes covid<NUMBER> among older individuals overrepresented medicare <NUMBER> <NUMBER> <NUMBER> <NUMBER> evaluated association drugs outcomes analyses stratified insurance groups ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint used deidentified administrative claims medicare advantage commercially insured members research database single large us health insurance provider database contains medical emergency inpatient outpatient pharmacy claims services submitted third party reimbursement available international classification diseases tenth revision clinical modification icd<NUMBER>cm national drug codes ndc claims respectively claims aggregated completion care encounters submission claims reimbursement two additional data sources included information covid<NUMBER> could linked claims first limited outpatient testing dataset included information sarscov<NUMBER> test results members underwent outpatient testing sarscov<NUMBER> <NUMBER> hospitalbased freestanding outpatient thirdparty labs states across united states <NUMBER> tests submitted thirdparty lab vendors second inpatient covid<NUMBER> dataset included dailyupdated record covid<NUMBER> inpatient admissions insurance enrollees claims information representing admitted hospital primary secondary diagnosis covid<NUMBER> etable <NUMBER> along current disposition admitted discharged transferred expired unknown ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint constructed cohorts patients two studies first outpatient study identified outpatients tested positive sarscov<NUMBER> included individuals least <NUMBER> years age least <NUMBER> months enrollment medicare advantage commercial insurance january december <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents tested positive sarscov<NUMBER> positive outpatient setting march <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> database satisfied inclusion criteria evaluated association ace inhibitors arbs respectively risk hospitalization outpatient cohort compared patients antihypertensive medications second second inpatient study identified inpatient cohort adults hospitalized covid <NUMBER> included patients age ≥<NUMBER> years least <NUMBER> months health insurance enrollment <NUMBER> available claims data diagnosis hypertension one claims receiving one antihypertensive agents hospitalized principal secondary diagnosis covid<NUMBER> january <NUMBER> <NUMBER> may <NUMBER> <NUMBER> efigure <NUMBER> evaluated association ace inhibitors arbs respectively mortality hospitalized individuals cohort compared patients antihypertensive medications studies diagnosis hypertension based icd<NUMBER> codes etable <NUMBER> drug treatment hypertension defined receipt one agents included <NUMBER> american heart association hypertension ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint guidelines <NUMBER> include firstline agents ace inhibitors arbs thiazide thiazidelike diuretics dihydropyridine nondihydropyridine calcium channel blockers well secondline agents betaadrenergic antagonists alpha blockers centrally acting alpha agonists loop diuretics potassium sparing diuretics mineralocorticoid receptor antagonists direct vasodilators individual drugs listed etable <NUMBER> information latter derived pharmacy claims defined cumulative supply greater <NUMBER> days july <NUMBER> <NUMBER> december <NUMBER> <NUMBER> identified <NUMBER> mutually exclusive exposure groups <NUMBER> patients receiving ace inhibitors <NUMBER> receiving arb without agents used active comparator analyses included remaining patients diagnosis hypertension received one antihypertensive agents drug classes ace inhibitor arb agents include first second line antihypertensive agents based <NUMBER> aha guidelines hypertension <NUMBER> use individual agents defined one pharmacy claims least <NUMBER> days medication supply agent july december <NUMBER> sensitivity analyses restricted control group individuals receiving least one first line antihypertensive agent drug classes ace inhibitor arb ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> combined information inpatient outpatient claims <NUMBER> identify potential confounders association ace inhibitors arb use patient outcomes included patient age sex race conditions would represent potential indications selective use ace inhibitors arbs diabetes myocardial infarction heart failure chronic kidney disease additional comorbidities included charlson comorbidity index peripheral vascular disease cerebrovascular disease hemior paraplegia dementia chronic pulmonary disease rheumatologic disease diabetes chronic complications malignancy metastatic solid tumor mild liver disease moderatetosevere liver disease acquired immunodeficiency syndrome human immunodeficiency virus icd<NUMBER> codes corresponding variables included etable <NUMBER> appendix race available medicare advantage members included information total number antihypertensive agents prescribed patients using pharmacy claims finally regional clustering cases identified using location sites submitting claims laboratory testing sarscov<NUMBER> hospital site inhospital outcomes outpatient study primary outcome inpatient hospitalization covid<NUMBER> defined hospitalization principal secondary diagnosis covid<NUMBER> linked inpatient dataset etable <NUMBER> assessed mortality inpatient hospitalization secondary outcome ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint inpatient study primary outcome inhospital mortality addition evaluated secondary composite outcome death discharge hospice hospital length stay outpatient inpatient studies created propensity scorematched cohorts patients hypertension treated ace inhibitors arbs antihypertensive medications constructed nonparsimonious multivariable logistic regression model receipt ace inhibitors arb antihypertensive dependent variable example modeled receipt ace inhibitor another antihypertensive excluding arb determine patients likelihood receiving agents based measured clinical characteristics applied strategy different pairs treatment comparisons ace inhibitor vs others arb vs others ace inhibitor vs arb briefly performed <NUMBER> matching recipients based propensity scores caliper width onetenth standard deviation logit propensity score <NUMBER> pursued <NUMBER> iterations find lowest mean absolute standardized difference among matched variables matched cohorts age gender race insurance type conditions may lead selective use ace inhibitors arbs ie diabetes myocardial infarction heart failure chronic kidney disease comorbidities charlson comorbidity index number antihypertensive agents used patient account regional clustering care practices response covid<NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint pandemic explicitly accounted census region lab testing site inpatient facility models evaluated performance propensity score matching using several strategies first assessed propensity score distributions unmatched matched cohorts calculated equipoise metric summarize degree overlap characteristics patients receiving drugs <NUMBER> <NUMBER> represents proportion individuals unmatched groups propensity score <NUMBER> <NUMBER> representing state equipoise two drugs value greater <NUMBER> implies two drugs empirical equipoise higher value indicating lower likelihood confounding indication <NUMBER> next evaluated standardized difference matched covariates propensity score matching specifically evaluated whether matching algorithm achieved standardized difference <NUMBER> matched cohort suggestive adequately matched groups <NUMBER> second evaluated success matching algorithm using priori defined negative control outcomes chose two negative control falsification endpointsclaims gastroesophageal reflux disease ingrown nail unlikely affected treatment assignment directional effect would represent covariate imbalance <NUMBER> third evaluated whether propensity matched cohort also adequately matched therapeutic classes nonantihypertensive agents directly included matching algorithm strategies designed evaluate potential residual confounding creating propensity score matched cohorts finally evaluated observations robustness assessing treatment effects <NUMBER> iterations propensity score ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint matching algorithm evaluating whether findings consistent across iterations varied degree matching individual covariates describe differences patients treated ace inhibitors arbs compared antihypertensive agents treated ace inhibitors using chi square test categorical variables ttest continuous variables duration follow expected vary across individuals outpatient inpatient covid<NUMBER> cohorts evaluated effects timetoevent analyses coxproportional hazards models unadjusted propensity scorematched cohorts reduce bias residual differences matched covariates evaluation patient outcomes included covariates included propensity score matching algorithm independent variables models <NUMBER> repeated analyses without additional covariate adjustment outpatient study index date represented day positive covid<NUMBER> test outpatient period study measured days positive covid<NUMBER> outcome interest hospitalization inpatient study index date represented first day hospitalization covid<NUMBER> period study measured days admission outcome interest death since hospitalization could end either patients death discharged alive created causespecific cox proportional hazards model competing risk analysis <NUMBER> <NUMBER> <NUMBER> analyses censored end observation period may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint given systematic differences patients enrolled medicare advantage commercial insurance particularly older age higher comorbidity burden higher risk covid<NUMBER> complications among medicare advantage enrollees evaluated quantitative qualitative interactions insurance type treatment groups assessment outcomes also created propensity scorematched cohorts within two insurance subgroups analyses performed using open source r <NUMBER> cran python <NUMBER> hypothesis tests <NUMBER>sided level significance set <NUMBER> except interaction tests level significance set <NUMBER> given exploratory nature study statistical tests adjusted multiple testing yale affairs exempted study review activities limited retrospective analysis deidentified data accessed accordance health insurance portability accountability act regulations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint median age individuals <NUMBER> years <NUMBER> women medicare advantage patients <NUMBER> african american patients receiving ace inhibitors arbs likely men diabetes without chronic complications receiving <NUMBER> antihypertensive drugs table <NUMBER> less likely chronic heart failure moderatetosevere renal disease compared patients receiving antihypertensive treatments patients receiving ace inhibitors similar receiving arbs higher rate dementia peripheral vascular disease table <NUMBER> matched <NUMBER> patients receiving ace inhibitors <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> achieving <NUMBER> standardized differences covariates figure <NUMBER> similarly matched <NUMBER> patients receiving arb <NUMBER> patients receiving antihypertensive agents efigure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> among <NUMBER> patients hospitalized covid<NUMBER> linked claims data <NUMBER> diagnosis hypertension outpatient prescription least one antihypertensive drug efigure <NUMBER> inpatient cohort included patients <NUMBER> states us efigure <NUMBER> included patients <NUMBER> medicare advantage enrollees median age hospitalized individuals <NUMBER> years <NUMBER> women <NUMBER> medicare advantage enrollees african american differences hospitalized patients treated ace inhibitors arbs agents included table <NUMBER> inpatient cohort <NUMBER> patients receiving ace ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inhibitors <NUMBER> patients receiving arbs propensity scorematched patients receiving antihypertensive agents efigure <NUMBER> covariate standardized differences <NUMBER> matching figure <NUMBER> equipoise comparisons ace inhibitors drugs ace inhibitors arb <NUMBER> lower arb comparisons table <NUMBER> outpatient cohort median <NUMBER> iqr <NUMBER> <NUMBER> days sarscov<NUMBER> testing patients receiving ace inhibitors less frequently hospitalized receiving antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> significant association arb therapy hospitalization rates <NUMBER> vs <NUMBER> individuals insurance p <NUMBER> propensity scorematched cohorts efigure table <NUMBER> differences priori chosen falsification endpoints propensity scorematched populations etable <NUMBER> differences association ace inhibitors hospitalization risk across insurance groups p interaction <NUMBER> lower risk hospitalization medicare advantage patients hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> observed commercially insured individuals hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint propensity scorematched analyses arb use associated significantly lower hospitalization risk individuals receiving antihypertensive agents hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> significant differences hospitalization rates propensity score matched cohorts patients receiving ace inhibitor compared arb hr <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant interactions insurancetype association arb outcomes pinteraction <NUMBER> among individuals outpatient cohort hospitalized association ace inhibitor arb use subsequent inhospital mortality etable <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> <NUMBER> died hospitalization <NUMBER> <NUMBER> discharged alive <NUMBER> <NUMBER> still hospitalized end observation period majority deaths <NUMBER> among medicare advantage population median length stay including patients died well discharged alive covid<NUMBER> hospitalizations <NUMBER> iqr <NUMBER> <NUMBER> days similar across patients died <NUMBER> iqr <NUMBER> <NUMBER> days discharged alive <NUMBER> iqr <NUMBER> <NUMBER> days observation period overall proportion covid<NUMBER> patients died differ significantly ace inhibitor therapy hospitalization compared antihypertensive agents <NUMBER> vs <NUMBER> p <NUMBER> propensity matchedcohort patients receiving ace inhibitors hospitalization inhospital mortality ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity table <NUMBER> similarly arb significantly different risk mortality compared antihypertensive agents <NUMBER> <NUMBER> <NUMBER> p <NUMBER> significant differences mortality patients receiving ace inhibitors arbs overall population without significant interaction insurance group treatment assignment patient outcome figure <NUMBER> table <NUMBER> findings consistent secondary outcome inhospital death discharge hospice etable <NUMBER> also association treatment ace inhibitor arb hospital length stay etable <NUMBER> sensitivity analyses focused individuals receiving least one first line antihypertensive agent control group varied covariate adjustment strategies consistent primary analysis etables <NUMBER> <NUMBER> iterations propensity score matching algorithm found lower risk hospitalization ace inhibitors across iterations pvalue less <NUMBER> <NUMBER> <NUMBER> iterations medicare advantage population first national study ace inhibitors arbs outpatients testing positive sarscov<NUMBER> found overall drugs confer additional risk benefit however among medicare advantage ace inhibitors associated almost <NUMBER> significantly lower risk hospitalization covid<NUMBER> effect observed arbs among hospitalized covid<NUMBER> find benefit harm medications collectively findings support change current use medications given lack effective therapies mitigate ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint harm virus study provide rationale testing use ace inhibitors older patients reduce risk severe sarscov<NUMBER> infection design several attributes provide confidence findings even though observational study restricted people hypertension receiving least one antihypertensive agent thereby limiting assessment individuals receiving treatment chronic illness therefore equally likely seek care healthcare needs covid<NUMBER> analyses explicitly compared individuals equipoise receiving either drug treatment moreover find evidence confounding disease severity choice therapy assessment priori defined falsification endpoints study included individuals across united states thereby limiting effect hospital regional care practices may bias evaluation treatment effects observations extends prior evidence supporting safety ace inhibitor treatment covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> show safety agents outpatient sarscov<NUMBER> infected individuals complements studies hospitalized <NUMBER> <NUMBER> <NUMBER> also national study complements single center single region studies <NUMBER> study intriguing finding subgroup individuals enrolled medicare advantage find ace inhibitors associated significantly lower risk hospitalization following infection sarscov<NUMBER> outpatient setting patients older frequently comorbidities vulnerable severe covid<NUMBER> disease <NUMBER> <NUMBER> findings particularly relevant medicare advantage group represented <NUMBER> covid<NUMBER> hospitalizations ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inpatient cohort also interestingly find association arbs despite clinical equipoise use drugs findings consistent prior evidence randomized clinical trials reduced risk pneumonia ace inhibitors observed arb <NUMBER> study inhospital outcomes adds literature studies reached contrasting conclusions regarding role ace inhibitor therapy inhospital mortality among hospitalized covid<NUMBER> patients find significant association mortality consistent others found association <NUMBER> <NUMBER> <NUMBER> however findings contrast certain studies found lower mortality hospitalized covid<NUMBER> patients treated ace inhibitors <NUMBER> <NUMBER> notably studies evaluated mortality risk covid<NUMBER> consistently designed detect potential causal association drug therapy outcomes <NUMBER> relied case control designs <NUMBER> pursued potentially biased assessment using comparators receiving therapy <NUMBER> <NUMBER> based data single health centers <NUMBER> moreover studied ace inhibitors arbs together despite potentially different mechanisms effects patient outcomes <NUMBER> rationale may specific ace inhibitor effect preclinical evidence suggests possible protective role ace inhibitors covid<NUMBER> ace inhibitors arbs associated upregulation ace<NUMBER> receptors <NUMBER> <NUMBER> receptors modulate local reninangiotensinaldosterone system interactions lung tissue <NUMBER> presence ace<NUMBER> receptors therefore exerts protective effect development acute lung injury infections sars coronaviruses lead dysregulation mechanisms endothelial ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> study important implications <NUMBER> ongoing randomized trials none align observations study <NUMBER> <NUMBER> trials <NUMBER> testing use ace inhibitors arbs treatment hospitalized covid<NUMBER> patients <NUMBER> using <NUMBER>day course arbs positive sarscov<NUMBER> test prevent hospitalization <NUMBER> however study suggests appropriate strategy test trial would prophylactic use ace inhibitor prevent hospitalization tested current study findings study interpreted light following limitations first study observational despite robust methods explicit assessments residual confounding understanding potential protective role ace inhibitors covid<NUMBER> requires dedicated randomized controlled trial second know proportion patients receiving antihypertensive agents continued treated drugs illness association continued use cessation patient outcomes third included data elements contingent upon individuals seeking care ailment filling medication using insurance provider would captured chose selfpay however expect sizeable proportion insured individuals would defer insurance coverage care fourth cannot account differences timing ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint presentation patients relative symptom onset however limited effect differential presentation patients across exposure groups focusing patients receiving treatment medical comorbidity ie hypertension varying class drugs moreover included patients across us accounted clustering patients thereby limiting effect local practice patterns may affect hospitalization thresholds therefore unlikely patients care seeking ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ant ihypert ensi e agent use roups propensit score ching roups aft er propensit score ching ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint sarscov<NUMBER> virus newly discovered member coronavirus family first described end <NUMBER> wuhan china third severe respiratory syndrome caused coronavirus <NUMBER> due easy spread via droplets direct contact quickly spread globally leading world health organization declare public health emergency <NUMBER> countries around world taking measures aimed preventing spread coronavirus main mechanism fighting disease <NUMBER> measures significant impact peoples lives many countries imposed travel restrictions <NUMBER> <NUMBER> leaving millions people change travel plans psychological economic impact mandatory isolation following possible exposure virus another matter concern <NUMBER> <NUMBER> <NUMBER> clinically disease presents incubation period <NUMBER> <NUMBER> days <NUMBER> cdc reports common symptoms fever cough shortness breath dyspnea chest pain confusion cyanosis represent alarm symptoms prompt people seek medical attention <NUMBER> largest metaanalysis available time writing article reports fever cough presenting symptoms <NUMBER> <NUMBER> patients respectively <NUMBER> fatigue gastrointestinal symptoms also frequently reported <NUMBER> hypertension diabetes mellitus commonly reported comorbidities <NUMBER> <NUMBER> <NUMBER> older individuals comorbidities likely develop endorgan damage requiring icu admission <NUMBER> acute respiratory distress syndrome ards acute kidney injury aki cardiac injury reported severe cases ards common <NUMBER> leukopenia less commonly eosinopenia typical laboratory findings bilateral groundglass patchy opacities lungs common radiologic abnormalities <NUMBER> <NUMBER> <NUMBER> creactive protein ddimer procalcitonin levels elevated especially cases severe disease <NUMBER> time writing clear guidelines treating sarscov<NUMBER> infections published clinicians seem treating manner similar seasonal flu purpose article look impact sarscov<NUMBER> infection hypertensive patients considering extremely high prevalence hypertension society fact hypertension among frequent comorbidities patients severe cases sarscov<NUMBER> infections believe important look deeply relationship two conditions angiotensin converting enzyme ace enzyme essential component human metabolism dysregulation associated number different clinical conditions including hypertension many studies done assess potential role ace ards development multiple animal models shown protective effect ace ii ards development <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> similarly sarscov uses ace ii receptor invade alveolar epithelium considered potential target future anticovid<NUMBER> therapies <NUMBER> <NUMBER> cardiovascular pathology ace inhibitorsangiotensin receptor ar blockers lead increased ace ii levels potentially increasing risk sarscov<NUMBER> infections pointed hanff et al <NUMBER> also evidence sarscov<NUMBER> lead downregulation ace ii toxic accumulation angiotensin ii <NUMBER> also noted ace ii expressed organs tissues well fact ace expressed gut heart kidney sarscov infections associated gastrointestinal symptoms virus often isolated stool cardiac damage aki speaks favor strong correlation ace expression covid infection <NUMBER> overall exact role ace enzyme angiotensin lung injury general well pathogenesis sarscov<NUMBER> covid <NUMBER> infections clear models true ace ii protective role ards ards feared complication covid <NUMBER> would reasonable assume ace ii would protective effect covid <NUMBER> ace ii receptor used virus infect alveolar epithelium raises issue whether availability receptor associated severity clinical findings moreover large percentage population treated ace inhibitors arbs whether treatments associated change outcomes covid <NUMBER> infections currently debated recognize difficulties performing basic science research especially animal models light current epidemic agree hanff et al would strongly encourage scientists keep researching possible connection ace receptor angiotensin ards ace inhibitors ar blockers currently among frequently prescribed medications western world commonly used patients suffering hypertension congestive heart failure proteinuria commonly due diabetes mellitus act reducing activity reninangiotensin system ras ras plays significant role sarscov<NUMBER> pathogenesis ards development would reasonable assume patients treated ace inhibitorsar blockers would impacted animal models suggest administration ace inhibitors ar blockers leads elevated number ace ii receptors pulmonary circulation <NUMBER> marin reported many patients latin america spain intending discontinue taking ace inhibitorsar blockers due fear infection <NUMBER> despite animal models showing potential association ace inhibition worsening lung injuries due sarscov clinical evidence support association <NUMBER> european society cardiology recommends discontinuing either drugs potential risks associated uncontrolled hypertension seem outweigh risks ace inhibition worsening covid <NUMBER> infection <NUMBER> danser et al reached conclusion <NUMBER> french health minister claimed use antiinflammatory medications ibuprofen could worsen covid <NUMBER> symptoms <NUMBER> although ace ii levels increased use nsaids evidence association severity covid <NUMBER> symptoms weak <NUMBER> fang et al however recommend monitoring patients taking controversial drugs possible choosing alternative treatments <NUMBER> despite health authorities including nhs suggest using paracetamolacetaminophen instead precautionary measure <NUMBER> overall impact ace inhibition sarscov<NUMBER> covid <NUMBER> pathogenesis point time difficult establish belief association two exists mostly based animal models clinical evidence association lacking despite lack clinical evidence appears case number patients plan discontinuing longterm therapies believing would decrease risk contracting andor dying covid <NUMBER> evidence relationship nsaid use severe sarscov<NUMBER> infections also weak although possible pathophysiologic link hypothesized case however many health authorities recommend using nsaids evidence comes light believe lot basic science research pathophysiology coronavirus infections ards development general needed clearer patterns emerge point may reasonable avoid starting new patients nsaids ace inhibitorsarbs avoided comes patients require treatments conditions discontinuation unlikely benefit patients evidence exacerbations comorbidities stronger evidence covid <NUMBER> disease severity news reports expert opinions patients hypertension presenting severe cases covid <NUMBER> moreover hypertension among frequently reported comorbidities patients <NUMBER> <NUMBER> <NUMBER> taken account however hypertension among prevalent chronic conditions western world affecting millions people fang et al point association diabetes hypertension covid <NUMBER> infections likely due association ace ii enzyme <NUMBER> li et al reported significantly higher prevalence hypertension cardiovascular comorbidities among covid <NUMBER> patients treated icu compared require icu treatment <NUMBER> also reported <NUMBER> infected sarscov<NUMBER> developed cardiac injury <NUMBER> chen et al also reported similar association <NUMBER> elevated troponin levels seen icu patients also pointed towards development myocardial injury <NUMBER> odds ratio developing severe case compared nonsevere case hypertensive patients <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> <NUMBER> none studies analyzed age potential confounder considering prevalence hypertension rises age older patients general likely suffer serious complications infectious diseases addressed international society hypertension point evidence patients hypertension overrepresented among severe sarscov<NUMBER> infections adjusted age <NUMBER> difficult assess impact hypertension outcome patients infected sarscov<NUMBER> multiple studies point significant association hypertension adverse outcomes however number potential confounders main age vast previously mentioned association antihypertensives severe covid <NUMBER> presentations also needs taken account number studies published far insufficient properly address questions hope case reports review articles become available literature clearer pattern emerge outcomes patients uncontrolled hypertension compared normotensive controls similar baseline characteristics outcomes hypertensive patients managed ace inhibitorsar blockers compared hypertensive patients managed calcium channel antagonists besides hypertension cardiovascular comorbidities also frequently reported patients severe cases covid <NUMBER> considering significant associations hypertension cardiac disease correlation would expected moreover significant association heart failure pulmonary disease particularly pulmonary hypertension possible consequences even mild cardiac damage would expected significant among patients preexisting cardiac disease li et al reported cardiocerebrovascular disease among prevalent comorbidities among patients severe cases covid <NUMBER> second hypertension <NUMBER> <NUMBER> respectively <NUMBER> zhou et al reported coronary disease third prevalent comorbidity hypertension diabetes <NUMBER> chen et al also found previous history coronary disease independent risk factor adverse outcomes <NUMBER> proposed mechanism findings pericytes high ace ii expression might cells targeted sarscov<NUMBER> <NUMBER> pericyte injury could lead endothelial dysfunction <NUMBER> patients preexisting heart failure likely elevated ace ii expression due pathophysiology chf could increase risk infection <NUMBER> et al found mortality critically ill patients infected sarscov<NUMBER> develop cardiac injury high <NUMBER> <NUMBER> also found elevation nterminal probtype natriuretic peptide levels usually biomarker congestive heart failure associated myocardial injury caused covid <NUMBER> considered together studies point association preexisting cardiovascular comorbidities adverse outcomes following sarscov<NUMBER> infections likely contributing factor finding observed myocardial damage subset covid <NUMBER> patients patients preexisting heart disease less likely recover moreover increased expression ace ii congestive heart failure could explain increased susceptibility virus ability address myocardial damage icu may prove important prognostic factor patients considering lack currently approved treatments aimed virus especially important ensure people comorbidities exposed first place research needed exact impact sarscov<NUMBER> cardiovascular system order develop protective potentially curative strategies covid <NUMBER> caused sarscov<NUMBER> talkedabout disease first half <NUMBER> elderly suffering chronic conditions risk adverse outcomes hypertension frequently reported comorbidity among patients severe infections followed diabetes cardiovascular diseases possibly related expression ace ii facilitating viral entry cells relationship ace inhibitorar blocker use incidence severe covid<NUMBER> conflicting present authorities recommend discontinuing longterm ace inhibitorar blocker treatments concern remains patients may inclined stop taking prescribed medicines fear another point contention use nsaids number public health authorities released statements claiming evidence association existed nevertheless recommended choosing alternative drugs possible pending investigation nsaids finally available evidence clearly points correlation preexisting cardiovascular comorbidities adverse outcomes sarscov<NUMBER> infections severe cases associated myocardial damage considering high prevalence hypertension cardiovascular diseases important continue researching association conditions covid<NUMBER> disclosures severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> previously known novel coronavirus<NUMBER> ncov <NUMBER> causes coronavirus disease<NUMBER> time publication april <NUMBER> <NUMBER> covid<NUMBER> pandemic led <NUMBER> cases <NUMBER> deaths across <NUMBER> countries according world health organization data <NUMBER> older patients covid<NUMBER> underlying pulmonary disease hypertension diabetes established cardiovascular disease worse prognosis counterparts without comorbidities <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> infects host cells binding human angiotensinconverting enzyme<NUMBER> ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> membranebound enzyme expressed lungs heart kidneys among many organs <NUMBER> <NUMBER> within heart pericytes express greatest levels ace<NUMBER> although cardiomyocytes endothelial cells also express ace<NUMBER> <NUMBER> ace<NUMBER> catalyzes conversion angiotensini angiotensinii angiotensin<NUMBER> angiotensin<NUMBER> respectively <NUMBER> angiotensinii promotes increased sympathetic tone sodium water retention fibrosis inflammation angiotensin type <NUMBER> receptor whereas angiotensin <NUMBER> counteracts effects binding mas receptor fig <NUMBER> <NUMBER> proposed reninangiotensinaldosterone system raas inhibitors predispose sarscov<NUMBER> infection worsen outcomes covid<NUMBER> upregulating ace<NUMBER> expression <NUMBER> angiotensinconverting enzyme inhibitors ace inhibitors angiotensin receptor type <NUMBER> blockers arbs mineralocorticoid receptor antagonists increase heart vascular kidney ace<NUMBER> expression activity animals <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chronic treatment ace inhibitor <NUMBER> months associated increased plasma angiotensin<NUMBER> level angiotensinii angiotensin<NUMBER> ratio whereas association observed immediate period acute ace inhibitor treatment <NUMBER> <NUMBER> spironolactone treatment increased ace<NUMBER> activity mrna human monocytederived macrophages patients heart failure <NUMBER> yet others support hypothesis raas inhibitors ace<NUMBER> counteract angiotensiniimediated pulmonary injury respiratory viral illness <NUMBER> <NUMBER> beneficial effects could attributable angiotensin<NUMBER> binding mas receptor promotes antiinflammatory signaling <NUMBER> one study acid aspiration sepsis lung injury ace<NUMBER> knockout mice mice pretreated recombinant human ace<NUMBER> attenuated lung damage <NUMBER> models treatment ace<NUMBER> knockout mice angiotensin type <NUMBER> receptor blocker also protected lung injury <NUMBER> administration recombinant human ace<NUMBER> beginning one day respiratory syncytial virus infection decreased pulmonary immune cell infiltration attenuated histologic lung injury mice <NUMBER> recombinant human ace<NUMBER> increased angiotensin<NUMBER> decreased angiotensinii concentrations patients acute respiratory distress syndrome stopped early futility significant difference partial pressure arterial oxygen fraction inspired oxygen ratio <NUMBER> data suggest ace<NUMBER> modulation may protect lung damage acute respiratory distress syndrome address whether ace<NUMBER> modulation may salvage lung function initial lung insult moreover unclear whether hypothetical benefits ace<NUMBER>mediated lung protection outweigh theorized ace<NUMBER>mediated increase sarscov<NUMBER> entry several questions relationship sarscov<NUMBER> ace<NUMBER> raas inhibitors must answered drawing conclusions raas inhibitors covid<NUMBER> inform design future studies first data support increase ace<NUMBER> expression alveolar epithelial cells raas inhibition animal models plasma ace<NUMBER> activity may represent enzymatic activity tissue level angiotensinii infusion mice decreases myocardial ace<NUMBER> protein level activity increases plasma ace<NUMBER> activity <NUMBER> furthermore increased plasma ace<NUMBER> levels associated adverse cardiovascular prognosis <NUMBER> may relevant differences ace inhibitors arbs differences within class respect effects circulating tissue ace<NUMBER> crosssectional analysis adults taking various antihypertensive agents ontreatment urinary ace<NUMBER> concentrations increased patients taking olmesartan ace inhibitors arbs <NUMBER> conversely <NUMBER> studies demonstrated higher ontreatment circulating levels angiotensin <NUMBER> patients receiving ace inhibitor arb <NUMBER> <NUMBER> spontaneously hypertensive rats sacubitrilvalsartan restored cardiac ace<NUMBER> mrna expression whereas valsartan <NUMBER> circulating angiotensin<NUMBER> may reflect ace<NUMBER> activity patients receiving sacubitrilvalsartan neprilysin converts angiotensin<NUMBER> angiotensini angiotensin<NUMBER> ace<NUMBER>independent factors also influence sarscov<NUMBER> infection covid<NUMBER> severity example sarscov<NUMBER> entry seems require tmprss<NUMBER> serine protease expressed ace<NUMBER>expressing cells <NUMBER> host genetics comorbidities likely play role susceptibility sarscov<NUMBER> infection outcome suggested high prevalence advanced age cardiac pulmonary comorbidities among patients covid<NUMBER> randomized clinical trials provide opportunity answer questions rigorous manner two ongoing trials compare losartan arb placebo active comparator hospitalized patients outpatients covid<NUMBER> clinicaltrialsgov nct<NUMBER> nct<NUMBER> nct<NUMBER> another clinical trial compare continuing ace inhibitor arb therapy switching alternative agent patients hypertension without covid<NUMBER> nct<NUMBER> epidemiologic studies performed estimate association raas inhibitor use risk covid<NUMBER> patients hypertension heart failure chronic kidney disease withdrawal raas inhibition increases risk decompensation patients heart failure adverse physiological changes occur shortly raas inhibitor withdrawal plasma angiotensin ii aldosterone cortisol norepinephrine levels increase pretreatment levels within <NUMBER>days ace inhibitor cessation patients heart failure new york heart association functional class iii iv symptoms <NUMBER> mean <NUMBER> days without ace inhibitor therapy left ventricular enddiastolic endsystolic volumes return pretreatment values patients heart failure reduced ejection fraction <NUMBER> worsening symptoms decreased exercise tolerance occurs within <NUMBER> weeks ace inhibitor withdrawal <NUMBER> even among patients recovery left ventricular function reversal left ventricular remodeling withdrawal neurohormonal blockade increases risk clinical relapse subclinical adverse left ventricular remodeling <NUMBER> discontinuing ace inhibitor arb therapy patients progression chronic kidney disease associated increased risk cardiovascular disease <NUMBER>year period <NUMBER> figure <NUMBER> interactions reninangiotensinaldosterone system coronavirus disease<NUMBER> complex raas regulates blood pressure sodium water retention plays important role pathogenesis cardiovascular disease angiotensinconverting enzyme converts angiotensini angiotensinii mediates vasoconstriction sodium water retention inflammation angiotensin type <NUMBER> receptor red arrows angiotensin converting enzyme<NUMBER> ace<NUMBER> counterbalances angiotensiniiangiotensin type <NUMBER> receptor pathway converting angiotensinii angiotensin<NUMBER> binds mas receptor mediate vasodilation antiinflammatory effects yellow arrows importantly angiotensiniiangiotensin type <NUMBER> receptor pathway leads cleavage membranebound ace<NUMBER> via adams<NUMBER> green arrow severe acute respiratory coronavirus<NUMBER> sarscov<NUMBER> binds ace<NUMBER> undergoes endocytosis infect host cells consequence sarscov<NUMBER> infection decreases membranebound ace<NUMBER> impairs beneficial effects angiotensin<NUMBER>mas receptor axis march <NUMBER> american college cardiology american heart association heart failure society america european society cardiology issued recommendations discontinuing raas inhibitors covid<NUMBER> pandemic <NUMBER> clinicians consider risk covid<NUMBER> exposure caring patients hypertension heart failure acute myocardial infarction diabetic nephropathy clinicians reinforce preventative measures patients must leave homes provide blood samples electrolyte renal function monitoring raas inhibitors <NUMBER> summary limited preclinical clinical evidence effects raas inhibitors covid<NUMBER> clinicians continue use raas inhibitors covid<NUMBER> pandemic according current standards care scientists must focus addressing several knowledge gaps inform clinical management covid<NUMBER> particularly among patients underlying pulmonary cardiovascular disease reninangiotensin system ras known play important role regulating blood pressure electrolyte water balance ras pathway consists cascade proteases producing bioactive molecules <NUMBER> angiotensinogen mainly released liver cleaved renin secreted juxtaglomerular cells kidney thus generating decapeptide angiotensin ang <NUMBER> <NUMBER> ang converted angiotensin ii ang ii angiotensinconverting enzymes ace expressed endothelial cells several organs lung heart kidney brain <NUMBER> <NUMBER> ang ii relevant molecule ras pathway performs function activating following gproteincoupled receptors angiotensin ii receptor type <NUMBER> at<NUMBER>r angiotensin ii receptor type <NUMBER> at<NUMBER>r <NUMBER> figure <NUMBER> effects exerted two membrane receptors opposite particular at<NUMBER>r induces detrimental effects inflammation fibrosis altered redox balance addition vasoconstrictive properties whereas at<NUMBER>r involved protective regenerating actions antiinflammatory antifibrotic neurodegenerative metabolic release vasodilatory molecules <NUMBER> <NUMBER> <NUMBER> therefore equilibrium point ras represented ang ii also converted heptapeptide ang<NUMBER> thanks action angiotensinconverting enzyme <NUMBER> ace<NUMBER> ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also generated cleavage ang endopeptidases binds mas receptors counteracting deleterious actions aceang iiat<NUMBER> axis especially pathological conditions <NUMBER> <NUMBER> several sources evidence suggest ras represents important target treatment lung pathologies <NUMBER> <NUMBER> indeed aceang iiat<NUMBER>r axis plays relevant role promoting acute lung injury ace<NUMBER>ang<NUMBER>mas pathway antagonize reduce pathological processes including pulmonary hypertension fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data demonstrated connection ras acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> experimental settings acute lung injury ace<NUMBER> deficient animals develop histological functional ards <NUMBER> particular ang ii involved number processes take place lung including genesis pulmonary edema due regulation pulmonary vasoconstriction vascular permeability response hypoxia stimulation lung production inflammatory cytokines induction alveolar epithelial cells apoptosis fibroproliferation <NUMBER> detrimental effects hypertension ang ii infusion <NUMBER> ace<NUMBER> pathway shown exert different effects cardiomyocytes heart <NUMBER> <NUMBER> <NUMBER> ang<NUMBER> infusion ameliorate myocardial performance cardiac remodeling survival animal model heart failure exerting beneficial effects <NUMBER> data correlated ace<NUMBER> overexpression cardiac fibrosis arrhythmia <NUMBER> <NUMBER> several sources evidence suggest ras represents important target treatment lung pathologies <NUMBER> <NUMBER> indeed aceang iiat<NUMBER>r axis plays relevant role promoting acute lung injury ace<NUMBER>ang<NUMBER>mas pathway antagonize reduce pathological processes including pulmonary hypertension fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data demonstrated connection ras acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> experimental settings acute lung injury ace<NUMBER> deficient animals develop histological functional ards <NUMBER> particular ang ii involved number processes take place lung including genesis pulmonary edema due regulation pulmonary vasoconstriction vascular permeability response hypoxia stimulation lung production inflammatory cytokines induction alveolar epithelial cells apoptosis fibroproliferation <NUMBER> inhibition detrimental effects hypertension ang ii infusion <NUMBER> ace<NUMBER> pathway shown exert different effects cardiomyocytes heart <NUMBER> <NUMBER> <NUMBER> ang<NUMBER> infusion ameliorate myocardial performance cardiac remodeling survival animal model heart failure exerting beneficial effects <NUMBER> data correlated ace<NUMBER> overexpression cardiac fibrosis arrhythmia <NUMBER> <NUMBER> several sources evidence suggest ras represents important target treatment lung pathologies <NUMBER> <NUMBER> indeed aceang iiat<NUMBER>r axis plays relevant role promoting acute lung injury ace<NUMBER>ang<NUMBER>mas pathway antagonize reduce pathological processes including pulmonary hypertension fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data demonstrated connection ras acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> experimental settings acute lung injury ace<NUMBER> deficient animals develop histological functional ards <NUMBER> particular ang ii involved number processes take place lung including genesis pulmonary edema due regulation pulmonary vasoconstriction vascular permeability response hypoxia stimulation lung production inflammatory cytokines induction alveolar epithelial cells apoptosis fibroproliferation <NUMBER> due regulatory effects ace ace<NUMBER> levels ang ii peptidases main players regulation blood pressure cardiovascular system <NUMBER> <NUMBER> endothelial ace<NUMBER> overexpression functions negative regulator ras thus reducing blood pressure <NUMBER> animal model ace<NUMBER> cardiomyocyte overexpression seems decrease detrimental effects hypertension ang ii infusion <NUMBER> ace<NUMBER> pathway shown exert different effects cardiomyocytes heart <NUMBER> <NUMBER> <NUMBER> ang<NUMBER> infusion ameliorate myocardial performance cardiac remodeling survival animal model heart failure exerting beneficial effects <NUMBER> data correlated ace<NUMBER> overexpression cardiac fibrosis arrhythmia <NUMBER> <NUMBER> several sources evidence suggest ras represents important target treatment lung pathologies <NUMBER> <NUMBER> indeed aceang iiat<NUMBER>r axis plays relevant role promoting acute lung injury ace<NUMBER>ang<NUMBER>mas pathway antagonize reduce pathological processes including pulmonary hypertension fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data demonstrated connection ras acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> experimental settings acute lung injury ace<NUMBER> deficient animals develop histological functional ards <NUMBER> particular ang ii involved number processes take place lung including genesis pulmonary edema due regulation pulmonary vasoconstriction vascular permeability response hypoxia stimulation lung production inflammatory cytokines induction alveolar epithelial cells apoptosis fibroproliferation <NUMBER> <NUMBER> sarsrelated coronavirus sarscov infection outbreak possible relation emerged ras viral infections virus characterized high mortality rate due clinical respiratory failure linked ards <NUMBER> intriguingly ace<NUMBER> shown receptor sarscov <NUMBER> <NUMBER> sars virus enter host cells endocytosis process mediated binding spike protein trimers hydrophobic pocket extracellular catalytic domain ace<NUMBER> <NUMBER> virus entry ace<NUMBER> levels decrease thus enhancing ang ii release may favor ards development <NUMBER> <NUMBER> animal models sarscov infection ace<NUMBER> knockout mice reduces development lung injury <NUMBER> sarscov human coronavirus nl<NUMBER> shown bind ace<NUMBER> invade host cells <NUMBER> moreover overexpressing ace<NUMBER> cell lines promoted efficient replication sarscov ace<NUMBER> neutralized antibodies viral replication inhibited <NUMBER> clinical studies serum ang ii levels shown significantly elevated patients acute lung injury <NUMBER> high serum ang ii levels associated severity mortality infection <NUMBER> at<NUMBER>r opposite effect at<NUMBER>r at<NUMBER>r agonists reduce lung damage <NUMBER> <NUMBER> <NUMBER> ang<NUMBER> mas receptor agonists alleviate acute lung injury mouse models <NUMBER> <NUMBER> <NUMBER> researchers also believe blocking at<NUMBER>r may reduce response inflammatory mediators reduce acute lung injury compared blocking ace <NUMBER> particular animal models lung injury ace inhibitor captopril significantly reduced lipopolysaccharide lps induced detrimental changes lung decreasing secretion tumor necrosis factor α interleukin <NUMBER> along reduction ang iiang<NUMBER> ratio reversing increased ratio ace ace<NUMBER> <NUMBER> data agreement recent evidence suggesting beneficial effects antiil<NUMBER> receptor human antibody tocilizumab treatment sarscov<NUMBER>induced ards <NUMBER> moreover recent study shown coronavirus disease covid<NUMBER> patients hypertension treated ace inhibitors at<NUMBER>r blockers different values viral load attenuation inflammatory response likely inhibition il<NUMBER> levels <NUMBER> sarscov<NUMBER> responsible coronavirus disease covid<NUMBER> shares ace<NUMBER> viral receptor sarscov <NUMBER> ace<NUMBER> highly expressed human lung tissue also nasal cavity oral mucosa <NUMBER> <NUMBER> currently majority patients covid<NUMBER> clinical infection exhibit mild symptoms fever myalgia fatigue nasal congestion sore throat cough <NUMBER> <NUMBER> minority patients rapidly develop complications severe pneumonia septic shock even clotting dysfunction present effective treatment covid<NUMBER> activation signaling pathway ace<NUMBER>ang<NUMBER>mas inhibition pathway aceang iiat<NUMBER>r may interesting therapeutic standpoint ace inhibitors inhibit formation angiotensin ii consequently effects triggered interaction receptors at<NUMBER>r vasoconstriction sodium water retention sympathetic activation cell growth at<NUMBER>r receptors <NUMBER> previous studies shown sarscov significantly reduces ace<NUMBER> lungs infected mice <NUMBER> <NUMBER> binding covid<NUMBER> ace<NUMBER> seems result exhaustion ace<NUMBER> thus inhibiting ace<NUMBER>ang<NUMBER>mas receptor pathway altering balance ras would lead exacerbation acute severe pneumonia <NUMBER> although authors believe detrimental effect ace inhibitors covid<NUMBER> patients assumption still controversial authors concluding ace inhibitors at<NUMBER>r inhibitors may reduce lung inflammatory response mortality may used patients covid<NUMBER> pneumonia <NUMBER> moreover scientific community recently focused attention at<NUMBER>r inhibitors possible benefit patients infected covid<NUMBER> experience pneumonia <NUMBER> even regard still doubts at<NUMBER>r antagonists effects indeed at<NUMBER>r antagonists may intuitively increase ace<NUMBER> expression <NUMBER> <NUMBER> yielding harmful consequences covid<NUMBER> patients since ace<NUMBER> identified functional receptor sarscov<NUMBER> mentioned virus entry ace<NUMBER> levels decrease reduction ace<NUMBER> levels one hand would cause lower production ang<NUMBER> ang ii hand would cause increase unconverted ang ii finding at<NUMBER>r blocked drug would act at<NUMBER>r triggering series protective events lung reduction vascular permeability edema reduction pulmonary fibrosis processes furthermore despite reduction small amount ace<NUMBER> remains able convert ang ii ang <NUMBER> allowing conservation pulmonary protective mechanisms mediated mas receptors <NUMBER> <NUMBER> reasons at<NUMBER>r blockers may paradoxically represent protective mechanism pulmonary lesions virus regard ace inhibitors action ace inhibits formation ang ii thus preventing negative effects mediated at<NUMBER>r positive ones deriving ang ii binding at<NUMBER>r transformation ang<NUMBER> ang<NUMBER> however produced degradation ang endopeptidase ace<NUMBER> intermediate formation ace<NUMBER> figure <NUMBER> although ace inhibition blocks degradation ang<NUMBER> ang<NUMBER> ang<NUMBER> still produced directly ang addition ace inhibitors prevent degradation ang<NUMBER> ang<NUMBER> <NUMBER> increasing levels therefore described at<NUMBER>r inhibitors case would also seem protective effects lung could preserved ace<NUMBER> regulated gene located x chromosome <NUMBER> thus suggesting differences may exist expression ace<NUMBER> men women moreover evidence ace<NUMBER> tissue levels regulated estrogen gupte thatcher et al <NUMBER> demonstrated highfatfed female mice exhibited elevated adipose ace<NUMBER> activity consequently increased plasma ang<NUMBER> levels without affecting systolic blood pressure moreover ovariectomy hffed female mice reducing adipose ace<NUMBER> activity promoted obesity hypertension contrary hffed males elevated systolic diastolic blood pressure abolished losartan <NUMBER> also know estrogen atrial myocardium modifies local ras homeostasis increasing ace<NUMBER>mrna levels <NUMBER> deprivation estrogen postmenopause causes loss cardiovascular protection women due possible shift ace<NUMBER>ras axis aceras pathways <NUMBER> shoemaker et al showed adipocytederived ace<NUMBER> contributes sex differences obesityhypertension regulation balance ang<NUMBER> ang ii benefit lost estrogen deprivation postmenopause <NUMBER> consider susceptibility sarscov<NUMBER> infection increase increasing ace<NUMBER> levels women prone infection men contrast epidemiological data available date show genderbased clinical differences manifestations sarscov<NUMBER> women getting slightly less ill men <NUMBER> greater number male patients <NUMBER> particular elderly subjects affected serious covid<NUMBER> infections compared female patients information contrast studies show level ace<NUMBER> decreases age <NUMBER> therefore appears higher young people generally develop less severe form covid<NUMBER> given apparent inconsistency speculate probably factors contribute severity disease information ethnicity patients affected covid<NUMBER> also important understand african afroamerican patients usually low plasma renin levels really less affected populations concept seems reinforced data covid<NUMBER> available world health organization moment hundreds cases covid<NUMBER> patients abruzzo region italy unpublished observations although observation may biased several temporal season disease developmentrelated issues evidence suggests sarscov<NUMBER> cause myocardial injury elevation highsensitivity cardiac troponin levels <NUMBER> also mechanism underlying myocardial injury linked relationship sarscov<NUMBER> ace<NUMBER> <NUMBER> also considered mortality rate higher patients history high blood pressure diabetes mellitus coronary heart disease <NUMBER> ace inhibitors at<NUMBER>r inhibitors withdrawal would prevent antihypertensive effect also cardioprotective properties drugs although relationship ras pathway covid <NUMBER> yet completely clear ongoing mechanistic observational studies needed clarify better pathophysiology well efficacy safety therapeutic strategies targeting ras pathway treatment andor prevention covid<NUMBER> pandemia evidence exists support use drugs act ras patients affected covid<NUMBER> matter fact segment population affected severe forms covid<NUMBER> usually affected arterial hypertension history heart disease <NUMBER> still information previous therapies relevant clinical aspects moreover recent study highlighted sarscov<NUMBER> cell entry depends ace<NUMBER> tmprss<NUMBER> serine protease interesting finding tmprss<NUMBER> blocked clinically approved protease inhibitor opens new scenarios therapeutic perspective <NUMBER> many research ideas allow us conduct studies next months aim better clarifying therapeutic strategies defeat sarscov<NUMBER> definitely ras probably play role protagonist important challenge medical scientists structure human phb<NUMBER> phb<NUMBER> related introduction figure s<NUMBER> phb<NUMBER> cytoprotection related phbs cytoprotection figure s<NUMBER> structural requirement flavaglines anticancer activities related flavaglines figure s<NUMBER> structural requirement aurilide cytotoxicity hela s<NUMBER> cells related aurilide figure s<NUMBER> structural requirement melanogenin derivatives induction pigmentation melanocytes related melanogenin supplemental table table s<NUMBER> list additional putative proteins interacting phb<NUMBER> detected proteomic approach related table <NUMBER> figure s<NUMBER> structural requirement aurilide cytotoxicity hela <NUMBER> cells suenaga et al <NUMBER> snyder et al <NUMBER> table s<NUMBER> list additional putative proteins interacting phb<NUMBER> detected proteomic approach biological consequence interactions explored yet mitogenactivated protein kinase kinase kinase <NUMBER> borro et al <NUMBER> nadh dehydrogenase ubiquinone ironsulfur protein <NUMBER> proteintyrosine phosphatase mitochondrial <NUMBER> paired amphipathic helix protein sin<NUMBER>a breast cancer metastasissuppressor <NUMBER> probable global transcription activator snf<NUMBER>l<NUMBER> probable global transcription activator snf<NUMBER>l<NUMBER> retinoblastomalike protein <NUMBER> retinoblastomalike protein <NUMBER> adpatp translocase zhu et al <NUMBER> <NUMBER>s ribosomal protein protein kinase c inhibitor protein importin<NUMBER> <NUMBER>s ribosomal protein s<NUMBER> collagen alpha<NUMBER>ix chain precursor ig gamma<NUMBER> chain c region factincapping protein subunit alpha betaactin renal carcinoma antigen plectin<NUMBER> transcription factor iiic subunit alpha heat shock protein hsp <NUMBER> developmentally regulated brain protein prohibitin<NUMBER> phb<NUMBER> formerly known bap<NUMBER> homolog phb<NUMBER> formerly bap<NUMBER> rea prohibitone pleiotropic proteins multiple functions phb<NUMBER> initially identified <NUMBER> mcclung collaborators screening potential tumor suppressors antiproliferative activities highly expressed normal resting regenerating rat liver mcclung et al <NUMBER> nuell et al <NUMBER> phbs since shown act hub many signaling pathways triggered growth factors immune response steroid hormones regulating metabolism mitochondrial biogenesis cell migration division survival phbs composed nterminal transmembrane domain evolutionarily conserved phb domain common scaffold proteins including stomatin flotillin hflkc cterminal coiledcoil domain involved interaction phb<NUMBER> phb<NUMBER> figure s<NUMBER> available online although structure phbs solved winter et al <NUMBER> able generate structural models human phbs based known structure flotillin<NUMBER> belongs family membrane proteins located mitochondrial inner membrane phb<NUMBER> phb<NUMBER> interact form heterodimers organized ringlike structures diameter <NUMBER> nm figure <NUMBER> back et al <NUMBER> coates et al <NUMBER> supercomplexes maintain structure mitochondria regulate functions tatsuta et al <NUMBER> phbs protect newly imported proteins degradation maaa mitochondrial atpases associated diverse cellular activities protease steglich et al <NUMBER> promote mitochondrial protein synthesis maintain organization copy number mitochondrial dna mtdna kasashima et al <NUMBER> act chaperones newly synthesized proteins mitochondrial complex nijtmans et al <NUMBER> gtpase optic atrophy <NUMBER> opa<NUMBER> mitochondrial fission morphogenesis merkwirth et al <NUMBER> phb<NUMBER> also interacts adaptor protein p<NUMBER>shc major mediator stressinduced apoptosis madireddi <NUMBER> adaptor protein activated uvc h <NUMBER> <NUMBER> reactive oxygen species ros induces generation ros mitochondria leading apoptosis gertz et al <NUMBER> remains unclear whether phb<NUMBER> modulates proapoptotic response nevertheless tempting speculate p<NUMBER>shc involved cytoprotective activities phbs ligands particularly oxidative stress bernard et al <NUMBER> fahrig et al <NUMBER> kathiria et al <NUMBER>a liu et al <NUMBER>b ribeiro et al <NUMBER>a phb<NUMBER> also regulated second messenger sphingosine<NUMBER>phosphate s<NUMBER>p controls diverse physiological processes several targets s<NUMBER>p binds high affinity phb<NUMBER> thereby maintains integrity mitochondrial respiration machinery strub et al <NUMBER> process involved preconditioning protection heart ischemiareperfusion injury phbs limited mitochondria also found nucleus endoplasmic reticulum plasma membrane macrophage phagosomes garin et al <NUMBER> modulate many aspects cell physiology roles extremely complex partly phbs regulated several tyrosine serine phosphorylations oglcnac modifications palmitoylations transamidations tyrosine nitrosylations phb<NUMBER> interacts physically second messenger pip<NUMBER> phb<NUMBER> interacts s<NUMBER>p ande mishra <NUMBER> strub et al <NUMBER> posttranslational modification phbs substantial effects activity figure <NUMBER> one bestdocumented examples akt phosphorylation phb<NUMBER> thr<NUMBER> blocks interaction shp<NUMBER> facilitates akt signaling ande mishra <NUMBER> shp<NUMBER> phosphatase facilitates akt signaling enhances insulin signaling additionally phosphorylation phb<NUMBER> thr<NUMBER> necessary activation craf raf<NUMBER> ras chiu et al <NUMBER> rajalingam et al <NUMBER> established activation craf ras requires heterodimerization phosphophb<NUMBER>thr<NUMBER> craf phosphorylation phb<NUMBER> thr<NUMBER> plasma membrane cancer cells activates pi<NUMBER>k akt craferk pathways promote proliferation metastasis chiu et al <NUMBER> contrast insulinreceptorinduced phosphorylation phb<NUMBER> tyr<NUMBER> promotes heterodimerization phosphatase shp<NUMBER> blocks akt signaling ande et al <NUMBER>a suggested regulation phb<NUMBER> transforming growth factor b tgfb responsible dual effect cytokine prostate cancer zhu et al <NUMBER> early stage tumorigenesis tgfb acts tumor suppressor subsequently promotes metastatic spread cancer progression binding tgfb receptor triggers crafmekerk pathway also activates smad <NUMBER> smad <NUMBER> thereby causing opposite effects figure <NUMBER> erk activates protein kinase c pkcd leads phosphorylation phb<NUMBER> consequently cell survival invasion however smad signaling also upregulates <NUMBER> protein inhibits pkcd leading hypophosphorylation phb<NUMBER> promotes apoptosis activity phb<NUMBER> regulated serine threonine phosphorylation particular ser<NUMBER> tyr<NUMBER> ross et al <NUMBER> sun et al <NUMBER> calciumcalmodulindependent protein kinase iv camkiv phosphorylates phb<NUMBER> ser<NUMBER> impeding ability repress transcriptional activity myocyte enhancer factor <NUMBER> mef<NUMBER> sun et al <NUMBER> consequence phosphorylation phb<NUMBER> activity transcription factors reported phb<NUMBER> also inhibits circadian transcription interacting casein kinase <NUMBER> ε ck<NUMBER>ε kategaya et al <NUMBER> phbs detected surface platelets microglial cells wintachai et al <NUMBER> endothelial cells adipose tissue kolonin et al <NUMBER> paclitaxelresistant cancer cells patel et al <NUMBER> intestinal epithelial cells sharma qadri <NUMBER> activated cells yurugi et al <NUMBER> platelets phb<NUMBER> phb<NUMBER> interact directly proteaseactivated receptor <NUMBER> par<NUMBER> promote platelet aggregation zhang et al mitochondrial inner membrane phb<NUMBER> phb<NUMBER> organized ringlike structures maintain structure regulate functions mitochondria interaction opa<NUMBER> maaa protease slp<NUMBER> stomatinlike protein <NUMBER> atad<NUMBER> atpase family aaa domaincontaining protein <NUMBER> mtdna <NUMBER> physiological role phb<NUMBER> surface microglial cells endothelial cells adipose tissue remains elusive demonstrated phb<NUMBER> surface cancer cells involved resistance paclitaxel patel et al <NUMBER> virulence antigen salmonella typhi causative agent typhoid interacts phb<NUMBER> phb<NUMBER> surface intestinal epithelial cells resulting downregulation mitogenactivated protein kinase mapk cascade inhibition early inflammatory responses patel et al <NUMBER> similarly considerable proportions total phb<NUMBER> phb<NUMBER> located surface activated cells contribute activation erk induced cell activation yurugi et al <NUMBER> phb<NUMBER> also present human serum embedded lipid droplets interacts complement protein c<NUMBER> promote innate immunity mishra et al <NUMBER> interestingly serum phb<NUMBER> phb<NUMBER> concentrations found significantly elevated patients colorectal cancer suggesting may serve biomarker type cancer mengwasser et al <NUMBER> brief presentation interactions phbs proteins provided table <NUMBER> list putative partners phb<NUMBER> see table s<NUMBER> phb<NUMBER> phb<NUMBER> involved growth resistance chemotherapy metastasis several mechanisms including activation rascrafmekerk pathway modulation tgfb signaling transcriptional regulation indeed phb<NUMBER> interacts transcription factor p<NUMBER> nucleus cancer cells increase transcriptional activity fusaro et al <NUMBER> p<NUMBER> tumor suppressor controls cell cycle apoptosis genomic stability angiogenesis chander et al <NUMBER> chander et al <NUMBER> fusaro et al <NUMBER> joshi et al <NUMBER> component ubiquitin ligase complexes skp<NUMBER>b overexpressed many breast cancers interacts phb<NUMBER> phb<NUMBER> promote degradation chander et al <NUMBER> chander et al <NUMBER> umanskaya et al <NUMBER> phb<NUMBER> acts activator fusaro et al <NUMBER> chaperone chander et al <NUMBER> p<NUMBER> depletion phb<NUMBER> leads attenuated activity p<NUMBER> cancer cells overexpressing skp<NUMBER>b consequently promotes survival phb<NUMBER> also important regulator retinoblastoma tumor suppressor protein rb family members p<NUMBER> p<NUMBER> wang et al <NUMBER>b proteins bind inhibit e<NUMBER>f transcription factors leading cellcycle arrest phb<NUMBER> represses activity e<NUMBER>f transcription factors interacting several proteins including rb histone deacetylases hdacs nucleosomeremodeling proteins brg<NUMBER> brm wang et al <NUMBER>a wang et al <NUMBER>b wang et al <NUMBER> growing body evidence indicates cellular localization phbs determinant function especially cancer cells patel et al <NUMBER> found phb<NUMBER> overexpressed surface cancer cells resistant taxoids doxorubicin etoposide also demonstrated redirection phb<NUMBER> cytoplasm cell surface critical drug resistance work suggests cellsurface phb<NUMBER> may serve biomarker chemoresistance cancer patients normal epithelial breast cells phb<NUMBER> located primarily mitochondria invasive noninvasive breast cancer cells mainly confined nucleus suggesting phb<NUMBER> local phbs integrate many signaling pathways eg akt crafmekerk camk pkc orchestrate various aspects cell physiology including metabolism transcription apoptosissurvival cytoskeleton reorganization differentiation ization associated tumorigenesis confocal microscopy experiments demonstrated phbs colocalize protooncogenes cmyc cfos p<NUMBER> rb neuroblastoma sknsh cells treatment anticancer drug camptothecin leads phb<NUMBER> p<NUMBER> exported nucleus mitochondria breast cancer cell lines fusaro et al <NUMBER> camptothecininduced translocation phb<NUMBER> dependent protein transporter crm<NUMBER> occurs preferentially transformed cell lines untransformed primary cells peptide corresponding nuclear export signal phb<NUMBER> prevented export phb<NUMBER> resulting protection cells apoptosis indicating translocation phb<NUMBER> nucleus mitochondria contributes tumorsuppressive effects rastogi et al <NUMBER>b one mechanism intracellular location phbs controlled involves signaling protein big<NUMBER>wdr<NUMBER> traps phb<NUMBER> cytoplasm consequently stimulates estrogensignaling pathway hormonerelated growth breast cancer cells kim et al <NUMBER> beyond activities phbs proteins <NUMBER> <NUMBER> utr phb<NUMBER> messenger rna mrna found suppress proliferation human breast cancer cells vitro growth breast tumors xenografted mice vivo manjeshwar et al <NUMBER> first demonstration rna molecule function tumor suppressor human breast cancer tumorsuppressor activity phb<NUMBER> mrna <NUMBER> <NUMBER> utr supported discovery oncogenic microrna<NUMBER>a mir<NUMBER>a upregulated many cancers chhabra et al <NUMBER> targets <NUMBER> <NUMBER> utr phb<NUMBER> downregulates phb<NUMBER> human gastric adenocarcinoma liu et al <NUMBER>a fletcher et al <NUMBER> demonstrated mir<NUMBER>a upregulated androgen receptor prostate cancer resulting reduced phb<NUMBER> mrna protein levels increased cancer cell growth interestingly adding phb<NUMBER> cells overexpressing mir<NUMBER>a blocked mir<NUMBER>ainduced growth demonstrating oncogenic activity mir<NUMBER>a strongly involves phb<NUMBER> signaling prostate cancer important question needs examined phbs display antiand protumorigenic roles cancers summarized table <NUMBER> dichotomy may reflect heterogeneity cancer cell types manifested alteration different signaling pathways consequently regulation transcription translation posttranslational modification phbs probably depends cancerous cell type involved posttranslational events eg phosphorylation sumoylation oglcnac modification palmitoylation transamidation modulate subcellular localization phbs downstream effects proliferation survival cells cell surface phb<NUMBER> promotes chemoresistance inner face plasma membrane contribute oncogenic activation craf however tempting speculate nucleus phb<NUMBER> displays antitumorigenic activity due action p<NUMBER> rb p<NUMBER> p<NUMBER> components mammalian replication machinery additional studies required decipher roles played signaling intracellular localization phbs oncogenesis many studies indicated phbs protect cells oxidative stress due excessive production impaired elimination ros jones <NUMBER> closely associated mitochondrial dysfunction important component etiology cancers inflammatory cardiovascular neurodegenerative diseases diabetes mellitus view central role phbs maintaining normal structure function mitochondria unsurprising phbs alleviate deleterious effect oxidative stress many stresses particular oxidative stress upregulate phb<NUMBER> phb<NUMBER> promote cell survival indeed phb<NUMBER> expression enhanced neurons various stresses including electrical stimulation hypoxiaischemia oxygenglucose deprivation zhou et al <NUMBER> exerciseinduced neuroplasticity ding et al <NUMBER> injection neurotoxin <NUMBER>hydroxydopamine park et al <NUMBER> schizophreniainduced oligodendrocyte dysfunction bernstein et al <NUMBER> phb<NUMBER> also upregulated liver steatohepatitis patients tsutsumi et al <NUMBER> fetal rabbit lung exposure hyperoxic conditions henschke et al <NUMBER> pancreatic bcells ethanol intoxication lee et al <NUMBER>b cardiac cells ischemichypoxic preconditioning muraguchi et al <NUMBER> chronic restraint stress cytoprotectant response involves translocation phb<NUMBER> nucleus cytoplasm mitochondria pancreatic bcells lee et al <NUMBER>b retina retinal epithelium lee et al <NUMBER>a ovarian granulosa cells chowdhury et al <NUMBER> figure s<NUMBER> sripathi et al <NUMBER> suggested localization trafficking phbs determined modulation binding specific lipids indeed strong binding phb<NUMBER> cardiolipin shown correlate localization phb<NUMBER> within mitochondria transformed epithelial cells oxidative stress contrast normal conditions cells phb<NUMBER> binds strongly pip<NUMBER> cardiolipin overexpression phb<NUMBER> protects pancreatic bcells ovarian granulosa cells cardiomyocytes apoptosis induced ethanol ceramide staurosporine serum withdrawal oxidative stressinduced injury consistent phb<NUMBER> cytoprotective role chowdhury et al <NUMBER> lee et al <NUMBER>b liu et al <NUMBER>b merkwirth et al <NUMBER> recently described critical role phb<NUMBER> survival neurons neuronspecific deletion phb<NUMBER> mouse forebrain impaired mitochondrial architecture leading tau hyperphosphorylation filament formation phenotype accompanied severe behavioral cognitive dysfunctions reminiscent alzheimers disease details mechanisms cytoprotection remain poorly documented actors identified involved s<NUMBER>p stat<NUMBER> s<NUMBER>p protects heart ischemiareperfusion damage directly activating phb<NUMBER> thereby regulating respiration cytochrome oxidase subunit iv assembly decreasing hearts susceptibility opening permeability transition pore ptp gomez et al <NUMBER> interleukin<NUMBER> il<NUMBER> increases phb<NUMBER> levels phosphorylation transcription factor stat<NUMBER> promote survival intestinal cells cardiomyocytes gratia et al <NUMBER> theiss et al <NUMBER>b intestinal epithelial cells vivo phb<NUMBER> interacts stat<NUMBER> modulate stat<NUMBER>mediated apoptosis kathiria et al <NUMBER>b cardiomyocytes il<NUMBER>induced upregulation phb<NUMBER> central cardioprotective effects il<NUMBER> oxidative stress gratia et al <NUMBER> importantly phosphorylated stat<NUMBER> protects cardiomyocytes oxidative stress stimulating respiration inhibiting ptp within mitochondria transcriptional effect boengler et al <NUMBER> would interesting determine whether phb<NUMBER> modulates mitochondrial action stat<NUMBER> inflammatory bowel diseases ibds characterized strong oxidative stresses associated downregulated antioxidant enzymes intestinal mucosa lihbrody et al <NUMBER> several studies vitro vivo indicated phb<NUMBER> alleviates intestinal inflammation promotes survival cells exposed oxidative stress intestinal epithelial cells phb<NUMBER> binds salmonella typhi antigen inhibit inflammatory response typhi infection sharma qadri <NUMBER> phb<NUMBER> expression abnormally low ulcerative colitis crohns disease two common forms ibd hsieh et al <NUMBER> theiss et al <NUMBER>a yeo et al <NUMBER> due overstimulation tumor necrosis factor tnfa signaling inflamed colon theiss et al <NUMBER>a downregulation phb<NUMBER> increases ros signaling tnfainduced autophagy promoting inflammation patients ibd kathiria et al <NUMBER>a interestingly transgenic mice overexpressing phb<NUMBER> intestinal epithelial cells exhibit reduced proinflammatory nuclear factor kb nfkb signaling colonic mucosa treatment tnfa demonstrating phb<NUMBER> plays critical role inflammation detailed examination mechanism action revealed phb<NUMBER> inhibits tnfainduced translocation nfkb downregulating expression importin a<NUMBER> protein involved nfkb nuclear import theiss et al <NUMBER>a vivo model ibd phb<NUMBER> transgenic mice exhibited lower oxidative stress colitis wildtype mice theiss et al <NUMBER>b cytoprotective effect due upregulation nuclear factor erythroid <NUMBER>related factor <NUMBER> nrf<NUMBER> transcriptional activator review antioxidant responses evidence phb<NUMBER> putative therapeutic target treating ibd comes observations adenovirusdirected administration enema nanoparticlebased colonic delivery phb<NUMBER> effectively enhanced levels phb<NUMBER> surface colonic epithelial cells alleviated colitis induced dextran sodium sulfate theiss et al <NUMBER> picard et al <NUMBER> recently demonstrated phb<NUMBER> accumulates nucleus osteoarthritic chondrocytes represses expression transcription factor pitx<NUMBER> suggesting involvement phb<NUMBER> etiology osteoarthritis addition phb<NUMBER> phb<NUMBER> also involved inflammation indeed heterozygous phb<NUMBER> à shown sensitive liver insults inflammatory aggressions wildtype animals confirming cytoprotective antiinflammatory role phb<NUMBER> liver sá nchezquiles et al <NUMBER> lucas et al <NUMBER> recently discovered phb<NUMBER> phb<NUMBER> induce immune response b cells interaction cd<NUMBER> phbs shown induce phosphorylation ikba phospholipase cg<NUMBER> protein kinase cabii leading nuclear translocation nfkb p<NUMBER> nucleus subsequent transcription oct<NUMBER> igg<NUMBER> ande mishra <NUMBER> ande et al <NUMBER>a established phb<NUMBER> key regulator insulin signaling adipocyte differentiation indeed phb<NUMBER> directly phosphorylated insulin receptor promote insulin signaling block akt signaling whereas phosphorylation phb<NUMBER> akt opposite effect interestingly phb<NUMBER> phosphorylated also conjugated olinked bnacetylglucosamine myoblast cells response insulin high glucose glucoseinduced oglcnac modification phosphorylation phb<NUMBER> may associated insulin resistance modification tyrosine phosphorylation phb ande et al <NUMBER>b gu et al <NUMBER> phb<NUMBER> inhibits pyruvate carboxylase decreases insulinstimulated oxidation glucose fatty acid adipocytes implying role promoting lipid accumulation vessal et al <NUMBER> crosslinking experiments showed phb<NUMBER> associates pyruvate carboxylase eps <NUMBER> homology domain protein <NUMBER> ehd<NUMBER> suggesting phb<NUMBER> shuttles extracellular space mitochondria mechanism involving lipid rafts ehd<NUMBER> recently ande et al <NUMBER> demonstrated treatment preadipocytes insulin peroxisome proliferatoractivated receptor g pparg agonist upregulates phb<NUMBER> thereby promoting preadipocyte differentiation adipocytes remarkably overexpression phb<NUMBER> sufficient induce adipogenesis phb<NUMBER> cell surface also marker adipose vasculature may possible therapeutic target obesity see several recent studies demonstrated internalization viruses involves phbs instance phb<NUMBER> interacts chikungunya virus wintachai et al <NUMBER> phb<NUMBER> interacts dengue virus kuadkitkan et al <NUMBER> phb<NUMBER> phb<NUMBER> interact severe acute respiratory syndrome coronavirus sarscov cornillezty et al <NUMBER> phb<NUMBER> phb<NUMBER> also interact hiv<NUMBER> glycoprotein promote replicative spread nonpermissive cells emerson et al <NUMBER> interestingly recombinant capsid protein vp<NUMBER> rvp<NUMBER> footandmouth disease virus dephosphorylates akt phosphophb ttr<NUMBER> lipid rafts downregulate craferk signaling inhibit metastasis cancer cells vitro vivo chiu et al <NUMBER> moreover using highthroughput mass spectrometry jang et al <NUMBER> discovered lipoteichoic acid major virulence factor grampositive bacteria binds phb<NUMBER> implicating phb<NUMBER> host immune responses infections activities phbs affected natural products eg flavaglines aurilide fully synthetic small molecules eg melanogenin adipotide chimeric peptide currently phase clinical trial compounds except adipotide examined variety activities became clear phbs molecular targets beststudied phb ligands flavaglines flavaglines unique cyclopentabbenzofuran skeleton ebada et al <NUMBER> ribeiro et al <NUMBER>b rocaglamide first compounds described isolated <NUMBER> years ago king et al <NUMBER> medicinal plants genus aglaia meliaceae southeast asia since <NUMBER> flavaglines including rocaglaol silvestrol identified figure <NUMBER>a figure s<NUMBER> see also table s<NUMBER> although flavaglines display myriad pharmacological effects due anticancer antiinflammatory neuroprotective cardioprotective properties anticancer properties attracted attention scientists ebada et al <NUMBER> ribeiro et al <NUMBER>b concentrations lownanomolar range flavaglines inhibit proliferation tumor cells toxic normal cells hausott et al <NUMBER> ribeiro et al <NUMBER>a su et al <NUMBER> thuaud et al <NUMBER> thuaud et al <NUMBER> zhu et al <NUMBER> show sign toxicity mice bernard et al <NUMBER> cencic et al <NUMBER> lee et al <NUMBER> thuaud et al <NUMBER> zhu et al <NUMBER> king et al <NUMBER> first demonstrate antileukemic activity rocaglamide mouse model subsequently ohse et al <NUMBER> established flavaglines strongly inhibit protein synthesis lee et al <NUMBER> demonstrated compounds delay growth human breast cancer cells athymic mice however tumors eradicated investigations interrupted since development targeted therapies approaches development cytostatic compounds changed radically gutierrez et al <NUMBER> consequence renewed interest flavaglines potential anticancer agents although flavaglines shown significant anticancer effects mouse models cancer alinari et al <NUMBER> cencic et al <NUMBER> hwang et al <NUMBER> king et al <NUMBER> lee et al <NUMBER> lucas et al <NUMBER> meurergrimes et al <NUMBER> thuaud et al <NUMBER> promising potential associated ability enhance vivo efficacy anticancer drugs particular relieve resistance tumors chemotherapies indeed flavaglines shown enhance doxorubicin chemosensitivity several mouse lymphoma models bordeleau et al <NUMBER> cencic et al <NUMBER> zhu et al <NUMBER> importantly flavaglines display overt sign toxicity mice studies consistent previous observations recently using affinity chromatographycoupled mass spectrometry polier et al <NUMBER> identified phb<NUMBER> phb<NUMBER> direct targets flavaglines binding flavaglines phbs inhibits rascrafmekerk signaling signaling essential survival cancer cells figure <NUMBER>b craf needs interact phbs phosphorylated ras thus participate signaling rajalingam et al <NUMBER> binding flavaglines phbs prevents interaction vitro vivo knockdown either phb<NUMBER> phb<NUMBER> small interfering rna sirna mimicked effects flavaglines inhibition capdependent translation arrest cellcycle progression via depletion cyclin d<NUMBER> cdk<NUMBER> cdk<NUMBER> cdc<NUMBER>a moreover rocaglamide strongly depleted phb<NUMBER> phosphorylated craf plasma membrane suggesting relocation phbs membrane involved mode action flavaglines various observations support idea flavaglines exert anticancer effects action phbs findings particular interest evidence rascraferk constitutes overactivated pathway many human cancers pathway promising target treatments oncology matallanas et al <NUMBER> maurer et al <NUMBER> bleumink et al <NUMBER> showed inhibition craferk signaling blocks capdependent protein synthesis indeed erk activates mnk<NUMBER> phosphorylates eif<NUMBER>e allowing capdependent synthesis occur proteins require phosphorylated eif<NUMBER>e synthesis involved oncogenesis angiogenesis chemoresistance thus vivo anticancer effects flavaglines seems consequence inhibition synthesis cyclins d<NUMBER> d<NUMBER> cdk<NUMBER> cdk<NUMBER> cdc<NUMBER>a cmyc bcl<NUMBER> survivin mcl<NUMBER> pim<NUMBER> kinases vascular endothelial growth factor vegf matrix metallopeptidase <NUMBER> mmp<NUMBER> bordeleau et al <NUMBER> cencic et al <NUMBER> nasr et al <NUMBER> polier et al <NUMBER> schatz et al <NUMBER> although inhibition rascraferk signaling pathway may involved flavaglineinduced suppression capdependent synthesis cells bleumink et al <NUMBER> difficult explain observed inhibition protein synthesis vitro craf mek erk absent observation suggests either another molecular target involved inhibition translation flavaglines phbs interact translational machinery control activity flavaglines induce apoptosis cancer cells myriad mechanisms ribeiro et al <NUMBER>b involving cytochrome c mi et al <NUMBER>b zhu et al <NUMBER> apoptosisinducing factor thuaud et al <NUMBER> caspase <NUMBER> thuaud et al <NUMBER> mapks jnk p<NUMBER> zhu et al <NUMBER> zhu et al <NUMBER> whether mechanisms involve phb<NUMBER> phb<NUMBER> another target remains determined effect flavaglines phbsinteracting proteins craf also issue needs examined silvestrol flavagline studied vivo anticancer properties alinari et al <NUMBER> bordeleau et al <NUMBER> cencic et al <NUMBER> hwang et al <NUMBER> kim et al <NUMBER> mi et al <NUMBER>a robert et al <NUMBER> schatz et al <NUMBER> however development compound severely limited sensitivity pglycoproteinmediated multidrug resistance suboptimal absorption distribution metabolism excretion adme characteristics gupta et al <NUMBER> liu et al <NUMBER> fortunately structureactivity relationship sar chander et al <NUMBER> fusaro et al <NUMBER> joshi et al <NUMBER> phb<NUMBER> interacts tumors suppressors rb p<NUMBER> p<NUMBER> repress e<NUMBER>fmediated transcription inhibit cell proliferation wang et al <NUMBER>a wang et al <NUMBER>b wang et al <NUMBER> phb<NUMBER> represses dna replication interacting components mammalian replication machinery rizwani et al <NUMBER> protumorigenic roles phbs review studies established deletion methyl ester amide position <NUMBER> results compounds escape multidrug resistance without loss cytotoxicity figure s<NUMBER> ribeiro et al <NUMBER>a thuaud et al <NUMBER> thuaud et al <NUMBER> addition anticancer effects flavaglines also display potent antiinflammatory neuroprotective activities indeed flavaglines nanomolar concentrations act immunosuppressors inhibiting production interferong tnfa il<NUMBER> il<NUMBER> lymphocytes proksch et al <NUMBER> immunosuppression mediated activation mapks jnk p<NUMBER> selectively inactivate nuclear factor activated cells nfat figure <NUMBER>c still known flavaglines activate jnk p<NUMBER> higher concentrations flavaglines also inhibit nfkb another transcription factor involved inflammation baumann et al <NUMBER> interestingly synthetic flavagline imd<NUMBER> inhibits nfkb signaling displays potent vitro antiinflammatory effects manifest inhibition figure s<NUMBER> illustrates translocalization phb<NUMBER> mitochondria noncancerous cells promote survival proinflammatory mediator release astrocytes microglia endothelial cells fahrig et al <NUMBER> figure <NUMBER>d importantly imd<NUMBER> protects dopaminergic neurons vitro vivo models parkinsons disease mpp induced neurotoxicity traumatic brain injury recent sar studies led identification fl<NUMBER> provides greater neuroprotection vitro imd<NUMBER> ribeiro et al <NUMBER>a neuroprotective activity flavaglines currently actively explored pharmaceutical company intermed discovery developing imd<NUMBER> figure <NUMBER>a treatment parkinsons disease studies prompted evaluations cytoprotective potential flavaglines tissues synthetic flavagline fl<NUMBER> figure <NUMBER>a displays potent cytotoxicity cancer cells thuaud et al <NUMBER> shown protect cardiomyocytes vitro vivo various stresses including anthracycline cardiotoxicity bernard et al <NUMBER> heart extremely sensitive toxicity anthracyclines doxorubicin medicines among effective anticancer drugs available antitumor activity hematopoietic solid tumors unfortunately clinical utility markedly hampered cardiotoxicity lead dilated cardiomyopathy congestive heart failure minotti et al <NUMBER> fl<NUMBER> protects cardiomyocytes apoptosis induced doxorubicin serum starvation bernard et al <NUMBER> interestingly stresses different natures doxorubicin causes oxidative stress whereas serum starvation blocks growth factor signaling necessary cell survival mimicking important component myocardial ischemia treatment fl<NUMBER> significantly reduces mortality attenuates apoptosis fibrosis hearts doxorubicintreated mice thus flavaglines may enhance anticancer efficacy anthracyclines alleviate main adverse effect cardiotoxicity anthracyclines central cancer chemotherapies discovery new class cardioprotective agents would extremely valuable clinically studies examine therapeutic application therefore warranted cardioprotective effects flavaglines mediated phosphorylation small heat shock protein hsp<NUMBER> figure <NUMBER>e hsp<NUMBER> critical protecting cells many types damage including cardiotoxicity doxorubicin exerts effects several ways including chaperone activity control redox homeostasis inhibition apoptosis kostenko moens <NUMBER> whether phbs another target involved cardioprotective effect flavaglines examined although cytoprotective antiinflammatory effects flavaglines yet demonstrated mediated binding phbs unlikely another target involved indeed pharmacological effects cytotoxicity cancer cells occur range concentrations far know natural product possesses complex threedimensional structure shown bind different classes proteins comparably high affinity would useful evaluate therapeutic application flavaglines elucidate mechanisms involved may seem odd anticancer drug also display various cardioor neuroprotective effects however precedents example rapamycin derivatives erlich et al <NUMBER> khan et al <NUMBER> malagelada et al <NUMBER> hdac inhibitors cardioand neuroprotectants addition anticancer effects bush mckinsey <NUMBER> mai et al <NUMBER> first clue understanding paradox may phb<NUMBER> localized mainly mitochondria normal cells nucleus cancer cells translocation phb<NUMBER> nucleus cytosol mitochondria promotes survival normal cells apoptosis cancer cells fusaro et al <NUMBER> therefore tempting suggest opposite behaviors flavaglines cancer normal cells consequences different intracellular localizations phbs although many academic studies demonstrated therapeutic potential flavaglines preclinical models cancers inflammatory cardiac diseases compounds yet examined clinical trial knowledge two pharmaceutical companies intermed discovery infinity pharmaceutical currently developing flavaglines treatment parkinsons disease cancers respectively aurilide isolated japanese sea hare dolabella auricularia suenaga et al <NUMBER> suenaga et al <NUMBER> aurilide cyclic depsipeptide displays strong cytotoxicity nanomolar subnanomolar concentrations panel cancer cell lines figure <NUMBER>a figure s<NUMBER> work involving affinity chromatography identified phb<NUMBER> molecular target aurilide sato et al <NUMBER> binding toxin activates proteolytic processing dynaminlike gtpase optic atrophy <NUMBER> opa<NUMBER> turn triggers remodeling mitochondrial cristae leading apoptosis devastating effect mitochondria probably explains extreme toxicity compound impedes study animal models precludes development medicament quest identify compounds modulate skin pigmentation snyder et al <NUMBER> screened taggedtriazine library unpigmented melanocytes figure <NUMBER>b figure s<NUMBER> identified melanogenin inducer pigmentation ec <NUMBER> <NUMBER> mm compound upregulates tyrosinase ratelimiting enzyme biosynthesis melanin snyder et al <NUMBER> conjugated melanogenin agarose support enabled identify phb<NUMBER> molecular target affinity chromatography biological investigations confirmed phb<NUMBER> responsible induction pigmentation immunofluorescence microscopy studies showed phb<NUMBER> localized mitochondria led authors suggest binding melanogenin phb<NUMBER> may disrupt interaction phb<NUMBER> transcriptional factor thereby causing translocation nucleus induction expression tyrosinase ratelimiting enzyme melanogenesis study first demonstrate unravel involvement phb<NUMBER> regulation mammalian pigmentation although discoveries may provide basis development novel cosmetics drugs treatment pigment disorders investigation direction reported recently wu wu <NUMBER> demonstrated phb<NUMBER> enriched lipid rafts hacat keratinocytes uvb irradiation protects cells uvbinduced apoptosis findings consistent notion phb<NUMBER> contributes protection skin uvb adipotide kolonin et al <NUMBER> staquicini et al <NUMBER> used phage display techniques identify peptide homologous region annexin a<NUMBER> targets phb<NUMBER> surface vascular endothelial cells white adipose tissue figure <NUMBER>c fusion proapoptotic sequence obtained adipotide ckggrakdcggd klaklak <NUMBER> chimeric peptide damages vasculature adipose tissue consequently disrupts blood supply adipocytes obese mice adipotide induced substantial loss weight normalized metabolism leading reversal obesity without adverse sign toxicity surprisingly food intake reduced suggesting unexpected relationship adipose tissue vasculature regulation feeding behavior kim et al <NUMBER> obese rhesus monkeys <NUMBER> weeks adipotide treatment led <NUMBER> reduction body fat also reduced food intake improved animals metabolic status ie reduced insulin resistance findings implications development treatment type <NUMBER> diabetes barnhart et al <NUMBER> adipotide currently developed biotech company arrowhead research corporation entered phase trial involving obese patients prostate cancer july <NUMBER> adipotide negative endocrine effect tumor growth expected slow tumor growth patients capsaicin component hot chili peppers inhibits proliferation many cancer cell lines using affinity chromatography fletcher et al <NUMBER> demonstrated capsaicin <NUMBER> mm binds phb<NUMBER> binding induces series proapoptotic events human myeloid leukemia cells including <NUMBER> translocation phb<NUMBER> mitochondria nucleus <NUMBER> dissociation phb<NUMBER> adenine nucleotide translocator <NUMBER> ant<NUMBER> leading noncompetitive inhibition ant activity <NUMBER> release cytochrome c cytosol figure <NUMBER>d latter two effects could caused depletion phb<NUMBER> mitochondria would compromise mitochondrial integrity promote apoptosis capsaicin used experiments concentrations much high therapeutically relevant work may constitute basis optimization program develop clinically useful drug sulfonyl amidine derivatives sulfonyl amidine inhibits osteoclastogenesis involved bone remodeling ic <NUMBER> <NUMBER> mm lee et al <NUMBER>c figure <NUMBER>e chang et al <NUMBER> used affinity chromatography identify molecular target involved process found aurilide cytotoxic depsipeptide binds phb<NUMBER> triggers remodeling mitochondrial cristae lead apoptosis b melanogenin binds phb<NUMBER> induce expression tyrosinase ratelimiting enzyme melanogenesis c adipotide chimeric peptide targets phb<NUMBER> surface vascular endothelial cells white adipose tissue proapoptotic sequence responsible damage tissue binding capsaicin phb<NUMBER> induces translocation mitochondria nucleus noncompetitive inhibition ant<NUMBER> release cytochrome c cytosol leading apoptosis myeloid leukemia cells e sulfonyl amidine inhibits osteoclastogenesis involved bone remodeling compound binds phb<NUMBER> three proteins proteins relevant target involved antiresorptive activity remains unknown f aftin<NUMBER> binds phb<NUMBER> vdac<NUMBER> mitofilin promotes neurons production neurotoxic peptide ab<NUMBER> involved etiology alzheimers disease g dihydrooxazole choxa alkylates phb<NUMBER> suggesting could used chemical probe analyze structure phb<NUMBER> compound binds phb<NUMBER> three proteins proteins relevant target involved antiresorptive activity remains determined investigating toxic amyloidb<NUMBER> ab<NUMBER> peptide produced alzheimers disease bettayeb et al <NUMBER> observed adenine derivative aftin<NUMBER> promotes ab<NUMBER> production neurons figure <NUMBER>f aftin<NUMBER> found interact three proteins related neural degeneration phb<NUMBER> voltagedependent anion channel <NUMBER> vdac<NUMBER> mitofilin choxa dihydrooxazole choxa displays cytotoxicity gi <NUMBER> <NUMBER> mm b<NUMBER>f<NUMBER> cells shown alkylate asp<NUMBER> phb<NUMBER> suggesting could used chemical probe analyze structure phb<NUMBER> trzeciakiewicz et al <NUMBER> figure <NUMBER>g regulation phbs cell survival apoptosis metabolism inflammation makes proteins promising therapeutic targets novel treatments cancer neurodegenerative metabolic inflammatory diseases intracellular localization translocation response proapoptotic signals differ substantially normal cancer cells divergence behavior fully understood may exploited develop therapeutic agents phase trial adipotide treatment obese patients prostate cancer may first step road developing phb ligands clinical value recent discovery flavaglines target phbs warrants studies class anticancer cytoprotective agent addition ongoing exploration roles phbs physiology physiopathology anticipate field stimulate research addressing classes phb ligands original pharmacological properties last years phbs found interact <NUMBER> proteins regulate myriad cellular events doubt coming years new partners new cellular regulations uncovered important issue determine alterations phb expression subcellular localization signaling involved etiology cancers also cardiac neurological inflammatory metabolic diseases translating knowledge clinical applications may lead development new medicines biomarkers diagnosis prognosis supplemental information includes five figures one table found article online httpdxdoiorg<NUMBER>jchembiol<NUMBER> sars coronavirus main protease sarscov pro essential replication virus regarded major antiviral drug target yang et al <NUMBER> tan et al <NUMBER> steuber hilgenfeld <NUMBER> peptide aldehyde inhibitors widely used research tools characterize substrate specificity serine cysteine proteases complex crystalline target enzyme provide wealth information specificitydefining subsites substratebinding site purpose previously described peptide aldehydes inhibitors sarscoronavirus main protease sarscov pro algharabli et al <NUMBER> major advantage aldehydes peptide electrophiles reversible binding <NUMBER> see front matter ó <NUMBER> elsevier bv rights reserved doi<NUMBER>jantiviral<NUMBER> abbreviations sarscov pro sars coronavirus main protease cmffh cinnamoylphepheh boc tertbutyl oxycarbonyl ibx <NUMBER>iodoxybenzoic acid fret fluorescence resonance energy transfer peg polyethylene glycol mpd <NUMBER>methyl<NUMBER>pentanediol mes <NUMBER>nmorpholinoethanesulfonic acid dmso dimethylsulfoxide activesite sulfhydryl cysteine proteases previously used property screen small library nonpeptide nucleophiles mostly amines molecules would efficiently enhance inhibition aldehyde formation stronger binding aldehydenucleophile ligation product second step process named dynamic ligation screening schmidt et al <NUMBER> efficient compound process amino group replaced aldehyde moiety reacted target enzyme resulting covalent adduct subsequently used screen library nucleophiles would react aldehyde way starting substratelike peptide aldehyde obtained lowlm nonpeptidic reversible inhibitor two fragments low inhibitory activity schmidt et al <NUMBER> interestingly turned peptide aldehydes aminoacid sequence deviating consensus sequence embracing cleavage sites polyprotein substrates surprisingly efficient inhibitors particular peptide aldehydes p<NUMBER> asp ser inhibited main protease relatively low ic <NUMBER> algharabli et al <NUMBER> although generally agreed s<NUMBER> specificity subsite enzyme strong preference large hydrophobic sidechains leu phe met fan et al <NUMBER> fan et al <NUMBER> lai et al <NUMBER> therefore assumed hydrophilic p<NUMBER> sidechain inhibitors would oriented towards solvent rather occupy s<NUMBER> pocket hydrophobic p<NUMBER> residue would binding pocket algharabli et al <NUMBER> schmidt et al <NUMBER> model based crystal structure peptidyl chloromethyl ketone bound sarscov main protease arrangement observed yang et al <NUMBER> show xray crystallography number peptide aldehyde complexes protein case instead hydrophilic ser asp residues p<NUMBER> position bind hydrophobic s<NUMBER> subsite order understand binding modes atomic interactions analyzed detail also report inhibition kinetics compounds reevaluate cleavage specificity enzyme far p<NUMBER> position concerned addition determined crystal structure sarscov pro complex aldehyde cmffh cinnamoylphepheh phenylalanine residue p<NUMBER> position exhibits high inhibitory activity sarscov pro k <NUMBER> ± <NUMBER> lm results show stringent substrate specificity sarscov pro respect p<NUMBER> p<NUMBER> positions overruled highly electrophilic character aldehyde warhead chemical synthesis peptide aldehydes acestlqh acnsfsqh acdsfdqh acnstsqh performed employing solidstate method algharabli et al <NUMBER> briefly protected glutamine aldehyde obtained racemizationfree oxidation corresponding amino alcohol dessmartin periodinane immobilized threonyl resin oxazolidine following ntertbutyl oxycarbonyl bocprotection ring nitrogen yield nprotected oxazolidine linker peptide synthesis performed resin synthesis cmffh carried amidation boclphenylalanine lphenylalanine methyl ester followed deprotection boc group acylation corresponding product cinnamoyl chloride provide ncinnamoyllphenylalanyllphenylalanine methyl ester cmffh obtained reduction ester nabh <NUMBER> cacl <NUMBER> alcohol oxidation ibx recombinant production purification sarscov pro authentic n c termini performed described previously xue et al <NUMBER> verschueren et al <NUMBER> substrate dabcylktsavlqsgfrkmeedansamide <NUMBER> purity biosyntan gmbh berlin germany contains mainprotease cleavage site indicated arrow used substrate fluorescence resonance energy transfer fretbased cleavage assay substrate stock prepared dissolving <NUMBER> mm peptide dmso dequenching dabcyl fluorescence due cleavage substrate catalyzed sarscov pro monitored <NUMBER> nm excitation <NUMBER> nm using cary eclipse fluorescence spectrophotometer experiments performed buffer consisting <NUMBER> mm trishcl ph <NUMBER> <NUMBER> mm nacl <NUMBER> mm edta order estimate population catalytically active pro dimers respective monomer dimer concentrations calculated according graziano et al <NUMBER> dimerization sarscov pro follows scheme þ md equilibrium dissociation constant k defined molar concentrations monomer dimer respectively total protein concentration expressed terms molar monomer equivalents substituting equation expression k yields solving quadratic equation gives follows aldehyde stock solutions prepared dissolving compounds dmso <NUMBER> mm aldehydes form covalent bonds aldehyde cho group inhibitor sulfhydryl sh group cys<NUMBER> sarscov pro binding inhibitors reversible schmidt et al <NUMBER> although strong therefore treated reversible tightbinding inhibitors measurement inhibition constant k sarscov pro incubated aldehyde inhibitor reaction buffer room temperature <NUMBER> min fret peptide substrate dabcylktsavlqsgfrkmeedans added reaction velocity calculated according substrate cleavage ascenzi et al <NUMBER> copeland <NUMBER> values intrinsic inhibition constant k aldehyde binding sarscov pro calculated according equation k app ascenzi et al <NUMBER> copeland <NUMBER> twenty peptide substrates harboring alternative aminoacid residues p<NUMBER> x swtsavxqsgfrkwa purchased gl biochemistry ltd shanghai china peptides correspond nterminal autocleavage site sarscov mpro exception p<NUMBER> ile replaced trp p<NUMBER> <NUMBER> met also replaced trp peptide substrate stocks dissolved dmso <NUMBER> mm determine k cat k substrate <NUMBER> mm substrate peptide incubated <NUMBER> lm sarscov mpro <NUMBER> mm trishcl buffer ph <NUMBER> aliquots reactions removed different times stopped addition <NUMBER> trichloroacetic acid separation products substrate carried using reversephase rp hplc linear gradient <NUMBER> acetonitrile <NUMBER> trifluoroacetic acid absorbance determined <NUMBER> nm peak areas calculated integration k cat k app ratio determined plotting substrate peak area using equation lnpa c à k cat k app â c e â pa peak area substrate peptide c e total concentration sarscov pro c experimental constant fan et al <NUMBER> fan et al <NUMBER> sarscov pro authentic chain termini concentrated <NUMBER> mgml crystallized vapor diffusion using sitting drops xue et al <NUMBER> crystals grew overnight <NUMBER>°c equilibration reservoir containing <NUMBER> polyethylene glycol peg <NUMBER> <NUMBER> mes ph <NUMBER> <NUMBER> <NUMBER>methyl<NUMBER>pentanediol mpd <NUMBER> dmso aldehydes dissolved <NUMBER> peg <NUMBER> <NUMBER> mes ph <NUMBER> <NUMBER> mpd <NUMBER> dmso concentration <NUMBER> mm crystals aldehyde complexes sarscov pro obtained either adding <NUMBER>ll aliquot aldehyde solution drop soaking crystals <NUMBER> h incubating enzyme <NUMBER> h <NUMBER>°c <NUMBER>fold excess aldehyde solution subsequent cocrystallizing <NUMBER>°c reservoir containing <NUMBER> peg <NUMBER> <NUMBER> mes ph <NUMBER> <NUMBER> mpd <NUMBER> dmso latter case nucleation initiated microseeding using crushed monoclinic space group c<NUMBER> crystals sarscov pro prior diffraction data collection aldehyde complex crystals obtained soaking cocrystallization transferred seconds cryoprotectant solution containing crystallization ingredients <NUMBER> mpd diffraction data collected <NUMBER> k joint embl university hamburguniversity lübeck synchrotron beamline x<NUMBER> desy hamburg germany using <NUMBER>mm mar ccd detector mar research hamburg germany synchrotron beamline bl<NUMBER> bessy berlin germany using mx<NUMBER> ccd detector rayonics evanston il statistics data collection processing refinement summarized table <NUMBER> data processed mosflm leslie <NUMBER> scaled using scala program ccp<NUMBER> suite collaborative computational project <NUMBER> evans <NUMBER> structure elucidation refinement carried using ccp<NUMBER> suite programs collaborative computational project <NUMBER> potterton et al <NUMBER> crystal structures determined molecular replacement using original xray structure sarscov pro authentic chain termini pdb id <NUMBER>h<NUMBER>z xue et al <NUMBER> initial model refmac murshudov et al <NUMBER> employed structure refinement computer graphics program coot emsley cowtan <NUMBER> used interpretation electron density maps model building gap volumes inhibitor protein subsites enzyme calculated using ucsfchimera pettersen et al <NUMBER> molecular graphics package pymol delano <NUMBER> used generate figures kinetic parameters sarscov pro authentic chain termini determined using fret substrate dabcylktsavlqsgfrkmeedans amide k value substrate determined <NUMBER> lm apparent k cat k value <NUMBER> à<NUMBER> á<NUMBER> à<NUMBER> however dissociation catalytically active sarscov pro dimer inactive monomers fan et al <NUMBER> taken account wide range k values reported pro dimer dissociation see grumtokars et al <NUMBER> overview enzyme authentic chain termini latter authors reported k <NUMBER> <NUMBER> lm pro dimer tends stabilized presence substrate cheng et al <NUMBER> used lower limit range estimation necessary corrections obtained k cat k value <NUMBER> à<NUMBER> à<NUMBER> k value determined study magnitude values derived data corrected dissociation typically range <NUMBER> <NUMBER> lm grumtokars et al <NUMBER> suggests much higher values reported previously eg verschueren et al <NUMBER> probably reconsidered initially four pentapeptide substrateanalogous aldehydes containing canonical p<NUMBER> residue glutamine namely acestlqh acnstsqh acdsfdqh acnsfsqh tested inhibition sarscov pro overall four analogues found reversible tightbinding inhibitors harboring canonical p<NUMBER> leu aldehyde acestlqh exhibited inhibition relatively low k <NUMBER> ± <NUMBER> lm aldehydes acnstsqh acdsfdqh acnsfsqh noncanonical p<NUMBER> residue exhibited moderate inhibition k values <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> lm surprisingly aldehyde cmffh carrying cinnamoyl group p<NUMBER> phe residue p<NUMBER> position even higher inhibitory activity sarscov pro four pentapeptide aldehydes k <NUMBER> ± <NUMBER> lm aldehydes acestlqh acnstsqh acdsfdqh acnsfsqh cmffh separately soaked crystals sarscov mpro crystals space group c<NUMBER> often observed sarscov pro lee et al <NUMBER> xue et al <NUMBER> verschueren et al <NUMBER> crystals contain one sarscov pro monomer per asymmetric unit dimer enzymatically active species formed symmetry crystal four pentapeptide aldehydes acestlqh acnstsqh acdsfdqh acnsfsqh bound extended conformations s<NUMBER>s<NUMBER> specificity subsites sarscov pro cmffh occupies sites s<NUMBER>s<NUMBER> remarkably p<NUMBER> phenylalanine side chain inhibitor bound deeply s<NUMBER> pocket generally considered specific glutamine <NUMBER>f à f c electron density maps aldehyde inhibitors shown fig <NUMBER> complexes continuous electron density aldehyde carbonyl catom inhibitor cys<NUMBER>sc sarscov pro fig <NUMBER> indicates formation thiohemiacetal result nucleophilic attack catalytic cysteine onto cterminal aldehyde inhibitor mainchain conformations sarscov pro five complexes basically identical overall root meansquare deviations rmsd <NUMBER> à <NUMBER> å ca atoms addition crystal soaking experiments also tried cocrystallize sarscov pro aldehydes crystals obtained predominantly space group p<NUMBER> <NUMBER> exception complex acnsfsqh still displayed space group c<NUMBER> however p<NUMBER> <NUMBER> crystals electron density aldehyde could observed thus presence inhibitors induced change space group cases compounds detected crystals exception acestlqh crystals complex pro diffracted <NUMBER> å enzyme monomers asymmetric unit electron density could seen residues p<NUMBER> gln p<NUMBER> leu inhibitor fig <NUMBER>e f crystallographic data refinement statistics six crystal structures summarized table <NUMBER> sarscov pro complex aldehyde inhibitor acnsfsqh thiohemiacetal adopts alternative configurations fig <NUMBER>a b likely result nucleophilic attack cys<NUMBER> onto planar carbonyl either side risomer thiohemiacetal oxygen forms hydrogen bond imidazole his<NUMBER> <NUMBER> å catalytic dyad fig <NUMBER>c whereas sisomer oxygen atom points away his<NUMBER> oxyanion hole forming hbonds mainchain amides gly<NUMBER> <NUMBER> å cys <NUMBER> <NUMBER> å fig <NUMBER>d previous xray nmr studies aldehyde binding various cysteine serine proteases demonstrated one configurations present structures complexes delbaere brayer <NUMBER> webber et al <NUMBER> robin et al <NUMBER> s<NUMBER> subsite large pocket lined residues his<NUMBER> met<NUMBER> cys<NUMBER> his<NUMBER> met<NUMBER> asp<NUMBER> arg<NUMBER>mc mc contribution mainchain atoms gln <NUMBER> fig <NUMBER> cleavage sites sarscov pro viral polyproteins p<NUMBER> position mostly found occupied leu phe accordingly almost inhibitors designed enzyme carry large hydrophobic group p<NUMBER> position therefore surprised find ser asp side chains p<NUMBER> position aldehydes bound hydrophobic site fig <NUMBER> sarscov pro complexes acnstsqh acnsfsqh hydrogenbonding interaction side chain p<NUMBER>ser residues s<NUMBER> subsite ser side chain small steric barrier ser binding large s<NUMBER> pocket serine quite reach bottom s<NUMBER> pocket distance oc atom carbonyl oxygen residue gln<NUMBER> <NUMBER> å leaving space water molecule locate accordingly find electron density suggesting presence wellordered water s<NUMBER> pocket although disordered water probably present pocket sides serine sidechain free spaces total volume <NUMBER> å <NUMBER> present substrate protein noted sidechain gln<NUMBER> contributes one wall s<NUMBER> pocket quite flexible adopts different conformations various inhibitor complexes allowing preventing access water pocket case sarscov pro complex acdsfdqh p<NUMBER> asp sidechain situated side chains met<NUMBER> met<NUMBER> form opposite walls s<NUMBER> pocket interestingly carboxylate oxygens undergo close interactions sulfur atoms two methionines distances r sd atoms met<NUMBER> met<NUMBER> one hand od<NUMBER> od<NUMBER> atoms respectively p<NUMBER>asp <NUMBER> <NUMBER> å fig <NUMBER> relative distances methionine sulfur atoms mainchain carbonyl oxygens carboxylate sidechains detected previously hydrophobic cores proteins proposed stabilize protein fold pal chakrabarti <NUMBER> also suggested interactions taken account protein engineering studies iwaoka et al <NUMBER> pal chakrabarti <NUMBER> best knowledge provide first description methioninecarboxylate interaction proteinligand complex unexpected finding ser asp binding s<NUMBER> subsite constitutes deviation dogma peptide inhibitors proteases contain aminoacid residues corresponding sequence specificity target enzyme unexpected observation p<NUMBER>asp residue aldehyde acdsfdqh binding hydrophobic s<NUMBER> pocket prompted us redetermine cleavage specificity sarscov pro respect p<NUMBER> position within context peptide substrate swtsavxqsgfrkwa <NUMBER> proteinogenic amino acids tested position p<NUMBER> x hplcbased assay protease concentration kept constant <NUMBER> lm canonical substrate leu p<NUMBER> position completely cleaved within two minutes therefore used standard compare proteolytic activities substrates results listed fig <NUMBER> study confirmed favored residues p<NUMBER> position substrate leu hydrophobic amino acids phe met val ile substrates polar amino acids p<NUMBER> poorly cleaved cleavage efficiency substrate p<NUMBER> ser <NUMBER>times lower best substrate p<NUMBER> leu furthermore peptide p<NUMBER> asp cleaved incubation sarscov pro <NUMBER> h s<NUMBER> subsite lined residues phe<NUMBER> asn<NUMBER> gly<NUMBER> ser<NUMBER> cys<NUMBER> his<NUMBER> glu<NUMBER> his<NUMBER> substrate specificity results fan et al <NUMBER> fan et al <NUMBER> lai et al <NUMBER> p<NUMBER> gln moreover sarscov pro complex structures described far lee et al <NUMBER> xue et al <NUMBER> yang et al <NUMBER> yang et al <NUMBER> yin et al <NUMBER> s<NUMBER> subsite occupied polar group ie side chain gln fivemembered lactam used glutamine surrogate shie et al synthesized series abunsaturated esters containing p<NUMBER> p<NUMBER> phenylalanine residues showed modest inhibitory activity sarscov pro ic <NUMBER> <NUMBER> lm shie et al <NUMBER> abunsaturated ethyl ester <NUMBER>dimethylaminocinnamoylphephe reported potent inhibitor inhibition constant <NUMBER> lm shie et al <NUMBER> computer model complex sarscov pro compound proposed p<NUMBER> p<NUMBER> phenyl groups occupy s<NUMBER> s<NUMBER> pockets respectively shie et al <NUMBER> however crystal structure complex aldehyde cmffh describe communication side chain p<NUMBER>phe inserted s<NUMBER> subsite fig <NUMBER>g order understand unexpected deviation commonly observed specificity compared interaction s<NUMBER> subsite observed structures complexes cmffh acestlqh latter corresponds exactly described cleavage specificity pro predominant s<NUMBER> specificity enzyme gln determined primarily his<NUMBER> complex formed acestlqh ne<NUMBER> his<NUMBER> donates <NUMBER>å hydrogen bond sidechain carbonyl oxygen oe<NUMBER> p<NUMBER>gln fig <NUMBER> complex cmffh side chain asn<NUMBER> undergoes <NUMBER>°rotation v<NUMBER> torsion angle compared conformation complex acestlqh fig <NUMBER> leading opening s<NUMBER> subsite towards solvent similar movement asn<NUMBER> observed crystal structure sarscov pro complex inhibitor called n<NUMBER> pdb id <NUMBER>wof regular conformation residue one observed structure found p<NUMBER>benzyl group cmffh binds s<NUMBER> subsite making hydrophobic interactions phe<NUMBER> leu<NUMBER> asn<NUMBER> p<NUMBER> cinnamoyl group cmffh s<NUMBER> subsite specificity seem stringent previously thought may well possible chemical groups accommodated thereby expanding opportunities designing synthesizing efficient inhibitors sarscov pro study report six crystal structures sarscov pro complex peptide aldehydes inhibition kinetics compounds crystal structures reveal mechanism aldehyde binding active site sarscov pro provide detailed information atomic interactions since asp ser found bind hydrophobic s<NUMBER> subsite phe located hydrophilic s<NUMBER> subsite sarscov pro conclude stringent substrate specificity sarscov pro respect p<NUMBER> p<NUMBER> positions overruled highly electrophilic character aldehyde warhead constitutes deviation dogma peptidic protease inhibitors comprise aminoacid sequence corresponding cleavage specificity target enzyme observed nonbonded interaction carboxylate oxygen atoms aspartate residue inhibitor thioether moieties two methionines forming part hydrophobic pocket target protein remarkable suggests interactions added repertoire computeraided drug design atomic coordinates structure factors deposited rcsb protein data bank id codes <NUMBER>sn<NUMBER> <NUMBER>sna <NUMBER>snb <NUMBER>snc <NUMBER>snd <NUMBER>sne see table <NUMBER> spread severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> already taken pandemic proportions infected <NUMBER> <NUMBER> people <NUMBER> countries <NUMBER> although major current focus public health authorities develop coordinated global response prepare health systems meet unprecedented challenge corollary concern identified particular interest clinicians investigators major interest hypertension hypertension coronary heart disease diabetes mellitus particularly elderly people increase susceptibility sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> given ace<NUMBER> angiotensinconverting enzyme <NUMBER> receptor allows coronavirus entry cells idea come preexisting use reninangiotensin system ras blockers might increase risk developing severe fatal sarscov<NUMBER> infection <NUMBER> commentary discusses concern concludes based current evidence reason abandon ras blockers patients receiving important class antihypertensive agents concerns either increased risk contracting sarscov<NUMBER> worsening course <NUMBER> li et al <NUMBER> demonstrated ace<NUMBER> receptor responsible sars coronavirus entry binding ace<NUMBER> receptor requires surface unit viral spike protein s<NUMBER> figure <NUMBER> <NUMBER> subsequent cell entry relies priming serine protease tmprss<NUMBER> transmembrane protease serine <NUMBER> <NUMBER> two recent reports confirmed sarscov<NUMBER> also enters cell via route <NUMBER> <NUMBER> importantly sarscov<NUMBER> entry cell could blocked sprotein neutralizing antibodies tmprss<NUMBER> inhibitors camostat mesylate <NUMBER> lung ace<NUMBER> expression occurs type <NUMBER> pneumocytes macrophages generally however pulmonary ace<NUMBER> expression review low compared organs like intestine testis heart kidney <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> ras ace<NUMBER> displays considerable homology ace angiotensinconverting enzyme <NUMBER> identity <NUMBER> similarity basis received name <NUMBER> <NUMBER> monocarboxypeptidase hydrolyzes multiple peptides including apelin opioids kinins angiotensins much work ace<NUMBER> centered biologic effects related formation angiotensin<NUMBER> angiotensin ii <NUMBER> <NUMBER> unlike ace ace<NUMBER> convert angiotensin angiotensin ii ace inhibitors block activity surprising homology concern active site ace<NUMBER> potent <NUMBER> enzymes known convert vasoconstrictor angiotensin ii angiotensin<NUMBER> <NUMBER> angiotensin<NUMBER> increasingly recognized organprotective properties oppose counterbalance angiotensin ii within ras known target peptide ace<NUMBER> cleavage angiotensin subsequent formation angiotensin<NUMBER> figure ace<NUMBER> membranebound enzyme soluble levels blood low <NUMBER> <NUMBER> cleavage membraneanchor shedding adam<NUMBER> disintegrin metalloprotease <NUMBER> figure underlies occurrence body fluids angiotensin ii via <NUMBER> angiotensin ii type <NUMBER> receptor upregulates adam<NUMBER> thus increasing soluble ace<NUMBER> levels <NUMBER> urine soluble ace<NUMBER> levels significant likely originate shedding proximal tubular membrane pathological states shedding ace<NUMBER> often increased resulting elevated soluble ace<NUMBER> levels blood urine body fluids <NUMBER> <NUMBER> indeed doubling soluble ace<NUMBER> reported cerebrospinal fluid hypertensive patients <NUMBER> however given far majority ace<NUMBER> membranebound even doubling unlikely significantly alter amount membranebound ace<NUMBER> instance <NUMBER> ace<NUMBER> occurs soluble form doubling would increase <NUMBER> still <NUMBER> ace<NUMBER> membranebound theoretically ras blockade might partly reverse thus returning percent membranebound ace<NUMBER> <NUMBER> unlikely seriously affect sarscov<NUMBER> entry depends membranebound fulllength ace<NUMBER> really crux question prevailing confusion panic witnessing medical community word came ace<NUMBER> receptor sarscov<NUMBER> part confusion social media public general stands times ace inhibitors confused ace<NUMBER> inhibitors <NUMBER> different enzymes <NUMBER> different active sites effect ace inhibitors ace<NUMBER> activity must therefore indirect one via respective substrates unlikely relationship sarscov<NUMBER> binding however limited reports ace inhibitors affect expression ace<NUMBER> heart kidney <NUMBER> <NUMBER> receptor blockers arbs alter ace<NUMBER> expression consistently several studies mrna protein level <NUMBER> <NUMBER> <NUMBER> upregulation best documented cardiac tissue renal vasculature yet even results diverse required high doses often differed per arb per organ given relationship adam<NUMBER> clear distinction made membranebound soluble ace<NUMBER> overview connections reninangiotensin system blockers ace<NUMBER> angiotensinconverting enzyme <NUMBER> coronavirus carboxypeptidase ace<NUMBER> converts ang ii angiotensin ii ang<NUMBER> ang ang<NUMBER> yet blocked ace angiotensinconverting enzyme inhibitors prevent conversion ang ang ii ace<NUMBER> also binds internalizes sarscov<NUMBER> severe acute respiratory syndrome coronavirus<NUMBER> b priming serine protease tmprss<NUMBER> transmembrane protease serine <NUMBER> shedding membranebound ace<NUMBER> disintegrin metalloprotease <NUMBER> adam<NUMBER> results occurrence soluble ace<NUMBER> longer mediate sarscov<NUMBER> entry might even prevent entry keeping virus solution <NUMBER> r ang ii via type <NUMBER> receptor upregulates adam<NUMBER> <NUMBER> r blockers arbs would prevent increase soluble ace<NUMBER> anything might imply decrease membranebound ace<NUMBER> measuring membranebound ace<NUMBER> vivo technically challenging publications humans reported levels ace<NUMBER> activity blood reflect soluble ace<NUMBER> protein circulating low levels <NUMBER> arbs drug class would truly upregulate membranebound ace<NUMBER> reasonable first assume <NUMBER> receptor blockade agreement assumption angiotensin ii acutely induced ace<NUMBER> internalization via <NUMBER> receptor ace<NUMBER>transfected neuroblastoma cells <NUMBER> ace inhibitors directional effect arbs although drugs limited data showing upregulation ace<NUMBER> esler esler <NUMBER> suggested difference due increased levels angiotensin ii occurring arb treatment ace inhibition high angiotensin ii levels would impose increased substrate load enzyme thus requiring upregulation stressed carboxypeptidase ace<NUMBER> multiple substrates alteration level one substrates angiotensin ii occurring fmolml levels ie many orders magnitude actual ace<NUMBER> concentration cannot possibly make meaningful difference substrate load taken together evidence animal studies arbs may upregulate membranebound ace<NUMBER> whereas ace inhibitors may current data however often conflicting vary arbs tissue eg heart versus kidney even reported upregulation tissue ace<NUMBER> arbs animal studies generally high doses could extrapolated humans would establish sufficient facilitate sarscov<NUMBER> entry like point potentially beneficial pulmonary effect arbs needs considered well acute lung injury alveolar ace<NUMBER> appears downregulated <NUMBER> <NUMBER> would decrease angiotensin ii metabolism thus resulting higher local levels peptide increases alveolar permeability fosters lung injury context one speculate increased ace<NUMBER> expression preexisting arbs treatment may actually protective course sarscov<NUMBER> infection clear hypertension coded recent sarscov<NUMBER> report <NUMBER> speculate might based use hypertension medication rather actual blood pressure measurement truly address whether patients hypertension likely get serious fatal sarscov<NUMBER> infections prospective cohort study incidence rates sarscov<NUMBER> infection cohort patients hypertension patients without hypertension required similar exposure history instead reported history hypertension versus sarscov<NUMBER> patients without adjustment eg age use ras blockers causal link assumption lacks evidence discussed therefore strongly recommend patients taking ace inhibitors arbs high blood pressure heart failure medical indications withdraw current treatment regimens unless specifically advised physician healthcare provider additional caveat resulting destabilizing blood pressure control hypertension might possibly occur medication changes would carry unacceptable risks precipitating strokes heart attacks risks clearly hypothetical simply discontinuing antihypertensive agents strongly discouraged option considering widespread use ras blockers throughout world particular asian people seem prone cough therefore arbs may preferable <NUMBER> available clinical database pandemic date insufficient provide sufficient detail variables interest hypertension diagnosis antihypertensive drugs prescribed test hypotheses proposed provide certitude hence information desperately needed although therapy currently established sarscov<NUMBER> patients field moving rapidly potential approaches considered include broad spectrum antivirals favipiravir remdesivir <NUMBER> tmprss<NUMBER> inhibition camostat mesylate <NUMBER> adam<NUMBER> upregulation specific approach might using soluble recombinant ace<NUMBER> protein intercept virus binding fulllength ace<NUMBER> anchored cell plasma membrane <NUMBER> approaches make sense treatment patients high risk acute respiratory distress syndrome preventive purposes goal course development sarscov<NUMBER> vaccine closing see reason abandon discontinue temporarily use ras blockers preventatively sarscov<NUMBER> patients <NUMBER> concerns agents particularly arbs affect expression ace<NUMBER> based animal models however challenged coronavirus infection evaluate impact ras blocker therapy since information lacking see rationale panic alter prescription critically important class antihypertensives therapeutic benefit opinion outweighs potential risk predisposing corona infection moreover unknown whether alternative antihypertensives carry risk another question infected individuals risk progress endstage renal disease decision based clinical judgment considering pros cons ras blockade acutely ill presence absence hypotension kidney function • ace<NUMBER> angiotensinconverting enzyme <NUMBER> receptor allows coronavirus entry cells • ace<NUMBER> fulllength form membranebound enzyme whereas shorter soluble form circulates blood low levels • ace inhibitors inhibit ace<NUMBER> ace ace<NUMBER> different enzymes • although angiotensin ii type <NUMBER> receptor blockers suggested upregulate ace<NUMBER> evidence fully consistent differs per angiotensin ii type <NUMBER> receptor blocker per organ • data supporting ace inhibitors angiotensin ii type <NUMBER> receptor blockers facilitate coronavirus entry increasing ace<NUMBER> expression • animal data support potential protective pulmonary cardiovascular effects elevated ace<NUMBER> expression • treatment ras blockers discontinued concerns coronavirus infection based currently available evidence unprecedented times coronavirus disease <NUMBER> covid<NUMBER> pandemic severe impact globally countries implemented strict lockdown social distancing isolation elderly vulnerable advised time writing review three million individuals affected globally <NUMBER> deaths <NUMBER> global infection curve flattened new infections continuing rise although pandemic originated china epicentre shifted europe presently affected country united states america usa timeline first cases atypical pneumonia linked huanan seafood wholesale market wuhan china described late december <NUMBER> china announced outbreak <NUMBER> december <NUMBER> closed market became apparent place origin early january <NUMBER> investigations chinese authorities continued contacts traced managed world health organization notified <NUMBER> january <NUMBER> novel coronavirus announced cause outbreak <NUMBER> <NUMBER> january <NUMBER> china shared viral gene sequence allow development reverse transcriptasepolymerase chain reaction rtpcr diagnostic kits <NUMBER> first case outside china confirmed thailand strict screening measures travel restrictions lockdown wuhan implemented <NUMBER> first case usa announced <NUMBER> january <NUMBER> <NUMBER> first cases europe reported france <NUMBER> january <NUMBER> individuals travel history hubei province china subsequent humantohuman transmission followed cases travel history reported <NUMBER> africa reported first case <NUMBER> february <NUMBER> egypt since number cases risen dramatically figure <NUMBER> third coronavirus outbreak many decades <NUMBER> previous two severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> mortality rates <NUMBER> <NUMBER> respectively <NUMBER> mortality rate sarscov<NUMBER> although lower compared sars mers seems devastating effect globally sarscov<NUMBER> singlestranded rna genome enveloped lipid membrane embedded glycoprotein spikes giving impression crown hence name coronavirus cov rna viruses use errorprone rna polymerase replication therefore high mutation rates easily mutate epidemics adapting local environment facilitate transmission <NUMBER> however mutations part virus life cycle impact outbreaks <NUMBER> zhu et al extracted viral rna respiratory samples three patients admitted wuhan <NUMBER> <NUMBER> january <NUMBER> chinese centre disease control prevention identified novel betacoronavirus one samples described <NUMBER> sequence homology bat sarslike cov caused sars outbreak <NUMBER> <NUMBER> <NUMBER> virus originally named <NUMBER> novel coronavirus <NUMBER>ncov later changed sarscov<NUMBER> seventh member coronavirus family six previously described covs four cause minimal common cold symptoms humans two members sarscov merscov covs zoonotic origins bats considered natural reservoir hosts <NUMBER> sarscov<NUMBER> sequence identity pangolin origin covs sarscov<NUMBER> <NUMBER> raised question whether virus pangolin origin <NUMBER> natural hosts namely bats limited inflammatory response seen lower interleukin il<NUMBER>b concentrations adequate type interferons giving rise generalized antiinflammatory milieu ability limit excessive inflammatory response <NUMBER> interestingly may also explain bats relatively long lifespan <NUMBER> years <NUMBER> type interferon known assist antiviral control cov cannot infect humans unless virus undergoes mutation recombination animal hosts sarscov<NUMBER> highly virulent virus original infection distribution mainland china found <NUMBER> patients <NUMBER> years age <NUMBER> patients less <NUMBER> years old <NUMBER> easily transmissible initial studies finding infected person capable infecting another <NUMBER> individuals <NUMBER> virus stable plastic stainlesssteel surfaces <NUMBER> h <NUMBER> enhancing ability spread relatively long incubation period worsens situation individuals may asymptomatic carriers two weeks thereby releasing virus surroundings process called viral shedding common symptoms covid<NUMBER> respiratory transmission via droplets directly surfaces direct contact sarscov<NUMBER> also detected stool may point possible faecooral route transmission <NUMBER> <NUMBER> risk comorbidity although covid<NUMBER> may present mildly flulike disease even asymptomatic patients develop significant cardiovascular adverse effects according present data <NUMBER> infected individuals mild flulike symptoms recover within two weeks <NUMBER> severe symptoms requiring hospitalization <NUMBER> become critically ill <NUMBER> differences presentation thought due viral load age presence comorbidities <NUMBER> many carriers may asymptomatic underestimated source transmission <NUMBER> effective screening contact tracing important identify highrisk individuals advise selfisolation transmission risk high trace possible cases limit community spread children may also possible carriers asymptomatic infection lu et al described children <NUMBER> years old may asymptomatic <NUMBER> cases <NUMBER> elderly considered high risk may due aging immune system concomitant lymphopaenia decreased cd<NUMBER>count tcell regulation <NUMBER> elderly people propensity excessive autoimmune inflammatory responses may exacerbated covid<NUMBER> infection <NUMBER> male patients associated comorbidities also increased risk risk factors complicated infection identified early studies corroborated increased risk associated age male sex certain comorbidities studies also described several laboratory clinical markers used determine prognosis first study reported <NUMBER> cases admitted early january <NUMBER> wuhan china median age <NUMBER> years adolescents children <NUMBER> male <NUMBER> exposure huanan seafood wholesale market cohort <NUMBER> <NUMBER> admitted intensive care unit icu lymphopaenia increased ddimer levels increased partial thromboplastin time ptt increased aspartate aminotransferase ast increased highsensitivity troponini hstni increased inflammatory cytokines indicated poor prognosis outcome <NUMBER> another early study described <NUMBER> hospitalized cases wuhan average age <NUMBER> years male <NUMBER> history exposure huanan seafood market age obesity comorbid illness associated increased mortality concern expressed individuals compromised immune function human immunodeficiency virus hiv increased age diabetics immunosuppressive therapy <NUMBER> subsequent study six family members shenzhen china returned visit wuhan described first persontoperson transmission virus <NUMBER> yang et al described clinical course outcomes <NUMBER> patients covid<NUMBER> pneumonia including <NUMBER> critically ill critically ill mean age <NUMBER> years <NUMBER> male <NUMBER> comorbidities <NUMBER> died <NUMBER> days median time seven days nonsurvival risk associated advance age comorbidities <NUMBER> li et al collected demographic information exposure history illness timelines <NUMBER> initial confirmed cases wuhan median age <NUMBER> years <NUMBER> male <NUMBER> cases linked original huanan seafood wholesale market evident humantohuman transmission described doubling cases every <NUMBER> days suggested <NUMBER>day observation quarantine period exposed persons described infected person spread virus average <NUMBER> people come contact none cases children postulated children may less likely infected milder symptoms <NUMBER> ruan et al examined factors associated increased mortality <NUMBER> patients wuhan collected demographic clinical laboratory data found age presence comorbidities secondary infections increased cardiac tn creactive protein crp il<NUMBER> concentrations predictors fatal outcome <NUMBER> cytokine storm occurs subgroup patients severe covid<NUMBER> defined hyperinflammatory state characterized fulminant fatal increase inflammatory cytokines subsequent multiorgan failure ferritin concentrations raised cytopaenia occurs approximately half patients develop significant pulmonary involvement acute respiratory distress syndrome ards <NUMBER> findings suggest study ruan et al mortality severely ill patients probably caused cytokine storm study <NUMBER> covid<NUMBER> patients two hospitals china one wuhan found <NUMBER> <NUMBER> died hospital increased risk inhospital death associated older age organ failure raised ddimer levels authors postulated could possibly used admission identify patients worse prognosis <NUMBER> wang et al examined epidemiological demographic clinical laboratory radiological treatment data <NUMBER> patients hospitalized covid<NUMBER> found <NUMBER> patients needed icu admission <NUMBER> died median patient age <NUMBER> years <NUMBER> male older age comorbidities abnormal laboratory tests including lymphopaenia increased ddimer increased lactate dehydrogenase ldh prolonged ptt associated worse prognosis <NUMBER> liu et al performed small study <NUMBER> patients shenzhen china eight males seven older <NUMBER> years found laboratory parameters associated worse prognosis decreased albumin concentrations lymphopaenia elevated crp ldh concentrations measured angiotensin ii concentrations enzymelinked immunosorbent assay elisa found increased increased angiotensin ii associated high viral load lung injury suggesting imbalanced renin angiotensin system ras authors therefore questioned possible utility angiotensin converting enzyme ace inhibitor angiotensin receptor blocker arb possible treatment modalities <NUMBER> first case diagnosed usa <NUMBER> january <NUMBER> young male patient travelled wuhan china never visited wuhan market healthcare facility also contact ill people city usas patient zero initially presented mild symptoms progressed pneumonia day nine laboratory results showed leucopaenia mild thrombocytopaenia elevated creatinine liver enzymes alkaline phosphatase alp alanine transferase alt aspartate transferase ast <NUMBER> arentz studied <NUMBER> critically ill covid<NUMBER>infected patients washington state mean age <NUMBER> years <NUMBER> male seventeen <NUMBER> admitted icu <NUMBER> developed cardiomyopathy mortality rate <NUMBER> elderly patients comorbidities <NUMBER> reninangiotensin system angiotensinconverting enzyme <NUMBER> ras normal physiology receptors ras important regulator blood pressure homeostasis renin protease secreted kidney cleaves angiotensinogen serpin family protein produced liver inactive angiotensin cleaved active angiotensin ii ace secreted kidneys lungs expressed ubiquitously vasculature angiotensin ii binds angiotensin type <NUMBER> at<NUMBER> receptors causes vasoconstriction secretion aldosterone antidiuretic hormone subsequent renal sodium water reabsorption raised blood pressure <NUMBER> angiotensin ii binds at<NUMBER> receptor leads increase blood pressure well inflammation fibrosis oxidative stress vasoconstriction <NUMBER> important regulation cardiovascular haemodynamic neurological endothelial functions <NUMBER> receptors ras <NUMBER> figure <NUMBER> angiotensin type <NUMBER> at<NUMBER> originally thought receptor angiotensin ii actions facilitated via receptor <NUMBER> genetic polymorphisms associated hypertension myocardial infarction abnormal activation at<NUMBER> associated cardiovascular disease inflammation atherosclerosis endothelial dysfunction oxidative stress insulin resistance cancer malignant hypertension at<NUMBER> receptor blockers arb selective antagonists used treat hypertension cardiovascular disorders b angiotensin type <NUMBER> at<NUMBER> <NUMBER> homology at<NUMBER> low expression adults concentrations decrease soon birth found low concentrations adult cardiovascular system adrenal glands kidney brain uterine myometrium skin upregulation may occur physiological stressful conditions vascular injury myocardial infarction cardiac failure <NUMBER> studies knockout mice demonstrated development hypertension mutation receptor also associated mental retardation plays role antidiuretic antinatriuretic functions also found brain tissue <NUMBER> investigated possible therapeutic target neuropathic pain however treatment poor efficacy many side effects c mas receptor angiotensin <NUMBER> produced ace<NUMBER> activation mas leads synthesis arachidonic acid activation nitric oxide synthase high expression mas found brain important cardiovascular regulation also found play important role testicular function immunolocalization angiotensin <NUMBER> mas receptors showed impaired spermatogenesis male infertility <NUMBER> knockout mice present altered heart rate decreased blood pressure possibly due imbalance formation reactive oxygen species protective role masangiotensin <NUMBER> made possible drug target angiotensin type <NUMBER> at<NUMBER> receptor beyond scope review homologue ace namely ace<NUMBER> identified <NUMBER> <NUMBER> ace<NUMBER> ace catalytic domains <NUMBER> identical alluding two genes common ancestor <NUMBER> ace<NUMBER> type transmembrane metallopeptidase enzymatic domain external surface cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> involved regulation cardiac function blood pressure control possibly counterpart ace <NUMBER> ace<NUMBER> regulates ras modulating endogenous concentrations angiotensin angiotensin ii <NUMBER> cleaves single residue angiotensin generate angiotensin <NUMBER> single residue angiotensin ii generate angiotensin <NUMBER> figure <NUMBER> possibly cleaves substrates apelin cardioprotective properties desarginine bradykinin promotes inflammation neurotensin involved regulation luteinizing hormone prolactin <NUMBER> <NUMBER> angiotensin <NUMBER> also converted angiotensin <NUMBER> ace binding mas receptor angiotensin <NUMBER> shifts balance vasoconstriction angiotensin ii vasodilation gives rise antiinflammatory antifibrotic effects increased synthesis vasodilation <NUMBER> inactivation ace<NUMBER> leads increased angiotensin ii concentrations impaired cardiac contractility <NUMBER> although ace<NUMBER> mrna found almost organs protein expression mainly lung airways type ii alveolar cells heart kidney intestine also found oral nasal mucosa skin lymph nodes thymus bone marrow spleen liver testis brain <NUMBER> ace<NUMBER> extracellular domain receptor site spike protein sarscov<NUMBER> gain entry cell specifically lung alveolar epithelial cells enterocytes plays important role entry covs <NUMBER> ace<NUMBER> enterocytes duodenum jejenum ileum may explain virus found stool samples support possible faecooral transmission route <NUMBER> <NUMBER> ace<NUMBER> receptor tongue oral mucosa may implicate possible route transmission dental practice <NUMBER> keeping observation male individuals higher risk sarscov<NUMBER> infection important note ace<NUMBER> gene mapped xchromosome <NUMBER> females two copies ace<NUMBER> gene males one copy possible theory males higher risk two forms ace<NUMBER> fulllength ace<NUMBER> found cell membranes consists transmembrane anchor extracellular domain receptor site spike protein sarscov<NUMBER> second form soluble form shed circulation form ace lacks membrane anchors circulates low concentrations <NUMBER> circulating levels reflect issue levels proposed soluble form ace<NUMBER> may inhibit binding sarscov<NUMBER> membranebound ace<NUMBER> therefore proposed soluble recombinant ace<NUMBER> potential treatment covid<NUMBER> <NUMBER> angiotensin ii binds at<NUMBER> receptor vasoconstriction inflammation fibrosis proliferation follow leading hypertension cardiac fibrosis thrombosis ards binding angiotensin <NUMBER> mas receptor leads vasodilatation antiapoptotic antifibrotic antiproliferation activity reduction blood pressure decreased cardiac fibrosis decreased thrombosis decreased ards <NUMBER> at<NUMBER> bound released antiinflammatory vasodilator reduces platelet aggregation may facilitate insulin action <NUMBER> therefore angiotensin ii binding at<NUMBER> inflammatory mediator via reactive oxygen species ros nuclear factor kappa b nfkb provides mitogenic stimulus smooth muscles leading oxidative stress common feature atherosclerosis diabetes mellitus hypertension hyperlipidaemia stimulation at<NUMBER> also leads upregulation adhesion molecules interferes insulin signalling leading insulin resistance ace inhibitors arb therapy found decrease circulating crp thought due decreased angiotensin ii stimulation at<NUMBER> disruption ace<NUMBER> mice leads severe cardiac contractility defects increased angiotensin ii concentrations expression hypoxiainduced cardiac genes ace also decreased cardiac phenotype rescued however loss ace<NUMBER> affect blood pressure kidney development mice postulated ace could potentially compensate loss ace<NUMBER> yet even mice treated ace inhibitor similar reduction blood pressure wild type therefore ace<NUMBER> apparent direct effect blood pressure <NUMBER> strong association ras cardiovascular disease neurodegenerative disorders acute lung injury demonstrated mice acid aspiration lung injury severe acute lung failure significant downregulation ace<NUMBER> noted expression ace unchanged leading marked increase angiotensin ii formation upregulated ace therefore ace promotes disease increased angiotensin ii acedeficient mice partly protected acidinduced lung injury recombinant ace<NUMBER> at<NUMBER> receptor expression protected mice severe lung disease scenario <NUMBER> inactivation ace ace<NUMBER> knockout background rescued mice severe lung failure therefore postulated ace promotes acute lung injury ace<NUMBER> alleviates <NUMBER> patel verma found high pulmonary ace<NUMBER> concentrations protect lung injury <NUMBER> loss ace<NUMBER> expression acute lung injury led leaky pulmonary blood vessels at<NUMBER> receptor stimulation however hydrostatic oedema could excluded causative factor emphasizing need studies local effects angiotensin ii lungs <NUMBER> pathology ras associated pulmonary hypertension pulmonary fibrosis <NUMBER> angiotensin ii upregulates expression profibrotic cytokines leading pulmonary fibrosis severe inflammation increased vascular permeability treatment ace inhibitors arb may attenuate <NUMBER> animal models ards found reduced ace<NUMBER> concentrations treatment exogenous ace<NUMBER> alleviated symptoms <NUMBER> studies found loss ace<NUMBER> rendered subjects susceptible heart failure postulated increasing ace<NUMBER> concentrations cardioprotective loss ace<NUMBER> also led agedependant cardiomyopathy pulmonary cardiac renal injuries <NUMBER> diabetes mellitus major comorbid risk factor covid<NUMBER> associated increased ace<NUMBER> expression may explain patients suffering diabetes greater susceptibility sars infection <NUMBER> ace<NUMBER> involved possible protective arm ras ace<NUMBER>angiotensin <NUMBER>mas axis counterbalances aceangiotensin iiat<NUMBER> axis associated vasoconstriction inflammation cell proliferation hypertrophy fibrosis tissue modelling therefore ace<NUMBER> protects rasinduced injuries decreasing angiotensin ii generating angiotensin <NUMBER> increases substrate availability protective axis <NUMBER> ace<NUMBER> knockout mice ace<NUMBER> inhibitors increased susceptibility myocardial infarction hypertension angiotensin iiinduced myocardial hypertrophy microvascular complication inflammation fibrosis diastolic systolic dysfunction oxidative stress ace inhibitors block ace arb block action angiotensin ii ati receptors lead increased ace<NUMBER> activity <NUMBER> drugs may alleviate inflammation decrease endothelial dysfunction increase insulin sensitivity <NUMBER> arbs potential block ras acei <NUMBER> angiotensin ii formed via nonace pathways humans <NUMBER> arbs known less sideeffects ace inhibitors another area interest peroxisome proliferatoractivated receptorgamma pparc insulin resistance strongly associated hypertension ace<NUMBER> expression increased use pparc agonists <NUMBER> pparc agonists thiazolidinediones attenuate development hypertension improve endothelial dysfunction angiotensin iiinfused rats <NUMBER> rats decreased at<NUMBER> expression therefore effects likely mediated at<NUMBER> receptor activation <NUMBER> however pparc agonists shown increase risk congestive heart failure possibly myocardial infarction medications effect ace<NUMBER> concentrations include mineralocorticoid antagonists aldosterone receptor antagonist spironolactone possibly increases ace<NUMBER> concentrations macrophages case heart tissue patients suffering chronic heart failure <NUMBER> statins possibly augment ace expression heart kidney tissue may also bring epigenetic changes ace<NUMBER> gene work needed determine exact mechanism findings <NUMBER> presently still paucity evidence ace inhibitors arb may impact ace<NUMBER>angiotensin <NUMBER> pathway lung heart brain ongoing research field needed human ace<NUMBER> functional receptor essential cellular entry covs receptor used sarscov gain access cells <NUMBER> kuba et al provided first genetic proof ace<NUMBER> crucial receptor sarscov vivo <NUMBER> ace<NUMBER> knockout wildtype mice infected sarscov knockout mice low levels viral replication lungs wildtype mice sarscov infection associated lung failure attenuated treatment blocking ras postulated sarscov infection downregulated ace<NUMBER> concentrations possibly explaining decline lung function observed viral infection <NUMBER> spike proteins covs facilitate viral entry target cells attaching ace<NUMBER> entry receptor <NUMBER> sarscov<NUMBER> like sarscov viral envelope studded spikes consisting glycoproteins made two subunits namely s<NUMBER> s<NUMBER> subunit s<NUMBER> binds cell surface bound ace<NUMBER> subunit s<NUMBER> fuses cell membrane <NUMBER> cellular serine protease tmprss<NUMBER> essential sprotein priming facilitates viral cell entry <NUMBER> tmprss expressed sarscov target cells <NUMBER> subunit s<NUMBER> spike binds membrane bound ace<NUMBER> tmprss<NUMBER> activates spike cleaves ace<NUMBER> receptor tmprss<NUMBER> also acts s<NUMBER> subunit causing irreversible conformational change facilitating fusion viral membrane host cell membrane endocytosis <NUMBER> <NUMBER> therefore ace<NUMBER> tmprss<NUMBER> essential cellular entry sarscov<NUMBER> binds human ace<NUMBER> <NUMBER>fold higher affinity sarscov <NUMBER> may due compact virus structure enabling better receptor affinity enhanced ability internalized figure <NUMBER> shows cellular entry sarscov<NUMBER> binding sarscov<NUMBER> may decrease ace<NUMBER> concentrations increase angiotensin ii angiotensin <NUMBER> ratio may exacerbate pulmonary injury tissue fibrosis <NUMBER> angiotensin <NUMBER> may provide resilience development pulmonary failure covid<NUMBER> supporting finding <NUMBER> oudit et al <NUMBER> determined sarscov infection detrimental effect cardiac function led cardiac dysfunction arrhythmias death measured ace<NUMBER> concentrations mice infected human strain sarscov hearts obtained autopsy patients died sars infection found sarscov infection led decrease ace<NUMBER> expression myocardium mice subsequent myocardial dysfunction sarscov mrna expression found <NUMBER> autopsy heart samples associated decreased ace<NUMBER> protein expression therefore postulated sarscov leads cardiac dysfunction downregulating myocardial ace<NUMBER> possibly due cytokinemediated downregulation ace<NUMBER> mrna <NUMBER> gastrointestinal system also spared effects sarscov<NUMBER> infection xiao et al found ace<NUMBER> abundant glandular cells gastric duodenal rectal epithelia <NUMBER> hamming et al described ace<NUMBER> small intestine underlining importance sarscov<NUMBER> involvement gastrointestinal system <NUMBER> interesting observation difference infection rate adverse outcomes adults children although reports less covid<NUMBER> infection children lack evidence ace<NUMBER> changes age <NUMBER> possible hypothesis children less susceptible covid<NUMBER> infection due crossprotective antibodies multiple upper respiratory tract infections lower respiratory tracts less ace<NUMBER> <NUMBER> limited studies data children available conclusive evidence support postulations children less likely adversely affected sarscov<NUMBER> infection lacking clear statistical data older people especially men affected covid<NUMBER> increased ace<NUMBER> described older individuals males <NUMBER> could possibly linked worse outcome population group yet evidence causal relationship ace<NUMBER> activity sarscov<NUMBER> mortality also ace<NUMBER> concentrations correlate degree disease severity <NUMBER> activation ras associated endothelial dysfunction multiple organ injuries therefore theoretically treatment focusing manipulation control system may beneficial <NUMBER> covid<NUMBER>infected patients worse prognosis suffer comorbidities especially cardiovascular ras inhibitors shown protective effect kidney myocardium may therefore dangerous withdraw treatment patients higher risk relapse patients cardiovascular renal disease also demonstrated <NUMBER> angiotensin ii concentrations found increased covid<NUMBER> infection positively correlated viral load lung injury <NUMBER> increased ace<NUMBER> concentrations may possibly lead greater susceptibility covid<NUMBER> infection may also cardioprotective led crossroad clinical decisionmaking ras blocking treatment may increase ace<NUMBER> facilitate virus entry beneficial effects patients suffering comorbid conditions cannot ignored lot learned studies involving respiratory viruses use ace<NUMBER>lowering treatment investigated study patients novel influenza h<NUMBER>n<NUMBER> virus avian origin eastern china <NUMBER> found <NUMBER> developed ards high mortality patients markedly elevated angiotensin ii concentrations poorer disease outcome predictive value higher crp authors speculated recombinant ace<NUMBER> angiotensin iilowering treatment ace inhibitors arb could beneficial <NUMBER> avian influenza h<NUMBER>n<NUMBER> primarily infects poultry birds since <NUMBER> also infecting humans increased angiotensin ii downregulation ace<NUMBER> linked infection severity mortality mice infected h<NUMBER>n<NUMBER> given recombinant ace<NUMBER> virusinduced lung injury ameliorated <NUMBER> use intravenous ace inhibitors arb experimental animals increases ace<NUMBER> expression cardiopulmonary circulation systems causing possible increased risk sarscov<NUMBER> infection <NUMBER> severe covid<NUMBER> outcomes described patients existing hypertension coronary artery disease diabetes chronic kidney disease <NUMBER> question asked whether current treatment regimens increasing risk infection theoretically ace<NUMBER> activity cell membranes decreased reduce ability sarscov<NUMBER> enter cells also decreases protective effects ace<NUMBER> various organ systems ace<NUMBER> expressed angiotensin ii may contribute organ damage covid<NUMBER> <NUMBER> concentrations found correlate viral load lung injury <NUMBER> downregulation ace<NUMBER> lung tissue may facilitate neutrophil infiltration leading angiotensin ii accumulation ras activation <NUMBER> covid<NUMBER> binds ace<NUMBER> enters cell expression ace<NUMBER> downregulated downregulation essentially removes brakes angiotensin ii possibly induces local activation immune cells lungs decreased ace<NUMBER> alveolar type ii cells leads surfactant deficit development lung injury <NUMBER> although increase ace<NUMBER> may lead higher cell infection rates proliferation virus may beneficial patients lung injury withdrawal may harmful especially highrisk patients <NUMBER> study acidinduced lung injury mice ace<NUMBER> downregulation sarscov worsened lung injury induced lung injury improved use arbs findings suggestive sarscov exacerbates lung injury decreasing ace<NUMBER> also reversible arbs <NUMBER> increase ace<NUMBER> heart tissue may cardioprotective therefore sarscov<NUMBER> could possibly influence fine balance angiotensin ii angiotensin <NUMBER> whereas treatment could block ras protect heart organs <NUMBER> cardiac tissue function may compromised increase angiotensin ii angiotensin <NUMBER> ratio loss ace<NUMBER> central nervous system specifically brain stem cardiovascular centre may cause increased sympathetic drive changes baroreflex worsening hypertension <NUMBER> loss ace<NUMBER> vasculature contribute endothelial dysfunction inflammation exacerbate existing atherosclerosis diabetes concerns increased ace<NUMBER> expression heart brain urine treatment arb may increase individuals risk infection little evidence available showing significant changes serum pulmonary ace<NUMBER> concentrations however significance ace<NUMBER> expression effect covid<NUMBER> pathogenesis mortality uncertain <NUMBER> therefore benefits outweigh risks joint statement issued <NUMBER> march <NUMBER> found experimental clinical evidence demonstrating beneficial adverse outcomes covid<NUMBER> patients using ace inhibitors arb available urgent additional research needed stated treatment discontinued patients become infected sarscov<NUMBER> <NUMBER> potential covid<NUMBER> treatment involving ace<NUMBER> system since early stages covid<NUMBER> pandemic emphasis finding possible treatment modalities number possible treatment targets identified based previous studies conducted sarscov specifically involving ace<NUMBER>angiotensin <NUMBER> pathway decreasing ace<NUMBER> downregulation ace<NUMBER> proposed possible treatment reduce susceptibility covid<NUMBER> infection however ensuing relatively unopposed action angiotensin ii could lead worsening hypertension inflammation thrombosis adverse lung cardiac outcome <NUMBER> study kuba et al determined infection sarscov downregulates expression ace<NUMBER> low ace<NUMBER> concentrations associated lung oedema acute lung injury contributed severe lung pathology patients already ace inhibitors time sarscov infection concluded modulating ras may therefore useful treating infection <NUMBER> studies also questioned use antiace<NUMBER> antibodies inhibit viral replication sarscov could possibly inhibit virusinduced cytopathicity dosedependent manner <NUMBER> increasing ace<NUMBER> trials underway evaluate safety efficacy recombinant human ace<NUMBER> arb losartan covid<NUMBER>infected patients infusion recombinant human ace<NUMBER> may act decoy interfere viral replication soluble ace<NUMBER> could potentially bind sarscov thereby prevent binding viral spike protein full length membranebound ace<NUMBER> <NUMBER> reducing viral infection cells <NUMBER> recombinant ace<NUMBER> shown reverse lung injury sarscovinfected patients <NUMBER> wang et al found ace inhibitors arb offer partial cardiovascular protection increasing ace<NUMBER> iv recombinant ace<NUMBER> may beneficial preventing pulmonary arterial hypertension acute lung injury <NUMBER> however circulating ace<NUMBER> concentrations usually low undetectable accurately represent amount membranebound ace<NUMBER> would sufficient sequester sarscov<NUMBER> circulation <NUMBER> proposed clinical trial recombinant ace<NUMBER> withdrawn due unknown effects possibility drug inducing significant hypotension <NUMBER> ace<NUMBER> interaction sarscov important development sarsassociated cardiomyopathy viral rna found myocardium postmortem examination associated cardiac injury due reduced expression ace<NUMBER> possibly played major role morbidity mortality patients infected sarscov recombinant ace<NUMBER> found normalize angiotensin ii concentrations suggesting may beneficial prevent organ damage caused sarscov question thus arose possible beneficial balance ras control reduce infection prevent organ damage covid<NUMBER>infected patients <NUMBER> targeting tmprss<NUMBER> protease inhibitors tmprss<NUMBER> block viral entry vitro inhibiting entry sarscov<NUMBER> cells <NUMBER> camostat mesylate serine protease inhibitor used japan treat chronic pancreatitis inhibits tmprss<NUMBER> block entry sarscov<NUMBER> bronchial epithelial cells vitro <NUMBER> <NUMBER> angiotensin ii many patients severe covid<NUMBER> infection admitted icu septic shock angiotensin angiotensin ii conversion ace occurs lungs significant lung injury may decrease decreased ace function found predictor mortality angiotensin ii novel vasopressor agent may beneficial patient population strategies decrease ace<NUMBER> may possibly attenuate sarscov<NUMBER> infectivity may happen number ways firstly endogenous angiotensin ii theoretically prevents infection binding ace<NUMBER> degradation therefore may compete sarscov<NUMBER> bind receptor secondly binding angiotensin ii at<NUMBER> causes internalization downregulation ace<NUMBER> lastly angiotensin ii causes at<NUMBER>dependent destruction ace<NUMBER> decreasing virus ability enter cells angiotensin ii yet available use commercially due number critically ill patients promising outcome drug made available compassionate use italy germany uk <NUMBER> angiotensin <NUMBER> another focus area use angiotensin <NUMBER> novel treatment covid<NUMBER> <NUMBER> experimental studies found angiotensin <NUMBER> reduced acute inflammatory response subsequent fibrosis acidinduced ards mice <NUMBER> angiotensin <NUMBER> protected lung inflammation fibrosis inhibited alveolar cell apoptosis attenuated endothelial cell activation loss barrier function oedema decreased synthesis proinflammatory profibrotic cytokines authors therefore recommended concentrations angiotensin <NUMBER> increased protect covid<NUMBER>infected patients <NUMBER> effects ace<NUMBER> covid<NUMBER> infections need evaluated randomized control trials necessary obtain highest level evidence although ace<NUMBER> beneficial effects regulating protective arm ras authors postulate high levels make patients susceptible covid<NUMBER> infection ras numerous attractive therapy targets covid<NUMBER> infection trials needed evaluate use ace inhibitors arbs covid<NUMBER> patients coronaviridae family comprises viruses genetic heterogeneity allow differentiation four genera αcoronavirus βcoronavirus γcoronavirus δcoronavirus sarscov<NUMBER> novel virus belonging coronavirus family causing ongoing global pandemic coronavirus rna genome ranging <NUMBER> <NUMBER> kilobases length widest among rna viruses degree variability although several coronaviruses potentially pathogenic humans produce minimally symptomatic disease <NUMBER> however <NUMBER> <NUMBER> outbreaks severe acute respiratory syndrome sars middle east respiratory syndrome mers respectively resulted relevant morbidity mortality due acute respiratory failure arf <NUMBER> <NUMBER> epidemic respiratory disease caused sars coronavirus <NUMBER> sarscov<NUMBER> began china spread countries novel coronavirus originally named <NUMBER>ncov subsequently sarscov<NUMBER> world health organization virus βcoronavirus belonging subgenus botulinum coronaviridae responsible zoonotic disease coronavirus disease <NUMBER> target airways may severely involve lung airspaces <NUMBER> lung parenchyma affected addition fever symptoms include dry cough dyspnoea serious cases potentially fatal arf <NUMBER> mechanisms older age underlying medical conditions negatively impact acute respiratory distress syndrome ards concurrent cytokine storm require understood sarscov<NUMBER> singlestrand positivesense rna genome identified highthroughput sequencing released virolo gicalorg virus originally discovered humans animal reservoir remains unclear although growing data support sarscov<NUMBER> chimeric virus high grade affinity genetic information bat coronavirus elevated similarity codon usage bias snake <NUMBER> also intermediate hosts sarscov<NUMBER> remain undetermined interaction viruses host cells entry site crucial disease onset progression influenza h<NUMBER>n<NUMBER> based evidence swine model receptor binding domain host cells may also used intracellular bacteria favouring infection enhancing burden symptoms <NUMBER> sarscov sarscov<NUMBER> virus tropism respiratory system sustained attachment angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> membraneanchored carboxypeptidase highly expressed airway epithelial type ii alveolar epithelial cells found virus cell entry receptor previously sarscov outbreak <NUMBER> focus review dissect knowledge ace<NUMBER> receptor airway lung epithelium attempt understand whether underlying diseases therapies able modulate expression affecting sarscov<NUMBER> cell entry infectivity large spike protein forms homotrimers protruding viral surface mediates coronaviruses attachment adhesion human target cells avian mammalian coronaviruses protein cleaved two smaller proteins although reported sarscov however two different functional regions described s<NUMBER> s<NUMBER> <NUMBER> s<NUMBER> subunit consists four core domains s<NUMBER>a s<NUMBER>d distal s<NUMBER> domain mediates receptor association stabilization whereas s<NUMBER> domain promotes structural rearrangements finally membrane fusion coronaviruses use different regions s<NUMBER> domain interact specific binding receptors acetylated sialoside attachment receptors expressed glycoproteins glycolipids host cell target endemic human coronaviruses oc<NUMBER> hku<NUMBER> nonacetylated sialoside attachment receptors bind domain sa merscov sarscov sarscov<NUMBER> small fragment s<NUMBER> region receptor binding domain rbd necessary binding peptidase domain ace<NUMBER> represents critical site virushost cell interaction <NUMBER> sarscov<NUMBER> low homology sprotein sarscov patches sequences rbd domain walls et al reported sarscov<NUMBER> sprotein boundary s<NUMBER> s<NUMBER> subunits site presumably due furin cleavage golgi compartment <NUMBER> particular sarscov sarscov<NUMBER> present conserved s<NUMBER> fusion machinery s<NUMBER> subunit highest divergence found within sa sb <NUMBER> changes sarscov<NUMBER> result functional advantage ectodomain attaches ace<NUMBER> <NUMBER> nm affinity approximately <NUMBER>to <NUMBER>fold higher sarscov <NUMBER> findings proposed rationale elucidating efficient transmission sarscov<NUMBER> humans ace<NUMBER> expression widely represented type ii lung alveolar cells oesophageal epithelial cells enterocytes cholangiocytes myocardial cells kidney proximal tubule cells bladder urothelial cells <NUMBER> singlenucleotide ace<NUMBER> polymorphisms associated sars susceptibility outcomes <NUMBER> furthermore experimental models binding protein ace<NUMBER> altered addition specific ace<NUMBER> inhibitor confirming inability inhibitor block sars infection <NUMBER> conversely sarscov<NUMBER> smediated entry target enabled mice immunized stabilized sarscov sprotein data support role sarscov neutralizing antibodies preventing receptor engagement <NUMBER> ace<NUMBER> extensively discussed receptor entry host alveolar cell murine ards model ace<NUMBER> protected lungs severe acute injury <NUMBER> <NUMBER> impaired tissue repair mechanisms increased vascular permeability fluid accumulation extraalveolar spaces oxidantantioxidant imbalance described relation ace<NUMBER> deficiency <NUMBER> <NUMBER> <NUMBER> attachment virion membrane fusion ace<NUMBER> expression downregulated resulting excessive production angiotensin ang enhancing oxidative stress mechanisms <NUMBER> contrast happens viral infections sarscov<NUMBER> internalization promoted hemagglutinin cleavage operated transmembrane serine protease <NUMBER> tmprss<NUMBER> cellsurface protein expressed epithelial cells within airway alveolar spaces <NUMBER> <NUMBER> viral priming mechanisms tmprss<NUMBER> dependent demonstrated previous coronaviruses influenza h<NUMBER>n<NUMBER> outbreaks <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> tmprss<NUMBER> involvement sarscov<NUMBER> currently investigation based vitro data camostat mesylate inhibitor protease activity tmprss<NUMBER> demonstrating sarscov<NUMBER> entry cell inhibition <NUMBER> phase iii study camostat mesylate nct<NUMBER> phase iiiii study nafamostat extremely potent tmprss<NUMBER> inhibitor nct<NUMBER> ongoing <NUMBER> <NUMBER> preliminary results expected <NUMBER> ace type <NUMBER> transmembrane monomeric glycoprotein expressed lungs intestine kidneys brain aorta adrenal medulla cleaves two amino acids ang produce ang ii ace<NUMBER> conversely cleaves single amino acid ang ii generate ang<NUMBER> <NUMBER> human lungs elevated ang iiang<NUMBER> ratio favours vascular permeability extraalveolar fluid accumulation conversely elevated levels ang<NUMBER> though mas receptor mas<NUMBER> activation widely present endothelial cells exert vasodilatory antiinflammatory antifibrotic effects <NUMBER> importantly ace<NUMBER> differs ace inhibited ace inhibitors acei <NUMBER> rat model ace<NUMBER> mrna expression significantly reduced copd rat lung compared wild type animals <NUMBER> likewise ace<NUMBER> overexpression intratracheal injection adace<NUMBER> significantly attenuated lung function deteriorations pathological manifestations copd supporting pathogenetic aceace<NUMBER> imbalance copd <NUMBER> similarly increment aceace<NUMBER> ratio reported murine model asthma however administration ace<NUMBER> activator counteracts cytokine storm il<NUMBER>β il<NUMBER> nfκb bcl<NUMBER> pakt pp<NUMBER> asthmatic rat model <NUMBER> uncertain extent smoking may play role ace<NUMBER> modulation lungs rats chronically exposed cigarette smoke exhibited significant reduction ace<NUMBER> expression well increase ace based data independently reported guan et al <NUMBER> zhang et al <NUMBER> incidence sarscov<NUMBER> appears lower patient smoking history contrast smoking seems associated adverse outcome mechanisms need fully explored previous data highlighted viral infections might amplify local inflammation chronic respiratory conditions atopic subjects hrv allergen exposure singularly increased icam<NUMBER> expression resulting migration immune effector cells airways <NUMBER> conversely sarscov<NUMBER> infection presence comorbid chronic respiratory disorders associated enhanced risk developing infection compared common clinical conditions however covid could evolve severe clinical outcomes copd subjects <NUMBER> however recognised regulation ace<NUMBER> following infection promote lung injury <NUMBER> lung reduced ace<NUMBER> levels prompt reduce ang<NUMBER> levels promotes protective tissues regeneration reduces reactive oxygen species ros <NUMBER> <NUMBER> covid covid<NUMBER> exhibits severe clinical course patients hypertension cardiovascular disease diabetes <NUMBER> <NUMBER> reninangiotensin system ras inhibitors cornerstone therapy many cardiovascular renal diseases drugs widely used reducing blood pressure hypertensive patients experimental clinical models show different responses administration agents interfering regulatory axis angiotensinreceptor blockers arb mineralocorticoidreceptor blockers seem increase levels ace<NUMBER> gene expression cardiac ace<NUMBER> activity <NUMBER> <NUMBER> whereas acei associated elevated cardiac ace<NUMBER> activity cardiac ace<NUMBER> mrna <NUMBER> early study documented increased cardiac ace<NUMBER> expression myocardial infarction rats treated agents blocking ang ii receptors compared placebo <NUMBER> similarly higher urinary ace<NUMBER> levels observed hypertensive patients treated olmesartan ang ii type <NUMBER> at<NUMBER> receptor antagonist <NUMBER> furthermore administration losartan another at<NUMBER> receptor antagonist counterbalanced smokeinduced decrease ace<NUMBER> restored extent aceace<NUMBER> ratio lung <NUMBER> small cohort study levels ang ii found markedly increased covid<NUMBER> plasma samples <NUMBER> results accordance previous studies reported high ang ii levels mice infected sars <NUMBER> experiments h<NUMBER>n<NUMBER> viruses showing ang ii levels related worse clinical outcomes <NUMBER> ras may represent doubleedged sword positive impact upregulating ace<NUMBER> demonstrated <NUMBER> suggesting potential role lung damage sarscov<NUMBER> infected patients <NUMBER> however risk increase susceptibility infection linked ace<NUMBER> upregulation due ras inhibitors remains uncertain needs clarified fang et al based higher prevalence hypertension diabetes mellitus chronic cardiovascular diseases among patients died covid<NUMBER> postulated acei arbs might favour severe disease progression <NUMBER> however recently multicentre retrospective study including <NUMBER> covid<NUMBER> inpatients hypertension use aceiarbs associated lower allcause mortality adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p ¼ <NUMBER> septic shock adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p ¼ <NUMBER> compared aceiarb nonuse unfortunately study designed detect differences acei arbs overall patient number aceiarb group limited <NUMBER> <NUMBER> <NUMBER> data support statements european society cardiology <NUMBER> american heart association heart failure society america american college cardiology <NUMBER> international society hypertension <NUMBER> italian society pharmacology <NUMBER> european society hypertension <NUMBER> recommend acei sartans discontinuation light current evidences however recent comment phadke et al <NUMBER> based unpublished observational data supports use losartan telmisartan block at<NUMBER> receptor avidly valsartan potentially prevent virus spread finally data nonsteroidal antiinflammatory drugs nsaids still far clarified earlier evidences rat models suggest ibuprofen thiazolidinediones may upregulate ace<NUMBER> expression <NUMBER> <NUMBER> <NUMBER> yet established whether observations may objectively influence clinical scenario patients sarscov<NUMBER> infection sufficient evidence support concept one main battles war covid played level ace<NUMBER> receptor viral cell entry healthy individuals ace<NUMBER> promotes lung homeostasis production ang<NUMBER> chronic respiratory conditions ace<NUMBER> downregulation may prevent sarscov<NUMBER> host cell interaction however patients preexisting copd infected sarscov<NUMBER> may experience poor clinical outcomes likely due reduced respiratory reserve data ace<NUMBER> modulation ras inhibitors inconclusive whilst subjects chronically exposed agents appear hypothetically higher availability cell receptors within lung remains uncertain whether may influence susceptibility developing sarscov<NUMBER> infection however ace<NUMBER> upregulation may also result enhanced host defence mechanisms counteract ace<NUMBER> virusinduced downregulation dissecting pathways major cell receptor sarscov<NUMBER> let us understand mechanisms viral induced direct lung injury effects perturbation ace<NUMBER> function manipulation ace<NUMBER> receptor expression implication viral cell entry potential major target therapy patients diabetes get coronavirus disease <NUMBER> covid<NUMBER> risk severe disease course mortality several factors especially impaired immune response heightened inflammatory response hypercoagulable state contribute increased disease severity however many contentious issues evidence rather limited theoretical concerns effects different antihyperglycaemic drugs similarly despite recognition angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor severe acute respiratory syndrome coronavirus <NUMBER> sars cov<NUMBER> role ace<NUMBER> lung injury conflicting results use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arb patients management patients diabetes times restrictions mobility poses challenges novel approaches like telemedicine useful need study natural course covid<NUMBER> patients diabetes understand individual regional ethnic variations disease prevalence course diabetes covid<NUMBER> evidence current status unanswered research questions high prevalence diabetes globally makes frequent comorbidity patients coronavirusassociated disease <NUMBER> though diabetes increases risk infection general studies reported prevalence diabetes almost similar general population patients covid<NUMBER> metaanalysis eight trials china showed diabetes present <NUMBER> <NUMBER> patients covid<NUMBER> <NUMBER> understandably prevalence diabetes patients covid<NUMBER> varies region age ethnicity known whether patients diabetes wellcontrolled blood glucose levels increased risk infection severe acute respiratory syndrome coronavirus <NUMBER> sars cov<NUMBER> patients diabetes develop covid<NUMBER> seen worse prognosis increased mortality studies <NUMBER> chinese patients diabetes hazard ratio <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> acute respiratory distress syndrome ards <NUMBER> reported metaanalysis nine studies china n <NUMBER> showed significant correlation severity covid<NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> similarly case fatality rate <NUMBER> patients diabetes opposed <NUMBER> without diabetes report <NUMBER> patients covid<NUMBER> chinese centre disease control <NUMBER> recent study <NUMBER> patients covid<NUMBER> <NUMBER> centres across usa found diabetes associated fourfold increase mortality <NUMBER> diabetes increases severity covid<NUMBER> unclear though several factors may responsible table <NUMBER> poor glycaemic control impairs several aspects innate adaptive immune response viral infections potential secondary bacterial infection lungs <NUMBER> <NUMBER> defects immunity namely inappropriate tcell action impaired natural killer cell activity defects complement action could reduce viral clearance <NUMBER> interestingly ards patients covid<NUMBER> driven severe hypoxaemia despite relatively wellpreserved lung mechanics preexisting proinflammatory state could accentuate cytokine storm believed responsible ards well multiorgan dysfunction covid<NUMBER> <NUMBER> context important note strong association type <NUMBER> diabetes obesity abnormal secretion adipokines cytokines like tnfalfa interferon may impair immunity predispose severe infection <NUMBER> diabetes associated increased plasminogen levels postulated increase virulence sars cov<NUMBER> <NUMBER> presence inflammation prothrombotic factors shown study <NUMBER> patients hospitalised covid<NUMBER> wuhan china significantly higher serum levels interleukein <NUMBER> erythrocyte sedimentation rate creactive protein ferritin fibrinogen ddimer reported patients diabetes compared without diabetes <NUMBER> increased viral replication diabetes may also due increase furin type<NUMBER> membranebound protease involved entry coronaviruses cell <NUMBER> addition preexisting comorbidities associated diabetes like hypertension coronary artery disease chronic kidney disease worsen prognosis lastly hypoglycaemia could occur treatment diabetes may additionally worsen clinical outcomes respect role angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor pathogenesis covid<NUMBER> patients diabetes intriguing sars cov<NUMBER> enters cell binding ace<NUMBER> process involves many steps several enzymes proteins <NUMBER> experimental evidence downregulation ace<NUMBER> diabetes <NUMBER> may predispose severe lung injury hand ace<NUMBER> receptor sars cov<NUMBER> downregulation might reduce entry virus cells issues discussed context use antihyperglycemic antihypertensive drugs precise effect treatment various oral antihyperglycaemic agents severity covid<NUMBER> known though theoretical considerations metformin shown modest benefits lower respiratory tract infections pulmonary tuberculosis <NUMBER> though gastrointestinal tolerability sick patients concern thiazolidinediones shown increase ace<NUMBER> levels <NUMBER> however propensity thiazolidinediones cause fluid retention risk congestive heart failure covid<NUMBER> would make agents unfavourable treatment glucagonlike peptide<NUMBER> agonists shown increase ace<NUMBER> increase surfactant experimental animals <NUMBER> practical significance changes ace<NUMBER> levels use thiazolidinediones glucagonlike peptide<NUMBER> agonists known sulfonylureas effective risk hypoglycaemia especially setting irregular meals might preclude use nevertheless sulfonylureas considered whenever blood glucose monitoring possible data regarding use dipeptidyl peptidase <NUMBER> dpp<NUMBER> inhibitors previous viral epidemics dpp<NUMBER> prime receptor middle east respiratory syndrome coronavirus responsible entry cell <NUMBER> hence possibility dpp<NUMBER> facilitating entry sars cov<NUMBER> cell cannot ruled context interesting postulation widespread use dpp<NUMBER> inhibitors india many countries might protecting individuals diabetes infection hand dpp<NUMBER> inhibitors potentially interfere immune response may harmful clinical data dpp<NUMBER> inhibitors shown generally case <NUMBER> increasing use sodium glucose cotransporter <NUMBER> sglt<NUMBER> inhibitors worldwide india interestingly sglt<NUMBER> inhibitors could also activate ace<NUMBER> indirectly especially used along ace inhibitors <NUMBER> hypothetical possibility sglt<NUMBER> inhibitors reducing lactate production reduction oxygen demand tissues could reduce viral entry raising cytosolic ph <NUMBER> caution dehydration possibility euglycaemic ketoacidosis need observed using sglt<NUMBER> inhibitors sick patients covid<NUMBER> insulin also shown increase ace<NUMBER> expression attenuating effect disintegrin metalloprotease adam<NUMBER> <NUMBER> practical relevance findings known present case insulin thus appears safe continue usual antihyperglycemic medications patients mild infection good general condition normal oral intake however sglt<NUMBER> inhibitors might need discontinuation due risk dehydration euglycaemic ketoacidosis metformin may also need stopped vomiting poor oral intake doses antihyperglyacemic drugs like sulfonylureas insulin may altered depending upon blood glucose levels hospitalised patients especially requiring intensive care would need insulin glycaemic control angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arb commonly used drugs patients diabetes especially hypertension kidney dysfunction lot literature debate whether drugs could benefit harm patients covid<NUMBER> infection issue discussed scientific experimental data support potential harm duet ace inhibitorsarb covid<NUMBER> lot interest ace inhibitors arbs following identification ace<NUMBER> receptor sars cov<NUMBER> ace inhibitors arbs increase levels ace<NUMBER> inhibiting conversion angiotensin <NUMBER> angiotensin <NUMBER> increased ace<NUMBER> expression could theoretically increase viral binding entry cell though clinical evidence support otherwise attractive hypothesis reduced angiotensin <NUMBER> result ace inhibition increased angiotensin <NUMBER> result increased activity ace<NUMBER> could reduce cytosolic ph could result favourable environment viral endocytosis <NUMBER> also angiotensin <NUMBER> shown increase sympathetic activity acting mas receptors brainstem could contribute cardiovascular morbidity observed patients <NUMBER> however concerns hypothetical minimal evidence scientific experimental data support benefit due ace inhibitorsarb covid<NUMBER> increased ace<NUMBER> might result increased viral entry limited availability serine protease tmprss<NUMBER> required viral binding <NUMBER> increased ace<NUMBER> consequently angiotensin <NUMBER> vasodilatory antifibrotic effects shown protective lung injury animals <NUMBER> treatment arbs reported reduce mortality ebola virus infection <NUMBER> previously small study ten patients ards showed recombinant ace<NUMBER> well tolerated led increase angiotensin <NUMBER> levels <NUMBER> <NUMBER> controlled studies use ace inhibitors arbs patients covid<NUMBER> <NUMBER> clinical evidence inconclusive one study china find association ace inhibitor use severity disease increased mortality patients covid<NUMBER> receiving ace inhibitors arbs another study <NUMBER> <NUMBER> one study usa find significant difference mortality patients received ace inhibitors arbs <NUMBER> subject situation far clear many unknown factors might operative interaction ace<NUMBER> diabetes ace inhibitorsarbs lung injury lack evidence either benefit harm prompted european society cardiology council hypertension european society hypertension american heart association advise continuing ace inhibitors arbs case patient develops covid<NUMBER> <NUMBER> clinical trial underway study arb losartan recombinant human ace<NUMBER> patients covid<NUMBER> several commentaries relationship diabetes covid<NUMBER> <NUMBER> however several unanswered questions remain knowledge information limited clearly research could lead important insights table <NUMBER> discussed <NUMBER> natural history covid<NUMBER> patients diabetes natural course disease infection patients diabetes sars cov<NUMBER> documented well example dont know incubation period different people diabetes also possible patients diabetes young short duration diabetes well controlled may less severe covid<NUMBER> infection possibility reduced viral clearance diabetes reported patients corticosteroids <NUMBER> could public health implications patients diabetes could remain infectious longer period without diabetes chloroquine also licensed use india patients type <NUMBER> diabetes although efficacy chloroquine proven used patients covid<NUMBER> <NUMBER> chloroquine weak antihyperglycaemic effect theoretical risk hypoglycaemia used combination antihyperglycaemic drugs b corticosteroids though neither effective recommended frequently used ards sepsis would worsen glycemic levels <NUMBER> covid<NUMBER> pancreatic beta cells significant expression ace<NUMBER> receptors pancreatic islets hyperglycaemia lasting <NUMBER> years reported patients sars <NUMBER> direct injury beta cells possibility patients recovering covid<NUMBER> might need major changes antihyperglycaemic regimen recently newonset diabetes reported patients covid<NUMBER> <NUMBER> <NUMBER> suboptimal lifestyle measures issues lockdown restrictions movement people lockdowns several parts world order contain pandemic poses challenges evaluation treatment patients diabetes limited opportunities exercise regular walks visits gyms swimming pools possible dietary irregularity could occur staying home b considerable mental stress unpredictability disease well social immobility brought excellent study healthy people china time huge burden covid<NUMBER> <NUMBER> c patients may find difficult procure healthy foods medicines insulin needles glucose strips etc partial complete lockdowns problem becomes pronounced elderly poor disadvantaged sections society could underreporting symptoms perceived need avoid visiting hospitals factors could cause glucose dysregulation could predispose patients complications like infections hyperosmolar coma ketoacidosis even acute cardiac events prediction model effect lockdown india blood glucose showed <NUMBER> increase hba<NUMBER>c end <NUMBER> days lockdown future increase diabetesrelated complications <NUMBER> <NUMBER> people wellcontrolled diabetes higher risk getting covid<NUMBER> infection nondiabetic individuals <NUMBER> effect obesity severity covid<NUMBER> people diabetes <NUMBER> specific diet supplement could help patients diabetes covid<NUMBER> <NUMBER> role renin angiotensin aldosterone system raas inhibitors raas determining predisposition covid<NUMBER> severity <NUMBER> use remote education advice telemedicine also emails texts helpful times impart education shown improve glycaemia telemedicine guidelines physicians india published <NUMBER> patients need educated need visit hospital urgently emergency situations like vomiting drowsiness shortness breath chest pain weakness limbs altered sensorium etc <NUMBER> <NUMBER> covid<NUMBER> testing patients diabetes given increased severity covid<NUMBER> patients diabetes case could made testing people diabetes presence disease would humongous task considering high prevalence diabetes highrisk groups like high hba<NUMBER>c comorbidities long duration diabetes elderly could chosen testing however utility approach remains proven frequent false negative tests repeated testing may required asymptomatic individuals since treatment currently recommended asymptomatic people therefore apart isolating detecting patients might prove meaningful clinically <NUMBER> ethnic variations severity covi<NUMBER> patients diabetes united states disease caused disproportionately fatalities blacks asians compared whites <NUMBER> south asia africa korea seen much lower mortality rest world whether different approaches topublic health measures innate immunity due ethnicityspecific variability response viral infection availability good medical resources remains studied interactions ethnicity diabetes severity covid<NUMBER> interest considering racial disparities prevalence diabetes according recent report prevalence covid<NUMBER> mortality due disease correlated significantly frequency allele ace gene <NUMBER> polymorphisms ace gene well several genes involved pathophysiology covid<NUMBER> might responsible individual ethnic variations disease course <NUMBER> benefits lockdown could positive effects social restrictions patients time selfcare could pay attention diet exercise motivated b people stopped reduced alcohol smoking nonavailability c significant fall air pollution result reduced industrial vehicular emissions <NUMBER> increase blood glucose reported shortterm rise pm <NUMBER> particulate matter <NUMBER> microns diameter glycaemic improvement could occur fall pollution <NUMBER> view issues highlighted important recognise importance diabetes vital comorbidity patients covid<NUMBER> several contentious issues ongoing research hopefully shed light behaviour covid<NUMBER> patients diabetes author contributions rg planned outline manuscript rg reviewed literature wrote manuscript rg ah edited manuscript conflict interest authors declare conflict interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causes coronavirus disease potentially fatal disease immense global public health concern initial cases reported december <NUMBER> wuhan china <NUMBER> since <NUMBER> confirmed covid<NUMBER> patients world april <NUMBER>th <NUMBER> total <NUMBER> deaths united states maximum number <NUMBER> confirmed cases total <NUMBER> deaths cases diagnosed new york <NUMBER> total <NUMBER> deaths <NUMBER> several studies including recent metaanalysis reported coexisting conditions including hypertension cardiac diseases cerebrovascular diseases diabetes common among patients covid<NUMBER> severe illness got admitted intensive care unit icu received mechanical ventilation died among patients mild illness <NUMBER> <NUMBER> notably frequent comorbidities reported studies patients covid<NUMBER> especially hypertension often treated angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arb <NUMBER> could theoretically result upregulation ace<NUMBER> epithelial cells lung intestine kidney blood vessels active binding target sarscov<NUMBER> virus <NUMBER> although raised concerns regarding use drugs covid<NUMBER> patients several animal studies presented conflicting findings regarding increased ace<NUMBER> expression due acei arb animal studies previous human studies suggested administration aceiarbs increase ace<NUMBER> expression <NUMBER> light findings paucity clinical outcome studies many professional cardiovascular hypertension societies including italian society pharmacology international society hypertension ish european society hypertension joint american heart associationamerican college cardiologyamerican heart failure association others recommended continued use aceiarbs covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> however since conception recommendations several clinical studies conducted evaluated association acei arb clinical severity mortality outcomes covid<NUMBER> patients therefore medical literature systematically reviewed current clinical evidence evaluating safety efficacy ace inhibitors arb covid<NUMBER> patients literature search conducted pubmedmedline database using key words viz ace inhibitors coronavirus arb coronavirus applied search filters include humans english language published till april <NUMBER> th <NUMBER> additional papers possible interest identified examining references pertinent review articles searching google scholar preprint servers like medrxiv biorxiv included studies evaluated clinical severity mortality outcomes patients covid<NUMBER> aceinhibitors arb excluded studies dealt invitro animal studies well evaluated ace expression levels figure <NUMBER> information demographics comorbidities pharmacotherapy acei arbs drugs clinical severity outcomes mortality extracted articles preliminary search pubmed google scholar preprint servers n<NUMBER> articles included review screening titles abstracts n<NUMBER> articles whose full text reviewed n<NUMBER> articles included review addition pertinent crossreferences n<NUMBER> total <NUMBER> articles found search based titles articles <NUMBER> excluded meet inclusion criteria abstracts <NUMBER> articles read subsequently full text <NUMBER> articles reviewed six articles shortlisted compared clinical andor mortality outcomes covid<NUMBER> patients acei arb nonusers <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally couple studies united kingdom china published preprint server also included <NUMBER> <NUMBER> finally eight studies included review table <NUMBER> included studies compared clinical severity related outcomes covid<NUMBER> patients acei arb nonusers however nonuniformity definition severe outcomes amongst studies table <NUMBER> richardson et al zhang p et al compared rates invasive ventilation found slightly higher equivalent patients aceiarb compared nonusers respectively addition richardson et al also reported slightly higher rates icu admissions patients acei <NUMBER> arb <NUMBER> compared nonusers <NUMBER> zhang p et al reported patients aceiarb lower rates septic shock hr <NUMBER> p value <NUMBER> acute respiratory distress syndrome ards hr <NUMBER> p value <NUMBER> compared nonusers <NUMBER> <NUMBER> hand guo j et al found patients aceiarb higher rates cardiovascular disease elevated troponin tnt levels compared nonusers <NUMBER> vs <NUMBER> <NUMBER> table <NUMBER> despite worldwide implementation public health measures like social distancing contact tracing mass testing aid control covid<NUMBER> global cases risen <NUMBER> million <NUMBER> patients lost lives april <NUMBER> th <NUMBER> <NUMBER> <NUMBER> requires attention several studies reported increased rates covid<NUMBER> associated mortality patients significant comorbidities viz hypertension cardiovascular disease chronic kidney disease heart failure etc <NUMBER> <NUMBER> although acei arb commonly prescribed treat comorbidities fact ace<NUMBER> receptor main binding site entry sarscov<NUMBER> caused concerns regarding use acei arb patients <NUMBER> <NUMBER> several evidencebased consensus position statements formulated various cardiovascular hypertension societies recommended continued use ace inhibitors arb covid<NUMBER> patients citing lack contrary clinical evidence <NUMBER> <NUMBER> <NUMBER> <NUMBER> since however several clinical studies evaluated association ace inhibitors arb covid<NUMBER> patients comorbidities imperative accurately predict clinical outcomes covid<NUMBER> patients especially comorbidities taking acei arb decide whether continue switch another medication however conflicting findings reported several studies meng j et al liu et al feng reported patients ace inhibitorsarb lower rates severe outcomes whereas richardson et al reported higher rates invasive ventilation icu admissions patients ace inhibitorsarb compared nonusers guo j et al found patients ace inhibitorsarb higher rates cardiovascular disease elevated troponin tnt levels pertinent note studies perform adjustment covariates matching analysis undermining statistical strength results certain extent <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however zhang p et al perform matching adjusted analysis <NUMBER> patients found slightly higher rates icu admissions patients ace inhibitors <NUMBER> arb <NUMBER> compared nonusers <NUMBER> <NUMBER> zhang p et al performed matching adjustment assessing mortality outcomes strengthening conclusions regarding safety aceiarb however large sample size study conducted new york <NUMBER> covid<NUMBER> patients richardson et al raised concerns worse mortality outcomes acei arb cannot overlooked <NUMBER> <NUMBER> several hypotheses put forward explaining positive negative aspects aceiarb administration covid<NUMBER> patients positive effects include ace<NUMBER> receptor blockade disabling viral entry heart lungs overall decrease inflammation secondary aceiarb suggesting use acei might protective respiratory complications negative effects include possible retrograde feedback mechanism ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ace<NUMBER> receptors upregulated may lead severe pneumonia increasing risk severe outcomes mortality <NUMBER> individuals ace<NUMBER> polymorphisms increased genetic predisposition increased risk sarscov<NUMBER> infection may harmful effects aceiarb <NUMBER> aspect worth considering needs evaluated future studies best knowledge systematic review comprehensive exploration analysis existing literature topic till date review limitations rigor due scarce existing data diverse study types available rapidly emerging knowledge base covid<NUMBER> poses possibility studies particularly unpublishedunder peer review remain uncaptured however tried best mitigate allowing broadest search terms including many databases repositories also tried comprehensively review analyze existing data considering inconsistent clinical studies conflicting hypothesis essential evaluate clinical outcomes covid<NUMBER> patients aceiarb future large studies particularly randomized controlled trials additionally evaluate association clinical outcomes ace<NUMBER> polymorphisms based ongoing trials studying effect losartan arb patients covid<NUMBER> outpatient inpatient settings nct<NUMBER> nct<NUMBER> <NUMBER> <NUMBER> concluded acei arb continued covid<NUMBER> patients albeit exercising caution larger clinical studies rct confirm safety additionally individual patient factors like ace<NUMBER> polymorphisms might confer higher risk adverse outcomes need evaluated ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint severity covid<NUMBER> identified hospitalization according guidelines established national health commission peoples republic china severity covid<NUMBER> pneumonia classified according diagnosis treatment scheme covid<NUMBER> chinese<NUMBER>thedition <NUMBER> severe illness defined blood oxygen saturation levels <NUMBER> less respiratory frequency <NUMBER>min greater partial pressure arterial oxygen fraction inspired oxygen ratio less <NUMBER> lung infiltrates <NUMBER> within <NUMBER> <NUMBER> hours septic shock respiratory failure andor multiple organ dysfunction failure non severe illness defined absence previously described characteristics mortality rates patients hypertension among <NUMBER> patients <NUMBER> classified mild disease covid<NUMBER>m <NUMBER> classified severe condition covid<NUMBER>s according new coronavirus pneumonia prevention control program published national health commission china regimens primary endpoint primary endpoint death transfer critical care unit organ support within <NUMBER>days symptom onset matching matching ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> results devastating multisystem disease affected millions people worldwide <NUMBER> pandemic sparked efforts identify modifiable risk factors investigate putative treatments first wave observational data hypertension quickly emerged key comorbidity potentially associated increased covid<NUMBER> mortality <NUMBER> <NUMBER> identification angiotensinconverting enzyme <NUMBER> ace<NUMBER> primary sarscov<NUMBER> binding site led concern angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs may increase sarscov<NUMBER> infection covid<NUMBER> mortality risk <NUMBER> <NUMBER> select experimental studies shown ace inhibitors arbs increase ace<NUMBER> expression certain tissues <NUMBER> <NUMBER> <NUMBER> however data continue emerge either temper refute early concerns <NUMBER> <NUMBER> addition concerns contrast prior experimental data suggest protective role reninangiotensin system ras inhibitors acute lung injury inflammation select viral pneumonias including sarscov virus responsible sars outbreak <NUMBER> informed decisions continue discontinue ace inhibitor arb therapy covid<NUMBER> hinge ongoing research understand roles ace<NUMBER> ras pulmonary biology welldesigned clinical trials targeting patient population review ras biology classic mediator hypertension may also hold key sarscov<NUMBER> entry pneumocytes potentially modulate subsequent lung injury also briefly review competing data regarding effect ras inhibition covid<NUMBER> identify key unmet needs studies designed address summarize consensus recommendations regarding use ras inhibition covid<NUMBER> ras crucial regulator numerous physiologic functions including fluid electrolyte balance perfusion inflammatory response two predominant ras axes aceangiotensin ang iitype <NUMBER> ang ii receptor <NUMBER> r pathway counterregulatory ace<NUMBER>ang<NUMBER>mas receptor masr pathway coexpressed tissues <NUMBER> ace exists membranebound soluble forms converts ang ang ii acts via <NUMBER> r <NUMBER> r ace<NUMBER> predominately membranebound converts ang ii ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> acts via masr <NUMBER> homeostasis pathways critical normal physiology pathologic conditions aceang ii upregulation andor ace<NUMBER>ang<NUMBER> downregulation propagates disease <NUMBER> <NUMBER> ras several effects cardiovascular system well target organs including kidney brain experimental models acquired genetic ace<NUMBER> deficiency associate several deleterious structural functional abnormalities attributed unopposed ang ii well reduced ang<NUMBER> including decreased cardiac contractility cardiac hypoperfusion myocardial dysfunction impaired kidney function albuminuria <NUMBER> <NUMBER> <NUMBER> vasculature ang ii acts <NUMBER> r resulting diminished nitric oxide vasoconstriction <NUMBER> kidneys ang ii promotes sodium fluid retention combination vasoconstriction raises blood pressure hand ang<NUMBER> activation masr results part release prostaglandin e <NUMBER> bradykinin nitric oxide decrease blood pressure via natriuresis diuresis vasodilation <NUMBER> <NUMBER> brain ace<NUMBER>ang<NUMBER> pathway reduces sympathetic activity increases nitric oxide synthase nitric oxide levels promoting vasodilation blood pressure decline <NUMBER> <NUMBER> addition effects vasculature ang<NUMBER> counteracts proinflammatory profibrotic effects ang ii heart kidneys <NUMBER> <NUMBER> animal models unopposed ang ii setting diminished ace<NUMBER> upregulated inflammatory cytokines interferonγ interleukin<NUMBER> monocyte chemoattractant protein<NUMBER> increased phosphorylation extracellular signalregulated protein kinase erk<NUMBER> cjun nterminal kinase jnk<NUMBER> signaling pathways <NUMBER> furthermore <NUMBER> r activation ang ii prothrombotic effects including enhanced platelet activation impaired fibrinolysis resulting hypercoagulability <NUMBER> <NUMBER> ang ii also stimulates plasminogen activator inhibitor<NUMBER> promoting thrombus production <NUMBER> prothrombotic effects ang ii downregulated ace<NUMBER>mediated conversion ang<NUMBER> subsequent ang<NUMBER> signaling via masr dysregulation pathway may contribute hypercoagulability endothelial dysfunction observed covid<NUMBER> <NUMBER> <NUMBER> increasing interest ras ace<NUMBER>ang<NUMBER> particular covid<NUMBER> pandemic given sarscov<NUMBER> spike protein binds ace<NUMBER> infect epithelial cells lung notably type ii alveolar epithelial cells mechanism observed sarscov <NUMBER> <NUMBER> lungs ras regulates pulmonary vascular tone alveolocapillary integrity inflammatory response alveolar epithelial cells endothelial cells smooth muscle cells fibroblasts resident immune cells ie alveolar macrophages express ras pathways though aceang ii expression generally much greater ace<NUMBER>ang<NUMBER> <NUMBER> lung injury upregulates stimulates de novo aceang ii expression notably ace<NUMBER>ang<NUMBER> suppression turn propagates injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov evidence suggests sarscov<NUMBER> downregulates ace<NUMBER> via endocytosis shedding thus could potentially shift ras towards aceang ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> acid aspirationinduced acute lung injury resulted acedependent increased ang ii concentrations lung plasma associated reduced ace<NUMBER> expression <NUMBER> rat acute respiratory distress syndrome ards model combination lipopolysaccharide mechanical ventilation decreased ace<NUMBER>ace activity ang<NUMBER>ang ii concentration ratios bronchoalveolar lavage fluid <NUMBER> patients ards elevated plasma ang ii levels <NUMBER> addition prior ace inhibitor arb use well ace genotype associated improved mortality patients ards <NUMBER> <NUMBER> ang ii binds <NUMBER> r increase pulmonary vascular permeability induce alveolar epithelial cell apoptosis fibroblast differentiation promote immune cell migration activation differentiation cytokine release <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed cytokine release activated type ii alveolar epithelial cells alveolar macrophages mediated part erk<NUMBER> p<NUMBER> mitogenactivated protein kinase signaling cascades regulated <NUMBER> r masr <NUMBER> <NUMBER> <NUMBER> ace<NUMBER>ang<NUMBER> pathway mitigates acute lung injuryards binding sarscov spike protein ace<NUMBER> downregulated ace<NUMBER> expression increased ang ii lung concentration enhanced <NUMBER> rmediated acute lung injury including increased lung elastance pulmonary edema <NUMBER> ace<NUMBER> deficiency worsened lung elastance pulmonary vascular permeability pulmonary edema inflammatory cell infiltration hyaline membrane formation decreased oxygenation several acute lung injury models catalytically active recombinant human ace<NUMBER> improved lung measures reduced lung ang ii concentration <NUMBER> phaseii clinical trial recombinant human ace<NUMBER> caused sustained decrease plasma ang ii sustained increase ang<NUMBER> <NUMBER> beneficial effects ace<NUMBER>ang<NUMBER> pathway acute lung injury extend beyond ang ii metabolism ang<NUMBER> binding masr lesser extent ang ii binding <NUMBER> r also exerts protective effect <NUMBER> several rodent models acute lung injury ang<NUMBER> infusion peptide cyclized reduced pulmonary vascular resistance edema increased pao <NUMBER> blocked increased tumor necrosis factor α increased bronchoalveolar lavage fluid ace<NUMBER>ace activity ang<NUMBER>ang ii concentration ratios protected alveolocapillary barrier failure neutrophil invasion <NUMBER> <NUMBER> intriguingly ang<NUMBER> restored systemic blood pressure reduced right ventricle pressure load part mediated beneficial arb effects <NUMBER> ras plays significant role acute chronic lung injury including sars given ace<NUMBER>s role sarscov<NUMBER> binding site ras likely plays role covid<NUMBER> pathophysiology though confirmatory clinical experimental data needed sarscov<NUMBER> cellular entry via ace<NUMBER> dependent upon priming sarscov<NUMBER> spike protein type ii transmembrane serine proteases <NUMBER> <NUMBER> addition sarscov<NUMBER> binds ace<NUMBER> higher affinity sarscov <NUMBER> therefore process increases ace<NUMBER> expression theoretically could increase likelihood viral binding cellular infection thus increase risk worse outcomes patients covid<NUMBER> ras inhibitors may increase cell surface ace<NUMBER> levels expression <NUMBER> ace<NUMBER> interacts <NUMBER> r cellular surface however ang ii binding <NUMBER> r interrupts <NUMBER> race<NUMBER> interaction promotes increased ace<NUMBER> internalization <NUMBER> among complications multiorgan disease covid<NUMBER> may increase risk acute kidney injury aki studies critically ill persons covid<NUMBER> rate aki ranges <NUMBER> <NUMBER> <NUMBER> <NUMBER> however aki estimates hospitalized patients vary substantially incidence aki outpatients covid<NUMBER> remains unknown <NUMBER> impairment autoregulatory response changes kidney perfusion <NUMBER> ace inhibitors arbs could theoretically increase risk aki highly susceptible individuals however aside demonstrated risks dual therapy <NUMBER> neither ace inhibitors arbs clearly increase aki risk randomized studies atrisk populations <NUMBER> moreover study directly demonstrated association ras inhibition risk aki patients covid<NUMBER> <NUMBER> despite theoretical increase ace<NUMBER> binding sites ras blockade could improve clinical outcomes persons infected sarscov<NUMBER> rationale supported preclinical studies losartan arb attenuated lung injury nonviral mouse model sarscov spike proteinenhanced acidinduced lung injury <NUMBER> study either infection sarscov use spike protein combined acidinhalation model substantially reduced ace<NUMBER> levels increased ang ii levels lung thus overarching hypothesis viral infection diminishes ace<NUMBER> protein activity leading ang ii accumulation reduced ang<NUMBER> aforementioned upregulation aceang ii concomitant suppression ace<NUMBER>ang<NUMBER> likely propagates lung injury sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> increased ang iiang<NUMBER> ratio leads vasoconstriction pulmonary vasculature reducing pulmonary blood flow alreadydamaged lung parenchyma face hypoxemia viral pneumonia predominance ang ii intensives immune response may contribute lung injury <NUMBER> however whether <NUMBER> r universally stimulates inflammation fibrosis remains unclear specific deletion <NUMBER> rs macrophages cells mice suggests activation <NUMBER> rs immune cell lineages limits rather propagates inflammation organ injury kidney models <NUMBER> <NUMBER> <NUMBER> r signaling macrophages cells contributes lung injury sarscov<NUMBER> infection remains unknown benefits ras inhibition covid<NUMBER> remain unclear may able extrapolate use ras inhibition types viral infections example mouse model h<NUMBER>n<NUMBER> influenza viral infection also decreased ace<NUMBER> levels resultant increased ang ii <NUMBER> ace<NUMBER> knockout mice worse outcomes viral infection contrast losartan mitigated lung injury wildtype mice influenza infection similar effect seen sarscov model <NUMBER> moreover respiratory syncytial virus models demonstrate similar improvements ras inhibition <NUMBER> data analogous viral infections provide favorable precedent use ras inhibition covid<NUMBER> several observational studies evaluated association ace inhibitor arb therapy development severity covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies several limitations including confounding indication collider bias conditioning specific factors like hospitalization forsymptom covid<NUMBER> testing may distort induce spurious associations ace inhibitor arb use covid<NUMBER> timedependent bias lack accounting multiple hypothesis testing accordingly studies show conflicting results regarding association ace inhibitor arb therapy covid<NUMBER> example zhang et al found ace inhibitor arb therapy associated lower risk mortality among individuals hospitalized covid<NUMBER> hubei province china <NUMBER> contrast rentsch et al found ace inhibitors arbs associated higher risk requiring intensive care among us veterans hospitalized covid<NUMBER> <NUMBER> research needed better understand magnitude direction associations dizzying pace research wake covid<NUMBER> pandemic yielded incomplete conflicting data regarding safety ras inhibitors patients covid<NUMBER> patients certain comorbidities heart failure chronic kidney disease decades research clearly demonstrate improved survival disease trajectory ras inhibitors <NUMBER> <NUMBER> given stakes decision continue hold medications patients providers need clear guidelines help navigate difficult situation understanding covid<NUMBER> continues evolve table <NUMBER> summarizes current consensus guidelines select organizations regarding use ras inhibitor therapy persons affected covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> measured consistent responses organizations continue ras inhibitor therapy sarscov<NUMBER> infection unless otherwise directed healthcare provider reflect lack highquality data overturn existing indications medications several confounding factors measurable unmeasurable underlie clinical decision continue discontinue start ras inhibitor therapy setting covid<NUMBER> confounding factors limit ability observational studies definitively answer question infection affect outcomes infected • strongly recommend routine use ace inhibitors arbs reninangiotensin system ras powerful biological system plays important role regulation systemic blood pressure maintenance fluid salt homeostasis multifactorial system since includes different components fig <NUMBER> first renin discovered <NUMBER> <NUMBER> whereas discovery last component angiotensinconverting enzyme <NUMBER> ace <NUMBER> relatively recent <NUMBER> <NUMBER> <NUMBER> three kinds ras known circulating b local c intracellular circulating ras acts systemic level substrate angiotensinogen released liver cleaved form angiotensin angi renin enzyme secreted juxtaglomerular cells kidney main effector peptide system angiotensin ii angii generated angi ace acting powerful vasoconstrictor b local tissue rass described several organs tissues synthesize angii locally since possess whole ras enzymatic machinery c recent studies revealed intracellular complete ras produce angii ras therefore considered endocrine paracrine intracrine system <NUMBER> endothelium continuous layer simple squamous epithelial cells endothelial cells contributes systemic homeostasis different functions barrier maintenance coagulation thrombolytic processes participation immune reactions synthesis different vasoactive compounds <NUMBER> direct injury mechanical chemical infective endothelium exposes basement membrane components blood leading series events called inflammatory cascade including alteration vascular integrity production release cytokines adhesion molecules procoagulant agents reactive oxygen species ros addition wellknown regulatory role hemodynamic homeostasis ras particular angii fig <NUMBER> also involved modulation inflammatory process <NUMBER> indeed angii regulate vascular permeability first step inflammatory response inducing synthesis prostaglandins vascular endothelial cell growth factor vegf <NUMBER> <NUMBER> moreover ras participates leukocyte extravasation critical step inflammatory response different levels angii activates leukocytes increases adhesion endothelial cells <NUMBER> via induction proinflammatory mediators like selectins adhesion molecules chemokines cytokines factors eg transforming growth factor tgfβ angii effects mediated receptor angiotensin receptor <NUMBER> at<NUMBER>r leads activation transcription factors including activating protein<NUMBER> ap<NUMBER> nuclear factorκb nfκb ensuing expression genes involved inflammation tissue injury <NUMBER> patients cardiovascular disease increased selectin expression plasma chemokine levels attenuated treatment losartan at<NUMBER>r antagonist <NUMBER> experimental studies demonstrated angii infusion dosages unable induce vasoconstriction increases leukocyte transmigration treatment angiotensin receptor antagonists suppresses leukocytes response <NUMBER> finally ras participates last phase inflammation cell growth tissue repair preclinical studies kidney <NUMBER> revealed angii induces cellular growth release several growth factors resulting organ hypertrophy massive matrix synthesis formation scarring studies demonstrated angii also induces fibrosis tissues heart <NUMBER> lung <NUMBER> well known ras involved pathophysiology several diseases occurring different organs eg heart kidney overactivation ras linked development atherosclerosis hypertension cardio vascular renal events myocardial infarction stroke congestive heart failure diabetes nephrosclerosis <NUMBER> tumorigenesis <NUMBER> several studies focused lung diseases pulmonary hypertension pulmonary fibrosis order better understand role ras field capillaries lungs one main sites ace expression <NUMBER> thereby lungs considered important source angii pulmonary hypertension characterized increased vascular resistances endothelial remodeling eventually leading right heart failure death context angii seems mediate proinflammatory signaling rather vasoconstriction resulting pulmonary vascular remodeling <NUMBER> indeed angii induce smooth muscle cells proliferation <NUMBER> consequent increase pulmonary artery wall thickness evidence demonstrated involvement ras pathophysiology pulmonary fibrosis angii upregulates expression tgfβ thus differentiation fibroblasts myofibroblasts increase extracellular matrix deposition <NUMBER> well alveolar epithelial cells apoptosis <NUMBER> among various scenarios ras role chapter focuses current knowledge role ras acute lung injury ali acute respiratory distress syndrome ards fig <NUMBER> ace key enzyme ras highly expressed lung endothelial cells represents ectoenzyme uniformly distributed along luminal surface catalytic site exposed bloodborne substrates <NUMBER> clinical data seem indicate ace activity related ali pathogenesis outcome <NUMBER> idell et al <NUMBER> found ace levels augmented bronchoalveolar lavage bal fluid ards patients compared normal subjects patients affected sarcoidosis fibrosis particular ace levels highest bal fluid patients ards infectious origin authors speculated ace bal fluid could marker endothelial damage two years earlier <NUMBER> fourrier et al <NUMBER> performed sequential measurements ace levels serum patients ards sepsis without ards found ards survivors ace levels biphasic evolution decreasing early phases illness increasing time weaning conversely ace levels ards nonsurvivors decreased early phases without later increase finally patients sepsis without ards levels ace remained elevated authors postulated low level circulating ace index pulmonary endothelial injury correlating presence severity ards ards appears relatively low incidence compared number subjects potentially risk developing syndrome thus genetic background predisposing illness postulated ace gene located chromosome <NUMBER>q<NUMBER> contains restriction fragment length polymorphism consisting insertion deletion alu repeated sequence intron <NUMBER> deletion alu sequence associated greater ace activity plasma peripheral blood mononuclear cells <NUMBER> marshall et al <NUMBER> performed retrospective study <NUMBER> comparing patients ards patients nonards respiratory failure found deletion alu sequence ace gene associated higher incidence ards increased mortality ards group suggesting increase ace activity correlates risk outcome ards different results obtained orfanos et al <NUMBER> <NUMBER> order assess whether pulmonary capillary endothelium bound pcebace activity could marker endothelial injury thus predicting development severity ali patients grouped according lung injury score lis pcebace activity measured authors observed pcebace activity decreased patients aliards compared nonards patients inverse correlation lis apache ii score data suggest pcebace dysfunction early marker presence severity endothelial cell damage fact deletion alu sequence leads higher activity ace related pathogenesis ards appears contrast fact pcebace activity reduced consequence pulmonary endothelial dysfunction maniatis et al <NUMBER> interpreted paradox inferring increased ace angii activity could generate superoxide anions interactions ros nitric oxide lead synthesis reactive nitrogen species damage pulmonary endothelium consequent reduction ace activity counterbalances proinflammatory activity another hypothesis crude losses endothelium result reduced pcebace activity whereas normally even normally active healthy zones lungs main biological activity ace cleavage angi give angii thus appears main effector ace responsible ards pathogenesis angii octapeptide several biological activities many already described review action mediated two different receptors at<NUMBER>r at<NUMBER>r show opposite biological effects fig <NUMBER> role angii pathogenesis aliards seems strongly linked proinflammatory properties kuba et al <NUMBER> showed murine model ali caused acid aspiration injection severe acute respiratory syndrome sars coronavirus spike proteins levels angii lungs increased degree increase proportional degree lung injury assessed histopathology angii levels significantly higher lungs mice subjected double injury acid aspiration viral infection however pulmonary edema hallmark aliards due increased hydrostatic pressure typical effect angii augmentation systemic pressure may promote pulmonary edema enhanced permeability studies <NUMBER> <NUMBER> demonstrated local angii able act directly vascular permeability stimulating vegf prostaglandins thus exerting primarily proinflammatory effect mediated hemodynamic alterations yielding important evidence assessment role angii pathogenesis aliards group <NUMBER> demonstrated receptor implicated angii action development ali at<NUMBER>r inhibition at<NUMBER>r attenuated ali shown increased compliance attenuated pulmonary edema ang ii may also play role regulation apoptosis type ii pneumocytes important phenomenon late phases ards fact proliferation type ii pneumocytes characteristic early phases ali reparative phenomenon apoptosis indicates evolution towards fibrotic role reninangiotensin system ards <NUMBER> v phase disease <NUMBER> angii seems promote apoptosis modulating fasfas ligand system <NUMBER> bears major implications pathogenesis evolution ali apoptosis alveolar epithelial cells wang et al <NUMBER> confirmed role angii modulation apoptosis alveolar epithelial cells cultured medium supplemented different doses angii angiotensinogen proteins able induce apoptosis alveolar epithelial cells concentrationdependent manner moreover authors observed nonselective angiotensin receptor antagonist saralasin could inhibit apoptosis induced proteins lisinopril aceinhibitor blocked apoptosis induced angiotensinogen angii data showed relationship angii alveolar epithelial cell apoptosis although alveolar epithelial cells express mrnas angii receptors at<NUMBER>r at<NUMBER>r selective inhibition at<NUMBER> blocked apoptosis caused angii <NUMBER> findings marshall et al showed angii could influence progression ali towards fibrotic disease angii mitogenic human adult fibroblasts via at<NUMBER> receptor stimulates autocrine release tgfβ profibrotic cytokine procollagen production fetal lung fibroblasts <NUMBER> finally rat model pulmonary fibrosis bleomycin augmented lung angii concentration whereas treatment ace inhibitor at<NUMBER> inhibitor able attenuate lung collagen accumulation tgfβ expression <NUMBER> several animal models <NUMBER> <NUMBER> <NUMBER> helped disclose relationship lipopolysaccharide lpsinduced ali angii mainly using selective inhibitors at<NUMBER> receptors first sepsisinduced ali characterized increased levels angii lung tissue treatment inhibitor at<NUMBER> led improvements permeability index vivo wetdry weight ratio quantification evans blue dye extravasation histological evidence edema vitro studies <NUMBER> supported data since monolayers rat pulmonary microvascular endothelial cells increased permeability following exposure angii increase permeability partially corrected adding inhibitor at<NUMBER> culture medium role angii inflammatory cascade endothelial dysfunction demonstrated cytokine levels sepsis induced secretion several proinflammatory cytokines lungs plasma including tumor necrosis factor tnfα interleukin il<NUMBER>β il<NUMBER> secretion partially inhibited infusion at<NUMBER> inhibitor two groups <NUMBER> <NUMBER> performed additional studies understand mechanisms underlying angiis proinflammatory actions groups found inhibition at<NUMBER> led lesser activation nfκb pathway mediated increased levels iκb inhibitor nfκb signal transduction mitogenactivated protein kinase mapk cascade cjun nterminal kinase jnk ap<NUMBER> seems also involved proinflammatory effects angii <NUMBER> ace<NUMBER> first human homolog ace discovered two independent groups <NUMBER> <NUMBER> human ace<NUMBER> expressed endothelium predominantly heart kidney testis <NUMBER> although expression also distributed lung liver small intestine brain <NUMBER> human ace<NUMBER> consists <NUMBER> amino acids type integral membrane glycoprotein extracellular domain containing potential metalloprotease zinc binding site single transmembrane domain cytoplasmic tail one catalytic domain shows <NUMBER> identity amino domain ace ace<NUMBER> carboxypeptidase since cleaves one cterminal residue substrate rather dipeptide ace fig <NUMBER> particular difference two enzymes makes ace<NUMBER> resistant action ace inhibitors since mimic dipeptidyl cterminal binding sites ace substrates ace<NUMBER> converts angi ang <NUMBER> angii ang <NUMBER> <NUMBER> <NUMBER> ang <NUMBER> converted ace ang <NUMBER> <NUMBER> rice colleagues <NUMBER> demonstrated ace<NUMBER> hydrolyzed angii efficiently angi therefore production ang <NUMBER> powerful vasodilator believed primary goal ace<NUMBER> activity ang <NUMBER> discussed depth later chapter moreover vasoactive peptides substrates ace<NUMBER> catalytic activity neurotensin kinetensin desarg bradykinin apelin<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> present lungs healthy diseased humans expressed type type ii alveolar epithelial cells bronchiolar epithelial cells <NUMBER> <NUMBER> ace<NUMBER> may play important role ali shown experimental studies imai et al <NUMBER> examined extensively ace<NUMBER>induced protection severe acute lung failure two murine models ali acid aspiration sepsis loss ace<NUMBER> ace<NUMBER> knockout mice resulted decreased compliance pulmonary edema leukocyte infiltration animal models pulmonary edema seemed predominantly due altered vascular permeability demonstrated evans blue accumulation rather hemodynamic causes indeed differences heart contractility pulmonary vascular tone found although authors exclude potential effect angii blood vessels underline protective action ace<NUMBER> counterbalances ace functions imai et al demonstrated ace angii at<NUMBER>r promoted ali different types knockout mice whereas ace<NUMBER> at<NUMBER>r protected ace<NUMBER> negatively regulates angii levels ace<NUMBER> lacking increase lungs plasma ace<NUMBER> appears play role also pathogenesis sars <NUMBER> ace<NUMBER> considered sars virus receptor interaction ace<NUMBER> virus leads endocytosis viral particles viral fusion cells absence ace<NUMBER> ace<NUMBER> knockout mice results dramatic reduction sarscoronavirus infection subsequent reduced histologic alterations leukocyte infiltration kuba et al <NUMBER> demonstrated vivo mechanism underlying elevated severity mortality viral infection sarscoronavirus infection downregulated ace<NUMBER> expression sars infection protective arm ras impaired loss ace<NUMBER> ability negatively regulate angii levels significantly increased lung tissue authors demonstrated inhibition at<NUMBER>r thus inhibition angii activity attenuated severity lung injury terms lung mechanical properties pulmonary edema sarscoronavirus challenged mice ang<NUMBER> biologically active heptapeptide fig <NUMBER> released angi angii different peptidases ace<NUMBER> one important ang<NUMBER> exerts action via receptor mas orphan g proteincoupled receptor <NUMBER> although also bind at<NUMBER>r affinity at<NUMBER>r modest compared angii ace<NUMBER>ang<NUMBER>mas arm consid v ered principal counterregulatory mechanism ras arm aceangiiat<NUMBER>r indeed two arms system act opposite ways first leading formation ang<NUMBER> simultaneously decreasing angii second forming powerful vasoconstrictor angii catabolizing ang<NUMBER> bradykinin <NUMBER> ang<NUMBER> substrate inhibitor ace since cleaved ndomain ace form ang<NUMBER> also inhibit function ace cdomain <NUMBER> ang<NUMBER> acts vasodilator inhibition ace addition release achieved indirect potentiation bradykinin <NUMBER> addition vasodilatory properties ang<NUMBER> interaction receptor mas exerts antiproliferative effect vascular smooth muscle cells fibromuscular tissue lung cancer cells moreover reduce organ remodeling limiting hypertrophy collagen deposition thus fibrosis subsequent improvement organ functions <NUMBER> recent study experimental models arthritis <NUMBER> showed antiinflammatory effects ang<NUMBER> mas receptor activation mas use mas agonist decreased release cytokines tnfα il<NUMBER>β rolling adhesion leukocytes endothelium injured site also decreased histological abnormalities classical signs inflammation pain edema authors suggested mas receptor agonists may novel therapeutic approach treatment arthritis humans limited information available concerning role ang<NUMBER> receptor healthy diseased lungs uhal et al <NUMBER> recently demonstrated protective effects ang<NUMBER> alveolar epithelial cell survival via masmediated inhibition apoptosis fact ang<NUMBER> inhibits jnk phosphorylation caspase activation nuclear fragmentation acting mas receptors blockade conversely favors apoptosis previously reviewed data show ras role aliards pathogenesis reason several experimental studies performed evaluate therapeutic role ras modulation setting example hagiwara et al <NUMBER> developed model lpsinduced ali rats showed therapy ace inhibitors could diminish interstitial edema alveolar cellular infiltration cytokine release probably via reduction ang ii levels inhibition nfκb pathway different model ali <NUMBER> induced association chronic ethanol ingestion endotoxemia alveolar epithelial permeability improved therapy lisinopril losartan drugs able reduce tgfβ levels lung tissue avoid glutathione depletion thus limiting epithelial dysfunction oxidative stress finally experimental model oleic acidinduced ali <NUMBER> confirmed captopril could attenuate pulmonary injury protecting vascular endothelium number circulating endothelial cells captopriltreated group reduced compared control group addition decreased expression intercellular adhesion molecule icam<NUMBER> activation nfκb pathway captopril treated rats also better pao <NUMBER> fio <NUMBER> ratio less edema clinical trial performed investigate effects ras modulation ards patients however retrospective cohort study <NUMBER> con<NUMBER> v zambelli grassi g bellani v ducted assess effects survival prior use ace inhibitors patients hospitalized community acquired pneumonia prior use ace inhibitors associated lower <NUMBER>day mortality far ace<NUMBER>ang<NUMBER>mas arm concerned antiinflammatory properties ace<NUMBER> proposed therapy aliards injection recombinant human ace<NUMBER> rhace<NUMBER> ace<NUMBER> knockout mice rescue phenotype decreased severity ali improved aliards symptoms wild type mice suggesting rhace<NUMBER> administration may novel potential therapeutic strategy ards <NUMBER> study evaluating therapeutic potential rhace<NUMBER> animal model lpsinduced lung injury <NUMBER> showed treatment rhace<NUMBER> reduced plasma tnfα angii levels improving inflammatory response pulmonary edema control animals receiving lps infusion developed pulmonary hypertension whereas treatment group mean pulmonary arterial pressure reduced without changes pulmonary artery occlusion pressure indicating pulmonary vasodilatory function ace<NUMBER> addition rhace<NUMBER> treatment improved lpsinduced arterial hypoxemia probably homogeneous perfusion ace<NUMBER> treated animals chapter reviewed main evidence concerning role ras components aliards addition well known cardiovascular renal regulatory properties ras participates different phases inflammation release cytokines extravasation leukocytes matrix deposition tissue repair aliards characterized powerful inflammatory response persists time attempting repair injury results formation scar tissue although ras modulation appears promising therapeutic strategy data need collected elucidate whether would feasible clinically effective means attenuating lung injury enhancement effects recently discovered aceangiiat<NUMBER>r arm may potential strategy decrease deleterious effects angii upplemental oxygen frequently used treatment pulmonary insufficiency premature infants implicated development bronchopulmonary dysplasia bpd bpd remains major cause morbidity mortality first year life infants significant respiratory problems throughout childhood including increased airway reactivity development restrictive airway disease <NUMBER> hyperoxia induces lung injury may contribute bpd comprehensive review literature reveals strong association exposure hyperoxia subsequent expression comorbidities hyperoxia directly cause lung injury generation reactive oxygen radicals prolonged exposure neonatal mice hyperoxia results impaired alveolarization capillary development increased lung fibrosis similar human bpd <NUMBER> among mechanisms believed contribute pathogenesis lung fibrosis ace<NUMBER> great importance since reninangiotensin system ras expressed functional human lung myofibroblasts cells believed important synthesizing collagens accumulate fibrotic lungs <NUMBER> studies tissue fibrogenesis tissue ras believed play key role initiation progression fibrous tissue accumulation variety organs ace inhibitors angiotensin receptor antagonists shown prevent fibrogenesis heart <NUMBER> liver <NUMBER> kidney <NUMBER> lungs <NUMBER> <NUMBER> ang ii produced ace main effector molecule ras ang ii potential pulmonary profibrotic mediator activates ang ii type receptor stimulates collagen synthesis studies done vivo showed angiotensin system upregulated oxygenexposed fetal lung fibroblasts <NUMBER> main function ace<NUMBER> convert octapeptide angiotensin ii heptapeptide ang <NUMBER> limits accumulation ang ii protects experimental lung fibrosis imai et al <NUMBER> demonstrated three different models acute respiratory distress syndrome ards used ace <NUMBER> knockout mice mice showed severe disease compared wildtype mice previous work laboratory demonstrated ace<NUMBER> protects fibrosis downregulated human experimental lung fibrosis models <NUMBER> inhibition ace<NUMBER> associated increased lung tissue injuryfibrosis earlier uhal et al <NUMBER> demonstrated existence angiotensin tgfβ<NUMBER> autocrine loop human lung myofibroblasts important context neonatal lung jiang et al <NUMBER> showed activation angiotensin system hyperoxiainduced lung fibrosis neonatal rats chou et al <NUMBER> showed blocking ang ii activity at<NUMBER>r angiotensin type receptor blocker losartan prevented lung fibrosis response hyperoxia role ace<NUMBER> models however yet evaluated function ace<NUMBER> cellular receptor sarscoronavirus demonstrated li et al <NUMBER> haga et al <NUMBER> articles demonstrated role tnfαconverting enzyme tace cleave ectodomain ace<NUMBER> viral entry lungs authors also showed tacedependent shedding ace<NUMBER> ectodomain completely dependent binding sarss protein ace<NUMBER> tace required viral entry <NUMBER> shedding blocked tace antagonists tapi<NUMBER> tapi<NUMBER> <NUMBER> tace also known adam<NUMBER> originally identified metalloprotease required processing membrane form tnfα release soluble factor <NUMBER> known involved cleavage release ace<NUMBER> ectodomain several tissues <NUMBER> given known involvement ras components lung fibroblast function <NUMBER> profibrotic action hyperoxic gas hypothesized ace<NUMBER> might expressed fetal lung fibroblasts might downregulated hyperoxia theorized downregulation ace<NUMBER> hyperoxia might prevented inhibiting shedding inhibitor tace enzyme causes shedding report findings ace<NUMBER> protein enzyme activity severely decreased hyperoxia human fetal lung fibroblast cultures also report tapi<NUMBER> prevents decrease table <NUMBER> shows number cells disrupted plasma membrane integrity measured trypan blue expressed percentage total cells cell cultures exposed hyperoxia showed modest less <NUMBER> statistically significant increase dead cells compared cells exposed room air exposure followed <NUMBER>h period recovery p <NUMBER> figure <NUMBER> shows western blotting caspase <NUMBER> marker apoptosis normalized βactin showed significant changes densitometry together data suggest slight decrease viability hyperoxiatreated cells following recovery period minor fraction <NUMBER> cells figure <NUMBER> shows effect hyperoxia ace<NUMBER> immunoreactive protein western blotting ace<NUMBER> immunoreactivity enzyme activity significantly decreased cells treated hyperoxia compared cells treated normoxia reduction <NUMBER> p <NUMBER> densitometry occurred cells allowed recover incubating normoxic serum free media <NUMBER> h figure <NUMBER> enzymatic activity measured ace<NUMBER> synthetic substrate completely inhibited synthetic peptide dx <NUMBER> p <NUMBER> competitive inhibitor ace<NUMBER> <NUMBER> figure <NUMBER>b showed significant reduction ace<NUMBER> fetal lung fibroblasts exposed hyperoxic normoxic gas imr <NUMBER> cells confluent culture exposed <NUMBER> h <NUMBER> oxygen <NUMBER> co <NUMBER> control cells incubated <NUMBER> <NUMBER> <NUMBER> co <NUMBER> <NUMBER> h end <NUMBER> h cells either harvested incubated additional recovery phase serum free media <NUMBER> h western blotting caspase <NUMBER> performed described materials methods despite slight decrease band intensity hyperoxiatreated cells quantitation densitometry demonstrated statistically significant difference caspase <NUMBER>βactin ratio shown hyperoxia normoxic recovery downregulates angiotensinconverting enzyme<NUMBER> ace<NUMBER> human fetal lung fibroblasts imr<NUMBER> cells exposed hyperoxic normoxic gas described figure <NUMBER> western blotting ace<NUMBER> protein performed normalized βactin b change ace<NUMBER> without recovery recovery hyperoxia caused significant decrease ace<NUMBER> immunoreactive protein <NUMBER> p <NUMBER> vs <NUMBER> <NUMBER> students ttest figure <NUMBER> shows addition tapi<NUMBER> exposure hyperoxia prevented reduction immunoreactive ace<NUMBER> otherwise would occur hyperoxiatreated cells p <NUMBER> next ace<NUMBER> immunoreactivity analyzed culture media collected hyperoxiaexposed cells figure <NUMBER> shows treatment fetal lung fibroblasts hyperoxia increased release soluble ace<NUMBER> culture supernatant p <NUMBER> tapi<NUMBER> prevented increase p <NUMBER> figure <NUMBER> shows treatment hyperoxia followed normoxic recovery significantly increased adam<NUMBER>tace immunoreactive protein threefold imr<NUMBER> cells p <NUMBER> hyperoxic gas alone without recovery increase adam<NUMBER>tace data shown expected inclusion tace inhibitor tapi<NUMBER> active site blocker ability reduce increase tace protein induced hyperoxia normoxic recovery data shown figure <NUMBER> panel c shows hyperoxia normoxic recovery also caused significant increase adam<NUMBER>tace mrna <NUMBER>fold p <NUMBER> methods preventing andor reducing effect oxygen injury remain elusive identification molecular mechanisms oxygen injury endogenous protective factors hyperoxia normoxic recovery reduces angiotensinconverting enzyme<NUMBER> ace<NUMBER> enzymatic activity ace<NUMBER> mrna imr<NUMBER> cells exposed hyperoxic normoxic gas described figure <NUMBER> recovery cells harvested assay ace<NUMBER> enzyme activity <NUMBER> without inclusion ace<NUMBER> competitive inhibitor dx<NUMBER> <NUMBER> µmoll enzyme assay vessel ace<NUMBER> enzymatic activity showed statistically significant reduction hyperoxia recovery complete blockage dx <NUMBER> p <NUMBER> vs <NUMBER> <NUMBER> anova dunnetts test b ace<NUMBER> mrna quantification qrtpcr showed significant change see methods details hyperoxia normoxic recovery reduces cellular angiotensinconverting enzyme<NUMBER> ace<NUMBER> tapi<NUMBER>sensitive mechanism imr<NUMBER> cells exposed hyperoxic normoxic gas described figure <NUMBER> recovery presence absence adam<NUMBER>tace inhibitor tapi<NUMBER> cell monolayers harvested ace<NUMBER> western blotting upper panel densitometry lower panel demonstrated significant reduction cell monolayerassociated ace<NUMBER> hyperoxia treated cells compared control p <NUMBER> vs ctl anova tukeys multiple comparison test addition tapi<NUMBER> prevented decrease figure <NUMBER> hyperoxia normoxic recovery increases soluble angiotensinconverting enzyme<NUMBER> ace<NUMBER> tapi<NUMBER>sensitive mechanism imr<NUMBER> cells exposed hyperoxic normoxic gas described figure <NUMBER> recovery presence absence adam<NUMBER> tace inhibitor tapi<NUMBER> cellfree culture supernatants harvested separately cell monolayer concentrated subjected western blotting ace<NUMBER> upper panel articles might provide much needed targets future design interventions lang et al <NUMBER> recently showed angiotensin ii angii mediates profibrotic effect hyperoxia cultured human lung fibroblasts authors study potential contributions ace<NUMBER> degrades angii angiotensininduced increase collagen production stimulated hyperoxia moreover previous work showed ace<NUMBER> protects lung fibrosis animal models degrading angii downregulated lungs patients idiopathic pulmonary fibrosis mechanisms yet fully identified <NUMBER> together issues led hypotheses hyperoxia might downregulate ace<NUMBER> ii modulation ace<NUMBER> might useful management prevention hyperoxiainduced lung injury example maintaining high levels tissue ace<NUMBER> prevention shedding andor replacement protein administration biologically active enzyme may hold potential therapeutic strategies treating hyperoxic lung injury support theory pharmaceutical preparation recombinant human ace<NUMBER> rhace<NUMBER> currently clinical trials acute lung injury glaxosmithkline pipeline drug gsk<NUMBER> ace<NUMBER> carboxypeptidase degrades angiotensin ii shown protective downregulated human interstitial pulmonary fibrosis experimentallyinduced lung fibrosis li et al <NUMBER> clear role ace<NUMBER> modulating acute lung injury shown demonstrations imai et al <NUMBER> showed absence ace<NUMBER> ace<NUMBER> knockout mice exacerbates experimental acute lung injury date potential role ace<NUMBER> hyperoxic lung injury explored recent years clinicians seeing less classical old bpd characterized pulmonary fibrosis alternating cystic emphysema chest xray evidence collagen deposition fibrosis <NUMBER> recently milder form termed new bpd described characterized abnormalities alveolar septation pulmonary edema less overt fibrosis <NUMBER> <NUMBER> adult animal models acute lung injury <NUMBER> ace<NUMBER> shown inhibit lung edema formation inflammation well fibrogenesis thus although little known role ace<NUMBER> alveolar septation figure <NUMBER> proposed role angiotensinconverting enzyme<NUMBER> ace<NUMBER> hyperoxiainduced lung fibrosis angiotensinogen agt produced either alveolar epithelial cells myofibroblasts <NUMBER> cleaved variety pulmonary aspartyl proteases <NUMBER> yield angiotensin ang turn cleaved various lung enzymes yield profibrotic angii angii degraded ace<NUMBER> yield antifibrotic peptide ang<NUMBER> acts receptor mas hyperoxia causes mechanisms yet unknown release ace<NUMBER> cell ectodomain cleavage mediated increased adam<NUMBER>tace mechanism hyperoxia theorized promote fibrosis promoting accumulation angii <NUMBER> <NUMBER> b reducing production antifibrotic peptide ang<NUMBER> <NUMBER> figure <NUMBER> hyperoxia normoxic recovery increases adam<NUMBER>tace fetal human lung fibroblasts imr<NUMBER> cells exposed hyperoxic normoxic gas described figure <NUMBER> recovery recovered western blotting adam<NUMBER>tace described materials methods western blotting adam<NUMBER>tace protein performed normalized βactin b densitometry hyperoxia normoxic recovery caused significant increase adam<NUMBER>tace <NUMBER>fold p <NUMBER> students ttest c replicate wells harvested recovery total rna followed qrtpcr described methods hyperoxia normoxic recovery also caused significant increase adam<NUMBER>tace mrna <NUMBER>fold p <NUMBER> students ttest articles oarhe et al ace<NUMBER> might expected protect new bpd well fibrotic old form regardless small percentage children bpd today present classic findings old bpd may continuum exists milder forms severe presentations therefore study ace<NUMBER> components ras hyperoxic lung injury possibility ameliorating severe possibly milder forms bpd associated hyperoxic injury remains critical ace<NUMBER> also shown involved virusinduced lung disease ace<NUMBER> cellular receptor sarscoronavirus required coronaviral entry inhibition shedding tace inhibitor related severity sarscov infection <NUMBER> <NUMBER> <NUMBER> liu et al <NUMBER> showed ace<NUMBER> protein levels significantly downregulated infection h<NUMBER>n<NUMBER> viruses dispensable viral replication also found ace<NUMBER> cleavage could regulated influenza neuraminidase zou et al <NUMBER> showed experimental mouse models infection highly pathogenic avian influenza h<NUMBER>n<NUMBER> virus results downregulation ace<NUMBER> expression lung increased serum ang ii levels genetic inactivation ace<NUMBER> causes severe lung injury h<NUMBER>n<NUMBER>challenged mice confirming protective role ace<NUMBER> h<NUMBER>n<NUMBER>induced lung pathologies authors also demonstrated administration recombinant human ace<NUMBER> ameliorates avian influenza h<NUMBER>n<NUMBER> virusinduced lung injury mice thus potential influence ace<NUMBER> downregulation hyperoxic gas viral infection interesting topic future investigation growing evidence study roles ace<NUMBER> normal pulmonary physiology pulmonary pathophysiology demonstrated alveolar epithelial cells primary site ace<NUMBER> expression mice <NUMBER> relatively less attention directed toward understanding role fibroblasts ace<NUMBER> mediated pulmonary physiology pulmonary pathophysiology knowledge present study first demonstrate ace<NUMBER> expressed human lung fibroblasts downregulated hyperoxia also first document downregulation could prevented tace antagonist hyperoxiatreated cells given known function ace<NUMBER> preventing lung collagen deposition experimental lung fibrosis <NUMBER> expression fibroblastic cells responsible collagen synthesis surprising indeed authors shown lung collagen accumulation neonatal rats exposed hyperoxic gas could prevented blockers angiotensin receptor at<NUMBER> <NUMBER> wellstudied pulmonary toxicity hyperoxic gas known involve apoptotic cell death alveolar epithelial cells <NUMBER> exposure cell line imr<NUMBER> high oxygen concentration often administered premature neonates <NUMBER> o<NUMBER> increase marker apoptotic cell death fetal human lung fibroblasts caspase <NUMBER> figure <NUMBER> although <NUMBER> oxygen cause minor increase necrotic cells <NUMBER> see table <NUMBER> seems unlikely small statistically significant effect would physiologic significance hyperoxic gas however cause significant decrease ace<NUMBER> figure <NUMBER> whether subphysiologic oxygen concentrations reduce ace<NUMBER> interesting topic research light published evidence downregulation ace<NUMBER> would expected lead accumulation ang ii downstream profibrotic pathways see figure <NUMBER> indeed hyperoxic gas previously shown increase angiimediated collagen synthesis human lung fibroblasts <NUMBER> either inhibition gene knockdown ace<NUMBER> increased autocrine angii generation human lung cells culture <NUMBER> furthermore heptapeptide ang<NUMBER> product ace<NUMBER> shown antifibrotic lung tissue <NUMBER> <NUMBER> inhibition ace<NUMBER> reduces production see figure <NUMBER> accordingly reduction cellular ace<NUMBER> induced hyperoxia would expected promote fibrogenesis increasing angii simultaneously decreasing ang<NUMBER> mechanism hyperoxia decreases ace<NUMBER> appears protein level significant change mrna occurred decrease prevented tapi<NUMBER> inhibitor adam<NUMBER>tace enzyme cleaves ace<NUMBER> ectodomain response sars coronavirus <NUMBER> demonstrated haga et al <NUMBER> present study also showed effect hyperoxia ace<NUMBER> appears involve upregulation adam<NUMBER>tace mrna protein see figure <NUMBER> turn mediates enzymatic shedding ace<NUMBER> ectodomain release extracellular space determination signaling mechanisms hyperoxia upregulates adam<NUMBER>tace interesting compelling topic future investigations notable decrease ace<NUMBER> occurred period hyperoxic exposure followed normoxic recovery <NUMBER> h figures <NUMBER> sequence redox poise variation reminiscent ischemiareperfusion injury many key signaling pathways induced ischemic period return normoxia <NUMBER> although unknown present mechanisms induced hyperoxic normoxic cycling may speculated involve mitochondrial redox sensing mechanisms known influenced reactive oxygen nitrogen species <NUMBER> elucidation pathways also interesting topic future inquiry summary study showed ace<NUMBER> expressed lung epithelial cells <NUMBER> also fetal human lung fibroblasts ace<NUMBER> protein enzyme activity mrna decreased hyperoxia cultured fetal lung fibroblasts ace<NUMBER> protein increased cell culture supernatants inhibition effects tapi<NUMBER> suggests mechanism mediated adam<NUMBER>taceinduced shedding ace<NUMBER> cell surface since known lung injury fibrosis abrogated ace<NUMBER> demonstration direct effect hyperoxia ace<NUMBER> human lung cells significant implications pathogenesis hyperoxic lung injury fibrogenesis viral infection lungs peptide dx <NUMBER> competitive inhibitor ace<NUMBER> purchased phoenix pharmaceuticals burlingame ca antibodies ace<NUMBER> obtained santa cruz biotechnology tapi<NUMBER> cell lines cultured confluence treated described control cells <NUMBER> oxygen hyperoxiaexposed cells <NUMBER> oxygen <NUMBER> co <NUMBER> <NUMBER> h exposure <NUMBER> fetal bovine serum cells allowed recover serumfree media normoxic gas <NUMBER> <NUMBER> <NUMBER> co <NUMBER> <NUMBER> h cells treated trypan blue viewed microscope blue stained cells marker dead cells counted cells treated propidium iodide dna count marker total cells total least <NUMBER> cells per microscopic field counted least three microscope fields per culture well counts field given culture well averaged obtain data used calculate numbers reported n <NUMBER> three culture wells <NUMBER> cells per condition total number necrotic cells percentage total cells calculated assess possible apoptosis caspase <NUMBER> detected western blotting cell lysates collected end <NUMBER>h exposure hyperoxia end <NUMBER>h recovery normoxic gas blotting methods described cells harvested protease inhibitor protease inhibitor cocktail p<NUMBER> sigma st louis mo soluble protein lysate <NUMBER> µg loaded run <NUMBER> trishcl polyacrylamide gels separated sdspage <NUMBER>× trisglycinesds buffer biorad berkeley ca gels transferred immunblot polyvinylidene fluoride blotting membrane blotting membrane blocked <NUMBER> nonfat dry milk <NUMBER> tween <NUMBER> trisbuffered saline western blot analysis ace<NUMBER> performed antiace<NUMBER> polyclonal antibody <NUMBER> abcam biotechnology cambridge antibodies caspase <NUMBER> adam<NUMBER>tace obtained cell signaling danvers ensure equal loading proteins membranes probed antibody βactin cell signaling technology bands visualized hrpconjugated goat antirabbit secondary antibody <NUMBER> dilution santa cruz biotechnology santa cruz ca using enhanced chemiluminescence detection standard techniques imr<NUMBER>s raised treated sixwell collagen icoated plates bd biosciences bedford harvested icecold complete trishcl buffer trishcl ph <NUMBER> <NUMBER>× complete protease inhibitor cocktail edtafree roche indianapolis lisinopril <NUMBER> μgl sigmaaldrich lisinopril added buffer means block activity ace halfarea black <NUMBER>well microtiter plate fluorogenic peptide substrate ace<NUMBER> mcayvadapkdnpoh rd systems minneapolis mn added final concentration <NUMBER> μmoll <NUMBER> μl cell lysate total volume <NUMBER> μl using complete trishcl buffer ice dx <NUMBER> final concentration <NUMBER> µmoll phoenix pharmaceuticals burlingame ca competitive inhibitor ace<NUMBER> also added half wells compare enzymatic ace<NUMBER> activity inhibition plate warmed room temperature fluorescence read plate reader <NUMBER> nm excitation <NUMBER> nm emission biotek fl<NUMBER> microplate fluorescence reader biotek burlington vt <NUMBER> min kinetic readings normalized respective dna concentrations clear <NUMBER>well microtiter plate <NUMBER> µl cell lysate <NUMBER> µl complete np<NUMBER> lysis buffer np<NUMBER> <NUMBER>× complete protease inhibitor cocktail ethylenediaminetetraacetic acidfree roche added total volume brought <NUMBER> µl addition <NUMBER> µl hoescht dye final concentration <NUMBER> µmoll microtiter plate covered rocked <NUMBER> medium speed plate placed <NUMBER> °c incubator <NUMBER> min fluorescence read plate reader <NUMBER> nm excitation <NUMBER> emission fl<NUMBER> microplate fluorescence reader imr <NUMBER> cells treatment extracted total rna trizol reagent invitrogen carlsbad ca following manufacturers protocol firststrand cdna synthesized total rna using superscript ii reverse transcriptase oligodt <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> invitrogen realtime pcr carried cdna synthesized <NUMBER> ng total rna sybr green pcr core reagents applied biosystems foster city ca according manufacturers instructions <NUMBER> μmoll specific primers human ace<NUMBER> sense <NUMBER>′cattggagcaagtgttggatctt<NUMBER>′ antisense <NUMBER>′gagctaatgcatgccattctca<NUMBER>′ adam<NUMBER> tace sense <NUMBER>′ttggtggtagcagatcatcg<NUMBER>′ antisense <NUMBER>′ctgggagagccaacataagc<NUMBER>′ βactin sense <NUMBER>′aggccaaccgcgagaagatgacc<NUMBER>′ antisense <NUMBER>′gaagtccagggcgacgtagc<NUMBER>′ thermal profile ace<NUMBER> βactin started <NUMBER> min activation <NUMBER> °c followed <NUMBER> cycles denaturation <NUMBER> °c <NUMBER> annealing <NUMBER> °c <NUMBER> extension <NUMBER> °c <NUMBER> ending dissociation curve analysis pcr products thermal profile adam<NUMBER> tace started <NUMBER> min activation <NUMBER> °c followed <NUMBER> cycles denaturation <NUMBER> °c <NUMBER> annealing <NUMBER> °c <NUMBER> extension <NUMBER> °c <NUMBER> reactions performed steponeplus realtime pcr system instrument applied biosystems threshold cycle c data collected using stepone software version <NUMBER> applied biosystems relative ace<NUMBER> expression normalized βactin calculated comparative ct method <NUMBER>−δδct δct ctace<NUMBER> − ctβactin δδct δct treatment − δct control media cells plated total volume <NUMBER> ml collected <NUMBER> ml conical tube containing <NUMBER> µl <NUMBER>× complete protease inhibitor edtafree cocktail roche cell debris sample removed centrifugation samples prepped dialysis using spectrapor biotech cellulose ester dialysis membranes mwco <NUMBER> kda spectrum laboratories rancho dominguez ca according manufacturers protocol membranes containing samples kept <NUMBER> °c <NUMBER> l beaker deionized water gentle stirring media sample became clear <NUMBER> completion dialysis samples transferred new <NUMBER> ml canonical tube frozen −<NUMBER> °c completely frozen samples lyophilized using labconco freeze dryerfreezone <NUMBER> system according manufacturers protocol lyophilized samples diluted <NUMBER> µl sterile deionized water western blot ace<NUMBER> βactin done standard protocols capability inducing elevated expression ace<NUMBER> angiotensinconverting enzyme <NUMBER> cellular receptor severe acute respiratory syndrome coronavirus <NUMBER> angiotensin ii receptor blockers arbs ace inhibitors treatment may controversial role facilitating virus infection reducing pathogenic inflammation aimed evaluate effects arbsace inhibitors coronavirus disease <NUMBER> covid<NUMBER> retrospective singlecenter study one hundred twentysix patients covid<NUMBER> preexisting hypertension hubei provincial hospital traditional chinese medicine wuhan january <NUMBER> february <NUMBER> <NUMBER> retrospectively allocated arbsace inhibitors group n<NUMBER> nonarbsace inhibitors group n<NUMBER> according antihypertensive medication one hundred twentyfive age sexmatched patients covid<NUMBER> without hypertension randomly selected nonhypertension controls addition medication history <NUMBER> patients hypertension admitted hubei provincial hospital traditional chinese medicine november <NUMBER> december <NUMBER> <NUMBER> covid<NUMBER> outbreak also reviewed external comparison epidemiological demographic clinical laboratory data collected analyzed compared groups frequency arbsace inhibitors usage patients hypertension without covid<NUMBER> comparable among patients covid<NUMBER> hypertension received either arbsace inhibitors nonarbsace inhibitors comparable blood pressure however arbsace inhibitors group significantly lower concentrations hscrp highsensitivity creactive protein p<NUMBER> pct procalcitonin p<NUMBER> furthermore lower proportion critical patients <NUMBER> versus <NUMBER> p<NUMBER> lower death rate <NUMBER> versus <NUMBER> p<NUMBER> observed arbsace inhibitors group nonarbsace inhibitors group although differences failed reach statistical significance findings thus support use arbsace inhibitors patients covid<NUMBER> preexisting hypertension effects angiotensin ii receptor blockers ace angiotensinconverting enzyme inhibitors virus infection inflammatory status clinical outcomes patients covid<NUMBER> hypertension singlecenter retrospective study editor journal allergy clinical immunology practice published contingency planning article shaker et al <NUMBER> guide allergistsimmunologists coronavirus disease <NUMBER> covid<NUMBER> pandemic provided suggestions logical approach quickly adjust services mitigate risk medical staff patients pandemic social distancing encouraged context ongoing worldwide debate regarding use angiotensinconverting enzyme ace inhibitors ibuprofen patients covid<NUMBER> concern drugs could worsen prognosis patients infection <NUMBER> <NUMBER> coronaviruses severe acute respiratory syndrome china <NUMBER> middle east respiratory syndrome middle eastern countries <NUMBER> use angiotensinconverting enzyme <NUMBER> ace<NUMBER> dipeptidyl peptidase <NUMBER> respectively receptors infect human cells <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> coronavirus involved covid<NUMBER> also depends ace<NUMBER> cell entry <NUMBER> drugs inhibit ace paradoxically upregulate ace<NUMBER> expression cell surface could theoretically facilitate coronavirus infection progression <NUMBER> definitive evidence effect clinically relevant retrospective observational studies suggest association use drugs worse outcome covid<NUMBER> <NUMBER> causeeffect association cannot confirmed ace inhibitors could confounding factors indicate comorbidities cardiopathy hypertension diabetes besides advancing age wellrecognized risk factors worse outcome covid<NUMBER> myocardial injury indicated increased serum levels troponin cardiovascular disease significant association fatal outcomes covid<NUMBER> <NUMBER> moreover withdrawal ace inhibitors could aggravate underlying disease make patients unstable overcome coronavirus infection coincidentally receptors coronavirus ace<NUMBER> dipeptidyl peptidase <NUMBER> enzymes break bradykinin addition main functions sarscov<NUMBER> binding ace<NUMBER> viral complex undergo endocytosis surface ace<NUMBER> downregulated figure <NUMBER> ace also degrades bradykinin drugs inhibit enzyme lead increase tissue bradykinin may even trigger cough angioedema hypersensitive individuals speculate whether excess bradykinin patients taking ace inhibitors could complicate coronavirus infection effects vasodilation increase vascular permeability cough reflex exacerbation <NUMBER> however study done investigating hypothesis current data justify discontinuation ace inhibitors patients risk covid<NUMBER> figure <NUMBER> interaction reninangiotensinaldosterone system bradykinin system sarscov<NUMBER> infection downregulation ace<NUMBER> type ii pneumocytes surface decreasing bradykinin degradation ace also degrades bradykinin drugs inhibit enzyme increase bradykinin levels red dashed line ace ace<NUMBER> dpp<NUMBER> degrade bradykinin blue dashed line ace<NUMBER> degrades angiotensin angiotensin <NUMBER> angiotensin ii angiotensin <NUMBER> blue solid line conversion angiotensin angiotensin ii dpp<NUMBER> dipeptidyl peptidase <NUMBER> experts opinions unpublished french cases suggested association use ibuprofen worse outcome covid<NUMBER> <NUMBER> studies supporting hypothesis recent publication stated ibuprofen also increases ace<NUMBER> expression authors provide reference supports statement <NUMBER> ibuprofen use could marker disease severity necessarily cause worse prognosis patients toxemic symptomatic fever asthenia myalgia prone use nonsteroidal antiinflammatory drugs nsaids ibuprofen indeed associated worse covid<NUMBER> outcomes whether possible association would relate specific agent ibuprofen larger group nsaids would require investigation european medicines agency concluded currently scientific evidence establishing link ibuprofen nsaids worsening covid<NUMBER> <NUMBER> knowledge sarscov<NUMBER> infection increases daily studies needed better understand influence ace inhibitors nsaids covid<NUMBER> severity present evidence generate even weak recommendation discontinue medications pandemic patients care must personalized ace inhibitors andor nsaids may used indicated weighing benefits risks past two decades coronaviruses caused three epidemic diseases covid<NUMBER> <NUMBER> severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> enveloped viruses positive sense singlestranded rna genome <NUMBER> kb sequence analysis revealed high sequence similarity among coronaviruses causing covid<NUMBER> sars mers <NUMBER> high similarity sars coronavirus usually termed sarscov <NUMBER>ncov also named sarscov<NUMBER> high similarity also favours understanding many aspects related infection human body thanks knowledge derived scientific experiments studies performed previously human infecting relatives sarscov<NUMBER> <NUMBER> also causing severe acute respiratory stress genome sarscov<NUMBER> contains least ten open reading frames orfs useful viral replication transcription coding structural proteins specifically four main structural proteins recognized spike envelope e nucleocapsid n membrane proteins spike protein plays critical role start viral infection proteins coronaviruses large membrane linked glycoproteins responsible binding receptors host cells membrane fusion <NUMBER> proteins organized s<NUMBER> s<NUMBER> domains respectively similar s<NUMBER> s<NUMBER> domains human immunodeficiency virus hiv influenza proteins s<NUMBER> domain characterized coronaviruses sarscov sarscov<NUMBER> included mediates initial highaffinity association receptors <NUMBER> experimental analyses proved sarscov<NUMBER> use known coronavirus receptors aminopeptidase n apn dipeptidyl peptidase <NUMBER> dpp<NUMBER> sarscov<NUMBER> instead requires angiotensinconverting enzyme <NUMBER> ace<NUMBER> enter cells <NUMBER> clearly shown sarscov <NUMBER> studies african green monkey kidney cell line vero e<NUMBER> permits viral replication highlighted mechanisms association s<NUMBER> domain sarscov human cell receptors authors confirmed soluble form ace<NUMBER> related enzyme termed ace blocked association s<NUMBER> domain vero e<NUMBER> cells also antiace<NUMBER> antiace antibodies blocked viral replication vero e<NUMBER> cells role ace<NUMBER> functional receptor sarscov recently confirmed also sarscov<NUMBER> <NUMBER> <NUMBER> demonstrated also sarscov<NUMBER> well sarscov use endosomal cysteine proteases cathepsin b l catbl transmembrane serine protease tmprss<NUMBER> protein priming cell lines step required viral entry cell <NUMBER> tmprss<NUMBER> previously revealed host cell factor critical entry cells viral replication affecting protein cell surface inducing virusplasma membrane fusion <NUMBER> furthermore lysosometropic reagents like e<NUMBER>d inhibits catbl failed completely inhibit sarscov<NUMBER> well sarscov entry cells indeed entry full inhibition also needed tmprss<NUMBER> inhibitors like camostat mesylate <NUMBER> concurrent action previously shown required robust blockade sarscov <NUMBER> host susceptibility sars cov<NUMBER> infection primarily determined affinity viral s<NUMBER> binding site receptor binding site rbd host ace<NUMBER> determines initial viral attachment step <NUMBER> moreover since bind ace<NUMBER> s<NUMBER> domain proteins require priming protein cell surface induce virusplasma membrane fusion viral entry <NUMBER> copresence molecule investigated determine possible occurrence infection cells ace<NUMBER> appeared restricted distribution human tissues initially reported expressed mainly heart kidney testis <NUMBER> interestingly remarkable findings since <NUMBER> <NUMBER> revealed surface expression ace<NUMBER> lung alveolar epithelial cells enterocytes small intestine well arterial venous endothelial cells arterial smooth muscle cells organs studied explaining relationship sars coronavirus infection together presence ace<NUMBER> vascular endothelium results highlighted possible routes entry sarscov recently singlecell transcriptomes showed presence ace<NUMBER> rna indicated ace<NUMBER> type ii alveolar cells lung esophagus upper stratified epithelial cells absorptive enterocytes ileum colon cholangiocytes myocardial cells kidney proximal tubule cells bladder urothelial cells suggesting organs could considered potential high risk <NUMBER>ncov infection particular presence ace<NUMBER> revealed also mucosa oral cavity highly enriched epithelial cells moreover research highlighted among different oral sites ace<NUMBER> expression higher tongue buccal gingival tissues also investigated expression pattern tmprss<NUMBER> public biological databases httpswwwproteinatlasorgensg<NUMBER>tmprss<NUMBER>tissue analysis revealed protein mrnas typically present lung physiological condition nevertheless interesting note tmprss<NUMBER> expression correlates sarscov infection upper lobe lung <NUMBER> protein almost present also paratyroids salivary glands mrna expression detected lung salivary gland tongue findings indicate mucosa oral cavity may potentially high risk route starting infection <NUMBER> worthy mention context chatepsins also contribute internalization virus <NUMBER> stimulated cytokines key proteins inflammatory response interleukin <NUMBER> il<NUMBER> leads relevant increase cathepsin l whereas tgfbeta<NUMBER> decreases amount cathepsin l mrna protein levels proving cytokines il<NUMBER> tgfbeta <NUMBER> modulate cathepsin gene expression <NUMBER> remarkably il<NUMBER> tgfbeta<NUMBER> appear overproduced covid<NUMBER> patients <NUMBER> <NUMBER> public data documented computed tomography ct radiography imaging covid<NUMBER> infected patients httpswwwsirmorgcategorysenzacategoriacovid<NUMBER> highlight cytokine stormsyndrome rather virus could cause severe lung injuries death <NUMBER> cytokine storm overproduction cytokines accumulation immune cells often associated lung inflammation fluid buildup lead respiratory distress mortality moreover widely known information also available wikipedia principal symptoms cytokine storm high fever fatigue nausea correspond principal ones covid<NUMBER> infected patients httpswwwworldometersinfocoronaviruscoronavirussymptoms cytokines proteins produced secreted broad range cells including immune cells endothelial cells fibroblasts various stromal cells response varied stimuli act chemical messengers released cells contact stimulus pathogen affecting actions cells binding receptors surface past two decades much learned diagnosis treatment cytokine storm syndromes even intervention sars <NUMBER> mers <NUMBER> development biological therapies variety rheumatic oncologic conditions offered novel approaches treating immune response going beyond targeted immune suppression corticosteroids relatively nonselective immune suppressants example recently number specific anticytokine approaches proven effective treating variety cytokine storm syndromes including triggered coronaviruses data becoming available cytokine content patients affected covid<NUMBER> patients involved previous pandemic infections <NUMBER> reveals intricate patterning gene expression associated inflammatory status possible side effect untargeted treatments <NUMBER> ras signalling although relevance sarscovs infection ace<NUMBER> <NUMBER> first discovered role transmembrane exopeptidase catalyses conversion angiotensin ii angii angiotensin <NUMBER> vasodilator <NUMBER> <NUMBER> angiotensin ii angii peptide hormone bind type <NUMBER> angiotensin ii receptor at<NUMBER> giving place number effects result vasoconstriction therefore increased blood pressure angii also stimulates release aldosterone adrenal cortex kidney promote sodium retention angii produced angiotensin transmembrane protein angiotensinconverting enzyme ace ace<NUMBER> discovered <NUMBER> <NUMBER> ace<NUMBER> may also convert angiotensin angiotensin <NUMBER> <NUMBER> prothrombotic activity <NUMBER> ras system acts homeostatic regulator blood pressure fluid electrolyte balance vascular resistance well function several organs fundamental role health disease complexity whole system complicated systemic local tissuespecificity includes wide range molecules different biological actions including alternative ang ii receptor angiotensin type <NUMBER> receptor at<NUMBER>r masrelated gproteincoupled receptor metabolites like aldosterone ang iii ang iv etc <NUMBER> simplistic way conventional consider aceangiiat<NUMBER>r ace<NUMBER>ang<NUMBER> pathways two main axes representing renin angiotensin system signalling ras signalling <NUMBER> discovery enzyme cleaves vasoactive peptide angii soon highlighted possible role treatment hypertension attracting attention also pharmacological applications several observations experimental evidence suggested beneficial role ace<NUMBER> diseases cardiovascular disfunctions <NUMBER> <NUMBER> ace<NUMBER> also essential expression neutral amino acid transporters influencing composition gut microbiota <NUMBER> ace<NUMBER> shown increase number pathologies including myocardial infarction <NUMBER> atherosclerosis <NUMBER> renal diseases <NUMBER> diabetes <NUMBER> <NUMBER> liver cirrhosis <NUMBER> inflammatory lung injuries <NUMBER> <NUMBER> studies general protective role enzyme inhibiting angiaceangii axis ras discussed <NUMBER> overwhelming scientific production field also reports spread role ace<NUMBER> increase antiinflammatory antioxidant agent several tissues lungs <NUMBER> liver <NUMBER> <NUMBER> neuroprotection <NUMBER> also atherosclerosis cerebral ischemia obesity chronic kidney disease asthma indeed induces cytokins depletion antiproliferative effects antifibrosis antihypertrophy effects <NUMBER> addressing key action role target therapies inflammatory diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> considered protecting predisposition acute respiratory distress syndrome ards <NUMBER> also demonstrated sarscov infection decrease due interaction virus favours syndrome <NUMBER> indicates reduction pulmonary ace<NUMBER> activity also contributes pathogenesis lung inflammation accompanied expression cytokins cooperate direct effects viral infection example among many loss ace<NUMBER> function mouse shows release proinflammatory chemokines cxc motif chemokine <NUMBER> cxcl<NUMBER> macrophage inflammatory protein<NUMBER> mip<NUMBER> cxc motif chemokine <NUMBER> kc tnfα airway epithelia increased neutrophil infiltration exaggerated lung inflammation injury <NUMBER> interesting smog nicotins also favour lung inflammation increasing ace activity therefore affecting ace<NUMBER> functionality <NUMBER> need reduce negative effects aceangiiat<NUMBER>r axis launched series therapeutic approaches aiming amplify ace<NUMBER>ang<NUMBER> axis ace inhibitors at<NUMBER>r blockers mineralocorticoid receptor blockers mrb pioglitazone ibuprofen <NUMBER> included reported direct effects suppression aceang iiat<NUMBER>r axis often increasing ace<NUMBER> ang <NUMBER> significantly <NUMBER> contrast inhibitory effects ace<NUMBER>ang<NUMBER> axis glucocorticoids <NUMBER> hand substances usually considered dangerous treatments negative effects ace<NUMBER> levels discovery role ace<NUMBER> membrane receptor sarscovs sarscov<NUMBER> raises controversial opinions concerning effect medical treatments facilitating virus infection human body comorbidity covid<NUMBER> several diseases like hypertension diabetes <NUMBER> conventional pharmacological treatments also consideration hypotheses therefore put forward especially social media suggest potential adverse effects angiotensin converting enzyme inhibitors acei angiotensin receptor blockers arbs sartans covid<NUMBER> action ras pathway also provoked justified alarmed recommendations different scientific societies <NUMBER> underlined lack evidence acei arb medication httpwwwnephjccomnewscovidace<NUMBER> however scientific evidence concerning effects pharmacological treatments acting ras signalling system available animals <NUMBER> <NUMBER> <NUMBER> <NUMBER> also human tissues treatments <NUMBER> reason careful analysis previous results help clarify possible relationships medical treatments predisposing covid<NUMBER> effort aimed depict main pathways determining infection sarscov<NUMBER> human body molecular framework establishment molecular model emerged represents ras signalling system components possible links sarscov<NUMBER> infection mediated transmembrane protein ace<NUMBER> <NUMBER> ace<NUMBER>m figure <NUMBER> documented solid lines well hypothetical edges dashed lines network inferred public available scientific research reported effects ace<NUMBER> shedding <NUMBER> andor internalization <NUMBER> mediated at<NUMBER>r one two receptor angotensin ii also shown ace<NUMBER> shedding determined cleavage ectodomain release plasma <NUMBER> producing free ace<NUMBER> ace<NUMBER>p alternative route represents ace<NUMBER> internalization <NUMBER> ectodomain supposed imported cell inhibiting functioning outside membrane producing indicated internalized ace<NUMBER> ace<NUMBER>i processes reported mediated at<NUMBER>r blocked arbs case at<NUMBER>r blockage eventually pharmacological treatments two routes working figure <NUMBER> panels b c model also includes spriming required entry sarscov<NUMBER> human cells <NUMBER> action described cytokins il<NUMBER> tgf beta <NUMBER> favouring limiting intracellular production cathepsins respectively <NUMBER> model represents documented role ace<NUMBER> levels triggering antiinflammatory response case high expression inhibiting <NUMBER> <NUMBER> possible connections lung severe damages also shown <NUMBER> figure <NUMBER> summarize effects treatments ras molecules resulting experimental studies animal <NUMBER> human tissues <NUMBER> molecules levels terms concentration activity reported table <NUMBER> interestingly results reported highlight treatments sartans alone combination ace inhibitors determine high activity ace<NUMBER> treatments ace inhibitors determine changes ace<NUMBER> activity colours figure <NUMBER> highlight differential levels molecules black corresponding control reported red high blue low solid red lines indicate favoured routes emerge case sarscov<NUMBER> presence possible pathways red routes inferred based molecule concentrations respective condition green boxes clinical parameters collected investigated disease progress monitoring since value could affected viral infection occurring example monitoring ang<NUMBER> angii levels could reveal activity ace<NUMBER> ras signalling pathways together ace<NUMBER>p levels cov<NUMBER>ace<NUMBER>p ace<NUMBER>p plasma bound virus levels could depict extent virus upload result high risk low risk medical treatments well disease development could traced appropriately timely configuring individual predisposition progress clinical conditions study inspired confirmed one covid<NUMBER> case naples sixty three years old man therapy hypertension treated reaptan aceinhibitor dosage set overweight man <NUMBER>kg man diet last year till reached <NUMBER>kg medical treatment showing weakness dosage reduced couple days discovered positive covid<NUMBER> declared positive man suggested change treatment using valsartan courtesy direct personal communication disease manifested mild fever nausea man fully recovered <NUMBER> days waiting negative confirmatory tests long term overdosage aceinhibitor treatment limited sarscov<NUMBER> virulence single case patient reported two main reasons clearly depicted model first virus attack hampered reduced ace<NUMBER> availability known triggered medical treatment <NUMBER> provoked decrease number viral sdomain receptors ace<NUMBER>m cell membranes therefore limiting viral entry cells second case shedding <NUMBER> would occurred favoured availability at<NUMBER>r blocked medical treatments ace<NUMBER>m cleaved released form soluble molecule acep thus increasing amount circulating sarscov<NUMBER> receptor domain plasma sarscov<NUMBER> replication blocked soluble forms ace<NUMBER> <NUMBER> hypothesize ace<NUMBER>p plasma sequesters sarscov<NUMBER> reduces probability viral internalization human cells conferring additional protection viral infection proactive compounds based administering individuals free ace<NUMBER> medical treatment already proposed limiting viral cellular invasion <NUMBER> <NUMBER> hence prolonged exclusive use aceinhibitors avoidance at<NUMBER>r blockade arbs sartans could exerted combine treatment could provided higher protection virus invasion patient later administering medical treatments based sartans inappropriately suggested fortunately affect milder progress disease favoured successful recovery highly probable due initial limited viral infection lack ace<NUMBER> cell receptors conferred overdosage treatment based aceinhibitors monitoring free ace<NUMBER>p soluble ace<NUMBER> bound viruses ace<NUMBER>v together angii ang<NUMBER> levels aldosterone positive patients appropriate clinical trial could support proposed hypothesis associated current screening monitoring disease predisposition testing unfortunately patient could monitored based parameters emergency status italy many information fight covid<NUMBER> inferred scientific efforts public biological databases thanks studies previous epidemic coronaviruses main effort exploit knowledge define sarscov<NUMBER> pathways infecting human body molecular bases considering risk factors related specific treatments molecular model elucidates relationships ras signalling sarscov infection including additional routes inferred based scientific evidence levels involved molecules estimated considering six different experiments related treatments hypertension animals <NUMBER> <NUMBER> <NUMBER> <NUMBER> human tissues treatments <NUMBER> results associated model highlight infection risk prone protective medical interventions case arbs sartans ace inhibitor treatments model reveals arbs alone combined treatments confer increased ace<NUMBER> activity cell membranes results higher risk viral infection contrast aceinhibitors combined arbs appear exert twoway protective role decreasing ace<NUMBER>m cell membranes increasing ace<NUMBER>p plasma thus offering possible alternative medical treatments hypertension one evidence positive fast recovering patient surely enough prove hypothesis evidence inspired encourage clinical trials appropriate statistics still lacking urgently required suggesting example monitoring ras metabolites free virus boundace<NUMBER> plasma could provide crucial information answer questions disease predisposition progress mechanisms affected viral infection approaches could associated screening diagnostic monitoring surely highlight novel opportunities example confirming administering efficacy ace<NUMBER> ace<NUMBER>like molecules prevent viral invasion organism data would also provide evidence convince mainstream beliefs evidence shown hardly accept model driven knowledge good news alternatives hypertension treatments suitable medical guideline could fast adopted based recommendations pertinent medical societies attention also focus monitoring covid<NUMBER> propensities diseases treatments trigger ace<NUMBER> increase therefore predisposing critical progress viral infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> parallel careful studies also consider covid<NUMBER> progress cases decreased ace<NUMBER> content occurs ards included <NUMBER> <NUMBER> beyond supportive presented model studies could also reveal additional pathways infection expanding current knowledge paving way novel investigations low ace<NUMBER> levels principle depress risk viral invasion since depletion viral receptor binding sites hand one keep consideration predispositions indeed revealed occurrence injuries triggered negative action ace<NUMBER>ang<NUMBER> axis ras signalling questions therefore arise play major role viral attack decrease viral receptor binding site presence preceding injuries medical care provided overcome injuries poor ace<NUMBER> content world health organization communicated sars typically attacks lungs three phases viral replication immune hyperreactivity pulmonary destruction httpswwwnationalgeographiccomscience<NUMBER>hereiswhatcoronavirusdoestothebody scientific evidence however highlights distribution sarscovs receptor ace<NUMBER> strictly correlate sarscovs cell tropism lungs expression patterns distribution different organs tissues molecules triggering viral entry <NUMBER> revealed virus could enter cells tongue <NUMBER> thanks copresence ace<NUMBER> proteases favouring spriming triggering initial immune response release specific cytokines il<NUMBER> could also cooperate spriming <NUMBER> remarkably il<NUMBER> tgfbeta<NUMBER> appears overproduced covid<NUMBER> patients <NUMBER> <NUMBER> evidence inflammatory response could also contribute viral entry highlights intriguing cooperative mechanism alarming scenario viral mechanisms infection evolution spreading infection lung cells could vascular system modulated patient predisposition ie ace<NUMBER> levels cell membranes along vascular endothelium <NUMBER> individual capability mount appropriate immune response initial lung disturb presumably due viral destruction lung infected cilia cells like sars produce necrotic cells shed onto luminal surface epithelium contributing less reactive tissue response <NUMBER> critical development disease depends additional conditions predisposing effects eventually due previous injuries inflammatory status preceding pharmacological treatments erroneous pharmacological treatments initial stage infection <NUMBER> <NUMBER> could facilitate virus fast spreading accompanied advantageous environment emerging side effects caused infection example ace<NUMBER> depletion injuries increased inflammation starting infection mouth secondary attack lungs via vascular transportation also suggested evidence early bilateral lung injuries highlighted computational tomography radiography images acute severe pneumonia result depletion ace<NUMBER> content cell membranes noticeable creating damages delayed mounting adaptive immune response <NUMBER> contributing alveoli engulfment due excessive innate response could furthermore justify emergency aged population could mount slower response putatively reduced leukocytes levels subsequent organ failure could facilitated initial higher ace<NUMBER>m content many key tissues <NUMBER> depleted viral attack organ failure also triggered infection mediated increase dangerous components aceangii axis ras signalling consequent cascades events cause typical effects like cardiovascular kidney injuries kidney high content ace<NUMBER> physiological conditions reninaldosterone branch part ras system playing role organ failure also linking aldosterone levels disease propensity also explains men disease prone women <NUMBER> comes evident number death number cases per sex male <NUMBER> female <NUMBER> reported disease statistics march <NUMBER> <NUMBER> httpswwwworldometersinfocoronaviruscoronavirusagesexdemographics concurrent events added severe cytokine storm damaging lung tissues causing hypoxia hypoxia main aspect today faced emergency hospitals medical intervention cytokines storm reduce acute respiratory distress syndrome need carefully targeted avoid immune depression consequent infection secondary pathogens although immune depression predisposing factor disease attention also focused avoiding medical treatments could increase ace<NUMBER>m content aim decrease inflammation <NUMBER> <NUMBER> relevant molecular connections elucidated proposed model accompanied depicting possible routes infection based scientific evidence analysis expression pattern per tissue main proteins involved viral entry public biological databases research also teaching although severe pandemy expected useful information available possible preparative actions suggested least since <NUMBER> <NUMBER> ready one example comes evidence infection connected ras signalling still lack appropriate trials investigate hypertension parameters risk assessment disease progress monitoring lack public digitalized data diagnostics hospitals medical surveillance home covid<NUMBER> positive patients manifest severe disease also evident shared tools diagnostics coordinated intervention fixed soon emergency must faced proper instruments working fight disease vaccine development adopting new repurposed antiviral medicines limit virus attack must also use knowledge disposal treat patients risk dying collecting data understanding disease includes primarily urgently implement evidencebased science driven approaches could efficiently accompany front line hospitals facing emergency implementation diagnostics methods medical treatments tools based monitoring individual clinical conditions setup appropriate intervention targeted groups patients profit joint action proactive scientific community support stakeholders really hope alerting foster actions table <NUMBER> report take home messages gained presented analysis covid<NUMBER> model presented dedicated website framework letsbe lets ready transdisciplinary initiative make scientific knowledge understandable accessible interested community conscious current fight prepared next information possible interest giving contribution please subscribe httpbigdatainhealthorgletsbe table <NUMBER> summary main evidence derived work presence ace<NUMBER> associated proteins favouring viral entry oral tissues suggests initial infection could arise preferentially mouth favoured clinical conditions arrested efficient immune response would spread lung vascular system provoking cytokine storm fatal infection lung tissues mediated previous concurrent medical treatments predisposition might enhance fast engulfment alveoli due response innate immune system accompanied cooperative effect misfunctioning ace<NUMBER>ang<NUMBER> axis ras signalling system contributes inflammatory response anymore protecting lungs injuries increase ace<NUMBER> content could favour viral invasion evidence ace<NUMBER> increase found scientific literature mineralocorticoid receptor blockers mrb ibuprofen arbssartans substances could sequester inactivate molecules reduce ace<NUMBER> content example at<NUMBER>r sequestering arbs sartans increases ace<NUMBER> content cell membranes substances could favour shedding internalization ace<NUMBER>m could decrease viral infection rate although side effects due decreased functioning ace<NUMBER>ang<NUMBER> ras signalling axis exclusive treatments aceinhibitors accompanied arbs sartan treatments could exert protective effect targeted actions based deep diagnostics reduce cytokine overload using general antiinflammatory treatments provided since cytokines appears favour others inhibit viral infection examples reported model provided figure <NUMBER> information cytokines average content covid<NUMBER> patients critical dead available wuhan patients sarscov previous pandemic diagnostic parameters could useful traced per patient could provide relevant information treatments investigations disease progression inappropriate treatments could favour attacks secondary pathogens eg decreasing cytokins inappropriate treatments could favour viral invasion eg increasing ace<NUMBER> content ace<NUMBER> levels increase number pathologies reviewed predispose infection high risk low risk treatments viral infection shown aresults vitro experiments human tubular cell lines hk<NUMBER> performed analyse response increasing dosages ang ii <NUMBER> show upregulation ace mrna ace well encoded protein ace reducing ace<NUMBER> ace<NUMBER>m content respectively bexposure losartan at<NUMBER>r blocker arb resulted decreased ace levels mrnas proteins increase ace<NUMBER> mrna protein results treatments sartans rats <NUMBER> revealed increased ace<NUMBER> ace<NUMBER> indicating high ace<NUMBER> activity high mrna levels agreement reported human cell lines <NUMBER> similar treatments b c increased mrna levels controllike ace<NUMBER> activity revealed exposure lisinopril ace inhibitor control like ace<NUMBER> mrna expression increased ace<NUMBER> activity resulted combination two treatments noticeable rats medicated lisinopril increased cardiac ace<NUMBER> gene transcription elicit comparable increase ace<NUMBER> activity green boxes parameters would need monitoring appropriate health risk assessments individuals angiotensinconverting enzyme ace homologue ace<NUMBER> discovered <NUMBER> ace related caroxypeptidase inhibited captopril <NUMBER> <NUMBER> ace<NUMBER> firstly shown expressed kidneys normotensive spontaneously hypertensive rat strains <NUMBER> subsequent studies demonstrated downregulation renal ace<NUMBER> three different models hypertension <NUMBER> moreover circulating cardiac levels angiotensin ii atii shown increase ace<NUMBER>null mice ace<NUMBER> principal pathway ang<NUMBER> formation atii ang<NUMBER> protecting excessive activation at<NUMBER> receptor heart tissues however newer findings suggested ace<NUMBER> important element reninangiotensin aldosterone system <NUMBER> following studies ace ace<NUMBER> focused attention researchers contribution diverse human disorders recently new coronavirus <NUMBER>ncov sarscov<NUMBER> outbreak affected people world highlighted role ace<NUMBER> virus <NUMBER> sequence identity severe acute respiratory syndrome sarsrelated coronaviruses sarscovs <NUMBER> sequence identity bat coronavirus remarkably sarscov<NUMBER> shown utilize similar cell entry receptor ace<NUMBER> sarscov <NUMBER> <NUMBER> recent study shown ace<NUMBER>binding pocket sarscov<NUMBER> spike protein receptorbinding domain rbd almost identical one sarscov rbd structural protein modeling led identification amino acid residues sarscov<NUMBER> rbd critical ace<NUMBER> binding notably residues either highly conserved comparable side chain chemical properties sarscov rbd similarity structure amino acid sequence stimulated intensive debate convergent evolution viruses rbds pressure enhanced binding ace<NUMBER> <NUMBER> ace<NUMBER> shown expressed membrane bound protein several human tissues lung intestine heart kidney surface expression protein j u r n l p r e p r f demonstrated ciliated bronchial cells lung alveolar epithelial cells also endothelial cells stated noticeable discovery <NUMBER> moreover recent silico analysis rnaseq profiles verified expression ace<NUMBER> mucosa oral cavity <NUMBER> figure <NUMBER> shows molecular mechanisms initiated sarscovs entry cells significance ace ace<NUMBER> processes ace converts ati atii finally ace<NUMBER> cleaves atii produce at<NUMBER> atii bind at<NUMBER>r initiate inflammation fibrosis lung tissue however binding at<NUMBER> masr inhibits process sarscovs exploits ace<NUMBER> entrance cells transmembrane serine protease tmprss<NUMBER> crucial role activation fusion virus cell membrane moreover furin protease proconvertase physiologically required activate proteins golgi apparatus mediates proteolysis spike protein s<NUMBER> subunit unique feature sarscov<NUMBER> <NUMBER> ace<NUMBER> levels decreased sarscov infected cells leading increase atii decrease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> j u r n l p r e p r f levels based receptor effects proteins mediated at<NUMBER>r masr two alterations synergic effects induction lung fibrosis moreover atii role degradation ace<NUMBER> ubiquitination <NUMBER> sarscovs also enhance expression levels mir<NUMBER>c<NUMBER>p mir<NUMBER> infected cells regarded ace<NUMBER> targeting mirnas <NUMBER> <NUMBER> ace angiotensin converting enzyme acei ace inhibitor angiotensinogen arb angiotensin ii receptor blocker current review discuss expression pattern function ace proteins relation underlying disorders administration certain medications existence common genomic variants within ace genes explain differences response affected individuals sarscov<NUMBER> agreement role ace<NUMBER> virus uptake cells upregulation human ace<NUMBER> increased disease severity mice infected sarscov <NUMBER> moreover injecting sarscov spike mice led downregulation ace<NUMBER> thus aggravating lung injury <NUMBER> <NUMBER> consequently ace<NUMBER> functions cellular receptor sarscov entrance also confers protective mechanism lung injury <NUMBER> based investigations level expression ace<NUMBER> important factor sarscov infection thus comorbid conditions influence expression protein might affect severity disease table <NUMBER> summarizes available data abnormal expression ace ace<NUMBER> human animal disorders several medications shown alter expression levels ace ace<NUMBER> administration medications modify risk infection sarscov also affect disease course table <NUMBER> summarizes results studies reported alteration ace ace<NUMBER> levels following administration certain medications j u r n l p r e p r f several potentially functional gene polymorphisms identified ace ace<NUMBER> table <NUMBER> shows results studies assessed association ace polymorphisms human disorders micorna mirnas regulators gene expression involved several acerelated pathways shown alter expression ace proteins altered ace proteins smallsized rnas bind <NUMBER>′ untranslated region <NUMBER>′ utr targets stimulate degradation target mrna suppress translation moreover mirnas interact <NUMBER>′ utr coding regions promoters thus regulating gene expression various mechanisms secretion mirnas extracellular components provides ability participate cellcell communication <NUMBER> table <NUMBER> shows results studies assessed association mirnas ace proteins hand metaanalysis reported association administration ace inhibitors reduction risk pneumonia notably ace inhibitors may efficient reducing risk pneumonia asian patients also treatment ace j u r n l p r e p r f inhibitors associated significant reduction risk pneumoniarelated mortality compared controls <NUMBER> may also related dual effect ace<NUMBER> viral infection protection acute respiratory distress syndrome although aceace<NUMBER> regulation complicated seems absence ace accumulation angiotensin may lead upregulation ace<NUMBER> whether could facilitate viral infection plausible ace<NUMBER> considered specific target coronavirus treatment <NUMBER> means populationbased differences ace<NUMBER> expression may affect efficacy future antiviral treatment brief summarize coronaviruses sarscov sarscov<NUMBER> utilize ace<NUMBER> receptor cell entry infection know severe consequence expression addition routine models investigation pathological events infections tissue engineering methods particularly advanced biomaterials functionalized scaffolds <NUMBER> would provide study models investigate potential approaches treatment disorder advance field functional studies obtained results safe invitro models work without additive applied human models <NUMBER> taken together data presented show diversity factors modulate ace angiotensin ii type <NUMBER> receptor <NUMBER> r <NUMBER> fig <NUMBER> ang ii signaling <NUMBER> r mediates effects vasoconstriction inflammation fibrosis whereas <NUMBER> r activation opposing effects vasodilation antiinflammatory response antifibrosis effects <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> homolog ace distinct enzyme active sites key counterregulatory enzyme degrades ang ii ang<NUMBER> thereby attenuating effects vasoconstriction sodium retention inflammation fibrosis mas receptor <NUMBER> ace<NUMBER> also cleaves angiotensin angiotensin<NUMBER> <NUMBER> effects ace<NUMBER> suppressed ace inhibitors aceis <NUMBER> normal physiological conditions activities aceang iiat <NUMBER> r axis ace ang iiat <NUMBER> r axis ace<NUMBER>ang<NUMBER>mas receptor axis dynamic equilibrium state maintaining normal function corresponding system <NUMBER> aceis <NUMBER> r blockers arbs inhibit aceang iiat <NUMBER> r pathway also modulate aceang iiat <NUMBER> r pathway ace<NUMBER>ang<NUMBER>mas receptor pathway <NUMBER> previous studies revealed cellspecific expression pattern ace<NUMBER> multiple organs ace<NUMBER> broadly expressed heart kidneys intestine well alveolar epithelial cells lungs principal target main site injury caused sarscov<NUMBER> <NUMBER> normal conditions ace<NUMBER> expression lungs lower organs including heart kidneys intestine <NUMBER> degree expression biological relevance ace<NUMBER> may vary depending tissue clinical state functional role ace<NUMBER> lungs appears relatively minimal normal conditions <NUMBER> ace<NUMBER> may upregulated certain clinical states probably organ protection shown experimental models ace<NUMBER> upregulated relatively high doses aceis arbs heart kidneys arteries leading organ protection <NUMBER> however evidence always consistent among diverse ras inhibitors distinct organs <NUMBER> tannosobetsu study japanese populationbased cohort previously showed urinary level ace<NUMBER> derived mainly kidneys significantly higher hypertensive patients treated olmesartan arb <NUMBER> year untreated control subjects patients treated calcium channel blockers including amlodipine longacting nifedipine acei enalapril arbs including losartan candesartan valsartan telmisartan <NUMBER> finding suggests olmesartan uniquely increases renal expression urinary excretion ace<NUMBER> potentially leading additional renal protection via pleiotropic effects however data showing effects ras inhibitors including aceis arbs expression ace<NUMBER> lungs lacking experimental animal models humans similar entry receptor sarscov sars sarscov<NUMBER> covid<NUMBER> invades host ace<NUMBER> host cellular receptor viral spike protein <NUMBER> fig <NUMBER> therefore expression distribution ace<NUMBER> key determinants coronavirus entry cells two distinct mechanisms sarscov<NUMBER> infection reported endocytosis ace<NUMBER>binding sarscov<NUMBER> entry <NUMBER> <NUMBER> transmembrane protease serine <NUMBER> tmprss<NUMBER>mediated cleavage sarscov<NUMBER> accompanied ace<NUMBER> <NUMBER> <NUMBER> fig <NUMBER> given ace<NUMBER> receptor allows coronavirus entry cells pretreatment ras inhibitors aceis arbs might modulate sarscov<NUMBER> infection development lung injury organ damage caused virus reported sarscov infection sars reduces ace<NUMBER> expression resulting lung injury via imbalance aceang iiat <NUMBER> r axis ace<NUMBER>ang<NUMBER>mas receptor axis <NUMBER> addition exposure sarscov spike protein mouse model induced acute lung injury rescued losartan arb <NUMBER> indicating activation aceang ii <NUMBER> r pathway involved lung injury also shown dysregulation ace<NUMBER> mediates acute lung injury mouse models infection viruses influenza virus respiratory syncytial virus <NUMBER> furthermore continued viral infection replication contribute reduced membrane ace<NUMBER> expression cultured cells <NUMBER> initial engagement sarscov<NUMBER> spike protein subsequent downregulation ace<NUMBER> abundance cell surfaces seen sarscov <NUMBER> conditions ace<NUMBER> converts ang ii angiotensinconverting enzyme ace converts angiotensin ang angiotensin ii ang ii ang ii signaling leads organ damage lung injury promoting inflammation fibrosis ang ii type <NUMBER> receptor <NUMBER> r opposing effects ang ii type <NUMBER> receptor <NUMBER> r angiotensinconverting enzyme <NUMBER> ace<NUMBER> converts ang ii ang<NUMBER> ang ang<NUMBER> ang<NUMBER> signaling attenuates effects inflammation fibrosis mas receptor masr suggested ace<NUMBER> upregulated ace inhibitors aceis <NUMBER> r blockers arbs ace<NUMBER> also receptor severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> ace<NUMBER>binding sarscov<NUMBER> internalized endocytosis cell membraneanchored ace<NUMBER> cell surface downregulated downregulation ace<NUMBER> promotes organ damage activation aceang iiat <NUMBER> r pathway deactivation ace<NUMBER>ang<NUMBER>masr pathway another mechanism sarscov<NUMBER> infection transmembrane protease serine <NUMBER> tmprss<NUMBER>mediated cleavage sarscov<NUMBER> accompanied ace<NUMBER> ace<NUMBER> also shed membrane disintegrin metalloproteinase <NUMBER> adam<NUMBER> soluble form ace<NUMBER> may intercept virus binding membraneanchored ace<NUMBER> cell plasma membrane possible increases expression soluble form ace<NUMBER> induced ras inhibitors would beneficial effects protection lung injury organ damage infection sarscov<NUMBER> ang<NUMBER> unable exert protective effects organs reported ang ii levels higher patients covid<NUMBER> n <NUMBER> healthy controls n <NUMBER> elevated plasma ang ii levels correlated total viral load degree lung injury <NUMBER> data regarding effects ras inhibitors lungspecific expression ace<NUMBER> lacking however even ras inhibitors modify expression ace<NUMBER> lungs possibility facilitation greater engagement entry sarscov<NUMBER> spike protein sarscov<NUMBER> infection conversely possible increase ace<NUMBER> expression induced ras inhibitors would protect lung injury organ damage covid<NUMBER> inhibiting downregulation ace<NUMBER>induced activation aceang iiat <NUMBER> r pathway fig <NUMBER> clinical trials currently underway test safety efficacy several arbs including losartan clinicaltrialsgov number nct<NUMBER> nct<NUMBER> nct<NUMBER> valsartan nct<NUMBER> telmisartan nct<NUMBER> patients covid<NUMBER> hand ace<NUMBER> membranebound enzyme distinctly shed membrane disintegrin metalloproteinase <NUMBER> adam<NUMBER> soluble form ace<NUMBER> exists body fluids <NUMBER> fig <NUMBER> pathological states shedding ace<NUMBER> increased resulting elevated soluble ace<NUMBER> levels blood urine body fluids <NUMBER> suggested soluble recombinant ace<NUMBER> protein intercepts virus binding membraneanchored ace<NUMBER> cell plasma membrane <NUMBER> restoration ace<NUMBER> administration recombinant ace<NUMBER> reported reverse lung injury mouse models viral infections <NUMBER> furthermore treatment recombinant human ace<NUMBER> safely reduced ang ii levels patients acute respiratory distress syndrome <NUMBER> clinical trials test whether administration recombinant ace<NUMBER> protein may beneficial restoring balance ras network potentially preventing organ injury also arranged patients covid<NUMBER> nct<NUMBER> nct<NUMBER> possible induction ace<NUMBER> lungs ras inhibitors would result increased soluble ace<NUMBER> may beneficial effect protection membraneanchored ace<NUMBER>mediated infection sarscov<NUMBER> fig <NUMBER> lack evidence still concerns increased risk sarscov<NUMBER> infection worsening lung injury covid<NUMBER> patients receiving ras inhibitors however withdrawal ras inhibitors switching ras inhibitor therapy another antihypertensive therapy may require careful followup avoid unstable control blood pressure clinical trials currently underway evaluate effects continuation nct<NUMBER> switching nct<NUMBER> discontinuation nct<NUMBER> nct<NUMBER> aceis arbs covid<NUMBER> patients based currently available evidence multiple societies specialty announced administration ras inhibitors continued stable hypertensive patients risk evaluated covid<NUMBER> <NUMBER> interestingly reported covid<NUMBER> patients hypertension receiving ras inhibitor acei arb n <NUMBER> significantly lower peak viral load sarscov<NUMBER> cells covid<NUMBER> patients receiving ras inhibitor n <NUMBER> <NUMBER> retrospective multicenter study hubei china unadjusted mortality rate significantly lower covid<NUMBER> patients hypertension taking acei arb n <NUMBER> <NUMBER> taking acei arb n <NUMBER> <NUMBER> <NUMBER> furthermore mixedeffect cox model adjustment age sex comorbidities inhospital medications showed risk allcause mortality lower group patients treated acei arb group patients treated acei arb <NUMBER> hand according report new york city area mortality rates patients hypertension taking acei arb n <NUMBER> taking acei n <NUMBER> taking arb n <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively though results unadjusted known confounders including age sex race ethnicity socioeconomic status comorbidities <NUMBER> detailed investigations using large number patients regarding ras inhibitors covid<NUMBER> need addressed conflict interest authors declare conflicts interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations clinical considerations patients diabetes times covid<NUMBER> pandemic dear sir todays reports global number confirmed cases covid<NUMBER> surpassed <NUMBER> number known cases increasing several thousand every day march <NUMBER> <NUMBER> publicly characterized covid<NUMBER> pandemic issue serious concern deserves momentous attention coronaviruses family viruses cause respiratory illnesses cause illness animals seven known types coronaviruses cause illness humans coronavirus sarscov<NUMBER> severe acute respiratory syndromecoronavirus<NUMBER> one viruses e causes illness currently known coronavirus disease<NUMBER> covid <NUMBER> though still learning exactly puts someone greater risk developing severe illness covid<NUMBER> early information indicates older patients chronic medical conditions hypertension diabetes cardiocerebrovascular diseases may higher risk <NUMBER>e<NUMBER> infection caused covid<NUMBER> likely disturb metabolic regulation diabetic patients covid<NUMBER> may face altered immune response background already compromised health status owing diabetesrelated complications andor aging important findings patients hyperglycemia viral infection significant worsening symptoms implies greater morbidity patients compared without diabetes <NUMBER> however pathophysiology association remains uncertain known whether hyperglycemia changes virulence infection virus modifies glycemic metabolism know diabetic patients susceptible infection impact glucose metabolism <NUMBER> dm disorder glucose metabolism chronic inflammatory condition characterized multiple changes lipid carbohydrate protein profiles <NUMBER> inflammatory processes due hyperglycemia leads increased synthesis glycosylation end products ages activates macrophages cells immune system increase oxidative stress promote synthesis proinflammatory cytokines besides stimulating synthesis adhesion molecules facilitate inflammation tissues <NUMBER> inflammatory process complications might provide higher propensity infections greater severity conditions another important issue inflammatory immune response occur diabetic patients acquire viral infection well whether virus interferes insulin secretion glycemic control stage biological mechanism relationship covid<NUMBER> diabetes known association severity cases death pronounced need develop hypothesis explain causal path underlying severe clinical presentation covid<NUMBER> infection subsequent death diabetic patients biochemical tests also essential clarify molecular pathophysiology involved association covid<NUMBER> dm substantial public health importance deserves proper attention since large diverse population affected globally nowadays comorbidity poses relevant threat human health prospective welldesigned studies elucidate biological mechanism best clinical management association urgently needed useful see review published journal diabetes covid <NUMBER> infection <NUMBER> highlight people diabetes death rate perhaps around four times background population note suggested <NUMBER>e<NUMBER> deaths chinawuhan people diabetes <NUMBER> clearly important understand confounders form associations risk factors dying covid<NUMBER> infection notably age cardiovascular disease cannot explain excess need understand better mitigate risk reported deaths occurring context pneumonitis <NUMBER> <NUMBER> particularly onset adult respiratory distress syndrome ards condition excess fluid alveoli blocks gas exchange air blood people diabetes many cardiovascular disease cvd without diabetes permeable vasculature identified since <NUMBER>s albumin lead kidneys microand macroalbuminuria even prior late blush retina intravenous fluorescence marker injection <NUMBER> leaky vasculature associated vascular inflammation metabolic syndrome steatohepatitis well cvd per se would seem far stretch absence research yet assume prior enhancement vascular permeability could account increased rate ards death people diabetes particularly type <NUMBER> diabetes also cvd aside research would suggest already albuminuria routine yearly test people diabetes higher liver enzyme markers alt perhaps diabetes associated dyslipidaemia low hdl cholesterol take particular steps selfisolate unclear fast vascular inflammation ameliorated improved blood glucose control nearly glucoselowering medications reduce microalbuminuria time tight glucose control infected persons insulin would meanwhile seem sensible poor glucose control known interfere leukocytelymphocyte function <NUMBER> dear editor recently published article highlighting special concerns managing patients diabetes times covid<NUMBER> pandemic <NUMBER> concerns use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arbs clarified publication <NUMBER> summarising current evidence regard try arrive reasonable conclusion absence vaccine antiviral drug covid<NUMBER> infection several therapeutic approaches studied one approach use inhibitors renin angiotensin system namely ace inhibitors arbs hand concern raised fact patients agents might increased risk infection severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor sars cov<NUMBER> well coronaviruses expressed type <NUMBER> alveolar epithelial cells endothelium sglycoprotein surface coronavirus binds ace<NUMBER> leads conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> ultimately leading internalization virion <NUMBER> viral sglycoprotein tmprss<NUMBER> ace<NUMBER> inhibition potential targets therapy possibly vaccine development ace<NUMBER> essential coronavirus infection blockade thought beneficial preventingtreating infection retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors <NUMBER> mice coronavirus induced lung injury showed improvement treated losartan <NUMBER> far cvid<NUMBER> infection concerned data ras activation effect blockade limited present hypokalaemia could marker ras activation high incidence hypokalaemia reported patients covid<NUMBER> infection <NUMBER> despite small studies suggesting benefit drugs acting ras data albeit scarce animal models human studies treatment ace inhibitors arb could cause regulation ace<NUMBER> <NUMBER> ibuprofen thiazolidinediones also shown <NUMBER> <NUMBER> increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however currently evidence support hypothesis view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension <NUMBER> <NUMBER> humanity trying understand coronavirus disease<NUMBER> time severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection overcomes frontiers spreads world four human infecting species coronavirus hcov<NUMBER>e hcovoc<NUMBER> hcovnl<NUMBER> hcqvhku<NUMBER> already known causative agent cold pneumonia viral family responsible sarscov middle east respiratory syndrome merscov outbreaks consequences species emerged wuhan china far catastrophic sarscov<NUMBER> infection depends viral polyprotein processing event catalysed main proteinase mpro also known <NUMBER>clpro since mpro unique virus found host cells protein prominent target development antivirals coronavirus infections <NUMBER> recently solution sarscov<NUMBER> mpro tridimensional structure allowed investigation potential inhibitors viral replication mpro composed three domains ichymotrypsin iipicornavirus <NUMBER>c proteaselike iiiglobular cluster involved protein dimerisation crystallography structures indicate region domains ii protein activity inhibition region contains catalytic cysteine <NUMBER> crystal structure sarscov<NUMBER> mpro published zhang et al <NUMBER> selected list existing antivirals drugs <NUMBER> compounds protease inhibitors <NUMBER> compounds drugbank database <NUMBER> ligands drugbank database used larger screening evaluating <NUMBER> compounds randomly selected crystal protein structure pdb <NUMBER>y<NUMBER>e energyminimised using mmtk package chimera version <NUMBER> <NUMBER> silico molecular docking ligand selection performed using pyrxvirtual screening tool consisting autodock <NUMBER> autodockvina <NUMBER> pyrxvirtual screening tool used docking protocol sarscov<NUMBER> mpro protein structure pdb <NUMBER>y<NUMBER>e checked missing atoms bonds contacts removal water molecules energy minimisation done following parameters force field amber ff<NUMBER>sb steepest descent steps <NUMBER> steepest descent step size <NUMBER> å conjugate gradient steps <NUMBER> conjugate gradient step size <NUMBER> å using molecular modelling toolkit mmtk package chimera version <NUMBER> <NUMBER> minimised structure used receptor docking analysis ii minimised structure saved pdb file imported pyrx software iii ligands imported pdb format well autodock tools module used generate pdbqt input files iv autodock vina algorithm used perform docking selected ligands autodock vina grid box set cover active site mpro following dimensions å centre x z <NUMBER> <NUMBER> <NUMBER> dimensions x z <NUMBER> <NUMBER> <NUMBER> docking simulation run exhaustiveness eight docking results evaluated using lowest binding affinity score kcalmol predicted build scoring function autodock vina module results showed <NUMBER> molecules scores <NUMBER> mpro partners supplementary data table due urgency providing therapeutics patients focus analysis commercially approved drugs argatroban blood clotting linagliptin diabetes saquinavir antiviral edoxaban blood clotting apixaban blood clotting cilazapril ace inhibitor betrixaban blood clotting alogliptin dipeptidyl peptidase <NUMBER> inhibitors sitagliptin dipeptidyl peptidase <NUMBER> inhibitors ramipril ace inhibitor lopinavir antiviral saxagliptin diabetes indinavir antiviral zofenopril ace inhibitor nelfinavir antiviral quinapril ace inhibitor dihydroergotamine antimigraine agents risperidone atypical antipsychotics astemizole antihistamine presented higher scores fig <NUMBER> list includes antiviral components expected drugs classified coagulation modifiers <NUMBER> ace inhibitors <NUMBER> lin et al <NUMBER> propose pathogenic mechanism disease based clinical evidence studies coronavirus strains divide clinical phase viraemia phase acute phase recovery specific effects covid<NUMBER> cardiovascular system remain unclear though reports acute cardiac injury arrhythmias hypotension tachycardia high proportion concomitant cardiovascular disease infected individuals particularly require intensive care <NUMBER> also signs coagulopathy many patients usually associated death <NUMBER> among coagulation modifiers argatroban direct thrombin inhibitor <NUMBER> prophylaxis treatment thrombosis patients heparininduced thrombocytopenia three compounds edoxaban apixaban betrixaban bind factor xa <NUMBER> edoxaban used prevent stroke systemic embolism patients atrial fibrillation <NUMBER> apixaban indicated control recurrence thromboembolic events stroke patients nonvalve atrial fibrillation betrixaban inhibits free prothrombinase bound factor xa concentrationdependent manner <NUMBER> <NUMBER> betrixaban potent inhibiting thrombinantithrombin complex <NUMBER> superposing sarscov<NUMBER> mpro factor xa thrombin structures presents rmsd value <NUMBER>ᾰ <NUMBER>ᾰ respectively low values indication fold similarity fig <NUMBER>ab thrombin known target argabotran serine protease <NUMBER> mpro protease leugln↓seralagly recognition sequence <NUMBER> similarity may indicate direct perturbation proclotting coagulation covid<NUMBER> mpro protein fact changes proclotting factors covid<NUMBER> patients already detected showing significant decreased antithrombin values increased ddimer fibrinfibrinogen degradation products fdp fibrinogen fib <NUMBER> additionally gradual progression disease severity mirrored increasing values ddimer fdp pattern might indicate activation coagulation system due throm bosis disseminated intravascular coagulation dic <NUMBER> heparin anticoagulant therapy associated better prognosis patients <NUMBER> also risk developing dic due sarscov<NUMBER> infection obvious negative impact prognosis <NUMBER> <NUMBER> previously speculated <NUMBER> moreover excessive activation fibrinolysis may observed cardiopulmonary bypass also leading dic haemorrhage <NUMBER> feasibility robustness interactions strengthened comparing docking results thrombin interaction argatroban corresponding crystallographic structure deposited code <NUMBER>hfp structures present rmsd <NUMBER>ᾰ indicating docking experimental structures almost identical fig <NUMBER>c addition comparison docking results factor xa interaction apixaban corresponding crystallographic structure deposited code <NUMBER>p<NUMBER> present rmsd <NUMBER>ᾰ also corroborates assertiveness approach fig <NUMBER>d finally important highlight score thrombin interaction argatroban <NUMBER> kcalmol <NUMBER> kcalmol sarscov<NUMBER> mpro otherwise apixaban interaction factor xa presents score <NUMBER> kcalmol <NUMBER> kcalmol sarscov<NUMBER> supplementary data table preliminary evidence argatroban affinity thrombin apixaban tends affinity sarscov<NUMBER> mpro also performed fold similarity investigation ace inhibitors aceis mpro high rmsd values <NUMBER> ᾰ <NUMBER> ᾰ ace receptors structures deposited codes <NUMBER>x<NUMBER> <NUMBER>ewb respectively indicate low structural conservation among proteins also use ace inhibitors contributes upregulation ace<NUMBER> expression <NUMBER> <NUMBER> even potential target treatment coronavirus infection groups suggest use inhibitors could lead higher viral loads ace<NUMBER> augmented expression <NUMBER> could drawback use aceis covid<NUMBER> treatment conclusion show potential applicability coagulation compounds first time knowledge treat covid<NUMBER> infection highlight fold similarity among sarscov<NUMBER> mpro coagulation factors thrombin factor xa effects similarity urgently investigated vitro approaches blockers reninangiotensin system risk covid<NUMBER> infection study objectives primary objective evaluate association use angiotensin receptor antagonists arbs angiotensin converting enzyme inhibitors aceis risk covid<NUMBER> infection secondary objectives assess association use arbs aceis severity covid<NUMBER> infection assess abovementioned associations men women assess abovementioned associations younger older patients animal studies shown angiotensin converting enzyme <NUMBER> ace<NUMBER> membranebound aminopeptidase abundantly expressed lungs heart well tissues <NUMBER> utilized coronaviruses functional receptor entrance cells <NUMBER> <NUMBER> <NUMBER> generated hypothesis drugs commonly used treatment hypertension heart failure renal disease postmyocardial infarction states angiotensin receptor antagonists arbs ace inhibitors aceis modify susceptibility severity mortality rate current human infections covid<NUMBER> wellknown association overexpression ace<NUMBER> consistent marked arbs aceis <NUMBER> <NUMBER> <NUMBER> modification interpreted lead increased risk infection due druginduced increase ace<NUMBER> substrate ie angiotensin ii <NUMBER> also suggested however contrary blockers reninangiotensin system might protective effect <NUMBER> <NUMBER> increased angiotensin ii might compete virus receptor level <NUMBER> ace<NUMBER> converts angiotensin ii inactive compounds <NUMBER> may directly attenuate tissue injury <NUMBER> making overexpression mechanistically favorable unfortunately published clinical data largely limited general demographic clinical characteristics patients focused information type antihypertensive treatment prescribed close time covid<NUMBER> infection <NUMBER> <NUMBER> means evidence available whether blockers reninangiotensin system modify human response covid<NUMBER> infection well whether modification might adverse protective sign <NUMBER> represents serious problem possibility blockers reninangiotensin system may relationship susceptibility covid<NUMBER> infection worldwide large echo media result many patients stopped use <NUMBER> <NUMBER> blockers reninangiotensin system widely used lifesaving drugs cardiovascular renal disease strong evidence treatment withdrawal associated marked increase related morbidity mortality risk <NUMBER> <NUMBER> <NUMBER> main goal populationbased casecontrol study evaluate association use arbs aceis risk covid<NUMBER> infection secondary objectives evaluate associations use arbs aceis severity covid<NUMBER> infection ii assess association interest men women iii assess association interest younger older patients populationbased casecontrol study carried lombardy region italy inclusion criteria cases beneficiaries regional health service age ≥ <NUMBER> years diagnosis covid<NUMBER> infection <NUMBER>st february <NUMBER>th march <NUMBER> diagnosis covid<NUMBER> infection since february <NUMBER>st <NUMBER> individual data patients confirmed diagnosis covid<NUMBER> infection signaled regional health authority several sources latter included public private hospitals inpatients among required assisted ventilation ii general practitioners outpatients receiving domiciliary care iii municipal registries deaths due covid<NUMBER> infection laboratories accredited regional health authority finally gave fundamental contribution active reporting system signaling patients underwent diagnostic procedure covid<NUMBER> diagnostic algorithm based protocol released world health organization ie nasopharyngeal swab specimens tested real time polymerase chain reaction sarscov<NUMBER> rna within three hours laboratory confirmation virus performed using real time reverse transcription polymerase chain reaction performing formal inspection individual signaling regional health authority carries record linkage provides official data daybyday new cases deaths process centralization ensures homogeneity signaling uniformity diagnostic testing along entire period observation date covid<NUMBER> diagnosis considered index date patients extracted registry march <NUMBER> <NUMBER> patients required assisted ventilation died intensive care classified criticalfatal infection remaining regarded affected mild clinical manifestations infection matching case five controls randomly selected target population matched gender age index date municipality residence density incidence approach used selecting controls use aceis arbs dispensed <NUMBER> previous hospitalizations cardiovascular disease cancer respiratory kidney disease suffered cases controls traced regional databases addition cases controls categorized according chronic related score cresc new index patients clinical profile derived inpatient outpatient services provided regional health service validated outcome prediction <NUMBER> major bloodpressure lowering agents dispensed cases controls <NUMBER> calcium channel blockers diuretics βblockers traced healthcare utilization databases along dispensation variety drugs lipidlowering agents mainly statins oral antidiabetic insulin antiplatelet antiarrhythmic anticoagulant digital nitrates inhaled corticosteroids immunosuppressant agents ie glucocorticoids calcineurin inhibitors antiproliferative agents monoclonal antibodies shortacting longacting βagonists sabalaba agents used chronic respiratory diseases animal studies shown angiotensin converting enzyme <NUMBER> ace<NUMBER> membranebound aminopeptidase abundantly expressed lungs heart well tissues <NUMBER> utilized coronaviruses functional receptor entrance cells <NUMBER> <NUMBER> <NUMBER> generated hypothesis drugs commonly used treatment hypertension heart failure renal disease postmyocardial infarction states angiotensin receptor antagonists arbs ace inhibitors aceis modify susceptibility severity mortality rate current human infections covid<NUMBER> wellknown association overexpression ace<NUMBER> consistent marked arbs aceis <NUMBER> <NUMBER> <NUMBER> modification interpreted lead increased risk infection due druginduced increase ace<NUMBER> substrate ie angiotensin ii <NUMBER> also suggested however contrary blockers reninangiotensin system might protective effect <NUMBER> <NUMBER> increased angiotensin ii might compete virus receptor level <NUMBER> ace<NUMBER> converts angiotensin ii inactive compounds <NUMBER> may directly attenuate tissue injury <NUMBER> making overexpression mechanistically favorable unfortunately published clinical data largely limited general demographic clinical characteristics patients focused information type antihypertensive treatment prescribed close time covid<NUMBER> infection <NUMBER> <NUMBER> means evidence available whether blockers reninangiotensin system modify human response covid<NUMBER> infection well whether modification might adverse protective sign <NUMBER> represents serious problem possibility blockers reninangiotensin system may relationship susceptibility covid<NUMBER> infection worldwide large echo media result many patients stopped use <NUMBER> <NUMBER> blockers reninangiotensin system widely used lifesaving drugs cardiovascular renal disease strong evidence treatment withdrawal associated marked increase related morbidity mortality risk <NUMBER> <NUMBER> <NUMBER> main goal populationbased casecontrol study evaluate association use arbs aceis risk covid<NUMBER> infection secondary objectives evaluate associations use arbs aceis severity covid<NUMBER> infection ii assess association interest men women iii assess association interest younger older patients populationbased casecontrol study carried lombardy region italy inclusion criteria cases beneficiaries regional health service age ≥ <NUMBER> years diagnosis covid<NUMBER> infection <NUMBER>st february <NUMBER>th march <NUMBER> diagnosis covid<NUMBER> infection since february <NUMBER>st <NUMBER> individual data patients confirmed diagnosis covid<NUMBER> infection signaled regional health authority several sources latter included public private hospitals inpatients among required assisted ventilation ii general practitioners outpatients receiving domiciliary care iii municipal registries deaths due covid<NUMBER> infection laboratories accredited regional health authority finally gave fundamental contribution active reporting system signaling patients underwent diagnostic procedure covid<NUMBER> diagnostic algorithm based protocol released world health organization ie nasopharyngeal swab specimens tested real time polymerase chain reaction sarscov<NUMBER> rna within three hours laboratory confirmation virus performed using real time reverse transcription polymerase chain reaction performing formal inspection individual signaling regional health authority carries record linkage provides official data daybyday new cases deaths process centralization ensures homogeneity signaling uniformity diagnostic testing along entire period observation date covid<NUMBER> diagnosis considered index date patients extracted registry march <NUMBER> <NUMBER> patients required assisted ventilation died intensive care classified criticalfatal infection remaining regarded affected mild clinical manifestations infection matching case five controls randomly selected target population matched gender age index date municipality residence density incidence approach used selecting controls use aceis arbs dispensed <NUMBER> previous hospitalizations cardiovascular disease including coronary artery disease percutaneous coronary intervention heart failure cancer respiratory including chronic obstructive pulmonary disease asthma kidney disease including chronic kidney disease dialysis suffered cases controls traced regional databases addition cases controls categorized according chronic related score cresc new index patients clinical profile derived inpatient outpatient services provided regional health service validated outcome prediction <NUMBER> major bloodpressure lowering agents dispensed cases controls <NUMBER> calcium channel blockers diuretics including subtypes ie thiazidethiazidelike loop mineralocorticoid receptor antagonists βblockers traced healthcare utilization databases dispensation drugs operating reninangiotensin system extended renin inhibitors sacubitrilvalsartan also trace blood pressure lowering drugs dispensed monotherapy combination therapies reninangiotensin system blocker vast majority drug treatments dispensed <NUMBER> include lipidlowering agents mainly statins oral antidiabetic whole commonly dispensed classes insulin antiplatelet antiarrhythmic anticoagulant digital nitrates inhaled corticosteroids nonsteroidal antiinflammatory drugs nsaids immunosuppressant agents ie glucocorticoids calcineurin inhibitors antiproliferative agents monoclonal antibodies shortacting longacting βagonists sabalaba agents used chronic respiratory diseases primary outcome measure odds ratios association use arbs aces covid<NUMBER> infection secondary outcome measures <NUMBER> odds ratios association use arbs aces criticalfatal covid<NUMBER> infection <NUMBER> odds ratios association use arbs aces covid<NUMBER> infection men women <NUMBER> odds ratios association use arbs aces covid<NUMBER> infection younger older patients <NUMBER> years ≥ <NUMBER> years old respectively better clinical characterization patients included study considered revised protocol indeed several comorbidities cotreatments included cardiovascular disease coronary artery disease percutaneous coronary intervention heart failure respiratory diseases chronic obstructive pulmonary disease asthma kidney disease chronic kidney disease dialysis diuretics thiazidethiazidelike loop mineralocorticoid receptor antagonists oral antidiabetic drugs metformin sulfonylureas dpp<NUMBER> inhibitors glp<NUMBER> agonists sglt<NUMBER> inhibitors thiazolidinediones oral antidiabetic agents nonsteroidal antiinflammatory drugs nonselective cox inhibitors selective cox<NUMBER> inhibitors primary analysis conditional logistic regression models fitted estimating odds ratio corresponding <NUMBER> confidence interval ci risk covid<NUMBER> infection associated exposure individual bloodpressure lowering drug adjustments made aforementioned baseline covariates secondary analyses analyses restricted strata criticalfatal infection stratifications gender age categories <NUMBER> years ≥<NUMBER> years performed secondary analyses two analyses performed verify robustness findings first minimize inconvenience exposure antihypertensive medicaments available december <NUMBER> data analyzed according three criteria ie prescriptions <NUMBER> ii least three consecutive prescriptions <NUMBER> iii least one prescription last quarter <NUMBER> assuming two latter criteria might identify reliably unchanged treatment second strategy used sarscov<NUMBER> rtpcr testing changed ie <NUMBER> february italian national institute health recommended swabbing would performed symptomatic patients rather suspected covid<NUMBER> cases done initial phase analyses stratified according date covid<NUMBER> diagnosis <NUMBER> february primary analysis conditional logistic regression models fitted estimating odds ratio corresponding <NUMBER> confidence interval ci risk covid<NUMBER> infection associated exposure individual bloodpressure lowering drug adjustments made aforementioned baseline covariates secondary analyses analyses restricted strata criticalfatal infection stratifications gender age categories <NUMBER> years ≥<NUMBER> years performed secondary analyses two analyses performed verify robustness findings first minimize inconvenience exposure antihypertensive medicaments available december <NUMBER> data analyzed according three criteria ie prescriptions <NUMBER> ii least three consecutive prescriptions <NUMBER> iii least one prescription last quarter <NUMBER> assuming two latter criteria might identify reliably unchanged treatment second strategy used sarscov<NUMBER> rtpcr testing changed ie <NUMBER> february italian national institute health recommended swabbing would performed symptomatic patients rather suspected covid<NUMBER> cases done initial phase analyses stratified according date covid<NUMBER> diagnosis <NUMBER> february work consideration publication section <NUMBER> institution time receive payment services third party government commercial private foundation etc aspect submitted work including limited grants data monitoring board study design manuscript preparation statistical analysis etc relevant conflicts interest yes ✔ relevant financial activities outside submitted work relevant conflicts interest yes ✔ place check appropriate boxes table indicate whether financial relationships regardless amount compensation entities described instructions use one line entity add many lines need clicking add box report relationships present <NUMBER> months prior publication patents whether planned pending issued broadly relevant work relationships activities readers could perceive influenced give appearance potentially influencing wrote submitted work yes following relationshipsconditionscircumstances present explain relationshipsconditionscircumstances present potential conflict interest ✔ relationships covered section <NUMBER> time manuscript acceptance journals ask authors confirm necessary update disclosure statements occasion journals may ask authors disclose information reported relationships based disclosures form automatically generate disclosure statement appear box section <NUMBER> dr apolone nothing disclose please visit httpwwwicmjeorgcgibinfeedback provide feedback experience completing form purpose form provide readers manuscript information interests could influence receive understand work form designed completed electronically stored electronically contains programming allows appropriate data display author submit separate form responsible accuracy completeness submitted information form six parts work consideration publication section asks information work submitted publication time frame reporting work initial conception planning present requested information resources received either directly indirectly via institution enable complete work checking means work without receiving financial support third party work supported funds institution pays salary institution receive thirdparty funds pay institution received funds third party support work government granting agency charitable foundation commercial sponsor check yes section asks financial relationships entities biomedical arena could perceived influence give appearance potentially influencing wrote submitted work disclose interactions entity could considered broadly relevant work example article testing epidermal growth factor receptor egfr antagonist lung cancer report associations entities pursuing diagnostic therapeutic strategies cancer general area egfr lung cancer report sources revenue paid promised paid directly institution behalf <NUMBER> months prior submission work include monies sources relevance submitted work monies entity sponsored research please note interactions works sponsor outside submitted work also listed question usually better disclose relationship grants received work outside submitted work disclose support entities could perceived affected financially published work drug companies foundations supported entities could perceived financial stake outcome public funding sources government agencies charitable foundations academic institutions need disclosed example government agency sponsored study involved drugs provided pharmaceutical company need list pharmaceutical company section asks patents copyrights whether pending issued licensed andor receiving royalties use section report relationships activities readers could perceive influenced give appearance potentially influencing wrote submitted work definitions instructions <NUMBER> <NUMBER> anything covered previous three boxes pending patent filed issued issued patent issued agency licensed patent licensed entity whether earning royalties royalties funds coming institution due time manuscript acceptance journals ask authors confirm necessary update disclosure statements occasion journals may ask authors disclose information reported relationships based disclosures form automatically generate disclosure statement appear box section <NUMBER> dr corrao reports grants european community grants italian medicines agency aifa grants italian ministry education university research miur grants novartis grants gsk roche grants amgen grants bms outside submitted work purpose form provide readers manuscript information interests could influence receive understand work form designed completed electronically stored electronically contains programming allows appropriate data display author submit separate form responsible accuracy completeness submitted information form six parts work consideration publication section asks information work submitted publication time frame reporting work initial conception planning present requested information resources received either directly indirectly via institution enable complete work checking means work without receiving financial support third party work supported funds institution pays salary institution receive thirdparty funds pay institution received funds third party support work government granting agency charitable foundation commercial sponsor check yes section asks financial relationships entities biomedical arena could perceived influence give appearance potentially influencing wrote submitted work disclose interactions entity could considered broadly relevant work example article testing epidermal growth factor receptor egfr antagonist lung cancer report associations entities pursuing diagnostic therapeutic strategies cancer general area egfr lung cancer report sources revenue paid promised paid directly institution behalf <NUMBER> months prior submission work include monies sources relevance submitted work monies entity sponsored research please note interactions works sponsor outside submitted work also listed question usually better disclose relationship grants received work outside submitted work disclose support entities could perceived affected financially published work drug companies foundations supported entities could perceived financial stake outcome public funding sources government agencies charitable foundations academic institutions need disclosed example government agency sponsored study involved drugs provided pharmaceutical company need list pharmaceutical company section asks patents copyrights whether pending issued licensed andor receiving royalties use section report relationships activities readers could perceive influenced give appearance potentially influencing wrote submitted work definitions instructions <NUMBER> <NUMBER> identifying information section <NUMBER> time manuscript acceptance journals ask authors confirm necessary update disclosure statements occasion journals may ask authors disclose information reported relationships based disclosures form automatically generate disclosure statement appear box section <NUMBER> dr ludergnani nothing disclose please visit httpwwwicmjeorgcgibinfeedback provide feedback experience completing form purpose form provide readers manuscript information interests could influence receive understand work form designed completed electronically stored electronically contains programming allows appropriate data display author submit separate form responsible accuracy completeness submitted information form six parts work consideration publication section asks information work submitted publication time frame reporting work initial conception planning present requested information resources received either directly indirectly via institution enable complete work checking means work without receiving financial support third party work supported funds institution pays salary institution receive thirdparty funds pay institution received funds third party support work government granting agency charitable foundation commercial sponsor check yes section asks financial relationships entities biomedical arena could perceived influence give appearance potentially influencing wrote submitted work disclose interactions entity could considered broadly relevant work example article testing epidermal growth factor receptor egfr antagonist lung cancer report associations entities pursuing diagnostic therapeutic strategies cancer general area egfr lung cancer report sources revenue paid promised paid directly institution behalf <NUMBER> months prior submission work include monies sources relevance submitted work monies entity sponsored research please note interactions works sponsor outside submitted work also listed question usually better disclose relationship grants received work outside submitted work disclose support entities could perceived affected financially published work drug companies foundations supported entities could perceived financial stake outcome public funding sources government agencies charitable foundations academic institutions need disclosed example government agency sponsored study involved drugs provided pharmaceutical company need list pharmaceutical company based disclosures form automatically generate disclosure statement appear box disclosure statement section <NUMBER> dr mancia reports personal fees bayer personal fees boehringer ingelheim personal fees cvrx personal fees daiichi sankyo personal fees ferrer personal fees medtronic personal fees menarini int personal fees merck personal fees novartis personal fees recordati personal fees servier outside submitted work please visit httpwwwicmjeorgcgibinfeedback provide feedback experience completing form h e ne w e ngl nd jou r na l f e dicine tudies animals shown angiotensinconverting enzyme <NUMBER> ace<NUMBER> membranebound aminopeptidase abundantly expressed lungs heart tissues <NUMBER> used coronaviruses functional receptor entrance cells <NUMBER> <NUMBER> angiotensinreceptor blockers arbs ace inhibitors considered firstchoice drugs hypertension heart failure postmyocardial infarction states chronic kidney disease also increase expression ace<NUMBER> <NUMBER> <NUMBER> given facts observations hypothesis use may modify susceptibility infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> humans developed however consensus whether risk severity sarscov<NUMBER> infection might increased reduced use agents <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current published clinical data largely limited small uncontrolled studies demographic clinical characteristics patients coronavirus disease <NUMBER> covid <NUMBER> little information regarding type antihypertensive treatment taking close time infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lack information problematic given possibility blockers reninangiotensinaldosterone system raas may affect susceptibility severity covid<NUMBER> issue received much press may influence patient behavior respect taking discontinuing agents despite advice number professional scientific societies discontinue <NUMBER> <NUMBER> <NUMBER> <NUMBER> date reports indicate withdrawal raas blockers patients conditions medications commonly used leads marked increase risk complications death <NUMBER> <NUMBER> <NUMBER> recent covid<NUMBER> epidemic spread increased exponentially italy earlier western country far severely hit part italy lombardy northern region sarscov<NUMBER> infected thousands patients associated high incidence hospitalization intensive care high mortality <NUMBER> regional health authority promptly established populationbased registry patients confirmed diagnosis infection sarscov<NUMBER> taking advantage regional availability databases health care use cover dispensed essential drugs services provided beneficiaries regional health service ie virtually residents carried casecontrol investigation evaluate association use raas blockers risk covid<NUMBER> analysis extended antihypertensive agents well large number medications data also analyzed according sex age severity covid<NUMBER> ie patients receiving intensive hospital care died vs patients disease residents lombardy <NUMBER> years age older beneficiaries regional health service formed target population <NUMBER> million people approximately <NUMBER> entire italian population age group italian citizens equal access essential health care services provided national health service lombardy association paired automated system databases collect variety information including codes international classification diseases <NUMBER>th revision clinical modification inpatient diagnoses services supplied public private hospitals well anatomical therapeutic chemical codes outpatient dispensation drugs reimbursed pharmacies filing doctors prescriptions various types data interconnected since single individual identification code used databases citizen enrolled preserve privacy identification code automatically deidentified inverse process allowed regional health authority request judicial authorities authors vouch accuracy completeness data fidelity study protocol available full text article nejmorg deidentified data extracted processed regional repository using statistical programs developed authors according protocol previously discussed approved regional health authority details databases health care use lombardy reported previous studies <NUMBER> <NUMBER> <NUMBER> since february <NUMBER> <NUMBER> patients diagnosis covid<NUMBER> revealed regional r aas blockers risk health authority several sources public private hospitals persons seen first aid service acute respiratory infection infected inpatients including received assisted ventilation general practitioners symptomatic outpatients receiving home care municipal registries deaths due laboratories accredited regional health authority diagnosis based protocol released world health organization <NUMBER>that positive nasopharyngeal swab specimens tested least two realtime reversetranscriptasepolymerasechainreaction assays targeting different genes e rdrp sarscov<NUMBER> february <NUMBER> diagnostic tests carried patients suspected cases whereas symptomatic patients tested february <NUMBER> onward date covid<NUMBER> diagnosis considered index date patient data extracted registry march <NUMBER> <NUMBER> excluded patients beneficiaries regional health service <NUMBER> patients became beneficiaries regional health service january <NUMBER> <NUMBER> <NUMBER> patients younger <NUMBER> years age index date <NUMBER> patients remaining <NUMBER> patients included study case patients among <NUMBER> patients received assisted ventilation died classified critical fatal infection remaining patients regarded relatively mildtomoderate clinical manifestations infection approximately half patients mildtomoderate cases received home care remaining patients hospitalized received intensive care case patient five controls randomly selected target population matched sex age index date municipality residence matching persons became beneficiaries regional health service january <NUMBER> <NUMBER> excluded target population patients received diagnosis covid<NUMBER> eligible potential controls became case patients matches risk covid<NUMBER> previous hospitalizations cardiovascular disease cancer respiratory disease kidney disease case patients controls traced regional databases <NUMBER>year period index date addition case patients controls categorized according chronic related score cresc new index patients clinical profiles derived inpatient outpatient services provided regional health service validated outcome prediction <NUMBER> detailed description cresc scores presence absence <NUMBER> diseases conditions patient provided supplementary appendix available nejmorg cresc values range <NUMBER> <NUMBER> higher values indicating worse clinical status major classes antihypertensive agents ace inhibitors arbs calciumchannel blockers diuretics including subtypes betablockers dispensed case patients controls <NUMBER> traced databases health care use addition ace inhibitors arbs drugs dispensed known act raas notedrenin inhibitors sacubitrilvalsartan latter used heart failure also noted antihypertensive drugs dispensed monotherapy combination therapies typically raas blocker another agent drugs dispensed <NUMBER> included lipidlowering agents mainly statins oral hypoglycemic agents noted together commonly dispensed individual classes insulin antiplatelet agents antiarrhythmic agents anticoagulant agents digitalis nitrates inhaled glucocorticoids nonsteroidal antiinflammatory drugs immunosuppressive agents ie glucocorticoids calcineurin inhibitors antiproliferative agents monoclonal antibodies shortacting βagonists longacting βagonists agents used chronic respiratory diseases diagnostic therapeutic procedural codes used current study shown table s<NUMBER> supplementary appendix betweengroup relative difference clinical features drug exposures used comparing case patients controls conditional logisticregression models fitted estimating odds ratio corresponding <NUMBER> confidence interval risk covid<NUMBER> associated exposures interest models separately included clinical features drug exposures listed unadjusted models well h e ne w e ngl nd jou r na l f e dicine <NUMBER> diagnosed february <NUMBER> march <NUMBER> <NUMBER> ace denotes angiotensinconverting enzyme arb angiotensinreceptor blocker cox cyclooxygenase cox<NUMBER> cyclooxygenase <NUMBER> dpp<NUMBER> dipeptidyl peptidase <NUMBER> glp<NUMBER> glucagonlike peptide <NUMBER> mv matching variable sglt<NUMBER> sodiumglucose cotransporter <NUMBER> † data patients received least one prescription <NUMBER> <NUMBER> patients <NUMBER> case patient <NUMBER> controls received renin inhibitors <NUMBER> patients <NUMBER> case patients <NUMBER> controls received sacubitrilvalsartan ‡ chronic related score new index patients clinical profile derived inpatient outpatient services provided regional health service validated outcome prediction <NUMBER> five categories progressively worsening clinical profile considered ci denotes confidence interval raas reninangiotensinaldosterone system † shown odds ratios covid<NUMBER> associated exposure treatments coexisting conditions absence exposure considered reference unless otherwise indicated estimates obtained fitting conditional logisticregression models unadjusted estimates estimates fully adjusted drugs coexisting conditions shown fully adjusted estimates obtained unique multivariate analysis ‡ data patients received least one prescription <NUMBER> available remaining <NUMBER> case patients <NUMBER> index date mean ±sd age case patients controls <NUMBER>±<NUMBER> years nearly <NUMBER> women matching variables table <NUMBER> shows arbs ace inhibitors frequently prescribed case patients controls percentage patients received arbs <NUMBER> among case patients <NUMBER> among controls relative difference <NUMBER> percentage patients received ace inhibitors <NUMBER> <NUMBER> respectively relative difference <NUMBER> antihypertensive drugs also used case patients controls difference usually larger ace inhibitors arbs particularly loop diuretics <NUMBER> vs <NUMBER> relative difference <NUMBER> mineralocorticoidreceptor antagonists <NUMBER> vs <NUMBER> relative difference <NUMBER> use renin inhibitors <NUMBER> case patient sacubitrilvalsartan <NUMBER> case patients uncommon analysis treatments carried case patients also used combination antihypertensive drugs frequently controls frequent history hospitalization cardiovascular noncardiovascular diseases according cresc index overall substantially worse clinical profile table <NUMBER> shows unadjusted estimates risk covid<NUMBER> according drugs shown table <NUMBER> suggested possible effect however multivariable adjustment neither arbs ace inhibitors significant association risk covid<NUMBER> also case calciumchannel blockers betablockers diuretics association covid<NUMBER> multivariable adjustment maintained loop diuretics nonantihypertensive drugs insulin antiplatelet agents anticoagulants immunosuppressant drugs drugs used respiratory disease compared patients use antihypertensive drugs <NUMBER> antihypertensive agents dispensed monotherapy combination two agents appeared greater risk covid<NUMBER> unadjusted crude analysis multivariable adjustment neither monotherapy combination therapy showed significant association risk covid<NUMBER> table <NUMBER> multivariable adjusted risk covid<NUMBER> increased patients previous hospitalizations cardiovascular noncardiovascular diseases also became progressively greater cresc increased table <NUMBER> data risk covid<NUMBER> infection associated use raas blockers drugs similar men women table <NUMBER> tables s<NUMBER> s<NUMBER> statistical evidence findings obtained entire cohort modified age severity clinical manifestations course covid<NUMBER> table <NUMBER> tables s<NUMBER> s<NUMBER> shown figure s<NUMBER> data covid<NUMBER> antihypertensive drugs consistent regardless whether drug use assessed loose strict criteria furthermore findings change substantially case patients stratified according date covid<NUMBER> diagnosis table s<NUMBER> present study use arbs ace inhibitors frequent among patients infected sarscov<NUMBER> among large number controls matched age sex place residence however major antihypertensive drugs calciumchannel blockers betablockers diuretics also used frequently patients covid<NUMBER> differences controls larger shown arbs ace inhibitors furthermore multivariable analysis data adjusted number treatmentrelated covariates markers patient clinical status use arbs ace h e ne w e ngl nd jou r na l f e dicine hibitors significantly associated risk covid<NUMBER> finally statistical evidence independent association use combination antihypertensive drugs ace inhibitor arb far common component risk covid<NUMBER> thus results provide evidence independent relationship raas blockers susceptibility covid<NUMBER> humans found patients covid<NUMBER> higher baseline prevalence cardiovascular conditions diseases hypertension coronary heart disease heart failure chronic kidney disease treatment medications studied often used observations confirm previous observations chinese investigators patients covid<NUMBER> generally poorer health general population <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> conclusion present study strongly supported evidence patients covid<NUMBER> frequently treated drugs many noncardiovascular diseases higher incidence previous hospitalizations variety causes higher scores chronic coexisting conditions controls <NUMBER> <NUMBER> <NUMBER> present study provides several additional findings first conclusion raas blockers modify susceptibility covid<NUMBER> applies sexes well younger older persons second data provide evidence rather modifying susceptibility covid<NUMBER> raas blockers alter evolution disease thereby mainly affecting severity study neither ace inhibitors arbs showed independent association covid<NUMBER> patients mildtomoderate disease severe disease third patients covid<NUMBER> much frequent use loop diuretics mineralocorticoidreceptor antagonists controls treatment loop diuretics associated increased risk covid<NUMBER> multivariable analysis rather suggesting association mechanistic support finding likely mean use loop diuretics reflects existence clinical conditions heart failure advanced renal damage severity appropriately quantified available clinical data scores observations study may account independent relationship found covid<NUMBER> noncardiovascular drugs although direct investigations appro priate experimental designs would required clarify issue one strength study large number case patients well inclusion large wellmatched control group without interpretation collected data would difficult also strength lombardy database included previous hospitalizations allowed drugs prescribed outpatients accurately observed pharmacists must file outpatient prescriptions claim reimbursement incorrect reports carry legal consequences limitations study include fact information drug use limited prescriptions actual drug consumption case patients controls could assessed drugs purchased patients doctors prescribed privately records national health service system well dispensed december <NUMBER> <NUMBER> captured analysis however availability free antihypertensive agents makes outofpocket purchase drugs rare exploratory analysis involving patients antihypertensive treatment taken regularly closer time infection modify results results reflect doses raas blockers used italian medical practice allow us investigate doses information included database likely control group included persons covid<NUMBER> since general population italy tested unmeasured confounders may responsible findings example given hypothesis raas blockers increase risk severe clinical manifestations covid<NUMBER> may preferential dispensation raas blockers patients better clinical profiles lower perceived likelihood development severe covid<NUMBER> however evidence patients received arbs ace inhibitors better clinical profile received antihypertensive medications finally results apply largely white population cannot generalized races present study provide evidence use ace inhibitors arbs independently associated risk covid<NUMBER> disclosure forms provided authors available full text article nejmorg data sharing statement provided authors available full text article nejmorg thank dr roberto blaco head epidemiologic observatory lombardy region designing managing populationbased covid<NUMBER> registry making data available current study thank mourad levy constructive correspondence interaction raas inhibitors ace<NUMBER> context covid<NUMBER> nat rev cardiol <NUMBER>s<NUMBER>x <NUMBER> comment article covid<NUMBER> cardiovascular system nat rev cardiol <NUMBER>s<NUMBER> <NUMBER> agree comments acknowledge different renin–angiotensin–aldosterone system raas inhibitors different effects angiotensinconverting enzyme <NUMBER> ace<NUMBER> levels ferrario colleagues<NUMBER> reported administration either ace inhibitors angiotensinreceptor blockers arbs increased levels ace<NUMBER> mrna lewis rats compared rats receiving placebo particular cardiac levels ace<NUMBER> mrna increased <NUMBER>fold <NUMBER>fold rats given either lisinopril ace inhibitor losartan arb respectively furthermore researchers found losartan treatment lisinopril treatment increased ace<NUMBER> activity compared placebo however researchers shed light mechanisms might account differences nevertheless li colleagues<NUMBER> found treatment captopril ace inhibitor significantly increase ace<NUMBER> protein expression rats acute lung injury furthermore wöstenvan asperen colleagues<NUMBER> reported rat model acute respiratory distress syndrome ace activity angiotensin ii expression increased whereas ace<NUMBER> activity angiotensin<NUMBER>–<NUMBER> levels reduced protective effects ace<NUMBER>–angiotensin<NUMBER>–<NUMBER>–mas receptor axis primarily mediated reductions angiotensin ii level<NUMBER> ace inhibitors arbs reduce angiotensin ii levels<NUMBER> former inhibit substrate angiotensin ii generation latter directly inhibit conversion angiotensin angiotensin ii therefore raas inhibitors including ace inhibitors arbs activate ace<NUMBER>–angiotensin<NUMBER>–<NUMBER>–mas receptor axis however mentioned comment article<NUMBER> whether patients coronavirus disease <NUMBER> covid<NUMBER> hypertension taking ace inhibitor arb switch another antihypertensive drug remains controversial one study use ace inhibitors arbs increase mortality <NUMBER> patients covid<NUMBER> cardiovascular disease<NUMBER> evidence required clarify effects ace inhibitors arbs patients covid<NUMBER> <NUMBER> march <NUMBER> european society hypertension published statement topic hypertension raas blockers covid<NUMBER> concluding available data support differential use raas blockers ace inhibitors arbs patients covid<NUMBER> ref<NUMBER> however authors cautioned statement reflected current evidence time release might need updating according new evidence indeed ace<NUMBER> might equivalent natural arb ace inhibitor<NUMBER> decreasing levels ace<NUMBER> shift balance raas promote ace–angiotensin ii–angiotensin ii receptor type <NUMBER> axis leading lung injury progression inflammatory storms increasing levels ace<NUMBER> transfer balance towards angiotensin<NUMBER>–<NUMBER>–mas receptor axis antiinflammatory antioxidant effects cardiopulmonary protective correspondence article mourad levy also suggest aliskiren treatment could interesting option context severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection given aliskiren reduce expression ace<NUMBER> although ace<NUMBER> identified functional receptor sarscov<NUMBER> role ace<NUMBER> progression covid<NUMBER> sarscov<NUMBER> infection still controversial benefits aliskiren use patients covid<NUMBER> needs investigation cell surface particularly cell types endowed proteolytic activity able modulate activity membrane proteins circulating regulatory peptides proteases peptidases mostly metalloenzymes using zinc cofactor structurally organised ectoenzymes catalytic sites facing extracellular space examples include neutral endopeptidase neprilysin nep aminopeptidases carboxypeptidases various specificities subjects article angiotensinconverting enzymes ace ace<NUMBER> ectopeptidases mainly exist single membranespanning proteins type cterminus intracellular type ii nterminus intracellular topology glycosylphosphatidylinositollinked proteins undoubtedly best studied ectopeptidases far ace largely physiological pathological roles almost <NUMBER> years ace unique mammalian enzyme distinct growing peptidase families discovery human homologue ace aceh ace<NUMBER> led resurgence studies ace biology coupled detailed structural information enzyme pace knowledge concerning ace<NUMBER> breathtaking comparison relatively leisurely developments understanding ace structure function several decades <NUMBER> period <NUMBER> years ace<NUMBER> cloned purified knockedout knockedin inhibitors developed <NUMBER>d structure determined new functions emerged ace<NUMBER> implicated cardiovascular renal biology diabetes obesity remarkably ace<NUMBER> may serve receptor severe acute respiratory syndrome sars virus cardiovascular diseases continue one leading causes death developed countries commonly resulting hypertension congestive heart failure major revolution treatment hypertension came development inhibitors ace ace inhibitors eg captopril lisinopril proved highly effective safe drugs used clinically treat hypertension also congestive heart failure renal disorders inhibition ace imposes effects primarily via ras ras mediates numerous effects cardiovascular system including blood pressure homeostasis maintenance fluid salt balance <NUMBER> ace crucial regulator ras converting inactive decapeptide angiotensin potent vasoconstrictor angiotensin ii <NUMBER> whilst also metabolising hypotensive peptide bradykinin <NUMBER> <NUMBER> novel mammalian homologue ace originally termed aceh subsequently ace<NUMBER> identified two distinct molecular strategies <NUMBER> <NUMBER> ace<NUMBER> gene maps human x chromosome encodes <NUMBER>aminoacid type membranebound glycoprotein apparent molecular weight approximately <NUMBER> kda aminoterminal domain ace<NUMBER> shares around <NUMBER> sequence identity corresponding domain somatic ace contains single hexxh zincbinding motif <NUMBER> intriguingly carboxyterminal domain displays <NUMBER> sequence homology collectrin enzymically inactive glycoprotein unknown function expressed exclusively kidney <NUMBER> ace<NUMBER> initially appeared limited tissue distribution ace significant levels detected heart kidneys testes gastrointestinal tract <NUMBER> <NUMBER> recent study however detected significant levels ace<NUMBER> expression wide variety tissues <NUMBER> first inspection owing high degree sequence similarity exists ace<NUMBER> ace could assumed ace<NUMBER> might function like ace dipeptidyl carboxypeptidase indeed previously characterised acelike proteins drosophila ace orthologues ance acer display activity <NUMBER> surprisingly however ace<NUMBER> functions carboxypeptidase cleaving single cterminal residue peptide substrate table <NUMBER> indeed ace<NUMBER> unable cleave archetypal ace substrates bradykinin hiphisleu insensitive potent ace inhibitors lisinopril captopril <NUMBER> characterisation using panel biologically active peptides provided consensus sequence proxprohydrophobicbasic protease specificity ace<NUMBER> <NUMBER> consensus sequence supported ace<NUMBER> active site model proposed guy et al <NUMBER> also ascertained chain length hydrolysed peptides limiting although cleavage dipeptides slow catalytic activity ace<NUMBER> like ace phand aniondependent <NUMBER> <NUMBER> <NUMBER> structures tace <NUMBER> drosophila homologue ance <NUMBER> recently elucidated minimum glycosylation requirement expression processing enzymically active tace investigated progressive deglycosylation <NUMBER> truncated soluble form tace lacking first <NUMBER> residues nterminus expressed cho cells presence glycosidasei inhibitor nbutyldeoxynojirimycin retained activity native enzyme yielded crystals diffracted <NUMBER> resolution natesh et al <NUMBER> described structure tace alone complex inhibitor lisinopril thereby provided detailed picture active site tace molecule overall ellipsoid shape central groove extends approximately <NUMBER> <NUMBER> protein dividing two subdomains active site located towards bottom groove simultaneously crystal structure drosophila ance determined <NUMBER> clear information presented minimally glycosylated form ance expressed purified crystallisation studies however previous report separate group shown ance require glycosylation secretion activity <NUMBER> data ance crystals revealed like ace large internal channel encompasses entire protein molecule active site located bottleneck connecting two chambers unequal size within cavity recently crystal structures extracellular domain lacking transmembrane cytosolic regions native inhibitorbound ace<NUMBER> determined <NUMBER>and <NUMBER> resolution respectively <NUMBER> data confirm integrity active site model ace<NUMBER> proposed guy et al <NUMBER> model based crystal structure tace indicated catalytic mechanism ace<NUMBER> resembles ace predicted structural differences active site ace dipeptidyl carboxypeptidase ace<NUMBER> carboxypeptidase responsible differences specificity also verified ace<NUMBER> structure essence main differences occur ligandbinding pockets particularly s<NUMBER>v subsite ace binding peptide carboxyterminus cavity tace larger ace<NUMBER> allowing extra amino acid bind specificity pocket importantly r<NUMBER> q substitution ace<NUMBER> ace appears largely responsible elimination s<NUMBER>v pocket ace<NUMBER> structural differences offer explanation classical ace inhibitor lisinopril unable bind ace<NUMBER> ace<NUMBER> crystals grown presence mln<NUMBER> <NUMBER> revealed unanticipated inverse binding orientation inhibitor active site fig <NUMBER> rationalised y<NUMBER> v substitution ace<NUMBER> ace whereby size s<NUMBER> pocket ace<NUMBER> considerably reduced longer accommodate bulky dichlorobenzyl group moreover explains substrates like bradykinin angiotensin<NUMBER> leuenkephalin poor substrates ace<NUMBER> good substrates ace another surprising observation absence bound chloride ace<NUMBER> identical position second binding site cl<NUMBER> tace <NUMBER> occupied cl<NUMBER> site largely responsible chloride activation ace <NUMBER> ace<NUMBER> clearly different ace displays unique enzyme function despite sequence similarity exists two proteins common features activity profiles first class selective inhibitors ace<NUMBER> includes series nonpeptide compounds whose design based upon substrate specificity ace<NUMBER> requirement centrally located carboxylate coordinate inhibitor <NUMBER> lead compound possesses subnanomolar affinity ic <NUMBER> <NUMBER> nm ace<NUMBER> <NUMBER> <NUMBER>and <NUMBER> <NUMBER>fold less affinity human tace bovine carboxypeptidasea cpa respectively using alternative strategy potent ace<NUMBER> peptide inhibitors identified screening constrained peptide libraries <NUMBER> stable peptide inhibitor ace<NUMBER> dx<NUMBER> displays k <NUMBER> nm angiotensin substrate dx<NUMBER> <NUMBER>aminoacid nterminal acetylated cterminal amidated peptide addition dipeptide prophe identified inhibitor ace<NUMBER> activity <NUMBER> finding would allow peptidebased approach inhibitor design comparison inhibitory effect prophe proleu substrate ace<NUMBER> weaker inhibitor prophe dipeptides ace<NUMBER> inhibitor compounds fundamental tools exploring ace<NUMBER> biology enzymology comparison ace<NUMBER> way first inhibitors ace discovered quite different teprotide nonapeptide owes potency selectivity natural selection component venom brazilian pitviper captopril hand owes potency selectivity chemical design guided hypothetical active site model also data substrate specificity ace comparison cpa example study carried cheung et al <NUMBER> major contributing factor design secondgeneration inhibitors ace active site binding properties substrates competitive inhibitors ace investigated using series simple triand dipeptides determined binding substrate inhibitor ace wholly dependent upon cterminal residues subsite interactions vein importance exhaustive study determine structureactivity correlations ace<NUMBER> critical systematic development inhibitor compounds although ace inhibitors designed part basis similarities enzymic properties ace cpa significant segmental homology found carboxypeptidases m<NUMBER> family upon solution crystal structure tace <NUMBER> contrast growing availability data enzyme kinetics possible physiological roles ace<NUMBER> comparatively little known ace<NUMBER> cellular level keeping predictions made peptide sequence interactions viral receptor recombinant ace<NUMBER> expressed cho hek<NUMBER> cells localised predominantly plasma membrane analysis media taken cells expressing ace<NUMBER> revealed presence soluble form ace<NUMBER> likely product proteolytic cleavage event indeed proteolytic release ace<NUMBER> observed cardiomyocytes ace<NUMBER> overexpressed <NUMBER> soluble form ace<NUMBER> detected urine dw lambert gi rice nm hooper aj turner unpublished data preliminary evidence indicates secretase responsible shedding ace<NUMBER> distinct ace dw lambert nm hooper aj turner unpublished data light ability soluble ace<NUMBER> prevent sars cov infection <NUMBER> study ace<NUMBER> secretion prime significance analysis ace<NUMBER> sequence reveals presence seven potential nglycosylation sequons <NUMBER> recently resolved crystal structure ace<NUMBER> provided evidence six sites n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> glycosylated clear data whether cterminal site also occupied <NUMBER> study reported soluble ace<NUMBER> expressed insect cells molecular weight <NUMBER> kda compared predicted <NUMBER> kda difference accounted presence carbohydrate groups molecular weight <NUMBER> kda also reported ace<NUMBER> rat mouse tissue <NUMBER> <NUMBER> noted however studies reported molecular weight <NUMBER> kda species <NUMBER> <NUMBER> indeed ace<NUMBER> overexpressed mammalian cells apparent molecular weight <NUMBER> kda reduced approximately <NUMBER> kda following enzymic deglycosylation <NUMBER> whilst difference reported molecular weights ace<NUMBER> insect mammalian cells assigned species differences posttranslational modification reasons remaining discrepancies unclear disruption normal glycosylation ace<NUMBER> expressed cho cells treatment glycosidase inhibitor tunicamycin prevented correct cellular sorting fulllength ace<NUMBER> abolished secretion truncated mutant lacking transmembrane cytosolic domains dw lambert k pogson aj turner unpublished observations resulting unglycosylated protein also catalytically inactive indicating requirement glycosylation membrane targeting activity vivo ace<NUMBER> expression confined endothelial cells renal tubular epithelium also identified vascular smooth muscle cells leydig sertoli cells testes <NUMBER> <NUMBER> first direct evidence concerning physiological role ace<NUMBER> provided studies transgenic ace<NUMBER> knockout mice ace<NUMBER> àà carried crackower et al <NUMBER> mice show gross abnormalities fertile normal blood pressure renal function despite moderately elevated angiotensin ii levels closer examination however revealed mice suffered severe cardiac dysfunction manifest profound decrease cardiac contractility resulting thinning left ventricle wall increase ventricle chamber dimensions disruption heart function associated upregulation genes induced hypoxia bore remarkable resemblance condition resulting cardiac surgery referred dcardiac stunningt significantly ablation ace gene ace<NUMBER> knockout background rescues cardiac phenotype suggesting ace<NUMBER> serves regulator effects ace ras separate study targeted disruption ace<NUMBER> gene resulted viable fertile progeny lacking gross anatomicalstructural abnormalities <NUMBER> displaying moderately elevated systolic blood pressure chronic infusion angiotensin ii level induce hypertension increased blood pressure decreased heart rate evident ace<NUMBER> null mice compared wildtype littermates thus appears absence ace<NUMBER> mice susceptible angiotensin iiinduced hypertension transgenic mice ace<NUMBER> overexpressed exclusively cardiac myocytes exhibited complete atrioventricular block <NUMBER> weeks age <NUMBER> transgenic mice appeared healthy grossly normal heart structure slightly lowered blood pressure however mice suffered increased susceptibility sudden cardiac death directly correlated transgene dose detailed electrophysiological analysis revealed severe progressive conduction rhythm disturbances along sustained ventricular tachycardia terminal ventricular fibrillation light observation gap junction proteins connexin<NUMBER> connexin<NUMBER> downregulated hearts transgenic mice suggested electrical remodelling result gap junction dysregulation surviving older mice expression human ace<NUMBER> cardiac myocytes progressively downregulated downregulation proteins control heartspecific amhc promoter phenomenon reported models coincided reciprocal upregulation connexin<NUMBER> resulting partial restoration cardiac phenotype however important note ace<NUMBER> normally expressed cardiac myocytes rather cardiac endothelium ability ace<NUMBER> cleave vasoactive peptides angiotensin ii indicates possible role blood pressure regulation theory given increased credence observation ace<NUMBER> gene maps candidate quantitative trait locus qtl saltsensitive rat model hypertension furthermore rats display reduced ace<NUMBER> mrna protein expression compared healthy littermates <NUMBER> overlapping qtls also identified rat models hypertension addition two single nucleotide polymorphisms snps identified ace<NUMBER> locus associated risk cardiovascular disease caucasian population <NUMBER> chronic administration omapatrilat dual inhibitor vasopeptidases ace neprilysin nep spontaneous hypertensive rats shrs results significant reduction blood pressure marked diuresis augmented renal excretion vasodilatory peptide angiotensin<NUMBER> <NUMBER> ace<NUMBER> capable producing angiotensin<NUMBER> angiotensin ii vitro abundantly expressed kidney <NUMBER> upon treatment shrs omapatrilat increased staining angiotensin<NUMBER> ace<NUMBER> observed renal proximal tubules simultaneous increase ace<NUMBER> mrna expression cortex authors suggest omapatrilat exerts effect inducing ace<NUMBER> expression resulting concomitant increase angiotensin<NUMBER> production angiotensin ii associated decrease blood pressure rather via inhibition ace nep known cleave angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> demonstrated concentrations angiotensin<NUMBER> kidney urine increased normal pregnancy rats <NUMBER> light evidence renal ace<NUMBER> expression brosnihan et al <NUMBER> investigated possibility changes ace<NUMBER> expression may associated previous finding levels angiotensin<NUMBER> increase pregnancy found renal distribution angiotensin<NUMBER> ace<NUMBER> similar change gestation however intensity staining elevated <NUMBER> <NUMBER> respectively pregnant rats findings suggest ace<NUMBER> primary candidate local production increased angiotensin<NUMBER> generation pregnancy evidence role ace<NUMBER> may play ras came study zisman et al <NUMBER> report upregulation ace<NUMBER> expression failing human heart ventricles parallel paper group presented evidence involvement novel angiotensin<NUMBER> activity intact failing heart <NUMBER> later study demonstrated formation angiotensin<NUMBER> correlated level ace<NUMBER> expression could completely abolished administration ace<NUMBER>specific inhibitor data indicated failing hearts major route increased production angiotensin<NUMBER> angiotensin ii via ace<NUMBER> rather angiotensin via neprilysin previously suggested separate study implicated renal ace<NUMBER> pathogenesis diabetic nephropathy <NUMBER> study shown ace<NUMBER> mrna protein expression levels significantly reduced kidneys <NUMBER>weekold streptozocininduced diabetic rats reduction ace<NUMBER> mrna expression influenced ace inhibitor treatment however decrease ace<NUMBER> protein expression prevented conditions thereby suggesting ace<NUMBER> protein expression associated ace activity contrast renal ace<NUMBER> protein found higher absence concomitant increase ace<NUMBER> mrna levels young diabetic mice dbdb onset diabetic nephropathy <NUMBER> balance ace ace<NUMBER> low versus high protein levels respectively may renoprotective early stages diabetes balance lost upon progression renal damage hence postulated ace<NUMBER> involved aetiology diabetes via ras role previously characterised disease state review see ref <NUMBER> collectively studies vivo provide strong evidence role ace<NUMBER> ras localised production angiotensin<NUMBER> angiotensin ii perhaps serving negative regulator vasoconstrictive effects ace maintain blood pressure homeostasis maintain cardiac renal function fig <NUMBER> surprising discovery ace<NUMBER> functional receptor sars coronavirus causative agent sars series elegant experiments li et al <NUMBER> coimmunoprecipitated virus attachment glycoprotein s<NUMBER> lysates african green monkey kidney cell line vero e<NUMBER> subjected precipitated proteins mass spectrometry among sequences number obtained corresponding ace<NUMBER> subsequently demonstrated recombinant soluble ace<NUMBER> ace able block association vero e<NUMBER> cells sars cov protein expression recombinant ace<NUMBER> s<NUMBER> protein resulted cell fusion formation syncytia <NUMBER>t cells cell line normally resistant sars cov infection furthermore <NUMBER>t cells expressing ace<NUMBER> permitted efficient replication coronavirus viral genome copies increased <NUMBER> <NUMBER>fold <NUMBER>h period compared <NUMBER>fold untransfected cells ace<NUMBER>specific antibody inhibited cytopathicity sarscov dosedependent manner expression profiling mrna performed harmer et al <NUMBER> demonstrates expression low levels ace<NUMBER> bronchus lung parenchyma taken together evidence primary sites murine ace<NUMBER> expression lung kidney <NUMBER> led li et al <NUMBER> suggest tissue distribution ace<NUMBER> consistent pathology sarscov furthermore hamming et al <NUMBER> recently provided evidence ace<NUMBER> abundantly expressed epithelia lung small intestine possible entry sites sars virus whilst research determining receptor binding properties sars cov protein progressed rapid rate little known residues ace<NUMBER> involved binding preliminary experiments performed li et al <NUMBER> indicate disrupting active site ace<NUMBER> effect s<NUMBER> binding studies required understand nature proteinprotein interactions recently widely assumed intricacies ras largely elucidated recent studies examining properties ace<NUMBER> however provided evidence crucial pathway may significantly complicated previously thought whilst yet precise physiological role ace<NUMBER> remains determined becoming increasingly apparent ace<NUMBER> may act counterbalance effects ace ras given significance ace inhibitors treatment number pathophysiological disorders contribution ace<NUMBER> regulation ras cannot ignored indeed modulation ace<NUMBER> activity may provide significant new therapeutic opportunity treatment cardiovascular disease either isolation conjunction existing ace inhibitors exciting possibility highlights need continuing efforts elucidate vivo roles biochemical properties emerging player ras fig <NUMBER> schematic representation reninangiotensin system ras ace angiotensinconverting enzyme nep neprilysin <NUMBER> angiotensin ii type receptor <NUMBER> angiotensin type ii receptor conversion angiotensin angiotensin<NUMBER> ace<NUMBER> kinetically much less favourable conversion angiotensin ii angiotensin<NUMBER> tors arbs known benefit harm cardiovascular kidney health associated discontinuing three articles published journal provide data whether ace inhibitors arbs indeed harmful context covid<NUMBER> epidemic observational studies looming possibility confounding unique strengths message consistent none three studies showed evidence harm continued use ace inhibitors arbs mehra et al <NUMBER> conducted database study involving patients hospitalized <NUMBER> countries three continents study included <NUMBER> patients received diagnosis covid<NUMBER> admitted hospital december <NUMBER> <NUMBER> march <NUMBER> <NUMBER> either died hospital survived hospital discharge multivariate logisticregression analysis age greater <NUMBER> years coronary artery disease congestive heart failure history cardiac arrhythmia chronic obstructive pulmonary disease current smoking associated increased risk inhospital death female sex associated decreased risk neither ace inhibitors arbs associated increased risk inhospital death secondary analysis restricted patients hypertension ace inhibitor arb would indicated also show harm mancia et al <NUMBER> conducted casecontrol study involving patients confirmed covid<NUMBER> lombardy region italy severely affected pandemic analysis <NUMBER> people confirmed sarscov<NUMBER> infection diagnosed february <NUMBER> march <NUMBER> <NUMBER> compared <NUMBER> controls matched according age sex municipality residence conditional logisticregression multivariate analysis neither ace inhibitors arbs associated likelihood sarscov<NUMBER> infection additional analysis comparing patients severe fatal infections matched controls also show association drugs severe covid<NUMBER> reynolds et al <NUMBER> conducted study based data electronic health records <NUMBER> patients new york university nyu langone health system tested covid<NUMBER> march <NUMBER> april <NUMBER> <NUMBER> total <NUMBER> patients positive test among <NUMBER> severe illness defined admission intensive care unit mechanical ventilation death propensityscore matching performed among tested patients among patients hypertension assess whether likelihood positive test result associated several antihypertensive drug classes well among covid<NUMBER>positive patients patients hypertension assess whether likelihood severe illness among positive test associated drug classes investigators bayesian analysis showed positive association analyzed drug classes including ace inhibitors arbs either positive test result severe illness taken together three studies provide evidence support hypothesis ace inhibitor arb use associated risk sarscov<NUMBER> infection risk severe covid<NUMBER> among infected risk inhospital death among positive test studies weaknesses inherent observational data find reassuring three studies different populations different designs arrive consistent message continued use ace inhibitors arbs unlikely harmful patients covid<NUMBER> several smaller studies china united kingdom come conclusion <NUMBER> <NUMBER> <NUMBER> <NUMBER> note mehra et al found use either ace inhibitors statins may associated lower risk inhospital death nonuse neither two studies estimated lower risk covid<NUMBER> likelihood positive test among patients treated agents unexpected result study mehra et al may due unmeasured confounding absence randomized trial regarded evidence prescribe drugs patients covid<NUMBER> professional scientific societies experts spoken one voice advising patients discontinue ace inhibitor arb therapy concern increased risk infection severe illness death covid<NUMBER> pandemic <NUMBER> <NUMBER> <NUMBER> data three studies support recommendations ultimately one randomized trials needed answer definitively question whether ace inhibitors arbs pose harm patients covid<NUMBER> disclosure forms provided authors available full text editorial nejmorg editorial published may <NUMBER> <NUMBER> nejmorg dear sir today’s reports global number confirmed cases covid<NUMBER> surpassed <NUMBER> number known cases increasing several thousand every day march <NUMBER> <NUMBER> publicly characterized covid<NUMBER> pandemic issue serious concern deserves momentous attention coronaviruses family viruses cause respiratory illnesses cause illness animals seven known types coronaviruses cause illness humans coronavirus sarscov<NUMBER> severe acute respiratory syndromecoronavirus<NUMBER> one viruses – causes illness currently known coronavirus disease<NUMBER> covid<NUMBER> though still learning exactly puts someone greater risk developing severe illness covid<NUMBER> early information indicates older patients chronic medical conditions hypertension diabetes cardiocerebrovascular diseases may higher risk <NUMBER> <NUMBER> <NUMBER> infection caused covid<NUMBER> likely disturb metabolic regulation diabetic patients covid<NUMBER> may face altered immune response background already compromised health status owing diabetesrelated complications andor aging important findings patients hyperglycemia viral infection significant worsening symptoms implies greater morbidity patients compared without diabetes <NUMBER> however pathophysiology association remains uncertain known whether hyperglycemia changes virulence infection virus modifies glycemic metabolism know diabetic patients susceptible infection impact glucose metabolism <NUMBER> dm disorder glucose metabolism chronic inflammatory condition characterized multiple changes lipid carbohydrate protein profiles <NUMBER> inflammatory processes due hyperglycemia leads increased synthesis glycosylation end products ages activates macrophages cells immune system increase oxidative stress promote synthesis proinflammatory cytokines besides stimulating synthesis adhesion molecules facilitate inflammation tissues <NUMBER> inflammatory process complications might provide higher propensity infections greater severity conditions another important issue inflammatory immune response occur diabetic patients acquire viral infection well whether virus interferes insulin secretion glycemic control stage biological mechanism relationship covid<NUMBER> diabetes known association severity cases death pronounced need develop hypothesis explain causal path underlying severe clinical presentation covid<NUMBER> infection subsequent death diabetic patients biochemical tests also essential clarify molecular pathophysiology involved association covid<NUMBER> dm substantial public health importance deserves proper attention since large diverse population affected globally nowadays comorbidity poses relevant threat human health prospective welldesigned studies elucidate biological mechanism best clinical management association urgently neededhomephilipphiliphomenewcastleacuktranslational clinical research institute medical school framlington place newcastle upon tyne ne<NUMBER> <NUMBER>hu ukdear sirit useful see review published journal diabetes covid <NUMBER> infection <NUMBER> highlight people diabetes death rate perhaps around four times background population note suggested <NUMBER> deaths chinawuhan people diabetes <NUMBER> clearly important understand whythere confounders form associations risk factors dying covid<NUMBER> infection notably age cardiovascular disease cannot explain excess need understand better mitigate riskit reported deaths occurring context pneumonitis <NUMBER> particularly onset adult respiratory distress syndrome ards condition excess fluid alveoli blocks gas exchange air bloodpeople diabetes many cardiovascular disease cvd without diabetes permeable vasculature identified since <NUMBER>s albumin lead kidneys micro macroalbuminuria even prior late blush retina intravenous fluorescence marker injection <NUMBER> leaky vasculature associated vascular inflammation metabolic syndrome steatohepatitis well cvd per seit would seem far stretch absence research yet assume prior enhancement vascular permeability could account increased rate ards death people diabetes particularly type <NUMBER> diabetes also cvdaside research would suggest already albuminuria routine yearly test people diabetes higher liver enzyme markers alt perhaps diabetes associated dyslipidaemia low hdl cholesterol take particular steps selfisolateit unclear fast vascular inflammation ameliorated improved blood glucose control nearly glucoselowering medications reduce microalbuminuria time tight glucose control infected persons insulin would meanwhile seem sensible poor glucose control known interfere leukocytelymphocyte function <NUMBER>yours sincerelyphilip hometranslational clinical research institute newcastle university ukreferences<NUMBER>guptarghoshasinghakmisraaclinical considerations patients diabetes times covid<NUMBER>diabetes metabolic syndr clin res rev<NUMBER>e<NUMBER>joint commission report whochina joint mission coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> february <NUMBER> available httpswwwwhointdocsdefaultsourcecoronavirusewhochinajointmissiononcovid<NUMBER>finalreportpdf accessed <NUMBER> march <NUMBER>the novel coronavirus pneumonia emergency response epidemiology team epidemiological characteristics outbreak <NUMBER> novel coronavirus diseases covid<NUMBER> — china <NUMBER> china cdc weekly <NUMBER> <NUMBER>x <NUMBER> available httpsgithubcomcmriversncovblobmastercovid<NUMBER>pdf china cvd weekly accessed <NUMBER> march <NUMBER>raskmadsenckingglvascular complications diabetes mechanisms injury protective factorscell metab<NUMBER>pozzilli p signore e leslie rdg infections immunity diabetes alberti kgmm zimmet p defronzo ra ed international textbook diabetes second edition chichester john wiley <NUMBER> <NUMBER> guptariteshfortis cdoc hospital chirag enclaverenin angiotensin system blockade covid<NUMBER> diseasedear editorwe recently published article highlighting special concerns managing patients diabetes times covid<NUMBER> pandemic<NUMBER> concerns use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arbs clarified publication<NUMBER> summarising current evidence regard try arrive reasonable conclusionin absence vaccine antiviral drug covid<NUMBER> infection several therapeutic approaches studied one approach use inhibitors renin angiotensin system namely ace inhibitors arbs hand concern raised fact patients agents might increased risk infection severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER>angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor sars cov<NUMBER> well coronaviruses expressed type <NUMBER> alveolar epithelial cells endothelium sglycoprotein surface coronavirus binds ace<NUMBER> leads conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> ultimately leading internalization virion<NUMBER> viral sglycoprotein tmprss<NUMBER> ace<NUMBER> inhibition potential targets therapy possibly vaccine developmentas ace<NUMBER> essential coronavirus infection blockade thought beneficial preventingtreating infection retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors<NUMBER> mice coronavirus induced lung injury showed improvement treated losartan<NUMBER> far cvid<NUMBER> infection concerned data ras activation effect blockade limited present hypokalaemia could marker ras activation high incidence hypokalaemia reported patients covid<NUMBER> infection<NUMBER>despite small studies suggesting benefit drugs acting ras data albeit scarce animal models human studies treatment ace inhibitors arb could cause regulation ace<NUMBER> ibuprofen thiazolidinediones also shown same<NUMBER> <NUMBER> increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however currently evidence support hypothesis view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension<NUMBER> <NUMBER>references<NUMBER>guptarghoshasinghakmisraaclinical considerations patients diabetes times covid<NUMBER> epidemicdiabetes metab syndr<NUMBER> mar <NUMBER>fanglkarakiulakisgrothmare patients hypertension diabetes mellitus increased risk covid<NUMBER> infectionlancet respir med<NUMBER> mar <NUMBER>s<NUMBER>hoffmannmkleineweberhkrügernmüllermdrostencpöhlmannsthe novel coronavirus <NUMBER> <NUMBER>ncov uses sarscoronavirus receptor ace<NUMBER> cellular protease tmprss<NUMBER> e ntry target cellsbiorxiv<NUMBER>henryczaizafounmstockeghamandesarroligaacwhitehdimpact angiotensinconverting enzyme inhibitors statins viral pneumoniaproc bayl univ med cent<NUMBER>yangpguhzhaozwangwcaoblaicyangxzhanglduanyzhangschenwzhenwcaimpenningerjmjiangcwangxangiotensinconverting enzyme <NUMBER> ace<NUMBER> mediates influenza h<NUMBER>n<NUMBER> virusinduced acute lung injurysci rep<NUMBER>chen li x song q hu c su f daij ye huangj zhang x hypokalemia clinical implications patients coronavirus disease <NUMBER> covid<NUMBER> medrxiv preprint doi <NUMBER>lixczhangjzhuojlthe vasoprotective axes reninangiotensin system physiological relevance therapeutic implications cardiovascular hypertensive kidney diseasespharmacol res<NUMBER>qiaowwangcchenbzhangfliuyluqguohyancsunhhugyinxibuprofen attenuates cardiac fibrosis streptozotocininduced diabetic ratscardiology<NUMBER>zhangwxuyzliubwuryangyyxiaoxqzhangxpioglitazone upregulates angiotensin converting enzyme <NUMBER> expression insulinsensitive tissues rats highfat dietinduced nonalcoholic steatohepatitisscientific world journal<NUMBER>position statement esc council hypertension aceinhibitors angiotensin receptor blockers mar <NUMBER> <NUMBER> httpswwwescardioorgcouncilscouncilonhypertensionchtnewspositionstatementoftheesccouncilonhypertensiononaceinhibitorsandang<NUMBER>esh statement covid<NUMBER> march <NUMBER> <NUMBER> httpswwweshonlineorgspotlightseshstatementoncovid<NUMBER>accessed <NUMBER> march <NUMBER> a<NUMBER> a<NUMBER> a<NUMBER> a<NUMBER> a<NUMBER> novel coronavirus disease covid<NUMBER> spreading worldwide caused <NUMBER> deaths far <NUMBER> mortality rate varies widely age across individuals ranging <NUMBER> among healthy youngadults <NUMBER> among older persons preexisting conditions <NUMBER> although pharmacological treatment assessed first observational studies patients severe disease reported high prevalence comorbidities often treated angiotensin converting enzyme ace inhibitors cerebrovascular diseases coronary heart disease hypertension diabetes <NUMBER> <NUMBER> <NUMBER> observing human pathogenic coronaviruses bind target cells angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies reported increase ace<NUMBER> expression mediated angiotensin ii typei receptor blockers arbs ace inhibitors consistently animals humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hypothesized increased expression ace<NUMBER> would facilitate infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> thus hypertension treatment ace<NUMBER>stimulating drugs well ace<NUMBER> polymorphisms might increase risk developing severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> consequently would lead serious conflict regarding treatment ace<NUMBER> reduces inflammation suggested potential new therapy inflammatory lung diseases cancer diabetes hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> wake two preliminary cohort studies reporting lower <NUMBER> similar <NUMBER> covid<NUMBER> mortality among inpatients hypertensive subjects treated arbs ace inhibitors potential predictors covid<NUMBER> disease severity including antihypertensive medications recently analyzed observational studies <NUMBER> <NUMBER> <NUMBER> one exception <NUMBER> increased risk emerged use arbs ace inhibitors however role potentially linked predictors including age cardiovascular comorbidities <NUMBER> <NUMBER> <NUMBER> differed across population analyzed still requires confirmation performed casecontrol study sarscov<NUMBER> infected subjects diagnosed two italian provinces retrieving admission pharmacological data two years infection order confirm potential independent predictors severelethal covid<NUMBER> including treatment ace inhibitors andor arbs casecontrol retrospective study compared proportion subjects treated arbs andor ace inhibitors among three groups subjects sarscov<NUMBER> infection asymptomatic infection mild disease defined fever malaise plus least one followings sore throat muscle pain shortness breath dry cough headache conjunctivitis diarrhea <NUMBER> hospital admission b severe disease requiring hospital admission intensive care unit c severe lethal disease requiring admission intensive care unit andor causing death sample includes subjects diagnosis infection made province ferrara april <NUMBER> province pescara italy april <NUMBER> <NUMBER> central laboratory university hospital ferrara central laboratory pescara hospital confirmed national institute health diagnoses made using real time reverse transcription polymerase chain reaction rrtpcr oropharingeal specimens assays originally proposed charitéuniversitätsmedizin berlin institute virology <NUMBER> endorsed <NUMBER> data background pharmacological treatment previous two years january <NUMBER> <NUMBER> obtained national database drug prescription integrated clinical chart information hospitalized subjects data collected following drugs ace inhibitors atc classes c<NUMBER>a c<NUMBER>b arbs c<NUMBER>c c<NUMBER>d insulin antidiabetic drugs a<NUMBER> information age gender preexisting conditions subjects obtained datalinkage hospital discharge abstracts italian sdo queried day diagnosis january <NUMBER>st <NUMBER> admission data revised manually two physicians lm mef following conditions included analyses malignant tumors major cardiovascular diseases heart failure myocardial infarction strokecvd type ii diabetes renal disease chronic obstructive pulmonary diseases copd bronchitis pneumonia asthma emphysema study complies declaration helsinki research protocol approved ethics committee emiliaromagna region code <NUMBER> approved march <NUMBER> <NUMBER> requirement informed consent waived retrospective pseudoanonymized nature data first differences across groups mild severe severelethal disease evaluated using twoway anova posthoc tukey hsd test continuous variables mantelhaenzsel chisquared test categorical ones sample restricted hypertensive subjects used compare subjects treated untreated ace inhibitors arbs multivariate logistic regression used investigate potential independent predictors severe severelethal covid<NUMBER> four models built two restricted hypertensive subjects b two included total sample models c models c fit predict severe severe disease grouped together models b predict severelethal disease repeated predict death similar results shown avoid redundancy recorded variables age gender cvd diabetes renal disease cancer copd included priori models exception treatments ace inhibitors arbs excluded models c multicollinearity hypertension standard diagnostic procedures adopted check models validity influential observation analysis dbeta change pearson chisquare similar multicollinearity interaction terms hosmerlemeshow test goodness fit c statistic area receiving operator curve statistical significance defined twosided pvalue<NUMBER> analyses carried using stata version <NUMBER> stata corp college station tx <NUMBER> sample <NUMBER> hypertensive subjects severelethal covid<NUMBER> <NUMBER> hypertensive subjects mild disease asymptomatic infection <NUMBER> statistical power detect difference <NUMBER> higher corresponding relative risk �<NUMBER> risk severelethal disease users arbs ace inhibitors exposed group non users controls sample consisted <NUMBER> subjects mean age <NUMBER>y <NUMBER> males <NUMBER> <NUMBER> severe symptoms <NUMBER> <NUMBER> severe lethal disease table <NUMBER> sample infected subjects compared available estimates general population two provinces <NUMBER> showed higher prevalence diabetes <NUMBER> sample versus ffi<NUMBER> general population hypertension <NUMBER> versus ffi<NUMBER> copd <NUMBER> versus ffi<NUMBER> cvd <NUMBER> versus ffi<NUMBER> <NUMBER> subjects deceased mean age <NUMBER> years <NUMBER> males <NUMBER> hypertensive <NUMBER> diagnosed cvd <NUMBER> diabetics twenty subjects severe disease younger <NUMBER> years youngest male aged <NUMBER> years deceased eight younger <NUMBER> years youngest female aged <NUMBER> years univariate analysis compared subjects mild disease severe severelethal disease significantly likely older diabetics hypertensive diagnosed copd cvd renal disease treated arbs andor ace inhibitors p<NUMBER> among hypertensive subjects n <NUMBER> however proportion treated arbs ace inhibitors whose medication discontinued followup <NUMBER> older age showed exponential increase <NUMBER> years compared subjects younger <NUMBER> years aors aged <NUMBER> �<NUMBER> years <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively model c table <NUMBER> male gender older age diabetes also predicted severelethal disease model table <NUMBER> main findings retrospective observational study following first confirmed among hypertensive subjects use ace inhibitors arbs two years preceding sarscov<NUMBER> infection affect severity covid<NUMBER> second older age male gender diabetes presence copd cvd independent predictors severe disease sharp increase risk among subjects older <NUMBER> years third older age male gender diabetes associated higher likelihood severe lethal disease several hypotheses made association covid<NUMBER> progression treatment ace inhibitors arbs <NUMBER> <NUMBER> <NUMBER> one side asked whether therapy discontinued sarscov<NUMBER> pandemic <NUMBER> <NUMBER> covid<NUMBER> strongly associated hypertension frequently treated arbs ace inhibitors <NUMBER> <NUMBER> <NUMBER> indeed hypothesized ace<NUMBER> upregulation mediated arbs lesser extent ace inhibitors might increase patients susceptibility sarscov<NUMBER> entry host cells viral propagation <NUMBER> <NUMBER> b virus binding ace<NUMBER> might reduce activity thus leading increased levels angiotensin ii consequent pulmonary vasoconstriction inflammation oxidative organ damage increased risk acute lung injury <NUMBER> opposite side scientists suggested harmful arbs ace inhibitors use patients cardiovascular risk factors known suspected covid<NUMBER> may even exert beneficial effect ace<NUMBER> upregulation could increase conversion angiotensin ii angiotensin<NUMBER> peptide potentially protective antiinflammatory properties <NUMBER> <NUMBER> recently large observational studies based upon inand outpatient electronic health records <NUMBER> <NUMBER> <NUMBER> examined association antihypertensive medications risk covid<NUMBER> andor severelethal disease results line previous findings absence risk ace inhibitors andor arbs use brief studies mancia et al <NUMBER> reynolds et al <NUMBER> reported difference covid<NUMBER> severity death treated untreated subjects arbs ace inhibitors instead results mehta et al <NUMBER> partially discordant study found association treatment arbs death treated ace inhibitors showed significantly higher risk icu admission sample order investigate potential beneficial effects ace inhibitors impact might larger patients diabetes copd cardiovascular diseases performed additional analyses stratified comorbidities found however significant differences risk severelethal covid<NUMBER> among treated untreated patients either cvd diabetes copd data shown besides sample size provenance differences previous studies studies included infected subjects hospitalized evaluated disease progression beyond mortality retrieved medications admissions electronic health records exception mehta et al assessed medications exclusively time testing sarscov<NUMBER> <NUMBER> overall present previous findings confirm preliminary chinese cohorts <NUMBER> <NUMBER> although confirmation randomized studies required <NUMBER> strongly support statements several experts <NUMBER> <NUMBER> scientific societies including european medicines agency <NUMBER> european society cardiology <NUMBER> american heart association <NUMBER> recommend continuation arbs ace inhibitors medication patients unless otherwise advised physicians regard role risk factors suggested severe covid<NUMBER> including age male gender hypertension diabetes copd major cardiovascular diseases correctly argued far available data unadjusted thus relative importance underlying health conditions unclear <NUMBER> <NUMBER> study found support potential role gender diabetes copd cvd beyond age covid<NUMBER> progression severe disease whereas gender diabetes significantly increased risk lethal severe outcome thus present study confirms prior findings independent relationship older age male gender death <NUMBER> copd progression towards severe disease <NUMBER> instead least two issues may influenced conflicting results role cvd copd predicting severe lethal disease association showed prior populations <NUMBER> lacking present well recent findings <NUMBER> first relatively small sample present study second marked difference population enrolled compared previous studies included randomly selected sarscov<NUMBER> negative subjects controls <NUMBER> given present scenario populationbased cohort studies longer followup clearly needed <NUMBER> clarify findings addition relatively small sample limitation present study lack tobacco smoking body mass index among variables recorded could extract information half deceased subjects well many hospitalized limitations lack evaluation severity underlying cardiovascular diseases absence data antihypertensive medications however potential role altering relationship arbs ace inhibitors risk severelethal covid<NUMBER> remains unclear none previous studies topic assessed cardiovascular diseases severity <NUMBER> <NUMBER> <NUMBER> two studies included use antihypertensive drugs multivariable analyses find substantial differences adjusted unadjusted relative risks death <NUMBER> <NUMBER> conclusions present study find association covid<NUMBER> severity treatment arbs ace inhibitors confirms previous findings supporting recommendation several scientific societies continue arbs ace inhibitors medication patients unless otherwise advised physicians thus reassured adjusted analyses substantially confirm prior reports indicating risk severe lethal covid<NUMBER> largely significantly increases among elderly males diabetics copd major cardiovascular diseases coronaviruses cov large family viruses cause illness ranging common cold severe diseases middle east respiratory syndrome merscov severe acute respiratory syndrome sarscov sarscov<NUMBER> caused rapidly spreading outbreak covid <NUMBER> <NUMBER> <NUMBER> infected cases <NUMBER> <NUMBER> deaths globally <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> httpscoronavirusjhuedumaphtml sarscov<NUMBER> positive strand rna virus seen infect humans angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> covid<NUMBER> infections emerging evidence demonstrates older individuals people underlying metabolic conditions diabetes mellitus hypertension hyperlipidemia higher risk morbidity mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> individuals hypertension diabetes cardiovascular disorders vascular complications renin angiotensin system ras known activated increase ace activity downregulation ace<NUMBER> modulation system aceinhibitors <NUMBER> receptor blockers considered firstline therapy well prevention management vascular complications regard questions arise differences ace<NUMBER> may explain exacerbated course disease patients metabolic diseases ii ace modulation covid<NUMBER> patients neutral beneficial harmful latter question may immediate therapeutic consequences millions patients moreover ace<NUMBER>based therapy proposed potential therapeutic approach covid<NUMBER> pneumonia <NUMBER> angiotensin converting enzyme <NUMBER> ace<NUMBER> single pass type <NUMBER> membrane monocarboxypeptidase discovered <NUMBER> decades ago <NUMBER> consists nterminal peptidase domain cterminal collectrin like domain <NUMBER> peptidase domain responsible main functions renin angiotensin system ras <NUMBER> ace<NUMBER> shares <NUMBER> homology nterminal catalytic domain ace hydrophobic region near cterminus likely serve membrane anchor <NUMBER> <NUMBER> ace<NUMBER> protein encoded ace<NUMBER> gene located chromosome xp<NUMBER> ace<NUMBER> proteins abundantly expressed apical surface welldifferentiated mostly ciliated airway epithelium lungs alveolar type<NUMBER> cells enterocytes small intestine <NUMBER> furthermore ace<NUMBER> protein expressed arterial venous endothelial cells arterial smooth muscle cells heart kidneys adrenal glands pancreas skeletal muscle adipose tissues <NUMBER> coronavirus sarscov<NUMBER> single stranded rna virus seen infect humans envelope spike glycoprotein sprotein responsible cov cell entry hosttohost transmission viral infection sprotein cleaves s<NUMBER> s<NUMBER> <NUMBER> furin cleavage site sarscov<NUMBER>s protein may provide priming mechanism <NUMBER> ectodomain s<NUMBER> binds peptidase domain ace<NUMBER> enzyme s<NUMBER> cleaved host cell serine protease tmprss<NUMBER> <NUMBER> resulting membrane fusion steps essential viral entry cells vivo study shows infection human airway epithelia sars coronavirus correlated state cell differentiation ace<NUMBER> expression localization <NUMBER> infection tends occur readily well differentiated ciliated cells higher ace<NUMBER> expression <NUMBER> observed ace<NUMBER> membrane expression plasma levels reduced infection sars coronavirus <NUMBER> sars cov spike protein found reduce ace<NUMBER> expression augment pulmonary injury <NUMBER> however treatment blockers reninangiotensin system reduced pulmonary injury activating ace<NUMBER>ang<NUMBER>mas axis classical endocrine model ras renin cleaves substrate angiotensinogen agt produce inactive peptide angiotensin ang converted angiotensin ii ang ii endothelial angiotensinconverting enzyme ace catalytic activity ace activate ang ii occurs extensively lung ang ii mediates vasoconstriction well aldosterone release adrenal gland resulting sodium retention increase blood pressure angiotensin <NUMBER> receptor <NUMBER> r however recent evidence suggests ras also includes local systems autocrine celltosame cell paracrine celltodifferent cell effects addition classical circulating ras wellknown classical endocrine effects particular ang ii generation tissue level tissue specific ras appears physiologic effects important circulatingsystemic ang ii circumstances important circulating ang ii therefore ras system involved controlling blood volume blood pressure tissue specific local systems directs tissue remodeling endothelial dysfunction fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> simplistically seen dual function system acts two apparently opposite arms one responsible main actions system constituted ace ang iiat <NUMBER> receptor axis counterregulatory arm formed ace<NUMBER>ang<NUMBER>mas axis catalytic activity ace results increased ang ii levels increased catabolism ang<NUMBER> whereas catalytic activity ace<NUMBER> predominantly ang ang ii leads formation ang<NUMBER> ang<NUMBER> acts gprotein coupled receptor mas known counterregulatory actions ang ii resulting vasoconstriction growth inhibitory effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> see ▶ fig <NUMBER> common mechanism diabetes hypertension metabolic disorders cause vascular complications endothelial dysfunction inflammation atherosclerosis disorders aceang iiat <NUMBER> receptor axis activated downregulation ace<NUMBER>ang<NUMBER>mas axis <NUMBER> <NUMBER> <NUMBER> leads increased local circulatory ang ii decrease ang<NUMBER> subsequent increased oxidative stress activation endothelium smooth muscle cell migration growth proliferation thrombosis <NUMBER> <NUMBER> <NUMBER> deficiency ace<NUMBER> leads increased formation atherosclerotic plaques blocking ace<NUMBER> results prevention atherosclerosis <NUMBER> ▶ fig <NUMBER> ace<NUMBER> present multiple organs various functions heart ace<NUMBER> prevents progressive cardiac fibrosis associated aging andor cardiac pressure overload beneficial heart failure <NUMBER> <NUMBER> forms chronic kidney disease including diabetic hypertensive nephropathy expression ace<NUMBER> reported reduced kidney tubules increased expression glomerula <NUMBER> imbalance postulated potential cause diabetic nephropathy adrenal glands local secretory ras stimulates aldosterone production serves amplification system circulating ang ii importantly regulation secretory adrenal ras independent circulatory ras activity adrenal ras correlates aldosterone production regulation potassium serum concentrations <NUMBER> severe diabetes associated hyporeninaemic hyperactivity adrenal gland <NUMBER> pancreas ace<NUMBER>ang<NUMBER>mas axis described protect function insulinproducing beta cells improving function islet microvascular endothelial cells activation endothelial nitric oxide synthase signaling pathways via ace<NUMBER>ang<NUMBER>mas axis may antiinflammatory beneficial effects pancreatitis <NUMBER> <NUMBER> skeletal muscle ace<NUMBER>ang<NUMBER>mas axis described decrease insulin resistance <NUMBER> ace<NUMBER> may exert potential antiobesity effects via stimulating brown adipose tissue formation induction browning white adipose tissue <NUMBER> study done survivors sars infections organ involvement correlated organ expression ace<NUMBER> significantly higher immunostaining lung kidney heart islets pancreas <NUMBER> series <NUMBER> <NUMBER> patients diabetes hospitalization resolved subsequently suggestive acute islet cell damage diabetes probably due use ace<NUMBER> receptor domain viral entry <NUMBER> respiratory system major site aceactivity source systemic ang ii synthesis locally produced ang ii may trigger increasing vascular permeability facilitating pulmonary edema ace<NUMBER>ang<NUMBER>mas axis highly expressed lungs may potentially induce pulmonary vasoconstriction response hypoxia important process preventing shunting patients pneumonia lung injury <NUMBER> acute respiratory distress syndrome ards mouse models ace<NUMBER> knockout mice displayed severe ards symptoms compared wildtype mice overexpression ace<NUMBER> appeared protective <NUMBER> ▶fig <NUMBER> schematic representation show renin angiotensin system diabetes interaction sarscov <NUMBER> ace<NUMBER> <NUMBER> sarscov <NUMBER> interacts ace<NUMBER> spike proteins priming tissue serene proteases uses ace<NUMBER> protein enter alveolar cells lungs <NUMBER> renin angiotensin system consists renin catalyzes conversion angiotensinogen angiotensin <NUMBER> ang <NUMBER> subsequent axis depends balance angiotensin converting enzyme ace ace<NUMBER> ace converts ang <NUMBER> ang ii acts angiotensin receptor <NUMBER> r whereas ace<NUMBER> converts ang<NUMBER> acts mas receptor <NUMBER> respiratory system activation ace leads proinflammatory profibrotic prohyperresponsiveness response respiratory system whereas ace<NUMBER>ang<NUMBER>mas induces protective mechanism antiinflammatory antifibrotic antihyperresponsiveness lower ace<NUMBER> put individuals higher risk respiratory distress <NUMBER> hypertension diabetes cvd ace related pathway activated downregulation ace<NUMBER> pathway results multiorgan complications seen metabolic diseases endothelial dysfunction promoting atherosclerosis increased cardiac fibrosis lv remodeling diabetic nephropathy hyperactivity adrenal gland decreases insulin release increases insulin resistance <NUMBER> infection covid<NUMBER> may exacerbate ace<NUMBER> deficiency patients organs maybe responsible multiorgan failure thus stimulation ace<NUMBER>ang<NUMBER>mas axis may antiinflammatory antifibrotic effects pulmonary system actions could potentially favorable recovery patients pulmonary inflammation possible ace ace<NUMBER> imbalance one potential mechanisms explaining patients cardiometabolic problems higher risk respiratory failure <NUMBER> animal model study reported infusion sars cov spike protein reduced ace<NUMBER> expression augmented pulmonary injury however treatment blockers reninangiotensin system reduced pulmonary injury activating ace<NUMBER>ang<NUMBER>mas axis <NUMBER> therefore may assumed inherent downregulation ace<NUMBER>ang<NUMBER>mas axis seen metabolic conditions exacerbated covid<NUMBER> state virus uses peptidase domain enzyme entry cells ii decrease ace<NUMBER> increase ace <NUMBER> covid<NUMBER> infections chest radiography typically shows patchy diffuse asymmetric airspace opacities bilaterally peripheral zones later stages ground glass opacities ct scan typically shows bilateral involvement different sars mers starts unilaterally moreover shows bilateral multifocal groundglass opacities peripheral lung involvement milder cases widespread consolidation patients go intensive care unit pleural effusion cavitation pulmonary nodules lymphadenopathy reported patients covid<NUMBER> important clinical observation covid<NUMBER> infection china individuals early infection exhibited symptoms interestingly even negative swab results due absence infection upper respiratory tract normal chest xrays however showed significant changes ct scan lungs <NUMBER> histopathological examination early covid<NUMBER> infected lungs serendipitously detected specimens operated lung cancer revealed exudative proliferative phases acute lung injury edema congestion alveolar septa inflammatory infiltrates macrophages type ii pneumocytes hyperplasia viral inclusions organization inflammatory exudates interstitial fibrosis <NUMBER> pathological findings corroborated ct findings patchy ground glass opacities intriguingly pathological findings inflammatory fibrotic changes known exacerbated animal models ace<NUMBER> knockout mice <NUMBER> histopathological examination autopsies individuals succumbed covid<NUMBER> infections showed degenerated necrotized cells myocardium blood vessels interstitial inflammatory infiltrates focal necrosis kidneys proteinaceous exudates bowmans capsule surrounding glomerulus degeneration shedding renal tubular epithelial cells hyaline casts microthrombi fibrotic foci reported <NUMBER> <NUMBER> changes myocardial fibrosis renal changes already seen chronic phase metabolic disorders due ace<NUMBER> downregulation may get exacerbated <NUMBER> <NUMBER> vast majority covid<NUMBER> patients mild symptoms however significant percentage critically ill admission intensive care unit icu approx <NUMBER> <NUMBER> case fatality rate globally john hopkins coronavirus resource center httpscoronavirusjhuedu mortality higher patients underlying hypertension type<NUMBER> diabetes mellitus cardiovascular disease <NUMBER> <NUMBER> <NUMBER> address performed cumulative analysis published data china south korea showed disproportionately higher percentage patients higher morbidity requiring icu care ards hypertension <NUMBER> type<NUMBER> diabetes <NUMBER> cvd <NUMBER> underlying disease moreover patients admitted icu higher systolic bp compared asymptomatic cases <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent series reported none nonsurvivors hypotension <NUMBER> ▶table <NUMBER> limitation data summarized ▶ table <NUMBER> posibility cases reported twice different series interestingly however recent case report mild case extensively followed australia low level monocyte chemoattractant protein<NUMBER> mcp<NUMBER> key biomarker type<NUMBER> diabetes related vascular complications found associated minor disease pathology <NUMBER> recent preprint study hypokalemia due renal potassium wasting reported <NUMBER> critically ill patients hypokalemia independent gastrointestinal symptoms <NUMBER> presence higher expression ace<NUMBER> receptors upregulation although initially thought risk factor infection unlikely case recent preprint study wherein integrated public genomics epigenomics transcriptomics data found expression ace<NUMBER> relatively high asian females young people lower males decreases age progression type<NUMBER> diabetes <NUMBER> contradicts hypothesis higher expression directly related increased susceptibility know sarscov<NUMBER> infections common males elderly patients metabolic disorders taken together observations suggest patients underlying type<NUMBER> diabetes hypertension andor cardiovascular diseases higher risk requiring critical care ventilation evidence although critically ill tend demonstrate normotension hypertension hypokalemia classical features activated ace related ras downregulation ace<NUMBER> pathway per current data appear higher ace<NUMBER> expression associated immediate predilection individuals risk tend lower ace<NUMBER> expression since ace<NUMBER> entry receptor cellular infection sarscov<NUMBER> blocking entry using ace<NUMBER>related therapy could feasible prevent spreading infection lungs whole body convalescent sera containing neutralizing antibodies sarss protein offer protection sarscov<NUMBER> infection <NUMBER> therefore suggested use recombinant human ace<NUMBER> protein saturate viral sprotein thus prevent cellular entry sarscov<NUMBER> <NUMBER> especially interest since ace<NUMBER> already developed experimental drug apn<NUMBER> gsk<NUMBER> adult respiratory distress syndrome ards therefore available clinical trials shown ace<NUMBER> could successfully prevent lung injury original sarscov<NUMBER> <NUMBER> ards favorable effects mice piglets results recent study humans disappointing <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> another crucial step cellular infection involves serine protease tmprss<NUMBER> cleaves viral sprotein tmprss<NUMBER> inhibitor camostat mesylate approved japan pancreatic inflammation shown prevent cellular infection sarscov<NUMBER> <NUMBER> consequently could prove useful covid<NUMBER> ace inhibitors <NUMBER> receptor blockers used diabetes cardiovascular disorders modulate system preference vasodilation maintenance endothelial integrity furthermore diabetic kidney reduced ace<NUMBER> protein expression could prevented ace inhibitor therapy suggestive upregulation ace inhibitor <NUMBER> worthwhile men▶table <NUMBER> mortality death morbidity icu stay associated cardiometabolic disease based reported cases literature tioning ace<NUMBER> receptor upregulation due angiotensin receptor blockers commonly used hypertension could considered risk factor increased transmission sarscov<NUMBER> however seen <NUMBER> receptors tends associate ace<NUMBER> cases prevent internalization ace<NUMBER> receptor hence may amenable viral entry <NUMBER> moreover mentioned earlier higher expression ace<NUMBER> associated higher susceptibility infection sarscov according scientific data detailed tempting speculate blocking aceang iiat <NUMBER> receptor axis <NUMBER> blockers commonly used antihypertensives may tilt balance favor ace<NUMBER>ang<NUMBER>mas axis may help accelerate respiratory recovery patients suffering covid<NUMBER> <NUMBER> however intriguing patients likely treated acei <NUMBER> blockers ones poorest prognosis covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover ace<NUMBER> upregulation concomitant ras inhibitions may ease viral infection consequently also possible ras blockade may detrimental effect covid<NUMBER> currently clinical data support one direction thus heart failure society america american college cardiology american heart association issued statement suggest definitive evidence harm benefit use aceinhibitors <NUMBER> receptor blockers patients continue take medications usual <NUMBER> utmost priority evaluate growing stock clinical data china worldwide determine ras inhibitors beneficial deleterious covid<NUMBER> know counsel patients taking ras inhibitors fact researchers planning clinical trial study losartan covid<NUMBER> patients <NUMBER> individuals underlying hypertension type <NUMBER> diabetes cardiovascular disease higher risk respiratory failure mortality covid<NUMBER> one possible mechanisms predilection may imbalance ace pathways therapeutics targeting viral entry ace<NUMBER> receptor aceang iiat <NUMBER> receptor axis well stimulating ace<NUMBER>ang<NUMBER>mas axis may beneficial individuals evidence needs gathered whether modulation renin angiotensin system would advantageous due upregulation mas activation harmful due concomitant ace<NUMBER> receptor upregulation acute management covid<NUMBER> coronaviruses cov belong family coronaviridae considered largest rna viruses genomes ranging <NUMBER> <NUMBER> kb <NUMBER> known exist across timeframe history cause upper lower respiratory tract infections <NUMBER> viruses proteases also prone progressive mutations mostly occur viral protein targets study identified potential natural product candidates inhibit proteases efficiently current study used computational biology screen dock library natural compounds inhibit human tmprss<NUMBER> facilitates entry sarscov<NUMBER> onto host cells threedimensional structure tmprss<NUMBER> built using online server swissmodel shown figure <NUMBER>a validated results model obtained swissmodel crosschecked rampage observing <NUMBER> <NUMBER> residues favored region <NUMBER> <NUMBER> residues allowed region <NUMBER> <NUMBER> residues outlier region indicated correct geometry threedimensional arrangement model shown figure <NUMBER>b alignment template pdb id <NUMBER>ce<NUMBER> target protein shown figure <NUMBER>c validated structure human serine protease <NUMBER> prepared molecular docking analysis using molecular operating environment moe software protein <NUMBER>d protonated energy minimized using energy minimization compute option moe software energy minimization binding pocket protein predicted using moe site finder option select active site residues binding pocket threedimensional atomic coordinates protein predicted active site residues tmprss<NUMBER> asn<NUMBER> arg<NUMBER> cys<NUMBER> val<NUMBER> arg<NUMBER> leu<NUMBER> asp<NUMBER> met<NUMBER> tyr<NUMBER> ile<NUMBER> tyr<NUMBER> lys<NUMBER> asn<NUMBER> pro<NUMBER> gly<NUMBER> met<NUMBER> lys<NUMBER> asn<NUMBER> ile<NUMBER> trp<NUMBER> natural product activity species source npass freely accessible database containing <NUMBER> natural compounds classified <NUMBER> different superclasses include alkaloids derivatives lipids lipidlike molecules benzenoids lignans neolignans associated compounds <NUMBER> natural products found kingdom superkingdom bacteria <NUMBER> fungi <NUMBER> metazoan <NUMBER> viridiplantae <NUMBER> <NUMBER> genera silico screening large databases costeffective timesaving approach towards drug discovery present study used two approaches compound screening ie pharmacophorebased approach molecular docking scorebased approach first compound screening approach selected <NUMBER> pharmacophoric features known inhibitor serine protease <NUMBER> camostat mesylate includes anionic cationic atoms hbond donor acceptor aromatic center pi ring center hydrophobic centroid based features known inhibitor got <NUMBER> compounds <NUMBER> result file second compound screening approach <NUMBER> compounds docked tmprss<NUMBER> evaluation potent inhibitors molecular docking analysis revealed <NUMBER> compounds docking score comparable lower standard inhibitor camostat mesylate fdaapproved drug compounds lowest docking score considered potent inhibitors interesting mention camostat approved japanese fda treatment chronic pancreatitis postoperative reflux esophagitis could considered offlabel treatment sarscov<NUMBER>infected patients standard inhibitor tmprss<NUMBER> ie camostat interacted four key residues protease active site forming seven hydrogen bonds shown figure <NUMBER> asparagine <NUMBER> forms arene cation backbone acceptor hbonds cys<NUMBER> forms areneh bond benzene ring ligand asparagine <NUMBER> forms two hydrogen bonds anhydrous carbonyl oxygen sidechain acceptor backbone acceptor aspartic acid <NUMBER> forms acidic hydrogen bond primary amine sidechain donor hydrogen bond secondary amine ligand selected topranked druglike compounds <NUMBER> compounds figure <NUMBER> shown table <NUMBER> docking score equal −<NUMBER> lower attempt identify active natural compounds drug development among druglike compounds compounds <NUMBER> npc<NUMBER> showed highest docking score −<NUMBER> selected druglike compounds showed interaction tmprss<NUMBER> docking score −<NUMBER> better docking score −<NUMBER> standard inhibitor compound <NUMBER> forms <NUMBER> hydrogen bonds active site residues receptor protein shown figure <NUMBER> among hbonds six residues asn<NUMBER> arg<NUMBER> arg<NUMBER> lys<NUMBER> asn<NUMBER> sidechain acceptor two residues asn<NUMBER> arg<NUMBER> backbone acceptor donor compound iupac name methyl <NUMBER>s<NUMBER>as<NUMBER>as<NUMBER>hydroxymethyl<NUMBER>trihydroxy<NUMBER>hydroxymethyloxan<NUMBER>yloxy<NUMBER>a<NUMBER>atetrahydrocyclopentacpyran<NUMBER>carboxylate common name geniposide one major iridoid glycosides gardenia fruit previously shown inhibit <NUMBER>lipoxygenase <NUMBER> tumorpromoting factor pglycoprotein <NUMBER> antiangiogenic activity <NUMBER> potential antiasthma properties <NUMBER> additionally geniposide shown recently protect sepsisinduced myocardial dysfunction activating ampkα suppress myocardial reactive oxygen species ros accumulation <NUMBER> present nearly <NUMBER> species belonging various families especially rubiaceae among representative tinospora capillipes native china paederia scandens native china cornus officinalis native china japan korea eucommia ulmoides native china lantana camara weed native mexico central america caribbean tropical south america paratinospora sagittata present southern taiwanese mainland chinese disjunction artemisia capillaries chinese medicinal herb plantago asiatica native china japan korea rehmannia glutinosa native china plantago depressa native china korea himalayas gardenia jasminoides native vietnam southern china korea taiwan japan myanmar india bangladesh admet indicators suggested compound gastrointestinal absorption capability cross bloodbrain barrier regarding metabolic role found substrate cyp<NUMBER> <NUMBER>a<NUMBER> enzyme inhibitor oatp<NUMBER>b<NUMBER> possesses estrogen androgen receptor well aromatase binding properties eye irritation ames toxicity carcinogenicity null toxicity honey bee fish high acute oral toxicity <NUMBER> kgmol plasma protein binding around <NUMBER> water solubility appeared low ld <NUMBER> lethal dose <NUMBER> rat acute toxicity <NUMBER> molkg pigc<NUMBER> prediction toxicity tetrahymena pyriformis <NUMBER> µgl plc<NUMBER> predicted toxicity values fish <NUMBER> mgl predicted localized mitochondria biodegradability negligible low asselta et al <NUMBER> suggested polymorphisms responsible enhanced expression tmprss<NUMBER> italian population hence increased mortality substitution mutation position <NUMBER> ie v<NUMBER>m probed docking perspective see drug would bind differently individuals carrying mutation binding energy values top <NUMBER> ligands studied native mutant proteins values binding mutant protein different binding native protein energy value difference <NUMBER> rootmeansquare fluctuation mainchain atom coordinates alpha carbon traces native tmprss<NUMBER> v<NUMBER>m mutant ligandbound native tmprss<NUMBER> mutant tmprss<NUMBER> structures also observed figure <NUMBER> binding site residues also altered significantly mutant topranked druglike compounds potential inhibitor tmprss<NUMBER> <NUMBER> marine natural product excavatolide compound <NUMBER> briaranetype diterpene cembranolide durumolide k compound <NUMBER> predicted toxic dibenzylcyclooctadiene lignan schisphenin compound <NUMBER> shisandra sphenanthera fungal decalactone dictyosphaeric acid obtained green alga dictyosphaeria versluyii antibacterial activity methicillinresistant staphylococcus aureus mrsa vancomycinresistant enterococcus faecium candida albicans <NUMBER> compound <NUMBER> endogenous cytidine <NUMBER> diphosphocholine known citicoline compound <NUMBER> beneficial effects transient global focal cerebral ischemia <NUMBER> <NUMBER>methoxyhydnocarpin compound <NUMBER> berberis species flavonolignan similar silymarin reported strong inhibitor nora pump endogenous efflux transporter aureus plasma membrane <NUMBER> compound <NUMBER> freefloating algae known sargassum pterphenyl antioxidant curtisian l compound <NUMBER> wild mushroom paxillus microcarpin compound <NUMBER> bianthraquinone asphodelus microcarpus green tea polyphenol epicatechin <NUMBER>o<NUMBER> omethyl gallate egcg<NUMBER>me compound <NUMBER> aromatase inhibitor isogemichalcone b compound <NUMBER> mainly artocarpus broussonetia genera among remaining <NUMBER> compounds docking score comparable standard drug inhibitor worth mentioning active principles popular herbs used ayurvedic traditional medicine components multiingredient food supplements formulations ie fuscaxanthone garcinia spp <NUMBER> docking score −<NUMBER> orthosiphonone <NUMBER> docking score −<NUMBER> java tea orthosiphon stamineus <NUMBER>hydroxy<NUMBER>deoxywithanolide u <NUMBER> docking score −<NUMBER> withania somnifera commonly known ashwagandha plant immense medicinal properties belonging family solanaceae <NUMBER> <NUMBER>s<NUMBER>rroseoside <NUMBER> docking score −<NUMBER> ocimum basilicum ocimum sanctum <NUMBER> molecules <NUMBER> <NUMBER> x <NUMBER> <NUMBER> supplements formulations ie fuscaxanthone garcinia spp <NUMBER> docking score −<NUMBER> orthosiphonone <NUMBER> docking score −<NUMBER> java tea orthosiphon stamineus <NUMBER>hydroxy<NUMBER>deoxywithanolide u <NUMBER> docking score −<NUMBER> withania somnifera commonly known ashwagandha plant immense medicinal properties belonging family solanaceae <NUMBER> <NUMBER>s<NUMBER>rroseoside <NUMBER> docking score −<NUMBER> ocimum basilicum ocimum sanctum <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rmsf nativetmprss<NUMBER> mutatedtmprss<NUMBER> tmprss<NUMBER>withligand mutatedtmprss<NUMBER>withligand <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rmsf nativetmprss<NUMBER> mutatedtmprss<NUMBER> tmprss<NUMBER>withligand mutatedtmprss<NUMBER>withligand current study aimed identify potential candidate molecules ability inhibit sarscov <NUMBER> acting tmprss<NUMBER> enzyme responsible priming proteins found surface virus <NUMBER> <NUMBER> spike proteins coronaviruses facilitate viral entry target cells glycoprotein composed s<NUMBER> s<NUMBER> subunits s<NUMBER> subunit contains signal peptide followed nterminal domain ntd rbd s<NUMBER> subunit contains conserved fusion peptide heptad repeats <NUMBER> <NUMBER> transmembrane domain cytoplasmic domain <NUMBER> observed previous studies human animal cell lines including vero mdckii equally susceptible virus entry driven sarss sars<NUMBER>s suggesting similarity choice receptors two coronaviruses <NUMBER> similarly also evident sequence analysis sars<NUMBER>s rbm responsible making contact ace<NUMBER> tends harbor kind amino acids present sarss indicating use ace<NUMBER> cellular entry <NUMBER> studies also proven ace<NUMBER> direct sactivating protease binds region distant ace<NUMBER> enzyme pocket <NUMBER> hence protease responsible protein activation available vicinity ace<NUMBER> anchored membrane <NUMBER> tmprss<NUMBER> serine protease family known longer potentially palmitoylated <NUMBER>residue cytoplasmic tail may position lipid rafts plasma membrane <NUMBER> context endosomal cathepsin l cysteine protease known sactivating enzyme capable cleaving protein promote viralcellular membrane fusion <NUMBER> <NUMBER> however tmprss<NUMBER> activity essential viral spread pathogenesis infected host whereas cathepsin bl dispensable <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several serine protease inhibitors designed available market including camostat mesylate used standard inhibitor study nafamostat mesylate bromohexine hydrochloride protein inhibitors pai<NUMBER> hai<NUMBER> <NUMBER> study focused inhibition tmprss<NUMBER> host serine protease less prone mutations time compared viral proteins using natural products purpose adapted computational analysis screen dock library natural compounds considered potential inhibitors tmprss<NUMBER> camostat mesylate japanese approved drug trade name fiopin taken standard drug compare docking scores physicochemical parameters standard drug known inhibit syncytium formation <NUMBER> <NUMBER> online swissmodell homology structure tmprss<NUMBER> generated tested using rampage tool showing <NUMBER> residues favored region <NUMBER> allowed ones thus indicating correct geometry <NUMBER>d arrangement active site deduced using moe software npass freely accessible database containing <NUMBER> compounds used mine potent inhibitors result <NUMBER> compounds identified potent candidates first phase physicochemical analysis compounds obtained docked tmprss<NUMBER> second phase analysis second phase identified <NUMBER> compounds binding energies comparable lower standard inhibitor camostat mesylate −<NUMBER> among compounds focused compounds lowest docking scores also following lipinski rule five shown table <NUMBER> amino acid sequence human transmembrane protease serine <NUMBER> uniprot accession o<NUMBER> isoform<NUMBER> <NUMBER> amino acids long chosen analysis retrieved fasta format uploaded online server swissmodel httpsswissmodelexpasyorg build homology model target protein threedimensional modelled structure validated uploading rampage server httpmordredbioccamacukrapperrampagephp screened natural product activity species source database npass available httpbidd<NUMBER>nusedusgnpass contains <NUMBER> compounds <NUMBER> pharmacophoreand molecular dockingbased screening performed using moe software pharmacophorebased screening selected pharmacophoric features standard serine protease inhibitor camostat mesylate trypsinlike protease inhibitor compound mining pharmacophorebased screened library compounds docked target protein identify lead compounds best docking scores molecular docking analysis threedimensional structure human tmprss<NUMBER> pdb format opened moe software chemical computing group montreal quebec canada <NUMBER>d protonation energy minimization done compute option till gradient <NUMBER> reached polar hydrogens added site finder used predict active site residues binding pockets protein molecular docking selected mdb file library used following parameters placement triangle matcher refinement rigid receptor poses <NUMBER> rescoring <NUMBER> <NUMBER> london dg docked compounds ranked based docking scores <NUMBER> compounds best docking scores evaluated according lipinskis rule five ligand properties moe software admet property analysis done using admetsar<NUMBER> httplmmdecusteducnadmetsar<NUMBER> based report tmprss<NUMBER> mutation makes individuals susceptible covid<NUMBER> reported mutation v<NUMBER>m suggestive changed disease susceptibility <NUMBER> studied respect docking conformation presence top compound protein residue modified pymol using mutagenesis function mutated protein docked structural binding apoand holoforms native mutated tmprss<NUMBER> proteins studied visualization done pymol moe proteinligand interaction potent approach mine drugs human judgment regarding interactions facilitated computational approaches study made use computational approach sift interactions beneficial exclusive tmprss<NUMBER> binding hence curb sarscov<NUMBER> priming compounds showing interactions low scores unfavorable parameters excluded able establish favorable interactions retained docking score compound <NUMBER> found −<NUMBER> indicating compound best drug candidate among promising features drug development binding site energy value altered docked tmprss<NUMBER> v<NUMBER>m mutant information adds important flexible dimension naturaldrug mining covid<NUMBER> led concrete predictions would hopefully confirmed experimentally urther vitro vivo testing compounds identified study necessary prior input clinical trial pipeline funding work funded san giuseppe moscati national hospital aorn avellino italy miur grant farb university salerno authors declare conflict interest funders role design study collection analyses interpretation data writing manuscript decision publish results n recent short report <NUMBER> suggested angiotensin receptor blocking drug arb prescribing hypertension may possibly adverse drug class increase angiotensinconverting enzyme<NUMBER> ace<NUMBER> expression protein molecular latch sarscov<NUMBER> virus entry cells covid<NUMBER> infections also suggested generally reducing ace<NUMBER> expression could therapeutic principle covid<NUMBER> control welcome medical letters four correspondents one dr ekan cüre <NUMBER> extends case possible pharmaceutical hazard covid<NUMBER> providing evidence actually drugs additional initially suspected increase membrane ace<NUMBER> expression three correspondents paolo verdecchia <NUMBER> francisco jose fernandezfernandez <NUMBER> liu colleagues <NUMBER> take different tack suggest increasing expression ace<NUMBER> lungs beneficial acute respiratory disease syndrome ards including perhaps due covid<NUMBER> accordingly pharmacologically inducing increased pulmonary ace<NUMBER> reninangiotensin system blockers might helpful covid<NUMBER> several types experiment animals give credence idea level human ace<NUMBER> expression may perhaps important covid<NUMBER> infection knockout mice genetically modified ace<NUMBER> totally resistant coronavirus infections <NUMBER> converse two studies transgenic mice bred overexpress human ace<NUMBER> <NUMBER> <NUMBER> hace<NUMBER> transgenic mice demonstrated markedly increased infectivity lethality exposed sars coronavirus despite type evidence commonly said arb aceinhibitor dosing humans induction ace<NUMBER> would insufficient matter anyway may lungs criticism discounted applying body relevant evidence experimental clinical described detail deriving studies arb aceinhibitor dosing used replenish ace<NUMBER> lungs lung failure syndromes resulting influenza virus acid inhalation noxious influences <NUMBER> <NUMBER> <NUMBER> <NUMBER> pulmonary ace<NUMBER> expression demonstrably increased reninangiotensin block context strong evidence improves survival <NUMBER> <NUMBER> <NUMBER> <NUMBER> short drugs question hypothesis induce increased pulmonary ace<NUMBER> expression biological benefit noncoronavirus arsd coronavirus exposure plausible ask whether biological effect druginduced pulmonary ace<NUMBER> expression may deleterious promoting infectivity lethality cüre cumhur cüre <NUMBER> importantly extend spectre possible pharmaceutical hazard covid<NUMBER> providing evidence statins specifically rosuvastatin <NUMBER> antidiabetic drugs possibly sodiumglucose transporter protein <NUMBER> sglt<NUMBER> inhibitors <NUMBER> certainly glucagonlike peptide<NUMBER> receptor glp<NUMBER> agonists <NUMBER> increase membrane ace<NUMBER> expression hypothesis <NUMBER> circumscribed specific focusing arbs hypertension cüre cumhur cüre demonstrate may need think broadly matter extended issue prescribing statins antidiabetics drugs increase ace<NUMBER> expression unclear drugs influence ace<NUMBER> expression action body sodium balance appears common link sodium depletion elevating ace<NUMBER> arbs less consistently aceinhibitors increase ace<NUMBER> expression decrease body sodium content <NUMBER> aldosterone reduces ace<NUMBER> expression <NUMBER> mineralocorticoid block spironolactone increases expression <NUMBER> suggested <NUMBER> elevated plasma angiotensin substrate ace<NUMBER> elevated arbs accompanies sodium depletion general may regulate expression linked enzyme ace<NUMBER> things turn simple may partly explain aceinhibition reduces body sodium direct action lowers plasma angiotensin elevates ace<NUMBER> less consistently arbs much aldosterone dosing dietary sodium loading reduces ace<NUMBER> expression <NUMBER> effect sodium ingestion relevant use proximal small intestine tissue accessed endoscopic biopsy used direct studies human ace<NUMBER> <NUMBER> direct exposure duodenum sodium meal could confounder three correspondents verdecchio et al <NUMBER> fernandezfernandez <NUMBER> liu colleagues <NUMBER> develop case first presented relation sars epidemic <NUMBER> severe lung injury pulmonary ace<NUMBER> depleted special form pulmonary ace<NUMBER> depletion seen coronavirus infections wherein virus binds ace<NUMBER> protein internalized depleting membrane ace<NUMBER> <NUMBER> depletion ace<NUMBER> accompanied accumulation angiotensin substrate lung adverse effects plasma concentration angiotensin rise substantially severe covid<NUMBER> infections <NUMBER> body experimental clinical evidence mentioned reninangiotensin block repleting ace<NUMBER> beneficial noncoronavirus ards caused influenza viruses acid inhalation noxious influences <NUMBER> <NUMBER> <NUMBER> <NUMBER> could benefit extend covid<NUMBER> infection trial arb losartan severe covid<NUMBER> infections based line thinking commenced clinicaltrialsgov identifier nct<NUMBER> trial may carry risks worsening infection benefit reninangiotensin system block acute severe lung disease shown experimentally coronavirus infections augmenting pulmonary ace<NUMBER> expression might increase coronavirus uptake viral load classic study kuba et al <NUMBER> often misquoted providing evidence arbs aceinhibitors benefiting coronavirus pneumonia kuba et al <NUMBER> actually administered coronavirus fragments spike protein replicable entire virus spike fragments depleted pulmonary ace<NUMBER> binding aggravating existing experimental pneumonia improved pharmacological reninangiotensin system block neither study others knowledge demonstrated benefit reninangiotensin block coronavirus infection transgenic experimental animals overexpressing hace<NUMBER> mentioned previously demonstrated increased infectivity lethality sar coronavirus <NUMBER> <NUMBER> augmentation virus uptake replication presumably overwhelmed specific pulmonary benefits hypotheses made testing hypothesis common drugs induce ace<NUMBER> overexpression may adverse covid<NUMBER> pandemic testing urgently required immediate direct clinical testing come interrogating pandemic databases china lombardy populations presence covid<NUMBER> illness illness severity death could matched age preexisting medical diagnoses drugs prescribed onset covid<NUMBER> illness multivariate analyses straightforward need differentiate effects ageing effects diseases increased prevalence accompanying ageing including hypertension heart failure diabetes possible effects drugs given treat diseases test hypothesis druginduced covid<NUMBER> risk experimental animals pretreat animals arbs aceinhibitors induced overexpressed ace<NUMBER> blinded experiment expose animals sarscov<NUMBER> virus would work mammals sufficient structural similarity ace<NUMBER> protein human ace<NUMBER> infected virus cursing human mammal may difficult test hypothesis clinicians live leaving prescribing unchanged hypertension easier alternative prescribing choices perhaps substitute calcium channel blockers betaadrenergic blockers arbs perhaps aceinhibitors decision change antihypertensive medication made chronic renal disease heart failure arbs aceinhibitors specifically protective changes really cannot recommended basis hypothesis simply discontinuing medication strongly discouraged option <NUMBER> hypotheses medicine fade away product time real importance enduring legacy hypothesis many plausibility believers urgency way forward prove hypothesis refute according five new studies therapy angiotensinconverting enzyme ace inhibitors angiotensinreceptor blockers arbs associated increased risk infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> increased risk severe disease inhospital death among patients covid<NUMBER> observations reassuring concerns raised possibility blockers renin–angiotensin–aldosterone system raas could predispose individuals severe covid<NUMBER> although findings studies published nejm lancet jama cardiology considered exploratory given observational findings consistent across different patient populations different study designs mehra colleagues used observational database <NUMBER> hospitals asia europe north america evaluate association cardiovascular disease drug therapy inhospital death <NUMBER> patients confirmed diagnosis covid<NUMBER> logisticregression multivariate analyses showed age <NUMBER> years coronary artery disease congestive heart failure cardiac arrhythmia chronic obstructive pulmonary disease current smoking independently associated increased risk inhospital death conversely use ace inhibitors <NUMBER> <NUMBER> ci <NUMBER>–<NUMBER> arbs <NUMBER> <NUMBER> ci <NUMBER>–<NUMBER> associated higher risk inhospital death mancia colleagues conducted populationbased case–control study lombardy italy <NUMBER> patients confirmed sarscov<NUMBER> infection <NUMBER> matched control individuals use ace inhibitors arbs frequent among patients covid<NUMBER> among control individuals conditional logisticregression multivariate analyses showed association drug classes likelihood sarscov<NUMBER> infection severity covid<NUMBER> reynolds colleagues carried observational study including data <NUMBER> patients tested sarscov<NUMBER> infection health network new york city ny usa bayesian analyses propensityscore models showed previous treatment antihypertensive drugs including ace inhibitors arbs associated either higher likelihood positive test sarscov<NUMBER> infection higher risk severe covid<NUMBER> similar findings obtained mehta colleagues cohort <NUMBER> patients tested sarscov<NUMBER> infection cleveland clinic health system ohio florida usa overlap propensity score weighting showed association use ace inhibitors arbs likelihood positive test <NUMBER> <NUMBER> ci <NUMBER>–<NUMBER> finally de abajo colleagues conducted case–population study seven hospitals madrid spain including <NUMBER> patients confirmed diagnosis covid<NUMBER> requiring hospital admission <NUMBER> matched controls conditional logistic regression analyses showed use raas inhibitors associated higher risk covid<NUMBER> requiring hospital admission compared use antihypertensive drugs adjusted <NUMBER> <NUMBER> ci <NUMBER>–<NUMBER> note patients diabetes mellitus taking raas inhibitors lower risk covid<NUMBER> requiring hospital admission interestingly findings suggest ace inhibitors arbs different effects patients covid<NUMBER> although findings contradictory mehra colleagues found ace inhibitor use well statin use associated better survival contrast secondary exploratory analysis mehta colleagues showed higher risk hospitalization among patients sarscov<NUMBER> infection taking ace inhibitors <NUMBER> arbs <NUMBER> however investigators authors accompanying editorials caution associations considered extreme caution potential unmeasured confounding given observational design studies small number patients secondary exploratory analysis use ace inhibitors arbs associated increased susceptibility covid<NUMBER> harmful effects patients covid<NUMBER> taken together studies suggest use ace inhibitors arbs associated increased susceptibility covid<NUMBER> harmful effects patients covid<NUMBER> various theories drugs ace inhibitors angiotensin ii receptor blockers arbs relation severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> clinical outcomes covid<NUMBER> circulating mainstream media medical literature based fact ace<NUMBER> facilitates sarscov<NUMBER> cell invasion via binding viral spike protein ace<NUMBER> however effect ace inhibitors arbs drugs ace<NUMBER> unclear theories based conflicting evidence mainly animal studies therefore clinical evidence urgently needed aim study investigate relationship use drugs clinical outcome patients covid<NUMBER> patients included several hospitals europe data collected userfriendly database digitalis external server analyses adjusted sex age presence cardiovascular disease hypertension diabetes results enable rational choices randomised controlled trials preventive therapeutic strategies covid<NUMBER> understanding pathophysiology covid<NUMBER> pandemic key develop strategies prevention treatment improve clinical outcomes known previous outbreak severe acute respiratory syndrome coronavirus sarscov cell invasion accomplished binding viral spike protein ace<NUMBER> <NUMBER> recent reports show sarscov<NUMBER> <NUMBER> <NUMBER> binding leads ace<NUMBER> downregulation may contribute lung injury since less ace<NUMBER> available potential protective effects shown acute respiratory distress syndrome ards <NUMBER> aces regulatory proteins blood pressure inflammation ace<NUMBER> key enzyme reninangiotensin aldosterone system raas converts angiotensin angiotensin ii binding angiotensin ii receptor type <NUMBER> leads vasoconstriction resulting rise blood pressure fibrotic proliferativeinflammatory effects ace<NUMBER> targeted reducing blood pressure ace inhibitors angiotensin ii receptor blockers arbs lead similar effects blocking effects angiotensin ii ace<NUMBER> degrades angiotensin angiotensin<NUMBER> angiotensin ii angiotensin<NUMBER> pathway involving mas receptor thought counteracting effects angiotensin ii associated protective effects heart lungs kidneys <NUMBER> however studies targeting pathway led beneficial effects cardiovascular renal diseases including hypertension <NUMBER> <NUMBER> addition role raas modulation ace<NUMBER> also involved degrading several substrates apelin bradykinin opioids recently involvement degrading bradykinin also suggested playing causal role development severe ards since downregulation ace<NUMBER> consequence virus binding may enhance proinflammatory bradykinin receptor leading local vascular leakage <NUMBER> fact patients previous cardiovascular disease cvd hypertension diabetes increased mortality risk due sarscov<NUMBER>induced infection could explained common factor use ace inhibitors arbs <NUMBER> <NUMBER> suggested several authors also reached mainstream media including cnn <NUMBER> <NUMBER> however welldesigned studies effects ace inhibitors arbs nonsteroidal antiinflammatory drugs ace<NUMBER> expression scarce show conflicting results conducted humans <NUMBER> <NUMBER> led statements several societies including european society cardiology european society hypertension emphasising lack evidence importance withdrawing ace inhibitors arbs considering major role blood pressure lowering nephroprotection cardiac protection <NUMBER> reply first rumours authors including versmissen et al argued raas inhibition might even beneficial infected <NUMBER> <NUMBER> <NUMBER> authors suggested arbs might beneficial ace inhibitors might <NUMBER> based theoretical grounds intervention studies either starting discontinuing ace inhibitors arbs currently recruiting patients covid<NUMBER> clinicaltrials gov however observational data humans urgently needed address real effect medication clinical course covid<NUMBER> starting potentially harmful interventions based theoretical conflicting evidence animal studies therefore comet study aims evaluate relationship use certain drugs starting ace inhibitors arbs clinical outcomes patients covid<NUMBER> main objective describe correlation use ace inhibitors arbs clinical outcome defined admission hospital duration stay intensive care unit icu admission survival patients confirmed covid<NUMBER> secondary aims address effect protocol drugs immunomodulatory agents including nonsteroidal antiinflammatory drugs corticosteroids observational cohort study designed patients included various hospitals europe pharmacist clinical pharmacologist treating physician participating investigators asked consecutively include patients registered emergency department ed certain day several days minimum <NUMBER> patients included ed registration incomplete patients covid<NUMBER> hospitalised specific period minimum <NUMBER> patients reached icu normal ward entered major criterion patient included covid<NUMBER> positive positive sarscov<NUMBER> pcr high clinical likelihood based bilateral pulmonary infiltrates explained another cause consensus local covid<NUMBER> expert team based clinical biochemical radiological criteria allow urgent analysis data entry undertaken two phases quick data entry number collected parameters minimised special focus medication following subject parameters collected patients year birth sex international classification primary careinternational classification diseases <NUMBER>th revision medical history including cvd diabetes hypertension body mass index normal <NUMBER> kgm <NUMBER> high <NUMBER> kgm <NUMBER> obese <NUMBER> kgm <NUMBER> prescribed medication anatomical therapeutic chemical code dose moment presentation smoking history clinical frailty score <NUMBER> logistic course presentation edtransmission fromto another hospital clinical course admissionadmission hospital <NUMBER> hours<NUMBER> hours icu admission icu survival easily accessible laboratory data presentation also entered second phase additional parameters may included specific clinical outcomes pulmonary embolism extensive laboratory parameters since medical history may incomplete ed recorded collaborating researchers medication data used confirm cvd diabetes heart failure hypertension correct medical history appears incomplete cvd including coronary artery disease cerebrovascular disease peripheral arterial occlusive disease considered present entered items medical history patient using antiplatelet therapy prevent bias misdiagnosed cvd especially case angina diabetes considered present antidiabetic medication used even absence note medical file prevent bias undiagnosed diabetes hypertension considered present entered item medical history antihypertensive medication used patient using one antihypertensive drugs without indication heart failure considered present entered item medical history patient using ace inhibitor arb beta blocker loop diuretic absence severe renal insufficiency outcome clinical outcome assessed <NUMBER> weeks date covid<NUMBER> diagnosis scored hospital admission hospital admission <NUMBER> hours hospital admission <NUMBER> hours without icu hospital admission <NUMBER> hours icu addition survival data collected relation ace inhibitorsarbs clinical outcomes first assessed univariate multivariate logistic regression analyses adjustments made following potential confounding factors sex age presence cvd diabetes hypertension doseresponse analysis performed support causal relationship since patients visiting ed included might representative larger population visiting hospital therefore aim compare use ace inhibitorsarbs dutch patients general dutch population similar age age group <NUMBER> years stichting farmaceutische kengetallen foundation pharmaceutical key numbers addition use blood pressurelowering agents drug classes lipidlowering drugs compared patients severe outcomes hospital admission short stay <NUMBER> hours medical ethical committee erasmus mc brabant concluded research fall scope medical research involving human subjects act nonwmo retrospective nature full anonymisation investigators hospital fill anonymised data sex birth year sign data transfer agreement patient assigned study number known investigator keep coding list hospital hospital see patients system data collected database digitalis nl external server stored using open clinica data treated according privacy regulations applicable europe erasmus mc privacy regulations collected data secured unauthorised access stored secured department hospital pharmacy data identify patient processed database protect respect privacy patients main research team including principal investigator see anonymised data main article submitted general medicine journal followup articles focusing deeply certain drug classes might submitted pharmacological journals journals specific area disease instance cardiovascular currently clinical trials targeting ace<NUMBER> raas bradykinin pathway initiated evidence might beneficial still weak results study may contribute rational choices randomised controlled trials addition negative effect use ace inhibitors arbs identified changing medication might easy intervention reduce morbidity mortality covid<NUMBER> instance ace inhibitors arbs used <NUMBER> dutch population gipdatabank nl almost half users aged <NUMBER> years serious limitation study selection bias especially ed registration unhospitalised patients incomplete however comparing ace inhibitors arbs indications similar preventing bias indication addition antihypertensive drugs lipidlowering drugs analysed due urgency need data time enter clinical data limited potentially leading incomplete data especially medical history however using detailed medication data largely correct incomplete medical history data response read great interest original investigation zhang et al <NUMBER> accompanying editorial shah et al <NUMBER> study question urgent important given potential relationships among ace angiotensinconverting enzyme inhibitor arb angiotensin receptor blocker use ace<NUMBER> expressionactivity coronavirus disease <NUMBER> covid<NUMBER> severity <NUMBER> <NUMBER> <NUMBER> appreciate authors appropriately tempered interpretation results based several limitations noted publication accompanying editorial nonetheless concerned many readers may still overinterpret impressive hazard ratios notably exposure assignments based antihypertensive medications administered point hospitalization patients survive long enough clinically stable enough achieve exposure ie ace inhibitorsarb use timedependent bias immortal time bias underestimates hazard exposure group <NUMBER> may result false exaggerated apparent protective effect ace inhibitorsarbs also fewer patients ace inhibitorsarbs expected <NUMBER> versus <NUMBER> prevalent use <NUMBER> suggesting substantial unmeasured confounding nonsystematic exposure ascertainment sicker patients almost invariably less likely receive ace inhibitorsarbs hospitalization limitations may explain contradictory results observational us veteran data show association baseline ace inhibitorsarb use need intensive care patients covid<NUMBER> unadjusted odds ratio <NUMBER> based several clinical mechanistic considerations believe equipoise regarding potential benefit harm ace inhibitorsarb use patients risk covid<NUMBER> <NUMBER> <NUMBER> current study reinforces urgent need randomized controlled trial evidence address important issue <NUMBER> currently conducting international multicenter randomized controlled trial replace covid trial randomized elimination prolongation angiotensin converting enzyme inhibitors angiotensin receptor blockers coronavirus disease <NUMBER> url https wwwclinicaltrialsgov unique identifier nct<NUMBER> randomizing patients chronic ace inhibitorsarbs hospitalized covid<NUMBER> continuation versus withdrawal ace inhibitorsarb upon admission evaluating hierarchical outcome including death mechanical ventilation pressor requirement markers severity critical illness another ongoing trial ireland url httpswwwclinicaltrialsgov unique identifier nct<NUMBER> randomizing outpatients hypertension continuation versus withdrawal ace inhibitorsarbs evaluating risk covid<NUMBER>related hospitalization mortality authors recently suggested angiotensinconverting enzyme ace inhibitors angiotensin ii receptor blockers arbs discontinued even temporarily given current pandemic sarscov<NUMBER> virus suggestion based hypothesis aceinhibitors arbs may favor entry diffusion sarscov<NUMBER> virus human cells aceinhibitors arbs may increase expression ace<NUMBER> receptors sites viral entry human organism ace<NUMBER> receptors ubiquitous although extremely abundant cell surface type <NUMBER> pneumocytes type <NUMBER> pneumocytes small cylindrical alveolar cells located close vicinity pulmonary capillaries responsible synthesis alveolar surfactant known facilitate gas exchanges increased expression ace<NUMBER> effect aceinhibitors arbs detected increased production angiotensin<NUMBER> mrna related ace<NUMBER> fear increased expression ace<NUMBER> induced aceinhibitors arbs may ultimately facilitate entry diffusion sarscov<NUMBER> virus however clinical evidence support hypothesis furthermore available data conflicting counterintuitive findings suggest arbs may beneficial harmful indeed studies conducted different laboratories demonstrated ace<NUMBER> receptors show downregulation ie opposite would happen aceinhibitors arbs effect interaction virus animal studies downregulation ace<NUMBER> found prevalent pulmonary areas infected virus surrounding areas studies virusinduced ace<NUMBER> downregulation would lead reduced formation angiotensin<NUMBER> ace<NUMBER> degrades angiotensin ii angiotensin<NUMBER> consequent accumulation angiotensin ii excess angiotensin ii would favor pulmonary edema inflammation phenomenon directly associated angiotensin ii levels along worsening pulmonary function detrimental effects blocked arbs experimental models light considerations reasonable conclude suggestion discontinue aceinhibitors arbs patients aim preventing limiting diffusion sarscov<NUMBER> virus based clinical evidence conversely experimental studies suggest arbs might useful patients limit pulmonary damage inhibition type <NUMBER> angiotensin ii receptors controlled clinical studies area eagerly awaited review discusses facts theories potential impact aceinhibitors arbs setting sarscov<NUMBER> pandemic aceinibitori sartani e sindrome respiratoria acuta da coronavirus <NUMBER> aceinhibitors angiotensin receptor blockers severe acute respiratory syndrome caused coronavirus authors recently suggested angiotensinconverting enzyme ace inhibitors angiotensin ii receptor blockers arbs discontinued even temporarily given current pandemic sarscov<NUMBER> virus suggestion based hypothesis aceinhibitors arbs may favor entry diffusion sarscov<NUMBER> virus human cells aceinhibitors arbs may increase expression ace<NUMBER> receptors sites viral entry human organism ace<NUMBER> receptors ubiquitous although extremely abundant cell surface type <NUMBER> pneumocytes type <NUMBER> pneumocytes small cylindrical alveolar cells located close vicinity pulmonary capillaries responsible synthesis alveolar surfactant known facilitate gas exchanges increased expression ace<NUMBER> effect aceinhibitors arbs detected increased production angiotensin<NUMBER> mrna related ace<NUMBER> fear increased expression ace<NUMBER> induced aceinhibitors arbs may ultimately facilitate entry diffusion sarscov<NUMBER> virus however clinical evidence support hypothesis furthermore available data conflicting counterintuitive findings suggest arbs may beneficial harmful indeed studies conducted different laboratories demonstrated ace<NUMBER> receptors show downregulation ie opposite would happen aceinhibitors arbs effect interaction virus animal studies downregulation ace<NUMBER> found prevalent pulmonary areas infected virus surrounding areas studies virusinduced ace<NUMBER> downregulation would lead reduced formation angiotensin<NUMBER> ace<NUMBER> degrades angiotensin ii angiotensin<NUMBER> consequent accumulation angiotensin ii excess angiotensin ii would favor pulmonary edema inflammation phenomenon directly associated angiotensin ii levels along worsening pulmonary function detrimental effects blocked arbs experimental models light considerations reasonable conclude suggestion discontinue aceinhibitors arbs patients aim preventing limiting diffusion sarscov<NUMBER> virus based clinical evidence conversely experimental studies suggest arbs might useful patients limit pulmonary damage inhibition type <NUMBER> angiotensin ii receptors controlled clinical studies area eagerly awaited review discusses facts theories potential impact aceinhibitors arbs setting sarscov<NUMBER> pandemic aceinibitori sartani e sindrome respiratoria acuta da coronavirus <NUMBER> aceinhibitors angiotensin receptor blockers severe acute respiratory syndrome caused coronavirus older individuals immunosuppressed patients <NUMBER> outbreak severe acute respiratory syndrome sars guangdong china traced sarscov new betacoronavirus outbreak nearly <NUMBER> patients diagnosed overall mortality <NUMBER> increased <NUMBER> patients <NUMBER> years age <NUMBER> disease thought originated infected bats easily contained transmission appeared require direct contact infected individuals distinct group <NUMBER>c bcoronavirus genetically related bat coronaviruses responsible another outbreak saudi arabia <NUMBER> disease termed middle east respiratory syndrome mers virus associated initial <NUMBER> mortality spread appreciably outside region <NUMBER> outbreak unknown respiratory illness wuhan china reported late december <NUMBER> causative agent identified sars coronavirus sarscov<NUMBER> disease called coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> disease rapidly become global pandemic major priority placed finding drugs prevent limit viral propagation infection coronaviruses share large genome around <NUMBER> kb express large replicase genes encoding nonstructural proteins involving approximately <NUMBER> kb genome undergo early transcription replicase gene contain viral envelope utilize ribosomal frameshifting nonstructural gene expression <NUMBER> viral genome composed <NUMBER>′cap structure leader sequence untranslated region utr composed multiple stem loop structures needed rna replication <NUMBER> <NUMBER>′end contains utr rna structures necessary viral rna synthesis well <NUMBER>′polya tail mimics mrna allowing translation replicaseencoded nonstructural proteins transcriptional regulatory sequences trss found <NUMBER>′end structural accessory genes accessory genes nonessential modulating viral pathogenesis <NUMBER> four main structural proteins termed spike membrane envelope e nucleocapsid n protein <NUMBER> kd responsible spike viral surface trimeric protein used viral attachment cell entry receptors <NUMBER> life cycle human coronaviruses begins viral attachment via protein cell entry receptors typically peptidases sarscov virus uses angiotensin converting enzyme <NUMBER> ace<NUMBER> main cellular receptor membrane serine protease tmprss<NUMBER> acting accessory protein stabilize cell entry cleavage protein following viral fusion cell membrane <NUMBER> <NUMBER> virus enters replicates within cytoplasm starting translation replicase gene assembly viral replicase complex <NUMBER> complex nonstructural genes act inhibit host cell translation promoting host mrna degradation enhancing viral rna synthesis replication <NUMBER> process results genomic subgenomic rna generated via negativestrand intermediates e structural proteins enter endoplasmic reticulum er move ergolgi intermediate compartment viral genomic progeny encapsidated n protein <NUMBER> assembly virions transported cell surface released exocytosis coronaviruses excess protein mediate cell fusion neighboring cells process may allow rapid viral transmission without detection host humoral immune response <NUMBER> accelerate pharma rd across targets disease areas immuneering developed disease cancelling technology dct identify targets drugs reversing disease gene expression fluency computational platform large scale high throughput silico screening dct quantifies similarity genomewide signatures disease signatures drug induced gene expression changes using cosine similarity uniquely relative methods dct quantifies pergene contribution overall disease amplification cancellation biased specific targets pathways fluency predicts quantitative binding affinity purely sequence unlike methods fluency single universal quantitative structureactivity relationship qsar model able accept molecule protein sequence input trained <NUMBER> million ic<NUMBER> values chembl fluency achieves near experimental level binding prediction accuracy well generating predictions binding site applied platforms determine repurposing existing drugs may helpful covid<NUMBER> infection <NUMBER> assessing established drugs binding ace<NUMBER> tmprss<NUMBER> two proteins used virus enter cells <NUMBER> scanning fda approved compounds transcriptomic disease cancellation coronavirus associated gene expression changes given covid<NUMBER> virus uses angiotensin converting enzyme <NUMBER> ace<NUMBER> main cellular receptor enter cell ran two fluency models ace<NUMBER> target input two different fluency models model model b run predict binding ace<NUMBER> chemicals selleckchem fda approved drug library initial ranking performance model shown table <NUMBER> included multiple known ace inhibitors scoring well enalaprilat ramipril lisinopril monopril captopril drugs enalaprilat best binding score model given reports possibility ace<NUMBER> induction driven ace<NUMBER> inhibition <NUMBER> multiple subsequent reports hinting benefit ace inhibition <NUMBER> <NUMBER> <NUMBER> <NUMBER> interested observe ace<NUMBER> specificity comparison ace<NUMBER> top hits binding ace<NUMBER> ace<NUMBER> compared calculating difference predicted binding ace<NUMBER> binding minus ace<NUMBER> binding using two fluency models table <NUMBER> according model brigatinib tirofiban hydrochloride aleuritic acid top ranked pbind brigatinib also highest ranked model specific ace<NUMBER> ace<NUMBER> glutathione ranked <NUMBER>th place model specific ace<NUMBER> ace<NUMBER> next consensus ranking using results models b used select top ace<NUMBER> binders table <NUMBER> enalaprilat tirofiban hydrochloride sotagliflozin showed balanced performance models order assess specificity fluency run top hits reverse predicting binding small molecule human proteome metric ramipril piperacillin sodium captopril high ranking ace<NUMBER> table <NUMBER> worst score far top hits considered r<NUMBER> explore potential covid<NUMBER> associated hits ran fluency models tmprss<NUMBER> target selleckchem fda approved drug library ranked hits based performance model ombitasvir elbasvir capecitabine top predicted binding hits tmprss<NUMBER> cefotiam hexetil hydrochloride bictegravir top <NUMBER> predicted hits models table <NUMBER> interestingly chloroquine diphosphate predicted model b bind ace<NUMBER> pbind <NUMBER> ranked <NUMBER> fda approved drugs predicted binding tmprss<NUMBER> pbind <NUMBER> ranked <NUMBER> hydroxychloroquine sulfate predicted model b bind ace<NUMBER> pbind <NUMBER> rank <NUMBER> tmprss<NUMBER> pbind <NUMBER> rank <NUMBER> results shown order confirm deny findings fluency applied disease cancelling technology approach searching fda approved drugs reverse coronavirus associated gene expression changes unlike version fluency run models b predicted binding rank reported higher pbind signifies higher binding affinity difference pbind ace<NUMBER> ace reported last two columns larger values reflecting increased predicted binding specificity ace<NUMBER> ace fluency dct applied target pathway agnostic way capturing full gene expression change data driven way publicly available gene expression data downloaded geo gse<NUMBER> healthy mice c<NUMBER>bl<NUMBER>nj infected ma<NUMBER> mouse version sarscov <NUMBER> lung tissue collected gene expression analysis robust differential expression signal detected infected uninfected mice day <NUMBER> fig <NUMBER>a table <NUMBER> genes changing opposite direction ma<NUMBER> infection glutamine treatment plotted fig <NUMBER>b interestingly glutamine precursor glutathione ranked highly fluency results table <NUMBER> thus two orthogonal approaches neural networks cosine distance used two different data types binding prediction gene expression arrived potential hit glutamineglutathione first utilized unbiased aibased systems algorithm interrogate <NUMBER> fda approved repurposing drugs binding ace<NUMBER> main sarscov<NUMBER> table <NUMBER> top ranked fluency hits binding ace<NUMBER> based consensus ranking using results models version fluency run models b predicted binding rank reported higher pbind signifies higher binding affinity lower reverse fluency rank signifies higher predicted specificity intended target human cell entry receptor rapid analysis repurposing approved drugs new indications allows immediate access potential agents could used urgent emerging diseases covid<NUMBER> ability identify drugs requires additional biologic validation vitro studies confirming receptor blockade inhibition sarscov<NUMBER> cell entry replication vivo ideally randomized table <NUMBER> top ranked fluency hits models binding tmprss<NUMBER> rank column indicates ranked position given model binding prediction controlled clinical trials global pandemic however time may allow usual drug development processes repurposing commonly available drugs may critical indeed anecdotal reports hydroxychloroquine azithromycin antiil<NUMBER> therapies received attention <NUMBER> <NUMBER> hydroxychloroquine predicted bind ace<NUMBER> model b supporting anecdotal reports detect azithromycin antiil<NUMBER> agents would anticipated mediate therapeutic activity ace<NUMBER> modulation validation needed determine unbiased aibased systems approaches superior anecdotal observations binding prediction analysis multiple known drugs identified potential ace<NUMBER> inhibitors table <NUMBER> surprisingly twelve ace inhibitors adds confirmation unbiased selection accurately identified drugs high likelihood receptor binding ace inhibitors agents commonly used treatment hypertension heart failure family drugs based various peptide compositions initially selected binding ace<NUMBER> catalyzes conversion angiotensin angiotensin ii thereby blocking reninangiotensin system ras lowering systemic blood pressure increasing sodium excretion increased renal water output ace inhibitors known bind ace<NUMBER> lacks carboxypeptidase activity ace<NUMBER> contain zincbinding domain exhibits metallopeptidase activity shares approximately <NUMBER> homology ace<NUMBER> <NUMBER> <NUMBER> model selected preferential ace<NUMBER> binding agents better predicted binding values prioritized see table <NUMBER> early studies largely used angiotensin catalysis major readout inhibition whether current ace inhibitors may block sarscov<NUMBER> binding remains speculative <NUMBER> addition due counter regulatory nature ace<NUMBER> ace<NUMBER> expression possible agents downregulate ace<NUMBER> receptors may increase ace<NUMBER> receptor expression could worsen coronavirus infection thus scanned binding ace<NUMBER> ace<NUMBER> top hits ranked predicted difference binding metric captopril enalaprilat monopril looked likely inhibit potentially solicit undesired feedback effect table <NUMBER> ramipril longacting ace inhibitor prodrug converted active metabolite ramiprilat liver may associated hepatic injury likewise monopril prodrug undergoes transformation liver active metabolite fosinoprilat contrast lisinopril orally active ace inhibitor undergo metabolic transformation excreted urine bind serum proteins may also associated hepatic toxicity drugs need used cautiously patients underlying liver disease captopril sulfhydrylcontaining proline analog potent specific activity blocking ace peptidyldipeptidase activity captopril may also antitumor activity inhibition tumor angiogenesis promotion antitumor immunity <NUMBER> analysis also identified drug involved glucose homeostasis used patients diabetes mellitus antihyperglycemic agents nateglinide table <NUMBER> derivative phenylalanine acts betaislet pancreatic cells atpsensitive potassium channels stimulates insulin secretion <NUMBER> drug used treatment type <NUMBER> diabetes mellitus sotaglifozin table <NUMBER> oral inhibitor sodiumglucose cotransporter subtype <NUMBER> sglt<NUMBER> expressed gastrointestinal gi tract sglt<NUMBER> expressed kidneys <NUMBER> knowledge agent previously known bind ace ace<NUMBER> glutathione another interesting agent predicted binding ai gene expression disease cancellation antioxidant demonstrating improved airway clearance pulmonary function cystic fibrosis <NUMBER> glutathione also evaluated adjunct patients receiving certain chemotherapy agents following lung transplantation management hiv parkinsons disease mixed results <NUMBER> fostamatinib r<NUMBER> table <NUMBER> oral inhibitor spleen tyrosine kinase syk converted active metabolite tamatinib approved treatment chronic immune thrombocytopenic purpura evaluated autoimmune disorders rheumatoid arthritis <NUMBER> r<NUMBER> may also mediate signal transduction downstream classical immunoreceptors including bcell receptor explaining may useful treating autoimmune diseases b cell hematologic malignancies <NUMBER> emricasan table <NUMBER> also called idn<NUMBER> thiol protease acts caspase<NUMBER> inhibitor received orphan g status us fda treatment liver disease chronic hepatitis c functions protect excessive hepatic cell apoptosis emricasan shown decrease hepatic aminotransferases patients hepatitis c viralinduced nonviral liver diseases <NUMBER> drug also shown activity zika virusmediated caspase <NUMBER> induction blocked viral infection neural cells vitro <NUMBER> potential antiviral activity emricasan identified drug repurposing screen following zika virus outbreak <NUMBER> <NUMBER> fosamprenavir identified table <NUMBER> protease inhibitor prodrug amprenavir antiretroviral drug approved treatment hiv disease agents known antiviral activity rna viruses especially interesting evaluation coronaviruses orlistat table <NUMBER> carboxyl ester reversible inhibitor gi lipases <NUMBER> orlistat initially isolated streptomyces toxytricini grampositive bacterium blocks hydrolysis absorption dietary fats approved us uk treatment obesity two drugs identified activity anticoagulants tirofiban hydrochloride table <NUMBER> argatroban table <NUMBER> tirofiban nonpeptide tyrosine derivative functions antagonist purinergic receptor platelet glycoproteiniibiia <NUMBER> drug inhibits platelet aggregation used treating acute coronary syndrome studied management ischemic stroke <NUMBER> contrast argatroban small molecule directly inhibits thrombin used management heparininduced thrombocytopenia <NUMBER> piperacillin table <NUMBER> broad spectrum semisynthetic betalactam ureidopenicillin antibiotic derived ampicillin piperacillin active gramnegative bacteria initially used treating pseudomonas aeruginosa infections later part combination antibiotics complex infectious indications <NUMBER> contrast macrolide antibiotics azithromycin inhibit bacterial protein synthesis piperacillin blocks bacterial wall synthesis since commonly used agents management patients pneumonia merit studies understand role ace<NUMBER> modulation potential role management covid<NUMBER> infection search potential covid<NUMBER> therapeutic approaches orthogonal unbiased way applied disease cancellation technology gene expression data animal model sarscov ranked compounds ability induce gene expression signals counteract diseaseassociated signals gene expression method glutamine top hit reversing coronavirus associated changes gene expression glutathione highly ranked fluency ace<NUMBER> binding precursor glutamine highly ranked gene expression dct suggesting deserve testing explore potential benefits sarscov<NUMBER> glutamine glutathione previously demonstrated antiviral activity herpes virus hsv infections <NUMBER> summary used novel aibased systems approach identify potential drugs currently available predicted bind ace <NUMBER> agents readily available could rapidly assessed laboratory clinic activity sarscov<NUMBER> infection clinical course covid<NUMBER> disease studies agents may provide new clinical strategies patients coronavirus diseases normal circumstances would conduct experimental validation prior submitting report publication given current public health emergency publishing work event others set quickly validate assess build upon findings although validation still needed report highlights aibased systems may utilized rapidly identify drugs repurposing new emerging human diseases ace<NUMBER> uniprot id q<NUMBER>byf<NUMBER> ace<NUMBER> uniprot id p<NUMBER> tmprss<NUMBER> uniprot id o<NUMBER> run separately protein target immuneerings fluency query fluency single universal quantitative structureactivity relationship qsar deep learning model takes protein amino acid sequence small molecule smiles input fluency trained experimental binding data chembl <NUMBER> model chembl <NUMBER> model b fluency predictions previously experimentally validated multiple targets case fluency used predict binding selleckchem fda approved drug library https wwwselle ckche mcomscree ningfdaappro veddruglibra ryhtml separately ace<NUMBER> ace<NUMBER> tmprss<NUMBER> top hits fluency run reverse predicting binding single small molecule <NUMBER> human proteins score specificity predicted binding scores ace<NUMBER> ace<NUMBER> compared top hits assess predicted specificity ace<NUMBER> ace<NUMBER> model reflected pbindxace<NUMBER>pbindxace columns similarity known binders reported pchembl value greater <NUMBER> chembl database ace<NUMBER> computed using tanimoto distance molecular fingerprints rdkit python top ranked fluency hits filtered evaluating individual rankings model model b well average rank predictions combined pbind scores models gene expression data downloaded geo gse<NUMBER> processed data background corrected quantile normalized summarized outlier removal author used <NUMBER> time points differential expression calculated ma<NUMBER> sarscov virus infected wild type mice lung samples mockinoculated wild type mice using limma rpackage version <NUMBER> <NUMBER> immuneering leveraged previously described <NUMBER> validated <NUMBER> <NUMBER> dct ran sarscov disease signature lincs drug perturbation database <NUMBER> results filtered adjusted pvalue significance maximal disease cancellation score angiotensinconverting enzyme<NUMBER> two independent approaches converged discovery ace<NUMBER> angiotensinconverting enzyme homologue aceh <NUMBER> ace<NUMBER> identified screening human genome database novel zinc metallopeptidases hence recognized close homolog ace see chapter <NUMBER> cloned human lymphoma cdna library <NUMBER> parallel sequence identified human heart failure cdna library <NUMBER> despite high similarity sequence ace particularly around active site ace<NUMBER> functions carboxypeptidase rather peptidyl dipeptidase cleaving cterminal amino acid susceptible substrates distinct binding specificity ace<NUMBER> demonstrated failure ace inhibitors block activity given overall similarity ace first potential substrates examined angiotensin peptides bradykinin <NUMBER> decapeptide angiotensin ang converted ace<NUMBER> ang<NUMBER>à<NUMBER> metabolized whereas vasoconstrictor octapeptide ang ii converted vasodilatory ang<NUMBER>à<NUMBER> subsequent detailed kinetic analysis revealed ang ii highly preferred ace<NUMBER> substrate ang hydrolyzed <NUMBER>fold efficiently ang ii k <NUMBER> μm k cat <NUMBER> <NUMBER> ang k <NUMBER> μm k cat <NUMBER> <NUMBER> <NUMBER> bradykinin hydrolyzed ace<NUMBER> desarg<NUMBER>bradykinin natural ligand bradykinin b <NUMBER> receptor substrate screened panel <NUMBER> biologically active peptides <NUMBER> hydrolyzed purified ace<NUMBER> cases single carboxypeptidase action three efficiently hydrolyzed substrates angiotensin ii apelin<NUMBER> dynorphin a<NUMBER>à<NUMBER> ang ii substrate physiological role ace<NUMBER> established cleavage product angiotensin<NUMBER>à<NUMBER> ang <NUMBER>à<NUMBER> acts mas receptor oppose actions ang ii <NUMBER> however emerging evidence ace<NUMBER> may control blood pressure controlling degradation apelin<NUMBER> another vasoactive peptide <NUMBER> <NUMBER> comparison sequences around cleavage site susceptible substrates suggested consensus sequence carboxypeptidase action prox<NUMBER>à<NUMBER> residuesprohydrophobicbasic <NUMBER> ace<NUMBER> optimum ph <NUMBER> zinc peptidase inhibited metal chelating agents <NUMBER> <NUMBER> several selective ace<NUMBER> inhibitors developed since discovery first mln<NUMBER> <NUMBER> designed exploiting knowledge ang ace<NUMBER> substrate nonpeptide inhibitor inhibitorbound crystal structure subsequently solved <NUMBER> mln<NUMBER> also known gl<NUMBER> originally unsuccessfully developed potential antiobesity drug recently examined antiinflammatory agent <NUMBER> peptide inhibitor ace<NUMBER> dx<NUMBER> identified phage libraries displayed k <NUMBER> nm <NUMBER> recently phosphinicpeptide inhibitor developed mimics enzyme transition state pseudopeptide inhibitor designated <NUMBER>f<NUMBER> k <NUMBER> nm <NUMBER> ace<NUMBER> gene located chromosome xp<NUMBER> contains <NUMBER> exons many resemble corresponding exons ace gene complete cdna sequence ace<NUMBER> encodes <NUMBER> amino acid protein resembles chimera composed single acelike catalytic ectodomain fused transmembrane protein collectrin tmem<NUMBER> <NUMBER> plays role regulation renal amino acid transport implicated insulin exocytosis βcell proliferation <NUMBER> homology ace ace<NUMBER> particularly striking around hexxh zincbinding motif identical hemgh two proteins crystal structure ace<NUMBER> solved within <NUMBER> years discovery <NUMBER> established structural basis unique catalytic activity ace<NUMBER> compared ace result subtle differences active sites example presence arginine position <NUMBER> ace<NUMBER> compared glutamine ace removes s<NUMBER> <NUMBER> pocket present active site ace thereby eliminating peptidyl dipeptidase activity <NUMBER> upon substrate inhibitor binding two catalytic subdomains ace<NUMBER> undergo hingebending movement <NUMBER> å towards closes active site cleft initiate substrate hydrolysis <NUMBER> key active site residues ace<NUMBER> figure <NUMBER> <NUMBER> identified sitedirected mutagenesis based structure single domain testicular form ace <NUMBER> fidelity model verified inhibitorbound crystal structure formation salt bridge arg<NUMBER> found critical substrate recognition since mutation abolished enzymatic activity like ace histidine ace<NUMBER> his<NUMBER> stabilizes tetrahedral peptide intermediate acting hydrogen bond donoracceptor mutation his<NUMBER> alanine reduced ace<NUMBER> activity <NUMBER>fold therefore also established his<NUMBER> critical active site residue activities ace ace<NUMBER> chloridedependent due presence cl<NUMBER> cl<NUMBER> sites ace comparable cl<NUMBER> site ace<NUMBER> chloride regulation however substratedependent <NUMBER> <NUMBER> chloride dependency ace<NUMBER> cl<NUMBER> site mediated several critical residues arg<NUMBER> trp<NUMBER> lys<NUMBER> correspond arg<NUMBER> trp<NUMBER> arg<NUMBER> testicular ace additionally arg<NUMBER> ace<NUMBER> identified mutagenesis residue important substrate selectivity effective inhibition ace<NUMBER> also dependent presence chloride ic <NUMBER> mln<NUMBER> <NUMBER>fold lower presence <NUMBER> mm nacl compared absence <NUMBER> preparation ace<NUMBER> protein expressed functional form mammalian cells chinese hamster ovary <NUMBER> baculovirusinfected insect cell sf<NUMBER> expression system <NUMBER> characterization ace<NUMBER> involved use truncated secreted form protein lacks transmembrane cytosolic domains <NUMBER> <NUMBER> baculovirusexpressed protein purified homogeneity sequential chromatography qae anion exchanger hydrophobic interaction chromatography monoq ion exchange gel filtration form subsequently used crystallization protein <NUMBER> main tissue sites expression ace<NUMBER> originally identified testis heart kidney <NUMBER> shown localized apical membrane polarized cells <NUMBER> however identified widely example liver intestine lung <NUMBER> <NUMBER> recently ace<NUMBER> localized brain <NUMBER> appears act central regulator cardiovascular function <NUMBER>à<NUMBER> major identified physiological function ace<NUMBER> conversion vasoconstrictor ang ii ang<NUMBER>à<NUMBER> vasodilator antifibrotic antiinflammatory peptide <NUMBER> <NUMBER> deletion ace<NUMBER> gene mice shown produce major defect cardiac contractility upregulation hypoxiainducible genes heart <NUMBER> deletion ace ace<NUMBER> genes led rescue observed cardiac phenotype <NUMBER> however subsequent gene deletion studies ace<NUMBER> produced mixed results much less effect baseline cardiac function <NUMBER> overall appears actions ace<NUMBER> may primarily relevant pathological states hypertension cardiac hypertrophy example levels ace<NUMBER> shown increase failing heart <NUMBER> postmyocardial infarction mi rat models <NUMBER> <NUMBER> well failing human heart tissue viral overexpression ace<NUMBER> attenuate heart hypertrophy preserve cardiac function postmi <NUMBER> overall therefore ace<NUMBER> appear play role cardiac homeostasis observations led consensus view ace<NUMBER> plays cardioprotective role acting counterbalance actions ace <NUMBER> <NUMBER> additionally decrease ace<NUMBER> expression associated diabetic nephropathy <NUMBER> ace<NUMBER> plays major antifibrotic role liver <NUMBER> unexpected roles ace<NUMBER> protein independent catalytic activity emerged firstly cellular receptor severe acute respiratory syndrome sars coronavirus causes severe acute lung failure identified ace<NUMBER> <NUMBER> also serves receptor another coronavirus nl<NUMBER> <NUMBER> binding either virus causes downregulation surface expression ace<NUMBER> loss surface ace<NUMBER> sars infection results diminished ability lung respond inflammatory lung cell damage due increased ratio levels ang iiang<NUMBER>à<NUMBER> administration recombinant human ace<NUMBER> vivo protect severe acute lung injury <NUMBER> ace<NUMBER> also functions chaperone small neutral amino acid transporter b <NUMBER> at<NUMBER> intestine transporting intracellular sites synthesis cell surface chaperone role mediated collectrinlike domain ace<NUMBER> collectrin serving main transporter b <NUMBER> at<NUMBER> kidney hartnup disorder inherited disease leading severe aminoaciduria mutation b <NUMBER> at<NUMBER> reduces affinity ace<NUMBER> collectrin leading intracellular sequestration <NUMBER> like ace ace<NUMBER> found soluble circulating form plasma also detectable urine result renal excretion soluble form represents ectodomain shed membranebound form following proteolytic cleavage adam<NUMBER> <NUMBER> present unclear circulating form physiologically active since activity plasma seems masked endogenous inhibitor retention ace<NUMBER> cell membrane regulated calmodulin binding calmodulin inhibitors increase cellular release ace<NUMBER> <NUMBER> given generally protective role ace<NUMBER> cardiovascular hepatic lung pathologies upregulation would seem therapeutic potential several strategies investigated date achieve ends including viral delivery administration recombinant soluble ace<NUMBER> range vivo disease models <NUMBER>à<NUMBER> ace<NUMBER> activators also developed using rational drug design approach <NUMBER> molecular docking model based open substratefree closed conformations ace<NUMBER> led identification xanthenone compound binds hinge site ace<NUMBER> subdomains <NUMBER> <NUMBER> compound increased ace<NUMBER> activity approximately <NUMBER>fold vitro shown reduce blood pressure spontaneously hypertensive rats <NUMBER> attenuate thrombus formation model hypertension <NUMBER> ace<NUMBER> multifaceted enzyme broad range biological functions discussed ace<NUMBER> resembles ace many structural aspects differs specificity since acts carboxypeptidase cytoplasmic domains ace ace<NUMBER> show homology distinct functions ace<NUMBER> hydrolyze bradykinin synthetic ace substrate hiphisleu ace<NUMBER> inhibited inhibitors ace cpa specifically designed ace<NUMBER> inhibitors mln<NUMBER> inhibit ace metallocarboxypeptidases known contain hexxh zinc binding motif bacterial origin include carboxypeptidase taq <NUMBER> <NUMBER> chapter <NUMBER> cobaltactivated carboxypeptidase hyperthermophilic archaeon pyrococcus furiosus <NUMBER> <NUMBER> chapter <NUMBER> ace<NUMBER> shares similarities specificity carboxypeptidases characterization remains somewhat limited coronavirus disease <NUMBER> covid <NUMBER> declared pandemic word health organization march <NUMBER> <NUMBER> soon satisfied epidemiological criteria infection <NUMBER> people <NUMBER> countries <NUMBER> march <NUMBER> <NUMBER> world witnessed half million cases covid<NUMBER> <NUMBER> deaths <NUMBER> suggests magnitude spread across world since first reported december <NUMBER> <NUMBER> wuhan hubei province china emerging data suggests older covid<NUMBER> patients comorbid conditions diabetes hypertension cardiac pulmonary disease particular susceptible compared general populations higher mortality therefore necessary relook subgroups covid<NUMBER> patients associated comorbidities review article collated available evidence emerged far outcomes comorbidities patients covid<NUMBER> focused outcomes patients covid<NUMBER> hypertension analyzed controversies surrounding use reninangiotensin system blockers rasb systematically searched pubmed medical database till march <NUMBER> <NUMBER> using mesh key words include covid<NUMBER> coronavirus hypertension diabetes cardiovascular disease angiotensin receptor blockers angiotensin converting enzyme inhibitors retrieved available literature published english language covid<NUMBER> reported outcomes different comorbidities association hypertension diabetes patients covid<NUMBER> unexpected given rising prevalence chronic diseases globally interestingly pooled data ten chinese studies n ¼ <NUMBER> reported characteristics comorbidities patients covid<NUMBER> associations hypertension diabetes presence established cardiovascular disease cvd larger varying <NUMBER> <NUMBER> average <NUMBER> <NUMBER>e<NUMBER> average <NUMBER> <NUMBER>e<NUMBER> average <NUMBER> respectively table <NUMBER> established cvd also present nearly <NUMBER> italian study <NUMBER> patients covid<NUMBER> consistent association hypertension patients covid<NUMBER> across studies unique concern needs serious attention increase mortality two chinese studies worked direction todate <NUMBER> patients covid<NUMBER> zhou et al found hypertension odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> whereas presence coronary artery disease <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> inhospital mortality univariate analysis <NUMBER> however association disorders covid<NUMBER> mortality longer significant multivariate regression analysis similarly analysis <NUMBER> patients covid<NUMBER> wu et al found hypertension hazard ratio hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> acute respiratory distress syndrome ards <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> death diabetic patients hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> ards hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p ¼ <NUMBER> death bivariate cox regression analysis <NUMBER> noted however neither studies adjusted confounding variables nevertheless study <NUMBER> patients covid<NUMBER> guo et al reported nearly twice increase mortality patients established cvd raised troponin tnt compared patients without cvd raised tnt <NUMBER> vs <NUMBER> respectively <NUMBER> chinese center disease control prevention summary report covid<NUMBER> reported case fatality rate cfr <NUMBER> <NUMBER> deaths among <NUMBER> confirmed cases however cfr elevated <NUMBER> hypertension <NUMBER> diabetes <NUMBER> presence cvd <NUMBER> unsurprisingly based findings researchers recently proposed course treatment prognosis covid<NUMBER> stratified based absence presence comorbidities type b c type denotes covid<NUMBER> patients pneumonia without comorbidities type b denotes covid<NUMBER> pneumonia comorbidities whereas type c denotes covid<NUMBER> patients multiorgan dysfunction <NUMBER> nonetheless still remains unclear whether increased association hypertension covid<NUMBER> heightened risk mortality directly related hypertension associated comorbidities antihypertensive treatment growing concern association hypertension cvd may confounded treatment certain antihypertensive medications rasb although recent paper proposed stop rasb suggested replace calcium channel blocker treating hypertension patients covid<NUMBER> <NUMBER> hypothesis questioned several colleagues <NUMBER>e<NUMBER> entry coronavirus cell facilitated spike protein attachment receptor host cell protein needs primed serine protease named tmprss<NUMBER> proteins different coronaviruses may utilise different receptors mers utilises cd<NUMBER> sars cov sars cov<NUMBER> utilise angiotensin converting enzyme<NUMBER> ace<NUMBER> <NUMBER> efficiency interaction sprotein ace<NUMBER> may key determinant transmissibility virus viral replication severity disease theory efficiency could influenced changes amino acid substitutions either viral sprotein <NUMBER> major outbreak sars cov occurred <NUMBER>e<NUMBER> minor localised outbreak mild symptoms <NUMBER>e<NUMBER> observed sprotein sars cov <NUMBER>e<NUMBER> outbreak bound ace<NUMBER> receptor much efficiently sars cov <NUMBER>e<NUMBER> outbreak consistent absence humantohuman transmission latter outbreak several molecular changes sprotein influence binding human ace<NUMBER> example substitution threonine serine position <NUMBER> protein reduces binding <NUMBER> similarly asparagine position <NUMBER> increased binding affinity <NUMBER> methylation position <NUMBER> also shown influence binding recently sprotein sars cov<NUMBER> shown similar sars cov barring gains function mutations important glutamine position <NUMBER> receptor binding domain explains increased transmissibility compared sars cov <NUMBER> b changes ace<NUMBER> receptor regard merscov employs cd<NUMBER> dpp<NUMBER> receptor cellular entry naturallyoccurring polymorphisms dpp<NUMBER> impact cellular entry merscov might thus modulate mers development infected patients <NUMBER> possibility similar variations polymorphisms ace<NUMBER> could affect viral entry disease course polymorphisms ace<NUMBER> gene identified however evidence affect susceptibility severity sars cov<NUMBER> infection <NUMBER> recent study found differential ace<NUMBER> gene expression human lung tissue racialgender differences higher gene expression lungs smokers compared nonsmokers could explain higher risk infection smokers <NUMBER> role ace<NUMBER> vascular bed opposite angiotensin converting enzyme ace ace converts angiotensin angiotensin ii vasoconstrictor ace<NUMBER> converts angiotensin ii angiotensin <NUMBER>e<NUMBER> causes vasodilatation binding mas receptor vascular bed <NUMBER> downregulation ace<NUMBER> observed animal models lung injury induced sars cov <NUMBER> recombinant ace<NUMBER> improved pulmonary blood flow oxygenation animals lung injury indicating ace<NUMBER> may main determinant lung injury caused sars cov <NUMBER> however lack human data except small study <NUMBER> patients acute respiratory distress syndrome showed recombinant ace<NUMBER> well tolerated led increase angiotensin <NUMBER>e<NUMBER> <NUMBER> considerable interest regarding role ras blockers covid<NUMBER> infection benefit harm postulated figure <NUMBER> illustrates interactions effect rasb covid<NUMBER> fig <NUMBER> rationale evidence harm evidence ace<NUMBER> expression increases use ace inhibitors arb especially heart kidney <NUMBER> <NUMBER> raised theoretical concern increasing ace<NUMBER> expression aceis arbs could facilitate entry virus host cell increase chances infection severity <NUMBER> also increased ace<NUMBER> expression elderly <NUMBER> extent predisposes elderly infection sarscov<NUMBER> known study <NUMBER> patients covid<NUMBER> guo et al reported increased trend mortality receiving rasb compared receiving mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients without rasb respectively <NUMBER> indeed increased association heightened mortality covid<NUMBER> observed consistently across studies elderly hypertensive diabetics known cvd however exactly known whether causal relation use rasb subgroups rasb due illness compared rest population moreover solid evidence back concern either covid<NUMBER> infection coronaviruses b rationale evidence benefit discussed increasing ace<NUMBER> levels coronavirus infection could reduce lung injury experimental study mice kuba et al found losartan showed significantly diminished lung injury pulmonary edema acid aspirationinduced acute lung injury addition sarscov spike protein compared placebo <NUMBER> similarly severe lung injury pulmonary edema prevented recombinant human ace<NUMBER> infusions losartan ace<NUMBER>knockout mice <NUMBER> mice coronavirus induced lung injury showed improvement treated losartan <NUMBER> moreover retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors <NUMBER> treatment arbs reported reduce mortality ebola virus infection <NUMBER> exact mechanism apparent benefit drugs coronavirus infection yet clear however could several explanations <NUMBER> increased ace<NUMBER> expression may result viral entry cell limited availability serine protease tmprss<NUMBER> camostat mesylate tmprss<NUMBER> inhibitor shown inhibit cellular entry sars cov<NUMBER> could potential therapeutic option <NUMBER> ii increased ace<NUMBER> expression cell membrane may also lead increased soluble ace<NUMBER> blood may actually bind sars cov<NUMBER> prevent interaction membrane bound receptor iii ras blockers increase angiotensin ii substrate ace<NUMBER> interaction ace<NUMBER> angiotensin ii could induce conformational change receptor binding domain ace<NUMBER> limiting ability bind sars cov<NUMBER> <NUMBER> iv ace<NUMBER> receptors present much higher density lung tissue children young adults compared older individuals thus upregulation ace<NUMBER> receptors use rasb time older people may emulate ace expression young people also possible ace<NUMBER> receptors increased ace<NUMBER> functions likely produce angiotensin <NUMBER>e<NUMBER> might provide resilience targetmediated destruction development pulmonary failure patients covid<NUMBER> <NUMBER> postulated positive effects lung also protective overwhelming infection covid<NUMBER> v indiscriminate discontinuation rasb patients heart failure may also lead readmission hospital increase mortality <NUMBER> collectively relationship ras activity use rasb sars cov<NUMBER> infection scarce indirect evidence ras activation covid<NUMBER> high incidence hypokalaemia <NUMBER> regards use rasb retrospective analysis <NUMBER> covid<NUMBER> hospitalised patients cardiovascular disease wuhan significant difference proportion aceiarb medication nonsurvivors survivors <NUMBER> however study <NUMBER> patient reported guo et al trend increase mortality patients covid<NUMBER> receiving rasb <NUMBER> compared receiving <NUMBER> <NUMBER> covid<NUMBER> increasingly associated comorbidities include hypertension diabetes special care required patients covid<NUMBER> associated comorbidities given heightened risk inhospital death view lack robust evidence either benefit harm bulk experimental evidence favour benefit reasonable patients continue using ace inhibitors arb recommended european society cardiology hypertension canada canadian cardiovascular society uk renal association international society hypertension european society hypertension american heart association <NUMBER>e<NUMBER> future studies reporting outcome stratified basis different antihypertensive agents covid<NUMBER> may enlighten us regard hereby declare conflict interest related article hypertension longterm medical condition known high blood pressure major risk factor vision loss stroke heart failure chronic kidney disease quarter worlds adult population <NUMBER> hypertension <NUMBER> therapeutic approaches focused reninangiotensinaldosterone system raas regulates blood pressure electrolyte balance humans <NUMBER> raas renin stimulates generation angiotensin angi converted vasoconstrictor angiotensin ii angii angiotensin converting enzyme ace two isoforms somatic testicular ace transcribed ace gene tissuespecific manner somatic form sace zinc dependent dicarboxypeptidase includes two homologous domains n domain c domain with<NUMBER> sequence identity zinc motif hexxh x amino acid residue <NUMBER> <NUMBER> past decades reported c domain human sace main angi converting site controlling blood pressure cardiovascular functions <NUMBER> ace hydrolyzes decapeptide aspargvaltyrilehisprophehisleu angi cleaving dipeptide cterminus produce octapeptide aspargvaltyrilehisprophe angii causes blood vessels narrow stimulates secretion hormone aldosterone resulting increased blood pressure <NUMBER> <NUMBER> ace also affects blood pressure inactivating vasodilators bradykinin angii causes blood vessels narrow stimulates secretion hormone aldosterone resulting increased blood pressure <NUMBER> <NUMBER> ace also affects blood pressure inactivating vasodilators bradykinin kallidin <NUMBER> therefore ace long major target treatment hypertension cardiovascular ailments use ace inhibitors <NUMBER> common synthetic ace inhibitors captopril enalapril alacepril lisinopril market decades <NUMBER> however reported diverse side effects including hyperkalemia skin rashes <NUMBER> impairment renal function <NUMBER> development angioedema <NUMBER> therefore peptides natural sources considered alternative ace inhibitors attracted researchers interest <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> structures ace complexes various ligands including synthetic inhibitors peptides available protein data bank pdb crystal structures ace determined high resolution give us overall insight structural molecular arrangement active sites <NUMBER> <NUMBER> <NUMBER> <NUMBER> crystal structure time ensemble averaged snapshot complete understanding proteins rigid flexible dynamic solution fluctuating among many conformational substates <NUMBER> addition structure knowledge dynamics enzyme understanding mechanisms activation inhibition crucial design better drugs <NUMBER> molecular dynamics md simulations known powerful tool molecular modeling investigating dynamics proteins applied various systems successfully <NUMBER> recently md simulations ace various ligands reported drug discovery molecular modeling interactions enzyme potential inhibitors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> order explore ligand binding effects dynamics mechanisms activation inhibition allatom md simulations sace carried without ligands simulations focus c domain angi mainly converted <NUMBER> ligandfree simulation apo observed mouth opening closing motions sace like pacman arcade game <NUMBER>s <NUMBER> large hinge bending motion implies existence preexisting backbone conformations figure <NUMBER> shows overall structure enzyme secondary structure sace predominantly alpha helical figure <NUMBER> structure elliptical shape dimensions approximately <NUMBER> × <NUMBER> × <NUMBER> å <NUMBER> cleft around active site expands <NUMBER> å pdb id <NUMBER>aph cleft divides sace two subdomains active site located inner surfaces two subdomains sace defined subdomain including nterminus zinc ion residues asp<NUMBER>leu<NUMBER> pro<NUMBER>gly<NUMBER> asp<NUMBER>gly<NUMBER> subdomain ii including cterminus residues glu<NUMBER>ala<NUMBER> gly<NUMBER>cys<NUMBER> gln<NUMBER>ser<NUMBER> two kinds inhibitors bppb bradykinin potentiating peptide b gluglyleuproproargprolysilepropro <NUMBER> spi spirulina derived heptapeptide thrmetgluproglylyspro <NUMBER> competitive mixed noncompetitive respectively used investigate difference inhibition mechanisms mixed type noncompetitive inhibition mode spi determined lineweaverburk plot model inhibition mechanism studied previous study <NUMBER> ribbon representation sace shows secondary structure two lips purple colored mouth n c indicate nand cterminus enzyme respectively zinc ion shown gray sphere rightmost panel shows two subdomains form two sides active site cleft subdomain residues <NUMBER> <NUMBER> <NUMBER> ii residues <NUMBER> <NUMBER> <NUMBER> colored blue red respectively arrow indicates active site near zinc ion putative binding pathway ligands first lip residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> belongs subdomain second <NUMBER> <NUMBER> <NUMBER> belongs subdomain ii simulation ligandfree sace apo initiated coordinates removing bound angii saceangii complex pdb id <NUMBER>aph <NUMBER> like others structure complex also closed state defined distance two lips figure <NUMBER> shorter <NUMBER> å <NUMBER> å simulation time went enzyme spontaneously opened mouth mouth gradually reclosed open state returning back semiopen open states defined open state distance longer <NUMBER> å semiopen state distances longer <NUMBER> å shorter <NUMBER> å observed multiple conversion open closed states <NUMBER> ns simulation figure <NUMBER> believe first work shows spontaneous opening closing motions ace md simulation video s<NUMBER> <NUMBER> yu et al ran md simulation ligandfree ace <NUMBER> ns report opening closing motions <NUMBER> shown gray sphere rightmost panel shows two subdomains form two sides active site cleft subdomain residues <NUMBER> <NUMBER> <NUMBER> ii residues <NUMBER> <NUMBER> <NUMBER> colored blue red respectively arrow indicates active site near zinc ion putative binding pathway ligands first lip residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> belongs subdomain second <NUMBER> <NUMBER> <NUMBER> belongs subdomain ii simulation ligandfree sace apo initiated coordinates removing bound angii saceangii complex pdb id <NUMBER>aph <NUMBER> like others structure complex also closed state defined distance two lips figure <NUMBER> shorter <NUMBER> å <NUMBER> å simulation time went enzyme spontaneously opened mouth mouth gradually reclosed open state returning back semiopen open states defined open state distance longer <NUMBER> å semiopen state distances longer <NUMBER> å shorter <NUMBER> å observed multiple conversion open closed states <NUMBER> ns simulation figure <NUMBER> believe first work shows spontaneous opening closing motions ace md simulation video s<NUMBER> <NUMBER> yu et al ran md simulation ligandfree ace <NUMBER> ns report opening closing motions <NUMBER> distance two lips angii bound sace complex green apo form blue along simulation time discarding equilibration stage conformation distance two lips longer <NUMBER> å defined open state distance shorter <NUMBER> å conformation defined closed state distance <NUMBER> <NUMBER> å conformation considered semiopen state snapshots sace orange purple lips shown superimposing subdomain ii crystal structure cyan order analyze mouth opening closing motion defined two lips calculated distance centers lip cα atoms throughout production stage simulations figure <NUMBER> two lips mouth defined lip subdomain composed residues ile<NUMBER>arg<NUMBER> pro<NUMBER>ala<NUMBER> arg<NUMBER>ala<NUMBER> cys<NUMBER>val<NUMBER> lip ii subdomain ii composed figure <NUMBER> distance two lips angii bound sace complex green apo form blue along simulation time discarding equilibration stage conformation distance two lips longer <NUMBER> å defined open state distance shorter <NUMBER> å conformation defined closed state distance <NUMBER> <NUMBER> å conformation considered semiopen state snapshots sace orange purple lips shown superimposing subdomain ii crystal structure cyan order analyze mouth opening closing motion defined two lips calculated distance centers lip cα atoms throughout production stage simulations figure <NUMBER> two lips mouth defined lip subdomain composed residues ile<NUMBER>arg<NUMBER> pro<NUMBER>ala<NUMBER> arg<NUMBER>ala<NUMBER> cys<NUMBER>val<NUMBER> lip ii subdomain ii composed residues pro<NUMBER>thr<NUMBER> gln<NUMBER>arg<NUMBER> ser<NUMBER>phe<NUMBER> angii bound sace quite stable <NUMBER> ns simulation time large backbone conformational change observed unlike apo form absence ligand enzyme mainly stayed closed semiopen states throughout entire simulation figure s<NUMBER> order investigate flexibility enzyme rootmeansquare deviation rmsd apo form angii bound form computed figure <NUMBER> expected rmsds showed strong correlation distances two lips due mouth opening motions conformation apo form deviated far away initial structure closed conformation reaching nearly <NUMBER> å rmsd value however rmsd values angii bound form fluctuated less <NUMBER> å compared unbound form ligand bound form relatively stable molecules <NUMBER> <NUMBER> x peer review <NUMBER> <NUMBER> residues pro<NUMBER>thr<NUMBER> gln<NUMBER>arg<NUMBER> ser<NUMBER>phe<NUMBER> angii bound sace quite stable <NUMBER> ns simulation time large backbone conformational change observed unlike apo form absence ligand enzyme mainly stayed closed semiopen states throughout entire simulation figure s<NUMBER> order investigate flexibility enzyme rootmeansquare deviation rmsd apo form angii bound form computed figure <NUMBER> expected rmsds showed strong correlation distances two lips due mouth opening motions conformation apo form deviated far away initial structure closed conformation reaching nearly <NUMBER> å rmsd value however rmsd values angii bound form fluctuated less <NUMBER> å compared unbound form ligand bound form relatively stable cα rootmeansquare fluctuation rmsf form calculated using production stage md simulation trajectories figure <NUMBER> analysis indicates subdomain flexible subdomain ii simulations interestingly overall flexibility subdomain ii didnt change much regardless presence angii significant difference two simulations large increment flexibility subdomain apo form notice subdomain closure movement proteins regarded common mechanism rearrangement critical groups around substrates inhibitors <NUMBER> structural report open conformation human ace yet angiotensin converting enzymerelated carboxypeptidase ace<NUMBER> homologue human sace ace<NUMBER> also identified cellular receptor sars coronavirus novel coronavirus <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> catalytic domains ace<NUMBER> sace share <NUMBER> sequence identity <NUMBER> crystal structures ace<NUMBER> without inhibitor reported first <NUMBER> pdb id <NUMBER>r<NUMBER>l <NUMBER>r<NUMBER> open conformation observed absence inhibitor inhibitor bound one showed closed conformation based two structures authors proposed large hingebending motion important catalytic activity inhibitor binding ace <NUMBER> superimposed closed open conformations ace compared ace<NUMBER> comparison revealed tremendous similarity two systems figure s<NUMBER> cα rootmeansquare fluctuation rmsf form calculated using production stage md simulation trajectories figure <NUMBER> analysis indicates subdomain flexible subdomain ii simulations interestingly overall flexibility subdomain ii didnt change much regardless presence angii significant difference two simulations large increment flexibility subdomain apo form notice subdomain closure movement proteins regarded common mechanism rearrangement critical groups around substrates inhibitors <NUMBER> structural report open conformation human ace yet angiotensin converting enzymerelated carboxypeptidase ace<NUMBER> homologue human sace ace<NUMBER> also identified cellular receptor sars coronavirus novel coronavirus <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> catalytic domains ace<NUMBER> sace share <NUMBER> sequence identity <NUMBER> crystal structures ace<NUMBER> without inhibitor reported first <NUMBER> pdb id <NUMBER>r<NUMBER>l <NUMBER>r<NUMBER> open conformation observed absence inhibitor inhibitor bound one showed closed conformation based two structures authors proposed large hingebending motion important catalytic activity inhibitor binding ace <NUMBER> superimposed closed open conformations ace compared ace<NUMBER> comparison revealed tremendous similarity two systems figure s<NUMBER> addition distance two lips calculated ace<NUMBER> based sequence alignment ace<NUMBER> sace two lips ace<NUMBER> identified lip composed residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> subdomain lip ii composed residues <NUMBER> <NUMBER> <NUMBER> subdomain ii distances lip lip ii computed <NUMBER> å <NUMBER> å closed open states respectively result consistent distance analysis sace figure <NUMBER> order test robustness definition backbone conformational states also calculated mouth open angles results showed similar pattern distances figure s<NUMBER> based calculations maximal hingebending movement was<NUMBER> • close value <NUMBER> • measured ace<NUMBER> structures <NUMBER> bppb competitive inhibitor isolated snake venom <NUMBER> crystal structure shows active site sace occupied octapeptide bppb closed conformational state complex pdb id <NUMBER>apj <NUMBER> set another system bppb bound sace carried <NUMBER> ns md simulation angii product catalytic function ace also considered competitive inhibitor leaving active site another substrate angi cannot bind site next reaction bppb bound sace simulation showed similar behavior angii bound one figure s<NUMBER> analyzed distance two lips mouth showing conformational changes closed semiopen states back closed state figure <NUMBER>a bppb bound ace flexible angii bound one made mouth closed tightly number hydrogen bonds ligands enzyme calculated simulation time figure s<NUMBER> average numbers <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> angii bppb respectively table <NUMBER> indicated opening closing motions affected interactions ligand enzyme addition distance two lips calculated ace<NUMBER> based sequence alignment ace<NUMBER> sace two lips ace<NUMBER> identified lip composed residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> subdomain lip ii composed residues <NUMBER> <NUMBER> <NUMBER> subdomain ii distances lip lip ii computed <NUMBER> å <NUMBER> å closed open states respectively result consistent distance analysis sace figure <NUMBER> order test robustness definition backbone conformational states also calculated mouth open angles results showed similar pattern distances figure s<NUMBER> based calculations maximal hingebending movement <NUMBER>° close value <NUMBER>° measured ace<NUMBER> structures <NUMBER> bppb competitive inhibitor isolated snake venom <NUMBER> crystal structure shows active site sace occupied octapeptide bppb closed conformational state complex pdb id <NUMBER>apj <NUMBER> set another system bppb bound sace carried <NUMBER> ns md simulation angii product catalytic function ace also considered competitive inhibitor leaving active site another substrate angi cannot bind site next reaction bppb bound sace simulation showed similar behavior angii bound one figure s<NUMBER> analyzed distance two lips mouth showing conformational changes closed semiopen states back closed state figure <NUMBER>a bppb bound ace flexible angii bound one made mouth closed tightly number hydrogen bonds ligands enzyme calculated simulation time figure s<NUMBER> average numbers <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> angii bppb respectively table <NUMBER> indicated opening closing motions affected interactions ligand enzyme addition competitive inhibition noncompetitive inhibition also common inhibition mechanism noncompetitive inhibition includes pure mixed noncompetitive inhibition surprisingly us mechanism mixed type noncompetitive inhibition ace studied molecules <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> intensively far previous study heptapeptide thrmetgluproglylyspro derived marine microalgae spirulina identified mixed noncompetitive inhibitor spi <NUMBER> investigated interactions dynamics ace bound mixed noncompetitive inhibitor md simulations conducted spi bound apo form spi bound angiisace complex form simulation spi bound sace started structure removing angii spi bound angiisace complex result spi docking simulation previous study <NUMBER> analysis distance two lips spi bound sace showed backbone conformational fluctuation closed semiopen states able see open conformational state figure <NUMBER>b words spontaneous conformational changes limited closed semiopen states stabilized spi video s<NUMBER> peptide spi formed <NUMBER> ± <NUMBER> hydrogen bonds sace averaged production stage whole simulation table <NUMBER> simulation spi bound angiisace complex peptide bound nterminal side mouth next angii figure <NUMBER> binding spi stabilized hydrogen bond interactions sace also angii <NUMBER> investigated presence hydrogen bonds md simulations average spi formed <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> pairs hydrogen bonds sace angii respectively together <NUMBER> ± <NUMBER> pairs table <NUMBER> spi formed hydrogen bonds frequently sace thr<NUMBER>asp<NUMBER> thr<NUMBER>ser<NUMBER> glu<NUMBER>arg<NUMBER> lys<NUMBER>glu<NUMBER> spisace residues order angii glu<NUMBER>arg<NUMBER> pro<NUMBER>arg<NUMBER> pro<NUMBER>val<NUMBER> spiangii residues order figure <NUMBER> table s<NUMBER> addition hydrogen bonds binding spi stabilized van der waals interactions sidechain pro<NUMBER> spi bound hydrophobic pocket formed ile<NUMBER> leu<NUMBER> trp<NUMBER> sace shown figure <NUMBER> clarity molecules <NUMBER> <NUMBER> x peer review <NUMBER> <NUMBER> addition competitive inhibition noncompetitive inhibition also common inhibition mechanism noncompetitive inhibition includes pure mixed noncompetitive inhibition surprisingly us mechanism mixed type noncompetitive inhibition ace studied intensively far previous study heptapeptide thrmetgluproglylyspro derived marine microalgae spirulina identified mixed noncompetitive inhibitor spi <NUMBER> investigated interactions dynamics ace bound mixed noncompetitive inhibitor md simulations conducted spi bound apo form spi bound angiisace complex form simulation spi bound sace started structure removing angii spi bound angiisace complex result spi docking simulation previous study <NUMBER> analysis distance two lips spi bound sace showed backbone conformational fluctuation closed semiopen states able see open conformational state figure <NUMBER>b words spontaneous conformational changes limited closed semiopen states stabilized spi video s<NUMBER> peptide spi formed <NUMBER> ± <NUMBER> hydrogen bonds sace averaged production stage whole simulation table <NUMBER> simulation spi bound angiisace complex peptide bound nterminal side mouth next angii figure <NUMBER> binding spi stabilized hydrogen bond interactions sace also angii <NUMBER> investigated presence hydrogen bonds md simulations average spi formed <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> pairs hydrogen bonds sace angii respectively together <NUMBER> ± <NUMBER> pairs table <NUMBER> spi formed hydrogen bonds frequently sace thr<NUMBER>asp<NUMBER> thr<NUMBER>ser<NUMBER> glu<NUMBER>arg<NUMBER> lys<NUMBER>glu<NUMBER> spisace residues order angii glu<NUMBER>arg<NUMBER> pro<NUMBER>arg<NUMBER> pro<NUMBER>val<NUMBER> spiangii residues order figure <NUMBER> table s<NUMBER> addition hydrogen bonds binding spi stabilized van der waals interactions sidechain pro<NUMBER> spi bound hydrophobic pocket formed ile<NUMBER> leu<NUMBER> trp<NUMBER> sace shown figure <NUMBER> clarity distance analysis spi bound saceangii showed similar behavior ligand bound simulations figure <NUMBER>b interestingly spi bound saceangii complex stayed closed state simulation time understandable since spi angii acting inhibitors number hydrogen bonds ligand enzyme largest among complexes table <NUMBER> closed state stabilized interactions angi sace also interactions spi sace addition interactions spi angii stabilized complex closed state analysis five rmsfs indicated stable system spi bound saceangii complex figure s<NUMBER> recognized binding spi saceangii complex slightly twisted subdomain figure s<NUMBER> active sites binding interactions well known ace various inhibitors conformational dynamics role activation mechanism studied intensively drug design might benefit backbone conformations observed md simulations never reached xray crystallography ligand bound forms unlike closed state open state sace detected experiments simulations far surprisingly decade since first proposal <NUMBER> study reported role large hingebending motion activation sace contrast lockandkey model many proteins take ligand conformational changes putative binding pathway sace might narrow accommodate substrate angi closed state figure <NUMBER> thus enzyme needs change backbone conformation take substrate catalytic function least semiopen state rearrangement sidechain may allow substrate enter active site figure s<NUMBER> two models enzyme mechanisms inducefit <NUMBER> preexisting equilibrium dynamics <NUMBER> represent conformational changes dynamics upon ligand binding former binding ligand induces conformational changes protein latter ligand binds certain preexisting conformation already present accessible equilibrium dynamics distance analysis spi bound saceangii showed similar behavior ligand bound simulations figure <NUMBER>b interestingly spi bound saceangii complex stayed closed state simulation time understandable since spi angii acting inhibitors number hydrogen bonds ligand enzyme largest among complexes table <NUMBER> closed state stabilized interactions angi sace also interactions spi sace addition interactions spi angii stabilized complex closed state analysis five rmsfs indicated stable system spi bound saceangii complex figure s<NUMBER> recognized binding spi saceangii complex slightly twisted subdomain figure s<NUMBER> active sites binding interactions well known ace various inhibitors conformational dynamics role activation mechanism studied intensively drug design might benefit backbone conformations observed md simulations never reached xray crystallography ligand bound forms unlike closed state open state sace detected experiments simulations far surprisingly decade since first proposal <NUMBER> study reported role large hingebending motion activation sace contrast lockandkey model many proteins take ligand conformational changes putative binding pathway sace might narrow accommodate substrate angi closed state figure <NUMBER> thus enzyme needs change backbone conformation take substrate catalytic function least semiopen state rearrangement sidechain may allow substrate enter active site figure s<NUMBER> two models enzyme mechanisms inducefit <NUMBER> preexisting equilibrium dynamics <NUMBER> represent conformational changes dynamics upon ligand binding former binding ligand induces conformational changes protein latter ligand binds certain preexisting conformation already present accessible equilibrium dynamics ligandfree apo md simulation able observe spontaneous conformational changes open closed states sace implying open closed backbone conformational states already present accessible regardless presence ligand addition several times conversions states <NUMBER>nanoseconds simulation indicate addition previous study using normal mode analysis nma testicular ace tace another isoform ace ace<NUMBER> showed intrinsic flexibility open closed conformational models ace <NUMBER> authors also proposed hingebending mechanism substrate entry active site based results md simulations available xray structures propose following activation mechanism sace figure <NUMBER> regardless presence ligand sace could open semiopen closed states terms backbone conformation absence substrate angi open state might favored closed state figure <NUMBER> enzyme becomes ready accept substrate catalytic function equilibrium however changed presence angi closed state becomes stable open state due binding substrate cterminal dipeptide hisleu angi hydrolyzed angii product enzyme activity might released sace semiopen state figure <NUMBER> figure s<NUMBER> release angii sace equilibrium conformational states goes back first stage notice semiopen conformation accessed condition molecules <NUMBER> <NUMBER> x peer review <NUMBER> <NUMBER> enzyme flexible dynamic indeed available ace structures resolved closed conformation either presence ligands mutations introducing mutations ligands chimera common methods enhance thermal stability crystalize protein addition absence open conformation ligandfree ace imply intrinsic flexibility ace one available structure open conformation resolved ace<NUMBER> <NUMBER> addition previous study using normal mode analysis nma testicular ace tace another isoform ace ace<NUMBER> showed intrinsic flexibility open closed conformational models ace <NUMBER> authors also proposed hingebending mechanism substrate entry active site based results md simulations available xray structures propose following activation mechanism sace figure <NUMBER> regardless presence ligand sace could open semiopen closed states terms backbone conformation absence substrate angi open state might favored closed state figure <NUMBER> enzyme becomes ready accept substrate catalytic function equilibrium however changed presence angi closed state becomes stable open state due binding substrate cterminal dipeptide hisleu angi hydrolyzed angii product enzyme activity might released sace semiopen state figure <NUMBER> figure s<NUMBER> release angii sace equilibrium conformational states goes back first stage notice semiopen conformation accessed condition similarly derive mechanism competitive inhibitor ligand competitive inhibitor bound complex becomes stable closed state qualitatively equilibrium shift way case substrate binding release inhibitor equilibrium goes back first stage apo form since angii occupies active site release angii sace cannot take substrate true substrate interestingly spi mixed noncompetitive inhibitor makes use interactions spi sace also angii stabilized sace closed state resulting deadend complex holding product enzyme angii active site <NUMBER> since spi share binding site substrate becomes noncompetitive even though spi noncompetitive binds next active site interacts substrate becoming mixed type inhibitor <NUMBER> binding sites various drugs drug candidates studied intensively along various ligands binding sites conformations various indicates binding specific ligand induce specific conformation binding site therefore overall large backbone open closed conformational state preexist sidechain minor backbone rearrangement may induced upon ligand binding similarly derive mechanism competitive inhibitor ligand competitive inhibitor bound complex becomes stable closed state qualitatively equilibrium shift way case substrate binding release inhibitor equilibrium goes back first stage apo form since angii occupies active site release angii sace cannot take substrate true substrate interestingly spi mixed noncompetitive inhibitor makes use interactions spi sace also angii stabilized sace closed state resulting deadend complex holding product enzyme angii active site <NUMBER> since spi share binding site substrate becomes noncompetitive even though spi noncompetitive binds next active site interacts substrate becoming mixed type inhibitor <NUMBER> binding sites various drugs drug candidates studied intensively along various ligands binding sites conformations various indicates binding specific ligand induce specific conformation binding site therefore overall large backbone open closed conformational state preexist sidechain minor backbone rearrangement may induced upon ligand binding apo simulation removed bound angii xray structure saceangii complex started md simulation removal angii additional perturbation sace structure checked equilibration apo system monitoring thermodynamic parameters energy temperature volume pressure figure s<NUMBER> addition monitored evolution secondary structure along simulation time recognized overall secondary structure well conserved stable except loop turn regions figure s<NUMBER> even though observe multiple opening closing motions one still consider apo system still equilibration stage apo structure still equilibration stage goes certain open conformation would xray structure open conformation like ace<NUMBER> calorimetric study showing drug binding entropically driven also supports dynamics ace <NUMBER> conclusion using allatom md simulations conversion open closed states sace observed absence ligand supporting hingebending motion essential enzyme activation preferred states well extent flexibility strongly dependent presence ligand transformation semiopen closed state bound forms directly influenced interaction residues binding sites substrate inhibitors interactions constrained enzyme structure remain semiopen closed states however would seem putative binding pathway narrow accommodate substrate inhibitors therefore semiopen conformation might state ligands bind md simulation results mechanistic model sace activation inhibition portends drug design hypotension treatment also wide applications molecular biophysics beyond potential binding sites spi sace searched docking simulations using flexpepdock protocol rosetta program <NUMBER> crystal structure human sace complex angii pdb id <NUMBER>aph used target since spi peptide noncompetitive inhibitor angii kept docking simulations avoid overlapping binding site peptide active site structure lowest score docking simulations chosen molecular dynamics simulation order relax structure table s<NUMBER> details docking simulations described previous study <NUMBER> total five molecular dynamics simulations carried bppb bound sace angii bound sace apo ligandfree spi bound saceangii complex spi bound sace two crystal structures sace cocrystallized ligands active site used build simulation systems sace complex natural inhibitory peptide bppb pdb id <NUMBER>apj sace complex angii pdb id <NUMBER>aph order simulate apo form angii removed active site crystal structure <NUMBER>aph spi bound saceangii complex lowest score docking simulations chosen run fourth md simulation last spi bound sace model generated removing angii docking simulation result charmm<NUMBER> force field explicit tip<NUMBER>p water molecules used simulations <NUMBER> crystallographic water molecules chloride ions zinc ion retained found xray crystal structures ligand chemical components original crystal structures including acetate ion betadmannose nacetyldglucosamine also retained modeled charmm general force field <NUMBER> five simulation systems solvated truncated octahedral box <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tip<NUMBER>p water molecules respectively solvated systems electrically neutralized adding counter ions final salt concentration became <NUMBER> simulations performed namd periodic boundary condition <NUMBER> solvation <NUMBER> steps energy minimization performed remove possible bad contacts md simulations started gradually heating systems <NUMBER> <NUMBER> k <NUMBER> ps constant volume condition order equilibrate density systems simulation switched constant pressure temperature npt conditions continued afterwards average pressure temperature maintained <NUMBER> bar <NUMBER> k respectively heavy atoms energy minimization heating first <NUMBER> ps npt simulation restrained harmonic potential force constant <NUMBER> kcalmol·a <NUMBER> harmonic position restraints removed allowing atoms systems relax bonds involving hydrogen atoms constrained allowing integration time step <NUMBER> fs nonbonded interactions smoothly truncated <NUMBER> å <NUMBER> å cutoff particlemesh ewald method used treat longrange electrostatic interactions <NUMBER> equilibration stages simulations determined based rmsd system energy calculations total simulation equilibration times bppbsace angiisace apo spisaceangii spisace <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively nanoseconds summary md simulations provided table s<NUMBER> production stage discarding initial equilibration stage used post simulation analysis except rmsd calculation post analyses visualization carried visual molecular dynamics vmd program <NUMBER> formation hydrogen bond identified using <NUMBER> å donoracceptor distance <NUMBER> degrees protondonoracceptor angle criteria following available online httpwwwmdpicom<NUMBER>s<NUMBER> figure s<NUMBER> conformational states sace md simulations figure s<NUMBER> table s<NUMBER> ratio forming hydrogen bond pairs simulation time s<NUMBER> major docking score functions table s<NUMBER> summary md simulations video s<NUMBER> mouth opening apo sace video s<NUMBER> spi bound sace authors declare conflict interest end december <NUMBER> chinese public health officials announced world health organization new unknown virus caused disease symptoms similar pneumonia wuhan khan fahad <NUMBER> immediately recognized virus coronavirus cov family rapidly spreading wuhan seeking identify track restrict new disease cov family called cov disease <NUMBER> still affecting many peoples china outbreaking countries type cov also spreading countries iran italy south korea memberships join <NUMBER> number covs currently increasing researchers trying figure main cause virus spread easily widely genetic structural analyzes identified main characteristic virus could increase efficiency speed virus transmission human cells belouzard et al <NUMBER> jaimes whittaker <NUMBER> also groups investigating receptor cell membranes introduces fusion new cov human hcs veljkovic et al <NUMBER> zheng perlman <NUMBER> cellular protein receptors virus provide potential targets development drugs pathogen kaufmann et al <NUMBER> papadopoulos et al <NUMBER> however welldeveloped experiments promising data required ensure mechanism indeed exploring transmission mechanism virus important prevent future outbreaks covid<NUMBER> spreads much easily sars virus infecting easily people already infected sars lai et al <NUMBER> liu et al <NUMBER> infect cell viruses use spike protein sp bind cell membrane process activated specific cellular enzymes trypsin furin cathepsin l jaimes whittaker <NUMBER> millet whittaker <NUMBER> genomic analysis new cov shown sp differs viruses du et al <NUMBER> li <NUMBER> indicating protein site activated hc enzyme called furin millet whittaker <NUMBER> figure <NUMBER> enzyme normally cleaves activates wide range substrates different organisms figure <NUMBER>a braun sauter <NUMBER> enzyme found many human tissues including lungs liver small intestine means virus potential invade different organs belouzard et al <NUMBER> healdsargent gallagher <NUMBER> scamuffa et al <NUMBER> furin activation site fas makes new cov much different cell entry sars probably affects stability virus consequently transmission process li et al <NUMBER> millet whittaker <NUMBER> yamada liu <NUMBER> several groups also identified site activation investigate virus spreads among humans basak et al <NUMBER> kim et al <NUMBER> kleineweber et al <NUMBER> porter et al <NUMBER> pointed viruses including influenza family viruses contain sites easily spread among people huang et al <NUMBER> menachery et al <NUMBER> tang et al <NUMBER> vlasak et al <NUMBER> viruses site activation found protein called haemagglutinin sp bernstein et al <NUMBER> koopman et al <NUMBER> lai et al <NUMBER> however researchers cautious significant role activation site helping cov facilitating spread amer et al <NUMBER> van doremalen et al <NUMBER> scientists also skeptical comparing influenza viral activation sites new cov transmission channels heymann shindo <NUMBER> yang et al <NUMBER> haemagglutinin protein surface influenza viruses sp covs yin et al <NUMBER> zmora et al <NUMBER> hand influenza virus caused deadliest recorded pandemic lacks even fas coutard et al <NUMBER> therefore studies cellular animal models required assay function activation site indeed covs unpredictable experiments developed assess modify activation site experiments done explain new covs successfully infects human cells huang et al <NUMBER> letko munster <NUMBER> experiments shown sp binds human cell receptor hulswit et al <NUMBER> example drug blocks receptor may make cov entry cells difficult interaction furin angiotensin converting enzyme<NUMBER> ace<NUMBER> sp furin furinlike proteases belong group proprotein convertases scientist pointed among several targets sp fusogenic envelope glycoprotein sars cov promising site treatment infectious diseases li et al <NUMBER> licitra et al <NUMBER> sps mediate cov fusion entry cov genetic material human cell senathilake et al <NUMBER> struck et al <NUMBER> afterwards spselective strategy used initial phase cov infection probably considered potential approach mitigate infection inside body furin induces cleavage sps rntr<NUMBER>ev site bergeron et al <NUMBER> results production two segments s<NUMBER> s<NUMBER> figure <NUMBER>b segment shows biological activity s<NUMBER> segment known globular section sp mediates attachment cov receptor ace<NUMBER> dominance ahelix structures li et al <NUMBER> <NUMBER>resdiue fragment sp determined proteinbinding site wong et al <NUMBER> s<NUMBER> known biomembraneanchored stalk domain leads covhuman cell fusion prabakaran et al <NUMBER> experiments also exhibited biomembraneanchored proprotein convertases prcos namely poco<NUMBER>b poco<NUMBER> cleave sps regard basak et al <NUMBER> employing intramolecularly quenched fluorogenic iqf proteins relied sarscov sp claimed poco<NUMBER>b poco<NUMBER> beside furin may result cleavage sps kinetic studies showed cleavage peptide occurred potentially furin well recombinant poco<NUMBER>b limited amount poco<NUMBER> furthermore demonstrated cleavage activity could inhibited pocoinhibitor a<NUMBER>pdx circular dichroism intensities revealed content bsheet conformation poco increases cleavage furin figure <NUMBER>c <NUMBER>h nuclear magnetic resonance nmr spectroscopy displayed peptide turn motif cterminal part close cleavage site coutard et al <NUMBER> revealed sp sarscov<NUMBER> possesses furinlike cleavage site absent cov clade genome sequence revealed sarscov<NUMBER> included lineage b bcov figure <NUMBER>a chen et al <NUMBER> presented sarscov<NUMBER> newly detected cov shows high level similarity sarscov structural analysis receptor binding domain rbd sp two viruses show <NUMBER> similarity residue sequences figure <NUMBER>b molecular modeling studies depicted sarscov<NUMBER> rbd provides stronger attachment ace<NUMBER> found distinct phe residue plays key role binding site due interaction ace<NUMBER> several kinds cov various genera s<NUMBER> s<NUMBER> binding site furin cleavage site fcs belouzard et al <NUMBER> important phase life cycle cov human cell entry fusion derived proteolytic activity relative fusion protein fp respective proteases jaimes whittaker <NUMBER> conventional approach explore cov life cycle clone fp gene appropriate vector transfect cells incubate related protease purify protein carry protein assays cong et al <NUMBER> li et al <NUMBER> approach shows number drawbacks need viral genome expensive synthesizing process availability monoclonal antibodies timeconsuming process therefore jaimes et al <NUMBER> reported fluorogenic peptide cleavage analysis assay proteolytic activity recombinant fp applied case cov sp less labor time intensive way another study xi et al <NUMBER> isolated one strain sarscov<NUMBER> zj<NUMBER> mild covid<NUMBER> patient reported presence <NUMBER> specific gene mutation theoretical analysis fcs case alignment cov family determined fcs may crucial site cov evolution zj<NUMBER> showed mutations close fcs f<NUMBER> led alterations conformation charge distribution surface sp employed adaptive poissonboltzmann solver apbs analysis exhibited binding site furin covered number negative residues figure <NUMBER>a f<NUMBER> site sarscov<NUMBER> namely zj<NUMBER> wuhanhu<NUMBER> ratg<NUMBER> almost covered positive moieties sars covered mixed negative positive residues f<NUMBER> site zj<NUMBER> showed positive charge distribution head negative residues basal site comparison wuhanhu<NUMBER> basak et al <NUMBER> c cd signals qsars<NUMBER> peptide incubation different concentrations recombinant furin basak et al <NUMBER> reprinted permission refs basak et al <NUMBER> braun sauter <NUMBER> f<NUMBER> site gz<NUMBER> negative charge distribution f<NUMBER> site wuhanhu<NUMBER> ratg<NUMBER> demonstrated limited level positive moieties zj<NUMBER> displayed positive charge distribution f<NUMBER> site species likely derived gene deletion gz<NUMBER> presented number negative charge distribution f<NUMBER> site limited negative charge distribution observed sarscov<NUMBER>associated virus figure <NUMBER>a hence deduced mutation close fcs site lead significant change protein conformation surface charges affected interaction ligands xi et al <NUMBER> hoffmann et al <NUMBER> depicted sarscov<NUMBER> cell entry relied ace<NUMBER> tmprss<NUMBER> limited protease inhibitor indeed exploring cellular factors employed sarscov<NUMBER> entry might result providing useful information viral outbreak number therapeutic approaches hoffmann et al <NUMBER> exhibited sarscov<NUMBER> utilizes sarscov receptor ace<NUMBER> specific cellular <NUMBER> code alignment residue sequences sprotein covzxc<NUMBER> sarscov<NUMBER> <NUMBER>ncov s<NUMBER>s<NUMBER> site coutard et al <NUMBER> b comparison structures sarscov rbd interaction ace<NUMBER> obtained molecular models sarscov<NUMBER> rbd reprinted permission refs coutard et al <NUMBER> internalization tmprss<NUMBER> serine protease sp cleavage tmprss<NUMBER> inhibitor developed clinical application block cellular internalization might result advancement therapeutic approach general demonstrated crucial similarities sarscov<NUMBER> sarscov infection reported promising target development antiviral platforms figure <NUMBER>b hoffmann et al <NUMBER> design enzyme inhibitors therapeutic platforms cov require control multiple pharmacologic features beyond interaction ace<NUMBER>and furintargeting drugs baron et al <NUMBER> kong et al <NUMBER> number pharmacologic characteristics show molecular underpinning chemical pathways within biological systems examples include drug transport pathways blood circulation drug drug metabolism side effects derived interactions drug wide range enzymes zumla et al <NUMBER> thus thermodynamic kinetic data pharmacological development drugs preclinical studies required overviewed far reducing levels ace<NUMBER> might provide great deal interest fighting cov point fact ace<NUMBER> induce protective impact covstimulated lung damage enhancing formation vasodilator angiotensin indeed attachment sp cov ace<NUMBER> triggers reduction levels ace<NUMBER> likely stimulating lung injury xu et al <NUMBER> reported vitamin used potential candidate mitigate lipopolysaccharideinduced acute lung damage via control reninangiotensin system therefore could suggested vitamin control outbreak cov inhibition ace<NUMBER> gurwitz <NUMBER> claimed angiotensin receptor blockers used promising sarscov<NUMBER> therapeutics also suggested probable way fighting cov could injection ace<NUMBER> result preventing interaction cov offinfected cells replenishing ace<NUMBER> infected cells studies indicated close correlation hypertension heart disease cov infection may associated prescription ace<NUMBER> inhibitors fang et al <NUMBER> indeed treatment cov infection ace<NUMBER> inhibitors leads upregulation receptor especially epithelial cells lung followed facilitation infection different kinds sarscov based reports attention given development furin inhibitors potential therapeutics platform sarscov<NUMBER> infection although great deal research required exhibit experimentally assertion inhibition furin furinlike enzymes may display promising antiviral platform actually recently demonstrated hcs infected several kinds viruses stimulate interferonbased activity block enzymatic activity furinlike enzymes lodermeyer et al <NUMBER> also revealed virus infection triggers upregulation receptors braun sauter <NUMBER> kim et al <NUMBER> inhibit furin trafficking postgolgi compartments also based crystal structure furin potent inhibitors like <NUMBER>dideoxystreptaminemediated inhibitor xi et al <NUMBER> similarity sarscov sarscov<NUMBER> hoffmann et al <NUMBER> reprinted permission refs hoffmann et al <NUMBER> xi et al <NUMBER> developed used clinical trials dahms et al <NUMBER> furinlike enzymes contributed several pathways one crucial point would limit systemic inhibition may lead adverse effects consequently likely small molecule active agents promising drugs probably administered inhalation presenting strong interaction furin stimulate prolonged inhibition deserve quickly analyzed examine antiviral impact sarscov<NUMBER> general details disclosed inhibitors furin furinlike enzymes may play key role blocking virus outbreak ongoing challenges future perspective ace<NUMBER> exhibited primary structures patterns vertebrates lineages structural investigations indicated ace<NUMBER> systems efficiently interact rbd sarscov<NUMBER> inducing serve promising hosts virus infection mathewson et al <NUMBER> poon peiris <NUMBER> furthermore deduced small molecular ligands inhibitors limit interaction ace<NUMBER> rbd developed combat spreading cov epidemic senathilake et al <NUMBER> isolating cultivating cov vitro may usually practical demand particular facilities accessible every bioresearch laboratory therefore necessity developing strategies assay human health response spread emerging cov performed normal laboratory systems apart viruses targeting humans several animal viruses also identical fps hence exhibiting comparable features human sites purifying kinds viruses display inevitable biological challenges making application pioneering devices examine unavoidable current drugs limited efficacy treating cov different populations species given high incidence cov resistance especially immunocompromised patients design new drugs target specific activities virus stop one stages infection cycle essential prajapat et al <NUMBER> yang et al <NUMBER> zhou zhao <NUMBER> recent years research focused blocking virus transmission hc rna polymerase activity virus hcvirus interactions schaack mehle <NUMBER> genetic changes reappearance emergence antigenic variants transmission cov humans require extensive measures control globalization vaccination drug followup immediate protection important tools dealing viral infections ahmed et al <NUMBER> due possible genetic modification cov producing suitable vaccine disease difficult kim et al <NUMBER> changes antigenic sites surface proteins especially sp important surface antigen virus give rise appearance new strains du et al <NUMBER> kleineweber et al <NUMBER> changes regions affect antibodies produced former strains therefore role immunity disease stebbing et al <NUMBER> emergence resistant strains drug selective pressure limited availability highrisk cases exacerbates need new therapeutic strategies zu et al <NUMBER> recent years compounds affecting different stages viruss life cycle introduced wide range antiviral strategies proposed including inhibiting entry stopping viral replication targeting intracellular signal transduction pathways peeri et al <NUMBER> recent decades targeting viral proteins inducing humoral cellular immune responses received great deal attention development antiviral compounds zumla et al <NUMBER> ability biomolecular systems cytokines interleukins bacterial derivatives improve immunogenicity xenografts evaluated novel strategy although immune system regulatory proteins received attention covs rna viruses replicating cytoplasm hcs transfer genetic materials human hcs dependent interaction envelope human hc biomembrane sp mediates cov entry conducts interaction cov receptor ace<NUMBER> hcs well mediating fusion hc biomembrane viral envelope also sarscov<NUMBER> furin substrate site facilitate cleavage sp review discussed overview role ace<NUMBER> furin binding cov hc biomembrane mediated sp also surveyed contribution fcs cov outbreak moreover considered ability small molecular inhibitors limiting interaction ace<NUMBER> furin sp used promising antiviral drugs vaccines paper may provide promising information development useful strategies combat spreading cov epidemic authors declare competing interests authors read approved final manuscript potential conflict interest reported authors research made possible grants nprp<NUMBER> qatar national research fund qnrf qatar foundation gcc<NUMBER> gcc collaborative research program qatar university httporcidorg<NUMBER> marty ks wong additional namesabbreviations angiotensin converting enzyme dipeptidyl carboxypeptidase peptidase p kininase ii angiotensin iconverting enzymeace angiotensin converting enzyme <NUMBER> peptidyldipeptidase peptidyldipeptidase aace<NUMBER> ace possesses dual actions convert ang ang ii degrade bradykinin development ace inhibitor first effective drug hypertension caused high renin activity ace<NUMBER> identified receptor sars severe acute respiratory syndrome coronavirus caused outbreak epidemic <NUMBER>à<NUMBER> ace discovered mid<NUMBER>s observation dialysis plasma kidney extract water saline incubation produced two separate pressor substances ang ang ii respectively <NUMBER> discovered second time <NUMBER> characterization bradykinin bk degrading enzyme kidney enzyme named kininase ii later found enzyme ace ace<NUMBER> discovered <NUMBER> two independent research groups cloned homologous ace could convert ang ang<NUMBER>à<NUMBER> yet also captoprilinsensitive <NUMBER> <NUMBER> two isozymes ace present mammals somatic ace testis ace somatic ace possesses two catalytic domains nand cdomains cterminal transmembrane segment stalk figure <NUMBER>d <NUMBER> somatic testis aces humans contain <NUMBER> <NUMBER> aa residues respectively testis ace possesses one catalytic domain catalytic domains zincmetallopeptidase active motif hemgh two histidine residues coordinate zinc ion stalk anchors enzyme membrane susceptible cleaved shedding enzymes resulting plasma ace activity figure <NUMBER>d <NUMBER> ace<NUMBER> chimaera protein single catalytic domain ace cterminal highly resembling collectrin may act chaperone protein deliver proteins brush border membrane gene mrna ace ace<NUMBER> genes located chromosome <NUMBER>q<NUMBER> xp<NUMBER> humans respectively testis ace transcribed gene alternative transcription starting site <NUMBER>th intron ace gene resulting cdomain stalk segment unique additional <NUMBER> aa nterminal sequence humans two catalytic domains result genedomain duplication duplication occurred multiple times evolution cnidarians crustaceans insects vertebrates possess acelike enzymes one two catalytic domains expression studies far performed nonmammalian ace ace<NUMBER> somatic ace expressed various tissues including blood vessels kidney intestine adrenal gland liver uterus especially abundant highly vascular organs retina lung testis ace expressed postmeiotic male germ cells highlevel expression found round elongated spermatids ace<NUMBER> expressed lung liver intestine brain testis heart kidney lung possesses highest amount ace contributes <NUMBER> total protein serum ace levels humans ranged <NUMBER> <NUMBER> <NUMBER> μgl dd <NUMBER> <NUMBER> <NUMBER> μgl ii heterozygous individuals <NUMBER> <NUMBER> <NUMBER> μgl <NUMBER> id see section pathophysiological implications genotype definition several enzymatic assays developed measurement ace activity plasma tissues usually involve artificial substrates hippurylhisleu n<NUMBER>furylacryloyllphenylalanylglycylglycine fapgg combination captopril inhibition methods developed mammals also extended vertebrates including birds amphibians fishes <NUMBER> however enzymatic methods may erroneous enzyme specificity artificial substrates could different lamprey ace activities different tissues measured captopril failed decrease ace activities indicating possible nonspecific enzyme measurement amphibian high captoprilsensitive ace activities found gonad intestine kidney lung moderate activities presented liver heart skin low negligible activities observed plasma muscle erythrocytes expression ace affected steroids thyroid hormone details regulation clear ace promoter regulation hypoxiainducing factor <NUMBER>α hif<NUMBER>α upregulates ace expression hypoxic conditions resulting increase ang ii concentration hypoxia ace<NUMBER> downregulated shown indirectly controlled ang ii hif<NUMBER>α <NUMBER> testis ace expression control highly specific regulated tissuespecific promoter located immediately <NUMBER> bp transcription start site frequently used testisspecific overexpression studies hypoxia induced high temperature decreased gill ace activity effect kidney carp promoters ace<NUMBER> mammals amphibians teleosts drive specific expression heart ciselement search results discovered wgatar motifs putative ace<NUMBER> promoters different vertebrates suggesting possible role gata family transcriptional factors ace<NUMBER> expression regulation none first ace inhibitor peptide antagonist called sq <NUMBER> gwprpeipp discovered snake venom orally active snake venom peptides studied produce first orally active form captopril lowers blood pressure essential hypertensive patients <NUMBER> common side effects captopril cough skin rash loss taste therefore derivatives enalapril lisinopril ramipril developed fewer side effects discovery nand cdomains ace specific domain inhibitors developed increase specificity ang mainly hydrolyzed cdomain vivo bk hydrolyzed domains developing cdomain selective inhibitor rxpa<NUMBER> degradation bk ndomain would permitted degradation could enough prevent accumulation excess bk causing angioedema <NUMBER> wellknown function ace conversion ang ang ii degradation bk play important role controlling blood pressure ace also acts natural substrates including encephalin neurotensin substance p besides involved blood pressure control ace possesses widespread functions including renal development male fertility hematopoiesis erythropoiesis myelopoiesis immune responses <NUMBER> ace<NUMBER> convert ang ii ang<NUMBER>à<NUMBER> thereby reducing concentration ang ii increasing ang<NUMBER>à<NUMBER> ace<NUMBER> also convert ang ang<NUMBER>à<NUMBER> subsequently converted ang<NUMBER>à<NUMBER> ace high expression ace<NUMBER> favors balance ang<NUMBER>à<NUMBER> ang ii accounts cardioprotective role ace<NUMBER> via ang<NUMBER>à<NUMBER>mas signaling pathway <NUMBER> aceknockout mice display normal blood pressure normal conditions sensitive changes blood pressure exercise aceknockout also affects renal function renal development serum urine electrolyte composition haematocrit male reproductive capacity stalk anchors enzyme membrane suspectible cleaved shedding enzymes resulting plasma ace activity ace<NUMBER> chimaera protein single catalytic domain ace cterminal highly resemble collectrin may act chaperone protein deliver proteins brush border membrane <NUMBER> deficiency testis ace affects male fertility exact role still clear although mice testis ace deficiency mate normally sperm quantity motility different wildtype mice survival sperm oviduct fertilization rate highly reduced <NUMBER> overexpression ace<NUMBER> hypertensive models normotensive animals reduced blood pressure ace<NUMBER>knockout mice displayed progressive cardiac dysfunction resembling longterm hypoxia coronary artery disease bypass surgery human could reversed concurrent aceknockout suggested cardioprotective function ace<NUMBER> counterbalance effects ace clinical implications inclusion ii deletion dd <NUMBER> bp alu repeats <NUMBER>th intron affects human plasma ace levels dd genotype frequently found patients myocardial infarction convincing evidence available association dd genotype hypertension <NUMBER> ace<NUMBER> identified receptor sars severe acute respiratory syndrome coronavirus sars virus binding downregulates cellular expression ace<NUMBER> binding induces clathrindependent internalization virusreceptor sarsace<NUMBER> complex ace<NUMBER> facilitated invasion sars virus rapid replication also ace<NUMBER> depleted cell membrane therefore damaging effects ang ii enhanced resulting acute deterioration lung tissues ace target hypertension control since <NUMBER>s ace inhibitors prescribed sole combinational treatment high blood pressure dual effects lowering ang ii slowing bk degradation human hypertensive patients ace<NUMBER> levels lower kidney heart compared normotensive volunteers supplemental information e figure <NUMBER>d u b c h p e r <NUMBER> <NUMBER> angiotensin converting enzymes e<NUMBER>d<NUMBER> e figure <NUMBER>d <NUMBER> phylogenetic tree angiotensin converting enzymes vertebrates unrooted phylogenetic tree angiotensin converting enzyme ace angiotensin converting enzyme <NUMBER> ace<NUMBER> constructed maximum likelihood method using fulllength sequences representative vertebrate species numbers branches indicate bootstrap values <NUMBER> replicates ace ace<NUMBER> form separate subclades u b c h p e r <NUMBER> <NUMBER> angiotensin converting enzymes e<NUMBER>d<NUMBER> e<NUMBER>d<NUMBER> e organisms evolve rapidly selective advantage quickly adapting host surroundings example amino acid changes surface protein hemagglutinin influenza virus sufficient evade hosts antibody detection within time span single season <NUMBER> effectively genotype monitor genome rapidly evolving heterogeneous population important capability amplify nucleic acid sequences samples taken population genotype shifting viral sequencing projects increased jcvi past years highthroughput mechanism rapidly select pcr primers high probability success necessary paper describe modifications made highthroughput primer design pipeline previously developed human resequencing <NUMBER> describe results <NUMBER> <NUMBER> viruses pcr primers designed measles virus mumps virus rubella virus human parainfluenza virus <NUMBER> <NUMBER> human respiratory syncytial virus b human metapneumovirus pcr primers remaining viruses also successfully designed using degenerate primer design pipeline included results discussion primers entire computationally designed set modified suit project specific laboratory pcr requirements thus utilized primer pairs completely true algorithms recommendations excluded viruses human coronavirus feline coronavirus canine coronavirus sars coronavirus human adenovirus human norwalk virus influenza viruses human influenza b avian influenza use degenerate primers selectively amplify set closely related sequences periodically found literature previous work computational tools included codehop <NUMBER> designs degenerate primers based conserved amino acid sequences hyden <NUMBER> tries maximize coverage degenerate primer pair minimal amount degeneracy viral sequences amino acid based methodology codehop would introduce larger set degenerate bases would necessary successfully amplify set isolates thus unnecessarily increasing potential nonspecific priming alternative products hydens objective focuses primer pair family genes rather whole genome sequencing potentially heterogeneous sample species viruses highthroughput environment goal jcvis degenerate primer design pipeline maximize success rate selected primer pairs given set sequences assumed represent target population important decide bases make degenerate also many combinations lead successful pcr high throughput features jcvis degenerate primer design pipeline inherited original nondegenerate version include dynamic tiling overlapping nonfixed amplicon set across entire target genome well capability predict primer pairs high success rates one either two amplification protocols standard high gc dynamic tiling allows selection amplicon set dependent landscape features template parameterizing minimum maximum optimal amplicon overlap amplicon sizes jcvi primer design pipeline crawls across template based last amplicon selected thus minimizing number successful amplicons necessary cover genome selecting amplicons predicted successful exhaustive search possible fixed tiling necessity designing highly successful primers highthroughput directed sequencing environment consequence prohibitively high labor costs required manually reprocess failures tuning pcr conditions work present utilizes two laboratory protocols based previous publication achieve comparable level success paper results degenerate primer design augmentation previously published highthroughput pcr primer design software <NUMBER> methodology used construct reference degenerate consensus sequence described degenerate primer design pipeline used design primers multiple viral projects across <NUMBER> different dna rna viruses including segmented nonsegmented viruses results <NUMBER> different nonsegmented viruses presented size genomes varied <NUMBER>kb <NUMBER>kb various degrees sampled genomic sequence variation gc content summary statistics primers designed <NUMBER> different nonsegmented viral genomes using two different pcr protocols described standard high gc protocols presented table <NUMBER> standard high gc protocols described briefly materials methods section table <NUMBER> contains actual sequencing success rates targeted viral consensus sequence relevant information regarding consensus sequences construction median amplicon coverage viruses approximately <NUMBER>x however many cases ends genomes lower minimum coverage e<NUMBER>x <NUMBER>x due inability select primer beyond end available sequence dynamic tiling produced even tiling amplicon coverage across genomes primers designed using standard protocol targeted organisms less <NUMBER> gc content included human parainfluenza virus hpiv<NUMBER> hpiv<NUMBER> measles virus mev mumps virus muv human respiratory syncytial virus hrsva hrsvb human metapneumovirus hmpva hmpvb organisms gc content exceeding <NUMBER> eg rubella virus rubv<NUMBER> rubv<NUMBER> high gc protocol used amplicons designed cover entire genome viruses full length complete sequences available ncbis viral genomes <NUMBER> used generate consensus sequences number sequences used generate consensus sequence percent degenerate bases across constructed consensus sequences described table <NUMBER> number sequences collected construct consensus sequence ranged <NUMBER> hrsva hrsvb <NUMBER> muv viral type single consensus file generated target less <NUMBER> degenerate bases two exceptions resultant percent ambiguity across constructed consensus sequence ranged <NUMBER> hrsvb <NUMBER> muv single consensus could generated less <NUMBER> ambiguity multiple consensus sequences constructed based sequence similaritybased clustering results two exceptions measles virus mev rubella virus rubvg<NUMBER> percent ambiguities exceeding <NUMBER> measles virus allele frequencies multiallelic positions filtered remove less dominant allele frequencies even percentage degenerate bases across constructed consensus sequence exceeded <NUMBER> even though less dominant allele frequencies expected threshold sequencing error percent degeneracy across consensus sequence close <NUMBER> decided stratifying sequences generating multiple consensus sequences may cost effective total success rate expected significantly impacted rubella virus input sequences stratified two genotypes total percentage degenerate bases initially constructed consensus sequence <NUMBER> see figure <NUMBER> computational stratification two sets sequences used input generate consensus sequences genotype <NUMBER> g<NUMBER> genotype <NUMBER> g<NUMBER> based <NUMBER> <NUMBER> sequences respectively reduced percent degeneracy across consensus sequence <NUMBER> <NUMBER> g<NUMBER> g<NUMBER> respectively g<NUMBER> contained many multiallelic positions filtered allelic frequency <NUMBER> <NUMBER> <NUMBER> clear whether attributed sequencing error within input sequences variations retained conservative degenerate primers computed independently g<NUMBER> g<NUMBER> consensus sequences redundant primer pairs two computes removed human respiratory syncytial virus hrsv separate sets primers designed hrsva hrsvb since <NUMBER> sequence dissimilarity across entire genome <NUMBER> ambiguity see figure <NUMBER> splitting sequences two subsets ensured sequences subset less <NUMBER> dissimilar sequences subset hrsva differed <NUMBER> hrsvb differed <NUMBER> percent ambiguity <NUMBER> hrsva <NUMBER> hrsvb human metapneumovirus hmpv appeared two distinct clades approximately <NUMBER> dissimilar initial sequences split two clades hmpva <NUMBER> ambiguity hmpvb <NUMBER> ambiguity separate primers pairs designed two clades independently viral genomes amplicons designed intended coverage depth <NUMBER>x <NUMBER>x exception hmpva hmpvb coverage depth <NUMBER>x multiple depths coverage increase likelihood successfully amplifying targeted region least second pair candidate primers selected primer design pipeline ensures second primer pair overlap previously selected primer pairs highthroughput sequencing environment wells plate processed additional amplicon coverage generated empty wells remained number amplicons designed exceeded number wells plate amplicons computationally reduced smaller subset every targeted region covered least one amplicon projects also differed sequencing requirements thus resulting varying amplicon numbers coverage depth depending virus type determining success degenerate primer design complicated process standard nondegenerate primer design degenerate primer design algorithm need accurately model predict outcome pcr heterogeneous population primer pairs constructed degenerate consensus sequence needs sufficiently represent targeted genomes population latter detrimentally impacted lack available sequence information potential heavily biased sequencing favouring strains specifically studied single laboratories success rates provided table <NUMBER> represent average success rates virus type percentage sequencing reactions performed however since effect isolate confounded inside average success rate gain deeper understanding success rate primer pairs across isolates graded approach taken necessary primer pair successful low percentage across samples possible primers match genotype isolate rather poorly selected primer pair based primer design algorithm alone primer pair isolate sequencing performed forward reverse directions sequence recovered isolate primer pair standard expectations high quality values length etc sequencing direction considered success success rates tallied forward reverse averaged sequencing directions per primer pair success rates graded cutoffs greater <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> percent isolates see table <NUMBER> cumulative graded approach necessary distinguish amplification failures either isolate target region specific note actual predicted success rates calculated based laboratory experiments predicted success rates based silico computations furthermore fairly uniform amplicon coverage across genomes eg figure <NUMBER> reported success rates inflated redundant stacking amplicons easytoamplify loci table <NUMBER> contains forward reverse average success rates viral consensus sequence directional set statistics sequencing success rate computed across isolates example hrsva <NUMBER> primers designed greater <NUMBER> isolates successfully sequenced separate pcr failure bias due gc content genome alone overall success rates primer pairs calculated high gc standard protocols separately standard protocol overall forward reverse averaged sequencing success rates primer pairs <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> isolates however greater <NUMBER> isolates consistent <NUMBER> primer pair success rate mumps virus primer failures recorded vp protein region rna editing insertion nontemplate g variable region sh gene consistent pattern plate location primer failures also discovered could issue related laboratory conditions due design primers high gc protocol three sequencing success rates primer pairs lower expected greater <NUMBER> isolates success rates <NUMBER> <NUMBER> <NUMBER> overall forward reverse total sequencing success rate respectively appear relationship percentages ambiguity consensus sequence success rates designed primers simple linear regression adjusted r <NUMBER> <NUMBER> lack correlation could result sequences represented degenerate consensus sequence poorly representing isolates accurately designed primer pair sequences success rates available additional file <NUMBER> highthroughput degenerate pcr primer design pipeline successful providing basis highquality viral sequencing results minimizing costs associated labor reprocessing genome finishing modular architecture primer design software made possible readily integrate new features pipeline result augmented primer design software coupled rtpcr modified productionverified prior pcr laboratory protocols serves powerful tool highthroughput degenerate primer design thus enabling quick effective sequencing diverse viral strains importance proper degenerate consensus sequence construction key input process described success rate designed primers supports effectiveness combined methodologies input degenerate primer design pipeline consensus reference sequence targeted genome consensus sequence used reference detecting alternative products template primer pair candidates selected segmented viruses subset entire genome targeted subset may specified template entire genome sequence still required reference detecting potential alternative amplification products generation consensus sequence ambiguity codes may established first generating multiple sequence alignment msa tool clustalw <NUMBER> muscle <NUMBER> using msatoconsensus generator cons emboss <NUMBER> one applications andes <NUMBER> sequence diversity targeted population genomic region significant recommended use tool andes determine necessary stratify population also filter positions potential variance various means described later material methods subsection constructing consensus sequence andes output set degenerate primer pairs theoretical amplicons based consensus reference sequence variety supplemental design information also generated among summary file critique results including information primer amplicon location reference melting temperatures primer dimer calculations along sequences primers adobe portable document format pdf file contains visualization tiling layout amplicons across targeted genome also generated along summary file figure <NUMBER> core architecture primer design remained unmodified original form coverage <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> dynamically tiled layout amplicons across targeted genome example tiling output single primer design run performed rubvg<NUMBER> green rectangle represents amplicon long black bar represents targeted region red xs targeted region represent locations <NUMBER>x coverage could achieved amplicon lengths rubvg<NUMBER> rubvg<NUMBER> using high gc protocol targeted <NUMBER> bp manager cm component determines dynamic tiling path across genome based results primer critiquor pc components examination candidate primer pairs pc component consists series tests critiques determine whether primer pair successful based empirical evidence previous sequencing experiments cm component utilizes primer<NUMBER> <NUMBER> generate list candidate primer pairs however primer<NUMBER> return error message ambiguity codes found userspecified template extra step performed convert ambiguity codes ns primer<NUMBER> generated list primer pair candidates embedded ns cm remaps ns back original ambiguity code passes degenerate primer pair candidates pc component additional critiquing following critique modules utilized pc component modified assess anticipated success primer pair candidates degenerate base positions instead using blast <NUMBER> small word size search primer binding sites reference consensus genome dreg emboss utilized dreg uses regular expressions highly flexible pattern recognition specification sequence matching based conditions laboratory protocol utilized highthroughput sequencing laboratory determined binding <NUMBER> base pairs <NUMBER> end sufficient polymerase initiate synthesis copy strand reason <NUMBER> base pairs three prime end degenerate primer sequence specified regular expression pattern detected primer binding sites analyzed determine whether alternative product formed based detected primer binding site orientation pairwise distances degenerate sequence primer pair candidate list disambiguated sequences generated enumerating possible nondegenerate primer sequences represented degenerate sequence self pairwise primer dimer predictions calculated within disambiguated primer sequence lists respectively primer melting temperatures computed averaging nearest neighbor thermodynamic calculations <NUMBER> melting temperatures disambiguated sequences derived degenerate sequence construction template andor reference consensus sequence ambiguous bases critical step prior executing degenerate primer design pipeline unlike using standard ie nondegenerate primers analyst must assume primers binding conserved regions surrounding target necessity degenerate primers presumes target population sufficiently heterogeneous insufficient conserved regions allow standard primers successfully bind amplify samples population degenerate primer design allows mixed population primer pairs simultaneously available pcr reaction thus increasing likelihood successfully targeting unknown sample heterogeneous population properly designed consensus sequence set consensus sequences represent heterogeneous population maximizing likelihood attaining pcr products samples time minimizing potential alternative products number alternative products may exhibit quadratic relationship number unique primer sequences involved pcr thus goal minimize number degenerate bases primer sequence maximizing proportion target population primers specifically bind end effect limit number degenerate bases per primer <NUMBER> preferably less <NUMBER> bases andes tools provide analyst two key methodologies support minimizing number degenerate bases utilized maximizing proportion population targeted abundance filtering sample stratification ultimately targeted percent degenerate bases consensus sequence <NUMBER> ideally less <NUMBER> abundance filtering andes performed using several techniques reduce number degenerate bases introduced consensus sequence filtering applied analyst assumes point mutations represented set sequences acquired population equally important polymorphisms may due sequencing error others may represent insignificant subpopulation given msa constructed set sequences determined reasonable representation population andes computes distribution nucleotides position nominal filter percentage filter applied remove presence alleles represented userspecified frequency percentage threshold respectively example degenerate base w required alleles exist population specific position however <NUMBER> samples <NUMBER> ts applying <NUMBER> percentage filter would change w nondegenerate base analyst believes polymorphism actually due sequencing error alternatively statistical filter combining frequency percentage may applied utilizes binomial distribution determine whether allele would detected upon resampling depth based userspecified confidence ie alpha lastly optimizationbased filter also available analyst specifies maximum percentage degenerate bases allowed consensus sequences algorithm iteratively removes alleles starting ones lowest proportion across samples maximum percentage degenerate bases achieved filtering techniques either remove alleles need targeted reduce number degenerate bases constructed consensus sequence sufficiently sample stratification necessary goal sample stratification reduce total variation combined population placing individuals clusters contain less intracluster variance entire population difference clusters used separate clusters less variation exist within formed clusters respect entire population stratification ie clustering performed andes given msa andes used compute distance matrix dendrogram based sequence similarity used generate clusters given userspecified cutoff maximum intracluster percent dissimilarity cutoff works well approximately <NUMBER> percent similarity within cluster undivided set sequences falls <NUMBER> number degenerate bases must introduced consensus sequence becomes high cluster created reduce amount intracluster dissimilarity separate consensus sequence subsequently generated represent subpopulation determining appropriate threshold methodologies important keep mind number sequences included since confidence real polymorphisms existing population attained sufficient sample size general landscape variation ascertained plot normalized entropy versus location sufficient conserved regions flanking highly variable regions sufficiently large amplicon size regions localized high rates variation generally introduce difficulty primer pair selection due primer designers dynamic tiling capabilities jcvi primer design pipeline automatically detects subregions targeted genome sequence may use standard protocol must use high gc protocol subregions separated proper primer design parameters utilized design selection primer pairs key parameters shared standard high gc protocols include optimalminimum amplicon dynamic tiling overlap <NUMBER> bp optimalminimummaximum primer lengths <NUMBER> bp low complexity filter <NUMBER> primer binding site hairpin detection <NUMBER> stem hydrogen bonds <NUMBER> bp loop circumference size maximum internal primer dimer <NUMBER> bp maximum end primer dimer <NUMBER> bp key parameters two protocols differed include minimummaximum amplicon melting temperatures <NUMBER>°<NUMBER>°c standard <NUMBER>°<NUMBER>°c high gc optimalminimummaximum amplicon sizes <NUMBER> bp standard <NUMBER> bp high gc maximum amplicon dynamic tiling overlap <NUMBER> bp standard <NUMBER> bp high gc mev exception primer design utilized project specific optimalminimummaximum amplicon size <NUMBER> bp reduce number amplicons necessary amplicon sizes selected shorter sequencing read length achieve full bidirectional coverage increasing accuracy downstream computational variation detection decreasing necessity manual review indeterminate base calls standard high gc protocols reverse transcription pcr rtpcr performed using qiagen one step rtpcr kit cat <NUMBER> viral sample underwent rtpcr reactions <NUMBER> pairs designed primers <NUMBER>well format qiagen one step rtpcr set <NUMBER>μl reactions containing <NUMBER>μl water <NUMBER>μl buffer qiagen <NUMBER>μl q solution qiagen <NUMBER>μl dntp qiagen <NUMBER>μl enzyme qiagen <NUMBER>μl rnaseout invitrogen <NUMBER>μl undiluted rna <NUMBER>μl primers <NUMBER>μm forward reverse mixed additional <NUMBER>μl q solution added rubvg<NUMBER> rubvg<NUMBER> reactions due high gc content genome genomes additional <NUMBER>μl water added reaction amplification done <NUMBER>well format mj research dna engine tetrad <NUMBER> thermal cycler following cycling conditions <NUMBER> cycle <NUMBER>°c <NUMBER> min <NUMBER> cycle <NUMBER>°c <NUMBER> min <NUMBER> cycles <NUMBER>°c <NUMBER> sec <NUMBER>°c <NUMBER> sec <NUMBER>°c <NUMBER> min <NUMBER> cycle <NUMBER>°c <NUMBER> min hold <NUMBER>°c amplification <NUMBER>μl reaction run <NUMBER> agarose gel <NUMBER> hour visualize bands confirm amplification unincorporated dntps dephosphorylated excess primers removed products using sapexo reaction containing <NUMBER> units shrimp alkaline phosphatase usb corporation <NUMBER> unit exonuclease usb corporation molecular biology grade water cycling program <NUMBER> cycle <NUMBER>°c <NUMBER> min <NUMBER> cycle <NUMBER>°c <NUMBER> min sanger sequencing reactions performed rtpcr product standard highthroughput sequencing system using big dye terminator v<NUMBER> applied biosystems m<NUMBER> sequencing primers forward primer tgtaaaacgacggccagt reverse primer caggaaacagctatgacc dye terminators removed ethanol precipitation sequences obtained <NUMBER>xl dna analyzer applied biosystems raw sequence data computationally trimmed remove primerderived sequence well low quality sequence genome sequences assembled using jcvis internally developed assembly software named flap unpublished based minimus component opensource amos project <NUMBER> httpamossourceforgenet sequencing data released genbank annotation found using bioproject id provided table <NUMBER> project name jcvi primer designer project home page httpsourceforgenetprojects primerdesigner operating system tested production linux programming language perl license gnu gpl restrictions use nonacademics none additional file <NUMBER> tabseparated values text file contains amplicon name forward reverse primer pair sequences estimated melting temperatures sequencing success rates number pcr attempts isolates amplicon name includes virus name start stop positions template pcr primer sequences <NUMBER>tailed forward reverse m<NUMBER> sequences tgtaaaacgacggccagt caggaaacagctatgacc respectively authors necessarily nhs nihr department health social care complete list investigators contributors interval trial previously provided <NUMBER> academic coordinating centre would like thank blood donor centre staff blood donors participating interval trial genotypetissue expression gtex project supported common fund office director national institutes health nih additional funds national cancer institute national human genome research institute nhgri national heart lung blood institute national institute drug abuse national institute mental health national institute neurological disorders stroke donors enrolled biospecimen source sites funded leidos biomedical inc leidos subcontracts national disease research interchange <NUMBER>xs<NUMBER> roswell park cancer institute <NUMBER>xs<NUMBER> laboratory data analysis coordinating center ldacc funded contract hhsn<NUMBER>c broad institute inc biorepository operations funded leidos subcontract van andel institute <NUMBER>st<NUMBER> additional data repository project management provided leidos hhsn<NUMBER>e authors would like thank staff iucpq biobank quebec respiratory heath research network valuable assistance lung eqtl dataset laval university already known topic  severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> responsible current coronavirus disease <NUMBER> covid <NUMBER> pandemic  serine protease tmprss<NUMBER> involved priming sarscov<NUMBER> spike protein cellular entry angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor  expression ace<NUMBER> tmprss<NUMBER> lung epithelium might implications risk sarscov<NUMBER> infection severity study adds  used human genetic variants proxy ace inhibitor drug effects cardiometabolic risk factors provide insight exposures affect lung ace<NUMBER> tmprss<NUMBER> expression circulating ace<NUMBER> levels  findings support hypothesis ace inhibitors effects ace<NUMBER> expression  found support association genetic liability type <NUMBER> diabetes mellitus higher lung ace<NUMBER> expression plasma ace<NUMBER> levels evidence inconsistent across studies objectives use human genetic variants proxy angiotensinconverting enzyme ace inhibitor drug effects cardiovascular risk factors provide insight exposures affect lung ace<NUMBER> tmprss<NUMBER> gene expression circulating ace<NUMBER> levels design twosample mendelian randomization mr analysis setting summarylevel genetic association data participants participants predominantly european ancestry variants proxy ace inhibitor drug effects cardiometabolic risk factors body mass index chronic obstructive pulmonary disease lifetime smoking index lowdensity lipoprotein cholesterol systolic blood pressure type <NUMBER> diabetes mellitus selected publicly available genomewide association study data sample sizes ranging <NUMBER> <NUMBER> participants genetic association estimates lung expression ace<NUMBER> tmprss<NUMBER> obtained genetissue expression gtex project <NUMBER> participants lung eqtl consortium <NUMBER> participants genetic association estimates circulating plasma ace<NUMBER> levels obtained interval study <NUMBER> participants main outcomes measures lung ace<NUMBER> tmprss<NUMBER> expression plasma ace<NUMBER> levels results association genetically proxied ace inhibition outcomes considered evidence positive association genetic liability type <NUMBER> diabetes mellitus lung ace<NUMBER> gene expression gtex p <NUMBER>x<NUMBER> <NUMBER> circulating plasma ace<NUMBER> levels interval p <NUMBER> lung ace<NUMBER> expression lung eqtl consortium study p <NUMBER> associations genetically predicted levels cardiometabolic traits outcomes conclusions study provide evidence support ace inhibitor antihypertensive drugs affect lung ace<NUMBER> tmprss<NUMBER> expression plasma ace<NUMBER> levels current covid<NUMBER> pandemic findings support change ace inhibitor medication use without clinical justification severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> responsible current coronavirus disease <NUMBER> covid<NUMBER> pandemic <NUMBER> serine protease tmprss<NUMBER> involved priming sarscov<NUMBER> spike protein cellular entry angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients frequently present respiratory tract infection symptoms respiratory failure main cause death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> follows expression ace<NUMBER> tmprss<NUMBER> lung epithelium might implications risk sarscov<NUMBER> infection severity covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> emerging evidence suggests patients underlying cardiometabolic risk factors airway disease likely suffer severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> speculated angiotensinconverting enzyme inhibitor acei angiotensin receptor blocker arb classes antihypertensive medication commonly prescribed patients cardiometabolic risk factors might affect expression ace<NUMBER> thus affect susceptibility sarscov<NUMBER> infection severity consequent covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although ace ace<NUMBER> dipeptidyl carboxydipeptidases distinct physiological effects ace cleaves angiotensin angiotensin ii consequently activates angiotensin ii receptor type <NUMBER> pathway resulting vasoconstriction inflammation contrast ace<NUMBER> degrades angiotensin ii angiotensin <NUMBER> angiotensin angiotensin <NUMBER> angiotensin <NUMBER> activates mas receptor vasodilatory antiinflammatory effects animal studies supported effects acei arb drugs ace<NUMBER> expression activity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> mixed findings associations acei arb drug use ace<NUMBER> activity levels human tissues also reported <NUMBER> <NUMBER> <NUMBER> important causal effects medications cardiometabolic traits ace<NUMBER> expression investigated identification mechanistic basis exposures affect risk severity covid<NUMBER> could provide useful insight disease prevention treatment could used inform optimal medication use strategies shielding vulnerable individuals well improving evidence base public health campaigns mendelian randomization approach uses genetic variants related exposure instrumental variables investigating effect exposure outcome <NUMBER> genetic variants treated analogously treatment allocation randomized controlled trial typically molecular measurements gene expression circulating protein levels regarded mendelian randomization investigations exposure variables following work rao lau <NUMBER> treat molecular measurements outcomes investigation aim study apply mendelian randomization investigate whether ace<NUMBER> tmprss<NUMBER> gene expression lung circulating levels ace<NUMBER> plasma associated <NUMBER> genetic variants ace gene region considered proxies effect acei drugs <NUMBER> genetic variants related cardiometabolic risk factors genetic associations exposure variables two different genetic instruments proxy acei drug effects considered first selected <NUMBER> singlenucleotide polymorphisms snps ace locus associated serum ace concentration outcome reduction initial glargine intervention origin trial strong pairwise correlation r <NUMBER> <NUMBER> <NUMBER> accounting correlation variants explain <NUMBER> variance serum ace concentration secondly selected single snp rs<NUMBER> located ace locus associated systolic blood pressure sbp p <NUMBER>x<NUMBER> <NUMBER> study <NUMBER> europeanancestry individuals <NUMBER> <NUMBER> blood pressure lowering allele snp associated <NUMBER>mmhg reduction sbp <NUMBER> snps locus associated sbp genomewide level significance p <NUMBER>x<NUMBER> <NUMBER> strong pairwise correlation r <NUMBER> <NUMBER> index variant <NUMBER> considered six cardiometabolic traits exposure variables body mass index bmi chronic obstructive pulmonary disease copd lifetime smoking index lowdensity lipoprotein cholesterol ldlc sbp type <NUMBER> diabetes mellitus t<NUMBER>dm traits chosen associated prognosis covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> genetic association estimates exposures obtained publicly available genomewide association study gwas summary data sources listed table <NUMBER> genetic variants selected instruments snps associated corresponding trait genomewide level statistical significance p <NUMBER>x<NUMBER> <NUMBER> uncorrelated r <NUMBER> <NUMBER> clumping correlated variants performed using twosamplemr package r <NUMBER> genetic associations expression ace<NUMBER> tmprss<NUMBER> lung tissue obtained two sources <NUMBER> genetissue expression gtex project <NUMBER> <NUMBER> lung eqtl expression quantitative trait loci consortium <NUMBER> gtex genetic association estimates obtained <NUMBER> individuals predominantly european <NUMBER> ancestry whole genome sequencing performed broad institutes genomics platform common variants minor allele frequency <NUMBER> retained genomewide eqtl analysis performed expression ace<NUMBER> tmprss<NUMBER> primary tissue samples taken lung genetic associations imputed variants across autosomal chromosomes adjusted five principal components genotype data <NUMBER> probabilistic estimation expression residuals factors <NUMBER> sequencing platform illumina hiseq <NUMBER> hiseq x sequencing protocol polymerase chain reactionbased free sex gene expression values samples normalized using trimmed means mvalues method edger <NUMBER> expression values normalized across samples using inverse normal transformation lung eqtl consortium genetic association estimates obtained <NUMBER> individuals european ancestry <NUMBER> tissue samples obtained three different institutions university british columbia laval university university groningen genomewide eqtl analysis performed expression ace<NUMBER> using probe set <NUMBER>tgiat two probe sets tmprss<NUMBER> <NUMBER>tgiat <NUMBER>tgiat subsequently referred <NUMBER> <NUMBER> participants genotyped using illumina human <NUMBER>m duo beadchip genotypes imputed using haplotype reference consortium reference panel expression values first standardized age sex smoking status using robust linear regression genetic associations estimated cohort separately using linear additive genetic model estimates combined across cohorts using inversevariance weighted model fixedeffects genetic association estimates circulating plasma ace<NUMBER> levels obtained subcohort <NUMBER> blood donors enrolled interval bioresource <NUMBER> plasma ace<NUMBER> levels measured using multiplex proximity extension immunoassay cardiovascular <NUMBER> panel olink bioscience uppsala sweden total <NUMBER> samples passed quality control data preprocessed using standard olink workflows including applying median centring normalization across plates median centred overall median plates followed log<NUMBER> transformation provide normalized protein levels npx npx values regressed age sex plate time blood draw processing days season residuals rankinverse normalized genotype data processed described previously <NUMBER> genomewide pqtl analysis performed linear regression rankinverse normalized residuals genotype snptest <NUMBER> first three components multidimensional scaling covariates adjust ancestry analysis investigating genetically proxied acei drug effects using rs<NUMBER> variant report genetic associations lung ace<NUMBER> tmprss<NUMBER> expression plasma ace<NUMBER> levels per blood pressurelowering allele mendelian randomization analyses estimates obtained inversevariance weighted method randomeffects model <NUMBER> polygenic analyses based ace gene locus accounted correlation variants <NUMBER> heterogeneity mendelian randomization estimates different genetic variants exposure trait expressed using <NUMBER> statistic <NUMBER> identified associations p <NUMBER> weighted median <NUMBER> mregger <NUMBER> contaminationmixture methods <NUMBER> robust inclusion pleiotropic variants performed sensitivity analyses mendelian randomization estimates represent change outcome per one standard deviation increase genetically predicted levels exposure continuous exposure traits per unit increase loge odds exposure binary traits outcome measures rankbased inversenormal transformed changes outcome measures standard deviation units data used work obtained published studies obtained relevant participant consent ethical approval variants used instruments genetic association estimates selected publicly available data sources provided supplementary tables <NUMBER> <NUMBER> study protocol details preregistered patient public involvement design reporting study ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint results analyses investigating genetically proxied acei drug effects displayed figure <NUMBER> evidence associations outcome measures analyses considering variants associated serum ace figure <NUMBER>a variant associated sbp figure <NUMBER>b main inversevariance weighted method mendelian randomization results cardiometabolic risk factors displayed figure <NUMBER> lung ace<NUMBER> expression plasma ace<NUMBER> concentrations figure <NUMBER> lung tmprss<NUMBER> expression evidence positive association genetic liability t<NUMBER>dm lung ace<NUMBER> gene expression gtex p <NUMBER>x<NUMBER> <NUMBER> circulating plasma ace<NUMBER> levels interval p <NUMBER> supplementary figure <NUMBER> similar point estimates obtained performing weighted median mregger contaminationmixture mendelian randomization sensitivity analyses robust presence pleiotropic variants although confidence intervals wider supplementary table <NUMBER> mregger method identify evidence directional pleiotropy biasing analysis supplementary table <NUMBER> evidence association genetic liability t<NUMBER>dm lung ace<NUMBER> gene expression lung eqtl consortium p <NUMBER> evidence association genetically predicted levels cardiometabolic traits ace<NUMBER> tmprss<NUMBER> gene expression gtex lung eqtl consortium circulating plasma ace<NUMBER> levels interval current covid<NUMBER> pandemic urgent need elucidate mechanisms underlying risk severity covid<NUMBER> view informing preventative therapeutic strategies study used human genetic variants proxy acei drug effects cardiometabolic risk factors provide insight exposures affect lung ace<NUMBER> tmprss<NUMBER> expression circulating ace<NUMBER> levels find association genetically proxied ace inhibition lung ace<NUMBER> tmprss<NUMBER> expression circulating plasma levels ace<NUMBER> results therefore provide evidence support acei antihypertensive drugs affect risk severity covid<NUMBER> effects ace<NUMBER> expression previously hypothesised <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously identified changes ace<NUMBER> expression human tissues following acei treatment may applicable lung circulating plasma levels <NUMBER> <NUMBER> findings support stance professional bodies supporting continuation acei arb antihypertensive drugs patients covid<NUMBER> unless clinical justification stopping <NUMBER> <NUMBER> indeed appropriate use medications proven benefit <NUMBER> <NUMBER> abrupt interruption also considerable harm <NUMBER> <NUMBER> also speculation acei arb antihypertensive drugs might reduce severity covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical trials explore currently planned <NUMBER> findings also consistent guidance patients start taking drug classes unless clinically indicated <NUMBER> results identified inconsistent support effect liability t<NUMBER>dm lung ace<NUMBER> expression plasma ace<NUMBER> levels association genetic liability t<NUMBER>dm lung ace<NUMBER> expression gtex project previously described <NUMBER> however identified association genetic liability t<NUMBER>dm lung ace<NUMBER> expression lung eqtl consortium discrepancy may attributable different populations considered gtex project lung eqtl consortium <NUMBER> <NUMBER> lung eqtl consortium considered lung tissue patients requiring resectional surgery samples gtex project taken healthy tissue deceased donors <NUMBER> <NUMBER> taken together results provide consistent support effect cardiometabolic traits lung ace<NUMBER> tmprss<NUMBER> expression plasma ace<NUMBER> levels association cardiometabolic traits severity covid<NUMBER> could attributable alternative mechanisms <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> risk factors still used stratify patients terms vulnerability similarly current findings support causal effect copd smoking lung ace<NUMBER> expression factors may still used inform risk models severe covid<NUMBER> <NUMBER> study number strengths used genetic variants instrumental variables studying effect acei drugs cardiometabolic risk factors therefore able investigate causal effects ace<NUMBER> tmprss<NUMBER> expression lung ace levels plasma <NUMBER> acei drugs effects used two complementary instrument selection strategies based associations variants ace locus circulating serum ace levels sbp respectively consistent findings approaches add strength conclusions mendelian randomization approach better able overcome confounding reverse causation bias limit causal inferences conventional epidemiological approaches <NUMBER> <NUMBER> considering independent cohorts assess lung expression ace<NUMBER> tmprss<NUMBER> <NUMBER> <NUMBER> plasma levels ace<NUMBER> <NUMBER> able explore consistency results conclusions therefore less vulnerable false positive findings study also limitations investigated ace<NUMBER> tmprss<NUMBER> expression lung circulating levels ace<NUMBER> plasma may expression tissues relevant risk severity covid<NUMBER> similarly cellular ace<NUMBER> may different biological effects circulating plasma ace<NUMBER> gwas analyses lung ace<NUMBER> expression plasma ace<NUMBER> levels performed according different protocols <NUMBER> <NUMBER> <NUMBER> may therefore directly comparable available genetic instrument arb antihypertensive drug class <NUMBER> able investigate precision analyses also limited notably lifetime smoking index results widest confidence intervals may therefore study sufficiently powered exclude clinically relevant effect exposures genetic variants used instrumental variables may pleiotropic effects affect outcome pathways independent exposure proxying bias consequent mendelian randomization estimates possible exclude possibility relatively low heterogeneity detected mendelian randomization estimates produced different variants along consistency observed performing analysis methods robust pleiotropy suggests unlikely major source bias <NUMBER> summary mendelian randomization study identify consistent evidence support acei antihypertensive drugs cardiometabolic traits affect lung expression ace<NUMBER> tmprss<NUMBER> plasma ace<NUMBER> levels findings therefore support deviation existing expert consensus guidelines management hypertension face current covid<NUMBER> pandemic <NUMBER> efforts made scientists news media ensure speculative stories little evidential support propagated <NUMBER> cardiometabolic risk factors used stratify patients terms vulnerability covid<NUMBER> data provide consistent support expression ace<NUMBER> tmprss<NUMBER> represents causal mechanisms underlying associations ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint figure <NUMBER> genetic associations ace<NUMBER> tmprss<NUMBER> gene expression lung gtex lung consortium circulating ace<NUMBER> protein levels plasma interval per one standard deviation increased ace concentration conferred variants ace gene b per blood pressurelowering allele rs<NUMBER> variant ace gene bottom panel two sets results tmprss<NUMBER> expression lung eqtl consortium refer two separate probe sets estimating gene expression b ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint figure <NUMBER> mendelian randomization estimates change tmprss<NUMBER> gene expression lung per unit increase genetically predicted levels exposure two sets results lung eqtl consortium refer two separate probe sets estimating gene expression ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint disease burden coronavirus infectious disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> increasing continuously million confirmed patients <NUMBER> thousand deaths globally <NUMBER> high prevalence diabetes important understand special aspects covid<NUMBER> infection people diabetes becomes even important parts world seeing restrictions mobility patients order contain pandemic recently group published article highlighting special considerations management diabetes todays times covid<NUMBER> pandemic <NUMBER> much data various parts world accumulated since association diabetes covid<NUMBER> management diabetes covid<NUMBER> infection innovative strategies medical consultation view limited access healthcare facilities patients chronic diseases review aims collate currently available data diabetes covid<NUMBER> infection specifically looks relation diabetes covid<NUMBER> terms epidemiology pathophysiology therapeutics review updated till time writing however data evolving conclusions made might change later searched pubmed database google scholar using key terms covid<NUMBER> sarscov<NUMBER> diabetes antidiabetic therapy april <NUMBER> <NUMBER> full texts retrieved articles accessed diabetes associated complications increase risk morbidity mortality acute infections due suppressed innate humoral immune functions levels glycated hemoglobin hba<NUMBER>c <NUMBER> linked <NUMBER> increased risk hospitalization pneumoniarelated severity bacterial infection <NUMBER> past viral pandemics witnessed association diabetes increased morbidity mortality diabetes considered independent risk factor complications death <NUMBER>e<NUMBER> outbreak severe acute respiratory syndrome sarscov<NUMBER> <NUMBER> similarly presence diabetes tripled risk hospitalization quadrupled risk intensive care unit icu admission influenza h<NUMBER>n<NUMBER> infection outbreak <NUMBER> <NUMBER> <NUMBER> outbreak middle east respiratory syndrome coronavirus merscov diabetes prevalent nearly <NUMBER> population odds ratio severe critical merscov ranged <NUMBER> <NUMBER> diabetic cohort <NUMBER> compared overall population mortality rate patients mers diabetes <NUMBER> <NUMBER> <NUMBER> emerging data suggests covid<NUMBER> common patients diabetes hypertension cardiovascular disease cvd although prevalence rate varied different studies well countrywise data pooled data <NUMBER> chinese studies n ¼ <NUMBER> characteristics comorbidities patients covid<NUMBER> singh et al <NUMBER> reported prevalence hypertension diabetes cvd <NUMBER> <NUMBER> <NUMBER> patients respectively similarly metaanalysis <NUMBER> trials included <NUMBER> covid<NUMBER> patients yang et al <NUMBER> reported prevalence <NUMBER> <NUMBER> <NUMBER> hypertension diabetes cvd respectively patients covid<NUMBER> epidemiology working group chinese center disease control prevention investigated <NUMBER> <NUMBER> patients covid<NUMBER> shown hypertension diabetes cvd associated nearly <NUMBER> <NUMBER> <NUMBER> patients respectively <NUMBER> contrast italian study onder et al found diabetes nearly <NUMBER> cvd associated nearly <NUMBER> <NUMBER> patients admitted covid<NUMBER> <NUMBER> similarly small study <NUMBER> patients united states bhatraju et al <NUMBER> reported diabetes associated <NUMBER> patient covid<NUMBER> study covid<NUMBER> surveillance group italy n ¼ <NUMBER> shown <NUMBER> patients covid<NUMBER> diabetes died covid<NUMBER> response team centers disease control prevention cdc usa reported prevalence <NUMBER> data <NUMBER> covid<NUMBER> patients <NUMBER> <NUMBER> table <NUMBER> summarizes prevalence comorbidities available studies todate patients covid<NUMBER> <NUMBER>e<NUMBER> noted findings could mere reflection high prevalence diabetes across globe including china diabetes capital world thus causality cannot inferred observed elevated proportions evolving data also suggest patients covid<NUMBER> diabetes often associated severe critical disease varying <NUMBER> <NUMBER> different studies <NUMBER>e<NUMBER> <NUMBER> <NUMBER> <NUMBER> wang et al <NUMBER> study <NUMBER> patients reported <NUMBER> patients covid<NUMBER> comorbidities including diabetes required admission icu compared <NUMBER> patients without comorbidities analysis <NUMBER> patients covid<NUMBER> wu et al <NUMBER> table <NUMBER> summarizes prevalence nonsevere mild moderate severe critical disease patients diabetes covid<NUMBER> fig <NUMBER> illustrates graphical representation nonsevere severe covid<NUMBER> patients diabetes interestingly prevalence nonsurvivors also higher diabetic subjects covid<NUMBER> varied <NUMBER> <NUMBER> different studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> summarizes prevalence survivors nonsurvivors among patients diabetes covid<NUMBER> fig <NUMBER> depicts graphical representation data univariate analysis <NUMBER> patients covid<NUMBER> zhou et al <NUMBER> found diabetes <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> inhospital mortality however association however cfr high <NUMBER> patients cvd <NUMBER> diabetes <NUMBER> hypertension <NUMBER> based findings acknowledging higher morbidities mortality associated comorbidities researchers recently proposed course treatment prognosis covid<NUMBER> stratified based absence presence comorbidities type b c type represents covid<NUMBER> patients pneumonia comorbidities type b denotes covid<NUMBER> pneumonia comorbidities type c denotes covid<NUMBER> pneumonia multiorgan dysfunction <NUMBER> <NUMBER> special aspects pathophysiology diabetes relationship antidiabetic drugs context covid<NUMBER> sars cov<NUMBER> like sars cov<NUMBER> utilises ace<NUMBER> receptor entry cell <NUMBER> ace<NUMBER> expressed type ii alveolar epithelial cells lungs upper respiratory tract also several locations like heart endothelium renal tubular epithelium intestinal epithelium pancreas sglycoprotein surface sars cov<NUMBER> binds ace<NUMBER> causes conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> furin ultimately leading internalization virion <NUMBER> cellular entry virus triggers inflammatory response recruitment helper cells produce interferon g leads recruitment inflammatory cells leading cytokine storm could lead organ damage multiorgan failure seen severe disease discussed diabetes associated poorer outcomes covid<NUMBER> study <NUMBER> patients covid<NUMBER> wuhan found increased time viral clearance patients diabetes <NUMBER> apart usual mechanisms impaired neutrophil chemotaxis phagocytosis diabetes predisposes infections general several specific factors responsible increased risk severity infection sars cov<NUMBER> diabetes increased ace<NUMBER> expression diabetic mice found increased expression ace<NUMBER> renal cortex liver pancreas lungs <NUMBER> recently phenomewide mendelian randomization study found diabetes causally related ace<NUMBER> expression <NUMBER> though significance observations clear present increased ace<NUMBER> expression might predispose people diabetes infection sars cov<NUMBER> b increased furin diabetes associated increase furin type<NUMBER> membranebound protease belonging proprotein convertase subtilisinkexin family pcsk involved entry coronaviruses cell increased furin reported diabetes might facilitate viral replication <NUMBER> c impaired tcell function alterations cd<NUMBER> lymphocytes reported animal models mers <NUMBER> lymphocytopenia observed patients covid<NUMBER> correlated prognosis <NUMBER> increased interleukin<NUMBER> il<NUMBER> several cytokines increased covid<NUMBER> infection amongst il<NUMBER> increased diabetes may play deleterious role covid<NUMBER> infection <NUMBER> monoclonal antibody il<NUMBER> receptor tocilizumab tested trial covid<NUMBER> <NUMBER> ace<NUMBER> receptors expressed pancreatic islets infection sars cov<NUMBER> seen cause hyperglycaemia people without preexisting diabetes hyperglycaemia seen persist <NUMBER> years recovery sars indicating transient damage beta cells <NUMBER> though similar effect reported covid<NUMBER> may important monitor blood glucose levels acute stage follow data differential effects oral antidiabetic drugs disease course covid<NUMBER> metformin antiproliferative immunomodulatory effects virtue inhibition amp activated protein kinase shown protective role pneumonia mouse models <NUMBER> one study patients tuberculosis patients treated metformin better survival receive metformin <NUMBER> median <NUMBER> years follow <NUMBER> patients diabetes mendy et al <NUMBER> showed metformin significantly associated decreased risk mortality patients chronic lower respiratory diseases hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> even adjustment multiple confounding factors study <NUMBER> patients follow <NUMBER>year period ho et al <NUMBER> showed metformin users significantly lower risk death hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> compared nonmetformin users patients coexistent chronic obstructive pulmonary disease diabetes thiazolidinediones tzd seen increase risk pneumonia study compared sulfonylureas <NUMBER> experimental studies suggest pioglitazone reduces steatohepatitis increasing ace<NUMBER> expression liver tissues <NUMBER> purported increase ace<NUMBER> expression relation covid<NUMBER> led researchers propose avoiding tzd patients diabetes covid<NUMBER> experimental studies also suggest liraglutide glp<NUMBER> receptor agonist increases ace<NUMBER> expression lungs type <NUMBER> diabetic rat improves right ventricular hypertrophy <NUMBER> implications findings current context covid<NUMBER> relation antidiabetic drugs yet fully clear dipeptidyl peptidase<NUMBER> dpp<NUMBER> tissue oligopeptides involved multiple biological processes include control activity growth factors chemokines bioactive peptides tcell activation beside regulating glucose metabolism <NUMBER> relationship coronavirus cellular typeii transmembrane protein dpp<NUMBER> cd<NUMBER> generated great interest recently dpp<NUMBER> serves receptor merscov way ace<NUMBER> receptor sars cov sars cov<NUMBER> <NUMBER> <NUMBER> experimental studies suggested certain polymorphisms dpp<NUMBER> associated reduced chance merscov infection <NUMBER> finding might explain perplexing absence merscov cases africa despite presence virus camels presumably frequent presence protective polymorphisms dpp<NUMBER> africans <NUMBER> moreover generated immense interest whether use dpp<NUMBER> inhibitors dpp<NUMBER>i reduce viral entry merscov one vitro study sitagliptin vildagliptin saxagliptin could block coronavirus viral entry cells <NUMBER> though ace<NUMBER> recognized main receptor sars cov<NUMBER> recent modeling study rule interaction cd<NUMBER> dpp<NUMBER> <NUMBER> moreover possible interaction dpp<NUMBER> reninangiotensin system ras pathways seems plausible although completely studied interestingly dipeptidyl aminopeptidase iiii cleaves angiotensin ii <NUMBER>e<NUMBER> angiotensin iii <NUMBER>e<NUMBER> iv <NUMBER>e<NUMBER> cascading favorable effect angiotensin<NUMBER> at<NUMBER> receptors similarly various endoand oligopeptidase cleaves angiotensin <NUMBER> directly angiotensin <NUMBER>e<NUMBER> favorable cascading effect suggest plausible interaction nonspecific dpp<NUMBER>i ace<NUMBER> theoretically possible therefore area needs future research regard studies found coadministration angiotensinconverting enzyme inhibitors acei dpp<NUMBER> inhibitors led increased sympathetic tone consequent adverse hemodynamic effect <NUMBER>e<NUMBER> interaction observed acei vildagliptin <NUMBER>to <NUMBER>folds increased risk angioedema noted possibly due diminished degradation bradykinin substance p <NUMBER> contrast experimental study sitagliptin shown inhibit ace could partially explain purported beneficial cv effects <NUMBER> dpp<NUMBER> inhibitors associated increased risk upper respiratory infections however agents shown lead increased risk pneumonia <NUMBER> present insufficient evidence either use dpp<NUMBER>i patients diabetes covid<NUMBER> <NUMBER> glycemic control important patient covid<NUMBER> though limited data association blood glucose levels disease course covid<NUMBER> present data infections like sars influenza h<NUMBER>n<NUMBER> shown patients poor glycemic control increased risk complications death <NUMBER> <NUMBER> patients mild infection normal oral intake continue usual antihyperglycemic medications however advisable discontinue sglt<NUMBER> inhibitors risk dehydration euglycemic ketosis metformin may also need stopped vomiting poor oral intake doses antihyperglycemic drugs like sulfonylureas insulin may altered depending upon blood glucose levels hospitalised patient covid<NUMBER> especially respiratory distress would require insulin ideally patients poor oral intake mechanical ventilation would require intravenous insulin infusion frequent monitoring blood glucose every hour every <NUMBER> h see next section however adjustment infusion rates would necessitate visit patient increase exposure medical personnel need explore alternate insulin administration strategies one use subcutaneous short acting insulin analogues approach used successfully mild moderate diabetic ketoacidosis however safety critically ill patients less clear <NUMBER> <NUMBER> secondly single dose basal insulin attempted critically ill patients one study thailand could attractive option would reduce contact patient considerably <NUMBER> needs research especially critically sick patients finally insulin pump continuous subcutaneous insulin infusion csii could option models advantage altering insulin rates remotely via bluetooth <NUMBER> fully automated closedloop glucose control tried critical illness feasible could useful treating patients covid<NUMBER> <NUMBER> blood glucose monitoring poses special challenge necessitates frequent visits patients bedside especially patient critically ill receiving intravenous insulin however attempts could made minimize exposure patient critically ill heshe may given glucose testing device selfmonitoring may taught blood glucose readings communicated phone necessary action taken continuous glucose monitoring cgm could help especially systems data remotely accessed without visiting patient though evidence cgm interference commonly prescribed medications like acetaminophen atenolol lisinopril shown useful reliable critically ill patients <NUMBER> <NUMBER> treatment ace inhibitors arb potential cause regulation ace<NUMBER> <NUMBER> mice coronavirus induced lung injury showed improvement treated angiotensin receptor blocker losartan <NUMBER> retrospective analysis showed reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors <NUMBER> however contrary view increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however evidence support hypothesis currently retrospective analysis <NUMBER> covid<NUMBER> hospitalised patients cardiovascular disease wuhan significant difference proportion aceiarb medication nonsurvivors survivors <NUMBER> view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension american heart association <NUMBER>e<NUMBER> several studies protective effect statins pneumonia <NUMBER> statins known increase ace<NUMBER> levels may protect viral entry sars cov<NUMBER> <NUMBER> however increase ace<NUMBER> could counterintuitive current context nevertheless statins known inhibit nuclear factor kappa b nfkb activation might help blunting cytokine storm <NUMBER> calcium channel blockers ccb shown reduce severity disease mortality patients pneumonia presumably inhibiting calcium influx cell <NUMBER> precise role agents covid<NUMBER> studied however seems safe continue drugs control blood pressure hypertensive patients since ccb effect ace<NUMBER> expression researchers proposed preferable use patients covid<NUMBER> hypertension <NUMBER> though aspirin antiinflammatory properties may advisable continue patients sepsis disseminated intravascular coagulation however patients underlying coronary artery disease needs continued anticoagulant unless otherwise contraindicated treatment diabetes poses challenge current times world going unprecedented pandemic lockdowns places people confined home opportunities exercise limited regular walks visits gyms swimming pools possible also considerable mental stress unpredictability disease well social immobility alterations daily routine affect dietary intake well stress could lead inappropriate eating access fresh fruits vegetables could limited may tendency eat packaged foods high calories saturated fat transfat patients may find difficult procure medicines insulin needles glucose strips etc partial complete lockdowns problem becomes pronounced elderly living alone factors could cause glucose dysregulation could predispose patients complications like infections hyperosmolar coma ketoacidosis even acute cardiac events care taken vary calorie intake markedly healthy balanced diet good amount protein fiber limitation saturated fats important maintain good glycemic control <NUMBER> exercise continued home based exercise like cycling treadmill stationary jogging resistance exercise small weights beneficial <NUMBER> regular intake antidiabetic drugs insulin important emphasized <NUMBER> telemedicine helpful times patients consult physician via telemedicine appropriate advice treatment given <NUMBER> article dealing telemedicine publication special issue <NUMBER> care feet emphasized order avoid foot related complications telemedicine temperature mats screen inflammation without visit clinic patients show inflammation called clinic <NUMBER> <NUMBER> patients need educated need visit hospital urgently emergency situations like vomiting drowsiness shortness breath chest pain weakness limbs altered sensorium etc diabetes associated increased incidence severity covid<NUMBER> experimental evidence effect diabetes viral entry cell inflammatory response infection important control blood glucose patients infected covid<NUMBER> treating diabetes present restrictions movement challenging however innovations like telemedicine useful trying times hereby declare conflict interest related article coronavirus <NUMBER> covid<NUMBER> pandemic affected <NUMBER> million people caused <NUMBER> lac deaths <NUMBER> countries duration four months medicine vaccine date treatment symptomatic management present treatment plan severe acute respiratory syndrome sars middle east respiratory syndrome mers past covid<NUMBER> recurring epidemic threats humans review undertaken search probable modes explored find drug treatment used treat covid<NUMBER> similar illness involving mainly respiratory system relatively benign coronavirus causing common cold taken novel form utilizing newer pathways enter host causing severe disease cases coronaviruses contain singlestranded <NUMBER> capped positivestranded ribonucleic acid rna molecule ranges <NUMBER> <NUMBER> kb viral membrane contains membrane glycoprotein spike glycoprotein envelop e glycoprotein nucleocapsid n protein member reninangiotensin system ras angiotensinconverting enzyme <NUMBER> ace<NUMBER> protein reported entrypoint receptor severe acute respiratory syndrome coronavirus sarscov novel sarscov<NUMBER> causing covid<NUMBER> viral protein interacts human ace<NUMBER> present transmembrane protein gain entry host <NUMBER> <NUMBER> <NUMBER> two enzymes reninangiotensin system ras angiotensinconverting enzyme ace ace<NUMBER> serve contrasting functions ace converts angiotensin agi angiotensin ii agii agii vasoconstrictor proinflammatory properties via type<NUMBER> receptor at<NUMBER>r ace inhibitors eg lisinopril at<NUMBER>r inhibitors commonly known angiotensin receptor blockers arb like losartan commonly used drugs cardiovascular diseases like hypertension cardiac failure involvement ras evolution pathogenesis lung diseases received attention recent years <NUMBER> histopathological reports postmortem studies covid<NUMBER> deaths show diffuse alveolar damage hyaline membrane deposition fibrin exudates consolidation fibroblastic proliferation extracellular matrix fibrinforming clusters air spaces <NUMBER> <NUMBER> postmortem findings sars deaths showed features diffuse alveolar damage dad pronounced pulmonary edema hyaline membrane formation areas interstitial thickening mild moderate fibrosis <NUMBER> <NUMBER> ace homolog ace<NUMBER> entry receptor virus expressed abundantly type ii alveolar cells may base rapid expansion sarscov vicious circle local alveolar wall destruction resulting rapidly progressive severe diffuse alveolar damage <NUMBER> considering postmortem findings lung may true covid<NUMBER> opposed ace soluble ace <NUMBER> shown protect lung injury less spoken angiotensin ii receptor type <NUMBER> at<NUMBER>r antiinflammatory antifibrotic effects lung tissue may significance light lung pathology presentation covid<NUMBER> imperative assess role ace<NUMBER> at<NUMBER>r natural forgotten protectors alveolar environment along arbs severe acute lung disease novel coronavirus angiotensinconverting enzyme ace dipeptidyl carboxypeptidase expressed predominantly lung capillary endothelium converts decapeptide angiotensin agi octapeptide angiotensin ii agii agii two main receptors at<NUMBER>r at<NUMBER>r angiotensin ii via at<NUMBER>r receptor causes vasoconstriction along many effects kidneys brain regulate body fluid volume blood pressure also proinflammatory properties study suggested activation pulmonary ras influences pathogenesis acute lung injury acute respiratory distress syndrome sars attenuated blocking reninangiotensin pathway <NUMBER> thus inhibition aceagiiatr<NUMBER> axis may beneficial setting enhanced activity ace inhibitors arbs used clinically block effects agii arbs may much greater potential block reninangiotensin system ace inhibition estimated <NUMBER> ag ii formed via nonace pathways eg chymase humans <NUMBER> <NUMBER> year <NUMBER> new homolog ace identified separately two groups named ace<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> zinc metalloprotease <NUMBER> identity <NUMBER> similarity ace <NUMBER> ace<NUMBER> converts agi ag <NUMBER> agii ag <NUMBER> removing one amino acid ace<NUMBER> inhibited classical ace inhibitors like captopril enalapril lisinopril <NUMBER> authors reported ace<NUMBER> expressed mainly heart kidney testis <NUMBER> <NUMBER> later study using immunolocalization ace<NUMBER> protein found ace<NUMBER> expressed many tissues including type type ii alveolar pneumocytes nasal oral nasopharyngeal mucosa enterocytes small intestine endothelial cells smooth muscles blood vessels tissues studied weakly bronchial epithelial cells <NUMBER> numerous animal studies conducted study ace<NUMBER> discovery sarscov used portal entry studies may projected covid<NUMBER> virus also gains entry receptor picture severe cases sars covid<NUMBER> acute respiratory distress demonstrated mice ace<NUMBER> required effective replication sarscov vivo ace<NUMBER> knockout mice showed low quantity virus infected sarscov <NUMBER> one hand ace<NUMBER> proved entry receptor novel cov hand ace<NUMBER> knockout mice showed severe acute lung injury aspiration endotoxin peritoneal sepsisinduced acute respiratory distress syndrome ards models loss ace<NUMBER> expression mutant mice resulted enhanced vascular permeability increased lung edema neutrophil accumulation worsened lung function <NUMBER> thus ace<NUMBER> protects murine lungs ards ace<NUMBER> knockout mice protective effect ace<NUMBER> probably reducing agii breaking ag <NUMBER> <NUMBER> hence protective effect ace<NUMBER> acute lung injury agii probable target another study mice downregulation ace<NUMBER> expression sarscov infections spike protein reported study also reported treatment exogenous recombinant ace<NUMBER> protein improved symptoms acute lung injury wild type mice well ace<NUMBER> knockout mice <NUMBER> thus ace<NUMBER> dual role one support virus entry host two protect severe lung injury relation ace<NUMBER> findings studies comparing viruses nl<NUMBER> sarscov intriguing nl<NUMBER> another human coronavirus uses ace<NUMBER> entry sarscov causes mild respiratory disease interaction ace<NUMBER> weaker sarscov protein interaction ace<NUMBER> nl<NUMBER>cov sarscov structural homology receptorbinding domain rbd yet two viruses recognize common ace<NUMBER> regions <NUMBER> whether loweraffinity interaction ace<NUMBER> difference ace<NUMBER> signaling following sarscov nl<NUMBER> protein binding protein accounts differential pathogenicity human coronavirus nl<NUMBER> sarscov remains determined <NUMBER> <NUMBER> recently demonstrated covid<NUMBER> cov binds ace<NUMBER> avidly sarscov <NUMBER> study comparing two viruses reported sarscov binds efficiently ace<NUMBER> nl<NUMBER> correlates ace<NUMBER> shedding <NUMBER> working ahead findings revised experimental setup another study found ace<NUMBER> shedding nl<NUMBER> robust depended fold increase viral replication occurred early phase replication <NUMBER> observations appears severity disease depends efficiency binding spike protein ace<NUMBER> sarscov cov<NUMBER> greater affinity nl<NUMBER> secondly shedding downregulation ace<NUMBER> expression seem determine potential severity lung disease associated higher viral replication study <NUMBER> found soluble ace<NUMBER> ectodomain specifically blocked infection sarscov sbearing pseudotypes finding may breakthrough covid<NUMBER> also <NUMBER> thus recombinant ace<NUMBER> may beneficial blocking virus entry reducing lung injury covid<NUMBER> via missing link thus doubleedged sword ace<NUMBER> must explored used appropriately conquering covid<NUMBER> strategic administration considered inclusion predefined agreedon treatment protocol covid<NUMBER> agii major effector peptide ras promotes vasoconstriction proliferation inflammation fibrosis within pulmonary vasculature lung parenchyma via stimulation at<NUMBER> receptors use losartan block at<NUMBER> receptor improved lung injury mouse model aforementioned detrimental effects agii may counterbalanced activation at<NUMBER> receptors <NUMBER> at<NUMBER>r given much attention discovery functions agii operated via at<NUMBER>r significance at<NUMBER>r cardiovascular renal pathologies became wellknown expression at<NUMBER>r healthy adults often low mainly identified renal cardiovascular adrenal medulla brain tissues myometrium ovaries <NUMBER> <NUMBER> contrast fetal tissues at<NUMBER>r dominant receptor subtype <NUMBER> adult at<NUMBER>rs reexpressed upregulated certain pathophysiological conditions mechanical injury ischemia like myocardial infarction vascular injury brain ischemia renal failure <NUMBER> <NUMBER> at<NUMBER>r exerts vasodilator antifibrotic antiinflammatory effects variety disease models well natriuretic antihypertensive effects renal disease <NUMBER> at<NUMBER>rspecific agonist may effectively dampen proinflammatory aggressive behavior rheumatoid synovitis <NUMBER> thus at<NUMBER>r proven antiinflammatory effects variety tissues activation at<NUMBER>r thought counterregulate pathophysiological effects angiotensin ii agii induced at<NUMBER>r <NUMBER> at<NUMBER>r research gained momentum first nonpeptide at<NUMBER>r agonist compound <NUMBER> c<NUMBER> introduced <NUMBER> <NUMBER> study investigated effect at<NUMBER>r agonist c<NUMBER> bleomycin model pulmonary fibrosis reported beneficial effects c<NUMBER> associated decreased infiltration macrophages lungs reduced lung inflammation diminished pulmonary collagen accumulation <NUMBER> monocrotaline mctinduced pulmonary hypertension rat model c<NUMBER> treatment reversed interstitial perivascular fibrosis furthermore decrease ace<NUMBER> messenger rna mrna levels observed mctinduced pulmonary hypertension animals reversed c<NUMBER> therapy twofold increase ace<NUMBER> levels concomitant decrease ace expression <NUMBER> protective effect ace<NUMBER> already emphasized furthermore c<NUMBER> treatment normalized at<NUMBER>at<NUMBER> receptor ratio restore lung ras balance c<NUMBER> treatment prevented well attenuated progression lung fibrosis accompanying pulmonary hypertension thus view inferences acute inflammatory lung pathology observed covid<NUMBER> may ameliorated at<NUMBER>r agonist three classes drugs affecting ras may candidates ameliorate acute lung pathology covid<NUMBER> possibility agii overexpression trigger covid<NUMBER> lung pathology inhibition may benefit arbs like losartan may beneficial ace inhibitors fact sufficient agii formed ace nondependent mechanisms cov<NUMBER> uses ace<NUMBER> gain entry host gaining entry causes shedding downregulation ace<NUMBER> sabotage antiinflammatory protective effect along observation soluble ace<NUMBER> ectodomain specifically blocked infection sarscov sbearing pseudotypes shows use soluble recombinant ace<NUMBER> may helpful reducing lung injury covid<NUMBER> speculation at<NUMBER>r may reexpressed covidrelated lung injury hence use at<NUMBER>r agonists may also explored elicit antiinflammatory antifibrotic effects bacterial communicable diseases menace created havoc prior antibiotic era however last decades public health focus largely noncommunicable diseases related lifestyle interventions sudden spurt covid<NUMBER> global spread demands innovative approaches using forgotten enzymatic pathways suggested study magnanimous improvements clinical outcome among covid<NUMBER> cases herein suggested interventions ace<NUMBER> at<NUMBER> receptors agonist along arbs may world facing major public health crisis due pandemic caused recentlydescribed coronavirus named sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> reaching proportions far surpass sars mers sarscov<NUMBER> epidemic started wuhan china december <NUMBER> spread <NUMBER> countries worldwide infected approximately <NUMBER> people <NUMBER> deaths attributed march <NUMBER> th <NUMBER> <NUMBER> sequencing analysis viral genome revealed mutations spike proteinwhich essential sarscov<NUMBER> attachment invasion host cellsmay favored spill bats humans <NUMBER> patients infected coronaviruses develop mild flulike disease common symptoms fever cough however study <NUMBER> patients <NUMBER> hospitals <NUMBER> provinces china <NUMBER> guan w et al <NUMBER> revealed <NUMBER> patients develop severe disease increased difficulty breathing pneumonia radiological imaging lungs revealed opacity <NUMBER> patients approximately <NUMBER> patients needed assisted ventilation <NUMBER> died <NUMBER> however coronavirus disease covid<NUMBER> may rapidly develop severe acute respiratory syndrome sars elderly subjects <NUMBER> yr especially comorbidities hypertension diabetes pulmonary diseases <NUMBER> <NUMBER> <NUMBER> intriguing unlike case influenza <NUMBER> children included risk group cases severe covid<NUMBER> children reported reports death children age <NUMBER> raises questions regarding cellular molecular mechanisms associated severity covid<NUMBER> understanding elucidating mechanisms may greatly improve knowledge pathogenesis disease thus guide health professionals better treat elderly population toward raise two main points discussion increased angiotensinconverting enzyme<NUMBER> ace<NUMBER> expression pulmonary heart tissues hypertensive patients chronic use at<NUMBER>r blockers ii antibodydependent enhancement ade previous exposure circulating coronaviruses entering hostusually aerosolized viral particles contact contaminated surfacesthe virus needs undergo biological cycle spike proteinsthat coded gene one open reading frames viral genomeneed interact viral receptors surface host cells sarscov<NUMBER> spike proteins bind angiotensinconverting enzyme<NUMBER> ace<NUMBER> expressed epithelial cells lungs <NUMBER> <NUMBER> main reason coronaviruses often cause respiratory disease notably ace<NUMBER> may also highly expressed intestinal tissues <NUMBER> leading diarrhea observed <NUMBER> patients sarscov epidemic <NUMBER> patients sarscov<NUMBER> infection diarrhea although viral particles may detected stool <NUMBER> attaching ace<NUMBER> receptorbinding domain rbd s<NUMBER> s<NUMBER> domains spike protein viral envelope fuses host cell membrane internalized genetic material positive rna strand approximately <NUMBER> kb released cytoplasm replication <NUMBER> thus importance ace<NUMBER> expression dynamics viral infectivity tropism pathogenicity evident ace<NUMBER> acerelated carboxypeptidase <NUMBER> amino acid transmembrane protein important member reninangiotensin system plays pivotal role regulation blood pressure <NUMBER> ace converts angiotensin ang angiotensin ii ang ii whereas ace<NUMBER> converts ang ii angiotensin <NUMBER> ang <NUMBER> angiotensin <NUMBER> ang <NUMBER> <NUMBER> ang ii ang <NUMBER> antagonizing effects ang ii binds angiotensin <NUMBER> receptor at<NUMBER>r inducing vasoconstriction increase blood pressure whereas ang <NUMBER> binds at<NUMBER>r leading vasodilatation decrease blood pressure <NUMBER> <NUMBER> reninangiotensin system affects blood pressure kidney function ace inhibitors at<NUMBER>r blockers widely used hypertensive cardiac patients <NUMBER> context chronic use ace inhibitors at<NUMBER>r antagonists may particular relevance patients infected sarscov<NUMBER> may alter dynamics ace<NUMBER> expression thus increase susceptibility sarscov<NUMBER> infection already demonstrated using hypertensive rat models at<NUMBER>r blockade elevates ace<NUMBER> expression treatment losartan lisinopril either alone combination significantly increases ace<NUMBER> mrna cardiomyocytes rats associated higher ang <NUMBER> plasma concentrations <NUMBER> corroborated analyzing heart tissue rats myocardial infarction treated losartan <NUMBER> concordantly olmesartan effective at<NUMBER>r antagonist significantly increased cardiac renal expression ace<NUMBER> wistarkyoto rats <NUMBER> agreement use perindopril ace inhibitor rats <NUMBER> another interesting feature dynamics ace<NUMBER> expression tissues ability cleaved cell surface metalloproteinase called adam<NUMBER> tace <NUMBER> ace<NUMBER> ectodomain gets cleaved releasing soluble ace<NUMBER> sace<NUMBER> whose role fully elucidated however shown higher concentration sace<NUMBER> plasma correlates poorer prognosis heart failure <NUMBER> notably sace<NUMBER> may also detected higher concentrations cerebrospinal fluid hypertensive patients corroborated nefh cre x at<NUMBER>ar floxflox mice indicating ace<NUMBER> sace<NUMBER> levels brain associated etiology neurogenic hypertension <NUMBER> demonstrated ace<NUMBER> may cleaved mechanisms instance sars spike protein may modulate adam<NUMBER> expression turn cleaves ace<NUMBER> soluble form found dependent cytoplasmic domain ace<NUMBER> sirna adam<NUMBER> ace<NUMBER> lacking intracellular domains abrogated phenomenon <NUMBER> interestingly increased shedding ace<NUMBER> correlates worsening disease probably increase ang ii instead ang <NUMBER> leads increased vascular permeability local inflammation interestingly ace<NUMBER> cleavage cell surface may also occur lung epithelial cells <NUMBER> thus cleavage ace<NUMBER> sace<NUMBER> would compromise effect ang <NUMBER> at<NUMBER>r thereby reducing pulmonary hypertension inflammation altogether depicted figure <NUMBER> data show modulating reninangiotensin axis alters ace<NUMBER> expression several tissues especially lung heart tissues use ace inhibitors at<NUMBER>r antagonists seems upregulate ace<NUMBER> expression facilitating viral attachment entry presence virus cytokines including tnfa leads ace<NUMBER> release cell membrane abrogating function counteract ang ii altogether ace<NUMBER> overexpression may facilitate viral replication lung tissue promote lung vascular permeability common feature severe sarscov<NUMBER> infection summary may greatly impact outcome sarscov<NUMBER> infection elderly hypertensive patients ace<NUMBER> putative attachment invasion receptor coronaviruses <NUMBER> <NUMBER> fact use tace inhibitors sars antiviral agents already proposed experimental models <NUMBER> <NUMBER> <NUMBER> antibodydependent enhancement ade phenomenon viruses use preexisting nonneutralizing antibodies previous exposure invade host cells fc receptormediated internalization commonly observed secondary dengue virus denv infection causing severe hemorrhagic disease <NUMBER> notably possibility ade zika virus zikv causative agent zikv congenital syndrome <NUMBER> denv intensely debated recently <NUMBER> <NUMBER> <NUMBER> moreover ade focus debate ebola <NUMBER> hiv <NUMBER> infections ade preexisting antibodies elicited previous viral exposure able neutralize viral particles secondary infection antigenicrelated virus instead iggopsonized viral particles target fcgr expressed endothelial immune cells facilitating viral internalization host cells intense viral replication endothelial cells may respond increasing vascular permeability allowing exudate extravasation bleeding however monocytes become highly activated may initiate cytokine storm <NUMBER> context sarscov<NUMBER> plausible think ade occurs mentioned introduction section elderly <NUMBER> yr patients susceptible infection unknown reasons coronaviruses general highly prevalent global population causing mild infection flulike symptoms seroconversion previous circulating coronaviruses probably widespread thus reasonable infer elderly patients obvious reasons exposed previous infections times younger subjects would imply vaster repertoire antibodies coronavirus epitopes produced longliving plasma cells fact recently shown expand sarscov<NUMBER> infection however whether antibodies either neutralizers enhancers must addressed worth mentioning concerning new sarscov<NUMBER> sequencing analysis viral genome isolated wuhan china indicated mutations mainly occurred within coding sequence spike protein less <NUMBER> sequence identity previously circulated coronaviruses <NUMBER> mutations may responsible spill bats humans also inducing ade changes spike epitopes may result interactions nonneutralizing antibodies corroborating novel epitope lacking previous isolates mapped <NUMBER> covid<NUMBER> hemorrhagic disease probable ade present mediated endothelial cells however already shown lung epithelial cells express high levels fcgriia <NUMBER> moreover immune cells including monocytes dendritic cells highly express receptor populations especially monocytes greatly account inflammatory infiltrate lungs pneumonia consistent transient lymphopenia observed patients circulating cells may migrate lungs conversely lung imaging patients severe covid<NUMBER> shows great degree lung opacity consistent edema cellular infiltrate <NUMBER> thus feasible lunginfiltrating monocytes expressing fcgr greatly favor sarscov<NUMBER> replication lung tissue accounting greater susceptibility elderly patients corroborating hypothesis young individuals children represent risk group severe disease greatly differs case influenza <NUMBER> instance context ade plausible think childrenas less exposure previous circulating coronavirusescarry restricted repertoire iggor lowaffinity igmwhich capable inducing ade context mapping complementarity determining regions cdrs iggs young elderly individuals would great importance find neutralizing antibodies also address hypothesis additionally previous studies mers sars already highlighted possibility ade recent report published wan et al elucidated mechanism monoclonal antibodies mabs induce ade human cells interestingly mabs target rbd sars mers spike proteins induced conformational changes protein favors interaction dipeptidyl peptidase <NUMBER> dpp<NUMBER> receptor mers <NUMBER> moreover immunocomplexes also promoted viral entry however increasing concentrations antibodies block viral invasion rbds become inaccessible consistent previous findings wang q et al <NUMBER> infected promonocytic cell line hlczthat expresses ace<NUMBER> fcgrwith sarscov<NUMBER> presence increasing concentrations antisera data demonstrated high concentrations antibodies neutralized virus whereas lower concentrations induced ade interestingly antisera also recognized spike proteinrelated antigens another study sarscov<NUMBER> using rhesus monkeys showed immunization fulllength spike glycoprotein led increased disease severity mostly increase neutralizing antibodies nab <NUMBER> study demonstrated nabs switched phenotype lunginfiltrating macrophages proinflammatory m<NUMBER> profile instead tissuehealing profile m<NUMBER> aggravated lung injury greatly contributed pathology conversely previous studies using samples deceased patients suffering sarscov infection indicated nab titers reached higher levels earlier patients compared patients survived <NUMBER> may indicate ade role preexisting antibodies fact relevant overall outcome infection thus indicated figure <NUMBER> circulating antibodies instead neutralizing current circulating sarscov<NUMBER> may bind viral particles thus promote fcmediated internalization lung epithelial cells infiltrating monocytes contributing worsening covid<NUMBER> recent mechanistic studies ade coronaviruses thus far although data consistent whether phenomenon ade observed patients severe covid<NUMBER> yet determined noteworthy however fact immune complexes lowavidity antibodies suboptimal concentrations also responsible worsening pulmonary disease caused h<NUMBER>n<NUMBER> <NUMBER> epidemic <NUMBER> conclusions sarscov<NUMBER> newest threat human health needs emergency action governments public health agencies worldwide especially pandemic potential recently declared world health organization context essential rapidly deeply address possibilities concerning severity infection especially elderly population accounts approximately <NUMBER> mortality rate present several relevant aspects may contribute increased susceptibility aforementioned population covid<NUMBER> believe increased expression ace<NUMBER> hypertensive patients treated ace inhibitors at<NUMBER>r blockers ii previous exposure circulating coronaviruses low neutralizing capacity sarscov<NUMBER> may greatly contribute increased susceptibility elderly patients covid<NUMBER> determine whether hypotheses correct investigations needed better understand etiology current sarscov<NUMBER> infection also better prepared future epidemics author contributions peron jps conceived wrote manuscript nakaya h helped editing manuscript dear editor recently published article highlighting special concerns managing patients diabetes times covid<NUMBER> pandemic concerns use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arbs clarified publication ii summarising current evidence regard try arrive reasonable conclusion absence vaccine antiviral drug covid<NUMBER> infection several therapeutic approaches studied one approach use inhibitors renin angiotensin system namely ace inhibitors arbs hand concern raised fact patients agents might increased risk infection severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor sars cov<NUMBER> well coronaviruses expressed type <NUMBER> alveolar epithelial cells endothelium sglycoprotein surface coronavirus binds ace<NUMBER> leads conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> ultimately leading internalization virion iii viral sglycoprotein tmprss<NUMBER> ace<NUMBER> inhibition potential targets therapy possibly vaccine development ace<NUMBER> essential coronavirus infection blockade thought beneficial preventingtreating infection retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors iv mice coronavirus induced lung injury showed improvement treated losartan v far cvid<NUMBER> infection concerned data ras activation effect blockade limited present hypokalaemia could marker ras activation high incidence hypokalaemia reported patients covid<NUMBER> infection vi despite small studies suggesting benefit drugs acting ras data albeit scarce animal models human studies treatment ace inhibitors arb could cause regulation ace<NUMBER> vii ibuprofen thiazolidinediones also shown viiiix increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however currently evidence support hypothesis view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension xxi fortis cdoc hospital diabetes allied sciences chirag enclave new delhi india correspondence riteshgupta<NUMBER>gmailcom severe acute respiratory syndrome virus <NUMBER> sarscov<NUMBER> causes respiratory disease led fatal coronavirus disease <NUMBER> pandemic late <NUMBER> sarscov<NUMBER> outbreak first reported wuhan china later led true crisis worldwide coronaviruses covs large enveloped nonsegmented positivesense rna viruses generally cause mild enteric respiratory diseases animals humans glass et al <NUMBER> human covs hcov<NUMBER>e oc<NUMBER> nl<NUMBER> hku<NUMBER> usually cause mild respiratory diseases fouchier et al <NUMBER> sarscov<NUMBER> causes acute highly lethal pneumonia clinical symptoms similar reported sarscov merscov<NUMBER> fouchier et al <NUMBER> contrast sarscov sarscov<NUMBER>infected patients rarely show prominent upper respiratory tract signs symptoms presentation infected individuals exhibit dry cough <NUMBER> dyspnea <NUMBER> findings bilateral groundglass opacities radiographic images huang et al <NUMBER> severe cases characteristic symptom respiratory distress ∼<NUMBER> grasselli et al reported mortality varies based race sex age comorbid conditions baud et al porcheddu et al <NUMBER> currently true mortality still wellestablished mortality may occur <NUMBER> days post infection based current literature severe sarscov<NUMBER> cases progressed within <NUMBER> days disease onset various laboratory abnormalities observed even preceding significant respiratory dysfunction lu et al <NUMBER> mortality related sarscov<NUMBER> china reported <NUMBER> sohrabi et al <NUMBER> severe cases predominantly reported elderly subjects preexisting conditions predominantly cardiovascular diseases hypertension congestive heart failure interestingly risk factors similar reported risk factors diabetes hypertension obesity associated merscov related mortality although merscov respiratory disease occurred younger individuals assiri et al <NUMBER> world health organization <NUMBER> clinical epidemiological observations may provide direction mechanism disease recent reports indicate significant portion sarscov<NUMBER> related hospitalization usa age <NUMBER> years given fact higher prevalence metabolic diseases including obesity hypertension cardiovascular diseases diabetes us population moore et al <NUMBER> infection may cause higher mortality virus gains entrance host cell via ace<NUMBER> receptor known epidemiological clinical manifestation sarscov<NUMBER> infection may explained perturbations physiological functions ace<NUMBER> receptor due receptor virus interaction discussed manuscript sarscov<NUMBER> singlestranded positivesense rna virus containing ∼<NUMBER> kilobase kb genome viral envelope consists lipid bilayer viral membrane envelope e spike structural proteins anchored unlike corona viruses sarscov<NUMBER> use aminopeptidase n apn dipeptidyl peptidase <NUMBER> dpp<NUMBER> receptor raj et al <NUMBER> similar sarscov sarscov<NUMBER> utilizes novel metallocarboxyl peptidase angiotensin receptor ace <NUMBER> gain entry human cells donoghue et al <NUMBER> turner et al <NUMBER> li et al <NUMBER> similar cov viral entry host cell spike proteins envelope sarscov<NUMBER> cleaved s<NUMBER> s<NUMBER> subunits kirchdoerfer et al <NUMBER> s<NUMBER> interact receptor harbors functional elements required membrane fusion virion s<NUMBER> proteinreceptor interaction pivotal determinant sarscov<NUMBER> infect host species s<NUMBER> contains receptor binding domain rbd directly binds peptidase domain pd ace <NUMBER> gain entry host cells turner et al <NUMBER> li et al <NUMBER> yan et al <NUMBER> despite high similarity rbd sarscov sarscov<NUMBER> several amino acid variations observed middle binding domain sarscov<NUMBER> provide increased affinity bind ace<NUMBER> effectively wang q et al <NUMBER> yan et al <NUMBER> peptidase activity ace<NUMBER> critical virion gain access host cytosol similar sarscov proteolytic cleavage s<NUMBER> containing receptor binding domain rbd cterminus s<NUMBER> protein sarscov<NUMBER> required initiate interaction pd ace<NUMBER> receptor li et al <NUMBER> yan et al <NUMBER> cleavage s<NUMBER> protein achieved aciddependent proteolytic cleavage one several host proteases including cathepsins transmembrane protease serine protease tmprss<NUMBER> tmprss<NUMBER> human airway trypsinlike protease hoffmann et al <NUMBER> exact protease identified proteolytic cleavage followed fusion viral cellular membranes furthermore shown protein cleavage occurs two different sites within s<NUMBER> portion protein first cleavage important separating rbd fusion domains protein second exposing fusion peptide cleavage s<NUMBER> ′ belouzard et al <NUMBER> binding s<NUMBER> ace<NUMBER> receptor triggers cleavage ace<NUMBER> disintegrin metallopeptidase domain <NUMBER> adam<NUMBER>tumor necrosis factorconverting enzyme tace ectodomain sites lambert et al <NUMBER> heurich et al <NUMBER> oarhe et al <NUMBER> additionally tmprss<NUMBER> cleaves ace<NUMBER> intracellular cterminal domain heurich et al <NUMBER> hoffmann et al <NUMBER> cleavages ectodomain endodomain adam<NUMBER> tmprss<NUMBER> facilitate effective cellular viral entry appears process leads shedding host ace<NUMBER> receptor belouzard et al <NUMBER> may contribute loss ace<NUMBER> function systemic release s<NUMBER>ace<NUMBER> complex generally fusion host plasma membrane occurs within acidified endosomes requires cleavage s<NUMBER> ′ exposing fusion peptide inserts membrane potential beneficial effect chloroquine sarscov<NUMBER> due effect endosomal uptake acidification process fusion host membrane followed formation funnel like structure built two heptad repeats s<NUMBER> protein antiparallel sixhelix bundle facilitating fusion release viral genome cytoplasm viral replication genome covs contains variable number world health organization <NUMBER> lu et al <NUMBER> porcheddu et al <NUMBER> sohrabi et al <NUMBER> zhou et al <NUMBER> baud et al open reading frames orfs twothirds viral rna mainly located first orf orf<NUMBER>ab translates two polyproteins pp<NUMBER>a pp<NUMBER>ab encodes <NUMBER> nonstructural proteins nsp remaining orfs encode accessory structural proteins fehr perlman <NUMBER> rest virus genome encodes four essential structural proteins including spike glycoprotein small envelope e protein matrix protein nucleocapsid n protein fehr perlman <NUMBER> replication subgenomic rna synthesis viral structural proteins e translated inserted endoplasmic reticulum er followed movement along secretory pathway endoplasmic reticulumgolgi intermediate krijnselocker et al <NUMBER> fehr perlman <NUMBER> protein directs proteinprotein interactions assembly virus interaction protein e protein required form viruslike particles vlps suggesting two proteins function together produce coronavirus envelopes central role ace<NUMBER> receptor viral entry point understanding functional role aceangiotensin receptor ace<NUMBER>mas receptor critical understanding pathophysiological changes due sarscov<NUMBER> infection understanding molecular downstream effects angiotensin ang cellular signaling may explain observed clinical picture severe respiratory distress myocardial injury renal failure increased mortality due sarscov<NUMBER> infection among aging population subjects cardiovascular metabolic diseases zhu et al <NUMBER> sequence analysis suggests ace ace<NUMBER> exhibit <NUMBER> amino acid homology ace<NUMBER> evolved gene duplication donoghue et al <NUMBER> ace<NUMBER> maps chromosome xp<NUMBER> spans <NUMBER> kb genomic dna contains <NUMBER> introns <NUMBER> exons turner et al <NUMBER> ace<NUMBER> gene encodes type membranebound glycoprotein composed <NUMBER> amino acids marian <NUMBER> functional domains include cterminal transmembrane anchoring region carboxyterminal domain nterminal signal peptide region hexxh zinc binding metalloprotease motif catalytic domain li et al <NUMBER> cerdàcosta xavier gomisrüth <NUMBER> ace receptors expressed almost tissues ace<NUMBER> expressed alveolar epithelial cells capillary endothelial cells ace<NUMBER> highly expressed capillary rich organs lungs kidneys also gut brain hamming et al <NUMBER> tikellis thomas <NUMBER> rocaho et al <NUMBER> genetic polymorphisms ace ace<NUMBER> associated hypertension cardiovascular disease stroke diabetes crackower et al <NUMBER> ramachandran et al <NUMBER> jang kim <NUMBER> fehr perlman <NUMBER> despite structural homology ace ace<NUMBER> divergent physiological function ace regulates renin angiotensin aldesterone system ras ace<NUMBER> counterbalances deleterious effect aceras pathway downstream ace<NUMBER>angiotensin <NUMBER>mas axis critical role ras shown pathogenesis metabolic inflammatory diseases de kloet et al <NUMBER> classical activation angiotensin ii depends renin ace activity prorenin <NUMBER>kd protein inactive precursor renin upon activation juxtaglomerular apparatus jg afferent arterioles kidneys specialized proteases cleave prorenin renin renin released blood cleaves angiotensinogen angiotensin ang ang physiologically inactive acts precursor ang ii conversion ang ang ii catalyzed ace ace expressed primarily vascular endothelium lungs kidneys wakahara et al <NUMBER> also epithelium lungs upper respiratory system ang converted ang ii binds angiotensin ii type type ii receptors kidney adrenal cortex arterioles brain figure <NUMBER>a ang ii acts adrenal cortex stimulate release aldosterone leading sodium water retention effects ang ii rapid effects aldosterone retarted due slower effects downstream targeted gene transcription overall physiological net effects ras activation increase total body sodium total body water increased vascular tone furthermore binding ang ii receptors results vasoconstriction gustafsson holsteinrathlou <NUMBER> endothelial injury watanabe et al <NUMBER> endovascular thrombosis tay lip <NUMBER> increase blood volume increased ang ii associated hypertension accelerated thrombosis arterioles activating coagulation cascade thrombin platelets senchenkova et al <NUMBER> singh karnik <NUMBER> interestingly thrombogenic effects angii platelets reversible application aspirin jagroop mikhailidis <NUMBER> cellular level angiotensin ii induces various signaling pathways including serinethreonine kinase erk jnkmapk well pkc malhotra et al <NUMBER> studies shown ang ii effectively induces il<NUMBER> tnfα possibly serine tyrosine kinases erkjnk mapk activation g protein coupled receptor activation interaction mineralocorticoid receptors funakoshi et al <NUMBER> han et al <NUMBER> ruizortega et al <NUMBER> luther et al <NUMBER> ang ii potent activator nicotinamide adenine dinucleotide phosphate nadph oxidase hence inducer reactive oxygen species ros production garrido griendling <NUMBER> furthermore ang ii activates neutrophils macrophages flux affected tissues inhibits production nitric oxide hence promotes vascular injury kato et al <NUMBER> nabah et al <NUMBER> considerations provide new visions develop targeted therapies ang ii functions pluripotent mediator enhance cytokines il<NUMBER> tnfα others oxidative injury ros endothelial injury inhibiting synthesis vasoconstriction therefore inhibition one targets instance il<NUMBER> may provide significant therapeutic benefit patients currently ongoing clinical trial study effect monoclonal antibodies il<NUMBER> receptor clinicaltrialsgov identifier nct<NUMBER> important note especially context sarscov<NUMBER> infection besides classical rasace mediated ang ii formation formation ang ii occur alternative pathways various proteases include tryptensin cathepsin g tonin kallikrein neutral endopeptidase chymase figure <NUMBER>a proteases cleave ang form ang ii kramkowski et al <NUMBER> lorenz <NUMBER> becari et al <NUMBER> uehara et al <NUMBER> proteases localized specific tissues lungs myocardium arterioles kidney brain sensitive ace inhibitors interestingly targeted inhibition ace using ace inhibitors decreased ang ii levels short period time ang ii levels return baseline <NUMBER> week treatment ace inhibitors mento wilkes <NUMBER> furthermore shown application ace ang ii receptor blocker arb inhibitors animal models leads increase expression ace<NUMBER> ishiyama et al <NUMBER> part protective function ace arbs considered due upregulation ace<NUMBER> therefore figure <NUMBER> dysregulation ang ii ang <NUMBER> loss protective function ace<NUMBER> receptor physiological condition balance ace ace<NUMBER> receptor activity ace regulates renin angiotensin aldosterone system ras cleaves ang produce ang ii ang ii potent vasoconstrictor detrimental endothelial epithelial function activating at<NUMBER> at<NUMBER> receptors counterbalance rasang ii output regulated ace<NUMBER> masg protein coupled receptor activity ace<NUMBER> cleaves ang ang ii ang<NUMBER> ang<NUMBER> respectively thereby activates masg protein coupled receptor protect cell death b sarscov<NUMBER> binds ace<NUMBER> gain entry epithelial cells lungs cleavage spike proteins protease trypsincathepsin g adam<NUMBER> ectodomain tmprss<NUMBER> endodomain sites facilitate viral entry cells process leads shedding host ace<NUMBER> receptors loss protective function loss function ace<NUMBER> activity prevents production ang <NUMBER> ang<NUMBER> lack ang<NUMBER> diminishes activity masg receptor leading loss protective functions including vasodilatation cell protection epithelial endothelial sites loss ace<NUMBER> function leads imbalance unchecked effects ang ii upregulation rasang ii pathway upregulation ang ii leads vasoconstriction thrombophilia microthrombosis alveolar epithelial injury respiratory failure therefore inhibiting proteolytic function trypsincathepsin adam<NUMBER> tmprss<NUMBER> direct activation masg receptor enhancing ang<NUMBER> overcome loss function ace<NUMBER> viable targets prevent tissue damage host possible upregulation ace<NUMBER> may provide available receptors viral entry hence higher viral load associated poor prognosis chu et al <NUMBER> also suggests subjects ace inhibitors activation alternative pathways may play significant role formation ang ii diaz <NUMBER> currently clinical trial ongoing assess effect acearb inhibitors clinicaltrialsgov identifier nct<NUMBER> sarscov<NUMBER> infection alternative pathways formation ang ii important highly unlikely acearb inhibitors play role clinical course sarscov<NUMBER> infection ace<NUMBER> acts ligand recently identified mas<NUMBER> receptor gproteincoupled receptor donoghue et al <NUMBER> santos et al <NUMBER> ace<NUMBER> monocarboxypeptidase cleaves ang nonapeptide ang <NUMBER> ang ii heptapeptide ang <NUMBER> santos et al <NUMBER> marian <NUMBER> peptides vasodilatory antiproliferative protective functions activating masg receptor ace<NUMBER>ang <NUMBER>mas<NUMBER> axis provides endogenous counterregulatory mechanism within reninangiotensin system ras balances deleterious effects aceang iiat<NUMBER> receptor axis santos et al <NUMBER> mice deficient mas<NUMBER> ace<NUMBER> receptors exhibit cardiac systolic dysfunction increased blood pressure myocardial interstitial fibrosis endothelial dysfunction exhibit increased susceptibility intravascular thrombosis chronic kidney disease metabolic abnormalities various biological abnormalities regulate cardiovascular system yamamoto et al <NUMBER> tikellis thomas <NUMBER> ace<NUMBER> activation prevents deleterious effects ang ii cells organisms cell death fibrosis angiogenesis thrombosis formation fragasilva et al <NUMBER> tikellis thomas <NUMBER> recent autopsy results sarscov<NUMBER> infected humans showed diffuse alveolar damage massive capillary congestion accompanied microthrombi vascular beds paucity inflammatory infiltrates menter et al <NUMBER> however pathological examination autopsies investigated sarscov<NUMBER> infection leads total destruction ace<NUMBER> receptors alveolar epithelial endothelial cells interestingly animal model sarscov oudit et al found marked decreased ace<NUMBER> expression heart infected mice oudit et al <NUMBER> key product ace<NUMBER> activity ang <NUMBER> considered biologically active member ras binding mas induces many beneficial actions vasodilation inhibition cell growth protection alveolar epithelial cell injury addition antifibrotic antithrombotic antiarrhythmogenic effects le tran forster <NUMBER> schindler et al <NUMBER> li et al <NUMBER> shown ace<NUMBER>ang<NUMBER>mas axis protective effect brain prevents ischemic stroke jiang et al <NUMBER> addition protective role cardiovascular system ace<NUMBER> direct protective role alveolar epithelial cells lungs ace<NUMBER> numerous physiological functions protective lung injury similar endothelial site ace<NUMBER> degrades octapeptide ang ii removing single amino acid cterminal end peptide generate heptapeptide ang<NUMBER> laboratory others shown ace<NUMBER> protects lung injury degrading ang ii vasoconstrictive proapoptotic lung epithelial cells wang et al <NUMBER> profibrotic li et al <NUMBER> uhal et al <NUMBER> b producing peptide ang<NUMBER> inhibits actions ang ii binding mas receptor gopallawa uhal <NUMBER> support protective role ace<NUMBER> pharmaceutical preparations recombinant ace<NUMBER> administered experimental animals protect lung cell death inhibit acute lung injury prevent lung fibrosis chronic injury lungs li et al <NUMBER> reyparra et al <NUMBER> evidence application specific competitive inhibitor ace<NUMBER> dx<NUMBER> primary cultures isolated aces increases level ang ii released serumfree culture medium autocrine mechanisms reduces amount released ang<NUMBER> importantly induces apoptosis inhibitable at<NUMBER> receptor blocker menter et al <NUMBER> thus functional ace<NUMBER> normally expressed alveolar epithelial cells viewed critical survival factor lung cells addition enzymatic product ace<NUMBER> ang<NUMBER> protects lung cells death antagonizing actions ang ii le tran forster <NUMBER> ang<NUMBER> applied cultures lung epithelial cells prevent lung cell death response either ang ii er stress inducer mg<NUMBER> nguyen uhal <NUMBER> ang<NUMBER> receptor mas jnkselective phosphatase mkp<NUMBER> appear critical protective action ang<NUMBER> response becauses irnas antisense knockdowns mas mkp<NUMBER> eliminate ability ang<NUMBER> prevent lung cell death gopallawa uhal <NUMBER> indeed ang<NUMBER> congeners peptide cyclic ang<NUMBER> gopallawa uhal <NUMBER> already shown protect lungs preclinical models acute lung injury simoes e silva et al <NUMBER> gopallawa uhal <NUMBER> currently targeted drugs specifically sarscov<NUMBER> recent efforts put forward drug repurposing screening various available antiviral agents aim identify possible treatments among lopinavir originally used treatment human immunodeficiency virus identified potential antiviral activity sarscov<NUMBER> unfortunately randomizedcontrolled openlabel trial involving hospitalized adult patients confirmed sarscov<NUMBER> infection showed benefit lopanavir studies suggested remdesivir gs<NUMBER> inhibitor rna polymerase originally developed treat ebola infections vitro activity multiple rna viruses including sarscov<NUMBER> mulangu et al <NUMBER> experimental data suggested micromolar concentration remdesivir chloroquine potentially blocked virus infection current clinical trials ongoing assess efficacy remdesivir treatment alone conjunction chloroquine sarscov<NUMBER> infection hydroxychloroquine chloroquine considered inhibitors endosomal trafficking sarscov<NUMBER> drugs used potential therapeutics drugs antimalarial drugs also used antiinflammatory drugs various autoimmune diseases including rheumatoid arthritis lupus erythematosus respiratory diseases sarcoidosis martin et al <NUMBER> talreja et al <NUMBER> despite high media coverage currently randomized clinical trials support efficacy sarscov<NUMBER> infection however conceivable efficacy may vary different stages virion life cycle virus interaction host drugs may beneficial early stages infection virus requires endosomal uptake fact preparation manuscript several nonrandomized clinical trials suggested lack significant efficacy antimalarial drugs treatment sarscov<NUMBER> infection magagnoli et al <NUMBER> corticosteroids conventional immunosuppressant drugs used suppress inflammatory responses cinatl et al <NUMBER> although cautions use widely used despite lack scientific data furthermore high incidence arterial hypertension diabetes congestive heart failure subjects covid<NUMBER> corticosteroids used caution welldescribed corticosteroids potentiate effect ang ii ras ullian et al <NUMBER> hence less likely corticosteroids provide significant clinical benefit clinical scenario considering significant sarscov<NUMBER> related risk factors hospitalization mortality among patients metabolic diseases including obesity arterial hypertension cardiovascular diseases diabetes may reflect overall activation ras system modulation ras activation ace<NUMBER>ang<NUMBER>mas pathway considered treatment disease furthermore clinical observation published clinical data suggest unique clinical presentation sarscov<NUMBER> patients patients present relatively preserved hemodynamics lack lactic acidosis respiratory distress appear hypercoagulable state menter et al <NUMBER> exhibit progressive renal failure stroke like features myocardial injury clinical observational studies indicate cases respiratory distress occurs many days general <NUMBER> days infection suggesting may direct effect initial viral infection rather hosts reaction loss function ace<NUMBER> dysregulation ang iiace<NUMBER> pathways well activation host proteases central hypothesis binding coronavirus spike protein ace<NUMBER> leads shedding ace<NUMBER> receptors various proteases turn leads loss protective function ace<NUMBER>mas axis lungs organs figure <NUMBER>b addition loss protective function ace<NUMBER>mas activation classical pathway acerasang ii alternative pathways tissue specific proteases including cathepsins chymaselike proteases leads excessive production ang ii tissue level process may shift balance protective ang <NUMBER>mas ace<NUMBER> function detrimental effects increased ang ii contributing lung epithelial endovascular injury therefore induction downstream pathway ace<NUMBER> activating ace<NUMBER>ang<NUMBER>mas axis may prove useful strategy preventing lung cardiovascular damage associated sarscov<NUMBER> infections decreased ace<NUMBER>mas activity augments ang iiat<NUMBER>r activity hazardous consequence increased pulmonary vascular endothelialepithelial injury lung pathology inhibiting activity proteases necessary cleavage viral spike proteins instance inhibition enzymatic activity adam<NUMBER> tmprss<NUMBER> could serve novel therapeutic targets could potentially block viral interaction receptor entry cells identification specific proteases development inhibitors targeting proteases necessary cleavage spike proteins may prove viable addition exploiting protective effect ang<NUMBER> analogs ave<NUMBER> ave<NUMBER> pinheiro et al <NUMBER> deleterious effect increased ang ii feasible might effective symptomatic treatment patients based importance ace<NUMBER> counterbalance deleterious effects ang ii loss ace<NUMBER> ang<NUMBER> may detrimental organism surprisingly little known effect sarscov<NUMBER> virus binding ace<NUMBER> viral binding receptor may modulate ace<NUMBER> enzymatic activity impact role survival factor critical questions yet answered include <NUMBER> effect sarscov<NUMBER> binding ace<NUMBER> enzymatic activity protective actions toward lung epithelial cells lung injury <NUMBER> effects sarscov<NUMBER> infection lung epithelial cellsendothelial cells ace<NUMBER> expression lungs organs <NUMBER> known inhibitors activators ace<NUMBER> effects binding sarscov<NUMBER> ace<NUMBER> receptor andor infection lung epithelial cells regardless questions fundamental importance understanding sarscov<NUMBER> biology need answered soon original contributions presented study included articlesupplementary material inquiries directed corresponding authors infectious disease caused new severe acute respiratory syndrome coronavirus‐<NUMBER> sars‐cov‐<NUMBER> covid‐<NUMBER> broke wuhan china spread almost every country world millions people infected many died everyday life changed completely disease accompanied range different symptoms figure <NUMBER> rapidly accumulating data show prognosis patients covid‐<NUMBER> good mild disease severe cases show relatively asymptomatic early progression followed rapid worsening symptom onset culminating acute respiratory distress syndrome ards significant disease manifestations figure <NUMBER> presence sars‐cov‐<NUMBER> detected multiple organs autopsy including pharynx lungs heart liver brain kidneys highlighting multiorgan tropism virus <NUMBER> early clinical experience suggested older age presence number comorbidities including hypertension cardiovascular disease diabetes mellitus chronic respiratory disease increased risk death patients covid‐<NUMBER> <NUMBER> <NUMBER> addition renin‐angiotensin aldosterone ras system specifically angiotensin‐converting enzyme <NUMBER> ace<NUMBER> protein identified playing important role facilitating entry coronaviruses including sars‐cov‐<NUMBER> target cells especially lungs <NUMBER> <NUMBER> therefore suggested angiotensin receptor blockers arbs ace inhibitors affect ace<NUMBER> expression may influence susceptibility severity infection sars‐cov‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hypertension common affecting estimated <NUMBER> billion individuals worldwide <NUMBER> prevalence hypertension increases age affecting approximately <NUMBER> older adults <NUMBER> addition ras inhibitors ace inhibitors arbs recommended widely used treatment hypertension <NUMBER> <NUMBER> <NUMBER> however hypertension single clinical entity instead manifests number different phenotypes asians disease characterized salt sensitivity high rates masked hypertension exaggerated morning bp surge nocturnal hypertension <NUMBER> nearly half patients hypertension worldwide <NUMBER> live south east asia <NUMBER> hope asia network established <NUMBER> member world hypertension league <NUMBER> <NUMBER> mission hope asia network improve management hypertension organ protection toward achieving “zero” cardiovascular events asia <NUMBER> <NUMBER> become even relevant current pandemic high rates infection several asian countries guidance hope asia network summarizes latest findings covid‐<NUMBER> hypertension including evidence‐based recommendations management hypertension current pandemic march <NUMBER> <NUMBER> italian institute health announced <NUMBER> covid‐<NUMBER> deaths italy <NUMBER> patients died average age <NUMBER> years median <NUMBER> years range <NUMBER>‐<NUMBER> years <NUMBER> least one comorbidity <NUMBER> hypertension common comorbidity italian cases affecting <NUMBER> patients <NUMBER> taking arbs ace inhibitors <NUMBER> however number factors could potentially confound possible relationship hypertension severe covid‐<NUMBER> table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> first age severe covid‐<NUMBER> hypertension common elderly addition identified risk factors table <NUMBER> generally associated aging andor vascular disorders common patients hypertension therefore risk developing severe covid‐<NUMBER> likely due underlying vascular endothelial dysfunction andor organ damage high blood pressure bp per se ace<NUMBER> receptors expressed endothelial cells <NUMBER> post‐mortem examinations detected presence viral infection endothelial cells <NUMBER> spike protein surface sars‐cov‐<NUMBER> binds extracellular domain transmembrane ace<NUMBER> protein priming transmembrane serine protease <NUMBER> tmprss<NUMBER> gain entry host cells figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> plays regulatory role ras converting angiotensin ang angiotensin <NUMBER>‐<NUMBER> ang <NUMBER>‐<NUMBER> angiotensin ii ang ii angiotensin <NUMBER>‐<NUMBER> ang <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> currently available data reflect possible role ace<NUMBER> heart failure myocardial infarction hypertension cardiovascular complications diabetes mellitus preclinical investigations suggest activation ace<NUMBER> might potential protect hypertension cardiovascular disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition angiotensin <NUMBER>‐<NUMBER> appears counteract negative effects ang ii attenuating inflammation suppressing vascular permeability vasorelaxant effects <NUMBER> <NUMBER> <NUMBER> furthermore ace<NUMBER> lungs renin‐angiotensin system shown play role pulmonary manifestations coronavirus infection <NUMBER> interaction ang ii angiotensin type <NUMBER> receptors at<NUMBER>r activates disintegrin metalloproteinase <NUMBER> adam<NUMBER> cell membrane via phosphorylation <NUMBER> turn adam<NUMBER> cleaves precursors tumor necrosis factor‐α tnfα interleukin il‐<NUMBER> receptor‐α il‐<NUMBER>rα cell membrane release tnfα soluble il‐<NUMBER>rα <NUMBER> tnfα activates nuclear transcription factor system nf‐κb induce production various inflammatory cytokines including il‐<NUMBER> figure <NUMBER> <NUMBER> represents potential mechanism cytokine storm seen patients covid‐<NUMBER> highlights potential agents blocking cytokine pathways especially il‐<NUMBER>‐stat<NUMBER> axis managing covid‐<NUMBER>‐related cytokine storm <NUMBER> fact sars‐cov‐<NUMBER> virus uses ace<NUMBER> mechanism enter infect cells meant concern cells high ace<NUMBER> expression would susceptible infection sars‐cov‐<NUMBER> given arb ace inhibitors shown experimentally increase expression ace<NUMBER> cell membranes <NUMBER> <NUMBER> much discussion potential higher infection rates severe disease patients treated agents despite theoretical possibility use ras inhibitors increases risk infection sars‐cov‐<NUMBER> severity covid‐<NUMBER> illness analyses including patients current pandemic indicate seem case table <NUMBER> effect hypertension therapy ace inhibitors arbs evaluated least three published studies date table <NUMBER> <NUMBER> <NUMBER> <NUMBER> reynolds et al looked history antihypertensive usage <NUMBER> <NUMBER> patients undergoing covid‐<NUMBER> testing new york usa <NUMBER> find association use ace inhibitors arbs beta‐blockers calcium channel blockers thiazide diuretics likelihood positive negative result covid‐<NUMBER> testing <NUMBER> also united states mehta colleagues failed find significant association use ace inhibitors arbs covid‐<NUMBER> test positivity <NUMBER> similar findings reported population case‐control study italy <NUMBER> data four studies published early may <NUMBER> also failed find significant association ras inhibitor use worse outcomes patients covid‐<NUMBER> table <NUMBER> <NUMBER> <NUMBER> <NUMBER> one retrospective case series proportion patients using ace inhibitors arbs differ significantly severe vs non‐severe covid‐<NUMBER> survivors non‐survivors <NUMBER> however in‐hospital covid‐<NUMBER> mortality rate higher patients vs without hypertension <NUMBER> vs <NUMBER> <NUMBER> studies death rates patients taking ace inhibitors andor arbs actually lower patients receiving antihypertensive therapies <NUMBER> <NUMBER> one studies china reported levels inflammatory markers high sensitivity c‐reactive protein procalcitonin significantly lower patients hypertension vs receiving ace inhibitors arbs <NUMBER> two possible mechanisms cardiovascular damage covid‐<NUMBER> first direct viral infection myocardial vascular cells systemic inflammatory reaction cytokine storm figure <NUMBER> myocardial injury time admission due disease progression strong indicator poor prognosis patients covid‐<NUMBER> troponin highly sensitive well‐known marker myocardial injury systematic review meta‐analysis data published <NUMBER> december <NUMBER> <NUMBER> march <NUMBER> including <NUMBER> patients <NUMBER> studies showed significant trend higher levels cardiac biomarkers patients severe covid‐<NUMBER> <NUMBER> meta‐regression analysis factor significantly associated higher levels cardiac injury biomarkers presence hypertension p <NUMBER> addition severe covid‐<NUMBER> markedly increased risk acute cardiac injury risk ratio vs mild disease <NUMBER> <NUMBER> confidence interval ci <NUMBER>‐<NUMBER> p <NUMBER> turn risk covid‐<NUMBER>‐related death significantly increased presence acute cardiac injury risk ratio <NUMBER> <NUMBER> ci <NUMBER>‐<NUMBER> <NUMBER> another analysis also reported patients severe covid‐<NUMBER> significantly higher levels troponin without severe disease standardized mean difference <NUMBER> ngl <NUMBER> ci <NUMBER>‐<NUMBER> ngl <NUMBER> early data wuhan china showed <NUMBER> patients admitted hospital covid‐<NUMBER> acute cardiac injury <NUMBER> subsequent analyses investigated associations underlying cardiovascular disease myocardial injury mortality hospitalized patients covid‐<NUMBER> n <NUMBER> <NUMBER> patients vs without myocardial injury defined elevated troponin levels significantly older <NUMBER> vs <NUMBER> years p <NUMBER> likely hypertension <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> <NUMBER> hospitalization myocardial injury higher rates ards <NUMBER> vs <NUMBER> p <NUMBER> acute renal injury <NUMBER> vs <NUMBER> p <NUMBER> death <NUMBER> vs <NUMBER> p <NUMBER> appearance myocardial injury increased risk death <NUMBER>‐fold compared patients without myocardial damage independent cardiac function based ecg echocardiography findings figure <NUMBER> <NUMBER> <NUMBER> d‐dimer biomarker reflects activation coagulation fibrinolysis <NUMBER> d‐dimer levels <NUMBER> µgml independent predictor in‐hospital death patients hospitalized covid‐<NUMBER> wuhan china hazard ratio <NUMBER> <NUMBER> ci <NUMBER>‐<NUMBER> p <NUMBER> <NUMBER> <NUMBER> µgml cutoff <NUMBER> sensitivity <NUMBER> specificity predicting in‐hospital mortality therefore might useful biomarker predicting outcome informing treatment decisions patients covid‐<NUMBER> cumulative rate thromboembolic events patients admitted hospital milan italy covid‐<NUMBER> n <NUMBER> <NUMBER> <NUMBER> intensive care <NUMBER> intensive care despite use thromboprophylaxis patients admitted intensive care unit three‐quarters treated general ward <NUMBER> half thromboembolic events occurred within <NUMBER> hours hospitalization <NUMBER> patients developed dic <NUMBER> consensus statement prevention treatment venous thromboembolism‐associated covid‐<NUMBER> infection published <NUMBER> recommends patients covid‐<NUMBER> undergo assessment risk venous thromboembolism bleeding monitored regularly facilitate diagnosis treatment venous thromboembolism use strategies pharmacologic andor mechanical prevent venous thromboembolism <NUMBER> key points regarding clinical management covid‐<NUMBER> particularly patients hypertension based evidence published may <NUMBER> <NUMBER> shown table <NUMBER> data rapidly compiled pandemic date indicate number factors biomarkers used identify patients covid‐<NUMBER> high risk severe disease adverse outcomes including death age seems important risk factor especially covid‐<NUMBER>‐related death hypertension common comorbidity covid‐<NUMBER>‐positive deceased patients <NUMBER> comorbidities cardiovascular diseases smoking chronic lung disease chronic kidney disease suppressed immune system also increase risks associated covid‐<NUMBER> infection especially multiple comorbidities exist patient <NUMBER> thorough history taking baseline assessments therefore important another important screening tool oxygen saturation indicates severe disease ≤<NUMBER> admission <NUMBER> <NUMBER> relevance ability tolerate hypoxia highlighted analysis china showing covid‐<NUMBER> patients high‐altitude origin lower mortality risk lower altitudes <NUMBER> determination relevant biomarkers especially troponin d‐dimer provides indication myocardial injury thrombotic risk help inform appropriate treatment strategies non‐hospitalized patients covid‐<NUMBER> ongoing management comorbid conditions essential minimize risk includes lifestyle factors diet sleep along maintaining regular medications eg antihypertensives antidiabetics patients hypertension current therapy ace inhibitors arbs continue treatment without negative effects covid‐<NUMBER> outcomes ras inhibitors particularly beneficial patients heart failure renal disease positive effect prognosis older patients hypertension comorbidities risk factors calcium channel antagonists might good option antihypertensive therapy maintaining good glycaemic control also important might help reduce risk infection sars‐cov‐<NUMBER> severity covid‐<NUMBER> <NUMBER> addition regular monitoring home bp help ensure achievement maintenance bp targets patients hypertension lockdown requirements could impact ability individuals get regular exercise regular exercise important maintaining health status <NUMBER> counteract negative consequences cardiovascular metabolic respiratory diseases <NUMBER> even unable get outside continuing form home‐based exercise would beneficial especially older adults <NUMBER> maintaining regular exercise could help ensure current viral pandemic contribute worldwide obesity epidemic turn increases rate cardiovascular metabolic comorbidities <NUMBER> ensuring world population burdened high rates noncommunicable diseases might help lessen impact future pandemics given patients comorbidities tend fare poorly infectious disease pandemic <NUMBER> another potential benefit physical activity ability stimulate immune function <NUMBER> something highly relevant global pandemic health care professionals also aware potential non‐infectious impacts covid‐<NUMBER> example non‐infected individuals might risk developing stress‐related physical health conditions gastrointestinal disturbances cardiovascular disease psychological disturbances anxiety depression strict lockdown social distancing rules enforced many countries slow spread novel coronavirus addition large proportion “elective” “non‐essential” procedures postponed canceled allow health care systems cope influx infectious disease cases created requirement large proportion health consultations conducted remotely telemedicine strategies ideally suited facilitating patient management absence face‐to‐face consultations value approach otherwise slow widely used clinical practice become clear <NUMBER> <NUMBER> one hidden “blessings” covid‐<NUMBER> pandemic may widespread adoption telemedicine approaches improve patient management out‐of‐office bp monitoring recommended approach diagnosis management hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore field medicine better placed many able continue effectively manage patients global pandemic new information communication technology‐based home bp monitoring devices perform automatic fixed‐interval bp measurement sleep store transmit data could facilitate novel approach patient management <NUMBER> validated wearable technologies evaluation home bp <NUMBER> <NUMBER> might also useful patient monitoring management covid‐<NUMBER> outbreak telemedicine‐based strategies managing bp implemented used effectively aftermath great east japan earthquake tsunami march <NUMBER> <NUMBER> highlighting potential use covid‐<NUMBER> pandemic ensure patients hypertension well‐controlled bp potential help mitigate negative effects hypertension prognosis patients covid‐<NUMBER> patients hypertension increased risk morbidity mortality become infected sars‐cov‐<NUMBER> although confounded factors age vascular disorders however usual antihypertensive therapy including ras inhibitors continue physicians need take holistic approach patient management due wide range possible complications biomarkers provide important prognostic information overall multidisciplinary management covid‐<NUMBER> based rapidly growing body evidence help ensure best possible outcomes patients including risk factors hypertension authors report potential conflicts interest relation article hypertension diabetes among leading causes endstage renal disease regions western world moreover contribute progression cardiovascular disease <NUMBER> <NUMBER> angiotensin iconvertingenzyme ace inhibitors shown broadest impact drug cardiovascular medicine reducing risk death stroke myocardial infarction diabetes renal disease <NUMBER> <NUMBER> ace inhibition results direct cardiovascular protective effects lowering levels angiotensin ii ang ii increasing bradykinin availability constant reduction blood pressure considered beneficial effect ace inhibitors experimental clinical studies progressive diabetic nondiabetic renal disease <NUMBER> <NUMBER> addition important haemodynamic effects reduced systemic blood pressure glomerular capillary pressure inhibition reninangiotensin system ras also produces important nonhaemodynamic benefits stimulation extracellular matrix degradation blockade macrophagemonocyte permeation glomerular vascular beds <NUMBER> hence efforts focused understanding physiological role ace design ace inhibitors interaction components ras angiotensin ii ang ii principal effector ras causes vasoconstriction directly indirectly stimulating angiotensin type <NUMBER> at<NUMBER> receptors present vasculature increasing sympathetic tone stimulating arginine vasopressin release longterm blood pressure regulated ang ii modulating sodium water reabsorption direct stimulation at<NUMBER> receptors kidney indirectly production release aldosterone adrenal glands thirst via central action <NUMBER> review classical enzymatic pathway ang ii formed begins cleavage precursor angiotensinogen renin aspartic proteinase decapeptide angiotensin ang cascade continues ace cleaving dipeptide cterminus ang form ang ii actions ang ii mediated via specific gproteincoupled receptors humans two angiotensin receptors described at<NUMBER> at<NUMBER> bind ang ii differing affinities <NUMBER> angiotensin ii cleaved variety enzymes produce bioactive angiotensin fragments angiotensin iii ang <NUMBER> angiotensin iv ang <NUMBER> angiotensin <NUMBER> ang <NUMBER> <NUMBER> whilst depiction figure <NUMBER> represents ras described textbooks role angiotensin fragments enzymes ace<NUMBER> neprilysin nep aminopeptidase prolyl carboxypeptidase prolyl endopeptidase implicated formation identification new angiotensin receptors at<NUMBER> mas pivotal redefining ras last decade particular interest review ace<NUMBER> possible physiological roles control blood pressure renal disease cardiac function reninangiotensin system last <NUMBER> years seen discovery new components interface classical depiction reninangiotensin system formation physiological endproduct angiotensin ii encased grey box angiotensin ii metabolised several bioactive fragments ang <NUMBER> ang iii ang iv different enzymatic pathways ace angiotensin converting enzyme ace<NUMBER> angiotensin converting enzyme <NUMBER> apa aminopeptidase apn aminopeptidase n ace<NUMBER> first human homologue ace described <NUMBER> <NUMBER> also known serve functional receptor severe acute respiratory syndrome sars coronavirus <NUMBER> date relatively little known cell biology ace<NUMBER> regulation expression normal pathological conditions northern blot analysis revealed highest levels ace<NUMBER> expression kidney heart testis <NUMBER> <NUMBER> extensive surveys shown detectable levels ace<NUMBER> expression tissues especially gastrointestinal tract <NUMBER> however human primary transformed vascular kidney cell lines examined date abundant source ace<NUMBER> protein expression emerged ace<NUMBER> levels generally order magnitude lower ace f j warner j turner unpublished observations expressed stably human embryonic kidney cells ace<NUMBER> found expressed predominantly cellsurface ectoenzyme consistent existence like ace type integral membrane peptidase figure <NUMBER> cellsurface location also consistent ability shed membrane soluble protein <NUMBER> dw lambert nm hooper aj turner unpublished observations ace <NUMBER> serve viral receptor <NUMBER> substrate specificity ace<NUMBER> classified member m<NUMBER> zinc metalloproteinase family along somatic testicular forms ace <NUMBER> amino acid sequence ace<NUMBER> displays approximately <NUMBER> identity human somatic ace regions surrounding catalytic active sites <NUMBER> unlike ace however ace<NUMBER> contains single catalytic domain compared two active sites nand cdomains somatic ace furthermore ace<NUMBER> carboxypeptidase rather peptidyl dipeptidase first mammalian carboxypeptidase identified contains hexxh motif rather typical carboxypeptidase alike motif hxxex <NUMBER> h ace<NUMBER> cleaves single hydrophobic basic residue cterminus limited range biologically active peptides <NUMBER> <NUMBER> indeed <NUMBER> peptides tested <NUMBER> served ace<NUMBER> substrates vitro assay conditions used <NUMBER> consequence substrate specificity ace<NUMBER> hence physiological roles differ ace <NUMBER> ace<NUMBER> inhibited classical ace inhibitors captopril lisinopril enalaprilat vitro <NUMBER> <NUMBER> two strategies used develop selective inhibitors ace<NUMBER> dales et al <NUMBER> employed substratebased design whereas huang et al <NUMBER> used peptide library selection using phage display technology strategies led identification inhibitors nanomolar potency ace<NUMBER> affect ace activity recent solution crystal structures human ace<NUMBER> ectodomain <NUMBER> testicular ace tace <NUMBER> well comparative modelling ace<NUMBER> active site <NUMBER> indicate catalytic mechanism ace<NUMBER> closely resembles tace however differences substrate specificity inhibitor sensitivity suggest distinctive differences exist substrate binding subsites ace<NUMBER> tace ace<NUMBER> cleaves single amino acid cterminus substrates whereas ace functions peptidyl dipeptidase basis difference relates primarily specificity pocket s<NUMBER> <NUMBER> subsite binding substrate cterminus ace<NUMBER> s<NUMBER> <NUMBER> subsite smaller result r<NUMBER> þ q substitution able accommodate one amino acid instead second terminal peptide bond compared tace <NUMBER> <NUMBER> action ace inhibitors captopril lisinopril based part upon ability mimic dipeptidyl cterminal binding ace substrates <NUMBER> amongst substrates cleaved efficiently ace<NUMBER> angiotensin ii dynorphin a<NUMBER> apelin peptides apelin<NUMBER> apelin<NUMBER> angiotensin desarg <NUMBER> bradykinin bcasomorphin ghrelin also hydrolysed ace<NUMBER> although lesser extent <NUMBER> <NUMBER> ndomain specific ace substrate haemoregulatory peptide nacetylserasplyspro <NUMBER> vasodilator bradykinin cleaved ace<NUMBER> although desarg <NUMBER> bradykinin ace<NUMBER> substrate vitro <NUMBER> hence possible ace<NUMBER> may terminate vivo actions desarg <NUMBER> bradykinin endogenous ligand bradykinin b <NUMBER> receptor detail <NUMBER> differences substrate specificity ace ace<NUMBER> summarised table <NUMBER> pertaining ras two angiotensin fragments produced ace<NUMBER> cleavage either ang ii ang ang <NUMBER> ang <NUMBER> respectively two pathways conversion ang ii ang <NUMBER> ace<NUMBER> kinetically substantially favourable vitro <NUMBER> <NUMBER> <NUMBER> <NUMBER> vivo humans <NUMBER> studies vitro show ace<NUMBER> <NUMBER>to <NUMBER>fold potent hydrolysing ang ii ang <NUMBER> prolyl endopeptidase prolyl carboxypeptidase <NUMBER> hence ability ace<NUMBER> form ang <NUMBER> vasodilator attracted attention increasing evidence suggest majority effects produced heptapeptide ang <NUMBER> counteracting pressor proliferative profibrotic actions ang ii thereby providing mechanism ang ii counterregulation <NUMBER> effects include vasodilatation antiproliferation <NUMBER> <NUMBER> increased baroreflex sensitivity <NUMBER> potentiation bradykinin activity b<NUMBER> receptors <NUMBER> <NUMBER> <NUMBER> <NUMBER> review inhibition cdomain ace activity <NUMBER> also noted addition ang ii counterregulatory effects ang <NUMBER> peptide shown produce effects either similar <NUMBER> <NUMBER> <NUMBER> <NUMBER> distinct ang ii <NUMBER> <NUMBER> santos coworkers <NUMBER> recently demonstrated ang <NUMBER> endogenous ligand <NUMBER> continues generated nonace pathways figure <NUMBER> <NUMBER> <NUMBER> future investigations required decipher known ang <NUMBER> effects attributed interaction mas receptor within ras hypothesised ace<NUMBER> generates ang <NUMBER> hydrolysis ang ii thereby maintaining state normal tension limiting vasopressor effects ang ii well hypertrophic prooxidative effects also noted bioavailability ang also regulatory step formation ang ii normal subjects inverse correlation ang <NUMBER> arterial pressure reported <NUMBER> several authors speculated ace<NUMBER> may important regulator blood pressure homeostasis contribute pathophysiology essential hypertension <NUMBER> <NUMBER> suggestion based upon genetic studies <NUMBER> <NUMBER> well data obtained vitro vivo <NUMBER> <NUMBER> <NUMBER> humans ace<NUMBER> gene located region x chromosome xp<NUMBER> <NUMBER> rat x chromosome ace<NUMBER> gene maps defined quantitative trait locus qtl associated hypertension previously identified rat models spontaneous dietinduced hypertension <NUMBER> observation suggests ace<NUMBER> may candidate gene hypertensionrelated qtl furthermore single nucleotide polymorphisms identified ace<NUMBER> locus associated number cardiovascular endpoints percutaneous transliminal coronary angioplasty coronary artery bypass grafting myocardial infarction catheterisation patients <NUMBER> stenosis <NUMBER> essential hypertension <NUMBER> rat models hypertension levels kidney ace<NUMBER> mrna protein expression markedly lower observed normotensive controls <NUMBER> based upon hypothesis mentioned reduced levels ace<NUMBER> increase ang ii availability reduce ang <NUMBER> formation therefore lead increase blood pressure trend observed vitro hypertensive rat models baseline systolic blood pressure saltsensitive sabra hypertensive rats sbhy <NUMBER> mm hg higher compared control saltresistant sabra normotensive rats sbny upon saltloading decrease ace<NUMBER> expression conjunction increase systolic blood pressure observed whilst change noted control animals example trend also reported spontaneously hypertensive rats shr strokeprone spontaneously hypertensive rat strains shrsp present hypertension without obvious external stimulus shr shrsp consistently reduced kidney ace<NUMBER> expression compared levels seen wistarkyoto control rats <NUMBER> whilst genetic vitro data follow apparent trend quite closely data produced vivo ace<NUMBER> knockout mice less obvious ace<NUMBER> mice allred coworkers <NUMBER> reported higher systolic blood pressures <NUMBER> mm hg ace<NUMBER> null mice control littermates increase blood pressure exacerbated chronic infusion ang ii reported increase blood pressure although preliminary data published abstract form <NUMBER> consistent findings sabra model sbhy rats lower ace<NUMBER> expression higher baseline blood pressure <NUMBER> furthermore allred et al <NUMBER> also observed threefold higher ang ii levels serum ace<NUMBER> null mice compared control mice following ang ii infusion observation accord current hypothesis ace<NUMBER> regulates level ang ii vivo maintains blood pressure homeostasis contrast change blood pressure observed <NUMBER>month old ace<NUMBER> null mice compared control littermates despite increase kidney heart plasma ang ii levels <NUMBER> <NUMBER> months old ace<NUMBER> null mice genders displayed impaired heart function male mice coincided slight reduction blood pressure result highlights genderspecific effect xlinked ace<NUMBER> cardiovascular system secondly suggests genetic factors may also contribute effects ace<NUMBER> aetiology essential hypertension considered multifactorial influenced genetic well environmental factors somewhat contradictory results two knockout mouse studies allred et al <NUMBER> crackower et al <NUMBER> may originate differences genetic makeup greatly influences phenotype gene knockouts add confusion hypothesis blocking ace<NUMBER> activity via intravenous bolus injection <NUMBER> mgkg selective ace<NUMBER> inhibitor dx<NUMBER> k <NUMBER> nm conscious shr produces dosedependent depressor response <NUMBER> response characterised decreased mean arterial pressure maximal average depressor response <NUMBER> mm hg average mean arterial pressure <NUMBER> mm hg reflex tachycardia <NUMBER> experiments warrant investigation since disagree vitro studies shr rats <NUMBER> vivo data discussed showing either increase change systolic blood pressure <NUMBER> <NUMBER> may possible inhibitor potentiating effects substrate ang ii instance apelin<NUMBER> hydrolysed ace<NUMBER> comparable kinetics ang ii <NUMBER> shown produce hypotensive effects increase water intake <NUMBER> <NUMBER> interaction endogenous receptor apj putative receptor related at<NUMBER> coreceptor hiv<NUMBER> virus <NUMBER> overall contradiction results vivo ace<NUMBER> gene ablation effect ace<NUMBER> inhibitor provides excellent example fundamental differences exist knockout animals never produced ace<NUMBER> may developed compensatory mechanisms animals ace<NUMBER> inhibited short span time kidney ace<NUMBER> displays similar localisation pattern observed ace primarily localised distal proximal renal tubules rarely glomerular cells rats humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> whilst hypothesised ace<NUMBER> may regulate blood pressure conversion ang ii ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unclear ace<NUMBER> important role renal function homeostasis two studies emerged investigating role ace<NUMBER> first diabetes <NUMBER> second production ang <NUMBER> pregnancy <NUMBER> animal models studied tikellis et al <NUMBER> brosnihan et al <NUMBER> absence hypertension suggesting ace<NUMBER> may role local production ang <NUMBER> intrarenal ras within kidney moreover studies provide first evidence presence ace<NUMBER> activity within kidney rat model diabetic nephropathy gene protein expression tubule ace<NUMBER> observed decrease line ace <NUMBER> however ace<NUMBER> ace increase protein expression diabetic glomeruli <NUMBER> finding keeping observation ace redistributed towards glomeruli renal vasculature away proximal tubules diabetic rat human kidney <NUMBER> <NUMBER> furthermore may suggest role glomerular ace possibly ace<NUMBER> mediating nephron injury increasing intraglomerular ang ii formation intrarenal expression ang ii increased diabetic nephropathy despite suppression systemic ras <NUMBER> increase glomerular ace may explain increase ang ii despite decrease tubule ace study brosnihan et al <NUMBER> also supports concept intrarenal ras presents data suggesting ace<NUMBER> prominent role local production ang<NUMBER> pregnancy nevertheless study ace<NUMBER> involvement systemic local ras systems required contribution ace<NUMBER> cardiac function ventricular remodelling heart failure whilst majority research concentrated possible role ace<NUMBER> hypertension counteracting actions ace new field research emerged identifying role ace<NUMBER> cardiac function especially ventricular remodelling heart failure first evidence ace<NUMBER> may role cardiac function demonstrated crackower et al <NUMBER> genetic ablation ace<NUMBER> mice resulted severe heart contractility defect increased levels ang ii kidney heart plasma upregulation hypoxiainduced genes heart findings led suggestion ace<NUMBER> essential regulator heart function <NUMBER> however remains unclear ras involved mediating heart dysfunction studies ras either blocked ace inhibitors angiotensin receptor antagonists suggest involvement ras regulation heart function cardiac hypertrophy <NUMBER> neither ace angiotensinogen at<NUMBER> receptor null mice show defects heart development function <NUMBER> review however ace also ablated alongside ace<NUMBER> mice cardiac phenotype double knockout restored wildtype littermates seems likely product ace may responsible cardiac impairment observed ace<NUMBER> null mice <NUMBER> however current literature would tend suggest ang ii responsible cardiac defect since ang ii promotes myocardial fibrosis cardiac hypertrophy <NUMBER> study effects ang ii role candidate substrates required ras ang ii key factors ventricular remodelling associated heart failure <NUMBER> review contrast ace<NUMBER> knockout study crackower et al <NUMBER> cardiomyocytespecific overexpression ace<NUMBER> mouse heart results conduction disturbances lethal ventricular arrhythmias outcomes association downregulation connexins suggesting overexpression ace<NUMBER> disrupts gap junction formation <NUMBER> whilst appear clear link ras loss cardiac function observed ace<NUMBER> null mice ang ii implicated gap junction dysregulation development conduction disturbances thought lead lethal ventricular remodelling heart failure <NUMBER> investigations ace<NUMBER> role cardiac function heart failure doubt provide greater insight roles novel enzyme since first descriptions ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> information rapidly accumulated possible functions variety biochemical genetic physiological studies yet much remains learned clear ace<NUMBER> important roles heart function possibly blood pressure regulation diabetes also identified sars receptor hence diversity biological roles perhaps surprising discovery relation novel enzyme important provide much fuller description expression sites enzyme regulation expression identification physiologically relevant peptide substrates angiotensin ii critical greater understanding ace<NUMBER> biology finally involvement ace<NUMBER> human pathologies needs critically evaluated potential therapeutic target exploited possible abstract debate continues medical literature role renin angiotensin system ras coronavirus disease <NUMBER> covid <NUMBER> pathophysiology implications use cardiovascular drugs acting ras could drugs include angiotensin converting enzyme inhibitors aceis angiotensin receptors blockers arbs harmful potential key therapeutic agents covid <NUMBER> debate arisen due finding underlying cardiovascular disease hypertension associated significantly increased risk hospitalisation death covid<NUMBER> <NUMBER> <NUMBER> addition viral receptor angiotensinconverting enzyme<NUMBER> ace<NUMBER> <NUMBER> <NUMBER> coronaviruses downregulate ace<NUMBER> antiinflammatory actions leading imbalance aceace<NUMBER> <NUMBER> may fundamental covid<NUMBER> pathophysiology key gender genetic differences regulation aceace<NUMBER> balance <NUMBER> <NUMBER> <NUMBER> may explain differences observed disease severity <NUMBER> <NUMBER> <NUMBER> social media amplification concern continuation ras medications current pandemic prompted cardiovascular societies publish position statements strongly advising continued use given lack evidence ras drugs unsafe substantial risk hospitalisation drugs withdrawn patients valid indications treatment <NUMBER> <NUMBER> three <NUMBER> large observational studies published new england journal medicine nejm support view evidence harm due ras medications covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> however given fundamental role ras covid<NUMBER> broader therapeutic indication acei arbs treatment patients established cardiovascular indications suggested <NUMBER> <NUMBER> yet tested randomised trials vitamin status may also linked ras impacts covid<NUMBER> vitamin negative regulator renin synthesis small study reported high rates vitamin deficiency covid patients requiring intensive care <NUMBER> vitamin ace role immune system may add complex dimension issue ras drugs vitamin status covid<NUMBER> <NUMBER> <NUMBER> covid<NUMBER> severe course patients preexisting cardiovascular disease <NUMBER> <NUMBER> <NUMBER> causes significant rate cardiovascular events <NUMBER> research required define pathological mechanisms basis observed gender age racial differences severity ras medications used greater confidence covid<NUMBER> patients valid indications use broader role manipulation ras covid<NUMBER> require randomised trial data coronavirus<NUMBER> sarscov<NUMBER> believed gain cell entry via viral spike protein binding ace<NUMBER> receptor <NUMBER> <NUMBER> virology research similar coronaviruses indicates viral cell infection followed rapid downregulation ace<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> system yang yinyang balance ras hypertension system ace<NUMBER> zinc metalloprotease discovered <NUMBER> <NUMBER> mainly breaks angiotensin ii ang ii main effector ras system ang<NUMBER> resulting decrease blood pressure vasoconstriction decreased inflammation ace<NUMBER> usually membrane bound shed covid infection acute lung injury myocardial infarction <NUMBER> whilst role circulating ace<NUMBER> unclear conditions advanced heart failure higher plasma ace<NUMBER> proportional worsening clinical status <NUMBER> <NUMBER> serum ace<NUMBER> levels also significantly higher hypertensive patients <NUMBER> gender differences described <NUMBER> greater levels male patients <NUMBER> debate whether observed higher levels male hypertensive diabetic patients related increased ace<NUMBER> expression compensatory mechanism whether due increased ace<NUMBER> shedding limiting tissue ace<NUMBER> activity causing excess tissue ang ii role circulating versus tissue ace<NUMBER> levels susceptibility covid infection unclear <NUMBER> viral downregulation ace<NUMBER> unopposed ace generates high ang ii causing increased bp vasoconstriction inflammation cell damage exacerbate matters active metabolite generated ace<NUMBER> ang<NUMBER> broken ace accentuating ras imbalance caused covid<NUMBER> <NUMBER> figure <NUMBER> covid<NUMBER> highly contagious spreading one province december <NUMBER> whole china <NUMBER> days despite extreme shutdown measures <NUMBER> may <NUMBER> disease infected <NUMBER> people <NUMBER> deaths worldwide <NUMBER> causing enormous global economic social impacts epidemiology <NUMBER> confirmed suspected asymptomatic cases china suggested mild disease <NUMBER> <NUMBER> fatality overall <NUMBER> early mortality figures different countries shown striking differences greater mortality europe compared asian countries <NUMBER> may relate fundamental differences racial ace ace<NUMBER> polymorphisms impacting susceptibility disease subsequent pathological severity population demographics clearly play role elderly patients greatest risk severe disease death key differences speed government actions implement extensive public health measures recommended world health organization also impacted mortality rates hospitals countries overwhelmed rapid rise cases <NUMBER> cases mild disease yet <NUMBER> severe disease chinese center disease control prevention ccdc epidemiology showed overall mortality <NUMBER> <NUMBER> death rate increased age comorbidities particularly cardiovascular disease <NUMBER> diabetes <NUMBER> hypertension <NUMBER> risk factors typically seen metabolic syndrome whilst clear comorbidities age increase mortality clear whether excess due impact comorbid conditions host inflammatory response alone impact treatment patient group taking <NUMBER> since ras system fundamentally involved covid<NUMBER> pathogenesis great speculation drugs widely used hypertension heart failure treatment acting ras may impact disease severity suggesting protective effect <NUMBER> <NUMBER> others concerned potential harm <NUMBER> drugs include arbs aceis combination drug valsartansacubitril entresto combines arb neprilysin inhibitor also known angiotensin receptorneprilysin inhibitor arni whilst evidence acei arb treatment may increase expression ace<NUMBER> tissues animal models data supporting quantifying effect human subjects clinical doses ras medications lacking <NUMBER> hence relevance possible medicationinduced alteration ace<NUMBER> levels welldescribed significant differences circulating levels ace<NUMBER> advanced heart failure hypertension males diabetics implications covid<NUMBER> severity unclear <NUMBER> <NUMBER> <NUMBER> increased ace<NUMBER> speculated increase susceptibility covid<NUMBER> allowing virus cells turn may exacerbate disease severity counter argument infected ace<NUMBER> could protective viral attack downregulation ace<NUMBER> antiinflammatory system <NUMBER> <NUMBER> three <NUMBER> large observational studies reported nejm examined issue found evidence increased risk adverse outcomes covid<NUMBER> patients taking acei arbs <NUMBER> <NUMBER> <NUMBER> adding weight previously reported smaller retrospective clinical studies <NUMBER> <NUMBER> <NUMBER> also showed excess mortality aceiarbs mehra et al <NUMBER> reported data <NUMBER> patients admitted covid<NUMBER> <NUMBER> hospitals europe asia north america confirmed age coronary disease heart failure cardiac arrhythmia chronic obstructive pulmonary disease current smoking associated increased inhospital mortality increased risk mortality associated risk acei arbs find use acei statins common survivors however randomised data multicentre chinese study <NUMBER> hospitalised patients covid<NUMBER> preexisting hypertension showed death rate <NUMBER> acei arb versus <NUMBER> nonusers p<NUMBER> data observational randomised even adjustment confounding variables lower mortality hazard ratio <NUMBER> p<NUMBER> persisted receiving aceiarbs hr <NUMBER> p<NUMBER> compared use antihypertensive agents <NUMBER> study separate treatment arbs acei <NUMBER> answer observed differences covid<NUMBER> death rates could lie key differences aceace<NUMBER> system balance related age gender racial variation genetic ace ace<NUMBER> polymorphisms environmental factors influencing ace<NUMBER> expression <NUMBER> <NUMBER> ace gene polymorphisms cause insertion deletion sequence gene ace activity levels dd carriers approximately twice found ii genotypes <NUMBER> possible impact ace genotype covid<NUMBER> disease state ability breakdown ang ii impaired could hypothesised cause greater quantity circulating ang ii marked imbalance ras severe disease genetic environmental factors influencing ace<NUMBER> expression could also result differences risk becoming infected first place affecting affinity ace<NUMBER> binding domain viral spike protein causing differences density ace<NUMBER> receptors present tissues lungs ace<NUMBER> polymorphisms may contribute significant differences disease severity determining extent aceace<NUMBER> imbalance particularly endothelium lungs virus attacks time disabling ace<NUMBER>mediated repair systems chen coworkers <NUMBER> <NUMBER> analysed <NUMBER> tissues thousands individuals found significantly higher tissue ace<NUMBER> asian females compared males ethnic groups described agedependent decrease ace<NUMBER> expression highly significant decrease type ii diabetic patients loci higher ace<NUMBER> expression almost <NUMBER> east asians <NUMBER> higher ethnic groups ace<NUMBER> suppressed inflammatory cytokines diabetes induced oestrogen androgen decreased elderly work chen coworkers suggests negative correlation covid<NUMBER> mortality tissue ace<NUMBER> levels population molecular level <NUMBER> circulating ace<NUMBER> however described increase pathological states hypertension diabetes heart failure perhaps differences circulating shed ace<NUMBER> tissuebound ace<NUMBER> key virus susceptibility subsequent disease severity gender differences ace<NUMBER> ace<NUMBER> x chromosome hence men one allele women two <NUMBER> <NUMBER> oestrogen believed upregulate ace<NUMBER> expression <NUMBER> giving premenopausal women advantage two alleles oestrogen upregulation making deficiency ace<NUMBER> ability rally less likely event viral attack support hypothesis chinese cdcc reported overall female mortality <NUMBER> including suspected cases well serologically confirmed cases versus <NUMBER> males difference marked serologically confirmed cases <NUMBER> female versus <NUMBER> male mortality overall ratio <NUMBER> males <NUMBER> females believed infected <NUMBER> hence men significantly less likely become infected likely severe pathophysiological expression disease whilst suggested <NUMBER> gender differences may driven substantially greater rates smoking chinese male population rates smoking covid<NUMBER> cases provided epidemiological study xlinked nature ace<NUMBER> gene females greater range phenotypes may greater role yet fully defined coronavirus pathogenesis gender differences range ace<NUMBER> phenotypes ability upregulate compensatory mechanisms face viral ace<NUMBER> downregulation may play role marked gender differences disease confirmed large observational studies marcia et al reporting <NUMBER> women <NUMBER> patients covid mehra et al reported <NUMBER> female patients <NUMBER> covid<NUMBER> patients requiring hospital admission furthermore reported improved survival female patients independent older age <NUMBER> serum ace<NUMBER> levels reported significantly lower females <NUMBER> fundamental differences immune responses viral infections based gender stronger humoral cellular immune responses described females <NUMBER> smoking linked upregulation ace downregulation ace<NUMBER> <NUMBER> could hypothesised make smokers less likely general population become infected virtue less ace<NUMBER> required viral entry however smoker becomes infected preexisting aceace<NUMBER> imbalance may result severe disease due greater inflammation higher risk ards multifactorial issues including poor baseline lung function bacterial superinfection evidence supporting picture seen data wuhan although smokers said comprise <NUMBER> male population china <NUMBER> rate current smokers reported covid<NUMBER> series seems well <NUMBER> huang et al due extreme complexity ras system another component may relevant causing greater mortality smokers covid<NUMBER> neprilysin metalloprotease number functions act breakdown ang ii ang<NUMBER> <NUMBER> role usually performed ace<NUMBER> highly expressed airways pulmonary interstitium alveolar cells study examining circulating neprilysin levels <NUMBER> communitybased subjects <NUMBER> years found lowest tertile group highest rates smokers p<NUMBER> higher rates hypertension p<NUMBER> <NUMBER> smokers low lung neprilysin activity may lack important safety mechanism could overcome virally mediated loss ace<NUMBER> might relevant patients taking entresto sacubitrilvalsartan medication proven benefit treatment patients heart failure neprilysin inhibition sacubitril component entresto may block alternate method generating antiinflammatory mediator <NUMBER> ace<NUMBER> viral attack less able clearly complex question impossible answer without data even recently reported observational studies sufficient patients taking entresto report safety drug covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> reports china showed patients severe disease leading intensive care unit icu admission death features consistent unopposed ras activity higher blood pressure bp admission hospital higher bp admission icu nonsurvivors <NUMBER> <NUMBER> mean systolic bp <NUMBER> mmhg requiring icu admission versus <NUMBER> mmhg milder cases p<NUMBER> <NUMBER> lower serum potassium levels combined high urinary potassium also reported severe patients <NUMBER> <NUMBER> suggesting ang iimediated activation aldosterone presence significant hypertension instead hypotension group patients admitted icu versus requiring icu particularly interesting clinical finding implications pathogenesis covid<NUMBER> excess ras activity without ace<NUMBER> balance break ang ii block adverse effects cellular damage fibrosis may play key role determining disease severity similar ras proinflammatory effects well known contribute heart failure figure <NUMBER> autopsy data published four covid<NUMBER> patients <NUMBER> described platelet rich clot formation occluding small vessels microangiopathic picture consistent virally mediated vascular damage aceace<NUMBER> imbalance caused viral ace<NUMBER> downregulation understanding aceace<NUMBER> imbalance covid<NUMBER> role age gender racial differences disease severity difference tissue bound circulating ace<NUMBER> could prove key treating disease support fundamental aceace<NUMBER> imbalance clinical relevance reported serum ang ii levels indeed significantly elevated covid<NUMBER> correlate viral load lung injury <NUMBER> <NUMBER> whilst ace formation ang ii blocked ace inhibitors <NUMBER> ang ii formed via nonace pathways chymase <NUMBER> making ace inhibitors potentially less effective arb blockers diminishing problem excess ang ii since acei may block <NUMBER> formation ang ii hand arbs highly selective blockers main receptor ang ii angiotensin receptor type <NUMBER> <NUMBER> receptor arbs decrease amount ang ii produced first place blocking <NUMBER> receptors activate key counter regulatory antiinflammatory cascade restore aceace<NUMBER> balance excessive circulating ang ii unable bind blocked <NUMBER> receptors binds at<NUMBER> receptors trigger counterregulatory antiinflammatory actions upregulates ace<NUMBER> expression <NUMBER> remove excessive circulating ang ii protective role increased tissue ace<NUMBER> expression seems plausible since groups higher levels younger people premenopausal women possibly asian populations <NUMBER> seem lower disease severity mortality <NUMBER> <NUMBER> compared european populations older population high rates comorbidities diabetes hypertension cardiovascular disease described higher circulating ace<NUMBER> levels due increased ace<NUMBER> shedding pointed another rna virus human immunodeficiency virus hiv higher expression binding sites cd<NUMBER> actually protected rather increased virulence <NUMBER> males one xlinked ace<NUMBER> allele could vulnerable phenotypes causing impaired ace<NUMBER> regulation patients preexisting hypertension may greater frequency ace polymorphisms result excessive ang ii levels exacerbated viral impairment ang ii clearance covid<NUMBER> disease major battlefront endothelium fought tissue ras already cases reported media families tragically affected high rates severe disease mortality line genetic factors playing significant role covid<NUMBER> pathophysiology <NUMBER> coronaviruses directly impact cellular systems ras important inflammatory pathways rna viruses remodel host membranes lipid metabolism creating suitable environment replication <NUMBER> lipid metabolism pathways impacted corona virus infection glycerophospholipids fatty acids significantly elevated sars cov<NUMBER>e infected cells upregulated phosphatidylinositol pi may promote coronavirus entry <NUMBER> covid<NUMBER> associated cardiac events significant serum troponin level elevation clinical setting <NUMBER> elevated lysophospholipids including lp<NUMBER> reported acute coronary syndromes causes undergoing coronary angiography <NUMBER> hcov<NUMBER>e infection upregulates fatty acids believed promote efficient coronavirus replication however yan coworkers <NUMBER> reported exogenous addition fatty acids may interfere viral replication upsetting delicate balance fatty acids causing reversion lysophospholipids phospholipids limiting viral replication possible manipulation fatty acids clinical setting may upset balance needed viral replication use drugs statins may also impact viral ability harness cellular lipid pathways clearly data needed investigate role fatty acid cholesterol manipulation finding statins decrease inhospital mortality even nonrandomised study <NUMBER> interest long term sequelae sars caused related coronavirus sars cov reported followup studies survivors <NUMBER> years include sleep disturbance characterised increased stage <NUMBER> sleep percentage diffuse myalgia chronic fatigue depression lung damage avascular femoral head necrosis <NUMBER> <NUMBER> <NUMBER> deranged lipid metabolism also reported sars survivors lipid metabolites including phosphatidylinositol pi lysophosphatidylinositol lpi associated cellular entry andor egress respiratory viruses lpis pis markedly upregulated recovered sars patients lpis thought critical role glucose homeostasis large proportion recovered sars patients reported glucose metabolic disorders including hyperinsulinaemia insulin resistance hyperglycaemia type <NUMBER> <NUMBER> diabetes <NUMBER> patients died sars found extensive lung damage well features systemic vasculitis autoantibodies human epithelial endothelial cells develop sarscov infection could explain severe deterioration patients phase ii disease may lead postinfectious cellular injury sarsinduced immunopathology survivors <NUMBER> longterm immunopathology could also risk covid<NUMBER> related virus also acts inflame endothelium due gender differences immune function female survivors may greater risk autoimmune mediated sequelae <NUMBER> immune system role vitamin ace vitamin deficiency related immune system dysfunction <NUMBER> inflammation cause prothrombotic state common europe winter vitamin potent negative endocrine regulator ras works predominantly suppressing renin synthesis <NUMBER> vitamin deficiency genetic geographical variation function may another factor contributing greater imbalance aceace<NUMBER> system leading differences disease severity covid <NUMBER> suggested vitamin supplementation could reduce risk covid<NUMBER> infection death <NUMBER> lau et al <NUMBER> reported small study vitamin levels <NUMBER> patients yet peer reviewed described vitamin deficiency <NUMBER> covid<NUMBER> patients icu <NUMBER> patients admitted ward bed found <NUMBER> patients age <NUMBER> admitted icu vitamin deficiency n<NUMBER> ace best known role blood pressure regulation converting angiotensin ang ii fact cleaves many peptides role innate adaptive immune responses ace expressed neutrophils macrophages role ace immune responses inflammation complex includes defence intracellular pathogens mediated via actions dependent ang ii reviewed bernstein coworkers <NUMBER> complex interactions mean acei arbs may impacts covid<NUMBER> disease impacting haemodynamic inflammatory pathways many agents investigation clinical trial treatment covid<NUMBER> far antiviral drugs vaccine officially approved covid<NUMBER> treatment hundreds trials listed covid<NUMBER> trial data base wwwwhoint international clinical trials registry small trial using hydroxychloroquine azithromycin showed promise decreasing viral carriage <NUMBER> <NUMBER> days <NUMBER> improvement <NUMBER> days reported china <NUMBER> combination could however carry risk arrhythmia due long qt group patients abnormal troponins endothelial dysfunction present arrythmias reported china <NUMBER> longer trials needed preliminary clinical data investigational rna antiviral agent remdesivir show survival benefit study <NUMBER> patients china show trend earlier recovery <NUMBER> adaptive covid<NUMBER> treatment trial actt study <NUMBER> patients lung involvement usa yet peer reviewed press release national institutes health nih <NUMBER> reports <NUMBER> faster recovery time p<NUMBER> <NUMBER> versus <NUMBER> days possibly trend survival benefit <NUMBER> versus <NUMBER> mortality p<NUMBER> variety therapeutic approaches addition vaccine may contribute covid<NUMBER> treatment prevention medium long term however current urgent situation <NUMBER> active cases <NUMBER> <NUMBER> serious critical many countries still exponential rise phase new cases treatment distributed large quantities needed economic impact pandemic addressed metaanalysis cardiac troponin results covid patients reported higher levels correlated severe disease <NUMBER> consistent either myocarditis acute coronary syndrome conditions manipulation ras commonly available drugs already indication based treating endothelial myocardial inflammation use drugs covid<NUMBER> patients meeting definition acute coronary syndrome another valid cardiovascular indication given confidence light recent studies showing detriment drugs covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> approach may one directed fundamental viral vascular pathogenesis broader therapeutic role ras inhibition covid<NUMBER> investigated two randomised trials examining effects arb losartan severity prognosis covid<NUMBER> hospitalised covid<NUMBER> patients nct <NUMBER> nonhospitalised patients nct<NUMBER> current global covid<NUMBER> pandemic many countries lockdown social economic paralysis impact covid<NUMBER> described warzone many patients dying lonely death isolated loved ones overcrowded hastily expanded hospitals currently supportive care available whilst many therapeutic agents investigation <NUMBER> <NUMBER> none yet approved use covid<NUMBER> demonstrated significant survival benefit even agents proven effective take time trials production large scale thinking covid<NUMBER> fundamentally cardiovascular disease attacks endothelium could provide momentum use safe established widely available medications acting ras already indicated acute coronary syndrome cardiac dysfunction present many patients covid<NUMBER> whilst data role vitamin covid pathogenesis needed replacing essential vitamin deficient seems safe cost effective easily achieved therapeutic strategy successful shift milder disease severity ease burden health care systems switching endogenous antiinflammatory pathways may also play key role decreasing risk longterm vascular autoimmune sequelae covid<NUMBER> survivors could pose economic burden pandemic although may questions answers hot debate medical literature role ras drugs acting system covid<NUMBER> consensus opinion safe use covid<NUMBER> <NUMBER> <NUMBER> view supported retrospective clinical data <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> managing global pandemic high death rate treatments aimed fundamental pathology meet scale problem appealing option data randomised clinical trials examining broader role ras agents covid<NUMBER> beyond existing indications awaited define role medications currently midst covid<NUMBER> pandemic caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> global shutdown third worlds population facing form lockdown quarantine measures unprecedented scale doubt etched history time writing <NUMBER> million people diagnosed infection <NUMBER> deaths worldwide expected even larger number asymptomatic mildly symptomatic undiagnosed time worlds focus novel coronavirus danger illnesses might overlooked members public urged attend emergency departments nonurgent matters dual intention protecting healthcare workers whilst freeing resources treat covid<NUMBER> patients indeed hospitals reported decrease number patients attending emergency departments myocardial infarctions cerebrovascular accidents <NUMBER> <NUMBER> likely patients concerned contracting virus attending hospital staying away reports delayed presentation patients acute myocardial infarctions <NUMBER> imperative lifethreatening conditions forgotten deal coronavirus addition acute conditions management stable chronic illnesses hypertension diabetes may also affected many hospitals worldwide cancelled inperson elective patient care including routine outpatient clinics moved towards telemedicine part social distancing measures also preserves resources help tackle supply chain problems challenges created surge patients infected novel coronavirus even circumstances important blood pressure blood glucose levels monitored regularly particularly important patients diabetes hypertension may higher risk complications covid<NUMBER> <NUMBER> early data china united states suggest hypertension appears prevalent comorbidity among patients admitted covid<NUMBER> present least <NUMBER> <NUMBER> <NUMBER> hypertensive patients develop covid<NUMBER> likely admitted hospital normotensive individuals <NUMBER> presence hypertension also seems associated poorer outcomes covid<NUMBER> <NUMBER> clear whether hypertension per se contributes increased morbidity whether patients hypertension underlying health problems data confirmed patients multiple comorbidities likely fare worse <NUMBER> bear mind though retrospective data patients admitted covid<NUMBER> therefore suggest association causation nevertheless interaction sarscov<NUMBER> virus ace<NUMBER> endothelial cell <NUMBER> raise possibility endothelial dysfunction commonly occurs hypertension <NUMBER> may exacerbate effect virus major problem pandemic hithertounknown organism early conflicting data cause uncertainty confusion management patients shown sarscov<NUMBER> binds cells via angiotensin converting enzyme ace <NUMBER> receptor <NUMBER> thereby gaining entry cells concern therefore raised start pandemic ace inhibitors angiotensin receptor blockers arbs medications commonly used hypertension heart failure could potential deleterious effect <NUMBER> ace<NUMBER> widely expressed cardiovascular system regulated drugs tissues subset animal models <NUMBER> <NUMBER> initial publications led considerable amount discussion debate counter argument ace inhibitors arbs shown protect lung injury experimental models coronavirus infections <NUMBER> agents also previously demonstrated reduce systemic inflammation could potentially reduce degree multiorgan failure seen severe covid<NUMBER> <NUMBER> also considered uncontrolled blood pressure heart failure could ensue result discontinuation therapies could contribute morbidity infected patients guidance promptly issued advising drugs discontinued <NUMBER> <NUMBER> subsequent data raised possibility patients treated ace inhibitors arbs indeed better outcome crucial caveat possibility unmeasured confounding bias precludes drawing causeeffect conclusions clinical studies available thus far recent retrospective study china comparing outcomes hospitalised patients covid<NUMBER> without ace inhibitors arbs hypertension suggested former allcause mortality lower adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> another retrospective study china showed fewer patients ace inhibitors arbs severe disease compared drugs <NUMBER> <NUMBER> respectively ace inhibitorarbtreated group also significantly higher cd<NUMBER> cd<NUMBER> cells trend towards lower il<NUMBER> levels <NUMBER> recent analyses preprints though suggested adjustment certain likely confounders signal improved outcomes longer strong first believed <NUMBER> end effects treatment ace inhibitors arbs positively identified rcts ongoing <NUMBER> also mounting concern possible thromboembolic complications virus possible procoagulable state <NUMBER> various factors lead hypercoagulable state inflammation hypoxia immobilisation dehydration diffuse intravascular coagulation described covid<NUMBER> addition hypertension also known associated hypercoagulable state <NUMBER> possible interaction two conditions might lead worsening thrombotic milieu still learning new virus information continues mount meantime would prudent continue guidelinebased management chronic conditions cardiovascular risk factors diabetes hypertension healthcare practitioners need ensure patients appropriately advised access drugs patients made aware despite lockdown pharmacies hospitals still open indeed british heart foundation recently issued notice reminding public ignore chest pain seek help immediately also report <NUMBER> drop patients presenting myocardial infarction since start pandemic <NUMBER> general practitioners family physicians still available consultations even telephone patients also encouraged monitor blood pressure home adherent treatment adopt healthy lifestyles many countries individuals allowed go exercise ensuring maintain social distancing take necessary precautions advised public health authorities current pandemic brought profound changes social economic lives many also changed way healthcare delivered prioritised even social restrictions relaxed hard imagine things would quickly ever go back pandemic whilst get used new normal way life remember diseases illness still still need care perhaps time much control chronic illnesses go back community patients ensure patients chronic illnesses forgotten fight sarscov<NUMBER> end collateral damage conflict interest authors declare conflict interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations ace<NUMBER> processes angiotensin <NUMBER> <NUMBER> receptor agonist angiotensin ii produce angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> mas receptor agonist angiotensin <NUMBER> respectively exact role reninangiotensin system ras needs clarified one group reported c<NUMBER>bl<NUMBER> ace<NUMBER> àà mice exhibit severe reduction cardiac contractility rescued ace ààace<NUMBER> àà double knockout <NUMBER> contrast another group disclosed ace<NUMBER> àà mice <NUMBER>svev c<NUMBER>bl<NUMBER> mixed background exhibit cardiac contractility defects increased susceptibility angiotensin iiinduced hypertension <NUMBER> third group revealed male ace ày mice susceptible heart failure death transverse aortic constriction normal littermates <NUMBER> supporting role ace<NUMBER> cardiac function transgenic mice overexpressing ace<NUMBER> heart lower mean arterial pressure rare focal myocyte vacuolization myofibril splaying nuclear enlargement many mice develop terminal ventricular fibrillation lethal arrhythmias <NUMBER> furthermore male ace<NUMBER> ày mice female ace<NUMBER> àà mice also accumulate fibrillar collagen renal glomerular mesangium leading development glomerulosclerosis kidneys <NUMBER> addition ace<NUMBER> àà mice exhibit lower body weights wild type mice reduced fat mass <NUMBER> moreover ace<NUMBER> also utilized severe acute respiratory syndrome sars coronavirus receptor infection <NUMBER> ace<NUMBER> àà mice resistant sars corona virus infection <NUMBER> finally ace<NUMBER> àà mice enhanced vascular permeability increased lung edema worsened lung function several murine acute respiratory distress syndrome ards models <NUMBER> many potential functions ace<NUMBER> small molecule inhibitors enzyme could utilized help define physiological roles protease ace<NUMBER> belongs zinc metalloprotease family reported classical ace inhibitors captopril lisinopril attenuate ace<NUMBER> enzyme activity part strategy discover lead molecules ace<NUMBER> inhibitor program directed screen ace<NUMBER> versus set metalloprotease inhibitors glaxosmithkline compound collection performed surprisingly although confirming classical ace inhibitors like captopril inactive screen thiol acid <NUMBER>a identified potent ace<NUMBER> inhibitor k app <NUMBER> nm <NUMBER> biphenyl analog <NUMBER>a known dual ace m<NUMBER> metalloprotease neutral endopeptidase neprilysin nep ec <NUMBER> inhibitor ace k app <NUMBER> nm nep k app <NUMBER> nm <NUMBER> also inhibits m<NUMBER> metalloprotease carboxypeptidase a<NUMBER> cpa ec <NUMBER> k app <NUMBER> nm speculating thiol functioned binding group active site zinc carboxylic acid served recognition element enzymes monocarboxypeptidase activity benzyl methylene pbiphenyl moieties surmised p <NUMBER> p <NUMBER> <NUMBER> substituents premise structure activity relationships p <NUMBER> position lead inhibitor explored goal improving potency reducing ace nep inhibitory activity thiol analogs <NUMBER>a<NUMBER>s prepared depicted scheme <NUMBER> acids <NUMBER>a<NUMBER>s activated situ via carbodiimide converted activated esters azahydroxybenzotriazole coupled amine hydrochloride <NUMBER> produce fully protected amides subsequent hydrolysis methyl ester well thioacetate lithium hydroxide afforded thiol acids <NUMBER>a<NUMBER>s <NUMBER> thiol acids <NUMBER>a<NUMBER>s produced three different routes acids <NUMBER>c <NUMBER>e prepared reaction commercially available thiols <NUMBER>c <NUMBER>e xs acetyl chloride contrast acids <NUMBER>k <NUMBER>m <NUMBER>n produced alcohols <NUMBER>k <NUMBER>m <NUMBER>n xo via mitsunobu reaction thioacetic acid <NUMBER> alternatively acids <NUMBER>a<NUMBER>b <NUMBER>d <NUMBER>f<NUMBER>j <NUMBER>l <NUMBER>o<NUMBER>s synthesized commercially available amino acids <NUMBER>a<NUMBER>b <NUMBER>d <NUMBER>f<NUMBER>j <NUMBER>l <NUMBER>o<NUMBER>s xnh diazotization amines afford bromides subsequent displacement bromides potassium thioacetate stereochemical inversion stereochemical erosion presumably resulting formation alactone nucleophilic trapping resulted mitsunobu diazotization reaction steps coupling amine <NUMBER> minor diastereomer could removed via chromatography structureactivity relationships p <NUMBER> analogs depicted table <NUMBER> r isomer <NUMBER>b derived l lphenylalanine displays p <NUMBER> benzyl substituent unnatural configuration orientation p <NUMBER> substituent detrimental ace<NUMBER> inhibitory activity diastereomer <NUMBER>b k app <NUMBER> nm well ace k app <NUMBER> nm loss inhibition surprising since nature evolved proteases recognize natural configuration physiological peptide substrates contrast nep k app <NUMBER> nm accommodated alternate configuration loss potency complete removal p <NUMBER> moiety caused modest loss inhibitory potency versus ace<NUMBER> h k app <NUMBER> nm decrease potency could arise reduced van der waals interactions due lack p <NUMBER> substituent increased entropic cost inhibitor bind protease given inhibitors increased rotational freedom combination factors contrast disomer <NUMBER>b ace activity k app <NUMBER> nm glycinelike analog <NUMBER>c affected elimination p <NUMBER> element nep potency k app <NUMBER> nm <NUMBER>c decreased order magnitude alaninederived analog <NUMBER>d k app <NUMBER> nm decreases rotational freedom even potent ace<NUMBER> inhibitor starting lead <NUMBER>a increasing selectivity versus ace k app <NUMBER> nm nep k app <NUMBER> nm contrast geminal dimethyl analog <NUMBER>e ace<NUMBER> k app <NUMBER> nm decreased inhibitory potency versus ace<NUMBER> also ace k app <NUMBER> nm nep k app <NUMBER> nm similar methyl analog <NUMBER>d linear p <NUMBER> ethyl nbutyl analogs <NUMBER>f et k app <NUMBER> nm <NUMBER>g nbu k app <NUMBER> nm also potent ace<NUMBER> inhibitors extensions p <NUMBER> also increased activity versus ace <NUMBER>f k app <NUMBER> nm <NUMBER>g k app <NUMBER> nm even versus nep <NUMBER>f k app <NUMBER> nm <NUMBER>g k app <NUMBER> nm hope improving selectivity thiolbased inhibitors versus ace nep effect branching along p <NUMBER> side chain inhibitor class explored branching along p <NUMBER> chain well tolerated <NUMBER> subsite ace<NUMBER> abranched isopropyl <NUMBER>h ipr k app <NUMBER> neopentyl <NUMBER>p ch <NUMBER> tbu k app <NUMBER> nm analogs maintained ace<NUMBER> inhibition bulkier branched analogs like abranched cyclohexyl <NUMBER>m cyh k app <NUMBER> nm phenyl <NUMBER>n ph k app <NUMBER> nm bbranched methylene cyclohexyl <NUMBER>q ch <NUMBER> cyh k app <NUMBER> nm methylene bnaphthyl <NUMBER>r ch <NUMBER> bnp k app <NUMBER> nm cbranched ethylene phenyl <NUMBER>s ch <NUMBER> <NUMBER> ph k app <NUMBER> nm large accommodated ace<NUMBER> <NUMBER> subsite contrast abranching p <NUMBER> moiety poorly tolerated ace <NUMBER> subsite resulting substantial decreases ace inhibitory activity abranched isopropyl <NUMBER>h k app <NUMBER> nm rsecbutyl <NUMBER>i k app <NUMBER> nm ssecbutyl <NUMBER>j k app <NUMBER> nm cyclobutyl <NUMBER>k k app <NUMBER> nm cyclopentyl <NUMBER>l k app <NUMBER> nm cyclohexyl <NUMBER>m k app <NUMBER> nm phenyl <NUMBER>n k app <NUMBER> nm analogs <NUMBER> subsite nep accepting abranching p <NUMBER> substituents ace enzyme less liberal ace<NUMBER> abranched isopropyl <NUMBER>h k app <NUMBER> nm rsecbutyl <NUMBER>i k app <NUMBER> nm ssecbutyl <NUMBER>j k app <NUMBER> nm cyclobutyl <NUMBER>k k app <NUMBER> nm cyclopentyl <NUMBER>l k app <NUMBER> nm cyclohexyl <NUMBER>m k app <NUMBER> nm phenyl <NUMBER>n k app <NUMBER> nm analogs lost inhibitory activity versus nep relative ethyl analog <NUMBER>f k app <NUMBER> nm thus abranching p <NUMBER> group enhanced selectivity ace<NUMBER> protease inhibition relative ace nep rsecbutyl analog <NUMBER>i k app <NUMBER> nm <NUMBER>fold selectivity versus ace <NUMBER>fold selectivity versus nep cyclopentyl <NUMBER>l k app <NUMBER> nm <NUMBER>fold selectivity versus ace <NUMBER>fold selectivity versus nep comparison abranching ace nep <NUMBER> subsites permissive bbranching p <NUMBER> groups thus isobutyl <NUMBER>o analog potent ace<NUMBER> inhibitor k app <NUMBER> nm also low nanomolar ace k app <NUMBER> nm subnanomolar nep inhibitor k app <NUMBER> nm ace less tolerant bulky bbranching neopentyl <NUMBER>p analog exhibiting potent dual ace<NUMBER> k app <NUMBER> nm nep k app <NUMBER> nm inhibition good selectivity ace k app <NUMBER> nm larger bbranched substituents like methylene cyclohexyl <NUMBER>q ace<NUMBER> k app <NUMBER> nm ace k app <NUMBER> nm nep k app <NUMBER> nm methylene bnaphthyl <NUMBER>r ace<NUMBER> k app <NUMBER> nm ace k app <NUMBER> nm nep k app <NUMBER> nm attenuate inhibitory activity three enzymes finally ethylene phenyl analog <NUMBER> shows like ace<NUMBER> k app <NUMBER> nm ace k app <NUMBER> nm less tolerant cbranching p <NUMBER> groups nep k app <NUMBER> nm accepted none thiolbased inhibitors potent inhibitor cpa model thiol <NUMBER>i <NUMBER> docked active site ace<NUMBER> based recent xray crystal structure <NUMBER> shown figure <NUMBER> provides insight sar thiol series addition binding imidazole nitrogens <NUMBER> <NUMBER> carboxylate <NUMBER> glu active site zinc coordinates thiol inhibitor also terminal carboxylate inhibitor forms electrostatic interactions guanidine <NUMBER> arg accepts hydrogen bonds imidazoles <NUMBER> <NUMBER> moreover carbonyl <NUMBER> pro accepts hydrogen bond amide nitrogen inhibitor amide carbonyl stabilized hydrogen bond <NUMBER> tyr furthermore p <NUMBER> <NUMBER> methylene biphenyl substituent <NUMBER>i forms significant lipophilic interactions quite large <NUMBER> <NUMBER> channel composed lengthwise canal two subdomains including residues <NUMBER> phe <NUMBER> thr <NUMBER> pro <NUMBER> asp <NUMBER> leu <NUMBER> thr <NUMBER> biphenyl substituent hypothesized occupy different part large pocket carboxyl inhibitor cocrystallized <NUMBER>r<NUMBER>l p <NUMBER> rsecbutyl group inhibitor forms van der waals interactions <NUMBER> pocket composed <NUMBER> thr <NUMBER> phe <NUMBER> tyr <NUMBER> arg shown closeup <NUMBER> subsite depicted figure <NUMBER> <NUMBER> tyr forms part pocket abranched methyl p <NUMBER> rsecbutyl group occupies larger substituents disfavored would require movement phenol side chain <NUMBER> tyr thus model agrees sar since <NUMBER> subsite tolerate cyclobutyl cyclopentyl substituents less accepting cyclohexyl group model inhibitor <NUMBER>i <NUMBER> docked active site ace focusing <NUMBER> subsite based xray structure lisinopril ace <NUMBER> shown figure <NUMBER> model apparent methyl group rsecbutyl p <NUMBER> moiety inhibitor <NUMBER>i bumps enzyme helping explain <NUMBER>fold selectivity ace<NUMBER> versus ace branching nature <NUMBER> val atom cg<NUMBER> makes portion <NUMBER> pocket smaller ace<NUMBER> <NUMBER> val homologous residue ace <NUMBER> tyr ace<NUMBER> <NUMBER> tyr <NUMBER> val substitution ace<NUMBER> ace resulting alteration <NUMBER> pocket volume helps explain reduced ability ace accommodate abranching p <NUMBER> substituents although xray structures nep cocrystallized thiolbased inhibitor pdb code <NUMBER>y<NUMBER>j <NUMBER> analog p <NUMBER> <NUMBER> biphenyl moiety pdb code <NUMBER>r<NUMBER>h <NUMBER> available nep belongs different metalloprotease family m<NUMBER> vs m<NUMBER> reasonable model thiol inhibitors bound nep could determined help explain increase nep selectivity abranched p <NUMBER> analogs likely protein movement accommodate potent nep inhibitors like <NUMBER>o required movement multiple amino acid residues proteins difficult predict accurately summary series athiol amidebased inhibitors ace<NUMBER> varied substituents p <NUMBER> position synthesized inhibitors containing linear alkyl p <NUMBER> moieties potent analogs ace<NUMBER> enzymatic assay smaller abranched p <NUMBER> substituents exemplified inhibitors <NUMBER>i <NUMBER>l maintained similar potencies increased selectivity versus ace nep information gained studies proven useful design ace<NUMBER> inhibitors inhibitors reported due course furthermore potent pan aceace<NUMBER>nep inhibitor <NUMBER>o potent dual ace<NUMBER>nep inhibitor <NUMBER>p identified tools may prove useful defining roles proteases play ras cascade hydrolyses carried reactions open atmosphere varying amounts disulfide products isolated likely aerobic oxidation enzyme assays contain reducing agent tris<NUMBER>chloroethylphosphate tcep prevent oxidation thiols disulfides assays dilutions <NUMBER> mm stock solutions thiols <NUMBER>a<NUMBER>s final assay concentrations done <NUMBER> aqueous acetonitrile prior protease inhibition studies standard conditions thiols corresponding disulfides showed enzyme inhibitory activity presumably disulfides reduced corresponding thiols tcep preincubation period substrates added contrast assays performed without tcep disulfides completely inactive potencies thiols attenuated probably partial aerobic oxidation corresponding disulfides preincubation period <NUMBER> alcohols <NUMBER>m <NUMBER>n commercially available alcohol <NUMBER>k prepared cyclobutane methanol three steps first oxidation alcohol pyridinium chlorochromate afforded aldehyde reaction aldehyde trimethylsilyl cyanide nmethyl morpholine noxide provided silyl protected cyano hypertension diabetes among leading causes endstage renal disease regions western world moreover contribute progression cardiovascular disease <NUMBER> <NUMBER> angiotensin iconvertingenzyme ace inhibitors shown broadest impact drug cardiovascular medicine reducing risk death stroke myocardial infarction diabetes renal disease <NUMBER> <NUMBER> ace inhibition results direct cardiovascular protective effects lowering levels angiotensin ii ang ii increasing bradykinin availability constant reduction blood pressure considered beneficial effect ace inhibitors experimental clinical studies progressive diabetic nondiabetic renal disease <NUMBER> <NUMBER> addition important haemodynamic effects reduced systemic blood pressure glomerular capillary pressure inhibition reninangiotensin system ras also produces important nonhaemodynamic benefits stimulation extracellular matrix degradation blockade macrophagemonocyte permeation glomerular vascular beds <NUMBER> hence efforts focused understanding physiological role ace design ace inhibitors interaction components ras angiotensin ii ang ii principal effector ras causes vasoconstriction directly indirectly stimulating angiotensin type <NUMBER> at<NUMBER> receptors present vasculature increasing sympathetic tone stimulating arginine vasopressin release longterm blood pressure regulated ang ii modulating sodium water reabsorption direct stimulation at<NUMBER> receptors kidney indirectly production release aldosterone adrenal glands thirst via central action <NUMBER> review classical enzymatic pathway ang ii formed begins cleavage precursor angiotensinogen renin aspartic proteinase decapeptide angiotensin ang cascade continues ace cleaving dipeptide cterminus ang form ang ii actions ang ii mediated via specific gproteincoupled receptors humans two angiotensin receptors described at<NUMBER> at<NUMBER> bind ang ii differing affinities <NUMBER> angiotensin ii cleaved variety enzymes produce bioactive angiotensin fragments angiotensin iii ang <NUMBER> angiotensin iv ang <NUMBER> angiotensin <NUMBER> ang <NUMBER> <NUMBER> whilst depiction figure <NUMBER> represents ras described textbooks role angiotensin fragments enzymes ace<NUMBER> neprilysin nep aminopeptidase prolyl carboxypeptidase prolyl endopeptidase implicated formation identification new angiotensin receptors at<NUMBER> mas pivotal redefining ras last decade particular interest review ace<NUMBER> possible physiological roles control blood pressure renal disease cardiac function reninangiotensin system last <NUMBER> years seen discovery new components interface classical depiction reninangiotensin system formation physiological endproduct angiotensin ii encased grey box angiotensin ii metabolised several bioactive fragments ang <NUMBER> ang iii ang iv different enzymatic pathways ace angiotensin converting enzyme ace<NUMBER> angiotensin converting enzyme <NUMBER> apa aminopeptidase apn aminopeptidase n ace<NUMBER> first human homologue ace described <NUMBER> <NUMBER> also known serve functional receptor severe acute respiratory syndrome sars coronavirus <NUMBER> date relatively little known cell biology ace<NUMBER> regulation expression normal pathological conditions northern blot analysis revealed highest levels ace<NUMBER> expression kidney heart testis <NUMBER> <NUMBER> extensive surveys shown detectable levels ace<NUMBER> expression tissues especially gastrointestinal tract <NUMBER> however human primary transformed vascular kidney cell lines examined date abundant source ace<NUMBER> protein expression emerged ace<NUMBER> levels generally order magnitude lower ace f j warner j turner unpublished observations expressed stably human embryonic kidney cells ace<NUMBER> found expressed predominantly cellsurface ectoenzyme consistent existence like ace type integral membrane peptidase figure <NUMBER> cellsurface location also consistent ability shed membrane soluble protein <NUMBER> dw lambert nm hooper aj turner unpublished observations ace <NUMBER> serve viral receptor <NUMBER> ace<NUMBER> classified member m<NUMBER> zinc metalloproteinase family along somatic testicular forms ace <NUMBER> amino acid sequence ace<NUMBER> displays approximately <NUMBER> identity human somatic ace regions surrounding catalytic active sites <NUMBER> unlike ace however ace<NUMBER> contains single catalytic domain compared two active sites nand cdomains somatic ace furthermore ace<NUMBER> carboxypeptidase rather peptidyl dipeptidase first mammalian carboxypeptidase identified contains h e x x h motif rather typical carboxypeptidase alike motif hxxex<NUMBER>h ace<NUMBER> cleaves single hydrophobic basic residue cterminus limited range biologically active peptides <NUMBER> <NUMBER> indeed figure <NUMBER> immuofluorescent staining b human embryonic kidney cells transiently expressing fulllength ace<NUMBER> cells grown coversfips fixed using <NUMBER> wv paraformaldehyde prior immunostaining polyclonal antipeptide antibodies directed sequences extracellular c<NUMBER> nterminal antibody <NUMBER> b cytoplasmic c<NUMBER> cterminal antibody <NUMBER> regions ace<NUMBER> donkey antirabbit fitc conjugate <NUMBER> used secondary untransfected hek cells transfected cells stained absence primary antibody displayed negative immunostaining ace<NUMBER> shown <NUMBER> x bar <NUMBER>an <NUMBER> peptides tested <NUMBER> served ace<NUMBER> substrates vitro assay conditions used <NUMBER> consequence substrate specificity ace<NUMBER> hence physiological roles differ ace <NUMBER> ace<NUMBER> inhibited classical ace inhibitors captopril lisinopril enalaprilat vitro <NUMBER> <NUMBER> two strategies used develop selective inhibitors ace<NUMBER> dales et al <NUMBER> employed substratebased design whereas huang et al <NUMBER> used peptide library selection using phage display technology strategies led identification inhibitors nanomolar potency ace<NUMBER> affect ace activity recent solution crystal structures human ace<NUMBER> ectodomain <NUMBER> testicular ace tace <NUMBER> well comparative modelling ace<NUMBER> active site <NUMBER> indicate catalytic mechanism ace<NUMBER> closely resembles tace however differences substrate specificity inhibitor sensitivity suggest distinctive differences exist substrate binding subsites ace<NUMBER> tace ace<NUMBER> cleaves single amino acid cterminus substrates whereas ace functions peptidyl dipeptidase basis difference relates primarily specificity pocket st subsite binding substrate cterminus ace<NUMBER> <NUMBER> p subsite smaller result r<NUMBER> q substitution able accommodate one amino acid instead second terminal peptide bond compared tace <NUMBER> <NUMBER> action ace inhibitors captopril lisinopril based part upon ability mimic dipeptidyl cterminal binding ace substrates <NUMBER> amongst substrates cleaved efficiently ace<NUMBER> angiotensin ii dynorphin a<NUMBER> apelin peptides apelin<NUMBER> apelin<NUMBER> angiotensin desarg<NUMBER>bradykinin flcasomorphin ghrelin also hydrolysed ace<NUMBER> although lesser extent <NUMBER> <NUMBER> ndomain specific ace substrate haemoregulatory peptide nacetylserasplyspro <NUMBER> vasodilator bradykinin cleaved ace<NUMBER> although desarg<NUMBER>bradykinin ace<NUMBER> substrate vitro <NUMBER> hence possible ace<NUMBER> may terminate vivo actions desarg<NUMBER>bradykinin endogenous ligand bradykinin b<NUMBER> receptor detail <NUMBER> differences substrate specificity ace ace<NUMBER> summarised table <NUMBER> pertaining ras two angiotensin fragments produced ace<NUMBER> cleavage either ang ii ang ang <NUMBER> ang <NUMBER> respectively two pathways conversion ang ii ang <NUMBER> ace<NUMBER> kinetically substantially favourable vitro <NUMBER> <NUMBER> <NUMBER> <NUMBER> vivo humans <NUMBER> studies vitro show ace<NUMBER> <NUMBER>to <NUMBER>fold potent hydrolysing ang ii ang <NUMBER> prolyl endopeptidase prolyl carboxypeptidase <NUMBER> hence ability ace<NUMBER> form ang <NUMBER> vasodilator attracted attention increasing evidence suggest majority effects produced heptapeptide ang <NUMBER> counteracting pressor proliferative profibrotic actions ang ii thereby providing mechanism ang ii counterregulation <NUMBER> effects include vasodilatation antiproliferation <NUMBER> <NUMBER> increased baroreflex sensitivity <NUMBER> potentiation bradykinin activity b<NUMBER> receptors <NUMBER> <NUMBER> <NUMBER> <NUMBER> review inhibition cdomain ace activity <NUMBER> also noted addition ang ii counterregulatory effects ang <NUMBER> peptide shown produce effects either similar <NUMBER> <NUMBER> <NUMBER> <NUMBER> distinct ang ii <NUMBER> <NUMBER> santos coworkers <NUMBER> recently demonstrated ang <NUMBER> endogenous ligand <NUMBER> clinical implications humans rats administration ace inhibitors leads accumulation ang <NUMBER> ace blockade prevents degradation ang <NUMBER> ang <NUMBER> whilst ang <NUMBER> continues generated nonace pathways figure <NUMBER> <NUMBER> <NUMBER> future investigations required decipher known ang <NUMBER> effects attributed interaction mas receptor within ras hypothesised ace<NUMBER> generates ang <NUMBER> hydrolysis ang ii thereby maintaining state normal tension limiting vasopressor effects ang ii well hypertrophic prooxidative effects also noted bioavailability ang also regulatory step formation ang ii normal subjects inverse correlation ang <NUMBER> arterial pressure reported <NUMBER> several authors speculated ace<NUMBER> may important regulator blood pressure homeostasis contribute pathophysiology essential hypertension <NUMBER> <NUMBER> suggestion based upon genetic studies <NUMBER> <NUMBER> well data obtained vitro vivo <NUMBER> <NUMBER> <NUMBER> humans ace<NUMBER> gene located region x chromosome xp<NUMBER> <NUMBER> rat x chromosome ace<NUMBER> gene maps defined quantitative trait locus qtl associated hypertension previously identified rat models spontaneous dietinduced hypertension <NUMBER> observation suggests ace<NUMBER> may candidate gene hypertensionrelated qtl furthermore single nucleotide polymorphisms identified ace<NUMBER> locus associated number cardiovascular endpoints percutaneous transliminal coronary angioplasty coronary artery bypass grafting myocardial <NUMBER> infarction catheterisation patients <NUMBER> stenosis <NUMBER> essential hypertension <NUMBER> rat models hypertension levels kidney ace<NUMBER> mrna protein expression markedly lower observed normotensive controls <NUMBER> based upon hypothesis mentioned reduced levels ace<NUMBER> increase ang ii availability reduce ang <NUMBER> formation therefore lead increase blood pressure trend observed vitro hypertensive rat models baseline systolic blood pressure saltsensitive sabra hypertensive rats sbhy <NUMBER> mm hg higher compared control saltresistant sabra normotensive rats sbny upon saltloading decrease ace<NUMBER> expression conjunction increase systolic blood pressure observed whilst change noted control animals example trend also reported spontaneously hypertensive rats shr strokeprone spontaneously hypertensive rat strains shrsp present hypertension without obvious external stimulus shr shrsp consistently reduced kidney ace<NUMBER> expression compared levels seen wistarkyoto control rats <NUMBER> whilst genetic vitro data follow apparent trend quite closely data produced vivo ace<NUMBER> knockout mice less obvious ace<NUMBER> mice allred coworkers <NUMBER> reported higher systolic blood pressures <NUMBER> mm hg ace<NUMBER> null mice control littermates increase blood pressure exacerbated chronic infusion ang ii reported increase blood pressure although preliminary data published abstract form <NUMBER> consistent findings sabra model sbhy rats lower ace<NUMBER> expression higher baseline blood pressure <NUMBER> furthermore allred et al <NUMBER> also observed threefold higher ang ii levels serum ace<NUMBER> null mice compared control mice following ang ii infusion observation accord current hypothesis ace<NUMBER> regulates level ang ii vivo maintains blood pressure homeostasis contrast change blood pressure observed <NUMBER>month old ace<NUMBER> null mice compared control littermates despite increase kidney heart plasma ang ii levels <NUMBER> <NUMBER> months old ace<NUMBER> null mice genders displayed impaired heart function male mice coincided slight reduction blood pressure result highlights genderspecific effect xlinked ace<NUMBER> cardiovascular system secondly suggests genetic factors may also contribute effects ace<NUMBER> aetiology essential hypertension considered multifactorial influenced genetic well environmental factors somewhat contradictory results two knockout mouse studies allred et al <NUMBER> crackower et al <NUMBER> may originate differences genetic makeup greatly influences phenotype gene knockouts add confusion hypothesis blocking ace<NUMBER> activity via intravenous bolus injection <NUMBER> mgkg selective ace<NUMBER> inhibitor dx<NUMBER> k <NUMBER> nm conscious shr produces dosedependent depressor response <NUMBER> response characterised decreased mean arterial pressure maximal average depressor response <NUMBER> mm hg average mean arterial pressure <NUMBER> mm hg reflex tachycardia <NUMBER> experiments warrant investigation since disagree vitro studies shr rats <NUMBER> vivo data discussed showing either increase change systolic blood pressure <NUMBER> <NUMBER> may possible inhibitor potentiating effects substrate ang ii instance apelin<NUMBER> hydrolysed ace<NUMBER> comparable kinetics ang ii <NUMBER> shown produce hypotensive effects increase water intake <NUMBER> <NUMBER> interaction endogenous receptor apj putative receptor related at<NUMBER> coreceptor hiv<NUMBER> virus <NUMBER> overall contradiction results vivo ace<NUMBER> gene ablation effect ace<NUMBER> inhibitor provides excellent example fundamental differences exist knockout animals never produced ace<NUMBER> may developed compensatory mechanisms animals ace<NUMBER> inhibited short span time kidney ace<NUMBER> displays similar localisation pattern observed ace primarily localised distal proximal renal tubules rarely glomerular cells rats humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> whilst hypothesised ace<NUMBER> may regulate blood pressure conversion ang ii ang <NUMBER> unclear ace<NUMBER> important role renal function homeostasis two studies emerged investigating role ace<NUMBER> first diabetes <NUMBER> second production ang <NUMBER> pregnancy <NUMBER> animal models studied tikellis et al <NUMBER> brosnihan et al <NUMBER> absence hypertension suggesting ace<NUMBER> may role local production ang <NUMBER> intrarenal ras within kidney moreover studies provide first evidence presence ace<NUMBER> activity within kidney rat model diabetic nephropathy gene protein expression tubule ace<NUMBER> observed decrease line ace <NUMBER> however ace<NUMBER> ace increase protein expression diabetic glomeruli <NUMBER> finding keeping observation ace redistributed towards glomeruli renal vasculature away proximal tubules diabetic rat human kidney <NUMBER> <NUMBER> furthermore may suggest role glomerular ace possibly ace<NUMBER> mediating nephron injury increasing intraglomerular ang ii formation intrarenal expression ang ii increased diabetic nephropathy despite suppression systemic ras <NUMBER> increase glomerular ace may explain increase ang ii despite decrease tubule ace study brosnihan et al <NUMBER> also supports concept intrarenal ras presents data suggesting ace<NUMBER> prominent role local production ang<NUMBER> pregnancy nevertheless study ace<NUMBER> involvement systemic local ras systems required contribution ace<NUMBER> cardiac function ventricular remodelling heart failure whilst majority research concentrated possible role ace<NUMBER> hypertension counteracting actions ace new field research emerged identifying role ace<NUMBER> cardiac function especially ventricular remodelling heart failure first evidence ace<NUMBER> may role cardiac function demonstrated crackowo er et al <NUMBER> genetic ablation ace<NUMBER> mice resulted severe heart contractility defect increased levels ang ii kidney heart plasma upregulation hypoxiainduced genes heart findings led suggestion ace<NUMBER> essential regulator heart function <NUMBER> however remains unclear ras involved mediating heart dysfunction studies ras either blocked ace inhibitors angiotensin receptor antagonists suggest involvement ras regulation heart function cardiac hypertrophy <NUMBER> neither ace angiotensinogen at<NUMBER> receptor null mice show defects heart development function <NUMBER> review however ace also ablated alongside ace<NUMBER> mice cardiac phenotype double knockout restored wildtype littermates seems likely product ace may responsible cardiac impairment observed ace<NUMBER> null mice <NUMBER> however current literature would tend suggest ang ii responsible cardiac defect since ang ii promotes myocardial fibrosis cardiac hypertrophy <NUMBER> study effects ang ii role candidate substrates required ras ang ii key factors ventricular remodelling associated heart failure <NUMBER> review contrast ace<NUMBER> knockout study crackower et al <NUMBER> cardiomyocytespecific overexpression ace<NUMBER> mouse heart results conduction disturbances lethal ventricular arrhythmias outcomes association downregulation connexins suggesting overexpression ace<NUMBER> disrupts gap junction formation <NUMBER> whilst appear clear link ras loss cardiac function observed ace<NUMBER> null mice ang ii implicated gap junction dysregulation development conduction disturbances thought lead lethal ventricular remodelling heart failure <NUMBER> investigations ace<NUMBER> role cardiac function heart failure <NUMBER> doubt provide greater insight roles novel enzyme since first descriptions ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> information rapidly accumulated possible functions variety biochemical genetic physiological studies yet much remains learned clear ace<NUMBER> important roles heart function possibly blood pressure regulation diabetes also identified sars receptor hence diversity biological roles perhaps surprising discovery relation novel enzyme important provide much fuller description expression sites enzyme regulation expression identification physiologically relevant peptide substrates angiotensin ii critical greater understanding ace<NUMBER> biology finally involvement ace<NUMBER> human pathologies needs critically evaluated potential therapeutic target exploited possible severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel coronavirus causes coronavirus disease <NUMBER> covid <NUMBER> infection characterized flulike symptoms progressing cases acute respiratory distress syndrome ards <NUMBER> <NUMBER> myocarditis <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> classified pandemic world health organization march <NUMBER> <NUMBER> disease reached nearly every country april <NUMBER> <NUMBER> <NUMBER> confirmed cases worldwide <NUMBER> deaths <NUMBER> death disability covid<NUMBER> combined lack approved treatments created unmet need efficacious therapies researchers pharmaceutical companies race develop vaccines antivirals turned remedies little supporting evidence least <NUMBER> iranians died <NUMBER> sustained blindness brain damage methanol poisoning mistaken belief alcohol could prevent coronavirus infection <NUMBER> social media propagated misinformation snorting cocaine bleach prevent infection <NUMBER> <NUMBER> <NUMBER> desperation acts speaks urgent unmet need effective therapeutics sarscov <NUMBER> intend review familiarize readers toxicities potential therapeutics covid<NUMBER> possible treatments toxicities review draws multiple sources combining news articles social media posts peerreviewed research identified substances included review based discussion media experience practicing physicians scientists pharmacists rely industry news reports source information available discussion presents knowledge novel therapeutics publicly known early april <NUMBER> supervising editor mark b mycyk md article discuss therapeutic options sarcov<NUMBER> using lifecycle sarscov<NUMBER> understand mechanism toxicity agent discuss <NUMBER> viral cell entry inhibitory eg chloroquine hydroxychloroquine apn<NUMBER> <NUMBER> viral replication inhibitors eg protease inhibitors nucleotide analogs <NUMBER> nucleic acid vaccines <NUMBER> miscellaneous medications azithromycin ace inhibitors ibuprofen sarscov<NUMBER> enveloped nonsegmented positivesense rna virus belongs coronaviridae family date seven coronaviruses known infect humans <NUMBER>e nl<NUMBER> oc<NUMBER> hku<NUMBER> merscov sarscov<NUMBER> three sarscov<NUMBER> merscov sarscov<NUMBER> causing severe disease humans <NUMBER> genetic sequence sarscov<NUMBER> closely resembles sarscov<NUMBER> betacoronavirus caused severe acute respiratory syndrome sars epidemic <NUMBER> much current understanding sarscov<NUMBER> based vitro vivo experiments conducted investigate pathogenesis sarscov<NUMBER> coronavirus spreads humans respiratory droplets sarscov<NUMBER> sarscov<NUMBER> gain entry spike protein surface viral capsid binds angiotensinconverting enzyme ii ace<NUMBER> type ii alveolar cells leading fusion viral host cell membranes injection viral rna host cytoplasm <NUMBER> inside cell virus replicates genetic material releases newly created virus particles virions steps opportunity treatments disrupt normal coronavirus life cycle researchers currently investigating treatments covid<NUMBER> developing vaccines novel drugs well testing existing medications vaccine sarscov<NUMBER> may clinically available <NUMBER> months <NUMBER> medications approved food drug administration fda purposess chloroquine repositioned treat covid<NUMBER> therapeutic repurposing ie repositioning expedited drugdevelopment strategy reuse currently fdaapproved therapeutics new medical indications march <NUMBER> fda granted emergency authorization use chloroquine phosphate hydroxychloroquine sulfate treat covid<NUMBER> <NUMBER> european medicines agency recommended restricting use pending outcome clinical trials <NUMBER> american academy clinical toxicology aact american association poison control centers aapcc american college medical toxicology acmt recommended joint press release use chloroquine hydroxychloroquine occur direction medical provider fdaapproved indication part trial treatment covid<NUMBER> part approved hospital protocol <NUMBER> discussion cover drugs intended exhaustive absence direct evidence expect drugs similar class similar toxicity chloroquine <NUMBER>aminoquinoline primarily used treat malaria infectious disease caused several plasmodia species chloroquine concentrates acidic environments digestive vacuole plasmodia spp golgi apparatus human cells chloroquine prevents plasmodia crystallizing heme hemozoin <NUMBER> leading buildup heme becomes toxic parasite golgi apparatus collection vesicles posttranslational modifications glycosylation occur chloroquine freely diffuses vacuoles acidic environment vacuole favors protonated charged form cannot freely diffuse away ion trapping leading buildup chloroquine vacuoles chloroquine alters glycosylation ace<NUMBER> decreases affinity ace<NUMBER> coronavirus spike protein reducing sarscov<NUMBER> entry vitro <NUMBER> additionally chloroquine hydroxychloroquine inhibit tolllike receptor tlr pathway tlr pathway involved proinflammatory cytokine signaling <NUMBER> chloroquine found inhibit sarscov<NUMBER> infection sequence structure homologies sarscov<NUMBER> sarscov<NUMBER> suggest chloroquine could reduce sarscov<NUMBER> infectivity <NUMBER> indeed one vitro study demonstrated chloroquine inhibits sarscov<NUMBER> entry <NUMBER> guangdong province recommended <NUMBER> mg chloroquine twice day <NUMBER> days person diagnosed covid<NUMBER> without contraindications chloroquine <NUMBER> one abstract commentary suggests efficacy cites audio transcript press conference guangdong china supporting data available <NUMBER> doses greater <NUMBER> grams chloroquine associated mortality due ventricular dysrhythmias hypokalemia <NUMBER> cardiovascular collapse profound hypotension occur within <NUMBER> hours overdose sodium channel blockade results qrs widening ecg <NUMBER> <NUMBER> <NUMBER> neurologic effects include seizures cns depression <NUMBER> oxidative stress lead hemolysis particularly patients g<NUMBER>pd deficiency potassium channel blockade result prolonged qtc interval torsades de pointes clinicians avoid using qt prolonging agents chloroquine toxicity present current pandemic man arizona died ingesting chloroquine phosphate form chloroquine used treating aquariums using selfmedicate <NUMBER> cases chloroquine poisoning reported nigeria <NUMBER> important store chloroquine safely avoid secondary harm little <NUMBER> mgkg chloroquine children could <NUMBER> pills requires medical evaluation <NUMBER> mgkg lowest fatal dose toddlers <NUMBER> hydroxychloroquine derivative chloroquine considered less toxic difference mechanisms action chloroquine hydroxychloroquine fully understood chloroquine hydroxychloroquine dealkylated desethylchloroquine cyp<NUMBER>a<NUMBER> <NUMBER>c<NUMBER> <NUMBER> hydroxychloroquine also dealkylated desethylhydroxychloroquine <NUMBER>d<NUMBER> <NUMBER> chloroquine hydroxychloroquine inhibit <NUMBER>d<NUMBER> increase serum concentrations metoprolol propranolol opiates antidysrhythmics antidepressants antipsychotics <NUMBER> minimum fatal dose hydroxychloroquine well defined minimum dose reported elicit severe symptoms hypotension hypokalemia ventricular dysrhythmias <NUMBER> g <NUMBER> one case report <NUMBER> full text available describes <NUMBER> year old died reportedly ingesting <NUMBER> g hydroxychloroquine <NUMBER> <NUMBER>yearold girl ingested <NUMBER> g hydroxychloroquine developed hypokalemia hypotension ventricular tachycardia survived intubation epinephrine infusion highdose diazepam potassium repletion <NUMBER> see treatment chloroquine hydroxychloroquine toxicity section three case reports describe total five severely symptomatic patients survived overdoses <NUMBER> g hydroxychloroquine aggressive interventions including epinephrine highdose diazepam <NUMBER> <NUMBER> <NUMBER> <NUMBER> data regarding efficacy hydroxychloroquine treating covid<NUMBER> limited one clinical trial peer reviewed suggests patients clinical diagnosis covid<NUMBER> <NUMBER> <NUMBER> received hydroxychloroquine clinically improved <NUMBER> days compared <NUMBER> <NUMBER> control group <NUMBER> study one patient received hydroxychloroquine developed rash without mucosal involvement another developed headache resolved without intervention <NUMBER> riou et al published prospective study <NUMBER> patients anticipated likely lethal ingestion chloroquine greater <NUMBER> g chloroquine compared <NUMBER> historical controls individuals treated epinephrine infusion initial <NUMBER> μgkgmin titrated sbp <NUMBER> mmhg <NUMBER> mgkg diazepam <NUMBER> min intubation nasogastric aspiration diazepam continued <NUMBER> mgkg per day <NUMBER> days ten <NUMBER> patients survived hospital discharge compared <NUMBER> <NUMBER> patients control group <NUMBER> diazepam perhaps intuitively incorporated combination therapy due animal <NUMBER> human evidence may beneficial combined overdoses study largely shaped recommended treatment epinephrine high dose diazepam though without controversy regarding generalizability hypokalemia common finding chloroquine hydroxychloroquine overdose likely due intracellular shift potassium retrospective study <NUMBER> patients chloroquine toxicity serum potassium lower <NUMBER> mmoll correlated mortality serum potassium decreased serum chloroquine levels increased <NUMBER> linear relationship serum potassium chloroquine concentrations suggests hypokalemia reflects effect chloroquine although severely ill patients also received epinephrine infusions betaadrenergic agonists cause intracellular potassium shifts total body potassium stores expected depleted setting chloroquine toxicity raising concern rebound hyperkalemia toxicity resolves clinicians recommend less aggressive potassium repletion supplementing normal daily potassium <NUMBER> meq per <NUMBER> h <NUMBER> though severe hypokalemia present would reasonable replete observing rebound hyperkalemia treatment acute toxicity hydroxychloroquine thought acute toxicity chloroquine qrs prolongation xenobioticinduced sodium channel blockade often treated sodium bicarbonate boluses infusions administration sodium bicarbonate may treat cardiac sodium channel blockade worsen hypokalemia patientspecific characteristics must considered weighing use therapy lipid emulsion therapy lead return spontaneous circulation given cardiac arrest either hydroxychloroquine ingestion combined ingestion hydroxychloroquine chloroquine <NUMBER> two case reports suggest lipid emulsion reverse hypotension averting cardiac arrest <NUMBER> <NUMBER> second case report one patient received lipid emulsion therapy develop significant cardiotoxicity beyond prolonged qtc interval although patient ingested smaller dose hydroxychloroquine <NUMBER> g <NUMBER> extracorporeal circulatory support could considered severe overdoses refractory treatments <NUMBER> chloroquine hydroxychloroquine lead retinopathy rare toxicity develop <NUMBER> years therapy <NUMBER> expected shortterm use <NUMBER> patients rheumatoid arthritis ever used hydroxychloroquine <NUMBER> discontinued eye complaints although probable definite retinal toxicity documented less <NUMBER> risk retinal toxicity increased fivefold lifetime exposure reached <NUMBER> kg <NUMBER> longterm use hydroxychloroquine also associated cardiomyopathy <NUMBER> <NUMBER> clinicians also mindful secondary effects increase demand chloroquine hydroxychloroquine treat covid<NUMBER> hydroxychloroquine used treat systemic lupus erythematosus sle patients sle unable fill prescriptions due shortages <NUMBER> state pharmaceutical boards noted surges prescriptions hydroxychloroquine chloroquine azithromycin written physicians either family members practice american medical association promptly denounced <NUMBER> apn<NUMBER> apeiron biologics recombinant human ace<NUMBER> protein first developed treat sars <NUMBER> may treat covid<NUMBER> preventing sarscov<NUMBER> entry reducing acute lung injury acting soluble molecular decoy sarscov<NUMBER> preventing virus binding cellular ace<NUMBER> dosedependent fashion <NUMBER> ace<NUMBER> vitro essential receptor sarscov<NUMBER> entry <NUMBER> also serves maintain normal lung physiology virion binds cell surface ace<NUMBER> lung protective signalingis lost preventing ace<NUMBER>mediated sarscov<NUMBER> interaction therefore restoring physiologic ace<NUMBER> signaling apn<NUMBER> may reduce acute lung injury <NUMBER> randomized unblinded clinical trial underway china investigate efficacy apn<NUMBER> reduce viral load duration covid<NUMBER> symptoms <NUMBER> phase trial apn<NUMBER> <NUMBER> haschke colleagues welltolerated cardiovascular side effects <NUMBER> healthy subjects toxicity recombinant proteins general arises inadvertent activation immune system unintentional immunogenicity binding recombinant proteins cell surface receptors triggering cellular signal transduction cascades consciously targeted offtarget binding unintentional immunogenicity lead formation antidrug antibodies deposit tissues immune complexes example immune complexes deposit kidney impairing kidneys ability filter toxins recover electrolytes immune system treats recombinant protein antigen treatment may precipitate serum sickness offtarget binding apn<NUMBER> could modulate reninangiotensin signaling altering blood pressure organ perfusion one abstract provides evidence <NUMBER> mgkg per day caused immunogenicity cardiovascular toxicity three healthy human volunteers <NUMBER> leronlimab cytodyn investigational humanized igg<NUMBER> monoclonal antibody ccr<NUMBER> receptors found lymphocytes chemokine receptor <NUMBER> ccr<NUMBER> first characterized role coreceptor human immunodeficiency virus hiv viral entry white blood cells <NUMBER> recognize pathogens dengue <NUMBER> staphylococcus aureus <NUMBER> also use ccr<NUMBER> signaling pathway entry virulence factor leronlimab repurposed investigated treatment option patients covid<NUMBER> experience respiratory complications result covid<NUMBER> singlearm openlabel multicenter clinical study set take place investigate clinical improvement total symptom score ie fever myalgia dyspnea cough currently leronlimab fasttrack designation fda hiv metastatic triplenegative breast cancer <NUMBER> serious side effects adverse events reported far leronlimab successfully completed nine phase <NUMBER> <NUMBER> <NUMBER> clinical trials <NUMBER> patients indications achieved primary efficacy endpoints <NUMBER> reasoning analogy approved therapeutics oncology acute toxicity humanized antibodies include <NUMBER> immunosuppression predisposing opportunistic infections viralinduced neoplasias <NUMBER> immunostimulation including dramatic cytokine storm fevers chills myalgias acute lung injury similar severe presentation covid<NUMBER> <NUMBER> hypersensitivity reactions <NUMBER> specificity antibodies likely give rise idiosyncratic side effect profiles antibodies cause degree immunosuppression immune cell activation expect humanized antibodies less likely cause serum sickness antibodies raised horse ie anavip raised sheep ie crofab anavip rare disease therapeutics inc crofab protherics inc antibody therapies used treat envenomation north american crotalids humanized antibody antibody raised nonhuman species modified increase similarity naturally occurring human antibodies provoke less humoral immune response humans example antibodies raised mice fc region replaced human sequences decrease immunogenicity <NUMBER> rna virus must coopt host machinery translating rna protein discussed biology coronavirus section genomes coronaviruses sequences nucleotides human cells treat effectively mrna produce virions virus must make copy rna genome using viral rnadependent polymerase synthesize proteins needed form virion including capsid spike proteins overall goal nucleotide analogs halt production new viral rna making impossible infected host cells become manufacturing sites new virions nucleotide analogs incorporating base replicating strand viral rna polymerase cannot elongate remdesivir gilead prodrug metabolized adenosine nucleotide analog demonstrated vitro efficacy sarscov<NUMBER> <NUMBER> favipiravir toyama chemical mimics adenosine guanine leading rnadependent rna polymerase make errorridden nonfunctional viral genome progeny <NUMBER> absence data remdesivir favipiravir toxicity one extrapolate toxicity reported nucleoside analogs metabolic acidosis occur therapeutic use usually month treatment <NUMBER> though also observed acute overdose severe metabolic acidosis elevated lactate toxicity nucleoside analogs high mortality peripheral neuropathy doserelated subacute phenomenon seen stavudine <NUMBER>′<NUMBER>′didehydro<NUMBER>′<NUMBER>′dideoxythymidine d<NUMBER>t didanosine ddi zalcitabine ddc <NUMBER> bone marrow suppression seen <NUMBER> patient starting <NUMBER>′ azido<NUMBER>′ <NUMBER>′dideoxythymidine azt treatment <NUMBER> pancreatitis myopathy observed several medications class <NUMBER> toxicities thought reflect mitochondrial dysfunction addition inhibiting viral polymerase nucleoside analogs also inhibit mitochondrial dna polymerasegamma leading decreased mitochondrial dna synthesis mitochondrial proteins <NUMBER> severe toxicity occurs offending agent stopped specific antidote though suggest treatment mitochondrial cofactors thiamine riboflavin lcarnitine vitamin c may help patients recover <NUMBER> additional idiosyncratic toxicities may also occur example tenofovir inducing crystalluria <NUMBER> protease inhibitors prevent infected cells forming competent new virions binding inactivating viral proteases halt viral replication viral proteases process initial products translation make final versions viral proteins viral proteases unique virus crystal structure sarscov<NUMBER> main protease recently identified <NUMBER> drugs effective one virus expected effective another virus unless viruses proteases sufficiently similar protease inhibitors target hiv protease example target hepatitis c protease even though rna viruses crystal structure sarscov<NUMBER> main protease identified closely resembles sarscov<NUMBER> known human proteases <NUMBER> screening hiv protease inhibitors sarscov<NUMBER> found nelfinavir ritonavir inhibited viral replication vitro <NUMBER> although study described efficacy nelfinavir determine nelfinavirs effects specifically due sarscov<NUMBER> protease inhibition another screening study identified lopinavir nelfinavir inhibiting sarscov<NUMBER> demonstrated treatment lopinavirritonavir abbvie ribavirin reduced mortality ards compared treatment ribavirin alone <NUMBER> ritonavir added lopinavir pharmacokinetic booster <NUMBER> ritonavir potent inhibitor cytochrome cyp <NUMBER>a<NUMBER> enzyme inactivates lopinavir regimen lopinavirritonavir ribavirin used postexposure prophylaxis healthcare workers treating patients severe middle east respiratory syndrome mers also caused coronavirus showed <NUMBER> decreased risk infection severe adverse effects reported <NUMBER> early experience treatment sarscov<NUMBER> suggests patients treated lopinavirritonavir commonly experience nausea vomiting well mild transaminase elevations <NUMBER> lopinavirritonavir seemed hasten recovery case series <NUMBER> hospitalized patients <NUMBER> larger randomized trial <NUMBER> test subjects <NUMBER> controls showed difference time clinical improvement <NUMBER> three studies many patients receiving combination left study due nausea vomiting diarrhea acute overdose protease inhibitors uncommon large overdose <NUMBER> g lopinavirritonavir generally well tolerated managed supportively <NUMBER> ritonavir potent inhibitor cyp<NUMBER>a<NUMBER> ki <NUMBER> ± <NUMBER>μm may slow metabolism drugs substrates cyp<NUMBER>a<NUMBER> leading potential dangerous drugdrug interactions <NUMBER> lopinavirritonavir associated increases transaminases <NUMBER> individuals treated hiv though clinically significant liver injury appears rare resolves drug removal <NUMBER> cholestatic pattern injury sometimes observed may explained lopinavir reducing expression bile salt export pump bsep human hepatocytes <NUMBER> latency period <NUMBER> month longer common may make less relevant feature treatment sarscov<NUMBER> genetic variations polymorphisms across patients lossoffunction cyp<NUMBER>a<NUMBER> <NUMBER> make patients susceptible metabolic toxicities <NUMBER> screening susceptibilities practical setting short duration treatment sarscov<NUMBER> arthralgias may occur <NUMBER> patients <NUMBER> achilles tendinopathy reported individuals taking lopinavirritonavir even shortterm use postexposure prophylaxis <NUMBER> protease inhibitors cause lipodystrophy characterized central adiposity dorsocervical fat deposition buffalohump extremity wasting used treat hiv multiple mechanisms may explain metabolic derangements including inhibition srebp<NUMBER> master regulator lipogenesis adipocyte differentiation direct inhibition glucose transporter<NUMBER> <NUMBER> goal vaccine develop longstanding immunity without exposure full brunt disease vivo phase trials new vaccine candidates currently underway evaluate safety immune response strimer refers vaccine made resemble spike protein protein capsid surface binds ace<NUMBER> alveolar cells initiate viral entry spike protein attractive target elicits immune response mutations spike protein may explain virulence sarscov<NUMBER> sarscov<NUMBER> spike protein binds ten times tightly ace<NUMBER> sarscov<NUMBER> spike protein <NUMBER> mutations also create need new therapeutics paper noted three monoclonal antibodies raised sarscov<NUMBER> spike protein strongly bind sarscov<NUMBER> spike protein strimer vaccine candidate expected tested preclinical studies shortly generation antibodies spike proteins sars mers <NUMBER> challenging spike proteins coronaviruses heavily glycosylated dna vaccines work inserting dna plasmids encode antigens host cells generates cellular humoral antigenspecific immunity allowing patient mount immune response target disease <NUMBER> <NUMBER> studies ongoing regarding effectiveness longevity vaccine immunogenicity several infections including hiv mers ebola zika gls<NUMBER> inovio pharmaceuticals inc geneone life science inc dna vaccine merscov entering phase <NUMBER> trials merscov coronavirus causes middle east respiratory syndrome gls<NUMBER> encodes merscov spike glycoprotein demonstrated immunogenic response nonhuman primates phase <NUMBER> studies gls<NUMBER> demonstrated local injection site symptoms patients along headaches malaise myalgia patients developed mild creatinine phosphokinase elevations renal injury myopathy developed <NUMBER> ino<NUMBER> inovio pharmaceuticals inc dna vaccine encodes sarscov<NUMBER> spike protein delivered intradermally <NUMBER> phase <NUMBER> clinical trial ino<NUMBER> started early april enhance uptake dna vaccines administered via electroporation device cellectra <NUMBER> safety tolerability studies cellectra identify severe adverse events though injection site pain mild elevations creatinine phosphokinase paresthesias described <NUMBER> animals received vaccine produced antibodies cells virus <NUMBER> phase <NUMBER> clinical trial ino<NUMBER> started beyond local tissue reactions dna vaccines raise concern adverse events plasmid integration host dna disrupting usual transcription vitro studies thus far suggest rate insertional mutagenesis lower rate spontaneous mutations mammalian cells generally dna vaccines appear safe without apparent offtarget effects idiosyncratic toxicities <NUMBER> messenger rna mrna vaccines direct production antigens unlike dna vaccines cannot integrate host genome lowering risk mutations <NUMBER> cytosol mrna vaccines direct antigen production rapidly degrade moderna therapeutics collaboration national institute allergy infectious disease announced launched phase trial mrna<NUMBER> mrna<NUMBER> vaccine novel lipid nanoparticle encapsulated mrnabased vaccine encodes prefusion stabilized form spike protein <NUMBER> prefusion form refers spatial conformation spike protein binds ace<NUMBER> antibody prefusion form could prevent viral entry well mitigate spread virions azithromycin macrolide antibiotic used ability inhibit bacterial protein synthesis binding <NUMBER>s subunit bacterial ribosome also used treat exacerbations copd reactive airway disease second use may reflect azithromycins modulatory effect immune cells reduces respiratory syncytial virus rsv release decreasing interferon signaling vivo inhibits proinflammatory cytokine release airway smooth muscle epithelial cells <NUMBER> prospective trial france <NUMBER> patients noted combination <NUMBER> mg hydroxychloroquine azithromycin <NUMBER> mg first day <NUMBER> mg day next <NUMBER> days reduced viral load effectively hydroxychloroquine alone <NUMBER> trial broke randomization declined treatment analyzed controls main toxicity azithromycin qtc prolongation leading cardiac dysrhythmias owing herg inward rectifying potassium channel blockade <NUMBER> one cohort study <NUMBER>day course azithromycin led nearly threefold increase cardiovascular death compared antibiotics <NUMBER> although followup cohort study similar size <NUMBER> prescriptions <NUMBER> metaanalysis prospective randomized controlled trials identified increased risk mortality <NUMBER> expect combination azithromycin chloroquine hydroxychloroquine likely precipitate cardiac dysrhythmias either alone azithromycin weakly blocks herg conducting potassium ions across cardiac membrane chloroquine hydroxychloroquine decrease number ions available transit concern media angiotensinconverting enzyme ace inhibitors may increase susceptibility sarscov<NUMBER> <NUMBER> ace inhibitors increase ace<NUMBER> expression human tissue <NUMBER> potentially creating binding sites sarscov<NUMBER> receptorbinding domain rbd sarscov<NUMBER> high affinity ace<NUMBER> however ace inhibitors shown reduce viral entry competitive inhibition spike protein binding ace<NUMBER> vitro <NUMBER> lastly alveolar cells infected coronavirus express less ace<NUMBER> cell surface normal cells vitro knocking expression ace<NUMBER> uninfected mice creates acute lung injury histologically similar seen sars suggesting intact ace<NUMBER> function serves lungprotective role <NUMBER> one could interpret findings suggest patients taking ace inhibitors may benefit stopping taking may benefit starting time however direct clinical evidence impact ace inhibitors clinical trajectory covid<NUMBER> retrospective study wuhan china identified hypertension diabetes cerebrovascular disease poor prognostic factors isolate relative risk attributable taking ace inhibitor <NUMBER> worse outcome study patients ace inhibitors may reflect generally poor outcomes patients multiple comorbidities patient abruptly discontinue ace inhibitor except direction physician blood pressure rapidly rises first <NUMBER> hours ace inhibitor discontinuation <NUMBER> could precipitate hypertensive emergencies subsequent acute pulmonary edema study stated ibuprofen increases ace<NUMBER> receptor expression provided supporting evidence neither <NUMBER> fda <NUMBER> recommends withholding ibuprofen symptomatic treatment covid<NUMBER> convalescent plasma refers pooled plasma immunoglobulins patients infected recovered disease ten patients seropositive sarscov<NUMBER> hypoxic intubated one dose <NUMBER> ml convalescent plasma led nearly immediately undetectable viral load improved oxygenation <NUMBER> days <NUMBER> five patients intubated radiographic evidence acute lung injury transfusion <NUMBER> ml convalescent plasma days <NUMBER> <NUMBER> admission reduced hypoxia five three able weaned mechanical ventilation <NUMBER> risks commonly associated plasma transfusion include <NUMBER> transfusionassociated acute lung injury trali <NUMBER> transfusionassociated circulatory overload taco <NUMBER> allergicanaphylactic reactions less common risks include <NUMBER> transmission infections <NUMBER> febrile nonhemolytic transfusion reactions <NUMBER> rbc alloimmunization <NUMBER> hemolytic transfusion reactions <NUMBER> metaanalysis studies used convalescent plasma treat sars influenza h<NUMBER>n<NUMBER> reported adverse effects beyond minor infusion reactions chills fevers <NUMBER> four critically ill patients sarscov<NUMBER> significant adverse events treated convalescent plasma supportive care <NUMBER> unmet need effective treatments covid<NUMBER> spurred pharmaceutical companies develop repurpose therapeutics sarscov<NUMBER> frontline providers may unfamiliar usage older therapeutics chloroquine medicines typically used subspecialists like dna vaccines protease inhibitors convalescent plasma therapy conjunction effective infection control policies combination measured reasoned repurposing existing therapies development vetting novel drugs guidance medical toxicologists may reduce morbidity mortality covid<NUMBER> avoid cases cure worse disease angiotensine inhibiteurs de lenzyme de conversion inhibiteur de lenzyme de conversion ii rénine récepteur de la prorénine résumé la découverte de lenzyme de conversion de langiotensine <NUMBER> ac<NUMBER> et un récepteur à la prorénine est une avancée récente dans la compréhension de la physiologie du système rénineangiotensine au sein de laxe inhibiteur de lenzyme de conversion de langiotensine <NUMBER>angiotensine <NUMBER>mas lac<NUMBER> contrebalance leffet vasoconstricteur prolifératif fibrosant et proinflammatoire de laxe aceangiotensine <NUMBER>at<NUMBER> le récepteur à la prorénine une fonction angiotensine dépendante liée à laugmentation de la production dangiotensine <NUMBER> et un aspect indépendant de langiotensine lié aux signaux intracellulaires lactivation de lac<NUMBER> et linhibition de lace de la rénine ont été considérées comme au centre de la régulation du système rénineangiotensine lobjet de cette revue générale est de discuter les fonctions biochimiques et biologiques de lace de lac<NUMBER> et de la rénine au sein et audelà du système rénineangiotensine et ainsi de proposer une perspective de développement dagents actifs extraits de plantes naturelles ou dalimentation produits liés à ces trois protéases © <NUMBER> elsevier masson sas tous droits réservés reninangiotensin system ras endocrine also paracrine intracrine system <NUMBER> mammals intravascular ras plays key role maintaining blood pressure homeostasis fluid salt balance tissue local ras involved physiological pathological processes tissue growth remodelling development inflammation <NUMBER> classical ras substrate angiotensinogen agt released circulation liver degraded enzyme renin originates kidney generating inactive angiotensin ang decapeptide comes contact angiotensiniconverting enzyme ace endothelial surface blood vessels cterminal dipeptide cleaved giving rise angiotensin ii ang ii main effector molecule ras interactions specific receptors particularly type <NUMBER> at<NUMBER> receptor ang ii stimulates wide variety signalling pathways heart blood vessels kidneys adipose tissue pancreas brain initiating physiological pathophysiological effects attributed ras <NUMBER> due function directly generating main effector ang ii ace together classical axis aceang iiat<NUMBER> core ras studies since discovery <NUMBER> homologue ace known angiotensiniconverting enzyme <NUMBER> ace<NUMBER> cloned two independent research groups <NUMBER> <NUMBER> evidence indicates ace<NUMBER> negatively regulates activated ras degrading ang ii heptapeptide ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover mas receptor g proteincoupled receptor resulting ang<NUMBER> counterbalances cardiovascular effects ang ii opposing many at<NUMBER> receptormediated actions <NUMBER> ace<NUMBER> axis ace<NUMBER>ang<NUMBER>mas becoming focus intense research regarding ras <NUMBER> discovery prorenin receptor prr introduction renin inhibitors also brought prorenin back spotlight <NUMBER> far straightforward cascade containing one substrate agt two proteases renin ace two peptides ang ang ii one receptor at<NUMBER> ras currently consists several axes upstream downstream classical cascade include two dozen peptidases nearly dozen ang fragments least six different receptors <NUMBER> review three critical proteases ace ace<NUMBER> renin within beyond ras thus intend find new connections natural plant andor food resources ras occurrence gene encoding structure ace ace ec <NUMBER> monomeric glycoprotein distributed many tissues biological fluids two isoforms ace humans somatic ace sace germinal ace gace somatic ace found many types endothelial epithelial cells <NUMBER> germinal ace testicular ace present exclusively germinal cells male testis although ace type integral membrane protein also released soluble enzyme extracellular fluids plasma seminal cerebrospinal fluids following posttranslational proteolytic cleavage membrane protein sheddase secretase <NUMBER> <NUMBER> <NUMBER> somatic ace gace encoded single gene containing <NUMBER> exons promoter sace situated <NUMBER> flanking region first exon whereas gace within intron <NUMBER> results different lengths two isoforms longer sace <NUMBER> kda transcribed exon <NUMBER> exon <NUMBER> excluding exon <NUMBER> whereas shorter gace <NUMBER> kda transcribed exon <NUMBER> exon <NUMBER> exon <NUMBER> encodes unique sequence nterminus gace whereas downstream exons encode common sequence isozymes <NUMBER> somatic ace gace consist <NUMBER>residue hydrophilic cterminal cytoplasmic domain <NUMBER>residue hydrophobic transmembrane domain anchors protein membrane nterminal ectodomain fig <NUMBER> heavily glycosylated mannose galactose fructose nacetylneuraminic acid nacetylglucosamine <NUMBER> ectodomain sace divided two similar domains n domain c domain encoded homologous exons <NUMBER> <NUMBER> respectively domain contains active hisgluxxhis hexxh sequence <NUMBER> somatic ace known metallopeptidase two homologous active sites <NUMBER> implies gene duplication event evolution <NUMBER> except unique sequence constituting nterminus gace identical cterminal half sace <NUMBER> due cleavage membranebound residues ace secretase soluble circulating ace lacks transmembrane portion cytosolic domain <NUMBER> threedimensional xray crystallographic structure deglycosylated truncated version gace c domain sace reveals preponderance ␣helices zinc ion two chloride ions incorporated deep narrow channel separates molecule two subdomains active site located toward bottom channel nterminal lid top molecule appears allow small peptide substrates access active site cleft fact structure bears little similarity carboxypeptidase m<NUMBER> family initial drug development ace inhibitors based instead resembles rat neurolysin m<NUMBER> family pyrococcus furiosus carboxypeptidase m<NUMBER> family despite sharing little sequence similarity two proteins <NUMBER> corradi et al <NUMBER> reported crystal structure n domain sace similarly ellipsoid shape central groove dividing two subdomains one contains nterminal region covers central binding cavity structure reveals differences active site contains one chloride ion equivalent chloride ii gace threedimensional structures c domains based gace n domains provide opportunity design domainselective ace inhibitors may exhibit new pharmacological profiles <NUMBER> <NUMBER> according catalytic mechanism critical amino acid residue involved peptidases classified four major types serine cysteine aspartic metallo <NUMBER> ace m<NUMBER> family metallopeptidase mae gluzincins <NUMBER> two histidine residues functional motif hexxh third distant glutamate positioned <NUMBER> residues towards cterminus ligands zinc cofactor <NUMBER> activated water molecule complexed zn <NUMBER> serves nucleophile attack carbonyl group targeted peptide bond <NUMBER> activity ace also chloride dependent chloride primarily activates active sites ace enhances binding substrates <NUMBER> active domain ace displays differences sensitivity chloride activation <NUMBER> activity c domain sace depends highly chloride ion concentration inactive absence whereas n domain completely activated relatively low concentrations anion still active absence chloride <NUMBER> <NUMBER> germinal ace depends chloride lesser extent compared c domain sace <NUMBER> cushman cheung <NUMBER> reported optimal vitro ace activity rabbit rung acetone extract presence <NUMBER> mm nacl ph <NUMBER> two active domains sace also subtly different substrate specificity hydrolyze bradykinin almost equally c domain active site hydrolyze ang substrate p <NUMBER> hippurylhisleu <NUMBER> efficiently n domain active site preferentially hydrolyzes ang<NUMBER> <NUMBER> luteinizing hormonereleasing hormone lhrh <NUMBER> haemoregulatory peptide nacetylserasplyspro acsdkp <NUMBER> alzheimer amyloid ␤peptide a␤ <NUMBER> fuchs et al <NUMBER> proved cterminal catalytic domain main site ang cleavage mice differentiation catalytic specificity might due subtle variation substratespecific amino acids <NUMBER> chlorideinduced conformational alteration active sites <NUMBER> ace acts exopeptidase cleave dipeptides free ctermini two typical substrates ang bradykinin certain substrates cholecystokinin <NUMBER> substrate p <NUMBER> lhrh <NUMBER> amidated ctermini ace displays exopeptidase activity also acts endopeptidase <NUMBER> prominent example endopeptidase activity ace hydrolyzing synthetic a␤<NUMBER> peptide four fragments a␤ peptide others corresponding products a␤<NUMBER> hydrolysis <NUMBER> thus ace might general impact metabolism biologically active peptides previously recognized <NUMBER> two substrates used often measuring ace activity inhibition vitro hippurylhisleu n<NUMBER>furylacryloyllphenylalanylglycylglycine fapgg ntermini blocked substrates two termini blocked developed <NUMBER> ace originally isolated <NUMBER> hypertensinconverting enzyme <NUMBER> ras ace cleaves decapeptide ang i<NUMBER> aspargvaltyrilehisprophehisleu octapeptide ang ii<NUMBER> removing cterminal dipeptide hisleu ras overactive ang ii exerts harmful effects primarily via at<NUMBER> receptor whereas at<NUMBER> receptor may oppose counterbalance effects mediated at<NUMBER> receptor exert protective actions <NUMBER> ang ii potent vasoconstrictor stimulates release aldosterone antidiuretic hormone vasopressin increases retention sodium water effects act directly concert raise blood pressure nonapeptide derivative ang desasp<NUMBER>ang i<NUMBER> prevents infarctionrelated noninfarctionrelated cardiac injuries disorders hisleu cleaved peptide ace produce ang iii<NUMBER> <NUMBER> <NUMBER> vasoconstriction activity ang ii ang iii exerts effects principle similar manner ang ii may equally even important mediating release vasopressin <NUMBER> ace also degrades ang<NUMBER> ang<NUMBER> degrades peptide inactive ang<NUMBER> fig <NUMBER> addition ace also termed kininase ii inactivates vasodilators bradykinin<NUMBER> argproproglypheserprophearg kallidin lysbradykinin kallikreinkinin system cleaving cterminal dipeptide phearg ace eventually cleaves primary metabolite bradykinin<NUMBER> shorter fragment bradykinin<NUMBER> <NUMBER> ang ii aldosterone ace may also implicated impairment nitric oxide bioavailability cell oxidative stress augmenting generation reactive oxygen species peroxynitrite <NUMBER> <NUMBER> ability hydrolyze neuropeptides enkephalin <NUMBER> <NUMBER> substrate p neurotensin <NUMBER> lhrh ace may involved functioning brain nervous system ace may affect digestive system hydrolyzing peptide hormone cholecystokinin gastrin <NUMBER> vivo experiment conducted azizi et al <NUMBER> proved acute ace inhibition could increase level natural stem cell regulator acsdkp plasma acsdkp substantially inhibits cell cycle entry normal haematopoietic stem cells protects haemopoiesis damage caused cycleactive cytotoxic agents <NUMBER> acsdkp also inhibit proliferation hepatocytes <NUMBER> lymphocytes <NUMBER> stimulate angiogenesis <NUMBER> vivo vivo antifibrotic effect ace inhibition partially mediated acsdkp <NUMBER> ace may also affect susceptibility alzheimers disease degrading a␤ preventing accumulation amyloid plaques vivo <NUMBER> brains amyloid precursor protein swedish mutation transgenic mice ace converts a␤ <NUMBER> a␤ <NUMBER> degrades a␤ chronic inhibition ace captopril enhances predominant a␤ <NUMBER> deposition <NUMBER> however inhibition brain ace activity a␤ <NUMBER> injected mice perindopril ameliorates cognitive impairment may therefore beneficial effect alzheimers disease well hypertension <NUMBER> using assumed mechanistic analogy zinc metallopeptidases plus knowledge several snakevenom peptides potentiate action bradykinin inhibiting ace efforts undertaken develop orallyactive peptide analogues potential use treatment hypertension <NUMBER> first compound captopril d<NUMBER>mercapto<NUMBER>methylpropanoyllproline analogue alapro sequence sulphydryl strong chelating group zinc ion adverse effects caused mercaptocontaining penicillamine prompted design nonsulphydryl ace inhibitors <NUMBER> results two active inhibitors enalaprilat lisinopril essentially tripeptide analogues zinccoordinating carboxyl group phenylalanine occupies s<NUMBER> groove enzyme lisinopril lysine analogue enalaprilat hydrophilic greater affinity enalaprilat later compounds variations first three inhibitors differences residing functionalities bind active site zinc s<NUMBER> pocket addition phosphonates ketones also useful chelators <NUMBER> currently <NUMBER> ace inhibitors marketed widely used firstline therapy cardiovascular diseases including hypertension heart failure heart attack left ventricular dysfunction according functional moiety divided three types thiol captopril carboxylate benazepril enalapril lisinopril moexipril perindopril quinapril ramipril trandolapril phosphate fosinopril ace inhibitors administrated clinically ethylester prodrugs good bioavailability inactive right converted active diacid molecules vivo esterases drug class ace inhibitors effective relatively low incidence side effects well tolerated common side effect ace inhibitors dry cough appears <NUMBER> patients may result discontinuation treatment another serious problem angioedema affects <NUMBER> patients lifethreatening two side effects generally attributed altered concentrations bradykinin <NUMBER> use ace inhibitors second third trimesters pregnancy contraindicated association increased risk foetopathy group conditions includes oligohydramnios intrauterine growth retardation hypocalvaria renal dysplasia anuria renal failure death exposure ace inhibitors first trimester pregnancy may place infant increased risk major congenital malformations <NUMBER> initial drug development clinical ace inhibitors based assumption active site related carboxypeptidase organized remove dipeptide rather single amino acid cterminus substrate known sace two active sites neither resembles carboxypeptidase sites identical clinical ace inhibitors however show little discrimination two active sites <NUMBER> ang hydrolyzed predominantly c domain sace vivo <NUMBER> bradykinin hydrolyzed active sites <NUMBER> therefore c domainselective inhibitor would allow degradation bradykinin n domain degradation could enough prevent accumulation excess bradykinin observed attacks angioedema c domainselective inhibition could possibly result specialized control blood pressure fewer vasodilatorrelated adverse effects <NUMBER> structureactivity study proved group substitution involving phenyl ring carbon chain sulphonyl propionyl moieties captopril essential better activity towards c domain ace <NUMBER> increasing evidence n domain sace responsible vivo degradation natural haemoregulatory hormone acsdkp <NUMBER> <NUMBER> <NUMBER> n domainselective inhibition might open novel therapeutic areas two phosphinic tetrapeptides rxpa<NUMBER> rxp<NUMBER> found highly selective inhibitors c n domains sace respectively <NUMBER> availability threedimensional structures c n domains sace makes structurebased design active sitespecific inhibitors possible <NUMBER> <NUMBER> ace<NUMBER> ec <NUMBER> also type transmembrane glycoprotein expression recognized ubiquitous appears susceptible cleavage releases catalytical active ectodomain disintegrin metalloprotease <NUMBER> adam<NUMBER> also known tumour necrosis factoralpha cleavage enzyme tace major protease soluble ace<NUMBER> shedding phorbol ester ionomycin endotoxin proinflammatory cytokines interleukin<NUMBER>␤ tumour necrosis factoralpha also acutely induce ectodomain release <NUMBER> calmodulin binding sites identified cytoplasmic tail ace<NUMBER> calmodulin inhibitors proved increase ace<NUMBER> shedding <NUMBER> cleavage site resides amino acids <NUMBER> <NUMBER> near predicted transmembrane domain residue lys <NUMBER> ectodomain plays important role dictating ace<NUMBER> ectodomain shedding <NUMBER> ace<NUMBER> <NUMBER> amino acids encoded <NUMBER> exons shares <NUMBER> sequence identity n c domains sace <NUMBER> ace<NUMBER> also belongs m<NUMBER> family metalloproteases consists single active site domain sequence comparison closely resembles n domain c domain sace fig <NUMBER> <NUMBER> addition conserved zinc metallopeptidase consensus sequence hexxh amino acids <NUMBER> conserved glutamate residue <NUMBER> residues cterminal second histidine zinc motif serves third zinc ligand <NUMBER> threedimensional structure truncated extracellular region human ace<NUMBER> shows active site domain residues <NUMBER> divided two subdomains ii form two sides long deep cleft connected floor active site cleft prominent ␣helix deeply recessed shielded proteolytic active site ace<NUMBER> common structural feature proteases avoid hydrolysis correctly folded functional proteins zinc coordinated <NUMBER> <NUMBER> glu <NUMBER> one water molecule subdomain near bottom whereas chloride ion coordinated arg <NUMBER> trp <NUMBER> lys <NUMBER> subdomain ii <NUMBER> ace<NUMBER> transmembrane cterminal domain shares <NUMBER> sequence identity collectrin fig <NUMBER> noncatalytic protein shown critical role amino acid reabsorption kidney <NUMBER> pancreatic beta cell proliferation possibly insulin exocytosis <NUMBER> unlike sace gace primarily dipeptidylcarboxypeptidases ace<NUMBER> functions predominantly monocarboxypeptidase substrate preference hydrolysis proline hydrophobic basic cterminal residue <NUMBER> like carboxypeptidase action model different active structure latter hxxe zincbinding motif third ligand histidine positioned <NUMBER> residues towards cterminus <NUMBER> ace<NUMBER> efficiently cleaves single residue phenylalanine ang ii generate ang <NUMBER> <NUMBER>fold higher catalytic efficiency conversion ang ang<NUMBER> removing cterminal leucine residue fig <NUMBER> substrates high catalytic efficiency apelin<NUMBER> dynorphin a<NUMBER> desarg<NUMBER>bradykinin <NUMBER> arg <NUMBER> ace<NUMBER> identified residue critical substrate selectivity <NUMBER> ace<NUMBER> activity also regulated chloride ions proposed chloride binding induces subtle changes conformation active site either facilitate hinder substrate binding <NUMBER> substrate ang ace<NUMBER> activity increases increased cl − plateau reached approximately <NUMBER> mm cl − substrate ang ii increase ace<NUMBER> activity observed cl − increases <NUMBER> mm increase cl − decreases ace<NUMBER> activity plateau reached <NUMBER> mm cl − ace<NUMBER> activity <NUMBER> mm cl − even lower absence cl − <NUMBER> mm consequently increase cl − <NUMBER> mm physiological concentration human plasma increases ang decreases ang ii cleavage ace<NUMBER> effect localized concentration ang ii kidney ace<NUMBER> high level expression extracellular chloride ion levels fluctuate thus vivo cl − sensitivity may serve homeostatic regulatory mechanism <NUMBER> ace<NUMBER> activity unaffected inhibitors ace captopril lisinopril enalaprilat carboxypeptidase benzylsuccinate potato carboxypeptidase inhibitor <NUMBER> major function ace<NUMBER> counterregulate ace activity reducing ang ii bioavailability increasing ang<NUMBER> formation result ace<NUMBER> plays crucial role maintaining balance two axes ace<NUMBER>ang<NUMBER>mas aceang iiat<NUMBER> ras chronic sustained imbalance may lead pathophysiology cardiovascular renal pulmonary central nervous systems <NUMBER> studies shown ace<NUMBER> overexpression recombinant ace<NUMBER> treatment attenuate hypertension animal models <NUMBER> <NUMBER> humans strong association ace<NUMBER> polymorphisms hypertension han chinese <NUMBER> addition ang ii system ace<NUMBER> may regulate blood pressure peptide systems bradykinin andor apelin <NUMBER> ace<NUMBER> gene delivery <NUMBER> ace<NUMBER> infusion <NUMBER> also beneficial effects atherosclerosis whereas ace<NUMBER> deficiency accentuates vascular atherosclerosis inflammation <NUMBER> animal models regarding heart function ace<NUMBER> null mice display impaired cardiac contractility <NUMBER> loss ace<NUMBER> wildtype mice accelerates adverse ventricular remodelling potentiation ang ii effects means at<NUMBER> receptors <NUMBER> ang<NUMBER> interaction mas receptor improve atrial tachyarrhythmias <NUMBER> myocardial performance cardiac modelling survival <NUMBER> <NUMBER> rodent heart failure models humans ace<NUMBER> gene variants might involved modulation left ventricular mass men <NUMBER> soluble ace<NUMBER> activity increased patients heart failure correlates disease severity exert cardioprotective actions <NUMBER> deletion ace<NUMBER> gene mice leads development glomerulosclerosis increased albuminuria <NUMBER> treatment ace<NUMBER> inhibitor mln<NUMBER> worsen renal damage streptozotocininduced diabetic mice <NUMBER> chronic treatment ang<NUMBER> improves renal endothelial dysfunction via mas receptor apolipoprotein edeficient mice increasing levels endogenous nitric oxide <NUMBER> whereas genetic deletion mas receptor mice leads reduction urine volume sodium retention microalbuminuria reduced renal blood flow associated upregulation at<NUMBER> receptor transforming growth factorbeta messenger ribonucleic acid <NUMBER> evidence indicates protective role ace<NUMBER>ang<NUMBER>mas renal function ace<NUMBER> also shown regulate cardiovascular functions brain regions overexpression ace<NUMBER> rostral ventrolateral medulla reduces high blood pressure heart rate spontaneously hypertensive rats shrs <NUMBER> nucleus tractus solitarius shrs ace<NUMBER> gene transfer improves baroreceptor heart rate reflex <NUMBER> mouse subfornical organ ace<NUMBER> overexpression inhibits at<NUMBER> receptor expression prevents ang iimediated pressor drinking responses <NUMBER> addition ace<NUMBER>ang<NUMBER>mas exert cerebroprotective functions endothelin<NUMBER>induced ischaemic stroke rodent models <NUMBER> ace<NUMBER> exerts host actions cardiopulmonary system include prevention endothelial dysfunction reduction pulmonary oxidative stress attenuation vascular impairment antiinflammatory effects anticardiac remodelling effects properties responsible protective role ace<NUMBER> pulmonary arterial hypertension <NUMBER> structurebased drug screening identified two ace<NUMBER> activators xanthenone <NUMBER>diethylaminoethylamino<NUMBER>hydroxymethyl<NUMBER>methylphenylsulphonyloxy<NUMBER>hxanthene<NUMBER>one xnt resorcinolnaphthalein xnt hydrogen bonds ace<NUMBER> residues lys <NUMBER> tyr <NUMBER> gly <NUMBER> <NUMBER> resorcinolnaphthalein involved three hydrogen bonds residues gln <NUMBER> gln <NUMBER> gly <NUMBER> xnt resorcinolnaphthalein modulate ace<NUMBER> activity possibly two mechanisms logically closed conformation enzyme cannot allow substrate active site presence compound free enzyme may shifted open form effectively increasing activity coefficient enzyme alternatively product release ratelimiting step ace<NUMBER> turnover ace<NUMBER> activity may enhanced presence compound enzymeproduct complex empties quickly ace<NUMBER> becomes available start another cycle xnt resorcinolnaphthalein enhance vitro ace<NUMBER> activity dosedependent manner show significant effects ace activity administration xnt shrs result decrease blood pressure improvements cardiac function reversal myocardial perivascular renal fibrosis <NUMBER> protective role xnt hypertensioninduced cardiac fibrosis associated activation ace<NUMBER> increases ang<NUMBER> inhibition extracellular signalregulated kinases <NUMBER> furthermore ace<NUMBER> activation xnt attenuates thrombus formation reduces platelet attachment vessels <NUMBER> xnt also prevents pulmonary vascular remodelling right ventricular hypertrophy fibrosis rat model monocrotalineinduced pulmonary hypertension <NUMBER> development xnt pursued translate vasoprotective concept ace<NUMBER> effective cardiovascular therapy <NUMBER> diminazine aceturate small molecule antiprotozoal agent shares structural similarity xnt recently demonstrated potent activator ace<NUMBER> decrease mean arterial pressure myocardial fibrosis shrs <NUMBER> intracerebroventricular infusion diminazine aceturate prior following endothelin<NUMBER>induced middle cerebral artery occlusion significantly attenuates cerebral infarct size neurological deficits rat model <NUMBER> data suggest diminazine aceturate may serve lead compound discovery next generation drugs treatment cardiovascular disease hypertension <NUMBER> interestingly peptidaseindependent actions ace<NUMBER> also elucidated ace<NUMBER> identified essential receptor coronavirus cov causes severe acute respiratory syndrome sars spike protein sarscov attaches virus cellular receptor ace<NUMBER> binding domain spike protein mediating interaction <NUMBER> ace<NUMBER>spike interaction leads endocytosis virus particles internalization ace<NUMBER> induces fusion virus host cells establishes sarscov infection release viral rnas cytoplasm <NUMBER> spike protein sarscov also induces tacedependent shedding ace<NUMBER> ectodomain involvement ace<NUMBER> cytoplasmic domain cellular tace ace<NUMBER> cytoplasmic tail promote viral entry infection observations indicate ace<NUMBER> shedding causative cellular signals may attributable sarscovinduced tissue damage <NUMBER> ace<NUMBER> inhibitor n<NUMBER>aminoethyl<NUMBER> aziridineethanamine identified effective blocking sarscov spike proteinmediated cell fusion <NUMBER> sarscov receptor function ace<NUMBER> independent catalytic activities ang ii degradation ace<NUMBER>mediated ang ii degradation still important lung protection sars pathogenesis <NUMBER> <NUMBER> consequence longterm activation ace<NUMBER> must determined effects ace<NUMBER> activators immune competence animals vulnerability sarscov infection must tested molecules ready preclinical trials <NUMBER> ace<NUMBER> also receptor human coronavirus nl<NUMBER> discovered <NUMBER> netherlands shown globally distributed <NUMBER> additionally due high homology collectrin transmembrane ace<NUMBER> binds b <NUMBER> at<NUMBER>family amino acid transporters contributes absorption neutral amino acids animal intestines <NUMBER> <NUMBER> thus ace<NUMBER> may involved multiple biological functions renin ec <NUMBER> key enzyme ras since discovery <NUMBER> years ago impressive quantity information renin compiled generally accepted active renin found circulation mammals almost exclusively originates kidney addition systemic renin number extrarenal tissues express renin part local tissuespecific rass within kidney renin predominantly produced juxtaglomerular cells prorenin gene transcription cells controlled several mechanisms among cyclic adenosine monophosphate campprotein kinase acamp response element binding protein stimulatory calciumprotein kinase c inhibitory cascades employed physiological cues whereas signal transducers activators transcription nuclear factor b transcription factors inhibitory members nuclear receptor superfamily probably become relevant pathological situations prorenin stored vesicles activated renin released upon demand release renin control intracellular camp stimulatory ca <NUMBER> inhibitory cyclic guanosine monophosphate signalling pathways meanwhile great number intrarenally generated systemically acting factors identified control renin secretion directly level reninproducing cells activating camp ca <NUMBER> signalling pathways <NUMBER> renin aspartyl protease typical structure made two lobes cleft lobes contains active site characterized two catalytic aspartic residues renin highly specific enzyme one known substrate agt <NUMBER> prorenin inactive precursor renin addition main organ kidney tissues brain adrenal gland submandibular gland glands reproductive system adipose tissue also able secrete prorenin surrounding milieu plasma contrast renin prorenin released constitutively renin prorenin levels usually well correlated physiopathological circumstances pregnancy diabetes prorenin levels exceed far renin <NUMBER> prorenin prosegment <NUMBER> amino acid residues attached nterminus mature renin prosegment folds active site cleft mature renin prevent catalytic interaction agt <NUMBER> proreninrenin conversion occurs kidney renin released juxtaglomerular cells several enzymes including proconvertase <NUMBER> cathepsin b proposed responsible irreversible cleavage prosegment prorenin form mature renin reversible nonproteolytic activation prorenin may also occur acidic ph andor low temperature prorenin capable undergoing conformational change involving unfolding prosegment enzymatic cleft nonproteolyticallyactivated prorenin fully enzymatically active <NUMBER> physiological conditions approximately <NUMBER> plasma prorenin open form also display enzymatic activity <NUMBER> traditional assumptions renin enzyme responsible cleavage agt prorenin inactive proenzyme challenged cloning human prr <NUMBER> <NUMBER> prr single transmembranedomain protein <NUMBER> amino acids large unglycosylated highly hydrophobic nterminal domain responsible renin prorenin binding short cytoplasmic tail <NUMBER> amino acids involved intracellular signalling <NUMBER> prr first identified cultured human mesangial cells bound well renin prorenin k nanomolar range <NUMBER> binding prorenin induced conformational change molecule increasing enzymatic activity virtually zero values similar active renin solution without proteolytic removal prosegment <NUMBER> <NUMBER> two regions human prorenin segment namely <NUMBER>p fkr <NUMBER>p gate accessible specific antibodies loosened active site cleft <NUMBER>p flkr <NUMBER>p handle protruding pentameric segment identified crucial nonproteolytic activation <NUMBER> renin bound prr displays <NUMBER>to <NUMBER>fold increase catalytic efficiency agt conversion ang compared free renin <NUMBER> <NUMBER> addition angdependent function cell surface related increased catalytic activity receptorbound prorenin renin activity activated prorenin increased activity renin leads formation ang agt prr system also angindependent intracellular effects necessarily related ras <NUMBER> pathological conditions like high blood pressure upregulate receptor whereas elevated prorenin concentrations downregulate receptor via translocation transcription factor promyelotic zinc finger protein nucleus <NUMBER> angindependent signalling pathways prorenininduced activation mitogenactivated protein kinase p<NUMBER> subsequent phosphorylation heat shock protein <NUMBER> result actin polymerization prorenininduced activation extracellular signalregulated kinase <NUMBER> p<NUMBER>p<NUMBER> signalling cascade leads intracellular expression profibrotic genes giving rise synthesis transforming growth factor␤ plasminogen activator inhibitor<NUMBER> collagen <NUMBER> fibronectin effects potentially increase cardiac renal hypertrophy fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> discovery prr confirmed hypothesis renin also hormone suggested blocking prr may new target renal cardiac endorgan protection <NUMBER> additionally mannose<NUMBER>phosphateinsulinlike growth factor ii receptor bind renin prorenin high affinity believed serve clearance receptor reninprorenin intracellular reninbinding protein also cloned found inhibitor renin activity deletion affected neither blood pressure plasma renin <NUMBER> discovery receptor prr antagonist designed based idea prosegment contains handle region binds receptor allowing prorenin become catalytically active nonproteolytic manner <NUMBER> antagonist also known hand region peptide hrp consisting <NUMBER> amino acids nh <NUMBER> rillkkmpsvcooh resembles handle region <NUMBER>p llkk <NUMBER>p rat prorenin prosegment thus competitively bind prr decoy peptide inhibit receptormediated activation prorenin <NUMBER> treatment hrp diabetic mice rats decreased renal content ang ii inhibited development nephropathy without affecting hyperglycaemia <NUMBER> <NUMBER> strokeprone shrs continuous subcutaneous administration hrp inhibited activation tissue ras without affecting circulating ras arterial pressure significantly attenuated development progression proteinuria glomerulosclerosis cardiac fibrosis <NUMBER> <NUMBER> infusion hrp human prr transgenic rats significantly inhibited development glomerulosclerosis proteinuria mitogenactivated protein kinase activation transforming growth factor␤ expression kidneys <NUMBER> future research able determine degree beneficial vivo effects hrp due prorenin blockade <NUMBER> related interference renin binding ras <NUMBER> decoy effects hrp however confirmed research groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace inhibitors at<NUMBER> receptor blockers arbs proven effective therapeutic agents treatment cvd however ace inhibitors arbs lead substantial compensatory rise circulating active renin ang peptides may eventually limit therapeutic potential <NUMBER> moreover increased ang seen ace inhibitors subsequently converted ang ii nonace pathways mediated chymase chymotrypsinlike anggenerating enzyme <NUMBER> addition side effects ace inhibitors cough angioedema metaanalysis randomized controlled trials <NUMBER> suggested arbs associated modestly increased risk new cancer diagnosis although conclusions exact risk cancer associated particular drug drawn <NUMBER> based study united states food drug administration conducting review assess possible link use arbs cancer therefore direct renin inhibition may alternative pharmacological approach ras inhibition renin ratelimiting step ras concept blocking ras origin inhibiting renin existed least <NUMBER> years <NUMBER> firstgeneration renin inhibitors peptide analogues agt secondgeneration compounds peptidomimetic agents dipeptide transitionstate analogue inhibitors active site renin inhibitors limited clinical use due poor metabolic stability oral bioavailability short duration action weak antihypertensive activity high cost synthesis <NUMBER> combination molecular modelling xray crystallographic analysis active site renin led development aliskiren new nonpeptide lowmolecularweight orallyactive renin inhibitor aliskiren high binding affinity renin appears bind hydrophobic s<NUMBER>s<NUMBER>binding pocket large distinct subpocket extends s<NUMBER>binding site toward hydrophobic core enzyme aliskiren potent competitive inhibitor renin poorly inhibits related aspartic peptidases shows effects cytochrome p<NUMBER> isoenzyme activities bound extensively blood proteins therefore low potential drug interactions <NUMBER> compared earlier renin inhibitors aliskiren resistant intestinal degradation possesses significantly improved oral bioavailability terminal halflife ranges <NUMBER> <NUMBER> hours makes suitable oncedaily dosing aliskiren monotherapy displays antihypertensive efficacy similar superior firstline antihypertensive drugs safety tolerability profile similar arbs combined various antihypertensive agents aliskiren exhibits synergistic effects <NUMBER> <NUMBER> aliskiren approved regulatory bodies europe united states use alone agents treatment hypertension <NUMBER> recent studies showed aliskiren treatment also markedly increased plasma concentration prorenin patients failed inhibit noncatalytic effects prorenin <NUMBER> <NUMBER> pharmaceutical company novartis reported addition aliskiren standard therapy patients recovering heart attack provide anticipated effect limiting adverse changes hearts left ventricle december <NUMBER> novartis announced early termination aliskiren trial type <NUMBER> diabetes using cardiorenal endpoints altitude advised aliskiren used combination ace inhibitors arbs patients diabetes study conducted type <NUMBER> diabetic patients high risk fatal nonfatal cardiovascular renal events aliskiren <NUMBER> mg given addition ace inhibitor arb overseeing data monitoring committee concluded study patients unlikely benefit aliskiren higher incidence adverse events related nonfatal stroke renal complications hyperkalaemia hypotension highrisk population <NUMBER> months combined therapy wwwnovartiscom aliskiren shown safe antihypertensive <NUMBER> patientyears data however seen ongoing telmisartan alone combination ramipril global endpoint trial ontarget combination telmisartan arb ramipril ace inhibitor associated adverse events without increase benefit patients vascular disease highrisk diabetes without heart failure <NUMBER> combination multiple safe drugs class may longer promising strategy last decade number foodderived compounds shown vitro ace inhibitory activity display significant antihypertensive activity rats humans among compounds foodderived ace inhibitory peptides widely studied <NUMBER> <NUMBER> quantitative structureactivity relationship study indicated potent ace inhibitory dipeptide large hydrophobic amino acid cterminus nonpolar amino acid possibly positively charged amino acid nterminus tripeptides favourable residues cterminus aromatic amino acids hydrophobic amino acids preferred nterminus positively charged amino acids preferred middle position <NUMBER> vitro halfmaximal inhibitory concentration ic <NUMBER> values foodderived ace inhibitory peptides <NUMBER>fold higher synthetic captopril higher vivo activities would expected vitro activities suggested foodderived peptides might act via different antihypertensive mechanisms possess higher affinities tissues slowly eliminated synthetic captopril <NUMBER> two lactotripeptides vpp ipp successfully commercialized data van mierlo et al however support blood pressurelowering effect two tripeptides caucasians <NUMBER> given discrepancy vivo vitro results investigation vivo clinical antihypertensive effects mechanisms foodderived ace inhibitors necessary three dipeptides ir kf ef pea protein hydrolate identified inhibiting renin activity vitro <NUMBER> oleic acid linoleic acid isolated rice cereals also vitro renin inhibitory activity <NUMBER> <NUMBER> series studies shown saponins different foodplant sources primarily soybean inhibit vitro renin activity <NUMBER> <NUMBER> <NUMBER> <NUMBER> among orally administered soybean saponin lead reduction blood pressure shrs direct evidence saponin suppressing plasma renin activity vivo still lacking <NUMBER> experiments required investigate biochemical biological properties plantfoodderived nonpeptides related renin inhibition significant conceptual progress made last years leads us conclude ace<NUMBER> could serve new direction improved therapeutics cardiovascular disease compared ace inhibitor therapy ace<NUMBER> endogenous regulator ras targeting ace<NUMBER> would produce vasoprotectiveantiproliferative peptide ang<NUMBER> would also influence vasoconstrictiveproliferative effects aceang iiat<NUMBER> axis part vasoprotectiveantiproliferative axis ace<NUMBER> effectively control fibrosis structural remodelling extremely beneficial pulmonary hypertension ace<NUMBER> activation may provide improved protection reversal ischaemiainduced neural damage thus direct activation ace<NUMBER> could result better outcomes cardiovascular disease additionally ace<NUMBER> multifunctional enzyme many biologically active substrates effects ace<NUMBER> substrates ang ang ii may hold relevance treatment cardiovascular disease <NUMBER> xnt analogues exist many natural plant resources shown various physiological functions using resources search vitro ace<NUMBER> activators would good starting point developing plant foodderived ace<NUMBER> activating agents ongoing experiments would characterize ace<NUMBER> activators compared ras regulatory drugs plantfoodderived bioactives appear natural safer consumer part daily diet bioactives food sources may result much lower healthcare cost plantfoodderived ras regulators could applied prevention hypertension initial treatment mildly hypertensive individuals <NUMBER> authors declare conflicts interest concerning article <NUMBER> years passed since reninangiotensin system ras initially described <NUMBER> since time ras become one bestcharacterized hormonal systems reflecting central role control blood pressure within ras angiotensin ii ang ii considered primary physiological product basic pathway leading ang ii formation remained unchanged theory ras cascade inaugurated hydrolysis precursor angiotensinogen angiotensin ang aspartic protease renin ang turn converted ang ii principally zinc metallopeptidase angiotensinconverting enzyme ace although heart serine protease chymase also appears play role fig <NUMBER> <NUMBER> throughout past decade formation function angiotensin fragments ang <NUMBER> ang <NUMBER> ang iii ang <NUMBER> <NUMBER> ang iv ang <NUMBER> <NUMBER> investigated particular role ang <NUMBER> greatest corresponding author impact since fragment mediates opposing effects ang ii thus providing novel channel regulation within ras <NUMBER> fig <NUMBER> ang <NUMBER> acts specific gproteincoupled receptor mas <NUMBER> ace identified fundamental regulator ras humans important target regulation blood pressure homeostasis classical ace inhibitors captopril lisinopril proven effective antihypertensive therapeutics <NUMBER> <NUMBER> human homologue ace discovered independently two groups using differing genomicbased strategies referred aceh <NUMBER> ace<NUMBER> <NUMBER> ability ace<NUMBER> produce ang <NUMBER> via two alternative pathways concert ace fig <NUMBER> led increasing therapeutic relevance interest recently ace<NUMBER> implicated cardiac dysfunction hypertension <NUMBER> <NUMBER> heart failure ventricular remodelling <NUMBER> <NUMBER> diabetes <NUMBER> ang <NUMBER> regulation pregnancy <NUMBER> functional receptor coronavirus cause severe acute respiratory syndrome sars <NUMBER> foundation future research biochemistry physiological role enzyme provided development specific ace<NUMBER> inmultiauthor review <NUMBER> hibitors <NUMBER> <NUMBER> elucidation crystal structures ace<NUMBER> <NUMBER> testicular ace tace <NUMBER> drosophila orthologue ance <NUMBER> orthologues human ace<NUMBER> identified rat mouse genomes display <NUMBER> <NUMBER> identity respectively nucleotide sequence human ace<NUMBER> human ace<NUMBER> gene consists <NUMBER> exons first <NUMBER> exons ace<NUMBER> similar size first <NUMBER> exons ace gene <NUMBER> <NUMBER> fig <NUMBER> ace<NUMBER> union exons <NUMBER> <NUMBER> jointly correspond exon <NUMBER> ace fig <NUMBER> zincbinding motif hexxh ace<NUMBER> located within exon <NUMBER> compared exon <NUMBER> ace gene significant difference ace<NUMBER> ace single ace<NUMBER> protein species appears formed mammalian ace gene gives rise two isoforms somatic ace sace two catalytic domains nand cdomain tace single catalytic domain resembles cdomain sace fig <NUMBER> initiation sites transcripts sace tace occur different regions ace gene control alternate tissuespecific promoters <NUMBER> regulatory elements ace<NUMBER> gene thus far described ace<NUMBER> gene maps x chromosome humans xp<NUMBER> <NUMBER> <NUMBER> rodents xq<NUMBER> <NUMBER> mice xf<NUMBER> <NUMBER> three different rat models either spontaneous saltinduced hypertension rat gene mapped defined quantitative trait locus qtl x chromosome hypertensive rat models reduction ace<NUMBER> gene protein expression observed suggesting ace<NUMBER> strong candidate hypertensive qtl x chromosome <NUMBER> furthermore two singlenucleotide polymorphisms identified ace<NUMBER> locus associated number cardiovascular endpoints caucasian subjects <NUMBER> strong association ace<NUMBER> gene hypertension strengthened tissuespecific expression ace<NUMBER> messenger rna mrna high levels single <NUMBER>kb transcript kidney heart <NUMBER> <NUMBER> immunohistochemical studies heart sections localised ace<NUMBER> endothelium ventricular intramyocardial vessels occasionally smooth muscle adventitia larger blood vessels surprisingly difference immunoreactive staining observed sections nonfailing failing hearts although ace<NUMBER> originally cloned human heart failure complementary dna cdna library <NUMBER> ace<NUMBER> activity increased human heart ventricles idiopathic dilated cardiomyopathy patients <NUMBER> kidney ace<NUMBER> observed endothelium intrarenal arteries figure <NUMBER> schematic diagram reninangiotensin system ras classical ras angiotensinconverting enzyme ace catalyses production angiotensin ang ii ang ang ii biologically active vasoconstrictor interacts angiotensin gproteincoupled receptors at<NUMBER> at<NUMBER> ang <NUMBER> metabolite ang ang ii opposing effects ang ii mediated via interaction mas ang <NUMBER> receptor ace<NUMBER> converts ang ii ang <NUMBER> <NUMBER>fold greater catalytic efficiency conversion ang ang <NUMBER> nep neprilysin apn aminopeptidase n apa aminopeptidase epithelia proximal tubules <NUMBER> zinc metalloproteases tace <NUMBER> neprilysin <NUMBER> ace<NUMBER> also highly expressed testes <NUMBER> <NUMBER> although ace<NUMBER> knockout male mice appear fertile <NUMBER> recently extensive assessment ace<NUMBER> expression using quantitative realtime polymerase chain reaction pcr tissue immunohistochemistry revealed even higher level ace<NUMBER> gene protein expression regions gastrointestinal gi tract addition high expression heart kidney testes <NUMBER> <NUMBER> open reading frame human ace<NUMBER> encodes <NUMBER>aminoacid polypeptide <NUMBER> hydropathy analysis ace<NUMBER> protein sequence reveals two hydrophobic regions potential <NUMBER>aminoacid signal peptide nterminus <NUMBER>aminoacid hydrophobic region near cterminus like ace ace<NUMBER> likely type integral membrane protein anchored cell membrane via hydrophobic region located towards cterminus protein nterminal region ace<NUMBER> contains active site faces extracellular space ace<NUMBER> localised cell surface stably transfected chinese hamster ovary cho cells immunofluorescence cell surface biotinylation studies f j warner turner j <NUMBER> unpublished data thus ace<NUMBER> like ace ectoenzyme poised cell surface hydrolyse circulating peptides human ace<NUMBER> six potential nglycosylation sites indicated presence asnxserthr motif positions asn <NUMBER> asn <NUMBER> asn <NUMBER> asn <NUMBER> asn <NUMBER> asn <NUMBER> primary structure <NUMBER> <NUMBER> complete deglycosylation denatured soluble ace<NUMBER> nglycosidase f hydrolyses classes asnlinked glycans results shift migration polypeptide <NUMBER> <NUMBER> kda predicted r unglycosylated ace<NUMBER> <NUMBER> comparatively sace contains <NUMBER> nglycosylation sites <NUMBER> located ndomain remaining <NUMBER> found cdomain sace tace addition nlinked glycans tace also extensively oglycosylated within first <NUMBER> amino acids nterminal sequence although olinked sugars essential expression activity <NUMBER> olinked glycosylation reported sace ace<NUMBER> whether presence sugar moieties associated ace<NUMBER> glycosylation necessary correct targeting activity remains established contribution five potential glycosylation sites expression processing activity human tace rabbit ace investigated <NUMBER> <NUMBER> <NUMBER> effort produce minimally glycosylated form tace crystallisation studies <NUMBER> glycosylation either first third sites nterminus sufficient produce catalytically active form human tace <NUMBER> similarly first second sites essential rabbit tace <NUMBER> seven potential glycosylation sites ace<NUMBER> first putative site asn <NUMBER> humans found conserved rat ace<NUMBER> well human mouse rabbit tace drosophila ance acer suggesting site essential maintaining activity overall studies sace tace <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> imply carbohydrate processing essential role expression maturation proteolytic activity membranebound soluble ace influencing polypeptide folding intracellular targeting transport similar studies required reveal potential glycosylation sites important processing ace<NUMBER> sace tace solubilised membrane surface action ace secretase <NUMBER> precise identity still unknown even thought member adamalysin adam family zinc metalloproteases <NUMBER> comparative inhibitor studies suggest ace secretase related although distinct wellcharacterised tumour necrosis factora convertase tace adam <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> also exists membranebound soluble form <NUMBER> <NUMBER> <NUMBER> cho cells stably expressing ace<NUMBER> active form ace<NUMBER> secreted cells medium <NUMBER> studies suggest soluble form ace<NUMBER> derived membranebound form via posttranslational proteolytic cleavage event similar occurring ace cleavage site human tace sace mapped arg <NUMBER> ser <NUMBER> bond sace numbering <NUMBER> amino acids proximal cell membrane vitro vivo <NUMBER> <NUMBER> exact sequences around cleavage site distance membrane appear direct determinants secretase activity <NUMBER> <NUMBER> may dependent conformational state juxtamembrane stalk region <NUMBER> juxtamembrane regions human ace ace<NUMBER> display minimal sequence homology nevertheless least two potential argser argleu secretase cleavage sites exist within juxtamembrane stalk region ace<NUMBER> whilst formation soluble ace<NUMBER> established vitro <NUMBER> <NUMBER> soluble form ace<NUMBER> yet detected vivo human body fluids although ace<NUMBER> detected urine collected rats c chappell <NUMBER> unpublished data majority studies rat mouse models <NUMBER> <NUMBER> thus far relied indirect means measuring ace<NUMBER> activity plasma changes levels either ang ii metabolite ang <NUMBER> radioimmunoassay <NUMBER> future investigation mechanisms involved solubilisation ace<NUMBER> whether secretory event regulated aid understanding physiological relevance ace<NUMBER> modulating ang ang ii potential substrates locally systemically ace<NUMBER> zinc metalloprotease belongs gluzincin clan metalloproteases thermolysin archetypal member catalysis members family occurs via mechanism whereby zinc facilitates nucleophilic attack water molecule scissile carbonyl bond substrate rather form covalent intermediate metalloproteases utilise coordination water molecule metal ion form noncovalent intermediate three ligands coordinate zinc ion conserved metalloproteases family fig <NUMBER>a ace<NUMBER> first two zinc coordinating ligands <NUMBER> <NUMBER> found within consensus sequence hexxh whereas third zinc ligand glu <NUMBER> lies <NUMBER> amino acids cterminal motif corresponding residues found two domains ace tace fig <NUMBER>a <NUMBER> <NUMBER> ace exxxd motif contains third zinc ligand e followed aspartyl residue ace<NUMBER> glu <NUMBER> replaces aspartyl residue whose role ace position first histidine zinc ligand fig <NUMBER>a mutagenesis asp <NUMBER> glu cdomain sace reduces eliminate activity wildtype ace <NUMBER> role glu <NUMBER> ace<NUMBER> remains explored based upon sequence alignment ace<NUMBER> closely resembles ndomain sace <NUMBER> similarity <NUMBER> identity overall protein sequence sace <NUMBER> although juxtamembrane transmembrane cytoplasmic domains ace<NUMBER> resemble sace share <NUMBER> identity <NUMBER>amino acid transmembrane glycoprotein collectrin derived renal collecting ducts <NUMBER> fig <NUMBER> ace<NUMBER> classified member m<NUMBER> family along sace tace drosophila ance acer however unlike cmls cell mol life sci vol <NUMBER> <NUMBER> multiauthor review <NUMBER> members m<NUMBER> family ace<NUMBER> carboxypeptidase rather peptidyl dipeptidase first mammalian carboxypeptidase identified contain hexxh motif rather typical carboxypeptidase alike motif hxxex <NUMBER> h sense ace<NUMBER> closely resembles bacterial carboxypeptidases m<NUMBER> family thermus aquaticus carboxypeptidase taqcp <NUMBER> pyrococcus furiosus carboxypeptidase pfucp <NUMBER> also utilize hexxh motif zinc binding <NUMBER> fig <NUMBER>a high sequence homology ace<NUMBER> bacterial carboxypeptidases however confined region surrounding catalytic binding domains consequently ace<NUMBER> separated m<NUMBER> family carboxypeptidases portrayed schematically cladogram based upon protein sequence alignment fig <NUMBER>b however despite lack sequence homology close similarities noted tertiary structures ace<NUMBER> <NUMBER> tace <NUMBER> pfucp <NUMBER> neurotensindegrading enzyme neurolysin <NUMBER> suggesting convergent structural evolution metalloproteases recent elucidation crystal structures human ace<NUMBER> <NUMBER> previously described comparative model ace<NUMBER> active site based upon crystal structure tace <NUMBER> <NUMBER> identified key active site differences ace<NUMBER> tace studies indicate catalytic mechanism ace<NUMBER> closely multiauthor review <NUMBER> sembles ace differences substrate specificity however suggest distinctive differences exist substrate binding subsites ace<NUMBER> tace ace<NUMBER> cleaves single amino acid cterminus substrates whereas ace functions peptidyl dipeptidase basis difference relates pocket s<NUMBER>¢ subsite binding substrate cterminus ace<NUMBER> s<NUMBER>¢ subsite smaller result r<NUMBER> fi q substitution able accommodate one amino acid instead second terminal peptide bond compared tace <NUMBER> <NUMBER> inhibitory action ace inhibitors captopril lisinopril based part upon ability mimic dipeptidyl cterminal binding ace substrates <NUMBER> feature may one factor contributes ineffectiveness captopril lisinopril inhibit proteolytic activity ace<NUMBER> <NUMBER> diverse range peptides screened potential physiological substrates ace<NUMBER> <NUMBER> <NUMBER> around <NUMBER> peptides identified hydrolysed significant extent ace<NUMBER> table <NUMBER> ace<NUMBER> cleaves ang ang ii although ace<NUMBER> almost <NUMBER>fold higher catalytic efficiency hydrolysis ang ii <NUMBER> ang also inhibits ace<NUMBER> hydrolysis fluorogenic substrate mcaapkdnpoh weakly k <NUMBER> mm <NUMBER> majority studies investigating physiological role ace<NUMBER> concentrated ability ace<NUMBER> hydrolyse ang ii role ras however ace<NUMBER> also hydrolyses opioid peptide dynorphin <NUMBER> hypotensive peptide apelin<NUMBER> comparable kinetics ang ii well desarg <NUMBER> bradykinin bcasomorphin growth hormone secretagogue ghrelin <NUMBER> ability ace<NUMBER> hydrolyse substrates ang ii suggests ace<NUMBER> may role peptidergic systems alignment substrates hydrolysed ace<NUMBER> reveals potential consensus sequence p <NUMBER> xp <NUMBER> fl x hydrophobicbasic cleavage site occurs p <NUMBER> cterminal hydrophobicbasic residue <NUMBER> vast majority peptides efficiently cleaved ace<NUMBER> possess proline penultimate position p <NUMBER> peptide phenylalanine cterminus however basic residue substituted cterminus observed neurotensin <NUMBER> neurotensin <NUMBER> ghrelin table <NUMBER> <NUMBER> <NUMBER> topology s<NUMBER> subsite particular residue y<NUMBER> appears determining factor limiting size residue found substrate p <NUMBER> position substrates mediumsized amino acids table <NUMBER> substrates inhibitors human soluble ace<NUMBER> adapted <NUMBER> sequence p <NUMBER> xp <NUMBER> ø x hydrophobicbasic hydrolysis reference sequence peptide depicted using singleletter codes amino acid arrow indicates site hydrolysis c complete hydrolysis p partial hydrolysis n hydrolysis indicate degree peptide substrates hydrolysed nd determined proline leucine bulky residues like tyrosine phenylalanine p <NUMBER> position cleaved <NUMBER> presence proline p <NUMBER> p <NUMBER> may also determinant ace<NUMBER> activity <NUMBER> instance ang dynorphin <NUMBER> contain proline p <NUMBER> position cleaved ace<NUMBER> whereas proline p <NUMBER> position observed ang <NUMBER> bradykinin prevents hydrolysis ace<NUMBER> exception neurotensin <NUMBER> despite proline p <NUMBER> position substrate ace<NUMBER> table <NUMBER> clarification rules governing ace<NUMBER> hydrolysis required current studies <NUMBER> <NUMBER> <NUMBER> established dependence ace<NUMBER> ph monovalent anions catalytic activity anion activation ang hydrolysis ace first recognised skeggs coworkers <NUMBER> <NUMBER> dependence ace chloride ions substrate <NUMBER> domainspecific <NUMBER> ace ace<NUMBER> exhibit preference clover monovalent ions fand br <NUMBER> <NUMBER> molecular mechanism anion activation yet fully understood although proposed chloride ions may induce slight change conformation active site facilitates binding <NUMBER> crystal structure lisinoprilcomplexed tace revealed two concealed chloride ions <NUMBER> four ligands arg <NUMBER> arg <NUMBER> trp <NUMBER> water bind first chloride ion cl<NUMBER> ligands tyr <NUMBER> arg <NUMBER> water molecule bind second chloride ion cl<NUMBER> located closer coordinated zinc ion <NUMBER> cdomain ace residue arg <NUMBER> equivalent arg <NUMBER> tace identified crucial residue clactivation sace activity <NUMBER> tyr <NUMBER> arg <NUMBER> conserved human ace<NUMBER> tyr <NUMBER> arg <NUMBER> addition known ace sequences <NUMBER> implying conserved residues may also involved mediating cleffect observed ace<NUMBER> related aces however native crystal structure ace<NUMBER> ectodomain shows single bound chloride ion instead two observed lisinoprilcomplexed tace <NUMBER> location single chloride ion native ace<NUMBER> structure almost identical position first chloride ion cl<NUMBER> lisinoprilcomplexed tace <NUMBER> <NUMBER> since native crystal structure tace solved <NUMBER> resolution crystal structure ace<NUMBER> complexed mln<NUMBER> ace<NUMBER> inhibitor high enough differentiate water chloride ions <NUMBER> remains unknown second chloride ion cl<NUMBER> lisinoprilcomplexed tace unique inhibitor bound state future sitedirected mutagenesis studies potential residues involved chloride binding give greater understanding mechanisms underlying anion activation <NUMBER> <NUMBER> abzgfspy <NUMBER> abzspyno <NUMBER> <NUMBER> markedly increases contrast presence chloride ions hydrolysis ang ii ace<NUMBER> essential fact hydrolysis ang ii inhibited ninefold <NUMBER> nacl <NUMBER> control ace<NUMBER> activity ph anion activation presents question physiological relevance ph chloride ion concentrations part relatively constant blood plasma ace ace<NUMBER> theoretically exposed physiological conditions ph <NUMBER> <NUMBER> mm cl based upon data presented guy coworkers <NUMBER> ace<NUMBER> would exhibit <NUMBER> maximal activity ang <NUMBER> active towards ang ii hence may anion activation serves regulate substrate specificity particularly organs kidney chloride ion concentrations fluctuate greatly first generation selective inhibitors ace<NUMBER> designed synthesised table <NUMBER> <NUMBER> <NUMBER> series nonpeptide compounds constructed based upon ace<NUMBER> substrate consensus px<NUMBER>p <NUMBER> flx hydrophobic requirement centrally located carboxylate coordinate zinc ion <NUMBER> lead resulted synthesis inhibitor mln<NUMBER> table <NUMBER> possessing subnanomolar affinity ic <NUMBER> <NUMBER> inhibitor concentration <NUMBER> nm ace<NUMBER> <NUMBER>and <NUMBER>fold less affinity human tace bovine carboxypeptidase respectively <NUMBER> using alternative strategy potent ace<NUMBER> peptide inhibitors identified screening constrained peptide libraries <NUMBER> potent inhibitor dx<NUMBER> <NUMBER>amino acid nterminal acetylated cterminal amidated peptide displays k <NUMBER> nm using ang substrate dx<NUMBER> exhibited combination competitive noncompetitive inhibition intravenous bolus injection dx<NUMBER> k <NUMBER> nm analogue dx<NUMBER> conscious spontaneously hypertensive rats shr produced dosedependent depressor response characterised decreased mean arterial pressure accompanied transient tachycardia <NUMBER> findings contrast hypothesis ace<NUMBER> linked systemic arterial pressure <NUMBER> hypothesis supported studies ace<NUMBER> knockout mice ablation ace<NUMBER> either direct effect blood pressure increased systolic blood pressure <NUMBER> <NUMBER> furthermore ace<NUMBER> mrna protein expression levels reduced shr compared control wistar kyoto rats <NUMBER> two possible explanations conflicting results first ang ii may sole physiological substrate involved mediating effects ace<NUMBER> blood pressure apelin<NUMBER> k cat k <NUMBER> ¥ <NUMBER> <NUMBER> <NUMBER> <NUMBER> cleaved ace<NUMBER> kinetics similar ang ii k cat k <NUMBER> ¥ <NUMBER> <NUMBER> <NUMBER> <NUMBER> apelin<NUMBER> also substrate <NUMBER> peptides also produce hypotensive systemic effects <NUMBER> <NUMBER> may accentuated absence ace<NUMBER> second inconsistencies observed among studies may originate fundamental differences exist animal never produced protein may develop compensatory mechanisms animal protein inhibited birth nevertheless recent development inhibitors discrepancies addressed well promote new studies ace<NUMBER> normal physiology disease remarkably short space time much knowledge accumulated structure enzymology physiological functions ace<NUMBER> much still remains elucidated counterbalancing roles ace ace<NUMBER> ras gaining credence metabolites example apelin may physiologically relevant substrates ace<NUMBER> implicated number disease conditions including hypertension diabetes cardiac function recently identity sars virus receptor opens new avenues ace<NUMBER> research particularly relation nature interactions viral spike glycoprotein ace<NUMBER> clinical studies required validate disease models purpose generally available ace<NUMBER> inhibitors fundamental importance recent structural solutions ace ace<NUMBER> facilitate design potent selective ace<NUMBER> inhibitors finally rapidly developing field may yet surprises new member ace gene family provide icine blog fang karakiulakis roth <NUMBER> gurwitz <NUMBER> https blogssciencemagorgpipelinearchives<NUMBER>angiotensinandthecoronavirus addressed involvement ace<NUMBER> receptor sars viruses raising concerns use angiotensinconverting enzyme inhibitors ace inhibitors example captopril lisinopril enalapril well angiotensin receptor blockers arbs example losartan valsartan telmisartan individuals hypertension cardiovascular renovascular diseases three publications report arbs increase ace<NUMBER> either based upon observation increased urinary ace<NUMBER> furuhashi et al <NUMBER> misquote recent report wan shang graham baric li <NUMBER> interactions sars cov ace<NUMBER> fang et al <NUMBER> amplification misquote https blogssciencemagorgpipelinearchives<NUMBER>angiotensinandthecoronavirus interpretation furuhashi et al <NUMBER> furuhashi et al <NUMBER> report increased urinary ace<NUMBER> indicates increase ace<NUMBER> synthesis likely incorrect three reasons increase urinary ace<NUMBER> seen olmesartan losartan candesartan valsartan telmisartan increase urinary ace<NUMBER> b soluble ace<NUMBER> ace<NUMBER> shed membranes reflecting distinctly different process ace<NUMBER> synthesis increased urinary ace<NUMBER> suggests reduction membrane bound ace<NUMBER> indeed suggested increased urinary ace<NUMBER> marker might causal factor diseases associated hyperactivity reninangiotensin system ras chronic kidney disease palau pascual soler riera <NUMBER> c urinary ace<NUMBER> likely reflects proximal tubule ace<NUMBER> expressed apical side tubular epithelial cells shed actions adam<NUMBER> also known tnfα converting enzyme tace tnfα convertase palau et al <NUMBER> wysocki et al <NUMBER> xiao et al <NUMBER> molecular weight shed ace<NUMBER> arising cell membranes healthy individuals is<NUMBER> and<NUMBER> kda mizuiri et al <NUMBER> well glomerular filtration limit urinary ace<NUMBER> would reflect ace<NUMBER> levels outside kidney wysocki et al <NUMBER> unless smaller fragments shed ace<NUMBER> retain immunoreactivity ace<NUMBER> antibody used elisa assay present time effects atr<NUMBER> blockers ace inhibitors membrane bound ace<NUMBER> human lung unknown suggestion increase sarscov<NUMBER> infectivity currently lacks sound rationale danser epstein batlle <NUMBER> vaduganathan et al <NUMBER> ace<NUMBER> plays important role inactivating angiotensin ang ii well generate ang <NUMBER> lazartigues feng lavoie <NUMBER> warner smith hooper turner <NUMBER> reduction activity could increase ability ang ii stimulate <NUMBER> receptors mediate pressor proinflammatory actions ang ii forrester et al <NUMBER> piqueras sanz <NUMBER> ranjbar et al <NUMBER> zhou ando macova dou saavedra <NUMBER> well reduce formation ang <NUMBER> reported cytoprotective properties lung vasculature li et al <NUMBER> ye liu <NUMBER> moreover unlikely inhibitors ace<NUMBER> activity would significantly compete overlapping binding sites ace<NUMBER> active site ace<NUMBER> hemgh domain amino acids <NUMBER> putative sarscov<NUMBER> spike protein binding domains amino acids <NUMBER> <NUMBER> <NUMBER> httpswwwncbinlmnihgovezproxylocallibrarynovaeduproteinnp<NUMBER> moreover binding sites sarscov<NUMBER> ace<NUMBER> reported sarscov<NUMBER> walls et al <NUMBER> reported overlap substrate binding site ace<NUMBER> based upon inability ace<NUMBER> inhibitor mln<NUMBER> dales et al <NUMBER> inhibit sarscov<NUMBER> binding ace<NUMBER> f li li farzan harrison <NUMBER> interest however promising concept administering exogenous ace<NUMBER> coupled fc region immunoglobulin neutralizing antibody serve decoy receptor inactivator sarscov<NUMBER> kruse <NUMBER> thereby preventing binding membrane bound clinical trials reninangiotensin systembased therapies including therapies targeting sarscov<NUMBER> ace<NUMBER> interactions listed clinicaltrialsgov april <NUMBER> <NUMBER> cytotoxic targeting sarscov<NUMBER> virus recently registered clinicaltrialsgov table <NUMBER> since inflammation one major causes morbidity sarscov<NUMBER> infection <NUMBER> receptors known cause inflammation forrester et al <NUMBER> piqueras sanz <NUMBER> ranjbar et al <NUMBER> zhou et al <NUMBER> <NUMBER> receptor blockers arbs present additional therapeutic modality minimize complications respiratory impairments caused virus ace inhibitors present equivalent therapeutic option arbs treatment hypertension cardiovascular renovascular disease ability protect bradykinin degradation manifested ace inhibitor cough well increased risk angioedema could cause concern messerli bangalore bavishi rimoldi <NUMBER> however ace inhibitors increase ang <NUMBER> production directly ang via endopeptidase activity karamyan speth <NUMBER> also protect ang <NUMBER> degradation inactive metabolite ang <NUMBER> chappell pirro sykes ferrario <NUMBER> abundant capacity synthesize ang ii lungs well <NUMBER> receptors mediate effects oakes fuchs gardner lazartigues yue <NUMBER> mouse model lung inflammation induced bacterial lipopolysaccharide arbs reportedly reduced pathological injury ye liu <NUMBER> gurwitz <NUMBER> noted large population individuals taking arbs treatment hypertension gurwitz <NUMBER> several retrospective surveys registered clinicaltrialsgov table <NUMBER> determine use arb ace inhibitor associated sarscov<NUMBER> infections degree morbidity death compared individuals taking nonarb antihypertensive medications readily inform us utility arbs ace inhibitors ameliorate disease writing american college cardiology american heart association heart failure society america recommend patients hypertension continue take arbs ace inhibitors directed httpswwwaccorglatestincardiologyarticles<NUMBER>hfsaaccahastatementaddressesconcernsreusingraasantagonistsincovid<NUMBER> well several biomedical societies listed recently vaduganathan et al <NUMBER> <NUMBER> using anamnestic data collected health record hospital general practitioner count number covid<NUMBER> patients enrolled treated ace inhibitors arbs observe whether antihypertensive ace inhibitors arbs increases severity clinical manifestation covid<NUMBER> note april <NUMBER> <NUMBER> <NUMBER> trials listed clinicaltrialsgov three viral decoy studies one withdrawn five arb therapy studies one ang <NUMBER> product ace<NUMBER> study two withdrawal ace inhibitor arb therapy without antihypertensive drug replacement studies five retrospective studies arb ace inhibitor use relationship covid infection incidence morbidity different types studies separated shading differences april <NUMBER> <NUMBER> four additional trials listed clinicaltrialsgov one additional arb therapy trial one withdrawal aceinhibitorarb therapy one retrospective study ace inhibitorarb therapy one study observe ras activity covid <NUMBER> patients robert c speth httpsorcidorg<NUMBER> background potential association use angiotensinreceptor blockers arbs angiotensinconvertingenzyme ace inhibitors risk coronavirus disease <NUMBER> covid<NUMBER> well studied methods carried populationbased casecontrol study lombardy region italy total <NUMBER> case patients infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> confirmed february <NUMBER> march <NUMBER> <NUMBER> matched <NUMBER> beneficiaries regional health service controls according sex age municipality residence information use selected drugs patients clinical profiles obtained regional databases health care use odds ratios <NUMBER> confidence intervals associations drugs infection adjustment confounders estimated means logistic regression results among case patients controls mean ±sd age <NUMBER>±<NUMBER> years <NUMBER> women use ace inhibitors arbs common among case patients among controls use antihypertensive nonantihypertensive drugs case patients worse clinical profile use arbs ace inhibitors show association covid<NUMBER> among case patients overall adjusted odds ratio <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> arbs <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> ace inhibitors among patients severe fatal course disease adjusted odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> arbs <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> ace inhibitors association variables found according sex conclusions large populationbased study use ace inhibitors arbs frequent among patients covid<NUMBER> among controls higher prevalence cardiovascular disease however evidence ace inhibitors arbs affected risk covid<NUMBER> reninangiotensinaldosterone system blockers risk covid<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> uses angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor spike protein invade cells replicate <NUMBER> ace<NUMBER> presents high homology ace key enzyme regulation blood pressure <NUMBER> animal studies reninangiotensinaldosterone system raas inhibitors category includes ace inhibitors angiotensinreceptor blockers reported increase expression ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> findings led researchers postulate use drugs might enhance access sarscov<NUMBER> cells predisposing patients infection increasing severity covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> hypothesis fuelled results first case series published age hypertension diabetes coronary heart diseaseconditions associated use raas inhibitorswere identified potential risk factors severe cases inhospital deaths <NUMBER> <NUMBER> <NUMBER> <NUMBER> contrast authors proposed use angiotensinreceptor blockers preventive measure even therapy covid<NUMBER> potential reduce lung injury caused angiotensin ii <NUMBER> raas inhibitors among widely used drugs globally indications hypertension heart failure kidney complications diabetes myocardial infarction hence discontinuation covid<NUMBER> could cause patients harm <NUMBER> scientific societies drug regulatory agencies alike advised discontinuation sound evidence available <NUMBER> provide solution urgent issue designed pharmacoepidemiological study aim assessing whether odds exposure raas inhibitors relative antihypertensive drugs higher among patients covid<NUMBER> admitted hospital general population adjusted age sex cardiovascular comorbidities risk factors casepopulation study used epidemiological approach conceived surveillance method assess adverse drug effects <NUMBER> provide rapid answer study question briefly method uses data series patients illness specific region cases data patients randomly sampled primary healthcare database region population controls assuming primary healthcare database represents source population cases random sample controls database would provide valid estimate prevalence exposure covariates source population approaching primary base paradigm casecontrol studies <NUMBER> collected data patients cases aged <NUMBER> years older pcrconfirmed diagnosis covid<NUMBER> admitted seven hospitals madrid spain march <NUMBER> march <NUMBER> <NUMBER> study period madrid region upward part outbreak average <NUMBER> inpatient admissions <NUMBER> intensive care unit icu admissions <NUMBER> deaths per day associated covid<NUMBER> official data available online seven participating hospitals belong national health system nhs distributed autonomous community madrid appendix p <NUMBER> cases selected consecutively according date admission hospital planned sample size met competitive manner population controls used random sample ten individuals per case individually matched cases sex age exact region ie madrid date day month extracted last available year <NUMBER> primary healthcare database base de datos para la investigación farmacoepidemiológica en atención primaria bifap figure <NUMBER> ethics research committee university hospital príncipe de asturias coordinating centre assessed study protocol granted favourable opinion march <NUMBER> <NUMBER> including waiver informed consent patients taking part study data extracted fully anonymised attempt made interview patients relatives study complied provisions spanish legislation declaration helsinki <NUMBER> scientific committee bifap granted access pseudonymised data controls march <NUMBER> <NUMBER> study protocol registered eu electronic register postauthorisation studies eupas<NUMBER> available online evidence study inhibitors reninangiotensinaldosterone system raas hypothesised predispose patients severe covid<NUMBER> hypothesis based two facts drugs reported upregulate expression angiotensinconverting enzyme ace <NUMBER> gateway used severe acute respiratory syndrome coronavirus <NUMBER> enter cells patients severe covid<NUMBER> high prevalence cardiovascular diseases many scientific societies adopted position recommending discontinuation treatment yet epidemiological evidence lacking hypothesis confirmed refuted searched pubmed april <NUMBER> <NUMBER> publications english since jan <NUMBER> <NUMBER> using search terms covid<NUMBER> ace inhibitors angiotensinconverting enzyme inhibitors angiotensin receptor blockers raas inhibitors ras inhibitors raas blockers ras blockers filtering human observational study result returned using casepopulation study design found difference risk covid<NUMBER> requiring admission hospital associated use raas inhibitors risk associated use antihypertensive drugs fully adjusted age sex cardiovascular comorbidities risk factors additionally found increased risk either ace inhibitors angiotensinreceptor blockers lack association raas inhibitors risk covid<NUMBER> requiring admission hospital observed severe fatal cases needing admission intensive care unit less severe inpatients available evidence supports raas inhibitors safe discontinued fear increased risk covid<NUMBER> information disease clinical disease course cases retrieved hospital medical records information drug exposure comorbidities admission mainly obtained electronic primary healthcare records accessed nhss primary healthcare data platform horus authorised healthcare workers madrid electronic case report forms sent weekly basis hospital coordinating centre data quality control done quality control involved selection random sample clinical records hospital doublechecking information collected drug exposure comorbidities horus information drug exposure comorbidities population controls obtained database bifap owned spanish agency medicines medical devices extracts infor mation electronic primary healthcare records nhs participating regions database contains information <NUMBER>·<NUMBER> million patients madrid distribution age sex among patients comparable population census region appendix pp <NUMBER> horus bifap databases access primary healthcare data patients madrid nhs catchment population seven hospitals taking part study population attending primary care main outcome variable admission hospital patients covid<NUMBER> confirmed positive pcr test hospitals posted inhouse protocols clinical management hospital admission based criteria issued ministry health including limited respiratory failure oxygen saturation <NUMBER> severe hypoxaemia partial pressure oxygen <NUMBER> mm hg breathing rate <NUMBER> breaths per min breathing ambient air abnormal chest xray compatible covid<NUMBER>associated pneumonia bilateral pneumonia unilateral pneu monia damage different lung lobes relevant clinical alterations including haemodynamic hepatic renal haematological derangements together clinically significant laboratory abnormalities abnormal increase ddimer ferritin lactate dehydrogenase creactive protein severe lymphocytopenia date admission considered index date followed patients identified admitted icu died hospital considering severity analysis patients considered severe cases antihypertensive drugs examined ace inhibitors angiotensinreceptor blockers renin inhibitors aldosterone antagonists calciumchan nel blockers diuretics βblockers αblockers cardiovascular indications appendix p <NUMBER> also grouped ace inhibitors angiotensinreceptor blockers renin inhibitors aldosterone antagonists alone combined drug variable called raas inhibitors calciumchannel blockers βblockers diuretics αblockers alone combined drugs different raas inhibitors variable called antihypertensive drugs defined exposure drug drugs interest current use individual prescription lasting month index date otherwise exposure defined nonuse main analysis generated variable following mutually exclusive categories nonuse antihypertensive drug current use raas inhibitors current use antihypertensive drugs used current use antihypertensive drugs reference category unless otherwise specified patient used raas figure <NUMBER> casepopulation study design covid<NUMBER> cases requiring admission hospital selected consecutively seven hospitals madrid spain data collected ten individuals per case matched age sex index date day month hospital admission cases matched controls <NUMBER> madrid region database bifap national primary healthcare database drug exposure comorbidities index date <NUMBER> cases <NUMBER> controls collected primary healthcare records nhs madrid cases horus online platform access primarycare clinical records healthcare centre nhs madrid controls bifap bifapbase de datos para la investigación farmacoepidemiológica en atención primaria nhsnational health system inhibitor concomitantly anti hypertensive drug always assigned raas inhibitor category subsequently disaggregated category current use raas inhibitors different pharmacological subgroups ace inhibitors angiotensinreceptor blockers excluding current users ace inhibitors aldosterone antagonists excluding current users ace inhibitors angiotensinreceptor blockers renin inhibitors excluding current users raas inhibitor analyses also disaggregated category current use antihypertensive drugs respective components calciumchannel blockers βblockers diuretics αblockers used current use calciumchannel blockers reference category among current users raas inhibitors distinguished used drugs monotherapy combined antihypertensive drug either fixeddose combinations concomitant use separate medicinal products date first prescription current treatment episode also extracted estimate duration treatment categorised <NUMBER> year longer <NUMBER> year estimated sample size needed different scenarios effect size ie odds ratio prevalence use antihypertensive drugs controls assuming α error <NUMBER>·<NUMBER> power <NUMBER> according calculation sample size <NUMBER> cases <NUMBER> <NUMBER> controls would allow us detect <NUMBER>·<NUMBER> greater prevalence use raas inhibitors among controls least <NUMBER> express quantitative variables mean sd qualitative variables frequencies percentages differences means assessed using students test differences percentages assessed using χ² test describe distribution comorbidities among cases controls association covid<NUMBER> requiring admission hospital assessed univariable conditional logistic regression calculate crude ors <NUMBER> cis adjusted age sex due matching assessing potential confounding factors covariates considered presence fol lowing comorbidities index date history hypertension diabetes dyslipidaemia defined use lipidlowering drugs ischaemic heart disease atrial fibrillation heart failure thromboembolic disease cerebrovascular acci dent asthma chronic obstructive pulmonary disease chronic renal failure cancer cardiovascular risk factors comorbidities constructed composite variable background cardiovascular risk following three categories patients history ischaemic heart disease cerebrovascular accident heart failure atrial fibrillation thromboembolic disease patients following cardiovascular risk factors cardiovascular disease hypertension dyslipidaemia diabetes chronic renal failure remainder patients without cardiovascular diseases risk factors assessed association current use raas inhibitors risk covid<NUMBER> requiring data n mean sd odds ratio <NUMBER> ci parentheses aceangiotensinconverting enzyme copdchronic obstructive pulmonary disease raasreninangiotensinaldosterone system exposure specific comorbidity drug compared nonexposure specific comorbidity drug crude odds ratios adjusted sex age †includes ischaemic heart disease cerebrovascular accident heart failure atrial fibrillation thromboembolic disease ‡includes hypertension dyslipidaemia diabetes chronic renal failure §patients counted several times current users two antihypertensive drugs belonging different pharmacological classes hence total exceeds <NUMBER> admission hospital compared either current use antihypertensive drugs main analysis nonuse antihypertensive drug univariable multivariable conditional logis tic regressions multivariable model included covariates described potential confounding fac tors exception hypertension calculate adjusted ors <NUMBER> cis current users raas inhibitors prevalence hypertension <NUMBER> appendix p <NUMBER> reason include hypertension multivariable model potential confounding minimal assessed potential effect modification age <NUMBER> vs ≥<NUMBER> years sex hypertension diabetes background cardiovascular risk stratified analysis assessed statistical interaction comparing adjusted ors across different strata using altman bland test interaction <NUMBER> statistical significance set p value less <NUMBER>·<NUMBER> however stratified analyses applied bonferroni correction allow multiple testing set statistical significance level p value less <NUMBER>·<NUMBER> <NUMBER>·<NUMBER> divided <NUMBER>ie number stratified analyses done according covid<NUMBER> severity differentiated two groups cases fatal cases requiring admission icu ie severe less severe cases group analysed association raas inhibitors described earlier compared adjusted across strata using altman bland test interaction <NUMBER> planned four sensitivity analyses first analysis correction secular trends control series sourced <NUMBER> population last available year bifap database cases <NUMBER> thus case prevalence use raas inhibitors increased time exposure among controls would underestimate <NUMBER> data result adjusted ors could overestimated assess magnitude potential problem examined trends use different antihypertensive drug sub groups madrid population bifap period <NUMBER> forecast result corresponding <NUMBER> via linear regression model divided prevalence use estimate <NUMBER> prevalence observed <NUMBER> every antihypertensive drug class took ratio indicator overestimation adjusted ors raas inhibitors ratio <NUMBER>·<NUMBER> overall <NUMBER>·<NUMBER> ace inhibitors <NUMBER>·<NUMBER> angiotensinreceptor blockers whereas antihypertensive drugs including calciumchannel blockers ratio close <NUMBER>·<NUMBER> appendix pp <NUMBER> sensitivity analysis corrected patterns use dividing adjusted raas inhibitors ace inhibitors angiotensinreceptor blockers respective estimated ratios <NUMBER> second assessed potential effect media alerts concerns association raas inhibitors severe covid<NUMBER> highlighted data n odds ratio <NUMBER> ci parentheses different pharmacological classes examined mutually exclusive categories patients used combinations counted applying following criteria ace inhibitors include current users ace inhibitors alone combined antihypertensive drug fixeddose combinations different medicinal products angiotensinreceptor blockers include current users angiotensinreceptor blocker alone combined antihypertensive drug ace inhibitor fixeddose combinations different medicinal products aldosterone antagonists include current users antagonist aldosterone alone combined antihypertensive drug ace inhibitor angiotensinreceptor blocker fixeddose combinations different medicinal products antihypertensive drugs include calciumchannel blockers diuretics βblockers αblockers alone combined excluding raas inhibitors either fixeddose combinations different medicinal products aceangiotensinconverting enzyme raasreninangiotensinaldosterone system adjusted sex age †adjusted matching variables plus history diabetes dyslipidaemia ischaemic heart disease heart failure atrial fibrillation thromboembolic disease cerebrovascular accident chronic obstructive pulmonary disease asthma cancer chronic renal failure number cases controls given number exposed raas inhibitors stratum resulting odds ratio adjusted matching variables comorbidities different one examined raasreninangiotensinaldosterone system several letters medical journals <NUMBER> <NUMBER> <NUMBER> news began appear spanish press social media networks march <NUMBER> <NUMBER> spanish agency medicines medical devices published note recommending discontinue drugs <NUMBER> news might influence adherence recorded treatment stratified results two study periods march <NUMBER> march <NUMBER> third excluded aldosterone antagonists renin inhibitors raas inhibitor group main analysis included aldosterone antagonists raas inhibitor group drugs also reported upregulate ace<NUMBER> expression <NUMBER> sensitivity analysis estimate adjusted ors among raas inhibitors excluding aldosterone antagonists renin inhibitors finally included hypertension multivariable model statistical analyses using statase version <NUMBER> funder study role study design data collection data analysis data interpretation writing report corresponding author full access data study final responsibility decision submit publication collected data <NUMBER> cases <NUMBER> <NUMBER> matched controls despite matched age sex cases greater prevalence diverse comor bidities controls table <NUMBER> prevalence use different subgroups antihypertensive drugs higher cases controls yielded positive associations risk covid<NUMBER> requiring admission hospital crude fully adjusted analyses compared nonuse antihypertensive drug adjusted raas inhibitors <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> antihypertensive drugs <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> appendix p <NUMBER> use antihypertensive drugs set reference category adjusted associated current use raas inhibitors <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> table <NUMBER> significant increase risk covid<NUMBER> requiring admission hospital observed either ace inhibitors angiotensinreceptor blockers find difference drugs used monotherapy combination drugs table <NUMBER> adjusted ors associated antihypertensive drugs compared nonuse different pharma cological subgroups <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> calciumchannel blockers <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> diuretics <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> βblockers <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> αblockers appendix p <NUMBER> current use cal ciumchannel blockers set reference category adjusted <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> raas inhibitors <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> ace inhibitors <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> angiotensinreceptor blockers appendix p <NUMBER> compared longterm longer <NUMBER> year users antihypertensive drugs longterm users raas inhibitors adjusted <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> risk covid<NUMBER> requiring admission hospital likewise compared shortterm users <NUMBER> year antihypertensive drugs shortterm users raas inhibitors adjusted <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> results assessment potential effect modification raas inhibitors age <NUMBER> ≥<NUMBER> years sex diabetes hypertension background cardiovascular risk shown figure <NUMBER> data n mean sd odds ratio <NUMBER> ci parentheses severe cases died admitted intensive care unit less severe cases inpatients different pharmacological classes examined mutually exclusive categories patients used combinations counted applying following criteria ace inhibitors include current users ace inhibitors alone combined antihypertensive drug fixeddose combinations different medicinal products angiotensinreceptor blockers include current users angiotensinreceptor blocker alone combined antihypertensive drug ace inhibitor fixeddose combinations different medicinal products antihypertensive drugs include calciumchannel blockers diuretics βblockers αblockers alone combined excluding raas inhibitors either fixeddose combinations different medicinal products aceangiotensinconverting enzyme raasreninangiotensinaldosterone system adjusted matching variables plus history diabetes dyslipidaemia ischaemic heart disease heart failure atrial fibrillation thromboembolic disease cerebrovascular accident chronic obstructive pulmonary disease asthma cancer chronic renal failure †including ace inhibitors angiotensinreceptor blockers aldosterone antagonists renin inhibitors table <NUMBER> compared current use antihypertensive drugs adjusted associated current use raas inhibitors <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> among severe cases <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> among less severe cases table <NUMBER> severity groups <NUMBER> cis adjusted ors ace inhibi tors angiotensinreceptor blockers compared antihypertensive drugs overlapped indicating significant differences table <NUMBER> first sensitivity analysis adjusted current use raas inhibitors compared current use antihypertensive drugs corrected secular trends <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> ace inhibitors <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> angiotensinreceptor blockers second sensitivity analysis march <NUMBER> adjusted associated current use raas inhibitors compared current use antihypertensive drugs <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> march <NUMBER> onwards <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> figure <NUMBER> third sensitivity analysis exclusion aldosterone antago nists renin inhibitors raas inhibitor group hardly effect overall adjusted <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> among severe cases <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> among less severe cases <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> appendix pp <NUMBER> <NUMBER> final sensitivity analysis inclusion hypertension multi variable model little effect adjusted ors raas inhibitors <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> ace inhibitors <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> angiotensinreceptor blockers <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> show current use raas inhibitors associated increased risk covid<NUMBER> requiring admission hospital including fatal cases admitted icu compared antihypertensive drugs substantial difference observed ace inhibitors angiotensinreceptor blockers among shortterm longterm users sex age background cardiovascular risk significantly affect results although use raas inhibitors associated reduced risk covid<NUMBER> requiring admission hospital patients diabetes results support hypothesis previous intake raas inhibitors facilitates increases severity covid<NUMBER> hypothesis emerged two facts linked finding raas inhibitors upregulate expression ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> observation hypertension diabetes ischaemic heart disease highly prevalent among patients severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> conditions raas inhibitors widely used however facts two pieces complex puzzle evidence support idea ace<NUMBER> might dual role covid<NUMBER> increasing <NUMBER> one hand ace<NUMBER> overexpression might increase susceptibility cells sarscov<NUMBER> hand downregulation associated older age male sex cardiovascular comorbidities heightened sarscov<NUMBER> binding internalisation <NUMBER> <NUMBER> could increase unopposed action angiotensin ii key role subsequent organ injury <NUMBER> ace<NUMBER> counteracts deleterious effect raas axis patients covid<NUMBER> liu colleagues <NUMBER> reported serum concentrations angiotensin ii signifi cantly higher infected individuals noninfected individuals linearly associated viral load lung damage ace<NUMBER> inactivates angiotensin ii increases generation angiotensin <NUMBER> peptide acting mas receptor exerts vasodilatory effect antiinflammatory antioxidative actions <NUMBER> patients acute respiratory distress syndrome ards reddy colleagues <NUMBER> observed higher ratio angiotensin <NUMBER>angiotensin among survivors nonsurvivors adds evidence idea counterregulation exerted axis ace<NUMBER>angiotensin <NUMBER>mas receptor benefits patients ards line theory recom binant soluble ace<NUMBER> shown animal models ards protect subjects lung injury <NUMBER> <NUMBER> <NUMBER> clinical trials underway patients covid<NUMBER> nct<NUMBER> finally knowledge case series patients covid<NUMBER> published date adjusted important potential confounding factors sex age cardiovascular comorbidities <NUMBER> study used controls matched cases sex age also adjusted number comorbidities knowledge two epidemiological studies published date aimed explore association raas inhibitors covid<NUMBER> comparing severe cases less severe cases among inpatients <NUMBER> <NUMBER> neither studies found increased risk severe outcomes associated drugs one study <NUMBER> substantially reduced risk death transfer critical care unit within <NUMBER> days admission hospital observed among users ace inhibitors <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> notably studies authors considered exposure ace inhibitors <NUMBER> days admission hospital also hospital stay study used population controls case series considered drugs used admission several cardiovascular comorbidities clearly linked severe covid<NUMBER> raas inhibitors often used treat cardiovascular conditions thus substantial confounding indication expected <NUMBER> view bias explains positive association found current use antihypertensive drug risk covid<NUMBER> requiring admission hospital compared nonuse drugs disappear full adjustment comorbidities problem mitigated current users raas inhibitors compared current users drugs share least partially indications safety issues <NUMBER> instance researchers recommended calciumchannel blockers suitable alternative treatment raas inhibitors calciumchannel blockers reported increase expression ace<NUMBER> <NUMBER> following reasoning antihypertensive drugs general calciumchannel blockers particular considered valid comparator group nonuse drugs followed approach reassuringly found increased risk using either drug groups reference group nevertheless raas inhibitors share indications antihypertensive drugs hence comorbidity pattern associated use drugs might overlap residual confounding indication could remain explore extent possibility examined comorbidity pattern associated various types antihypertensive drugs among controls found much fewer differences among types drug compared nonusers reinforces validity approach appendix p <NUMBER> risk reduction associated raas inhibitors among individuals diabetes admitted hospital covid<NUMBER> explained chance deserves comment diabetes reported risk factor severe covid<NUMBER> <NUMBER> biological underpinning clinical observation yet known experimental models diabetes mice shown ace activity high lungs <NUMBER> activity also occurs humans patients diabetes covid<NUMBER> might present great imbalance aceace<NUMBER> ratio ace activity would high due diabetes ace<NUMBER> would low due downregula tion induced sarscov<NUMBER> could explain increased severity covid<NUMBER> among patients diabetes also protective effect raas inhibitors suggested data lack increased risk covid<NUMBER> requiring admission hospital associated raas inhibitors compared antihypertensive drugs found patients severe less severe disease suggesting outpatient use drugs neither facilitates aggravates infection study several limitations first used different data sources extract information cases hospital records primary healthcare records horus consulted case case local researchers controls bifap database automatically extracted data primary healthcare records however horus bifap access primary healthcare data main source determining comorbidity drug exposure study making major information bias unlikely second cases recorded march <NUMBER> whereas controls sourced records march <NUMBER> might affected results due secular trends use antihypertensive drugs however corrected secular trends saw little change estimated adjusted third collect data smoking lifestyle habits eg exercise diet alcohol intake might affected association raas inhibitors covid<NUMBER> requiring admission hospital however habits correlated several comorbidities included regression model fourth obtained information drug prescriptions adherence treatment cannot guaranteed hence used term drug use say drug prescribed effect nonadherence results difficult measure would probably cause nondifferential misclassification exposure relevant would distort estimates towards null value fifth collect information clinical analytical covariates patients stay hospital collect information inhospital treatment eg raas inhibitors continued withheld hospital might interesting assessment association antihypertensive drugs severity fatality due covid<NUMBER> sixth analyse dose effects finally observational study residual confounding due unmea sured unknown confounders cannot ruled summary results present study suggest outpatient use raas inhibitors increase risk covid<NUMBER> requiring admission hospital including severe forms finding confirmed using data sources study designs populations meanwhile data available along important role ace inhibitors angiotensinreceptor blockers management several cardiovascular diseases support discontinuation preventive measure covid<NUMBER> declare competing interests publication study data made available reasonable request corresponding author proposal detailed description study objectives statistical analysis plan needed assessment requests additional materials might also required process assessment deidentified participant data provided approval principal researchers participating hospitals severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus responsible coronavirus disease <NUMBER> pandemic associated high risk acute respiratory distress syndrome mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> facilitates sarscov<NUMBER> entry host cells respiratory tract altered ace<NUMBER> regulation speculated play role pathogenesis covid<NUMBER> <NUMBER> setting covid<NUMBER> pandemic increasing interest physiologic pathophysiologic function ace<NUMBER> <NUMBER>• briefly review role ace<NUMBER> reninangiotensin system therapeutic potential ace<NUMBER> potential interactions ace<NUMBER> sarscov<NUMBER> role covid<NUMBER> pathophysiology counterregulatory effects ace<NUMBER> reninangiotensin system ace<NUMBER> monocarboxypeptidase single enzymatic binding site acts key counterregulatory component reninangiotensin system <NUMBER> ace<NUMBER> known homolog ace shares <NUMBER> sequence identity somatic ace <NUMBER> similarity area surrounding active site <NUMBER> <NUMBER> ace<NUMBER> expressed surface endothelial epithelial cells membranebound form well soluble form several tissues throughout body including kidneys heart gastrointestinal tract lungs <NUMBER> <NUMBER> ace converts angiotensin ang ang ii acts ang ii type <NUMBER> receptor <NUMBER> r resulting vasoconstriction sodium fluid retention kidney oxidative stress inflammation fibrosis impaired fibrinolysis <NUMBER> <NUMBER> direct opposition cascade physiological effects aceang ii pathway net effect ace<NUMBER>ang<NUMBER> pathway vasodilation antiinflammation ace<NUMBER> hydrolyzes ang ii converting ang<NUMBER> see fig <NUMBER> conversion ang ii ang<NUMBER> diminishes availability ang ii bind <NUMBER> r forestalling vasoconstrictive proinflammatory prothrombotic effects <NUMBER> r activation <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally ang<NUMBER> acts mas receptor causing release nitric oxide prostaglandin e <NUMBER> bradykinin <NUMBER> resulting vasodilation natriuresis reduction oxidative stress inflammation <NUMBER> <NUMBER> ace<NUMBER> also cleaves several peptides including converting ang ang<NUMBER> lessbioactive peptide <NUMBER> ace<NUMBER> plays important role development several pathologic conditions including hypertension cardiac hypertrophy kidney disease example human kidney tissue ratio ace ace<NUMBER> expression higher subjects hypertension compared without hypertension <NUMBER> findings consistent morepronounced vasoconstrictive antinatriuretic effects ace compared ace<NUMBER> activity hypertensive individuals several experimental human studies also demonstrated reduction glomerular ace<NUMBER> expression diabetic nondiabetic kidney disease <NUMBER> correspondingly experimental studies mice show pharmacologic inhibition ace<NUMBER> promotes development microalbuminuria diabetic nephropathy <NUMBER> <NUMBER> human data suggest ace<NUMBER> may upregulated individuals existing cardiovascular disease speculated compensatory response counteract deleterious effects ang ii <NUMBER> sarscov<NUMBER> ace<NUMBER> facilitates viral entry host cells may also protective effects severe acute lung injury <NUMBER> given vasodilatory natriuretic antiinflammatory antifibrotic effects via increased ang<NUMBER> decreased ang ii soluble ace<NUMBER> proposed potential therapeutic target hypertension chronic kidney disease cardiovascular disease viral respiratory disease experimental studies chronic administration soluble ace<NUMBER> fig <NUMBER> counterregulatory role ace<NUMBER> reninangiotensin system figure demonstrates conversion angiotensinogen ang renin ang ang ii ace ang ii ang<NUMBER> ace<NUMBER> ang ii acts <NUMBER> r receptor increase vasoconstriction fluid sodium retention kidney oxidative stress resulting increased blood pressure ang<NUMBER> acts mas receptor resulting vasodilation increased fluid sodium excretion kidney reduction oxidative stress resulting reduced blood pressure associated degradation ang ii increase ang<NUMBER> <NUMBER> <NUMBER> <NUMBER> animal studies consistently demonstrate reduction blood pressure recombinant ace<NUMBER> administration mouse models recombinant ace<NUMBER> attenuated diabetic kidney injury <NUMBER> myocardial remodeling <NUMBER> recombinant ace<NUMBER> also proposed treatment severe viral pneumonia acute respiratory distress syndrome recombinant ace<NUMBER> reduces acute lung injury acute respiratory distress syndrome mice viral pneumonia <NUMBER> children infected respiratory syncytial virus higher plasma ang ii concentration compared healthy controls suggesting upregulation aceang ii downregulation ace<NUMBER>ang<NUMBER> supporting ace<NUMBER> potential therapy respiratory syncytial viral lung disease humans ace inhibitors block conversion ang ang ii ang ii receptor blockers directly inhibit <NUMBER> r medications decrease blood pressure inflammation mitigate fibrosis hypertension cardiovascular disease chronic kidney disease several animal models antihypertensive agents shown increase ace<NUMBER> expression heart kidneys <NUMBER> <NUMBER> <NUMBER> <NUMBER> however humans ace inhibitors ang ii receptor blockers associated increased kidney ace<NUMBER> expression circulating ace<NUMBER> activity <NUMBER> <NUMBER>• ace<NUMBER> binding site sarscov<NUMBER> viral spike protein facilitates viral entry host cell recent speculation ace inhibitors ang ii receptor blockers may increase risk development severity covid<NUMBER> due potential upregulation ace<NUMBER> medications <NUMBER> however sarscov<NUMBER> facilitates ace<NUMBER> endocytosis downregulates ace<NUMBER> expression promotes ace<NUMBER> shedding cell surface leading increase ang ii concentration decrease ang<NUMBER> likely important covid<NUMBER> pathophysiology due proinflammatory effects ang ii corresponding loss ang<NUMBER>mediated counterregulation <NUMBER> prothrombotic effects excess ang ii could underlie covid<NUMBER> hypercoagulability <NUMBER> <NUMBER>• upregulation aceang ii downregulation ace<NUMBER>ang<NUMBER> vascular endothelium could promote covid<NUMBER>associated vasculopathy <NUMBER> <NUMBER> extrapolating sarscov animal models increased ang ii patients covid<NUMBER> due loss ace<NUMBER> could mediate acute lung injury acute respiratory distress syndrome <NUMBER> experimental models ang ii administration induces <NUMBER> rmediated ace<NUMBER> internalization degradation <NUMBER> ace inhibitors ang ii receptor blockers may therapeutic benefit covid<NUMBER> reducing ang ii concentration <NUMBER> r activation thus remains unclear ace inhibitors ang ii receptor blockers beneficial harmful effect sarscov<NUMBER> infection covid<NUMBER> ace<NUMBER> important counterregulatory effects reninangiotensin system implicated covid<NUMBER> pathogenesis medications act reninangiotensin system including ace inhibitors ang ii receptor blockers may impact covid<NUMBER> infection severity via potential interactions ace<NUMBER> however direction magnitude effects unknown time several international societies released statements discouraging discontinuation ace inhibitors ang ii receptor blockers patients treated medications hypertension heart failure chronic kidney disease amidst covid<NUMBER> pandemic <NUMBER>• given clear benefits agents hypertension chronic kidney disease coronary heart disease diabetes urgent need research improve understanding relationship agents act reninangiotensin system outcomes among individuals covid<NUMBER> several studies currently underway <NUMBER>• funding information jbc supported k<NUMBER>hl<NUMBER> national heart lung blood institute tch supported t<NUMBER>hl<NUMBER> national heart lung blood institute ams supported r<NUMBER>hl<NUMBER> national heart lung blood institute uc<NUMBER>dk<NUMBER> national institute diabetes digestive kidney diseases loan repayment program award national heart lung blood institute apb supported <NUMBER>k<NUMBER>hl<NUMBER> national heart lung blood institute conflict interest authors declare conflicts interest relevant manuscript angiotensin converting enzyme ace ec <NUMBER> chloride zinc dependent dipeptidyl carboxypeptidase ubiquitously existing mammalian species main isoform predominantly expressed lung membranebound singe peptide glycoprotein bioactive component reninangiotensin system ras kallikreinkinin system kks ace plays significant role blood pressure regulation fluid electrolyte balancing cardiovascular system development vascular remodeling hydrolyzing angiotensin potent vasopressor peptide angiotensin ii deactivating vasodepressor peptide bradykinin inhibitors captopril enalapril benazepril fosinopril et al developed recent years tested treating hypertension nice vasodepressive effect clinical trial obtained side effects reported cough sexual hypoacusis synthetic drugs used long time screening natural antihypertensive drugs properties ace need understood depth article reviews structurefunction relationship ace well gene polymorphism inhibitor development <NUMBER> structure function <NUMBER> three splicing transcripts existing humans encoded ace gene transcript <NUMBER> ubiquitously distributed many tissues termed somatic ace sace consists <NUMBER> amino acids transcript <NUMBER> transcript <NUMBER> referred testicle ace tace expressed testis mature sperm consisting <NUMBER> amino acids <NUMBER> amino acids respectively molecular weight sace <NUMBER> <NUMBER> da contains one nterminal signal peptide sequence <NUMBER>aa two large homologous catalytically active sites referred ndomain cdomain one hydrophobic transmembrane domain <NUMBER>aa one cytosolic domain metalloprotease cleavage site residue <NUMBER> sace shed plasma membrane truncating cterminus secreted serum soluble form sace exist two forms tissue ace plasma ace tissue ace anchors plasma membrane transmembrane domain whereas plasma ace also named soluble ace form contains one catalytic domain transcript <NUMBER> molecular weight <NUMBER> nterminal signal peptide sequence residue <NUMBER> <NUMBER> transcript <NUMBER> residue <NUMBER> cterminus identical cterminal domain sace except slight differences signal peptide nterminus <NUMBER> <NUMBER> transcript <NUMBER> molecular weight <NUMBER> whose sequence identical transcript <NUMBER> except differences residue <NUMBER> carboxyl end frameshift mutation molecular differences ace transcripts rooted alternative splicing terminal sites encoding gene ace locates base <NUMBER>q<NUMBER> chromosome <NUMBER> kb length contains <NUMBER> exons <NUMBER> introns expression products sace tace derived gene using alternative promoters <NUMBER> contributes difference n terminal sequence sace transcribed exons <NUMBER> <NUMBER> whereas tace transcribed <NUMBER> promoter sace <NUMBER> flanking region first exon whereas promoter tace located within intron <NUMBER> gene initiates two alternative sites also contains two potential polyadenylation sites downstream termination codon <NUMBER> bp apart tace uses proximal site whereas sace uses distal one <NUMBER> analysis structure ace gene suggests catalytically active sites sace similar sequence also exon structure exons <NUMBER> <NUMBER> respectively characterized consensus zincbinding motif hegmhthis suggested ace gene arises duplication coded ancestral gene segment <NUMBER> <NUMBER> quantitative rtpcr harmer et al <NUMBER> found ace expressed <NUMBER> tissues examined expression particularly high ileum jejunum duodenum testis lung pulmonary blood vessels prostate sace expressed human tissues whereas tace found testis adolescence regulation hormone sace tace products tissuespecific stagespecific expression implied exerted specific biological function <NUMBER> presence zn <NUMBER> ace hydrolyzes peptide bond phe <NUMBER> <NUMBER> decapeptide angiotensin ang release octapeptide angiotensin ii ang ii cterminal dipeptide hisleu ang ii one potent vasoconstrictor upon binding type <NUMBER> receptor ang ii contracts vascular smooth muscle stimulates secretion aldosterone na k reabsorption kidney induces watersodium retention blood volume increase subsequently result blood pressure increase positive inotropic effect chronotropic effect heart ace inactivates vasodilator sequential cleavage two cterminal dipeptides named kininase <NUMBER> besides substrates angiotensin bradykinin ace also hydrolyze wide range vasoactive peptide enkephalin substance p neurotensin demonstrated ace degrade amyloid peptide overexpression alzheimers disease vitro <NUMBER> testicular germ cells kondoh et al <NUMBER> identified ace glycosylphosphatidylinositol gpianchored proteinreleasing gpiase factor addition peptidase activity ace also plays role gpiase releasing gpianchored proteins sperm membrane aceknockout sperm lost eggbinding ability <NUMBER> significant relationship ace iddd genotypes development cardiovascular diseases polymorphism ace involves insertion deletionid <NUMBER>base pair alu repeat sequence near <NUMBER> end intron <NUMBER>this partially associated concentration ace circulation serum ace activity dd genotype twice high ii genotype ace polymorphism reported associate hypertension cardiovascular diseases left ventricle hypertrophy myocardial infarction diabetes dd genotype shown risk factor cardiovascular diseases <NUMBER> significant association cardiovascular diseases hypertension allele ace gene documented africanamerican chinese japanese bangladeshi turkish population influences population backgrounds environmental heterogeneity also found study associating ace id gene polymorphism hypertension bangladeshi population morshed et al <NUMBER> found following among three ace id variants dd genotype associated highest value mean systolic blood pressure mean diastolic blood pressure ii genotype associated least value however association id polymorphism hypertension tested sexspecific relationship dd genotype hypertension much closer men women one reason estrogen women might play protective effect hypertension sexdifference remarkable younger subjects elderly subjects <NUMBER> <NUMBER> bradykinin stimulates release tissue plasminogen activator tpa endothelial cells sequence tace identical cdomain sace except tace first <NUMBER> residues human sace tace<NUMBER> carboxyterminal transmembrane cytosolic sequences tace<NUMBER> tace<NUMBER> amineterminal distinct transmembrane cytosolic sequences none drosophila ance acer membraneanchoring sequence carboxyl end ace<NUMBER> homologous collectin nonenzymatic protein associated renal injury n amineterminus c carboxyterminus sp signal peptide tm transmembrane domain hemgh locations activesite zincbinding motif hexxh locations activesite zincbinding motif degraded inactivated ace thus ace inhibitor shown reduce incidence myocardial infarction retaining tpa study relationship id polymorphism coronary thrombogenesis dd genotype associated higher ace activity contributed coronary thrombogenesis myocardial infarction inhibiting bradykinin <NUMBER> <NUMBER> sequence tace identical cdomain sace except first <NUMBER> residues human sace tace<NUMBER> carboxyterminal transmembrane cytosolic sequences tace<NUMBER> tace<NUMBER> amine terminal distinct transmembrane cytosolic sequences neither drosophila ance acer membraneanchoring sequence carboxyl end ace<NUMBER> homologous collectin nonenzymatic protein associated renal injury high homology ace catalytical active domains indicates ancestral gene acelike proteinases also found animal species including chimpanzee cow rabbit mouse chicken goldfish electric eel house fly mosquito torn fly silk worm drosophila melanogaster melanogaster bacteria xanthomonas sp shewanella oneidensis ace homologs consist m<NUMBER> gluzincin family ance consisting <NUMBER> amino acids one form acelike protein melanogaster catalytical activity resembles cdomain human sace acer second acerelated protein identified melanogaster catalytical activity similar ndomain sace ance acer singledomain enzyme secretive ectoenzyme without cterminal membrane anchoring hydrophobic sequence expressed successively pupal development melanogaster performed different physiological functions four additional acelike genes found adh region melanogaster chromosome <NUMBER> reflected ancestral gene structure presented protostome deuterostome lineages suggested duplication within ace gene vertebrate genomes predates divergence lineages <NUMBER> <NUMBER> <NUMBER> first homologue ace known human termed aceh ace<NUMBER> ace<NUMBER> zinc dependent carboxy peptidase contains <NUMBER> amino acids including one nterminal hydrophobic signal peptide sequence <NUMBER>aa one catalytically active site <NUMBER>aa one hydrophobic transmembrane domain <NUMBER>aa ace<NUMBER> also shedd cell surface proteolytic cleavage juxtamembrane region ace<NUMBER> <NUMBER> sequence identity <NUMBER> sequence similarity two active sites ace <NUMBER> identical overall tace ace<NUMBER> expressed specific tissues human heart kidney testis distributes coronary endothelial cells vascular smooth muscle cells renal tubular epithelial cells ace<NUMBER> converts ang form ang<NUMBER> cleaving single cterminal leu ang ii form ang<NUMBER> removing cterminal phe product ang<NUMBER> hydrolyzed cterminal dipeptide ace generating vasodilator ang<NUMBER> <NUMBER> therefore ang<NUMBER> acts competitive inhibitor ace counterbalancing vasoconstriction exception ang ang ii substrates ace<NUMBER> also include neurotensin kinetensin desarg bradykinin however ace<NUMBER> fails cleave bradykinin hiphisleu shows substrate specificity ace<NUMBER> ace activity ace<NUMBER> cannot inhibited acei captopril lisinopril enalaprilat perform different physiological functions sophisticated regulation vivo ace<NUMBER> gene orients human x chromosome sexspecificity implies sexspecificity appeared ras cardiovascular physiology possible relation ace<NUMBER> <NUMBER> regarded ace<NUMBER> play crucial role cardiovascular physiological regulation closely identified membrane receptor sars coronavirus sarscov infects cells attachment sprotein cell surface infectivity sarscov inhibited blocking sprotein bound functional receptor ace<NUMBER> <NUMBER> ace<NUMBER> anchoring plasma membrane functional receptor sarscov mediates fusion viral host membranes antibodies compounds affinity ace<NUMBER> well soluble ace<NUMBER> able prevent virus entry lang et al <NUMBER> found interferonand interleukin<NUMBER> downregulated expression ace<NUMBER> vero e<NUMBER> cells screening <NUMBER> controlled chinese medicinal herbs ho et al <NUMBER> identified emodin inhibited interaction sprotein ace<NUMBER> vero e<NUMBER> cells <NUMBER> <NUMBER> ace drug target screening antihypertensive agents snake venoms exert favorable inhibitory effects ace nonapeptide compound termed sq<NUMBER> obviously hypotensive activity works injected work taken orally restrict medicine value ace shares similar advanced structure carboxypeptidase lbenzylsuccinic acid strong inhibitor carboxypeptidase succinyl amino acid designed target compound acei natural peptideinhibitors ace snake venom cterminal proline succinylproline synthesized first target compound physiological activity systematically studied later modifying structure compounds oral nonpeptide compound captopril found new ideal hypotensive basis structure two new oral hypotensive drugs enalapril lisinopril developed <NUMBER> <NUMBER> acei inhibits activity ace myocardium kidney vessel wall via decreasing blood pressure inhibiting myocardial vascular hypertrophy also improve autonomic nervous activity patients chronic heart failure vasodilator initially acei maybe associated blockade endocrine cardiac tissue paracrine autocrine tested myocardium hypertrophy myocardial fibrosis reduced ventricular remodeling improved thus acei used hypotensive drug also widely used treatment cardiovascular systemurinary system endocrine system diseases demonstrated class drugs distinctly improve heart function decrease urinary protein nephropathies delay progression renal failure long term usage acei also improve patients living quality prolong life span <NUMBER> <NUMBER> <NUMBER> acei reduces vasoconstriction induced ang ii also blocks degradation bradykinin well substrates increased bradykinin concentration brings side effects cough <NUMBER> <NUMBER> development single domain specific inhibitor expected solve problem rxp<NUMBER> reported ndomainspecific inhibitor sace <NUMBER> increases concentration acsdkp serum hematoregulator suggests acsdkp specifically cleaved ndomain differences occur two active sites sace <NUMBER> rxpa<NUMBER> designed highly specific inhibitor cdomain sace study georgiadis et al <NUMBER> focused roles two active sites cleavage ang bradykinin two active sites ace tissue plasma inhibited rxp<NUMBER> rxpa<NUMBER> together largest bradykinin protection observed whereas one active site inhibited either rxp<NUMBER> rxpa<NUMBER> half activity protected leads conclusion active sites sace equally participate degradation bradykinin full inhibition ang cleavage required blockade two active sites ace plasma circulatory system ace ndomain tissues specifically inhibited without differences ang conversion whereas selectively inhibited cdomain ang conversion completely blocked shows active domains plasma sace contribute hydrolyzation ang ang iang ii conversion depends exclusively ace cdomain thus ace cdomainspecific inhibitor regarded sufficiently regulate hypertension two forms sace plasma ace tissue ace two catalytically active sites appear different catalytical capability specific substrates shows membranebound ace soluble ace appear obey different mechanisms <NUMBER> study van esch et al <NUMBER> demonstrated selective ace cdomain inhibitor sufficient prevent ang ii inducing vasoconstriction supplies new path screen safer hypotensive agents acei <NUMBER> ace cdomain specific inhibitor regarded treatment cardiovascular diseases fewer side effects higher safety sufficiently blocks ang ii generation incomplete inhibition bradykinin degradation maintains bradykinin concentration offers novel path new generation drug structure designing important roles ras cardiovascular system draw attentions recently ace inhibitor always used first line treatment hypertension heart failure new members acei identified continually research molecular mechanism carried deeply ranges widely pioneer peptideinhibitors synthetic small molecules domainspecific inhibitors natural drugs hope screening domainspecific inhibitory leading compounds natural products well traditional chinese medicine selectively block cdomain ace less toxicity side effects sars infectious disease high mortality rate caused human coronavirus sarscov ksiazek et al <NUMBER> severity global spread <NUMBER> sars outbreak led search specific antiviral compounds sarscov results vitro studies case reports clinic published consensus treatment yet established major efforts made understand mechanism sarscov replication order identify drug targets specific antiviral compounds chu et al <NUMBER> liu et al <NUMBER> thiel et al <NUMBER> vastag <NUMBER> wu et al <NUMBER> coronaviruses enveloped positivestrand rna viruses initiate infection susceptible cells binding human angiotensin converting enzyme<NUMBER> ace<NUMBER> host cell membrane via viral protein li et al <NUMBER> xu et al <NUMBER> following receptor binding membrane fusion infectious genomic rna delivered cytoplasm viral gene expression initiated resulting translation two replicasetranscriptase polyproteins two enzymes responsible replication viral genome well generation multiple subgenomic mrnas including encoding structural proteins spike membrane e envelope n nucleocapsid de haan et al <NUMBER> complex set regulatory mechanisms controls viral gene expression additional virusencoded enzymes helicase proteases crucial production infectious virus particles thiel et al <NUMBER> progeny virions assembled endoplasmatic reticulumgolgi apparatus released infected cells exocytosis viral entry assembly processes well enzymatic steps involved viral replication constitute potential targets antiviral therapy understanding mechanism viral replication key step towards identification effective drugs virus development rapid screening assays also essential antiviral drug discovery present standard infectivity assay sarscov based viral infection veroe<NUMBER> cells followed visual monitoring cytopathic effects cpe ksiazek et al <NUMBER> lowthroughput nature assay format limits use efficient screening large chemical libraries study describes development stable cell line susceptible sarscov constitutively expresses egfp used automated screening inhibitors virus activity high degree correlation virus replication reduced egfp signal expected highly cytopathic viruses sarscov background egfp signal rapidly reduced extensive cell death specificity selectivity compounds active sarscov screening assay determined parallel screening cytotoxicity inhibition porcine coronavirus using similar assay formats set assays used screening test panel <NUMBER> randomly chosen chemical compounds demonstrate application drug discovery porcine kidney cell line llcpk<NUMBER> african monkey kidney cell line veroe<NUMBER> kindly provided dr k andries jjprd beerse belgium dr g van ham institute tropical medicine antwerp belgium respectively llcpk<NUMBER> veroe<NUMBER> cell lines maintained dulbeccos modified eagles medium dmem cambrex bioscience walkersville walkersville md supplemented <NUMBER> fetal calf serum fcs highclone logan ut <NUMBER> lglutamine invitrogen carlsbad ca <NUMBER> gentamycin invitrogen packaging cell line retropack pt<NUMBER> purchased bd biosciences clontech palo alto ca grown rpmi <NUMBER> medium invitrogen supplemented <NUMBER> fcs <NUMBER> gentamycin retroviral vector plnce containing egfp coding sequence cytomegalovirus immediateearly promotor kind gift dr e kandel university illinois chicago il sarscov strain <NUMBER> obtained centers disease control prevention cdc atlanta ga tgev strain purdue<NUMBER> obtained jjprd beerse belgium af<NUMBER> antibody directed ace<NUMBER> purchased rd systems europe abingdon uk produce retroviruses egfp gene delivery pt<NUMBER> cells transfected plnce using lipofectamine invitrogen according manufacturers instructions supernatant transfected pt<NUMBER> cells collected used transduce llcpk<NUMBER> veroe<NUMBER> cells transduced cells incubated <NUMBER> days <NUMBER> • c <NUMBER> clones cell line screened homogeneous high egfp signal fluorescence activated cell sorting facs clones also analyzed susceptibility sarscov tgev infection growth capacity seeding <NUMBER> <NUMBER> <NUMBER> <NUMBER> cellsml monitoring egfp signal <NUMBER> days constitutively egfp expressing cell lines designated veroe<NUMBER>egfp llcpk<NUMBER>egfp virus culture screening assays carried certified biosafety level<NUMBER> laboratory llcpk<NUMBER> cells inoculated tgev veroe<NUMBER> cells inoculated sarscov subsequently incubated humidified incubator <NUMBER> • c <NUMBER> co <NUMBER> <NUMBER> days majority cells showed cpe cell culture supernatants clarified centrifugation <NUMBER> × g <NUMBER> min stored −<NUMBER> • c use <NUMBER> cell culture infectious dose ccid <NUMBER> determined titration llcpk<NUMBER> veroe<NUMBER> cells depending virus using <NUMBER> serial fivefolddilution steps <NUMBER> days incubation <NUMBER> • c plates inspected cpe test compounds serially diluted fourfold cell culture medium mixed <NUMBER> ccid <NUMBER> tgev <NUMBER> ccid <NUMBER> sarscov <NUMBER> llcpk<NUMBER>egfp veroe<NUMBER>egfp cells corresponding final concentration <NUMBER> cellsml <NUMBER>well blackview plates corning corning ny plates sealed gas permeable membrane incubated humidified incubator <NUMBER> • c <NUMBER> co <NUMBER> <NUMBER> days wells examined egfp expression using argon laserscanning microscope microscope settings excitation <NUMBER> nm emission <NUMBER> nm fluorescence images wells converted signal values results expressed ec <NUMBER> values defined concentration compound achieving <NUMBER> inhibition virusreduced egfp signals compared untreated virusinfected control cells test cytotoxicity cells incubated serial compound dilutions described absence virus challenge <NUMBER> cytotoxic concentration cc <NUMBER> determined comparing egfp signal treated wells control wells containing untreated cells calculated similarly ec <NUMBER> two selectivity indices si calculated cytotoxicityantiviral activity si provides measure range compound effective without cytotoxic calculated ratio cc <NUMBER> ec <NUMBER> tgevsarscov si represents specificity compound inhibiting sarscov tgev calculated ratio tgev ec <NUMBER> sarscov ec <NUMBER> validity reduced egfp expression marker virus activity determined titration sarscov stock veroe<NUMBER>egfp cells calculating titers based egfp signal cpe similar experiments performed using tgev llcpk<NUMBER>egfp cells determine sensitivity assays defined lowest virus titer resulting detectable decrease egfp signal serially diluted sarscov tgev stocks added respective indicator cells egfp signals recorded described screening assay determine intraand interexperiment reproducibility <NUMBER> veroe<NUMBER>egfp cellsml added together <NUMBER> ccid <NUMBER> sarscov <NUMBER> wells <NUMBER>well plate additional <NUMBER> wells plate seeded <NUMBER> uninfected veroe<NUMBER>egfp cellsml controls egfp signal well recorded <NUMBER> days post plating described screening assay experiment repeated three separate days intraexperimental variation determined calculating mean egfp signals virusinfected control cells plated within day interexperimental variation determined calculating mean egfp signal experiments performed three separate days standard deviation sd coefficient variation cv signal ratio control versus virusinfected cells calculated intraand interreproducibility experiments demonstrate specificity assay defined ability detect selective sarscov inhibitors serial dilutions ace<NUMBER> antibody prepared phosphate buffered saline pbs sigma st louis mo analyzed parallel sarscov tgev cytotoxicity screening assays described identify potential classes pharmacological agents active sarscov range previously described antiviral compounds tested table <NUMBER> antiviral agents included compounds targeting viral cellular factors ribavirin et al <NUMBER> azt furman et al <NUMBER> zhang et al <NUMBER> included representatives widely used class nucleoside analogs inhibiting viral polymerases selected antiviral protease inhibitors implicated active sarscov yamamoto et al <NUMBER> wu et al <NUMBER> chu et al <NUMBER> meriting inclusion lopinavirritonavir range nonspecific antiviral reagents included aurintricarboxylic acid ata dextran sulfate <NUMBER> ds<NUMBER> novaron glycirrhizin snitrosonacetylpenicillamine included due previously reported activities sarscov unclear mechanisms action cinatl et al <NUMBER> keyaerts et al <NUMBER> additionally variety antiviral compounds acting cellular targets included p<NUMBER> map kinase inhibitors tgf␤ inhibitors <NUMBER> ace inhibitors table <NUMBER> separately <NUMBER> randomly chosen compounds proprietary chemical library tested compounds dissolved <NUMBER> mm dimethylsulphoxide dmso sigma diluted cell culture medium final dmso concentration <NUMBER> provide convenient indicator cells highthroughput screening assays stable cell lines constitutively expressing egfp generated veroe<NUMBER> llcpk<NUMBER> cell lines transduced packaging retrovirus carrying egfp gene <NUMBER> clones isolated cell line subsequent characterization studies cells subjected facs analysis egfp expression select clones exhibiting profile high mean fluorescence intensity homogeneous signal fig <NUMBER> egfp expressing clones evaluated susceptibility virus infection showing clones susceptible either sarscov tgev measured cpe induction virus challenge data shown growth characteristics veroe<NUMBER>egfp llcpk<NUMBER>egfp clones similar parental veroe<NUMBER> llcpk<NUMBER> cell lines data shown indicating egfp expression affect cell proliferation expected transduced cells showed exponential growth dependent initial cell density representative example shown fig <NUMBER> moreover growth experiments showed final seeding density <NUMBER> cellsml suitable keeping cells exponential growth phase throughout <NUMBER>day assay period taking selection criteria account clone <NUMBER> veroe<NUMBER>egfp clone <NUMBER> llcpk<NUMBER>egfp data shown selected indicator cells seeded density <NUMBER> cellsml screening assays ensure reliable screening platform reduced egfp expression validated marker virusinduced cytopathic activity robustness specificity assays determined validity using quantification reporter gene egfp measure viral activity determined virus titration experiments calculating titers based cpe egfp measurements titration experiments showed virusconcentration dependent loss egfp expression virus titers scored methods good agreement table <NUMBER> confirming egfp expression serve marker activity two viruses assay sensitivity determined lowest virus titer resulting least twofold decrease egfp signal indicator cells showed significant reduction egfp signal virus titers low <NUMBER> ccid <NUMBER> sarscov <NUMBER> ccid <NUMBER> tgev fig <NUMBER> confirming measurement egfp expression cells allows sensitive detection low levels virus assay robustness intraand interassay variation assessed multiple egfp measurements day several days signal ratio uninfected control cells virusinfected cells varied <NUMBER> <NUMBER> suggesting sufficient dynamic range measure antiviral activity test compounds table <NUMBER> specificity assay defined ability detect selective sarscov inhibitors determined testing antiace<NUMBER> antibody specific sarscov receptor screening assays antibody showed selective potent inhibition sarscov noncytotoxic concentrations fig <NUMBER> table <NUMBER> antiviral ec <NUMBER> value <NUMBER> measuring virus inhibition based egfp signal table <NUMBER> <NUMBER> using cpe readout data shown shows close correlation egfp expression viral cytopathic activity together validation experiments showed screening system reproducible specific detection agents active sarscov sarscov screening system initially used test selection pharmacological agents compounds included agents targeting different viral factors well inhibitors cellular p<NUMBER> kinase tgf␤ ace table <NUMBER> one <NUMBER> ace inhibitors table <NUMBER> showed selective antiviral activity sarscov using cytotoxicityantiviral activity si criterion <NUMBER> however llcpk<NUMBER>egfp cell line appeared sensitive cytotoxic effects compound veroe<NUMBER>egfp cell line indicating ace inhibitor may exhibit cellular effects observed sarscovveroe<NUMBER>egfp assay system tested agents showed antiviral activity cytotoxic concentration table <NUMBER> data shown test possible use assay system highthroughput setting total <NUMBER> small molecule compounds tested selective antiviral activity sarscov sixtyfour compounds active sarscov assay <NUMBER> compounds exhibited cytotoxicityantiviral activity si least <NUMBER> listed compounds ar table <NUMBER> ec <NUMBER> values ranged <NUMBER> <NUMBER> <NUMBER> antisarscov active noncytotoxic compounds <NUMBER> showed tgevsarscov si least <NUMBER> absence cytotoxic effects two indicator cell lines compounds n p table <NUMBER> together results show combination assays used screening system potential provide efficient basis drug discovery important aspect drug screening new viral diseases choice assay system drug candidate fulfill number requirements regarding potency target specificity cytotoxicity thus screening system designed three parallel types assays similar setup readout evaluate parameters concurrently initial screening phase susceptible cell lines equipped egfp reporter genes used quantification cytotoxicity sarscov tgev activity assay system readily applied highthroughput screening many advantages assays based laborious subjective scoring cpe plaque formation assay system described study requires minimal manipulation assay setup staining washing fixation manual inspection tissue culture plates especially advantageous working hazardous viruses sarscov strategy use parallel counterscreening chemical compounds porcinespecific member coronavirus family employed select drug candidates high specificity human sarscov highly virusspecific compounds likely exhibit welldefined single viral target binding site greatly facilitates structureactivity analysis optimization active compounds identified initial screening thus platform three parallel screening assays described obtains data potentially useful compounds initial screening step simple infectivity assays therefore speeds downstream drug development course conceivable potent antiviral drug candidates developed compounds targeting multiple coronaviruses compounds active coronaviruses may selected data obtained screening system analyzed separately analyzing panel reported antiviral compounds different mechanisms activity tested screening system finding ace inhibitor showed selective activity sarscov line reported usage ace<NUMBER> receptor virus li et al <NUMBER> ribavarin although active wide range viruses used sars therapy et al <NUMBER> shown study inactive sarscov vitro noncytotoxic concentration line previous reports tan et al <NUMBER> cinatl et al <NUMBER> wu et al <NUMBER> yi et al <NUMBER> variation results obtained study novaron glycirrihizin snitrosonacetylpenicillamine compared previously published results may due assay conditions including virus strain multiplicity infection detection method compound concentration handling cinatl et al <NUMBER> keyaerts et al <NUMBER> notably independent groups also observed lack antisarscov activity glycyrrhizin hertzig et al <NUMBER> yi et al <NUMBER> table <NUMBER> screening activities validation general antiviraland chemical library compounds assay system also evaluated setting chemical library screen compounds selectively active sarscov noncytotoxic compound concentrations identified library screen compounds show potential optimization potent inhibitors sarscov merit detailed characterization regarding mechanism action conclusion report describes robust screening system identification drug candidates selectively active sarscov screening system meets requirements successful highthroughput assay minimal manipulation assay setup low sample volume automated detection endpoint furthermore system offers considerable benefits first round screening regard fig <NUMBER> titration ace<NUMBER> antibody veroe<NUMBER> cells ace<NUMBER> antibody showed concentrationdependent protection egfp signal sarscov challenge quadruple wells infected treated veroe<NUMBER>egfp cells shown numbers indicate tested antibody concentration gml vc virus control cc cell control mc medium control ing selectivity specificity toxicity compound resulting improved data set initial screen comparison existing assays based simpler observation plaque formation analysis cpe system ease handling good level containment well suited drug discovery sarscov applicable emerging highrisk pathogenic viruses newly identified coronavirus sarscov<NUMBER> causes severe pneumonia coronavirus disease <NUMBER>covid <NUMBER> rapidly spread across world initial outbreak point wuhan china late <NUMBER> <NUMBER> become global health emergency march <NUMBER> <NUMBER> world health organization declared pandemic status novel coronavirus outbreak since approved drug specifically targeted virus exists point time drug repositioningrepurposing thought effective feasible approach toward clear present threat researchers initiated studies employing various means order find potential therapeutics <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> genome close severe acute respiratory syndrome coronavirus sarscov <NUMBER> past efforts cure rna virus infections including experiences sars middle east respiratory syndrome mers epidemics several potential target proteins drugs proposed <NUMBER> <NUMBER> <NUMBER>clike main proteinase surface glycoprotein <NUMBER> rnadependent rna polymerase thought promising targets anticovid<NUMBER> therapeutics example antihiv drug lopinavirritonavir proposed treat sars <NUMBER> <NUMBER> expected effective toward sarscov<NUMBER> <NUMBER>clike proteinase <NUMBER> <NUMBER> additionally antiviral drug remdesivir expected target rnadependent rna polymerase <NUMBER> recent studies drug repositioningrepurposing involve variety computational methods network analysis text mining machine learning structurebased drug repositioning sbdr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> among methods sbdr promising find abbreviations ace<NUMBER> angiotensin iconverting enzyme <NUMBER> mers middle east respiratory syndrome rbd receptorbinding domain sarscov severe acute respiratory syndrome coronavirus sbdr structurebased drug repositioning world health organization specific drugs toward defined target protein prompted quick structure analyses sarscov<NUMBER> <NUMBER>clike proteinase surface glycoprotein <NUMBER> <NUMBER> although structure analyses many sarscov<NUMBER> proteins would soon follow predictions protein structures homologyknowledgebased theoretical methods would required structure analyses completed especially proteins currently focus drug targets presented study therefore homology models sarscov<NUMBER> proteins ligand complexes comprehensively constructed also structural models complexes sarscov<NUMBER> proteins potential drugs proposed comparing ligand molecules proteins approved experimental natural drugs amino acid sequences sarscov<NUMBER> proteins table <NUMBER> retrieved refseq database ncbi <NUMBER> structural modeling templates sought sird system httpsirdnagahamaibioacjpsird accepted multiple query sequences sought similar sequences <NUMBER> sequence identity query known structures protein data bank pdb <NUMBER> using blast <NUMBER> system also sought templates protein complex structures two proteins multiple query associated ligand bound query proteins coordinates template structures obtained pdb <NUMBER> rendered biological quaternary structures initial structural models constructed using modeller <NUMBER> cases resultant models contain residues rare dihedral angles ramachandran outliers rare shape side chains rotamer outliers short atomatom distances atomic crashes models modified iteratively applying molecular dynamics geometry minimization procedures phenix <NUMBER> eliminate aforementioned outliers finally manual model modifications visual inspection coot resolving rotamer outliers atomic crashes <NUMBER> model quality evaluated molprobity <NUMBER> percentages rotamer outlier ramachandran outlier crash score monitored model achieve less <NUMBER> <NUMBER> <NUMBER> respectively modeling sarscov<NUMBER> protein complexes potential drugs molecular formula <NUMBER> drugs total retrieved kegg database <NUMBER> drugbank database <NUMBER> molecular formula <NUMBER> metabolites total used natural medicines natural drugs obtained knapsack database <NUMBER> structures ligand molecules known complex structures sought template search process exhaustively compared drugs using complig <NUMBER> complig matches molecular graphs evaluates similarity score two molecules b minm selected drug molecules built protein models superposing drug molecules known original ligand molecules complig according graph matching results dihedral angles drug molecules adjusted toward corresponding angles original ligand molecules corresponding atoms superposed drug known ligand fixing coordinates latter models proteindrug complexes modified phenix coot constraints drug molecules generated using elbow application phenix hydrogen bonds evaluated canonical parameters constraints relaxed <NUMBER> å <NUMBER> degrees <NUMBER> using chimera <NUMBER> proteinligand complexes also assessed using dsx score function <NUMBER> sarscov<NUMBER> genome encodes <NUMBER> genes open reading frames polyprotein orf<NUMBER>ab processed <NUMBER> proteins polypeptides cleavages papainlike proteinase <NUMBER>clike proteinase activities <NUMBER> <NUMBER> <NUMBER> result template search appropriate structural templates found <NUMBER> sarscov<NUMBER> proteins among total <NUMBER> homology models constructed table <NUMBER> <NUMBER> unmodeled proteins included short orfs namely nsp<NUMBER> <NUMBER> amino acid residues orf<NUMBER>b <NUMBER> residues orf<NUMBER> <NUMBER> residues probable membrane proteins nsp<NUMBER> orf<NUMBER>a orf<NUMBER> orf<NUMBER> annotated sosui server <NUMBER> since considerable amount structural studies already done sarscov merscov proteins available templates viruses highsequence similarity <NUMBER> sarscov<NUMBER> proteins two proteins namely papainlike proteinase nsp<NUMBER> nucleocapsid phosphoprotein could modeled single structural model result homology search template structures covering entire protein unavailable template structures separated <NUMBER> <NUMBER> fragmentdomain models respectively consequently coverages structural model <NUMBER> <NUMBER> total residues papainlike proteinase nsp<NUMBER> nucleocapsid phosphoprotein respectively table <NUMBER> third region papainlike proteinase nsp<NUMBER> nsp<NUMBER> <NUMBER>clike proteinase nsp<NUMBER> endornase surface glycoprotein envelope protein cterminal region nucleocapsid phosphoprotein modeled homomultimer heteromultimeric models nsp<NUMBER> nsp<NUMBER> modeled hetero<NUMBER>mer rnadependent rna polymerase nsp<NUMBER> nsp<NUMBER> modeled heterotetramer <NUMBER> stoichiometry <NUMBER>to<NUMBER> exonuclease nsp<NUMBER> formed heterodimer <NUMBER>oribose methyltransferase nsp<NUMBER> also formed heterodimer homotrimer surface glycoprotein modeled complex human angiotensin iconverting enzyme <NUMBER> ace<NUMBER> table <NUMBER> although models sarscov<NUMBER> protein would useful structurebased virtual screening potential drugs proteins sought rather simple knowledgebased method presented study ligand molecules complexed homologs sarscov<NUMBER> protein pdb extracted structurally similar molecules ligands sought among approvedexperimental drugs retrieved kegg database <NUMBER> drugbank database <NUMBER> many approved drugs morphine aspirin penicillin adapted natural medicines <NUMBER> <NUMBER> molecules natural medicines expected serve argent therapeutics therefore ligand structures also compared components natural medicines natural drugs registered knapsack database <NUMBER> original ligand molecules detected drug molecules summarized table <NUMBER> total <NUMBER> ligand molecules matched <NUMBER> approvedexperimental <NUMBER> natural drugs complex models sarscov<NUMBER> proteins several promising drugs high similarity score placed higher ranking constructed follows <NUMBER>clike proteinase involved processing viral polyprotein <NUMBER> enzyme one extensively studied drug targets thus analyzed complex various peptide mimetic inhibitors <NUMBER> <NUMBER> <NUMBER> <NUMBER> unexpectedly ligands show high similarity known drug molecules table <NUMBER> peptide mimetic drug carfilzomib showed highest score template ligand ligand code azp <NUMBER>clike proteinase homolog fig <NUMBER>a however similarity score ligand drug <NUMBER> carfilzomib irreversible proteasome inhibitor targeted subunits chymotrypsinlike activity approved refractory multiple myeloma waldenstr€ oms macroglobulinemia <NUMBER> <NUMBER> complex model carfilzomibsarscov<NUMBER> <NUMBER>clike proteinase constructed model carfilzomib formed parallel bsheet his<NUMBER>glu<NUMBER> side chains his<NUMBER> cys<NUMBER> met<NUMBER> leu<NUMBER> phe<NUMBER> gln<NUMBER> contributed major interactions fig <NUMBER>bc residues conserved template sarscov model sarscov<NUMBER> proteins carfilzomib covalently binds active site threonine epoxy moiety epoxy moiety also reactive thiol group cysteine although possible covalent linkage carfilzomib catalytic cys<NUMBER> sarscov<NUMBER> <NUMBER>clike proteinase explicitly modeled epoxy moiety placed close catalytic residue model fitness ligand sarscov<NUMBER> <NUMBER>clike proteinase model evaluated dsx function score carfilzomib <NUMBER> even better à<NUMBER> inhibitor n<NUMBER> complex crystal structure sarscov<NUMBER> <NUMBER>clike proteinase pdb id <NUMBER>lu<NUMBER> surface glycoprotein used viral entrance host cell cell surface receptor human angiotensin iconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> ace homolog ace<NUMBER> sharing <NUMBER> amino acid sequence identity major target hypertension medicating drugs several acedrug complexes reported <NUMBER> <NUMBER> <NUMBER> lisinopril enalaprilat captopril show similar structures fig <NUMBER>a targeted toward ace approved hypertension treatments <NUMBER> <NUMBER> <NUMBER> <NUMBER> structural complex models drugs bound protein zn <NUMBER> coordination glu<NUMBER> his<NUMBER> his<NUMBER> fig <NUMBER>bc residues conserved template ace model ace<NUMBER> structures drug molecules also formed electrostatic interactions arg<NUMBER> arg<NUMBER> even though residues conserved ace ace<NUMBER> gln<NUMBER> ser<NUMBER> ace sarscov<NUMBER> surface glycoprotein interacted ace<NUMBER> receptorbinding domain rbd bound drugs direct interaction rbd fig <NUMBER>c suggesting drugs would directly interfere hostpathogen interaction dsx scores lisinopril enalaprilat captopril models à<NUMBER> à<NUMBER> à<NUMBER> respectively scores considerably inferior à<NUMBER> specific inhibitor mln<NUMBER> crystal structure human ace<NUMBER> complex pdb id <NUMBER>r<NUMBER>l <NUMBER> complex <NUMBER>oribose methyltransferase nsp<NUMBER> nsp<NUMBER> involved modification viral rna caps <NUMBER> structure <NUMBER>oribose methyltransferase subunit determined complex sadenosyllmethionine ligand code sam <NUMBER>methylguanosine<NUMBER>triphosphate<NUMBER>guanosine gtg sinefungin sfg <NUMBER> <NUMBER> <NUMBER> among ligands sadenosyllmethionine used therapeutic depression liver disorders fibromyalgia osteoarthritis <NUMBER> also authentic substrate enzyme sinefungin natural drug produced streptomyces griseolus experimentally used antibiotics <NUMBER> <NUMBER> <NUMBER> fig <NUMBER>a residues <NUMBER>oribose methyltransferase ser<NUMBER> asp<NUMBER> asn<NUMBER> asp<NUMBER> met<NUMBER> involved major interactions sinefungin fig <NUMBER>bc residues conserved among template proteins sarscov betacoronavirus sarscov<NUMBER> drugs similar ligands several investigational adenosine a<NUMBER> receptor agonists namely tecadenoson selodenoson trabodenoson found fig <NUMBER>a molecules share adenosine moiety moiety interacts aforementioned <NUMBER> conserved residues complex models dsx scores sinefungin tecadenoson selodenoson trabodenoson à<NUMBER> à<NUMBER> à<NUMBER> à<NUMBER> respectively scores sinefungin selodenoson comparable à<NUMBER> genuine substrate sadenosyllmethionine complex crystal structure merscov <NUMBER>oribose methyltransferase pdb id <NUMBER>yni presented study knowledgebased models sarscov<NUMBER> proteins constructed homology modeling comparison known ligands drugs since considerable number structure analyses already reported coronavirus proteins including sarscov <NUMBER> <NUMBER> sarscov<NUMBER> proteins could modeled based highly similar <NUMBER> sequence identity <NUMBER> coverage average templates table <NUMBER> several drugs suggested bind sarscov<NUMBER> targets table <NUMBER> procedure employed presented study largely limit extent search depends presence ligands known complex structures however noteworthy binding suggested drugs homologous proteins sarscov<NUMBER> targets would probable presence structural evidences complex models constructed several highscored andor highranked drugs unexpectedly drug detected one promising drug targets <NUMBER>clike proteinase similarity score higher <NUMBER> previous study score <NUMBER> suggested required highly similar interactions ligand protein <NUMBER> implied inhibitors bound <NUMBER>clike proteinase known structures considerably deviated approved proteasetargeted drugs example antihiv drug lopinavirritonavir expected target sarscov<NUMBER> <NUMBER>clike proteinase <NUMBER> <NUMBER> showed limited similarity score <NUMBER> known ligand ligand code axp sarscov <NUMBER>clike proteinase fig <NUMBER>a one possible reason low similarity drugs protease inhibitors tend higher molecular weight thus molecular structures showed large variety another reason would majority protease inhibitory drugs targeted toward serine zinc proteases <NUMBER> <NUMBER> also expected drug lopinavirritonavir designed hiv protease aspartic protease proteases structurally distinct <NUMBER>clike proteinase known cysteine protease observation implies structure optimizations would likely required repurposed drugs sarscov<NUMBER> <NUMBER>clike proteinase consequently presented study suggested carfilzomib targeted toward threonine protease approved multiple myeloma treatment <NUMBER> <NUMBER> marginally resembling drug model showed however carfilzomib fits well even better specific inhibitor n<NUMBER> according dsx score active site forming considerable stabilizing interactions severe steric hindrance fig <NUMBER>c another potential target complex surface glycoprotein ace<NUMBER> prevent virus entry cell <NUMBER> <NUMBER> many hypertension drugs targeted ace presented study highlighted approved drugs namely lisinopril enalaprilat captopril potential ligands ace<NUMBER> expectation advance find drug bound ace<NUMBER> also interfered interactions surface glycoprotein ace<NUMBER> however models revealed drugbinding site ace<NUMBER> existed inside deep cleft center ace<NUMBER> molecule ligands interact directly surface glycoprotein fig <NUMBER>c human ace<NUMBER> demonstrated change conformation open close forms pdb ids <NUMBER>r<NUMBER>l <NUMBER>r<NUMBER> respectively upon inhibitor binding <NUMBER> thus conformational change involves interface rbd surface glycoprotein drug bound drugbinding site might interfere binding ace<NUMBER> surface glycoprotein indirectly allosteric inhibition mechanism however highly expected obvious conformational change observed interface region comparing open close conformations ace<NUMBER> predicted drugs targeted toward ace ace<NUMBER> ace ace<NUMBER> diverge considerably amino acid sequences <NUMBER> identity fitness drugs evaluated lower specific inhibitor ace<NUMBER> therefore effects predicted ace drugs preventing surface glycoproteinace<NUMBER> interactions would highly promising another target presented results highlighted <NUMBER>oribose methyltransferase nsp<NUMBER>nsp<NUMBER> complex less focused target drug repurposing <NUMBER>oribose methyltransferase required finalize cap structure <NUMBER>me gpppa <NUMBER>ome coronavirus rnas transferring methyl group <NUMBER> oh group ribonucleotide sadenosyllmethionine <NUMBER> <NUMBER> cap structure essential viral mrnas translated escape innate immune system host cell thus inhibition enzyme might prevent virus propagation despite overall sequence identities templates sarscov human betacoronavirus sarscov<NUMBER> enzymes relatively low <NUMBER> residues interacting drugs conserved among suggested drugs enzyme sinefungin naturally occurring verified inhibitor <NUMBER>oribose methyltransferase since toxicity detected <NUMBER> however appreciation natural drug carefully considered although tecadenoson examined clinical trial atrial fibrillation passed phase ii test final results formally reported point time <NUMBER> trabodenoson designed treating ocular hypertension primary openangle glaucoma <NUMBER> failed phase iii clinical trial test due lack superiority placebo selodenoson designed control heart rate <NUMBER> seems still developmental stage since tecadenoson trabodenoson appeared cleared phase tests drugs would worth examining covid<NUMBER> dsx score suggested fitness sinefungin selodenoson comparable genuine substrate <NUMBER>oribose methyltransferase several structure determinations sarscov<NUMBER> proteins example endornase pdb ids <NUMBER>vww <NUMBER>vw<NUMBER> nucleocapsid phosphoprotein <NUMBER>vyo nsp<NUMBER> rnadependent rna polymerasensp<NUMBER>nsp<NUMBER> complex pdb id <NUMBER>bv<NUMBER> reported modeling presented study executed although many proteins analyses undoubtedly would take considerable time structures potential targets experimentally elucidated period structural determinations theoretical models might useful presented structural models freely available binds webpage httpswwwbind sjpsarscov<NUMBER> also deposited bsmarc repository bsm<NUMBER> <NUMBER> work partly supported platform project supporting drug discovery life science mo sk ts conceived designed study ah cs sn ms ts constructed models ah cs ts wrote manuscript authors commented manuscript classical concept conversion angiotensin vasoconstrictor angiotensin ii ang ii well degradation potent vasodilator bradykinin catalyzed angiotensinconverting enzyme ace ectoenzyme particularly abundant endothelial surface lungs <NUMBER> well known ace plays pivotal role reninangiotensin system ras consequently regulation blood pressure volume homeostasis vascular function cell growth investigators aware ras century initial discovery renin <NUMBER> tigerstedt bergman classic ras paradigm renin released juxtaglomerular cells kidney circulation converts angiotensinogen liver angiotensin angiotensin subsequently hydrolyzed ace lung form ang ii ace potential hydrolyze many proteins appreciated enzymatic processing angiotensin ang ii cardiovascular effects extensively reported addition ace mediates hydrolysis bradykinin typically considered blood pressurelowering effects bradykinin may also act regulator cardiac function <NUMBER> interestingly ace readily hydrolyzes bradykinin angiotensin therefore net physiological effect ace increase production vasoconstrictor decrease availability vasodilator involvement endothelial factors nitric oxide endothelial derived hyperpolarizing factors produced consequences bradykinin receptor activation may also considered <NUMBER> last <NUMBER> decades become increasingly apparent despite providing initial benefits hemodynamic support continued ras activation may contribute progression worsening disease heart failure respect finding ace tissue ace primarily localized <NUMBER> various tissues organs within endothelia parenchyma well inflammatory cells gained pathophysiological importance considering rapid progress understanding molecular physiology ras many complexities surprising details would continue emerge unexpected however <NUMBER> years research major new concepts would surface requiring scientists clinicians rethink system role cardiovascular regulation recently discovered distinct isoform ace expressed humans found almost exclusively testis tace <NUMBER> recently two major conceptual changes would considered regarding ras ace aceinhibitors cardiovascular system first surprising discovery occurred <NUMBER> discovery ace <NUMBER> aceh may produce factors vasodilator properties <NUMBER> second new concept discovered ingrid fleming groups <NUMBER> <NUMBER> <NUMBER> termed outsidein signaling authors mechanism bradykinin aceinhibitors activate several kinases may regulate protein synthesis review two new concepts date section tissue ace cardiac hypertrophy considered emphasis given organ protection aceinhibitors said physiologic conditions high levels tissue ace found capillary bed lungs <NUMBER> <NUMBER> considered integral part classic ras <NUMBER> <NUMBER> hand tissue sites including heart express relatively low levels ace least physiologic conditions <NUMBER> within normal heart density ace right atrium higher left atrium ventricles larger part tissue ace found endothelium large small coronary arteries arterioles immunohistochemical analysis revealed half capillaries immunoreactive ace coronary venous vessels almost completely devoid enzyme <NUMBER> <NUMBER> sites cardiac tissue ace expression include endocardial layer cardiac valves little ace found normal adult cardiomyocytes situ <NUMBER> pathologic activation local ras including tissue ace several deleterious effects cardiovascular functions <NUMBER> <NUMBER> <NUMBER> tissue ace plays critical role endothelial function direct pleiotropic actions ang ii also bradykinindependent mechanism tissue ace largely localized endothelium endothelial dysfunction often associated activation tissue ace activation disrupts balance vasodilatation vasoconstriction moreover vascular smooth muscle cell growth inflammatory oxidative state vessel wall altered fig <NUMBER> endothelial dysfunction occur response number risk factors injury ischemiareperfusion hypertension diabetes mellitus hypercholesteremia cigarette smoking ang ii produced activated endothelial ace impairs nitric oxide bioactivity mainly oxidative stress ang iiinduced production superoxide radicals − <NUMBER> scavenge nitric oxide reduce endotheliumdependent vasodilatation <NUMBER> <NUMBER> action independent effects ace degrading bradykinin modulating endothelialdependent vasodilation response activation b <NUMBER> receptor evidence ace expression increased atherosclerosis ang ii may contribute disease progression increasing oxidative stress chemoattractant adhesion molecule expression leading inflammation ang ii also favor proliferative inflammatory prothrombotic actions fig <NUMBER> fact substantial evidence atherosclerosis plaque represents important target ace inhibitor action see yet ace upregulation risk factors restricted vasculature <NUMBER> myocytes fibroblasts also recruited ace expression injured hearts <NUMBER> <NUMBER> <NUMBER> moreover macrophages invade injured myocardium bring high levels ace activity interstitial sites ang ii accumulates <NUMBER> <NUMBER> mast cells cardiac tissue also source ang ii action chymase fig <NUMBER> <NUMBER> tissue ace upregulation described virtually models cardiac injury including hypertrophy pressure <NUMBER> volumeoverload <NUMBER> myocardial infarction <NUMBER> heart failure <NUMBER> <NUMBER> elevated enzyme levels found exclusively affected ventricle elevated wall stress believed critical factor cardiac ace induction <NUMBER> notably unstressed cardiomyocytes cell culture reported express ace cardiomyocytes thus able generate ang ii locally especially response mechanical stretch <NUMBER> increased local formation ang ii increased bradykinin degradation favors unbalanced effects may favor cardiovascular disease progression whereas cardiac ace increases failing heart pulmonary ace decreases pulmonary congestion complicates condition <NUMBER> opposing regulatory steps may protect angiotensin conversiondegradation lung increase ace substrates heart <NUMBER> indeed aceinhibitors effectively reduce systemic high blood pressure aggravate pulmonary congestion exert organprotective actions increasingly apparent contribution tissue ace ang ii concert several factors development maintenance left ventricular hypertrophy fig <NUMBER> angiotensin ii type <NUMBER> receptors <NUMBER> rs also upregulated experimentally induced cardiac hypertrophy <NUMBER> ang ii shown cause hypertrophy direct action cardiomyocytes pinto et al <NUMBER> ohmichi et al <NUMBER> found pathologic remodeling early myocardial infarction occurs predominantly subjects ace dd genotype observations authors attracted attention ace gene polymorphism however genotype consistently associated hypertension prevalence extent coronary artery disease myocardial infarction <NUMBER> <NUMBER> thus role genetic variability ace remains fully elucidated discussed cardiac pressurevolume overload leads hypertrophy tissue ace major player even <NUMBER> rstimulation ang ii isolated cardiomyocytes leads induction characteristic hypertrophic phenotype including protein synthesis cell growth reexpression fetal gene programme absence proliferation <NUMBER> great number intracellular signaling pathways involved hypertrophic response characterized last decade involved molecules operate isolation participate orchestrated response generates interdependent crosstalking networks explains fact mechanisms involved cardiac hypertrophy still completely clear eg <NUMBER> several pathways ang ii linked growth regulation cardiac cells described <NUMBER> among transactivation different receptor systems seems play pivotal role fig <NUMBER> hypertrophic effect ang ii cardiac noncardiac cells delayed requires hours days appears involve sequential parallel activation variety protein kinases normally associated signaling pathways downstream tyrosine kinase receptors kinases typically implicated mediating cardiac growth include mitogenactivated protein kinases mapks extracellular signalregulated kinases <NUMBER> <NUMBER> erk<NUMBER> phosphatidylinositol <NUMBER>kinase pi<NUMBER>kdependent signaling kinases protein kinase b pkbakt mtors<NUMBER> kinase axis <NUMBER> <NUMBER> activation pathways readily explained classical g proteincoupled receptor gpcr signaling example protein kinase c pkcdependent activation erk<NUMBER> yet mobilization additional growthdependent kinases <NUMBER> r difficult elucidate first evidence gpcrmediated transactivation epidermal growth factor receptor egfr lacks intrinsic tyrosine kinase activity provided daub et al <NUMBER> thus potentially explaining proliferation triggered nonclassical gpcr signaling <NUMBER> studies support idea <NUMBER> r activation ang ii start cascade lead cardiac hypertrophy fig <NUMBER> proposed pathway starting <NUMBER> rdependent transactivation egfrs cardiomyocytes may involve stimulation membranebound metalloproteases mmps turn cleave egfr ligands heparinbinding egf hbegf plasma membraneassociated precursor prohbegf mechanisms <NUMBER> r activates mmps unclear may fig <NUMBER> schematic diagram depicting signaling cascade activated classical g proteincoupled receptor gpcr activation side longterm gcrpmediated hypertrophy side b classical <NUMBER> r signaling side responsible acute ang ii actions vasoconstriction occurs via g protein g q<NUMBER> leading activation phospholipase cß pcb subsequent generation second messengers diacylglycerol dag inositol trisphosphate ip<NUMBER> turn stimulate protein kinase c pkc mobilize intracellular calcium side b starting dashed arrows depicted longterm gcrpmediated hypertrophy process may dependent upon egfr transactivation termed triple membranepassing signaling tmps tmps attributed intracellular signaling mechanism epidermal growth factor receptor egfr transactivation require matrix metalloprotease mmpdependent extracellular cleavage proheparinbinding egf prohbegf liberate soluble hbegf may activate egfr following activation several intracellular kinases activated may play pivotal role regulating cellular growth proliferation classical gpcr signaling via pkcactivation also concur activation erk<NUMBER> adam disintegrin metalloproteinase inhibitor metalloenzymes acronyms see also text involve ca <NUMBER> tyrosine kinase src prolinerich tyrosine kinase <NUMBER> pyk<NUMBER> subsequent activation egfr leads mobilization signaling pathways include erk<NUMBER> pi<NUMBER>k akt mtors<NUMBER> kinase fig <NUMBER> kinases may play pivotal role regulating cellular growth proliferation via increase translation efficiency capacity <NUMBER> finally must kept mind hypertrophic effects ang ii well adrenaline seen mediated increased production several endogenous factors including endothelins ets fibroblast growth factor fgf fig <NUMBER> instance ang ii upregulate endothelin converting enzyme<NUMBER> increase level precursor et prepropeptide <NUMBER> absence fgf hypertension evoked ang ii induce cardiac hypertrophy <NUMBER> due crosstalk et<NUMBER> ang ii contributing cardiac hypertrophy atherosclerosic plaques attempts done use endothelin receptor blockers treatment cardiovascular diseases spite beneficial effect obtained pulmonary hypertension conflicting results obtained congestive heart failure particular terms event reduction heart failure <NUMBER> <NUMBER> antihypertensive treatment aiming reducing blood pressure sufficient due present state art doubts aceinhibitors firstline antihypertensive substances due vascular myocardial protective effects side effects well known ace inhibition decreases risk myocardial infarction way may independent ability decrease blood pressure recent metaanalysis four clinical trials confirmed ace inhibitor administration also beneficial acute myocardial infarction treatment <NUMBER> even two trials among included metaanalysis cooperative new scandinavian enalapril survival study ii third subanalysis italian group study streptokinase myocardial infarction gissi queried beneficial effect aceinhibitors early phase acute myocardial infarction possible explanation doubtful benefit resides fact early phase increase level bradykinin vasodilator cardiodepressor may appropriate <NUMBER> <NUMBER> europa <NUMBER> hope <NUMBER> trials also well planned well executed studies showed beneficial effects aceinhibitors secondary prevention cardiovascular events patients coronary heart disease unfortunately two studies presented cannot directly compared nevertheless studies learned many things aceinhibitors organ protectors confirming principal target ace inhibitor action tissue sites also learned concentrations aceinhibitors past considered relatively high doses indeed adequate doses heart failure early association βblockers aceinhibitors also emerging adequate strategy <NUMBER> <NUMBER> humans animals aceinhibitors <NUMBER> r antagonists shown prevent regress development hypertrophy <NUMBER> <NUMBER> <NUMBER> <NUMBER> underlying mechanisms cardiovascular remodeling relevant therapies aiming counteracting mechanisms recently reviewed <NUMBER> particular aceinhibitors βblockers aldosterone antagonists proven effective modulating process remodeling reducing occurrence adverse events heart failure <NUMBER> <NUMBER> pharmacokinetic properties various aceinhibitors indicate differences binding characteristics tissue ace <NUMBER> <NUMBER> tissue ace thought increase inflammation vasoconstriction thought promote vascular remodeling plaque stabilization decrease myocardial infarction occurrence ace inhibition treatment attributed inhibition local tissue ace vasculature <NUMBER> however recent study examined question found correlation tissue ace affinity risk first nonfatal myocardial infarction hypertensive patients study aceinhibitors categorized <NUMBER> groups based relative affinity tissue ace <NUMBER> higheraffinity tissue aceinhibitors consisted quinapril benazepril ramipril loweraffinity tissue aceinhibitors consisted lisinopril enalapril fosinopril captopril nevertheless universal definition literature constitutes tissueace inhibitor <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> undoubtedly comparative experimental clinical studies address significance drug differences impact clinical events whatever outcome studies increase capacity manage highly beneficial tools ace <NUMBER> homologue ace capable producing angiotensin peptides may vasodilator properties <NUMBER> significant difference ace ace <NUMBER> genes ace gene gives rise two isoforms somatic ace tace single ace <NUMBER> protein species appears formed humans somatic ace resides chromosome <NUMBER> chromosome <NUMBER> <NUMBER> mouse rats respectively consists <NUMBER> exons germinal tace expressed testes arises promoter located within intron <NUMBER> downstream gene duplication makes protein single domain catalytic site ace <NUMBER> gene located region x chromosome humans xp<NUMBER> mice xf<NUMBER> rodents xq<NUMBER> maps quantitative trait loci qtl hypertensive rats <NUMBER> <NUMBER> <NUMBER> <NUMBER> humans ace <NUMBER> gene highly expressed endothelium heart tubular epithelia kidney gastrointestinal tract <NUMBER> <NUMBER> <NUMBER> mice ace <NUMBER> also observed lungs <NUMBER> importantly humans two single nucleotide polymorphisms ace <NUMBER> qtl associated cardiovascular disease <NUMBER> <NUMBER> ace <NUMBER> although structurally similar ace different catalytic profile ace acts dipeptidylpeptidase generating ang ii angiotensin trough removal cterminal dipeptide hisleu ace <NUMBER> carboxypeptidase catalyses conversion vasoconstrictor ang ii angiotensin<NUMBER> ang <NUMBER> removing carboxyterminal amino acid phenylalanine moreover ace <NUMBER> cleave cterminal aminoacid angiotensin nonapeptide angiotensin<NUMBER> ang <NUMBER> may converted ang <NUMBER> ace fig <NUMBER> table <NUMBER> biological function ang <NUMBER> ang <NUMBER> still poor understood ang <NUMBER> may potentiate ang iiinduced vasoconstriction ang <NUMBER> may play important role regulator cardiovascular function ang <NUMBER> serves substrate ace form ang ii known act vasoconstrictor prohypertrophic factor angiotensin also metabolized ace <NUMBER> form ang <NUMBER> action still well understood starting either ang ii ang <NUMBER> ace <NUMBER> catalyzes production ang <NUMBER> opposing effect ang ii via interaction mas ang <NUMBER> receptor appears ace ace <NUMBER> ducing vasodilatation apoptosis growth arrest <NUMBER> <NUMBER> <NUMBER> basis ace <NUMBER> expression physiological role substrates suggested ace <NUMBER> may act tissuespecific negative feedback regulator activated ras <NUMBER> thus ace ace <NUMBER> may ultimately opposing physiological effects contrast ace ace <NUMBER> hydrolyze bradykinin inhibited typical aceinhibitors <NUMBER> <NUMBER> accepted neither ace angiotensin deficient mice exhibit defects heart development susceptible heart disease <NUMBER> recent studies ace <NUMBER> knockout mice report apparently conflicting results importance enzyme cardiovascular function <NUMBER> <NUMBER> <NUMBER> reduction ace <NUMBER> levels would lead reduced degradation vasoconstrictors reduced formation vasodilators thus favoring blood pressure increase fact line mice lacking ace <NUMBER> gene allred et al <NUMBER> reported elevated levels baseline blood pressure last report seems also agreement observation reduced ace <NUMBER> levels several rat models hypertension sabra hypertensiveprone strain sbhy spontaneously hypertensive rats shr spontaneously hypertensive strokeprone rats shrsp <NUMBER> <NUMBER> however also reported ace <NUMBER> deficient mice show reduction heart contractility significant decrease blood arterial ventricular pressure awake anesthetized animals compared littermate controls <NUMBER> <NUMBER> possible reunification apparently conflicting results ace <NUMBER> knockout mice may derive fact reduction blood pressure accompanied impaired heart function <NUMBER> <NUMBER> may thus argued ace <NUMBER> knockout mice initially excessive uncontrasted ang iimediated effects occur lead increased vascular tone pressure long lasting ang ii action sustains pathological cell growth leads impaired cardiac function resembles sort cardiac stunninghibernation observed murphy et al <NUMBER> thus heart stunning may responsible reduction blood pressure intriguing ace <NUMBER> knockout mouse ablation ace expression abolished cardiac dysfunction phenotype mouse <NUMBER> observation double mutant mouse aceace <NUMBER> knockout mouse displays normal cardiac function supports idea unopposed effects ang ii may account cardiac dysfunction single ace <NUMBER> knockout mouse also proposed ace <NUMBER> function may limited ras fact ace <NUMBER> cleave cterminal residues several peptides apelins ghrelin desarg bradykinin ßcasamorphin neurotensines dynorphyn a<NUMBER> physiological functions ace <NUMBER> substrates well functions formed products summarized table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> minireview emerging role apelins cardiovascular system extensively reviewed crosstalk ras peptides exists two forms apelin apelin<NUMBER> apelin<NUMBER> recently identified endogenous ligands human apj orphan receptor homologies <NUMBER> r <NUMBER> <NUMBER> <NUMBER> apelin displays diuretic effect found supraottic nucleus hypothalamus seems inhibit electrical activity vasopressinreleasing neurons <NUMBER> apelin exerts also nitric oxidedependent vasodilator positive inotropic activities apjdeficient animals ang ii hypertensive response resulted enhanced thus suggesting spite similarity <NUMBER> rs apjreceptors activation latter may counteract pressor effect activation former receptors also proposed ang ii may induce release apelin vascular endothelial cells <NUMBER> positive inotropic activity apelin demonstrated isolated preparations intact animals <NUMBER> <NUMBER> <NUMBER> related pkc activation consequent na h exchanger phosphorylationactivation resulting increase intracellular na concentration activate ca <NUMBER> na exchanger leading increase intracellular ca <NUMBER> concentration thus favoring increase contractility proposed due property apelin could therapeutic use heart failure <NUMBER> <NUMBER> <NUMBER> although reported two weeks apelintreatment signs hypertrophy appear <NUMBER> longterm studies aimed ascertaining whether apelin may induce hypertrophy required said ace <NUMBER> cannot inhibited aceinhibitors <NUMBER> <NUMBER> recently novel ace <NUMBER> peptide inhibitors described <NUMBER> use ace <NUMBER> antagonists useful elucidation ace <NUMBER> function vivo finally ace <NUMBER> unique among mammalian carboxypeptidases contains hexxh zinc motif resembles bacterial enzyme thermus aquaticus taq carboxypeptidase functional receptor sars coronavirus <NUMBER> <NUMBER> new concept discovered ingrid fleming groups <NUMBER> <NUMBER> <NUMBER> using human umbilical vein endothelial cells porcine aortic endothelial cells stably transfected human somatic ace model fleming coworkers <NUMBER> <NUMBER> <NUMBER> demonstrated ramiprilat perindoprilat increased casein kinase <NUMBER> ck<NUMBER>mediated phosphorylation ace ser <NUMBER> coimmunoprecipitation studies revealed ace associates ck<NUMBER> inhibitors increase aceassociated ck<NUMBER> activity interestingly bradykinin angiotensin increases ace ser <NUMBER> phosphorylation ck<NUMBER> activity suggesting naturally occurring signal transduction pathway bradykinin require classical receptor exists importantly possibility ck<NUMBER>mediated phosphorylation result crosstalk signal transduction pathways ruled control experiments use porcine endothelial cells <NUMBER> r bradykinin b <NUMBER> receptors subsequently two aceassociated proteins cjun nterminal kinase jnk map kinase kinase <NUMBER> mkk<NUMBER> identified addition ck<NUMBER> fig <NUMBER> authors <NUMBER> <NUMBER> <NUMBER> reported association proteins ace also provided convincing evidence aceassociated jnk activity increased cells treated aceinhibitors bradykinin interestingly jnk activation binding ace dependent phosphorylation ace ser <NUMBER> activation jnk ramiprilat results accumulation phosphorylated cjun nucleus reported activate transcription ace ace increased response ramiprilat via mechanism dependent jnk activity human umbilical vein endothelial cells culture mouse lung vivo words fleming coworkers <NUMBER> <NUMBER> <NUMBER> clearly demonstrated binding ace inhibitor ace results activation jnk well phosphorylation cjun translocation nucleus signaling pathway therefore likely affect expression several proteins particular expression ace recently lungs mice primary cultures human endothelial cells fleming groups showed ramiprilatinduced acedependent increase cyclooxygenase<NUMBER> cox<NUMBER> expression promoter activity prevented inhibition jnk <NUMBER> authors suggest ace signaling cascade involving phosphorylation ace ser <NUMBER> consequent ac tivation jnk activator protein<NUMBER> cox<NUMBER> explain enhanced production prostacyclin welldocumented consequence ace inhibitory therapy <NUMBER> importantly authors able demonstrate signaling pathway initiated aceinhibitors cell culture also activated whole animal suggests intracellular signaling termed outsidein signaling authors mediated aceinhibitors bradykinin may important physiological mechanism authors suggest <NUMBER> ace added class socalled nonreceptor cell surface proteins identification ace signaling molecule activated binding aceinhibitors may account beneficial effects drugs cardiovascular system course understanding full spectrum physiological events initiated ace outsidein signaling require additional studies summary evidence important effects ang ii independent classical g protein coupling counterbalancing roles ace ace <NUMBER> ras suggest system clearly operates physiological levels far beyond simple regulation vascular tone body fluid homeostasis remarkable short period time many new concepts accumulated role tissue ace atrs organ hypertrophy revealing new aspects include receptor mediate endocytosis tyrosine phosphorylation signaling map kinase activation transactivation egfr ace <NUMBER> substrates involved feedback regulation ras also extraras systems fact ace <NUMBER> catalyze conversion opiods apelins peptides also intriguing outsidein signaling bradykinin old substrate may play new role gene regulator acting ace new concepts particular outsidein signaling deviate original one aceinhibitors considered important reduce ang ii levels aceinhibitors may mimic new effects bradykinin clarification physiological role ace <NUMBER> outsidein signaling apelins may hopefully lead development new therapeutics heart failure hypertension recent structural solutions ace ace <NUMBER> could facilitate future design specific drugs different affinity argued therapeutic point view new concepts taken account choose ace inhibitor ang ii receptor antagonist course comparative experimental clinical studies must address topic light new concepts surprised rapidly evolving field new concepts emerge next future recent media reports publications question whether medicines could worsen novel coronavirus disease covid<NUMBER> caused infection sarscov<NUMBER> coronavirus reports mention angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs commonly used drugs treat patients hypertension heart failure kidney complications diabetes mellitus well ibuprofen overthecounter drug prescribed used treat arthritis rheumatic diseases among indications article summarizes current evidence regarding risk drugs unfavorable course covid<NUMBER> common comorbidities reported epidemiological studies patients covid<NUMBER> hypertension diabetes mellitus coronary heart disease cerebrovascular disease higher number comorbidities increase age correlated poorer clinical outcomes guan et al <NUMBER> yang et al <NUMBER> zhang et al <NUMBER> epidemiological data show probability dying infection sarscov<NUMBER> virus increases age <NUMBER> patients ≤ <NUMBER> years old <NUMBER> patients aged <NUMBER> years <NUMBER> patients ≥ <NUMBER> years old novel coronavirus pneumonia emergency response epidemiology team <NUMBER> world health organization <NUMBER> therefore surprising find association use drugs commonly prescribed older patients poorer outcomes covid<NUMBER> however association alone yet describe anything causality role angiotensinconverting enzyme <NUMBER> ace<NUMBER> covid<NUMBER> reason suspicion drugs might worsen prognosis covid<NUMBER> stems current reports example ace inhibitors may lead increase number ligands sarscov<NUMBER> coronavirus docks hypothesis expressed commentary nature reviews cardiology letter british medical journal sommerstein gräni <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> membranebound aminopeptidase serves receptor coronavirus therefore entry portal cells ace<NUMBER> also entry receptor sarscov caused <NUMBER> sars outbreak therapy drugs arbs ace inhibitors ace<NUMBER> receptors formed theoretically producing docking sites new coronavirus ace inhibitor lisinopril arb losartan among <NUMBER> commonly used drugs combined <NUMBER> million prescriptions per year usa alone iqvia institute <NUMBER> patients would represent substantial group people risk among coronaviral structural proteins spike protein facilitates viral entry host cell protein consists two functional domains s<NUMBER> domain s<NUMBER> domain s<NUMBER> domain mediates attachment virus surface receptors host cell whereas s<NUMBER> domain mediates subsequent fusion viral host cell membranes endocytic entry virus hoffmann et al recently shown sarscov<NUMBER> protein engages ace<NUMBER> crucial entry receptor employs host cell serine protease tmprss<NUMBER> protein priming hoffmann et al <NUMBER> furthermore direct binding sarscov<NUMBER> protein ace<NUMBER> confirmed recent cryoem studies walls et al <NUMBER> ace<NUMBER> primarily located lungs mostly expressed alveolar epithelial type ii cells type ii cells secrete surfactant hence critical gas exchange function lungs injury cells could explain severe lung injury observed covid<NUMBER> pneumonia ace<NUMBER> also found heart intestines kidneys blood vessels soluble form serum may explain covid<NUMBER> addition pneumonia cause multiple organ failure severe cases ace<NUMBER> part reninangiotensin system role lung injury ace<NUMBER> constitutes important alternative reninangiotensin system ras pathway counterbalances classical ras pathway guignabert et al <NUMBER> classical ras pathway angiotensin ii formed angiotensin ace<NUMBER> induces aldosterone secretion salt water retention inflammation severe arteriolar vasoconstriction via binding at<NUMBER> receptor contrast ace<NUMBER> primarily hydrolyzes angiotensin ii two biologically active products ras cascade angiotensin<NUMBER> angiotensin<NUMBER> promote vasodilation also reduce cell growth inflammatory responses guignabert et al <NUMBER> animal experiments response <NUMBER> sars outbreak shown infection sarscov leads dysregulation ras reduced ace<NUMBER> expression increase angiotensin ii increases lung damage kuba et al <NUMBER> notably injection sarscov protein mice worsened acute lung failure vivo effect could attenuated blocking classical ras pathway kuba et al <NUMBER> imai et al observed ace<NUMBER> protected severe acute lung injury experimental murine model acute lung injury whereas components classical ras pathway including ace<NUMBER> angiotensin ii at<NUMBER>a receptor promoted disease pathogenesis induced lung edema impaired lung function furthermore recombinant ace<NUMBER> protected mice severe acute lung injury current evidence therefore suggests ace<NUMBER> serves entry receptor sarscov<NUMBER> protect lungs injury may case covid<NUMBER> interestingly monteil et al showed human recombinant soluble ace<NUMBER> hrsace<NUMBER> already tested phase <NUMBER> phase <NUMBER> clinical trials treatment acute lung injury pulmonary hypertension significantly block early stages sarscov<NUMBER> infection vitro monteil et al <NUMBER> result phase <NUMBER> clinical trial hrsace<NUMBER> treatment covid<NUMBER> recently initiated europe eudract number <NUMBER> knowledge ace<NUMBER> regulation response drugs predominantly based animal experiments rodents treatment ace inhibitors arbs increased cardiac renal ace<NUMBER> expression andor ace<NUMBER> activity ferrario et al <NUMBER> soler et al <NUMBER> animal models arterial hypertension myocardial infarction pressure overload diabetes mellitus cardiac ace<NUMBER> downregulated compared healthy control animals ocaranza et al <NUMBER> tikellis et al <NUMBER> qiao et al <NUMBER> wang et al <NUMBER> zhao et al <NUMBER> treatment arb ibuprofen pioglitazone reversed decrease ace<NUMBER> expression diseased animals whereas almost effect ace<NUMBER> expression observed control animals qiao et al <NUMBER> wang et al <NUMBER> zhao et al <NUMBER> cox<NUMBER> inhibitors pparγ ligand investigated precise mechanisms established thus remains unclear whether effects ibuprofen pioglitazone ace<NUMBER> expression drug class effects data humans scarce patients heart failure acute phase myocardial infarction treatment ras inhibitors showed increase cardiac circulating ace<NUMBER> explained severity heart disease rather ras inhibitor treatment zisman et al <NUMBER> goulter et al <NUMBER> epelman et al <NUMBER> although animal data suggest drugs arbs ace inhibitors ibuprofen pioglitazone upregulate cardiac renal ace<NUMBER> evidence animal experiments fully consistent remains unclear whether results transferable humans although primary target sarscov<NUMBER> ace<NUMBER> cell surface alveolar type ii cells data druginduced changes pulmonary ace<NUMBER> lacking although evidence comorbidities significant effects ace<NUMBER> expression difficult assess net effect ace<NUMBER> expression patients moreover would shown druginduced increase ace<NUMBER> expression sufficient facilitate sarscov<NUMBER> entry local inflammatory process severe covid<NUMBER> induce parenchymal injuries damage alveolarcapillary unit shi et al <NUMBER> local inflammation involves production prostaglandins inducible cyclooxygenase <NUMBER> cox<NUMBER> recruitment activation effector cells polymorphonuclear neutrophils contributes development pain fever occur infection main reason nsaids commonly used infections alternatively cox<NUMBER> also pivotal role resolution inflammation thereby preventing selfinflicted damage immune response levy et al <NUMBER> nsaids work inhibiting activity cyclooxygenase enzymes cox<NUMBER> cox<NUMBER> thereby blocking production prostaglandins involved recruitment activation effector cells polymorphonuclear neutrophils pmns given dual role cox<NUMBER> inflammatory response amplifying initial acute phase promoting resolution question arises whether taking nsaids sarscov<NUMBER> infection could improve complicate course disease question becomes particularly important twophase immune response sarscov<NUMBER> infection first immune defensebased protective phase second inflammationdriven damaging phase leading acute respiratory distress syndrome ards respiratory failure subsequent fatality shi et al <NUMBER> due current novelty covid<NUMBER> data concerning influence nsaid use covid<NUMBER> outcomes remain needed retrospective study critically ill <NUMBER> h<NUMBER>n<NUMBER> influenza pandemic patients show evidence nsaid use affects mortality epperly et al <NUMBER> following sars outbreak caused sarscov investigators discovered nsaid indomethacin direct antiviral activity sarscov via blocking viral rna synthesis independent cox inhibition amici et al <NUMBER> furthermore antiviral activity confirmed vivo dogs infected canine coronavirus amici et al <NUMBER> human studies performed confirm positive effect indomethacin treatment sarscov sarscov<NUMBER> infections notably observational studies suggest association prehospital nsaid exposure protracted complicated course pneumonia voiriot et al <NUMBER> survey french national agency medicine health products safety revealed infections caused varicella bacterial infections could aggravated nsaids ibuprofen ketoprofen based report safety committee european medicines agency recently initiated review drugs mechanisms nsaid use may lead complicated course pneumonia uncertain could assumed intake nsaids suppresses main symptoms inflammation fever pain therefore delays timely detection pneumonia subsequent start appropriate therapy voiriot et al <NUMBER> accordingly nsaid drug labels warn drugs could mask signs symptoms infection another mechanism could immunological effects nsaids impaired resolution inflammation thus resulting prolonged disease voiriot et al <NUMBER> summary currently scientific evidence establishing clear link arbs ace inhibitors ibuprofen worsening covid<NUMBER> contrast experimental data support idea ace<NUMBER> serves entry receptor sarscov<NUMBER> also protects lungs acute injury ras inhibitors may therefore even beneficial covid<NUMBER> infection available information date support interruptions changes ongoing chronic treatments ibuprofen ras blockers recommendations follows based currently available evidence effective treatment ras blockers discontinued switched relatively hypothetical risk worsening covid<NUMBER> justify discontinuing switching arbs ace inhibitors due specific risk destabilizing blood pressure control stroke heart attack worsening heart failure van der wardt et al <NUMBER> halliday et al <NUMBER> insufficient control concomitant diseases caused drug discontinuation could make patients susceptible sarscov<NUMBER> infection complicate course disease currently insufficient evidence recommend patients take ibuprofen medically indicated reasons change antiinflammatory medication light covid<NUMBER> pandemic nsaids used lowest effective dose shortest possible period choice drug treat fever pain covid<NUMBER> based benefitrisk assessment known side effects eg kidney damage gastrointestinal ulceration respective treatment guidelines cases recommend paracetamol first treatment option fever pain associated infections author contribution statement oz sh cqs screened literature contributed manuscript authors read approved manuscript funding information open access funding provided projekt deal open access article licensed creative commons attribution <NUMBER> international license permits use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesby<NUMBER> recent media reports publications question whether medicines could worsen novel coronavirus disease covid<NUMBER> caused infection sarscov<NUMBER> coronavirus reports mention angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs commonly used drugs treat patients hypertension heart failure kidney complications diabetes mellitus well ibuprofen overthecounter drug prescribed used treat arthritis rheumatic diseases among indications article summarizes current evidence regarding risk drugs unfavorable course covid<NUMBER> common comorbidities reported epidemiological studies patients covid<NUMBER> hypertension diabetes mellitus coronary heart disease cerebrovascular disease higher number comorbidities increase age correlated poorer clinical outcomes guan et al <NUMBER> yang et al <NUMBER> zhang et al <NUMBER> epidemiological data show probability dying infection sarscov<NUMBER> virus increases age <NUMBER> patients ≤ <NUMBER> years old <NUMBER> patients aged <NUMBER> years <NUMBER> patients ≥ <NUMBER> years old novel coronavirus pneumonia emergency response epidemiology team <NUMBER> world health organization <NUMBER> therefore surprising find association use drugs commonly prescribed older patients poorer outcomes covid<NUMBER> however association alone yet describe anything causality role angiotensinconverting enzyme <NUMBER> ace<NUMBER> covid<NUMBER> reason suspicion drugs might worsen prognosis covid<NUMBER> stems current reports example ace inhibitors may lead increase number ligands sarscov<NUMBER> coronavirus docks hypothesis expressed commentary nature reviews cardiology letter british medical journal sommerstein gräni <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> membranebound aminopeptidase serves receptor coronavirus therefore entry portal cells ace<NUMBER> also entry receptor sarscov caused <NUMBER> sars outbreak therapy drugs arbs ace inhibitors ace<NUMBER> receptors formed theoretically producing docking sites new coronavirus ace inhibitor lisinopril arb losartan among <NUMBER> commonly used drugs combined <NUMBER> million prescriptions per year usa alone iqvia institute <NUMBER> patients would represent substantial group people risk among coronaviral structural proteins spike protein facilitates viral entry host cell protein consists two functional domains s<NUMBER> domain s<NUMBER> domain s<NUMBER> domain mediates attachment virus surface receptors host cell whereas s<NUMBER> domain mediates subsequent fusion viral host cell membranes endocytic entry virus hoffmann et al recently shown sarscov<NUMBER> protein engages ace<NUMBER> crucial entry receptor employs host cell serine protease tmprss<NUMBER> protein priming hoffmann et al <NUMBER> furthermore direct binding sarscov<NUMBER> protein ace<NUMBER> confirmed recent cryoem studies walls et al <NUMBER> ace<NUMBER> primarily located lungs mostly expressed alveolar epithelial type ii cells type ii cells secrete surfactant hence critical gas exchange function lungs injury cells could explain severe lung injury observed covid<NUMBER> pneumonia ace<NUMBER> also found heart intestines kidneys blood vessels soluble form serum may explain covid<NUMBER> addition pneumonia cause multiple organ failure severe cases ace<NUMBER> part reninangiotensin system role lung injury ace<NUMBER> constitutes important alternative reninangiotensin system ras pathway counterbalances classical ras pathway guignabert et al <NUMBER> classical ras pathway angiotensin ii formed angiotensin ace<NUMBER> induces aldosterone secretion salt water retention inflammation severe arteriolar vasoconstriction via binding at<NUMBER> receptor contrast ace<NUMBER> primarily hydrolyzes angiotensin ii two biologically active products ras cascade angiotensin<NUMBER> angiotensin<NUMBER> promote vasodilation also reduce cell growth inflammatory responses guignabert et al <NUMBER> animal experiments response <NUMBER> sars outbreak shown infection sarscov leads dysregulation ras reduced ace<NUMBER> expression increase angiotensin ii increases lung damage kuba et al <NUMBER> notably injection sarscov protein mice worsened acute lung failure vivo effect could attenuated blocking classical ras pathway kuba et al <NUMBER> imai et al observed ace<NUMBER> protected severe acute lung injury experimental murine model acute lung injury whereas components classical ras pathway including ace<NUMBER> angiotensin ii at<NUMBER>a receptor promoted disease pathogenesis induced lung edema impaired lung function furthermore recombinant ace<NUMBER> protected mice severe acute lung injury current evidence therefore suggests ace<NUMBER> serves entry receptor sarscov<NUMBER> protect lungs injury may case covid<NUMBER> interestingly monteil et al showed human recombinant soluble ace<NUMBER> hrsace<NUMBER> already tested phase <NUMBER> phase <NUMBER> clinical trials treatment acute lung injury pulmonary hypertension significantly block early stages sarscov<NUMBER> infection vitro monteil et al <NUMBER> result phase <NUMBER> clinical trial hrsace<NUMBER> treatment covid<NUMBER> recently initiated europe eudract number <NUMBER> knowledge ace<NUMBER> regulation response drugs predominantly based animal experiments rodents treatment ace inhibitors arbs increased cardiac renal ace<NUMBER> expression andor ace<NUMBER> activity ferrario et al <NUMBER> soler et al <NUMBER> animal models arterial hypertension myocardial infarction pressure overload diabetes mellitus cardiac ace<NUMBER> downregulated compared healthy control animals ocaranza et al <NUMBER> tikellis et al <NUMBER> qiao et al <NUMBER> wang et al <NUMBER> zhao et al <NUMBER> treatment arb ibuprofen pioglitazone reversed decrease ace<NUMBER> expression diseased animals whereas almost effect ace<NUMBER> expression observed control animals qiao et al <NUMBER> wang et al <NUMBER> zhao et al <NUMBER> cox<NUMBER> inhibitors pparγ ligand investigated precise mechanisms established thus remains unclear whether effects ibuprofen pioglitazone ace<NUMBER> expression drug class effects data humans scarce patients heart failure acute phase myocardial infarction treatment ras inhibitors showed increase cardiac circulating ace<NUMBER> explained severity heart disease rather ras inhibitor treatment zisman et al <NUMBER> goulter et al <NUMBER> epelman et al <NUMBER> although animal data suggest drugs arbs ace inhibitors ibuprofen pioglitazone upregulate cardiac renal ace<NUMBER> evidence animal experiments fully consistent remains unclear whether results transferable humans although primary target sarscov<NUMBER> ace<NUMBER> cell surface alveolar type ii cells data druginduced changes pulmonary ace<NUMBER> lacking although evidence comorbidities significant effects ace<NUMBER> expression difficult assess net effect ace<NUMBER> expression patients moreover would shown druginduced increase ace<NUMBER> expression sufficient facilitate sarscov<NUMBER> entry local inflammatory process severe covid<NUMBER> induce parenchymal injuries damage alveolarcapillary unit shi et al <NUMBER> local inflammation involves production prostaglandins inducible cyclooxygenase <NUMBER> cox<NUMBER> recruitment activation effector cells polymorphonuclear neutrophils contributes development pain fever occur infection main reason nsaids commonly used infections alternatively cox<NUMBER> also pivotal role resolution inflammation thereby preventing selfinflicted damage immune response levy et al <NUMBER> nsaids work inhibiting activity cyclooxygenase enzymes cox<NUMBER> cox<NUMBER> thereby blocking production prostaglandins involved recruitment activation effector cells polymorphonuclear neutrophils pmns given dual role cox<NUMBER> inflammatory response amplifying initial acute phase promoting resolution question arises whether taking nsaids sarscov<NUMBER> infection could improve complicate course disease question becomes particularly important twophase immune response sarscov<NUMBER> infection first immune defensebased protective phase second inflammationdriven damaging phase leading acute respiratory distress syndrome ards respiratory failure subsequent fatality shi et al <NUMBER> due current novelty covid<NUMBER> data concerning influence nsaid use covid<NUMBER> outcomes remain needed retrospective study critically ill <NUMBER> h<NUMBER>n<NUMBER> influenza pandemic patients show evidence nsaid use affects mortality epperly et al <NUMBER> following sars outbreak caused sarscov investigators discovered nsaid indomethacin direct antiviral activity sarscov via blocking viral rna synthesis independent cox inhibition amici et al <NUMBER> furthermore antiviral activity confirmed vivo dogs infected canine coronavirus amici et al <NUMBER> human studies performed confirm positive effect indomethacin treatment sarscov sarscov<NUMBER> infections notably observational studies suggest association prehospital nsaid exposure protracted complicated course pneumonia voiriot et al <NUMBER> survey french national agency medicine health products safety revealed infections caused varicella bacterial infections could aggravated nsaids ibuprofen ketoprofen based report safety committee european medicines agency recently initiated review drugs mechanisms nsaid use may lead complicated course pneumonia uncertain could assumed intake nsaids suppresses main symptoms inflammation fever pain therefore delays timely detection pneumonia subsequent start appropriate therapy voiriot et al <NUMBER> accordingly nsaid drug labels warn drugs could mask signs symptoms infection another mechanism could immunological effects nsaids impaired resolution inflammation thus resulting prolonged disease voiriot et al <NUMBER> summary currently scientific evidence establishing clear link arbs ace inhibitors ibuprofen worsening covid<NUMBER> contrast experimental data support idea ace<NUMBER> serves entry receptor sarscov<NUMBER> also protects lungs acute injury ras inhibitors may therefore even beneficial covid<NUMBER> infection available information date support interruptions changes ongoing chronic treatments ibuprofen ras blockers recommendations follows based currently available evidence effective treatment ras blockers discontinued switched relatively hypothetical risk worsening covid<NUMBER> justify discontinuing switching arbs ace inhibitors due specific risk destabilizing blood pressure control stroke heart attack worsening heart failure van der wardt et al <NUMBER> halliday et al <NUMBER> insufficient control concomitant diseases caused drug discontinuation could make patients susceptible sarscov<NUMBER> infection complicate course disease currently insufficient evidence recommend patients take ibuprofen medically indicated reasons change antiinflammatory medication light covid<NUMBER> pandemic nsaids used lowest effective dose shortest possible period choice drug treat fever pain covid<NUMBER> based benefitrisk assessment known side effects eg kidney damage gastrointestinal ulceration respective treatment guidelines cases recommend paracetamol first treatment option fever pain associated infections author contribution statement oz sh cqs screened literature contributed manuscript authors read approved manuscript funding information open access funding provided projekt deal open access article licensed creative commons attribution <NUMBER> international license permits use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesby<NUMBER> angiotensinconverting enzyme ace ace<NUMBER> share homology catalytic domain provide different key functions reninangiotensin system ras ace cleaves angiotensin ang generate angiotensin ii ang ii <NUMBER> <NUMBER> whereas ace<NUMBER> reduces angiotensin ii levels <NUMBER> <NUMBER> negative regulator system importance ras acute respiratory distress syndrome ards recently reemerged owing identification ace<NUMBER> receptor severe acute respiratory syndromecoronavirus sarscov <NUMBER> <NUMBER> sars spread throughout world causing <NUMBER> deaths due ards <NUMBER> studies demonstrated ace<NUMBER> protects mice acute lung injury <NUMBER> well sarsmediated lung injury <NUMBER> article review role ras particular ace<NUMBER> pathogenesis ards possible applications modulating ras treatment ards also discussed ards severe form acute lung injury multiple predisposing factors ards reported include sepsis acid aspiration trauma infections viral pathogens sarscov moreover recently h<NUMBER>n<NUMBER> avian influenza virus caused high lethality due ards <NUMBER> despite recent progress mortality associated ards remains high pharmacological therapy shown largescale trials impact mortality ards <NUMBER> factors predicting onset severity ards poorly understood low incidence ards relatively large group patients risk shown also large differences plasma ace concentrations individuals concentrations tend similar within families <NUMBER> suggest involvement genetic components pathogenesis ards human ace gene dcp<NUMBER> located chromosome <NUMBER>q<NUMBER> contains restriction fragment length polymorphism defined presence insertion absence deletion <NUMBER>bp alu repeat sequence intron <NUMBER> nearly <NUMBER> variance plasma ace activity accounted ace insertiondeletion id polymorphism allele associated higher ace activity <NUMBER> importantly recent cohort studies ards showed significant association ace id polymorphism susceptibility mortality ards <NUMBER> dd genotype frequency increased patients ards compared control cohort ninetysix patients fulfilling criteria ards genotyped ace polymorphism together individuals three comparison groups <NUMBER> patients nonards respiratory failure ventilated intensive care unit icu <NUMBER> icu patients undergoing coronary artery bypass grafting <NUMBER> individuals general population group dd genotype frequency increased patients ards compared icu p <NUMBER> coronary artery bypass grafting p <NUMBER> general population group p <NUMBER> addition ace dd allele significantly correlated mortality ards group another study showed patients carrying ace ii genotype significantly increased survival rate <NUMBER> study <NUMBER>day mortality rates significantly different three ace genotypes <NUMBER> <NUMBER> <NUMBER> ii id dd respectively p <NUMBER> ards group taken together data suggest potential role ras pathogenesis ards implicate genetic factors susceptibility progression syndrome addition genetic correlation studies substantial clinical studies suggest possible activation ras patients ards instance patients ards elevation ace levels bronchoalveolar lavage fluid observed despite reduction circulating ace <NUMBER> reduced circulating ace levels may reflect loss enzyme release damaged pulmonary vascular endothelium may representative activity lung compartment also reported pulmonary capillary endotheliumbound pceb ace activity correlates severity lung injury patients acute lung injury <NUMBER> data suggest possible activation ras patients ards interestingly recent retrospective epidemiological studies demonstrated prior outpatient use ace inhibitor associated decreased mortality patients hospitalized communityacquired pneumonia although studies needed examine whether ace inhibitors protective used inpatient settings patients lacking traditional indications use medications <NUMBER> <NUMBER> novel homologue ace cloned termed ace<NUMBER> <NUMBER> <NUMBER> ace ace<NUMBER> share homology catalytic domain provide different key functions ras ace cleaves angiotensin generate angiotensin ii <NUMBER> <NUMBER> whereas ace<NUMBER> reduces angiotensin ii levels <NUMBER> <NUMBER> biological effects ang ii mediated two specific receptors ang ii receptor type <NUMBER> <NUMBER> r ang ii receptor type <NUMBER> <NUMBER> r <NUMBER> <NUMBER> targeted disruption murine ace<NUMBER> resulted increased ang ii levels impaired cardiac contractility aged mice upregulation hypoxiainduced genes heart <NUMBER> worsened heart failure following aortic banding <NUMBER> loss ace ace<NUMBER> background pharmacological inhibition ras least partially reverse cardiac phenotypes <NUMBER> genetic data demonstrate ace<NUMBER> counterbalances function ace negatively regulates ang ii levels within ras fig <NUMBER> group investigated role ace<NUMBER> ards using ace<NUMBER> knockout mice <NUMBER> acid aspirationinduced ards endotoxininduced ards well peritoneal sepsisinduced ards ace<NUMBER> knockout mice exhibited severe disease compared control mice express ace<NUMBER> loss ace<NUMBER> expression mutant mice also resulted enhanced vascular permeability increased lung edema neutrophil accumulation worsened lung function note pathologic manifestations occurred without apparent changes heart contractility pulmonary vascular tone among experimental groups mechanistically negative regulation ang ii levels ace<NUMBER> accounts part protective function ace<NUMBER> ards example <NUMBER> inhibitor treatment additional ace gene deficiency ace<NUMBER> knockout background rescues severe phenotype ace<NUMBER> single mutant mice acute lung injury addition ace knockout mice <NUMBER> r knockout mice <NUMBER> r knockout mice showed improved symptoms acute lung injury therefore acute lung injury ace ang ii <NUMBER> r promote acute lung injury whereas ace<NUMBER> <NUMBER> r figure <NUMBER> current view reninangiotensin system angiotensin serves substrate ace ace<NUMBER> angiotensin ii known act vasoconstrictor well mitogen smooth muscle cells fibroblasts mainly angiotensin ii type <NUMBER> receptor function angiotensin <NUMBER> well understood ace ace<NUMBER> involved production vasodilator peptide angiotensin <NUMBER> protect lung injury <NUMBER> importantly treatment catalytically active enzymatically inactive recombinant ace<NUMBER> protein improved symptoms acute lung injury wild type mice well ace<NUMBER> knockout mice suggesting ace<NUMBER> protein possible novel therapeutic target ards fig <NUMBER> within months following publication sarscov genome ace<NUMBER> identified potential receptor cell line studies vitro <NUMBER> ace<NUMBER> binds sarscov spike supports syncytia formation fusion spikeprotein expressing cells large multinucleated cells also seen real sars infections using mouse sars infection model ace<NUMBER> knockout mice group provided evidence ace<NUMBER> indeed essential sars infections vivo <NUMBER> ace<NUMBER> knockout mice infected sars coronavirus resistant virus infection virus titers lung tissues infected ace<NUMBER> knockout mice <NUMBER> <NUMBER> fold lower isolated lungs sarscovinfected wild type mice thus without excluding second functional sarscov receptor ace<NUMBER> essential receptor sars infections vivo despite many studies sarscov one mystery sarscov contrast coronaviruses infections sarscov trigger severe lung disease high mortality accumulating evidence indicates severe sars infections dependent burden viral replication well immunopathologic consequences host response studies implicated involvement ras sars pathogenesis intriguingly wild type mice infected sarscov showed markedly downregulated ace<NUMBER> expression lungs similarly treatment recombinant sarsspike protein absence virus components downregulates ace<NUMBER> expression vitro vivo thus sarscovinfected spike proteintreated wild type mice resemble ace<NUMBER> knockout mice similar ace<NUMBER> mutant mice spiketreated wild type mice show markedly severe pathology acute lung injury addition spiketreated mice ang ii peptide levels increased worsened ards symptoms could partially reversed <NUMBER> r blocker treatment thus downregulation ace<NUMBER> expression sarscov infections might play causal role sars pathogenesis especially disease progression ards pulmonary circulation potentially important target ras activation lung instance ang ii via type <NUMBER> receptor <NUMBER> r induces pulmonary vasoconstriction response hypoxia suggesting important roles <NUMBER> r elevating pulmonary vascular tone result pulmonary edema <NUMBER> also infusion ang <NUMBER> ang ii <NUMBER> produce pulmonary edema independent catecholamine release data suggest important role ras regulating pulmonary vascular tone might also contribute pathogenesis ards addition increased vascular tone subsequent hydostatic edema formation accumulating data suggest ang ii also increases vascular permeability via <NUMBER> r whereas stimulation <NUMBER> receptors exerts opposite effect <NUMBER> several mediators implicated ang ii regulated vascular permeability changes including eicosanoids ie leukotriene c <NUMBER> prostaglandin e <NUMBER> <NUMBER> vascular permeability factor however relatively studies addressed whether ras involved increased vascular permeability observed ards study demonstrated loss ace<NUMBER> results increased vascular permeability using evans vol <NUMBER> <NUMBER> <NUMBER> drug discovery today disease mechanisms immunodisorders autoimmunity figure <NUMBER> schematic diagram proposed role reninangiotensin system development ards ards induced sarscov infections acid aspiration pneumonias sepsis pathogenic conditions generation ang ii ang mediated ace ang ii contributes acute lung failure stimulation angiotensin ii type <NUMBER> receptor <NUMBER> r whereas ace<NUMBER> angiotensin ii type <NUMBER> receptor <NUMBER> r negatively regulate pathway protect acute lung failure however additional ace<NUMBER>regulated ang iiindependent pathways seem also contribute ards wwwdrugdiscoverytodaycom blue dye injections vivo indicator albumin leakage mice vascular permeability significantly attenuated lungs <NUMBER> r mutant mice data indicate loss ace<NUMBER> expression increased ang ii levels trigger leaky pulmonary blood vessels <NUMBER> r stimulation ards <NUMBER> ace ace<NUMBER> unspecific proteases cleave additional substrates might also play important roles aceace<NUMBER>regulated ards independent ang ii one ace ace<NUMBER> targets bradykinin peptide metabolites bradykinin key effecter kallikreinkinin system also functions major proinflammatory mediator bradykinin degraded two main kinases ace also known kinase ii system neutral endopeptidase biological effects bradykinin mediated b<NUMBER> receptor b <NUMBER> r b<NUMBER> receptor b <NUMBER> r b <NUMBER> r mediate known effects bradykinin including antiproliferative antioxidant antithrombotic effects <NUMBER> vivo effects mediated via b <NUMBER> r b <NUMBER> r still poorly characterized recent study suggests expression b <NUMBER> r induced cytokines inflammation rats <NUMBER> albeit role bradykinin ang iiinduced inflammation remains unclear ace<NUMBER> remove vitro assays cterminal residue apelin vasoactive peptides neurotensin neurotensinrelated peptide kinetensin moreover opioid peptides dynorphin <NUMBER> bcasamorphin also substrates ace<NUMBER> contrast ace ace<NUMBER> metabolize bradykinin catalytically inactivates desarg <NUMBER> bradykinin lysdesarg <NUMBER> bradykinin <NUMBER> <NUMBER> thus although many ace<NUMBER> functions attributed regulation ang ii levels ang ii probably part ace<NUMBER> story ace<NUMBER> substrates might play major role understanding ace<NUMBER> functions importantly preliminary results suggest inhibition bradykinin receptor also alleviate ards yi jmp unpublished recently critical importance ras pathogenesis ards established genetic animal models ace<NUMBER> protects murine lungs acute lung injury induced acid aspiration endotoxin shock peritoneal sepsis <NUMBER> addition ace knockout mice <NUMBER> r knockout mice <NUMBER> r knockout mice showed improved symptoms acute lung injury <NUMBER> consistent experimental studies <NUMBER> <NUMBER> <NUMBER> also ace<NUMBER> identified key sarscov receptor <NUMBER> <NUMBER> importantly ace<NUMBER> plays protective role sarscovmediated lung injury <NUMBER> therefore acute lung injury ace ang ii <NUMBER> r promote acute lung injury whereas ace<NUMBER> <NUMBER> r protect lung injury findings might provide opportunity develop recombinant ace<NUMBER> novel drug ards along <NUMBER> r inhibitor ace inhibitor possibly treat emerging infectious lung diseases avian influenza h<NUMBER>n<NUMBER> diseases affect lung function table <NUMBER> addition ace<NUMBER> unspecific protease would also interesting investigate role ace<NUMBER> metabolites including angiotensin<NUMBER> desarg<NUMBER>bradykinin apelin dynorphin ards look forward use angiotensin systemmodulating agentsmolecules particular ace<NUMBER> novel therapeutic agents treat severe acute lung failure syndrome affects millions people without yet effective drug treatments reported studies references vivo mouse <NUMBER> <NUMBER> angiotensin ii receptor type <NUMBER> <NUMBER> r inhibitor human <NUMBER> vivo mouse <NUMBER> <NUMBER> vivo rat <NUMBER> angiotensin converting enzyme ace inhibitor vivo mouse <NUMBER> vivo rat <NUMBER> coronaviruses cov long recognized causative agents diseases negatively impact production livestock poultry companion animals holmes <NUMBER> bovine coronavirus bcov classified order nidovirales family coronaviridae subfamily coronavirinae genus betacoronavirus species betacoronavirus <NUMBER> prevalent worldwide antibodies detected majority cattle hostshifting events involving cross species transmission bcov described past involving captive wild ruminants alekseev et al <NUMBER> dogs kaneshima et al <NUMBER> humans holmes <NUMBER> enteric infections associated bcov recognized alpaca crias cebra et al <NUMBER> detected intestinal tissue adult alpacas suffering hemorrhagic enteritis genova et al <NUMBER> article reports occurrence betacoronavirus similar bcov fecal samples <NUMBER> <NUMBER> week old alpaca crias high peruvian andes based partial nucleotide sequencing rnadependent rna polymerase rdrp gene february march <NUMBER> <NUMBER> fecal samples normally consistency <NUMBER> <NUMBER> week old asymptomatic crias six farms la raya experimental research station melgar province puno department peru located <NUMBER> sea level used study three farms alpacas cattle shared pastures method sampling animals complied principles ethical committee use animals school veterinary medicine animal science university são paulo total rna fecal samples extracted using trizol reagent tm invitrogen ® cdna synthetized using <NUMBER> ng random primers invitrogen ® <NUMBER> u moloney murine leukemia virus mmlv reverse transcriptase invitrogen ® following manufacturers recommended protocol detection cov performed using pancoronavirus nested pcr reaction specific primers targeting rdrp gene chu et al <NUMBER> taq dna polymerase invitrogen ® used pcr nested according manufacturers protocol amplicons cov purified using exosapit pcr product cleanup affymetrix ® sequenced abi prism <NUMBER> genetic dna analyzer applied biosystems ® maximum likelihood tree using gtr substitution model constructed using mega v <NUMBER> software tamura et al <NUMBER> eleven <NUMBER> fecal samples positive coronavirus positive samples came crias two different farms located approximately <NUMBER> mixed alpacacattle pastures phylogenetic analysis generated sequences <NUMBER> nt segregated within species betacoronavirus <NUMBER> fig <NUMBER> majority sequences obtained study genbank kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> farm <NUMBER> kp<NUMBER> farm <NUMBER> identical ab<NUMBER> kakegawa strain bcov af<NUMBER> quebec strain bcov area analysis kp<NUMBER> kp<NUMBER> farm <NUMBER> similarity <NUMBER> <NUMBER> respectively compared previously reported rdrp sequence alpaca betacoronavirus usa dq<NUMBER> nucleotide identities peruvian partial sequences <NUMBER> kp<NUMBER> <NUMBER> kp<NUMBER> <NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> kp<NUMBER> nestedpcr detected cov <NUMBER> fecal samples characterized betacoronavirus <NUMBER> fig <NUMBER> betacoronavirus <NUMBER> includes strains covs similar bcov found domestic wild ruminants well strains found canines porcines humans probably originated common ancestor similar bcov perlman netland <NUMBER> peruvian sequences closely related kakegawa mebus quebec strains bcov <NUMBER> identity less related usa isolate alpaca cov <NUMBER> could due geographical isolation farms maintaining strain virus circulation population unlike north american alpaca cov strain jin et al <NUMBER> new world camelids colocated cattle <NUMBER> years south america although identification coronavirus infection diarrhea alpacas recent possible virus crossed species earlier interspecies contact primo <NUMBER> cebra et al <NUMBER> genetic analysis gene would help better understand nature interspecies transmission event could led origin alpaca coronaviruses perlman netland <NUMBER> bidokhti et al <NUMBER> knowledge first detection bcovlike coronavirus fecal samples peruvian alpaca crias despite clinical significance bcovlike coronavirus identified study remains determined due study design current coronavirus disease <NUMBER> pandemic associated unprecedented morbidity mortality <NUMBER> recent publications transplant literature report varying rates mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> early reports china italy shown coexisting conditions including diabetes mellitus hypertension congestive heart failure coronary artery disease common among patients developed severe symptoms covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> conventional medical management comorbidities often includes use reninangiotensinaldosterone system raas inhibitors interestingly coronaviruses interact angiotensinconverting enzyme <NUMBER> ace<NUMBER> facilitate entry target cells <NUMBER> raising concerns several published commentaries preexisting use raas inhibitors may increase risk developing severe manifestations severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> citing preclinical studies demonstrated correlation increased levels circulating ace<NUMBER> raas inhibitors medical community suggested preemptive discontinuation raas inhibitors covid<NUMBER> medications might theoretically promote viral entry <NUMBER> given common use raas inhibitors among solid organ transplant recipients cardiovascular disease polycythemia sought review raas cascade mechanism sarscov<NUMBER> entry pertinent data related effect raas inhibitors ace<NUMBER> guide management solid organ transplant recipients covid<NUMBER> pandemic raas cascade vasoactive peptides orchestrate key physiological processes including blood pressure regulation fluid electrolyte balance cardiac renal function <NUMBER> <NUMBER> classical view cascade renin cleaves angiotensinogen generates angiotensin ang cleaved angiotensinconverting enzyme ace generating ang ii figure <NUMBER>a ang ii active form angiotensin binds receptors adrenal cortex releasing aldosterone ang ii also induces arterial vasoconstriction promotes fibrosis parallel pathway mediated ace<NUMBER> homolog ace generates ang <NUMBER> ang ang <NUMBER> ang ii figure <NUMBER>b ang <NUMBER> article protected copyright rights reserved organprotective properties oppose vasoconstrictive inflammatory sodium retaining remodeling properties ang ii ace<NUMBER> predominantly membranebound enzyme membrane anchor cleaved disintegrin metalloprotease <NUMBER> adam<NUMBER> releasing ace<NUMBER> blood urine body fluids membranebound ace<NUMBER> found pneumocytes along transmembrane protease serine <NUMBER> tmprss<NUMBER> required facilitate sarscov<NUMBER> entry target cells <NUMBER> hand soluble ace<NUMBER> shown significantly block early stages sarcov<NUMBER> infections vitro experiments represents potential therapeutic intervention <NUMBER> figure <NUMBER> although ace<NUMBER> shares significant homology ace <NUMBER> identity <NUMBER> similarity substratebinding pocket site distinct ace therefore classical ace inhibitors acei directly affect ace<NUMBER> enzymatic activity <NUMBER> addition acei use may protective reduces ang ii increases alveolar permeability would potentiate acute lung injury several animal studies reported mixed findings effect acei ace<NUMBER> mrna expression enzymatic activity cardiac <NUMBER> renal tissues <NUMBER> comparison angiotensin ii type receptor blockers arbs consistently upregulate ace<NUMBER> mrna protein level cardiac tissue <NUMBER> renal vasculatures <NUMBER> though effect varies across study models requires high doses arbs upregulation ace<NUMBER> arbs may protective lung injury via ang<NUMBER> vasodilatory peptide <NUMBER> contrast studies humans assess effect raas inhibitors ace<NUMBER> expression <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> important note studies reported level ace<NUMBER> activity blood urine quantifying membranebound ace<NUMBER> vivo human cardiac kidney tissue would technically challenging invasive evidence support soluble ace<NUMBER> reliable surrogate membranebound ace<NUMBER> interestingly membranebound ace<NUMBER> protein expression found decreased human autopsy hearts positive sarscov toronto sars outbreak <NUMBER> <NUMBER> hypothetically animal data extrapolated article protected copyright rights reserved humans increased membranebound ace<NUMBER> human myocardium associated preexisting use raas inhibitors may potentially protective covid<NUMBER>associated myocarditis kidney transplant recipients cardiovascular disease posttransplant erythrocytosis commonly prescribed acei arb <NUMBER> <NUMBER> studies raas blockade kidney transplant patients mixed regards patient graft survival <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly rare condition calls use arb posttransplant antibodymediated rejection related angiotensin ii type receptor at<NUMBER>r g proteincoupled receptor expressed endothelial cell surface <NUMBER> italy found <NUMBER> mortality rate <NUMBER> contrary higher mortality rates single center cohort study spain found <NUMBER> mortality rate among <NUMBER> patients infected covid<NUMBER> article protected copyright rights reserved onset pandemic midapril <NUMBER> <NUMBER> article protected copyright rights reserved potential unconfirmed risk factors coronavirus disease <NUMBER> covid<NUMBER> adults children may include hypertension cardiovascular disease chronic kidney disease well medications commonly prescribed conditions ace angiotensinconverting enzyme inhibitors ang ii angiotensin ii receptor blockers coronavirus binding ace<NUMBER> angiotensinconverting enzyme <NUMBER> crucial component reninangiotensinaldosterone system underlies much concern children uniquely impacted coronavirus reasons unclear review highlight relationship covid<NUMBER> hypertension use ace inhibitors ang ii receptor blockers lifetime risk cardiovascular disease pediatric perspective briefly summarize reninangiotensinaldosterone system comprehensively review literature pertaining ace <NUMBER>ang<NUMBER> pathway children clinical evidence ace inhibitors ang ii receptor blockers affect important pathway given importance ace <NUMBER>ang<NUMBER> pathway potential differences adults children crucial children included coronavirusrelated research may shed light potential mechanisms children decreased risk severe covid<NUMBER> ace<NUMBER> angiotensinconverting enzyme <NUMBER> covid<NUMBER> ace inhibitor ang ii angiotensin ii receptor blocker use pandemic pediatric perspective potential unconfirmed risk factors coronavirus disease <NUMBER> covid<NUMBER> adults children may include hypertension cardiovascular disease chronic kidney disease well medications commonly prescribed conditions ace angiotensinconverting enzyme inhibitors ang ii angiotensin ii receptor blockers coronavirus binding ace<NUMBER> angiotensinconverting enzyme <NUMBER> crucial component reninangiotensinaldosterone system underlies much concern children uniquely impacted coronavirus reasons unclear review highlight relationship covid<NUMBER> hypertension use ace inhibitors ang ii receptor blockers lifetime risk cardiovascular disease pediatric perspective briefly summarize reninangiotensinaldosterone system comprehensively review literature pertaining ace <NUMBER>ang<NUMBER> pathway children clinical evidence ace inhibitors ang ii receptor blockers affect important pathway given importance ace <NUMBER>ang<NUMBER> pathway potential differences adults children crucial children included coronavirusrelated research may shed light potential mechanisms children decreased risk severe covid<NUMBER> ace<NUMBER> angiotensinconverting enzyme <NUMBER> covid<NUMBER> ace inhibitor ang ii angiotensin ii receptor blocker use pandemic pediatric perspective new coronavirus sarscov<NUMBER> covid<NUMBER> identified cause severe acute respiratory syndrome sars severe form viral pneumonia associated high mortality virus spread china rest world real short period important severity leading world health organization consider global emergency sarscov<NUMBER> rna virus sharing <NUMBER> viral genome sarscov responsible <NUMBER> outbreak wu <NUMBER> several studies confirmed virus able penetrate human cells binding ace<NUMBER> protein angiotensinconverting enzyme <NUMBER> part reninangiotensin system ras guoping et al <NUMBER> considered possible membrane receptor also noted patients infected virus sick days functional variations concentrations enzymes components ras zhou et al <NUMBER> defense mechanism human host helps infection responsible worsening clinical conditions consequence corrected pharmacologically gurwitz <NUMBER> reninangiotensin system ras physiological mechanism able regulate different functions body particular important regulation blood pressure volume circulating plasma volemia tone arterial muscles different mechanisms ras enzymatic cascade main enzyme pathway classical renin converts angiotensinogen released liver angiotensin ang ang subsequently converted angiotensin ii ang ii angiotensinconverting enzyme ace also another nonclassical enzyme pathway mediated ace<NUMBER> atlas <NUMBER> pathway ace<NUMBER> converts ang ii angiotensin <NUMBER> ang <NUMBER> ang angiotensin <NUMBER> ang <NUMBER> ace<NUMBER> type membrane metallocarboxypeptidase high ace homology functions distinct two enzymes also expressed differently tissues example ace<NUMBER> expressed renal cardiovascular pulmonary gastrointestinal tissues ace activity highly expressed lungs brain kidneys nehme et al <NUMBER> aspects correlation various stages sarscov<NUMBER> infection ras variation remain clarified sarscov<NUMBER> infection divided three phases first asymptomatic slightly symptomatic second third severe characterized hyperinflammatory state second third phase seems worst damage caused generalized inflammatory state caused cytokine storm responsible severe lung injury multiorgan dysfunction watkins <NUMBER> several studies shown variation ras related sarscov<NUMBER> infection involved stages ace<NUMBER> identified input membrane receptor sarscov<NUMBER> epithelial lung cells evidence may suggest increased expression ace<NUMBER> related increased risk sarscov<NUMBER> infection addition described variations ras noted various stages sarscov<NUMBER> infection particular evidence showed increased activation system early stages decreased subsequent stages although data showing variations conflicting entirely clear zheng et al <NUMBER> fang et al <NUMBER> certainly activation ras known change conditions copd asthma viral infections smokers demonstrating system related correct lung airway function evidence suggests physiological balance ras system especially aceace<NUMBER> likely altered sarscov<NUMBER> viral infection ras imbalance likely play role lung lesion inflammatory state activation aspects yet clarified direction pharmacological approach regulated concentration aceace<NUMBER> could way moderate severe lung damage virusinduced bavishi et al <NUMBER> ferrario et al <NUMBER> addition ace<NUMBER> shown play role fibrogenesis inflammation different organs including lungs studies patients infected sarscov<NUMBER> showed ace<NUMBER> expression rapid increase first hours viral infection begins rapid downregulation lung tissue patient enters stage two three infection however possible ace<NUMBER> protective effect decreases worsening lungs inflammatory state addition specific studies show ace<NUMBER> expression decreased respiratory diseases pulmonary fibrosis copd also noted ang ii ang <NUMBER> ang <NUMBER> different biological effects fact biological effects ang ii vasoconstrictor aldosterone release stimulant cause also myocardial hypertrophy interstitial fibrosis endothelial dysfunction increase inflammation state oxidative stress increased coagulation biological effects altered cause serious complications patient sarscov<NUMBER> infection ang ii cause increased inflammation production il<NUMBER> tnf tumor necrosis factor inflammatory cytokines recinos et al <NUMBER> yamamoto et al <NUMBER> lee et al <NUMBER> however important note biological effects mediated at<NUMBER> receptors at<NUMBER>r ace<NUMBER> reduce negative effects ang ii several mechanisms example conversion ang ii ang <NUMBER> ang<NUMBER> opposite biological effects ang ii mas receptor masr type ii receptors ang ii at<NUMBER>r masr expressed surface bronchial muscle alveolar epithelium lungs magalhaes et al <NUMBER> ang <NUMBER> antiinflammatory antifibrosis effects masr agonist effect meng et al <NUMBER> addition masr expressed platelets ang <NUMBER> mediates antiaggregant effects fang et al <NUMBER> pai et al <NUMBER> fragasilva et al <NUMBER> able increase prostacyclines fragasilva et al <NUMBER> description suggest pharmacological modulation ras different stages sarscov<NUMBER> infection could beneficial effective therapy pharmacological approach modulating ras could clinical benefit fight sarscov<NUMBER> infection agents acting ras distinguished angiotensin converting enzyme inhibitors aceis angiotensin ii receptor blockers arbs direct renin inhibitors dris bavishi et al <NUMBER> agents currently indicated treatment various cardiovascular diseases excellent clinical efficacy aceis able reduce blood pressure acting ace inhibition converts ang ang ii arbs ang ii antagonists type <NUMBER> receptor at<NUMBER>r finally dris block plasma renin activity inhibit conversion angiotensinogen ang three different classes described different effects regulation enzymatic expression ras fact basis vitro studies seems use aceis blockade enzyme ace increases expression enzyme ace<NUMBER> stimulating synthesis pathways although data fully confirmed moment contradictory vaduganathan et al <NUMBER> use arbs seems linked slight increase expression ace ace<NUMBER> finally use dris inhibiting upstream ras cascade seems inhibit expression consequently decrease ace ace<NUMBER> concentrations shows available agents able act different modulation ras expression components evidences suggest ras could modulated pharmacological approach avoid complications viral infection scientific debate still ongoing several months whether increased ace<NUMBER> using aceis arbs could risk factor covid<NUMBER> infection moment epidemiological data show correlation use aceis arbs increased likelihood infection complications sarscov<NUMBER> however increase ace<NUMBER> severe stages viral infection could beneficial increase ace<NUMBER> synthesizes ang <NUMBER> ang<NUMBER> vasodilating antinfiammatory antifibrotic properties schindler et al <NUMBER> imai et al <NUMBER> addition use arbs increases stimulation at<NUMBER>r ang ii vasodilating antifibrotic antioxidant effects conclusion currently evidence demonstrate use aceis arbs discontinued treated patients represent risk factor increases likelihood sarscov<NUMBER> infection mancia et al <NUMBER> however shown activation ang iiat<NUMBER>r axis promote lung damage increasing ace<NUMBER> activating ang <NUMBER>masr axis may protect lung damage kuster et al <NUMBER> european society hypertension <NUMBER> ras modulating agents may beneficial combating sarscov<NUMBER> infection clinical studies necessary confirm hypotheses extensive epidemiological studies designed investigate real correlation ras covid<NUMBER> particular clarify whether increase ace<NUMBER> aceis arbs considered important risk factor sarscov<NUMBER> infection whether increase ace<NUMBER> severe stages infection play protective role believe based current evidence literature modulating ras system right time correctly could enormous clinical benefit avoid serious complications covid<NUMBER> authors read approved final manuscript coronaviruses covs singlestranded rna genome size range <NUMBER> <NUMBER> kb positive sense covered enveloped structure<NUMBER> shape either pleomorphic spherical characterized bears clubshaped projections glycoproteins surface diameter <NUMBER>–<NUMBER> nm<NUMBER> among rna viruses rna genome cov one among largest<NUMBER> number open reading frames orfs cov genome ranges six ten<NUMBER> cov genetic material susceptible frequent recombination process give rise new strains alteration virulence<NUMBER> seven strains human covs include <NUMBER>e nl<NUMBER> oc<NUMBER> hku<NUMBER> middle east respiratory syndrome merscov severe acute respiratory syndrome sarscov <NUMBER>novel coronavirus ncov responsible infection special reference involvement respiratory tract lower upper respiratory tract eg common cold pneumonia bronchiolitis rhinitis pharyngitis sinusitis system symptoms occasional watery diarrhea<NUMBER> among seven strains three strains proved highly pathogenic sarscov merscov <NUMBER>ncov caused endemic severe cov disease<NUMBER> reservoir sarscov unknown bats subsequent spread himalayan palm civets hypothesized<NUMBER> merscov also zoonotic origin middle east transmission camels<NUMBER> among sarscov outbreak started <NUMBER> guangdong province china second outbreak merscov outbreak <NUMBER> saudi arabia<NUMBER> previous two attacks cov known cause milder disease two outbreaks highlighted adaptive potential changing environmental conditions classified “emerging viruses” knowledge structure metabolic pathways cov pathophysiology covassociated diseases important identify possible drug targets<NUMBER> important structural proteins cov spike protein trimeric membrane protein envelop e protein nucleocapsid n protein viruses betacovs also hemagglutinin esterase glycoprotein<NUMBER> rna genome cov seven genes conserved order orf<NUMBER>a orf<NUMBER>b oef<NUMBER> e n <NUMBER> <NUMBER> direction twothird part rna genome covered orf<NUMBER>ab produces two viral replicase proteins polyproteins pp<NUMBER>a pp<NUMBER>ab<NUMBER> sixteen mature nonstructural proteins nsps arise processing two pps nsps take part different viral functions including formation replicase transcriptase complex remaining genome part virus encodes mrna produces structural proteins ie spike envelope membrane nucleocapsid accessory proteins<NUMBER> another important envelopassociated protein expressed strains cov protein<NUMBER> rna genome cov packed nucleocapsid protein covered envelope<NUMBER> case sarscov transmission droplet infection respiratory secretions close persontoperson contact<NUMBER> also spread sweat stool urine respiratory secretions<NUMBER> virus enters body binds primary target cells enterocytes pneumocytes<NUMBER> thereby establishing cycle infection replication target cells cov epithelial renal tubules tubular epithelial cells kidney immune cells cerebral neuronal cells<NUMBER> cov attaches target cells help spike protein–host cell protein interaction angiotensin converting enzyme<NUMBER> ace<NUMBER> interaction sarscov<NUMBER> dipeptidyl peptidase<NUMBER> dpp<NUMBER> merscov<NUMBER> receptor recognition virus genome nucleocapsid released cytoplasm host cells viral genome contains orf<NUMBER>a orf<NUMBER>b genes produce two pps pp<NUMBER>a pp<NUMBER>b<NUMBER> help take command host ribosomes translation process<NUMBER> pp<NUMBER>a pp<NUMBER>b take part formation replication transcription complex<NUMBER> processing pp protease produces <NUMBER> nsps nsps specific functions suppression host gene expression nsp<NUMBER> nsp<NUMBER> formation multidomain complex nsp<NUMBER> nsp<NUMBER> protease role replication<NUMBER> nsp<NUMBER> nsp<NUMBER> transmembrane tm proteins<NUMBER> nsp<NUMBER> nsp<NUMBER> act primase<NUMBER> nsp<NUMBER> – rnabinding protein dimeric form important viral infection induction disturbance dimerization nsp<NUMBER> way overcome cov infection<NUMBER> nsp<NUMBER> acts cofactor activation replicative enzyme<NUMBER> nsp<NUMBER> shows rnadependent rna polymerase activity nsp<NUMBER> shows helicase activity nsp<NUMBER> shows exoribonuclease activity nsp<NUMBER> shows endoribonuclease activity nsp<NUMBER> methyltransferase activity<NUMBER> nsps important role replication transcription<NUMBER> synthesized proteins e entered endoplasmic reticulum ergolgi intermediate compartment ergic complex make structure viral envelope<NUMBER> hand replicated genome binds n protein forms ribonucleoprotein rnp complex outer cover formed e proteins<NUMBER> finally virus particle comes ergic making budlike structure<NUMBER> mature virions form vesicle fuses plasma membrane releases virus particles extracellular region<NUMBER> detailed structure cov life cycle depicted figures <NUMBER> <NUMBER> infection sarscov merscov cause surge proinflammatory cytokines chemokines cause damage lung tissue<NUMBER> deterioration lung function finally lung failure cases<NUMBER> currently specific antiviral drug treatment covassociated pathologies treatment strategies focus symptomatic management supportive therapy only<NUMBER> therapeutic agents development used offlabel ribavirin interferon ifnα mycophenolic acid<NUMBER> many newspaper articles citing effectiveness antihiv drugs ritonavir<NUMBER> lopinavir<NUMBER> either alone combination oseltamivir<NUMBER> remdesivir chloroquine<NUMBER> among ritonavir remdesivir chloroquine showed efficacy cellular level<NUMBER> need experimental support validation welldefined therapy available specifically targets cov article reviewed possible protein structures could potential targets development therapeutic approach treatment cov screened pubmed rcsb database keywords hcov ncov corona virus serscov merscov <NUMBER>ncov crystal structure xray crystallography structure nmr structure target drug target till feb <NUMBER> <NUMBER> database files extracted using endnote title abstract screening done using rayyan qcri full texts screened articles screened possible inclusion systematic review articles evaluated different druggable targets cov evaluated different therapeutic measures identifiable target included review main components s<NUMBER> domain nterminal domain ntd cterminal domain ctd s<NUMBER> domain acts major antigen surface virus<NUMBER> receptorbinding domain rbd<NUMBER> <NUMBER> residues ace<NUMBER> interact rbd contain <NUMBER> amino acids sarscov spike protein<NUMBER> contact k<NUMBER> ace<NUMBER> r<NUMBER> residue rbd play important role point mutated d<NUMBER> r<NUMBER> rbd disturbs binding activity ace<NUMBER> s<NUMBER> domain interacts ace<NUMBER> dpp<NUMBER> receptors host antiace<NUMBER> antibody blocked viral entry replication vero e<NUMBER> cells<NUMBER> one another mechanism virus binding host cell using dendritic cellspecific intercellular adhesion molecule<NUMBER> grabbing nonintegrin dcsign receptor lsign lymph nodes liver<NUMBER> protein seven <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> glycosylation asparaginelinked sites pivotal lsign dcsignbased virus entry host<NUMBER> s<NUMBER> subunit two heptad repeat regions hr <NUMBER> <NUMBER> hydrophobic fusion peptide<NUMBER> rbd targeted many drug designing studies<NUMBER> peptide sequence sequence similarity rbd protein hampered s<NUMBER>rbd ace<NUMBER> interaction prevented entry sarscov vero cells ic<NUMBER> around <NUMBER> μm<NUMBER> sarscov rbdspecific antibody fm<NUMBER> failed inhibit occurrence infection<NUMBER> oc<NUMBER>hr<NUMBER>p peptide derived heptad repeat <NUMBER> regions s<NUMBER> domain hcovoc<NUMBER> optimized form ek<NUMBER> showed pancov fusion inhibition property<NUMBER> structure protein data bank pdb id <NUMBER>zuv <NUMBER>zvm shows stable <NUMBER>helix bundle structure αhcov long βhcovhr<NUMBER> domain<NUMBER> chloroquine antimalarial agent inhibits serscov elevation endosomal ph alters terminal glycosylation ace<NUMBER> ultimately interferes virus receptor binding<NUMBER> inhibitors ssaa<NUMBER>e<NUMBER> block sace<NUMBER> interaction ssaa<NUMBER>e<NUMBER> inhibits host protease cathepsin l important viral entry ssaa<NUMBER>e<NUMBER> prevents fusion host viral cell membrane<NUMBER> kao et al identified <NUMBER> small molecules targeted sace<NUMBER>mediated entry virus human cell<NUMBER> <NUMBER>t cells expressing ace<NUMBER> one agents ve<NUMBER> showed significant inhibition sarspseudovirus entry<NUMBER> vero e<NUMBER> cells two molecules tetraogalloyl betadglucose luteolin also inhibited sarspseudovirus sarscov infection<NUMBER> virusinfected vero e<NUMBER> cells sirna sequences sarscov inhibited sarscov replication<NUMBER> s<NUMBER> antibody origin memory bcells sarscovinfected persons neutralizes wide spectrum isolates sarscov<NUMBER> s<NUMBER> antibody fab fragment binds sarscov complex neutralize structures also available pdb ids <NUMBER>nb<NUMBER> <NUMBER>nb<NUMBER> <NUMBER>nb<NUMBER> monoclonal antibody m<NUMBER> competitive role rbd binding pdb id <NUMBER>dd<NUMBER> monoclonal antibody generated immunizing spike protein serscov transgenic mice bcells covinfected persons<NUMBER> spikespecific monoclonal antibodies <NUMBER>r cr<NUMBER> block sace<NUMBER> interactions thus neutralize infection human sarscov hku<NUMBER> tor<NUMBER> palm civet strain sz<NUMBER> mice vaccinated sarsn dna showed tcell immune response induction proliferation<NUMBER> cytotoxic tcell response seen sarsdnatransfected alveolar epithelial cells e protein smallest <NUMBER>–<NUMBER> kda size tm structural protein cov<NUMBER> two distinct domains comprise e protein hydrophobic domain charged cytoplasmic tail however structure highly variable among different members cov family<NUMBER> e protein special role viral morphogenesis especially assembly egress<NUMBER> covs lacking e protein show lower viral titer immature inefficient progenies<NUMBER> oligomerization e proteins leads formation ion channels<NUMBER> however importance ion channels still clear many studies infer e protein acts coordination intracellular proteins modulates activity proteins<NUMBER> e protein also acts virulence factor<NUMBER> e protein important role cov assembly budding formation<NUMBER> apart e protein found around er golgi body regions<NUMBER> hexamethylene amiloride blocks e proteinassociated ion channel activity mammalian cells expressing serscov envelop protein<NUMBER> maintenance shape viral envelope important function protein<NUMBER> protein performs job interacting cov proteins<NUMBER> incorporation golgi complex new virions<NUMBER> stabilization nucleocapsid protein<NUMBER> protein characterized three tm domains<NUMBER> cterminal inside long nterminal short outside<NUMBER> details protein structure available uniprot<NUMBER> multiple protein–protein interactions protein plays crucial role viral intracellular homeostasis<NUMBER> interaction m–m m–s m–n proteins takes special part viral assembly<NUMBER> m–s interactions necessary interaction spike protein ergic complex also known golgi complex later incorporated new viral progenies<NUMBER> m–n interactions crucial stabilization rnp complex nucleocapsid–rna complex forms viral core<NUMBER> protein n protein major viral envelope proteins defining viral shape also takes part formation release viruslike particles<NUMBER> protein also takes part sensitization host virus<NUMBER> protein sarscov activates nuclear factor kappa pathway ifnbeta pathway tolllike receptordependent mechanism mutated protein v<NUMBER> failed illicit ifnbeta response<NUMBER> mice vaccinated sarsm dna showed tcell immune response induction proliferation<NUMBER> cytotoxic tcell response seen sarsdnatransfected alveolar epithelial cells structure nucleocapsid protein n protein conserved across different members cov family three characteristic intrinsically disordered regions idrs nucleocapsid n protein narm central linker cl ctail<NUMBER> ntd ctd major structural functional domain nucleocapsid protein important function n protein ntd rna binding primary job ctd dimerization<NUMBER> cl region rich arginine serine residue content also contains large number phosphorylation sites<NUMBER> cterminal idrs take important part nucleocapsid protein oligomerization n–m protein interactions<NUMBER> formation maintenance rnp complex important functions n protein<NUMBER> also regulates replication transcription viral rna host inhibits protein translation ef<NUMBER>αmediated action<NUMBER> alteration host cell metabolism host cell cycle n proteins reported inhibit cdk<NUMBER> apoptosis<NUMBER> human peripheral blood n protein inhibits cell proliferation inhibition cytokinesis<NUMBER> ntd contains sites rna binding rnabinding sites ntd n protein identified observing interactions ribonucleoside <NUMBER>monophosphates amp ump cmp gmp<NUMBER> using information interaction amp ump binding ntd nucleocapsid protein inhibitors rna binding designed threedimensional structure complex see pdb <NUMBER>lmc <NUMBER>lm<NUMBER> <NUMBER>lm<NUMBER> <NUMBER>li<NUMBER> respectively<NUMBER> one molecule designed strategy n<NUMBER>oxo<NUMBER>dihydrophenanthridine<NUMBER>yl n n dimethyl amino pj<NUMBER> designed using hcovoc<NUMBER> model<NUMBER> binding pj<NUMBER> ntd affects genome binding replication process cov<NUMBER> crystal structure covoc<NUMBER> nntd inhibitor pj<NUMBER> complex given pdb id <NUMBER>kxj<NUMBER> basis interactions pj<NUMBER> ntd nucleocapsid protein another inhibitor designed h<NUMBER> <NUMBER>chloro<NUMBER>morpholin<NUMBER>ylethylamino quinoxaline<NUMBER>dione also inhibits rna binding<NUMBER> highlights importance ntd rna binding herbal products catechin gallate gallocatechin gallate polyphenolic compounds shown inhibitory action sarscov<NUMBER> ctd n protein primary role oligomerization especially cterminal end cterminal tail peptide sequence n<NUMBER>–<NUMBER> competes oligomerization process significant inhibition viral titer seen <NUMBER> μm concentration<NUMBER> n<NUMBER> nucleocapsid protein peptide showed high binding affinity human mhc<NUMBER> t<NUMBER> cells peptide sequence successful activating tcells cytotoxic transgenic animals peptide showed potential selective killing nucleocapsid protein expressing cells potential candidate dna vaccine<NUMBER> n proteintargeted peptides importance np<NUMBER> np<NUMBER> np<NUMBER> <NUMBER>clpro present homodimer form cyshis dyad active site shows protease activity<NUMBER> mutated ser<NUMBER> phe<NUMBER> positions abolishes dimerization <NUMBER>clpro pdb id <NUMBER>f<NUMBER>g<NUMBER> protease cleave <NUMBER> sites p<NUMBER> position pp<NUMBER>a pp<NUMBER>ab produce mature protein anchors replicationtranscription complex<NUMBER> also releases mature nsps<NUMBER> nbenzo<NUMBER>triazol<NUMBER>ylnbenzyl acetamido phenyl carboxamides also found important inhibitors clpro structure clpro inhibitor ml<NUMBER> ic<NUMBER> <NUMBER> μm reported cid <NUMBER> pdb id <NUMBER>v<NUMBER>m<NUMBER> another structure clpro inhibitor ml<NUMBER> pdb id <NUMBER>mds ic<NUMBER> <NUMBER> μm reported<NUMBER> metalconjugated peptidomimetic compounds showed inhibitory activity <NUMBER>clpro<NUMBER> small molecules also act inhibitor arylboronic acids quinolinecarboxylate derivatives thiophenecarboxylate phthalhydrazidesubstituted ketoglutamine analogs<NUMBER> flavonoids also reported inhibit mpro<NUMBER> gc<NUMBER> also protease inhibitor activity<NUMBER> crystal structure mpro small molecule inhibitor n<NUMBER> also reported pdb id <NUMBER>amq<NUMBER> lopinavir ritonavir inhibitors hiv protease also inhibit mpro<NUMBER> silico studies directed among commercially available drugs colistin valrubicin icatibant bepotastine epirubicin epoprostenol vapreotide aprepitant caspofungin perphenazine also bind lopinavirritonavirbinding site cov<NUMBER> plpro cleaves nterminal region pp generate three nsps nsp <NUMBER> <NUMBER> <NUMBER> plpro catalytic core domain contains <NUMBER> amino acid responsible cleaving replicase substrates consensus sequence lxgg required cleavage<NUMBER> higher doses zinc zinc conjugates found inhibit types sars protease clpro plpro<NUMBER> benzodioxole inhibit plpro enzyme crystal structure interaction shown pdb id <NUMBER>ovz <NUMBER>owz<NUMBER> silico approach another new lead identified <NUMBER> optimized compound <NUMBER>h configuration enzyme ic<NUMBER> <NUMBER> μm antiviral ec<NUMBER> <NUMBER> μm <NUMBER>g r configuration enzyme ic<NUMBER> <NUMBER> μm antiviral ec<NUMBER> <NUMBER> μm found important inhibitors<NUMBER> crystallized structural details interactions visualized pdb database pdb id <NUMBER>fe<NUMBER> <NUMBER>e<NUMBER>s<NUMBER> many protease inhibitors used treatment covid<NUMBER> eg lopinavir–ritonavir combinations<NUMBER> enzyme present envelope cov specifically among betacoronaviridiae<NUMBER> marker cov influenza virus evolution<NUMBER> mediates reversible attachment oacetylatedsialicacids acting lectins receptordestroying enzymes<NUMBER> interactions complex sialic acid visualized pdb id <NUMBER>cl<NUMBER> ntpasehelicase plays important role central dogma virus<NUMBER> sarscov helicase enzyme member sf<NUMBER> enzyme prefers atp datp dctp substrates also hydrolyzed ntps<NUMBER> toxicity issues main obstacles development inhibitors helicase nonspecificity inhibitors may cause serious toxicity<NUMBER> however despite theoretical limitations helicase increasingly recognized druggable target different disease conditions<NUMBER> entered host cell subsequent life cycle serscov requires low ph<NUMBER> inhibitors phsensitive endosomal protease block cov infection<NUMBER> several different small compounds molecules reported virus infection amiodarone gets accumulated acidic organelles vacuoles exposure amiodarone shows alteration intracellular organelles especially enlargement late endosomes invitro environment amiodarone inhibited coronavirus infection vero cells<NUMBER> priori trypsin cleavage protein essential successful viral entry however trypsin cleavage also affect efficacy amiodarone<NUMBER> rcsb database one pdb pdb id <NUMBER>lu<NUMBER> <NUMBER>ncov complex n<NUMBER> inhibitor complete sequence <NUMBER>ncov available<NUMBER> however <NUMBER> similar batslcovzc<NUMBER> <NUMBER> sirs covzsc nucleotide blast ncbi highlights amount recombination processes changes occurred <NUMBER>ncov changes protein structural functional levels total <NUMBER> trials registered till date chinese clinical trial registry<NUMBER> dated feb <NUMBER> <NUMBER> keywords <NUMBER>ncov covid<NUMBER> among pharmacotherapeutic agents evaluated highlighted agents evaluated highdose vitamin c favipiravir adalimumab dihydroartemisinin piperaquine leflunomide dipyridamole chloroquine hydroxychloroquine suramin sodium lopinavirritonavir arbidol umifenovir tablets ifnalpha <NUMBER>b important agents evaluated huoshen particles xiyanping injection shenfu injection etc many traditional chinese medicines background use stem cells also evaluated frequently<NUMBER> nil conflicts interest physiologic homeostasis blood pressure electrolyte balance abnormal activation ras associated pathophysiology cardiovascular diseases hypertension myocardial infarction heart failure <NUMBER> <NUMBER> <NUMBER> many years angiotensinconverting enzyme ace known key enzyme regulation ras <NUMBER> <NUMBER> year <NUMBER> novel homologue ace cloned termed angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> despite sequence similarity metalloprotease catalytic domains ace ace<NUMBER> differ substrate specificity difference important physiological consequences whereas ace cleaves decapeptide angiotensin ang octapeptide angiotensin ii ang ii <NUMBER> <NUMBER> ace<NUMBER> functions carboxypeptidase cleaving single residue ang generating angiotensin<NUMBER> <NUMBER> <NUMBER> single residue ang ii generate angiotensin<NUMBER> <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> targeted disruption murine ace<NUMBER> resulted increased systemic ang ii levels impaired cardiac contractility aged mice upregulation hypoxiainduced genes heart <NUMBER> genetic data first time demonstrated ace<NUMBER> functions negative regulator ang ii levels within ras heart recently ace<NUMBER> identified functional receptor severe acute respiratory syndrome sarscoronavirus sarscov vitro <NUMBER> <NUMBER> vivo <NUMBER> several months <NUMBER> newly identified illness termed sars spread rapidly throughout world causing <NUMBER> deaths disrupting travel economics social life <NUMBER> <NUMBER> <NUMBER> novel coronavirus termed sarscov identified causative sars pathogen <NUMBER> <NUMBER> death rate following infection ∼<NUMBER> due development atypical pneumonia characterized high fever development acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> ards severe form acute lung injury characterized pulmonary edema accumulation inflammatory cells severe hypoxia <NUMBER> <NUMBER> <NUMBER> ards high mortality rate <NUMBER> affects nearly one million individuals worldwideyear ards triggered various diseases sepsis trauma aspiration acute pancreatitis pneumonias including infections sarscov avian human influenza viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov receptor ace<NUMBER> expressed lungs healthy diseased humans <NUMBER> recent studies definitely showed ace<NUMBER> indeed essential receptor sars infections mice vivo <NUMBER> pathogenesis ards ang ii upregulated ace drives severe lung failure via ang ii type <NUMBER> at<NUMBER> receptor <NUMBER> hand ace<NUMBER> ang ii type <NUMBER> receptor regulate opposing effects protective roles lung injury addition sarscovmediated downregulation ace<NUMBER> appears play causative role severe acute lung injury sars enhanced activation at<NUMBER> receptors <NUMBER> beneficial effects ace inhibitors at<NUMBER> receptor blockers hypertension clinics functionally proven vivo models using mice deficient ace angiotensinogen ang ii type <NUMBER>a receptor mice show lower blood pressure <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> vitro activity ace<NUMBER> cleave ang ii angiotensin<NUMBER> encouraged researchers propose ace<NUMBER> also major regulator blood pressure homeostasis initial study showing reduced ace<NUMBER> expression different hypertensive rat strains <NUMBER> upregulation ace<NUMBER> expression reported undernutrition programmed hypertension rats <NUMBER> at<NUMBER> receptor blockertreated <NUMBER> alltrans retinoic acidtreated <NUMBER> hypertensive rats accompanied reduction blood pressure hand surprising find ace<NUMBER> knockout mice per se show apparently normal blood pressures <NUMBER> however likely mousestrainspecific background genes might influence effects ace<NUMBER> blood pressure despite ace ace<NUMBER> involved production vasodilator peptide angiotensin <NUMBER> drvyihpf red arrowheads ace cleavage site blue arrowheads ace<NUMBER> cleavage sites noted ace<NUMBER> unspecific protease cleave multiple additional substrates apelin direct correlation essential hypertension ace<NUMBER> polymorphisms earlier clinical study <NUMBER> two recent chinese population studies indicated ace<NUMBER> g<NUMBER>a polymorphism associated cardiac incompetence essential hypertension patients hypertension metabolic syndrome patients <NUMBER> <NUMBER> findings implicated significance ace<NUMBER> g<NUMBER>a polymorphism cardiovascular diseases note studies investigated single nucleotide polymorphisms snps located introns ace<NUMBER> gene effects snps activity andor expression ace<NUMBER> still unknown nevertheless data hypertensive rats human ace<NUMBER> snps implicate possible significance ace<NUMBER> blood pressure regulation studies awaited initially ace<NUMBER> identified cloned human failing heart tissue <NUMBER> line increased ace<NUMBER> expression failing heart reported independently <NUMBER> <NUMBER> <NUMBER> <NUMBER> protective role ace<NUMBER> pressureoverloadinduced heart failure recently shown transverse aortic constriction model using ace<NUMBER> knockout mice <NUMBER> furthermore function ace<NUMBER> basal condition defined echocardiography measurements showing progressive impairment heart contractility aged ace<NUMBER>genedeficient mice without histological changes heart <NUMBER> observed phenotype ace<NUMBER> mutant mice resembles defective heart found patients cardiac stunninghibernation <NUMBER> cardiac stunning hibernation reflect adaptive responses prolonged states tissue hypoxia occur coronary artery disease following bypass surgery <NUMBER> <NUMBER> pathologically chronic hypoxic conditions lead compensatory changes myocyte metabolism <NUMBER> upregulation hypoxiainduced genes <NUMBER> <NUMBER> possibly resembling myocytespecific vascular endothelial growth factor mutant mice <NUMBER> link cardiac stunninghibernation heart defect observed ace<NUMBER> knockout mice investigated interestingly additional deletion ace gene ace<NUMBER> mutant background rescued cardiac contractility phenotype ace<NUMBER> single knockout mice also reversed increased ang ii peptide levels <NUMBER> normal cardiac functions aceace<NUMBER> doublemutant mice suggest aces catalytic products account least part observed contractile impairment old ace<NUMBER> singlemutant mice <NUMBER> observations first time demonstrated genetic level ace<NUMBER> counterbalances enzymatic actions ace seems increased local cardiac ang ii might cause cardiac abnormalities ace<NUMBER>deficient mice nevertheless remains unclear elevated heart ang ii levels induce cardiac hypertrophy ace<NUMBER>deficient mice instance experimental models well established cardiomyocytes express ang ii receptors undergo hypertrophy fibrosis response ang ii stimulation <NUMBER> thus important note ang iiindependent pathways could also play important role aceace<NUMBER>regulated heart functions major sites ace expression body vascular endothelial cells lungs thus proposed systemic ang ii mainly generated lung <NUMBER> <NUMBER> <NUMBER> experimentally possible role ang ii lung disease implied animal models pulmonary fibrosis elicited bleomycin irradiationmediated lung injury bleomycininduced pulmonary fibrosis rats mice ace inhibitors at<NUMBER> receptor blockers attenuate epithelial apoptosis interstitial fibrosis collagen deposition <NUMBER> <NUMBER> <NUMBER> <NUMBER> reports implicated ace inhibitors at<NUMBER> receptor blockers possible therapy pulmonary fibrosis seen idiopathic pulmonary fibrosis <NUMBER> sarcoidosis <NUMBER> irradiationinduced pneumonitis <NUMBER> fibrosis develops side effect chemotherapy cancer patients <NUMBER> however enough published clinical studies make firm conclusion whether inhibitors indeed show beneficial effects recent cohort study ards showed significant association ace insertiondeletion polymorphism susceptibility outcome ards <NUMBER> allele human ace gene confers increased ace activity plasma dd genotype frequency increased patients ards compared control groups <NUMBER> moreover dd allele significantly associated mortality ards group thus based inhibitor experiments rodents ace allelic correlation studies humans suggested ras could role acute lung failure pulmonary fibrosis group investigated role ace<NUMBER> ards using ace<NUMBER> knockout mice three different ards models acidaspirationinduced ards endotoxininduced ards peritoneal sepsisinduced ards ace<NUMBER> knockout mice show severe disease compared wildtype mice <NUMBER> loss ace<NUMBER> expression mutant mice resulted enhanced vascular permeability increased lung edema neutrophil accumulation worsened lung function importantly treatment catalytically active recombinant ace<NUMBER> protein improved symptoms acute lung injury wildtype mice well ace<NUMBER> knockout mice <NUMBER> thus ace<NUMBER> plays protective role acute lung injury mechanistically negative regulation ang ii levels ace<NUMBER> accounts part protective function ace<NUMBER> ards example at<NUMBER> inhibitor treatment additional ace gene deficiency ace<NUMBER> knockout background rescues severe phenotype ace<NUMBER> singlemutant mice acute lung injury <NUMBER> addition ace knockout mice at<NUMBER>a receptor knockout mice showed improved symptoms acute lung injury <NUMBER> therefore acute lung injury ace ang ii at<NUMBER> receptor function lunginjurypromoting factors ace<NUMBER> protects lung injury <NUMBER> however similar heart also evidence ace<NUMBER>regulated ang iiindependent pathways <NUMBER> <NUMBER> might play critical role controlling ards following acute lung injury fig <NUMBER> within months publication sarscov genome <NUMBER> <NUMBER> ace<NUMBER> identified potential receptor using vitro cell line studies <NUMBER> ace<NUMBER> demonstrated bind sarscov spike support syncytia formation fusion spikeproteinexpressing cells large multinucleated cells also seen real sars infections <NUMBER> identification ace<NUMBER> sars receptor vitro liverspecific icam<NUMBER>grabbing nonintegrin lsign also known cd<NUMBER>l reported second receptor sarscov infection <NUMBER> fig <NUMBER> certainly receptors seem functional vitro viral entry unclear whether receptors required vivo sars infections using sars infection model ace<NUMBER> knockout mice group able show ace<NUMBER> indeed essential sars infections vivo <NUMBER> ace<NUMBER> knockout mice infected sarscov resistant virus infection <NUMBER> lung histology ace<NUMBER> knockout mice challenged sarscov showed signs inflammation <NUMBER> whereas sarsinfected wildtype mice displayed mild inflammation leukocyte infiltration <NUMBER> <NUMBER> <NUMBER> thus ace<NUMBER> essential receptor sars infections vivo moreover importance lsign sars infection recently highlighted genetic analyses polymorphism determines different numbers <NUMBER> tandem repeat domains exon <NUMBER> human lsign protein <NUMBER> individuals homozygous tandem repeats ie number tandem repeats alleles less susceptible sars infections ones heterozygous repeats ie different number tandem repeats allele <NUMBER> would interesting investigate functional importance lsign vivo sars infections using acute lung injury acid aspiration pneumonia sepsis generation ang ii ang enhanced ace ang ii induces acute lung failure stimulation at<NUMBER> receptor ace<NUMBER> ang ii type <NUMBER> receptor negatively regulate pathway protect acute lung failure hand sarscov infection mediated binding sarsspike protein ace<NUMBER> lsign downregulates protective molecule ace<NUMBER> thus leads severe lung injury acute lung failure model systems lsign transgenic mice genetically compare role lsign ace<NUMBER> ace<NUMBER>genedeficient mice one mystery sarscov contrast coronaviruses infecting humans infections sarscov trigger severe lung disease high mortality accumulating evidence indicates severe sars infections dependent burden viral replication well immunopathologic consequences host response sars pathogenesis see reviews <NUMBER> <NUMBER> moreover studies implicated involvement ras sars pathogenesis first ace<NUMBER> critical sars receptor vivo second ace<NUMBER> components ras play central role controlling severity acute lung failure disease process started <NUMBER> intriguingly identification ace<NUMBER> sars receptor reported sars patients develop impaired heart contractility using echocardiograhic measurements <NUMBER> certainly observed decrease left ventricular performance acute infection phase may related systemic inflammatory condition <NUMBER> unique sars nevertheless interesting contemplate possible link impaired heart function sars patients reduced heart contractility ace<NUMBER> mutant mice line idea wildtype mice infected sarscov showed markedly downregulated ace<NUMBER> expression lungs <NUMBER> well hearts unpublished moreover treatment recombinant sarsspike protein without virus components downregulates ace<NUMBER> expression vitro vivo <NUMBER> thus spiketreated wildtype mice resemble ace<NUMBER> knockout mice similar ace<NUMBER> mutant mice spiketreated wildtype mice show enhanced ras signaling leading markedly severe pathology acute lung injury therefore downregulation ace<NUMBER> expression spike sarscov infections might possible explanation sars pathogenesis especially disease progression ards although enhanced ras signaling unique sarscov infection downregulation virus receptor interaction virus ligand also seen viruses instance cd<NUMBER> receptor hiv internalizes hiv gp<NUMBER> resulting disruption immune cell functions <NUMBER> cd<NUMBER> measles receptor downregulated measles hemagglutinin leading impairment complement pathways immune systems <NUMBER> hand consequences downregulation sialoglycoconjugate receptor influenza virus <NUMBER> yet unknown finding enhanced ras signaling severe acute lung injury consequences ace<NUMBER> downregulation sarscov might possibly implicate emerging infectious lung diseases like h<NUMBER>n<NUMBER> avian flu may also utilize receptor downregulation system impair host immuneinflammatory systems induce severe lung diseases thus interesting investigate consequences downregulation virus receptors upon virus infection ace<NUMBER> identified key factor protection ardsacute lung injury ace<NUMBER> functions critical sars receptor vivo since sars spikeproteinmediated ace<NUMBER> downregulation appears contribute severity lung failure findings may explain sarscov turned lethal virus addition acid aspiration ards mouse model strong downregulation ace<NUMBER> protein injured lung observed ace expression remained unchanged thus recombinant ace<NUMBER> protein could treatment block spreading sars also protect sars patients developing lung failure furthermore findings could apply investigating therapeutic efficacy ace<NUMBER> ards develops emerging lung infectious diseases like avian influenza h<NUMBER>n<NUMBER> <NUMBER> diseases affect lung function <NUMBER> addition recombinant ace<NUMBER> protein therapy ace<NUMBER> gene therapy would another candidate recently lentivirusmediated gene delivery ace<NUMBER> rat hearts shown successfully attenuate ang iiinduced cardiac hypertrophy <NUMBER> however especially acute phase ards tissuespecific delivery exogenous recombinant ace<NUMBER> protein might first line choice avoiding systemic adverse effects look forward elucidation pathophysiological role ace<NUMBER> use ace<NUMBER> therapeutic target angiotensini converting enzyme ec number <NUMBER> ace commonly known extensively glycosylated integral membrane protein wei et al <NUMBER> ripka et al <NUMBER> functions zinc dependent dipeptidyl carboxypeptidase remove cterminal dipeptide peptide substrates zinc dependent manner cushman cheung <NUMBER> das soffer <NUMBER> ace key component renin angiotensin aldosterone system raas essential hormone system responsible homeostasis blood pressure mammals ace processes precursor peptide angiotensin give angiotensin ii potent vasoconstrictor also destroys vasodilating properties second peptide bradykinin skeggs et al <NUMBER> zaman et al <NUMBER> acharya et al <NUMBER> gonzalezvillalobos et al <NUMBER> ace therefore functions increase blood pressure long targeted treatment hypertension cardiovascular ailments use ace inhibitors turner hooper <NUMBER> two isoforms mammalian ace somatic sace testicular tace ace soubrier et al <NUMBER> integral membrane proteins transcribed twentysix exon gene sace consists two homologous domains ndomain cdomain arranged tandem functional active site tace expression driven intragenic promoter giving rise single domain protein identical cdomain sace illustrated fig <NUMBER> ehlers et al <NUMBER> hubert et al <NUMBER> wei clauser <NUMBER> corvol et al <NUMBER> whilst sace widely expressed tace expressed solely developing spermatids thought role reproduction caldwell et al <NUMBER> langford et al <NUMBER> sibony et al <NUMBER> sibony et al <NUMBER> fuchs et al <NUMBER> male mice lacking tace infertile krege et al <NUMBER> hagaman et al <NUMBER> however mechanisms behind yet clear <NUMBER> study bernstein coworkers demonstrated tace knockout mice produce normal amounts motile sperm unable fertilise eggs reintroducing tace rescues phenotype interestingly unable rescue effects decreased blood pressure resulting knockout sace cdomain suggests tace could targeted producing male contraceptive without affecting function sace bernstein et al <NUMBER> addition proposed role tace reproduction becoming increasingly clear sace also involved physiological processes outside blood pressure regulation relationship tace sace strongly suggests latter arose result gene duplication event would enabled enzyme evolve acquire new functions hubert et al <NUMBER> two domains somatic ace share greater <NUMBER> overall sequence identity rising circa <NUMBER> catalytic regions yet display markedly different biophysical biochemical properties example ndomain significantly thermally stable resistant proteolysis cdomain sturrock et al <NUMBER> voronov et al <NUMBER> important differences also observed catalytic properties two domains cdomain able process angiotensin angiotensin ii much efficiently ndomain whilst domains equally able hydrolyse bradykinin cdomain alone appears sufficient vivo regulation blood pressure georgiadis et al <NUMBER> number substrates also identified hydrolysed efficiently ndomain compared cdomain include gnrh gonadotropinreleasing hormone abeta<NUMBER> amyloid beta peptide angiotensin <NUMBER> acsdkp nacetylserylaspartyllysylproline rousseau et al <NUMBER> deddish et al <NUMBER> anthony et al <NUMBER> masuyer et al <NUMBER> evidence ndomain divergent evolution become involved physiological processes activity ndomain towards peptide acsdkp particularly interesting acsdkp involved regulating proliferation fibroblasts response injury recent detailed study bernstein et al showed mice treated chemotherapy drug bleomycin induce lung injury level lung damage much greater mice mutated sace ndomain compared wildtype mice sace cdomain mutations strong evidence therefore ndomain plays important role preventing lung injury likely due role regulating proliferation acsdkp bernstein et al <NUMBER> involvement ace processes outside blood pressure regulation particular differences substrate specificity two domains sace highlight growing need new generation ace inhibitors current ace inhibitors designed structural information instead based peptides isolated venom brazilian pit viper bothrops jararaca ferreira <NUMBER> ferreira et al <NUMBER> ondetti et al <NUMBER> cushman et al <NUMBER> patchett et al <NUMBER> inhibit domains sace equally structural studies crucial understanding reasons observed differences achieving goal new generation ace inhibitors initial discovery partial purification ace occurred <NUMBER>s yet <NUMBER> first human ace structure tace reported one main reasons <NUMBER> years elapsed discovery ace report first structure extensive glycosylation estimated <NUMBER> weight enzyme shown essential expression function gordon et al <NUMBER> corradi et al <NUMBER> ultimately structure tace determined using minimally glycosylated truncated construct lacking transmembrane domain structure tace predominantly helical twentyseven αhelices six short βstrands combine form ellipsoid shaped molecule fig <NUMBER>a b structure shows six glycosylation sites located surface protein key features molecule include large central channel nterminal lid channel stretches approximately <NUMBER> å across almost entirety molecule effectively dividing two subdomains channel narrows centre catalytic zinc ion found shown fig <NUMBER>c nterminal lid formed three nterminal fig <NUMBER> schematic representation domain structures sace tace sace consists two homologous domains nand cdomains contain functional active site illustrated hexxh zinc binding motif two domains joined short linker sequence lr unique sace ndomain cdomain extracellular transmembrane tm domain towards cterminus sace followed cterminus ct intracellular contrast tace single domain protein one active shown single hexxh zinc binding motif <NUMBER> residues nterminus nt tace unique taking place linker region lr sace like sace tace extracellular transmembrane domain tm cterminus ct positioned inside cell helices α<NUMBER> α<NUMBER> α<NUMBER> appears prevent enzyme hydrolysing large folded substrates <NUMBER> structure ndomain sace determined providing first opportunity two domains sace compared overall structure ndomain essentially identical cdomain predominantly helical ellipsoid shaped molecule long channel narrows centre catalytic zinc ion found total comprises <NUMBER> helices <NUMBER> αhelices <NUMBER> relatively short βstrands fig <NUMBER>a b comparing structures n cdomains provides insight observed differences substrate specificity structures domains solved lisinopril inhibitor slightly selective cdomain bound although lisinopril bound broadly conformation structures minor differences mainly concentrated <NUMBER> binding pocket help explain selectivity example asp<NUMBER> ndomain takes place glu<NUMBER> cdomain glu<NUMBER> forms electrostatic interactions lysyl side chain lisinopril asp<NUMBER> unable replicate fig <NUMBER>c corradi et al <NUMBER> studying structures nand cdomains sace significant progress already made towards design domain specific inhibitors rxpa<NUMBER> developed phosphinic peptide library highly selective cdomain k three orders magnitude lower ndomain structure cdomain bound rxpa<NUMBER> reported <NUMBER> corradi et al <NUMBER> provides insight reasons specificity inhibitor fig <NUMBER> cdomain phe<NUMBER> <NUMBER> subsite makes aromatic interaction phe p <NUMBER> position rxpa<NUMBER> ndomain phe<NUMBER> replaced tyr<NUMBER> would able replicate aromatic interaction furthermore structure suggests hydroxyl group tyr<NUMBER> would within <NUMBER> å p <NUMBER> phe preventing inhibitor binding conformation fig <NUMBER>d relevant differences observed <NUMBER> subsite development rxpa<NUMBER> suggested pro trp p <NUMBER> p <NUMBER> positions respectively important determinants cdomain selectivity <NUMBER> subsite cdomain lined two valine residues val<NUMBER> val<NUMBER> create hydrophobic environment pro trp ndomain valines replaced ser<NUMBER> thr<NUMBER> destroying hydrophobic environment fig <NUMBER>d second phosphinic peptide rxp<NUMBER> developed selectively inhibits ndomain fig <NUMBER>a b structure ndomain complex fig <NUMBER> structure human tace b cartoon representation tace structure helices shown cyan βstrands magenta loops pink catalytic zinc ion shown grey sphere centre long substrate binding channel effectively divides molecule two subdomains also visible active site inhibitor lisinopril two chloride ions shown orange spheres three nterminal helices form lid substrate binding channel shown clearly viewing molecule angle used b role lid capping substrate binding channel highlighted c three nterminal helices form lid shown purple rest molecule shown cyan surface representation lisinopril zinc shown bound active site c molecule viewed angle b rxp<NUMBER> reported <NUMBER> anthony et al <NUMBER> shows twelve hydrogen bonds nine residues forming enzyme inhibitor fig <NUMBER>c two would conserved cdomain interestingly two residues differ arg<NUMBER>glu<NUMBER> tyr<NUMBER>phe<NUMBER> located <NUMBER> subsite fig <NUMBER>d illustrating interactions enzyme inhibitors site important determinant domain selectivity structural studies inhibitor binding ace able provide essential information relating subtle differences substrate binding pockets two domains able exploited design new domain specific ace inhibitors may include cdomain specific inhibitors use treatment hypertension also ndomain specific inhibitors targeting roles ace physiological processes addition increasing understanding mammalian ace involved range processes outside blood pressure regulation recent years number homologues ace identified emphasise diverse range functions enzymes overall fold identical save additional region cterminus ndomain structure serves linker region two domains centre substrate binding channel inhibitor lisinopril visible well zinc ion grey sphere single chloride ion orange sphere c lisinopril binding tace ndomain although residues forming direct interactions lisinopril conserved tace ndomain differences seen subsites particularly <NUMBER> binding pocket subsite residues show cyan tace magenta ndomain sticks labelled following colour scheme lisinopril bound tace shown light blue ndomain light pink important differences include orientation glu<NUMBER> tace compared asp<NUMBER> ndomain prevent interactions lysyl side chain lisinopril ndomain position position backbone thr<NUMBER> arg<NUMBER> prevents long positive side chain arginine coming contact repelling lysyl side chain lisinopril year <NUMBER> study aiming find novel genes involved heart failure identified cdna coding human homologue ace tipnis et al <NUMBER> first evidence ace homologue humans protein appropriately named ace<NUMBER> angiotensin converting enzyme <NUMBER> ec number <NUMBER> like ace ace<NUMBER> type integral membrane protein single catalytic domain includes zinc binding site ace<NUMBER> domain sace share <NUMBER> sequence identity appears two enzymes arisen following gene duplication event allowed considerable divergence ace<NUMBER> sequence krege et al <NUMBER> contrast widespread expression sace ace<NUMBER> expression appears confined heart kidneys testis furthermore ace ace<NUMBER> quite distinct biochemical properties evidence ace<NUMBER> dipeptidyl carboxypeptidase activity routinely found ace instead removes single residue cterminus peptide substrates include neurotensin kinetensin bradykinin substrate ace<NUMBER> although able cleave angiotensin removes single cterminal residue give nonapeptide ang<NUMBER> ace<NUMBER> inhibited ace inhibitors captopril lisinopril enalaprilat tipnis et al <NUMBER> donoghue et al <NUMBER> crackower et al <NUMBER> fig <NUMBER> binding cdomain specific inhibitor rxpa<NUMBER> tace b structure cdomain specific inhibitor rxpa<NUMBER> c key residues tace active site interacting rxpa<NUMBER> rxpa<NUMBER> shown sticks carbon atoms green side chains tace residues also shown sticks cyan carbon atoms active site zinc ion shown grey sphere rxpa<NUMBER> binds similar conformation lisinopril fig <NUMBER> two key differences tace cyan ndomain magenta likely decrease affinity rxpa<NUMBER> ndomain phe<NUMBER>tyr<NUMBER> substitution eliminates interaction phenyl moiety inhibitor whilst val<NUMBER>ser<NUMBER> val<NUMBER> thr<NUMBER> substitutions destroy hydrophobic environment around tryptophan group e <NUMBER> binding pocket side chains close proximity rxpa<NUMBER> shown sticks illustrates inhibitor fill subsite interactions could potentially increased improve efficacy rxpa<NUMBER> structure ace<NUMBER> reported <NUMBER> provides explanations function ace<NUMBER> zinc dependent carboxypeptidase many observed differences ace ace<NUMBER> towler et al <NUMBER> extracellular portion ace<NUMBER> shown consist two distinct domains first residues <NUMBER> zinc metallopeptidase sharing <NUMBER> sequence identity catalytic domains ace second residues <NUMBER> <NUMBER> identical human collectrin poor electron density observed collectrinlike domain towler et al <NUMBER> first acelike domain like ace predominantly helical consists two subdomains ii forming sides cleft stretching <NUMBER> å along <NUMBER> å across molecule depth <NUMBER> å base cleft catalytic site located approximately halfway along length molecule towards one side illustrated fig <NUMBER>a location active site marked presence catalytic zinc ion ace characteristic zinc dependent proteases catalytic zinc ion coordinated two histidines glutamic acid his<NUMBER> his<NUMBER> glu<NUMBER> absence inhibitor water molecule completes coordination zinc ion location catalytic site means shielded cleft separates two subdomains fig <NUMBER>a similar effect achieved ace catalytic site located centre long substrate binding channel capped nterminal lid like ace ace<NUMBER> extensively glycosylated electron density observed six nlinked glycosylation sites three disulphide bonds ace<NUMBER> structure conserved ace shown sticks carbon atoms magenta rxp<NUMBER> also shown sticks green carbon atoms essential zinc shown grey sphere two key differences nand cdomain active sites likely affect rxp<NUMBER> binding cdomain arg<NUMBER> magenta replaced glu<NUMBER> cyan resulting loss interaction inhibitor similarly phe<NUMBER> cyan cdomain unable hydrogen bond rxp<NUMBER> tyr<NUMBER> magenta ndomain interesting feature ace<NUMBER> seen ace large conformational change inhibitor binding two subdomains move relative close around inhibitor active site illustrated fig <NUMBER> differences subsites ace<NUMBER> compared ace help explain observed differences substrate specificity catalytic properties ace<NUMBER> <NUMBER> subsite defined four residues large bulky side chains tyr<NUMBER> arg<NUMBER> phe<NUMBER> thr<NUMBER> likely restrict size residues accommodated p <NUMBER> position substrates bradykinin angiotensin substrates ace ace<NUMBER> phenylalanine tyrosine respectively p <NUMBER> position side chains unlikely accommodated restricted <NUMBER> subsite fig <NUMBER>e another significant difference two enzymes observed <NUMBER> subsite glutamine residue ace replaced ace<NUMBER> arg<NUMBER> large arginine side chain effectively blocks <NUMBER> subsite prohibiting ace<NUMBER> acting dipeptidyl peptidase ace fig <NUMBER>e also explains ace<NUMBER> inhibited classical ace inhibitors captopril lisinopril enalaprilat make contacts <NUMBER> subsite crackower et al <NUMBER> catalytic zinc ion also moves positions also shown green purple inhibitor shown sticks orange carbon atoms bound active site e key differences tace cyan ace<NUMBER> purple restrict size <NUMBER> binding pocket probably restricting space ace<NUMBER> remove terminal residue cterminus peptide substrates whilst ace removes cterminal dipeptide ace<NUMBER> exceedingly important enzyme study shown important role heart failure crackower et al <NUMBER> luft <NUMBER> kuba et al <NUMBER> santos et al <NUMBER> also identified receptor coronavirus linked outbreak severe acute respiratory syndrome sars li et al <NUMBER> structural details recognition characterised reported <NUMBER> wu et al <NUMBER> also important study ace<NUMBER> improve understanding ace homologues diverged properties ace<NUMBER> highlight range processes ace homologues may involved potential benefits may come studying many years thought ace confined mammals critical role blood pressure homeostasis recently become apparent ace many substrates addition angiotensin bradykinin involved large number physiological processes outside raas furthermore discovery ace<NUMBER> illustrates homologues ace could arisen gene duplication events evolved different equally important functions <NUMBER> first ace homologue outside mammals identified housefly musca domestica lamango isaac <NUMBER> since ace homologues found every insect genome sequence date conservation among insects indicative essential role ace homologues yet given insects lack form circulatory system resembling found mammals significant questions remain exact nature role roles one first insect ace homologues studied detail ance drosophila melanogaster first identified <NUMBER> ance shares <NUMBER> sequence identity human tace used successfully model studying structural basis inhibitor binding human ace cornell et al <NUMBER> tatei et al <NUMBER> although ance able hydrolyse angiotensin bradykinin two major substrates mammalian ace insect homologues peptides identified lot research performed try elucidate physiological function ance thus insect ace homologues wider sense ance mutant embryos develop normally die early larval stages indicates ance essential role physiological process critical survival high levels ance expression observed gut epithelium amniosera suggesting ance may involved processing peptides required contraction heart gut muscle cornell et al <NUMBER> tatei et al <NUMBER> ance expression also concentrated around reproductive organs male female flies suggesting role reproduction evidence obtained <NUMBER> study using insects hypomorphic ance alleles male flies homozygous hypomorphic ance alleles infertile result sperm failing develop properly suggesting ance may required processing peptide involved spermatogenesis schoofs et al <NUMBER> investigation <NUMBER> showed ance expression concentrated secondary cells accessory glands testis accessory glands produce number peptides mix sperm seminal fluid induce physiological behavioural changes female insect mating reasonable suggest ance involved spermatogenesis male may also role female mating mind dup<NUMBER>b suggested potential ance substrate dup<NUMBER>b induce egg laying females order functional basic cterminal dipeptide must removed propeptide theory would make dup<NUMBER>b good substrate ance yet possible investigate hypothesis ance already expressed female reproductive organs rylett et al <NUMBER> order understand effect ance female mating tissue specific ance knockdowns female flies would need performed ance insect ace homologue implicated reproduction seems increasingly likely conserved function enzymes wijffels et al <NUMBER> hurst et al <NUMBER> ekbote et al <NUMBER>a ekbote et al <NUMBER>b macours hens <NUMBER> vercruysse et al <NUMBER> example ace shown necessary egg laying female anopheles stephensi mosquitoes suggested may required process myotropic peptide needed contractions oviduct drosophila also produces second ace homologue acer acer cdna first identified <NUMBER> outset clear ance acer code distinct proteins unique physiological roles unlike ance acer found neither amniosera midgut found developing heart cells shown necessary heart development taylor et al <NUMBER> houard et al <NUMBER> additionally acer involved heart function adult flies rnai used specifically knockdown acer adult drosophila resulted ageassociated changes heart contraction leading decreased life span yet mechanisms behind remain determined liao et al <NUMBER> acer also implicated regulation circadian rhythms suggestion expression temporally regulated expression clock flies lacking active acer display decreased nighttime sleep increased fragmentation sleep get mechanisms behind unclear suggested acer processes peptides involved metabolism resulting metabolic changes upon losing acer causing behavioural changes leading observed effects sleep rather acer involved circadian rhythms per se carhan et al <NUMBER> ishimoto et al <NUMBER> based evidence obtained far clear ance acer distinct physiological roles therefore surprising different substrate inhibitor specificities example unlike ance mammalian ace acer unable cleave angiotensin also much lower affinity bradykinin basis differences one would predict must variations active sites two enzymes taylor et al <NUMBER> coates et al <NUMBER> bingham et al <NUMBER> structure ance first published <NUMBER> <NUMBER> å resolution kim et al <NUMBER> followed <NUMBER> higher resolution <NUMBER> å structures different crystal form native enzyme number enzyme inhibitor complexes akif et al <NUMBER> akif et al <NUMBER> overall architecture ance conserved human ace molecule also heavily glycosylated three nlinked glycans visible structure asn<NUMBER> asn<NUMBER> asn<NUMBER> structure yet determined acer however <NUMBER> bingham coworkers proposed model three dimensional structure acer based ance structure reported kim et al <NUMBER> kim et al <NUMBER> bingham et al <NUMBER> comparing model ance structure explanations offered observed differences substrate specificity two homologous enzymes ance negatively charged side chains asp<NUMBER> glu<NUMBER> likely form electrostatic interactions cterminal arginine bradykinin based acer model asp<NUMBER> replaced his<NUMBER> would unable replicate interaction explaining decreased affinity rate hydrolysis bradykinin acer compared ance ance acer also behave differently towards cdomain selective inhibitor rxpa<NUMBER> acer inhibited rxpa<NUMBER> k <NUMBER> μm whereas inhibition observed ance cdomain selectivity rxpa<NUMBER> partially attributed two valine residues <NUMBER> pocket one conserved acer replaced threonine ance mutation would decrease hydrophobicity pocket accommodates tryptophan moiety rxpa<NUMBER> hence decreasing affinity inhibitor ance compared acer cdomain kim et al <NUMBER> bingham et al <NUMBER> potentially interesting features acer active site proposed based modelled structure bingham et al <NUMBER> small differences significant implications substrate inhibitor specificity whilst remains great deal learnt vivo functions acer indeed ance clear like mammalian ace enzymes involved number important physiological processes follows studying enzymes particularly structural perspective increase understanding diverse range functions ace homologues anopheles gambiae one mosquito vectors responsible transmission plasmodium falciparum causative agent malaria makes gambiae exceedingly important organism study transpires gambiae also particularly interesting organism study terms ace ten gambiae ace homologues anoaces largest number found insect genome far holt et al <NUMBER> reasons many anoace homologues yet clear understanding different functions enzymes surely help us understand biological roles insect ace homologues indeed mammalian ace outside blood pressure regulation furthermore one anoace<NUMBER> appears consist two catalytic domains arranged tandem seen sace first instance two domain ace homologue reported insects burnham et al <NUMBER> indicates two domain arrangement selected one occasion must surely way advantageous studying anoace<NUMBER> may help us understand benefits arrangement <NUMBER> burnham coworkers investigated gene expression patterns different anoace homologues try infer potential physiological roles one key observations expression anoace<NUMBER> <NUMBER> <NUMBER> upregulated <NUMBER> h following blood meal burnham et al <NUMBER> similar observation previously reported stephensi mosquito suggesting insect ace homologues may conserved role processing peptides involved metabolism anoace expression levels also observed alter response challenging immune system mosquitoes anoace<NUMBER> upregulated infection salmonella typhimurium anoace<NUMBER> infection staphylococcus aureus conversely anoace<NUMBER> expression reduced mosquitoes challenged beauveria bassiana burnham et al <NUMBER> observations alone course enough conclude anoace homologues important role immune response indicate area investigated given evidence mammalian tace insect ace homologues involved reproduction likelihood anoace homologues similar role cannot ignored early stage indication anoace proteins may fulfil role studies likely knock studies required investigate identifying enzyme role could highly significant possibility designing gambiae specific ace inhibitors use insecticides nine anoace genes six anoace<NUMBER> <NUMBER>a <NUMBER>b <NUMBER> <NUMBER> <NUMBER> <NUMBER> clustered together chromosome likely arisen relatively recent gene duplication events indeed anoace<NUMBER> <NUMBER> predicted share <NUMBER> sequence identity whilst anoace<NUMBER>a <NUMBER>b coded gene identical save first exon burnham et al <NUMBER> anoace<NUMBER> share many common features melanogaster ance acer six anoace proteins successfully modelled based structure ance pdb code <NUMBER>x<NUMBER>y akif et al <NUMBER> using automated mode swissmodel arnold et al <NUMBER> kiefer et al <NUMBER> would predicted given high sequence identity crucial active site residues ance conserved models though differences subsites indicating probable differences substrate preference differences summarised table <NUMBER> <NUMBER> subsite identified crucial region conferring inhibitor substrate binding specificity nand cdomains human sace hubert et al <NUMBER> gordon et al <NUMBER> dive et al <NUMBER> corradi et al <NUMBER> corradi et al <NUMBER> kröger et al <NUMBER> anthony et al <NUMBER> example substitution tyr<NUMBER> ndomain phe<NUMBER> cdomain crucial cdomain selectivity rxpa<NUMBER> phe<NUMBER> forming aromatic interaction phenyl moiety p <NUMBER> position rxpa<NUMBER> tyr<NUMBER> unable replicate gordon et al <NUMBER> corradi et al <NUMBER> anoace<NUMBER> <NUMBER> models phenylalanine position cdomain phe<NUMBER> suggesting could form interaction aromatic group p <NUMBER> anoace<NUMBER> <NUMBER> also conserved negative charge position glu<NUMBER> cdomain replaced arg<NUMBER> ndomain fig <NUMBER>a two observations suggest anoace<NUMBER> <NUMBER> cdomain sace may accommodate substrates similar functionalities p <NUMBER> position contrast anoace<NUMBER> models tyrosine position ndomain tyr<NUMBER> indicating would tolerate aromatic group p <NUMBER> may instead preference group could form hydrogen bond unlike ndomain anoace<NUMBER> large positive side chain position arg<NUMBER> like cdomain anoace<NUMBER> <NUMBER>a <NUMBER>b glutamate whilst anoace<NUMBER> serine fig <NUMBER>b models therefore suggest anoace<NUMBER> share features nand cdomains human sace <NUMBER> subsite may well reflected substrate inhibitor binding properties based models anoace<NUMBER> appear potentially significant differences <NUMBER> subsite compared two domains sace example nand cdomain conserved phenylalanine reside phe<NUMBER> phe<NUMBER> respectively replaced tyrosine anoace<NUMBER> fig <NUMBER>c could potentially significant consequences inhibitor substrate interaction stacking interaction phenyl moiety p <NUMBER> rxpa<NUMBER> rxp<NUMBER> would maintained interestingly tyrosine conserved position melanogaster ance also interesting substitutions position equivalent cdomain glu<NUMBER> negative charge retained ance anoace<NUMBER> model ndomain anoace<NUMBER>a <NUMBER>b <NUMBER> <NUMBER> lost replaced serine ndomain glutamine significantly though anoace<NUMBER> lys<NUMBER> occupies position fig <NUMBER>c large positive lysine side chain likely significant effect type groups anoace<NUMBER> accommodate <NUMBER> subsite anoace<NUMBER> models also conserved positive charge either lysine arginine <NUMBER> subsite although conserved lys<NUMBER> ance replaced gln<NUMBER> leu<NUMBER> nand cdomains respectively fig <NUMBER>c introduction large positive side chains domains sace quite large pocket space likely influence size charge functionalities accommodated anoace<NUMBER> <NUMBER> subsite based models anoace<NUMBER> <NUMBER> additional negative charge <NUMBER> subsites compared ance two domains sace anoace<NUMBER> glu<NUMBER> takes place small nonpolar side chain subsites fig <NUMBER>c overall models suggest <NUMBER> subsites anoace<NUMBER> quite polar environments compared sace models presented sufficient determine effect may binding properties work needed investigate comparatively little variation <NUMBER> <NUMBER> subsites anoace<NUMBER> models compared subsites potentially significant difference position cdomain val<NUMBER> residue implicated selectivity rxpa<NUMBER> cdomain contributes hydrophobic environment tryptophan moiety inhibitor lost ndomain val<NUMBER> replaced thr<NUMBER> interestingly valine position conserved anoace<NUMBER> replaced threonine anoace<NUMBER> small difference significant effect determining domain selectivity rxpa<NUMBER> highlights subtle variations subsites enzymes significant effects biochemical properties table <NUMBER> comparison amino acid residues comprising binding pockets nand cdomains human sace drosophila melanogaster ance models anopheles gambiae ace homologues anoace<NUMBER> cnance ano<NUMBER> ano<NUMBER>a ano<NUMBER>b ano<NUMBER> ano<NUMBER> ano<NUMBER> ano<NUMBER> y<NUMBER> s<NUMBER> e<NUMBER> q<NUMBER> t<NUMBER> a<NUMBER> a<NUMBER> g<NUMBER> g<NUMBER> n<NUMBER> a<NUMBER> v<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> s<NUMBER> t<NUMBER> t<NUMBER> v<NUMBER> n<NUMBER> s<NUMBER> t<NUMBER> t<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> d<NUMBER> q<NUMBER> q<NUMBER> e<NUMBER> d<NUMBER> d<NUMBER> q<NUMBER> q<NUMBER> q<NUMBER> d<NUMBER> v<NUMBER> t<NUMBER> t<NUMBER> v<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> s<NUMBER> q<NUMBER> t<NUMBER> t<NUMBER> t<NUMBER> g<NUMBER> d<NUMBER> k<NUMBER> anoace<NUMBER> clustered together chromosome thought arisen relatively recent gene duplication event anoace<NUMBER> predicted considerably different anoace homologues belonging different functional grouping likely acquired highly diverged functions burnham et al <NUMBER> akif et al <NUMBER> perhaps surprising anoace<NUMBER> much challenging model experimentally determined crystal structure surely needed study mechanism action enzyme detail seems enzyme make exceedingly interesting case study could reveal unknown roles ace homologues aiding understanding increasingly complex enzyme discovery anoace<NUMBER> gene appears code protein two homologous catalytic domains arranged tandem provided first evidence two domain ace homologue insects means domain arrangement also seen sace selected three separate occasions burnham et al <NUMBER> organisation must surely way advantageous studies human sace resulted suggestion may negative cooperativity two domains georgiadis et al <NUMBER> binevski et al <NUMBER> andújarsánchez et al <NUMBER> burnham et al <NUMBER> corradi et al <NUMBER> however evidence required conclusion reached studying structure function anoace<NUMBER> could potentially yield lot information benefits organisation angiotensin converting enzyme known studied half century however last decade truly begun understand diverse range physiological functions enzyme homologues appreciate ace homologues extensive functions outside blood pressure regulation structural studies greatly improved understanding different biochemical properties ace homologues elucidation human tace structure <NUMBER> huge breakthrough study ace followed report ndomain structure <NUMBER> structure melanogaster homologue ance also frequently used model human ace discovery subsequent study ace homologues organisms significantly melanogaster highlighted diverse range functions enzyme ace homologues conserved insects amongst proposed roles substantial evidence essential role reproduction studying insect ace homologues already greatly improved understanding mammalian enzyme enzymes also important study right nowhere evident gambiae ace homologues gambiae genome codes ace homologues seen insect genome thus far includes twodomain enzyme comparable sace initial genomic studies indicated enzymes may involved metabolism immune response reproduction however much evidence required confirm could potentially achieved treating mosquitoes ace inhibitors observing effect similar approach previously taking stephensi indicated ace homologues involved reproduction however unlikely distinguish functions different anoace homologues hence better approach may use rnai selectively knockdown individual genes liao et al recently used approach successfully work acer liao et al <NUMBER> fig <NUMBER> features active sites anoace<NUMBER> models compared nand cdomains human sace images ndomain selective inhibitor rxp<NUMBER> shown sticks green carbon atoms cdomain selective inhibitor rxpa<NUMBER> sticks orange carbon atoms catalytic zinc ion grey sphere <NUMBER> subsite anoace<NUMBER> <NUMBER> key residues anoace<NUMBER> <NUMBER> shown grey sticks using anoace<NUMBER> numbering cdomain shown cyan sticks ndomain magenta anoace<NUMBER> <NUMBER> share conserved phenylalanine phe<NUMBER> cdomain replaced tyrosine ndomain residue makes important contacts domain selective inhibitors suggests anoace<NUMBER> <NUMBER> may share binding preferences cdomain also conserved negative charge asp<NUMBER> replaced positive arg<NUMBER> ndomain conserved valine val<NUMBER> replaced thr<NUMBER> ndomain similarity ndomain though example ser<NUMBER> replaced phe<NUMBER> cdomain b <NUMBER> subsite anoace<NUMBER> <NUMBER> subsites anoace<NUMBER> models similar represented anoace<NUMBER>a shown light orange sticks features shared nand cdomains sace tyr<NUMBER> conserved ndomain replaced phe<NUMBER> cdomain whilst glu<NUMBER> conserved cdomain replaced positive arg<NUMBER> ndomain residues likely significant effects substrate inhibitor binding properties c <NUMBER> subsite anoace<NUMBER> common features anoace<NUMBER> models represented anoace<NUMBER>a light orange unique features anoace<NUMBER> anoace<NUMBER> <NUMBER> shown violet grey sticks respectively anoace<NUMBER> models share conserved tyrosine tyr<NUMBER> replaced phenylalanine nand cdomain models unique positively charged residue found cdomains shown lys<NUMBER> anoace<NUMBER> arg<NUMBER> anoace<NUMBER> anoace<NUMBER> positively charged residue lys<NUMBER> replaced neutral negatively charged residues nand cdomains models contract anoace<NUMBER> <NUMBER> additional negative charge introduced glu<NUMBER> substitutions charged residues likely significant effect substrate inhibitor binding properties discussed melanogaster ance successfully used model inhibitor binding human ace unreasonable consider may possible use anoace<NUMBER> similar way model human sace order learn rationale presence two homologous domains arranged tandem modelled active sites gambiae ace homologues based structure melanogaster ance compared human melanogaster enzymes whilst course substitute experimentally determined crystal structures indicated key differences could potentially exploited design insect specific ace inhibitors perhaps targeting role reproduction longer term inhibitors could designed use insecticides would particularly useful considering gambiae vector transmission malaria causing parasite p falciparum  lipidlowering therapy reninangiotensinaldosterone system inhibitors era covid<NUMBER> pandemic novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> disease <NUMBER> covid <NUMBER> pandemic associated severe respiratory disease incidence increased mortality <NUMBER> angiotensin converting enzyme ace <NUMBER> homologue ace also receptor coronaviruses <NUMBER> ace<NUMBER> highly expressed lungs heart gastrointestinal gi tract kidney thus affecting cardiovascular system cv immune system <NUMBER> overexpression ace<NUMBER> reported enhance viral entry replication intracellularly <NUMBER> covid<NUMBER> also called sarscov<NUMBER> may also use ace<NUMBER> receptor initiate infection leading severe complications heart acute coronary syndrome acs fulminant myocarditis lungs pneumonia acute respiratory distress syndrome ards gi tract diarrhoea syndrome <NUMBER> ace<NUMBER> gene expression affected several factors including gender ace<NUMBER> gene xlinked ace<NUMBER> gene polymorphisms comorbidities increased presence cvd hypertension diabetes drug therapy <NUMBER> regard drugs angiotensin ii receptor blockers arbs mineralocorticoid receptor antagonists mra reported raise ace<NUMBER> activity human animal studies <NUMBER> animal studies available showing statins may also increase ace<NUMBER> activity <NUMBER> <NUMBER> era covid<NUMBER> pandemic drug effect may considered potentially worrying <NUMBER> context recently even suggested arbs could replaced ace inhibitors statin treatment may discontinued pandemic particularly primary prevention settings <NUMBER> however implementing strategies consider several issues firstly covid<NUMBER> infection progresses ace<NUMBER> downregulated thus potentially generating inflammatory response leading impaired cardiac contractility acute lung injury <NUMBER> <NUMBER> <NUMBER> therefore reduced ace<NUMBER> expression linked worse outcomes hand ace<NUMBER> overexpression associated several beneficial effects ie prevention adverse cardiac remodelling fibrosis improvement vascular endothelial dysfunction reduction blood pressure protection ards <NUMBER> <NUMBER> statins arbs reported exert benefits secondly combination statinsarbs used <NUMBER> ebola virus disease epidemic sierra leone leading improved outcomes increased survival <NUMBER> drugs affect host response infection virus especially preventing endothelial dysfunction shared feature several virus infections <NUMBER> combination seemed promote return homeostasis allowing patients ebola virus infection recover <NUMBER> third patients cardiovascular disease cvd shown prone covid<NUMBER> infection worse prognosis <NUMBER> <NUMBER> elevated inflammatory markers creactive protein crp interleukin<NUMBER> il<NUMBER> recognised predictors covid<NUMBER> infection severity mortality suggesting virusactivated cytokine storm syndrome <NUMBER> <NUMBER> therefore well immunomodulation covid<NUMBER> treatment also target reduction inflammation context statins consistently reported exert immunomodulatory antiinflammatory properties <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also previously suggested statins could enhance host defence suppress inflammation thus representing practical inexpensive adjunctive alternative hostdirected treatment infections viruses fungi protozoa bacteria <NUMBER> similarly data supporting antiinflammatory role arbs <NUMBER> <NUMBER> <NUMBER> fourth statins may also prevent viralinduced acute coronary syndrome also covid<NUMBER> positive patients stabilising atherosclerotic plaques <NUMBER> well prevent acute kidney injury aki <NUMBER> acute cardiac injury aki predictors covid<NUMBER>induced mortality <NUMBER> statin therapy may prevent complications thus increase survival note statins protect contrastinduced aki ciaki <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical importance especially hospitalised patients undergo diagnostic therapeutic procedures involving administration contrast media eg computed tomography lungs fifth effective lipidlowering therapy llt significant cholesterol reduction might significantly suppress coronavirus infection show infectious bronchitis virus ibv coronavirus drugrelated cholesterol reduction disrupts lipid rafts important element cellular entry coronavirus enable binding coronavirus host cells consequently infection <NUMBER> also observed studies porcine deltacoronavirus pdcov cholesterol present cell membrane viral envelope coronaviruses positivesense enveloped rna viruses contributes pdcov replication acting key component viral entry thus pharmacological sequestration cellular viral cholesterol effective llt significantly blocked virus attachment internalisation <NUMBER> mechanisms might suggest critical role statins llts inhibition coronavirus infection covid<NUMBER>positive patients majority baseline cvd atherosclerosis origin worst prognosis patients high especially high extremely high risk cvd <NUMBER> thus intensive llt statins andor fixed combination ezetimibe proprotein convertase subtilisinkexin type <NUMBER> pcsk<NUMBER> inhibitors seems critical indeed best maximally improve therapy adherence thus better prognosis infected cvd patients <NUMBER> <NUMBER> context premises pcsk<NUMBER> inhibitors monoclonal antibodies relation abovementioned high cytokine storm infection discontinued contrast pcsk<NUMBER> inhibitors continued achieve lowdensity lipoprotein cholesterol ldlc lowering based lower better principle might significantly stabilise atheroma plaque reduce risk cvd events reduce inflammation <NUMBER> <NUMBER> <NUMBER> recent available data confirmed role pcsk<NUMBER> inhibition reducing process inflammation via decreasing main vascular inflammatory markers reducing infiltration monocytes subendothelial layer inhibiting monocyte migration apart reduction proinflammatory mediators pcsk<NUMBER> inhibitors could ameliorate vascular inflammation <NUMBER> finally direct local antiinflammatory action pcsk<NUMBER> inhibitors independent ldlc reduction shown animal models however still merits investigation <NUMBER> <NUMBER> special interest due fact coronavirus might also use different receptors enter host cell treatment pcsk<NUMBER> inhibitors beneficial effects ldlc lowering via inhibition ldlreceptors ldlr might exert antiviral effect among others hepatitis c viral hcv infection downregulation surface expression ldlr cluster differentiation cd <NUMBER> hepatic cells positive association increased inflammatory responses well septic shock <NUMBER> recent paper confirmed association pcsk<NUMBER> levels resistance antibiotics condition patients hospitalised intensive care units finding clinical importance covid<NUMBER> infection era <NUMBER> sixth conflicting results regarding possible effects statins ards development outcomes <NUMBER> <NUMBER> suggested statins act beneficially hyperinflammatory ards patients defined increased biomarkers inflammation coagulation endothelial activation <NUMBER> hypoinflammatory patients <NUMBER> <NUMBER> potential benefit arbs survival ards patients also reported <NUMBER> <NUMBER> nevertheless paucity data field thus research needed elucidate association statin therapy arbs acute lung injury note drugdrug interactions also considered context simvastatin lovastatin contraindicated patients lopinavir ritonavir therapy due increased risk rhabdomyolysis <NUMBER> atorvastatin rosuvastatin statins used lowest possible dose based instructions included summary product characteristics spc <NUMBER> taking account careful treating covid<NUMBER> disease patients statins antiviral drugs antibiotics including macrolides might increase risk statinassociated muscle symptoms sams <NUMBER> <NUMBER> therefore careful monitoring highly recommended avoid unnecessary drugrelated side effects time optimising llt therapy achieve individuals ldlc goal context patients high cvd risk requiring intensive llt reasonable initiate therapy polypillsfixed combinations statins lower doses ezetimibe without pcsk<NUMBER> inhibitors available aimed reducing risk sams <NUMBER> <NUMBER> position statement european society esc council <NUMBER> march <NUMBER> well national international societies highlights lack evidence harmful effects ace inhibitors arbs incidence progression covid<NUMBER> infection strongly supports continuation usual antihypertensive therapy <NUMBER> <NUMBER> regarding statins beneficial effects inflammation vascular heart lung function strongly support continuation use due significant effect cvd prevention pcsk<NUMBER> inhibitors also continued available physicians wait strong evidence recommendations international scientific societies altering patients drug therapy covid<NUMBER> era dr niki katsiki maciej banach contributed equally paper nk given talks attended conferences participated trials sponsored angelini astra zeneca bausch health boehringer ingelheim elpen mylan novonordisk sanofi servier mb speakers bureau abbottmylan abbott vascular actavis akcea amgen biofarm krka msd polpharma sanofiaventis servier valeant consultant abbott vascular akcea amgen daichii sankyo esperion freia pharmaceuticals lilly msd polfarmex resverlogix sanofiaventis grants sanofi valeant dpm given talks attended conferences sponsored amgen novonordisk libytec r e f e r e n c e zinc metallopeptidase angiotensinconverting enzyme <NUMBER> ace<NUMBER> known human homologue key regulator blood pressure angiotensinconverting enzyme ace since discovery <NUMBER> ace<NUMBER> implicated heart function hypertension diabetes effects mediated part ability convert angiotensin ii angiotensin <NUMBER> <NUMBER> unexpectedly ace<NUMBER> also serves cellular entry point severe acute respiratory syndrome sars virus enzyme therefore prime target pharmacological intervention several disease fronts approaching <NUMBER> years since discovery dual role zinc metallopeptidase angiotensinconverting enzyme ace production vasoconstrictor angiotensin ii ang ii destruction vasodilator bradykinin <NUMBER> <NUMBER> perhaps surprising therefore discovery homologue ace<NUMBER> take place almost half century later took application two independent genomicsbased approaches reveal presence ace<NUMBER> human genome <NUMBER> <NUMBER> given widespread use ace inhibitors aceis treatment hypertension cardiovascular conditions immediate interest ace<NUMBER> potential therapeutic target possibility emphasized relatively high levels ace<NUMBER> expression human heart kidney <NUMBER> <NUMBER> first surprises emerged basic characterization nature ace<NUMBER> activity despite close similarity ace conservation many key active site features ace<NUMBER> displayed distinct preference substrates operating exclusively carboxypeptidase removing single amino acids unlike ace removes dipeptides cterminus peptide <NUMBER> <NUMBER> hence ace<NUMBER> could convert angiotensin ang ang ii unable inactivate bradykinin furthermore ace<NUMBER> susceptible inhibition aceis tested revealed pharmacology ace<NUMBER> subsequent three years key role ace<NUMBER> emerging conversion octapeptide ang ii metabolite angiotensin<NUMBER> <NUMBER> ang <NUMBER> <NUMBER> example compensatory increase ang <NUMBER> <NUMBER> levels failing human heart ventricles correlated upregulation ace<NUMBER> <NUMBER> cardiac myocyte ang <NUMBER> <NUMBER> levels increased ischaemic cardiomyopathy <NUMBER> physiological role ang <NUMBER> <NUMBER> controversial generally appears oppose pressor proliferative profibrotic actions ang ii <NUMBER> acts gproteincoupled receptor would suggest ace ace<NUMBER> might act counterbalances reninangiotensin system ras figure <NUMBER> successful production ace<NUMBER> null ace<NUMBER> <NUMBER> mice supports hypothesis <NUMBER> ace<NUMBER> knockout mice show major cardiac contractility defects increased levels ang ii <NUMBER> overall studies mice suggest ace<NUMBER> key regulator cardiac function although mechanism mediated unclear however double knockouts ace ace<NUMBER> genes deleted show cardiac defects ace<NUMBER> knockout alone <NUMBER> emphasizing yinyang nature ace ace<NUMBER> expression ace<NUMBER> transgenically overexpressed mouse heart cardiac defects observed notably lethal ventricular arrhythmia associated disruption gap junction formation <NUMBER> high incidence sudden death mice correlated levels ace<NUMBER> transgene expression surviving older mice showed spontaneous downregulation transgene restoration normal figure <NUMBER> counteractions angiotensinconverting enzyme ace angiotensinconverting enzyme <NUMBER> ace<NUMBER> angiotensin metabolism classical reninangiotensin pathway decapeptide ang ie ang <NUMBER> <NUMBER> derived angiotensinogen via action renin converted ace vasoactive ang ii ang <NUMBER> <NUMBER> removal cterminal dipeptide hisleu <NUMBER> <NUMBER> increasing evidence ang <NUMBER> <NUMBER> counterbalance actions ang ii <NUMBER> formed ang ii action ace<NUMBER> possibly ang action neprilysin nep although ace<NUMBER> convert ang ang <NUMBER> <NUMBER> turn converted ang <NUMBER> <NUMBER> ace nep pathway unlikely occur significant levels vivo metabolism ang ace<NUMBER> kinetically unfavourable compared conversion ang ii gi rice et al unpublished hence shown ang cardiac function also indirect associations ace<NUMBER> expression hypertension particular crackower et al <NUMBER> noted rat ace<NUMBER> gene maps defined quantitative trait locus associated hypertension additionally two single nucleotide polymorphisms ace<NUMBER> gene locus associated human cardiovascular disease <NUMBER> another disease model ace<NUMBER> expression recently studied diabetes streptozotocininduced diabetes rat expression renal tubule ace<NUMBER> mrna protein substantially reduced whereas increase ace<NUMBER> protein expression seen diabetic glomeruli <NUMBER> significance changes underlying mechanisms involved remain elucidated clearly searches possible correlations ace<NUMBER> mrna protein overor underexpression human cardiovascular renal disease warranted determine whether correlations mirror effects observed rodent models several potent relatively selective inhibitors ace<NUMBER> described <NUMBER> <NUMBER> modelling active site ace<NUMBER> <NUMBER> based recently reported structure human ace <NUMBER> facilitate development new classes specific inhibitors active site model also provides explanation differences substrate specificity inhibitor sensitivity ace ace<NUMBER> <NUMBER> ace<NUMBER> gateway sars several months <NUMBER> virus caused newly identified illness severe acute respiratory syndrome sars spread rapidly china throughout asia canada beyond causing almost <NUMBER> deaths disrupting travel economics even scientific conventions death rate following infection approached almost <NUMBER> almost mysteriously appeared perhaps result public health measures disease faded away reemerge china year speed infection spread severity symptoms led massive effort identify agent responsible within months identified positive strand rna virus classified member coronavirus family sarscov genome sequenced <NUMBER> <NUMBER> search underway identify cellular receptor virus coronaviruses nterminal portion s<NUMBER> domain viral spike glycoprotein mediates initial highaffinity binding receptor surface susceptible cells spike sits viral envelope projects outwards give coronalike appearance virus hence name replication strategy virus summarized figure <NUMBER> figure <NUMBER> depicts coronavirusinfected cell michael farzan colleagues <NUMBER> demonstrated s<NUMBER> domain sarscov protein bound african green monkey kidney cell line vero e<NUMBER> permissive viral replication able coimmunoprecipitate protein responsible viral binding entry sarscov receptor glycoprotein r <NUMBER> <NUMBER> identified mass spectrometry ace<NUMBER> identity confirmed showing ace<NUMBER> overexpressed human cells nonpermissive viral infection sarscov entry replication facilitated process blocked ace<NUMBER> antibody <NUMBER> tissue distribution ace<NUMBER> also appears show correlation sites sarscov infection disease pathology independently xiao et al <NUMBER> confirmed ace<NUMBER> sarscov receptor showed receptorbinding domain probably located residues <NUMBER> <NUMBER> spike glycoprotein farzans group <NUMBER> established recognition region within <NUMBER> amino acid sequence residues <NUMBER> <NUMBER> smaller fragments unable bind ace<NUMBER> crucial aspartic acid region essential binding ace<NUMBER> modelling ace<NUMBER> structure based known structure ace provided another approach predicting potential binding contacts ace<NUMBER> sarscov protein <NUMBER> ultimately experimental studies essential identify nature interactions two proteins recent solution structure ace<NUMBER> <NUMBER> supports much earlier modelling active site enzyme <NUMBER> facilitate studies ace<NUMBER> protein interactions two unexpected features ace<NUMBER> inhibitor binding arise structural studies <NUMBER> first inhibitor binding induced large conformational change enzyme replicase attaches <NUMBER> <NUMBER> end input genome begins e replication fulllength antigenome f synthesis negative strand subgenomic rnas serve templates synthesis g new genomic rna h viral subgenomic mrnas sgrnas respectively coronavirus mrnas conserved <NUMBER> <NUMBER> ends dark blue box <NUMBER> <NUMBER> coterminal polyadenylated thought eight sgrnas produced sarscov infected cells encode viral structural proteins shown j release virus occurs processing assembly virus particles golgi apparatus rough endoplasmic reticulum although primary replication occurs cytoplasm recent evidence suggests coronaviruses related viruses use nuclear factors facilitate replication process <NUMBER> nucleus cytoplasm aligns crucial residues catalysis second inhibitor binds enzyme inverse orientation predicted binding acei lisinopril active site ace <NUMBER> another zinc peptidase aminopeptidase n apn acts receptor several coronaviruses <NUMBER> receptor distribution correlated sites infection however apart zincbinding region apn ace<NUMBER> bear discernible sequence homology show different membrane topology several features probably facilitate usurping plasma membrane peptidases viral receptors exist ectoenzymes bulk protein including catalytic domain faces extracellular space heavily glycosylated also abundantly expressed certain cell types example apn constitutes <NUMBER> membrane protein kidney brush border catalytic domain responsible coronaviral interaction either ace<NUMBER> apn mutations key active site residues affect viral infection probably reflects fact catalytic site ace<NUMBER> buried deep narrow cleft within protein accessible oligopeptide substrates enzyme relatively short space time ace<NUMBER> gained prominence several disease states cardiovascular origin originally predicted close similarity ace physiological correlations ace<NUMBER> also appearing recently example ace<NUMBER> immunoreactivity kidney shown double pregnancy rats leading suggestion ace<NUMBER> might contribute localized overproduction ang <NUMBER> <NUMBER> kidney observed pregnancy might protect rises blood pressure <NUMBER> therefore conceivable deficient expression ace<NUMBER> might underlie pathological conditions pregnancy preeclampsia perhaps much attention date focused ability ace<NUMBER> produce ang <NUMBER> <NUMBER> ang ii future analysis physiological roles ace<NUMBER> needs bear mind metabolize range biologically active peptides angiotensinrelated peptides <NUMBER> <NUMBER> example hydrolyse desarg<NUMBER>bradykinin endogenous ligand bradykinin b <NUMBER> receptor context availability potent selective inhibitors ace<NUMBER> <NUMBER> <NUMBER> provide valuable pharmacological tools exploring physiology pathology enzyme therapeutic potential ace<NUMBER> inhibitors cardiovascularrelated diseases however questionable given apparent cardioprotective nature ace<NUMBER> activity much study needed area indeed mechanisms selectively increasing cardiac renal ace<NUMBER> levels might desirable conditions require understanding factors regulate tissuespecific expression biggest surprise however identification ace<NUMBER> viral receptor <NUMBER> although current data consistent ace<NUMBER> sarscov receptor might receptors coreceptors virus yet discovered effective therapies sars urgently required major outbreaks occur studies coronaviruses vaccination approach might viable although without limitations <NUMBER> hence soluble ace<NUMBER> fragments ace<NUMBER> antibodies might provide alternative antiviral therapeutic approaches although possible sideeffects blocking ace<NUMBER> unknown indeed infection sarscov might affect ace<NUMBER> function adversely could turn contribute pathology disease given ability viruses usurp cellsurface peptidases prevalence ace respiratory tissues ace might role receptor yet unidentified virus recent coronavirus pandemic crisis due viral infection severe acute respiratory syndromerelated coronavirus<NUMBER> sarscov<NUMBER> causing uncontrolled inflammatory conditions human lung soon first transmission emergence sarscov animals humans china <NUMBER> <NUMBER> genetically evolved betacoronavirus genus similar human viruses discovered chinese horseshoe bats rhinolophus sinicus <NUMBER> date pneumonia epidemiologically caused diverse viruses example adenovirus influenza virus middle east respiratory syndrome virus mersv parainfluenza virus respiratory syncytial virus rsv sarscov enteric enveloped cov cause pneumonia human hosts world health organization reported official terminology <NUMBER>novel coronavirus <NUMBER>ncov <NUMBER> january <NUMBER> february <NUMBER>th edited name disease caused <NUMBER>ncov coronavirus disease<NUMBER> covid<NUMBER> academia international committee taxonomy viruses ictv provided official nomenclature virus sarscov<NUMBER> due similarity novel coronavirus sarscov <NUMBER> sarscov<NUMBER> spreading causing global healththreatening emergency <NUMBER> researchers race develop antiviral drugs sarscov<NUMBER> even declared worldwide pandemic threatening human lives preventive therapeutic drugs patients infected sarscov<NUMBER> yet discovered covs enveloped forms also infect gastrointestinal track git although enteric viruses naked morphology <NUMBER> covs also rarely infect neural cells <NUMBER> unfortunately solid information coronaviruses infect humans animals reciprocal infectivity cause zoonotic viral outbreak contrast influenza viruses known selectively utilize sialic acid sa linkages <NUMBER> currently limited information available βcovs sarscov receptor usage infectible cell types different species host cell surface oacetylated sas recognized lectinlike spike proteins sars cov<NUMBER> first step attachment host cells infectious virus interaction host cell surface mediated sialoglycans important phenomenon eukaryoteparasite coevolution oglcnac minor glycan source mainly found nucleus cytosol figure <NUMBER> apart general roles glycans covs recognize host cells attach host cell surface molecules enter host cells example activity hemagglutininesterase enzyme relies typical carbohydratebinding lectin receptordestroying enzyme rde domains βcovs target <NUMBER>oacetylated sas certain species switched recognizing <NUMBER>oacetyl sa instead <NUMBER> crystallographic data molecular structure type ii provides explanation switching mechanism acquire <NUMBER>o acetyl sa binding event follows orthodox ligand–receptor interaction lri lectin–carbohydrate interaction lci lectin–glycan interaction lgi lectin–sphingolipid interaction lsi protein–glycan interaction pgi protein–carbohydrate interaction pci also protein–protein interaction ppi recently <NUMBER> protein candidates suggested sarscov<NUMBER>human protein interacting proteins ppis among <NUMBER> human proteins druggable host factors characterized possible fdaapprovable drugs <NUMBER> ppi involved however carbohydrates glycans may serve coreceptors codeterminants previous reports suggest carbohydrates act receptor determinants cases general principles pci stereochemistry potentiate sa–ligand switch way simple conformational shifts lectin esterase domain indicates examination natural adaptation directed carbohydratebinding proteins measure observe carbohydrates leading virus evolution toward transitional host tropism <NUMBER>carbon sas mainly animalspecific anionic sugars attached terminal sugars sas exist two forms neugc neuac neugc differentially modified form parental sa form neu<NUMBER>ac sas structurally diverse example several modified sa forms known structures including neuraminic acid neuc nacetyl neuraminic acid neuac nglycolyl neuraminic acid neugc nodiacetyl neuraminic acid occurs horses nodiacetyl neuraminic acid occurs bovines nacetyl odiacetyl neuraminic acid occurs bovines figure <NUMBER> sialyltransferases sts biosynthesize different sa linkages sa linkage diversity occurs α<NUMBER> α<NUMBER> α<NUMBER> α<NUMBER> sa gal residues figure <NUMBER> example formation α<NUMBER> sa α<NUMBER> sa structures α<NUMBER>st α<NUMBER>st utilize substrates galβ<NUMBER>glcnac figure <NUMBER> frequent modification sas oacetylation positions c<NUMBER> c<NUMBER> c<NUMBER> c<NUMBER> sa figure <NUMBER> mammal avianinfectible covs consist broadranged subfamily coronavirinae ictv recommended classification follows riboviria realm—nidovirales order— cornidovirineae suborder—coronavirida family—orthocoronavirinae—coronavirus genus four cov genera <NUMBER> αcov βcov γcov δcov <NUMBER>ncov sarscov<NUMBER> belong βcov genus zoonotic cause mammalian infection causing respiratory disease human lung αcov βcov genus target mammal hosts δcov γcov genus target avians certain mammals βcov genus b c lineages among lineage b includes sarscov sarscov<NUMBER> lineage c includes merscov b lineage sarscov c lineage merscov classified βcovs exhibit lethal rates <NUMBER> <NUMBER> humans respectively covs humans associated respiratory infections colds clinical importance experienced previous outbreak <NUMBER> sarshuman cov hcov hcovhku<NUMBER> hcovnl<NUMBER> <NUMBER> human infectious hcov includes seven species including αcov hcovnl<NUMBER> hcov<NUMBER>e βcov sarscov sarscov<NUMBER> hcovoc<NUMBER> hcovhku<NUMBER> merscov cov rna sequences mutate high frequency among known rna viruses covs bear longest genome sizes <NUMBER> <NUMBER> kb length rna nucleotide sequences cov ssrna genomes isolated covid<NUMBER> patients wuhan show high homology <NUMBER> nucleotide sequence previously known bat sarslike covzxc<NUMBER> strain <NUMBER> previous sarscov initial wuhan cov isolates belong βcov genus therefore termed sarscov<NUMBER> <NUMBER>ncov <NUMBER> sarscov<NUMBER> infects human respiratory tracts causes outbreaks pneumonia sarscov<NUMBER> novel cov originates wuhan district china genome sequence sarscov<NUMBER> exhibits <NUMBER> sequence homology sarscov rna sequence <NUMBER> merscov sequence <NUMBER> rna viruses glycoprotein pdb <NUMBER>vsb biggest protein heavily glycosylated nterminal domain ntd sequence binds host receptor enter er host cells sarscov<NUMBER> sglycoprotein bears <NUMBER> nglycan sequons protomer therefore trimeric glycoprotein surface dominated <NUMBER> nglycans glycoprotein mediates direct indirect interaction virus host cells infection cycle covs exhibit surface glycoprotein bears receptorbinding domain rbd glycoprotein distinct spike structure glycoprotein binds host receptor host furinlike protease cleaves glycoprotein liberates spike fusion peptides allowing entry virus host cell <NUMBER> furinlike proteasegenerated s<NUMBER> s<NUMBER> exist s<NUMBER>s<NUMBER> complex s<NUMBER> homotrimeric form interacts host cell membrane s<NUMBER> penetrates cytosolic area sarscov merscov s<NUMBER> cterminal domains ctds dual role virus entry via attachment fusion s<NUMBER> ntd binds carbohydrate receptors s<NUMBER> domains act rbd ctd s<NUMBER> recognizes protein receptors via rbds rna viruses n protein recognizes viral rna genome n protein pdb <NUMBER>m<NUMBER>m binds rna genome via ntd ctd n protein tethers viral rna replicase–transcriptase complex rtc nsp<NUMBER> pdb <NUMBER>vxs cov blocks innate immune responses hosts entrance host cells cov transcription particle release rna chaperones nonspecific nucleic acid binding proteins potentiate ssrna conformation shifts representatively n protein known rna chaperone protein example glycogen synthase kinase <NUMBER> gsk<NUMBER> phosphorylates sarscov nprotein thus gsk<NUMBER> inhibition contributes reduced replication activity sarscov <NUMBER> addition heterogeneous nuclear ribonucleoprotein a<NUMBER> hnrnp a<NUMBER> regulates preformed mrna splicing nucleus continuous translation hnrnpa<NUMBER> interacts sarscov n protein form replication transcription complex ssrna genome biosynthesis <NUMBER> e protein abundant structural protein needed assemble virus particles cytosol tm protein e protein smallest structural protein mw <NUMBER> kda e protein ntd extracellular region ctd cytosolic region e protein bears ectodomain ntd endodomain ctd also ion channel domain e protein present cytosolic region infected cells limited amount incorporated envelope virions <NUMBER> e proteins assemble bud new virus particles protein contains three tm domains abundant structural protein mw <NUMBER> kda consists small glycosylated ntd extracellular region ctd cytoplasmic region protein forms scaffold virus assembly cytosol via binding glycoprotein n protein <NUMBER> example e protein n protein coexpressed protein form viruslike particles vlps released cells e protein involved cov assembly covs bud ergic trafficking membrane vesicles transported via exocytosissecretory pathway <NUMBER> dimeric protein binds nucleocapsidm protein binds glycoprotein glycoprotein retention ergicgolgi complex mn protein complex keeps n protein–rna complex stable nucleocapsid viral assemblym e proteins constitute virus envelope successful release viruslike particles hemagglutinates destroys receptors rna viruses covs bear rdes used effective attachment hosts also reversely detachment hosts example enveloped rna viruses evade hosts via rdes currently rderelated functional enzymes neuraminidase na saoacetylesterase known saoacetylesterase originally identified influenza c virus nidoviruses cov torovirus well salmon anemia virus teleost orthomyxovirus origin evolution cov saoacetylesterases correlated viruses fusion event glycoprotein specific hcov attachment saassociated receptors host <NUMBER> acetylesterase activity <NUMBER> early sarelated biology influenza ab viruses found recognize chicken erythrocytes <NUMBER> <NUMBER> caused hemagglutination clumping virusborne hemagglutinin phenomena widely found influenza viruses paramyxoviruses newcastle disease ndv mumps virus sas various derivatives <NUMBER> chemically different structures formed basic nacetylneuraminic acid neu<NUMBER>ac main ring pyranose glycerol side chain sa modified acetyl lactyl methyl sulfogroups individually multiple combinations <NUMBER> multiple enzymes involved modifications <NUMBER> historically first discovered sa crystallized gunner blix via hot mild acid extraction bovine submaxillary mucin <NUMBER> consisted two acetyl groups among one acetyl group attached nitrogen <NUMBER> blix isolated <NUMBER>oacetyl sa common sa nacetylneuraminic acid neu<NUMBER>ac chemically described <NUMBER>oacetylnacetylneuraminic acid neu<NUMBER>ac<NUMBER> neu<NUMBER>ac<NUMBER> neu<NUMBER>ac neu<NUMBER>gc naturally occurring sa species mammals common modification oacetylation fact oacetylation sas common organisms oacetyl modification occurs single positions c<NUMBER> c<NUMBER> c<NUMBER> c<NUMBER> sa well combined cpositions yield neu<NUMBER>ac<NUMBER> neu<NUMBER>ac<NUMBER> neu<NUMBER>ac<NUMBER> sas neu<NUMBER>ac<NUMBER>nac chemical biologic mimic neu<NUMBER>ac<NUMBER> saglycans c<NUMBER> andor c<NUMBER> oacetylations catalyzed sa oacetyltransferase enzyme cas<NUMBER> domain containing <NUMBER> casd<NUMBER> figure <NUMBER> casd<NUMBER> catalyzes addition acetyl groups sa c<NUMBER> late golgi apparatus compartment <NUMBER> thereafter enzyme termed “migrase” transfers additional acetylgroup c<NUMBER> c<NUMBER> although enzyme identified <NUMBER> casd<NUMBER> uses acetylcoenzyme donor substrate cmpneu<NUMBER>ac acceptor substrate weak activity cmpneu<NUMBER>gc biologically sa oacetylation event confers merits hosts protection pathogenic invasion maintenance systemic selfhomeostasis oacetylation event sas protects sacontaining glycans neuraminidase nasialidase action oacetylgroups inhibit microbial na activity chemical structure oacetyl group quite unstable susceptible esterase enzymes sialic acid cleavage diacetylated neu<NUMBER>ac<NUMBER> bacterial nas decreases twofold compared monooacetylated neu<NUMBER>ac oacetylated glycan modification invites interaction viruses antibodies mammalian lectins <NUMBER> therefore sa oacetylation modification confers specific functions organisms example horse c<NUMBER>oacetyl modification neu<NUMBER>ac sa occupies <NUMBER> total sa content c<NUMBER>oacetylated neu<NUMBER>ac neu<NUMBER>ac<NUMBER> inhibits influenza a<NUMBER> virus ha deacetylation reagents naoh naio<NUMBER> treatment completely hemagglutinate neu<NUMBER>ac<NUMBER> elimination c<NUMBER>oacetyl group <NUMBER> c<NUMBER>oacetyl neu<NUMBER>ac species found various sources equine erythrocyte gm<NUMBER> starfish rubens fish <NUMBER> c<NUMBER>oacetylated neu<NUMBER>ac facilitates initial attachment viruses target cells like influenza c virus infectious salmon anemia virus isav member orthomyxoviridae family contains hef proteins mediate virus entry exit c<NUMBER>oac neu<NUMBER>ac major receptor determinant isav receptor binding destruction <NUMBER> influenza c virus recognizes c<NUMBER>oac neu<NUMBER>ac acetylesterase rde isav cleaves c<NUMBER>oac via <NUMBER>saoacetylesterase short turnover time whereas c<NUMBER>oac neu<NUMBER>ac cleaved <NUMBER>saoacetylesterase long turnover time <NUMBER> position sa oacetylation linked functions including substrate differentiation enzymes nas esterase c<NUMBER> oac previous development oac siteselective na inhibitors based conceptual consideration different oac positions oac sas sitespecific c<NUMBER> neu<NUMBER>ac considered potential position modification historically inhibitors influenza b virusessialidases designed vonitzstein <NUMBER> <NUMBER> ac groupbased c<NUMBER> substitution interacts amino acid glu<NUMBER> present active site sialidase guanidineattached c<NUMBER> c<NUMBER>–c<NUMBER> unsaturated sa neu<NUMBER>ac<NUMBER>en inhibits activity sialidases isolated influenza virus singapore<NUMBER> b virus victoria<NUMBER> scenario applied sialidase inhibition human parainfluenza virus type <NUMBER> hn fusion proteins <NUMBER> c<NUMBER> neu<NUMBER>ac<NUMBER>en substituted alkyl groups oethyl group example zanamivir substitution <NUMBER>guanidino group ic<NUMBER> <NUMBER> μm thus sialidase inhibition important c<NUMBER> modification neu<NUMBER>ac<NUMBER>en later oseltamivir tradename tamiflu basel switzerland zanamivir tradename relenza london uk established <NUMBER> drugs exhibit adverse side effects restrict clinical use sa <NUMBER>oacetylation hosts allows hosts evade influenza virus hemagglutinin ha recognition lectins factor h fh cd<NUMBER>siglec<NUMBER> sialoadhesinsiglec<NUMBER> instead influenza c virus ha recognizes hosts βelimination permethylation eliminate <NUMBER>oacetyl group sas chemical modification c<NUMBER> position neu<NUMBER>ac<NUMBER> generates <NUMBER>nacetyl analog <NUMBER>acetamido<NUMBER>deoxynacetylneuraminic acid neu<NUMBER>ac<NUMBER>nac mimic neu<NUMBER>ac<NUMBER> influenza c virusbinding capacity cleaved <NUMBER> sa oacetylesterase regulates presence <NUMBER>oac <NUMBER>oac sa oacetylation deacetylation involved development cancer immunology sa oacetylation alters host lectin bindings siglecs <NUMBER> presence <NUMBER>oac also reduce activity nas <NUMBER> sa modifications regulate pathogen binding pathogen nas influenza abcd viruses use sa entry receptors influenza b subtypes bind sas via ha na allow endocytosis virus fusion viral envelope endosomes contrast influenza c subtypes bear one coated glycoprotein termed fusion protein hef hef acts ha na hef recognizes <NUMBER>oacetyl sa entry cells esterase domain removes <NUMBER>oacetylgroups liberates virus mucus misassembled virus aggregates budding <NUMBER>oac cells prevents na activity ha binding influenza type virus <NUMBER> influenza b viruses bear two spikes receptorbinding ha na <NUMBER> hef indeed ancient type saoacetylesterase contrast ab influenza c virus bears one spike triple functions hef homotrimer <NUMBER> hef subunit bears two neu<NUMBER>ac<NUMBER>binding sites binds <NUMBER>oacetyl group parallel another modification oacetylation found indeed influenza c virus bears saoacetylesterase <NUMBER> converts <NUMBER>nacetyl<NUMBER>oneuac neu<NUMBER>ac<NUMBER> <NUMBER>neu<NUMBER>ac <NUMBER>oacetyl sa unique determinant influenza c virus receptor neu<NUMBER>ac<NUMBER> crucial receptor activity neu<NUMBER>gc neu<NUMBER>ac <NUMBER> neu<NUMBER>ac<NUMBER> essential determinant influenza virus c typespecific host cell tropism nas cleave αketosidic linkages dgal galnac saoacetylesterases cleave different oacetyl linkages figure <NUMBER> ohgroup tyr<NUMBER> guanidino group arg<NUMBER> interact ch<NUMBER>cocarbonyl oxygen <NUMBER> hef saoacetylesterase found several enveloped ssrna viruses influenza c virus also certain covs toroviruses <NUMBER> covs different orthomyxoviruses hold segmented − ssrna genome instead evolutionary linked family coronaviridae order nidovirales <NUMBER> covs toroviruses coronaviridae family specific oac sa receptors glycoproteins similar influenza c virus hef covs toroviruses bear gene form class envelope membrane proteins <NUMBER> amino acid residues bear <NUMBER> <NUMBER> nglycosylation sites <NUMBER> multimer forms enter virions bovine cov bcov hcovoc<NUMBER> similar influenza c virus recognize neu<NUMBER>ac<NUMBER> bear sa<NUMBER>oacetylesterase <NUMBER> cov hes oacetylesterases enzymes found torovirus cov influenza c virus evolutionarily interspeciesmutated <NUMBER> homology heterologous rna recombination <NUMBER> horizontal gene transfer therefore viral hes diverse widespread evolution hes envelope proteins found covs orthomyxoviruses toroviruses coronaviral hes involved virus attachment sa species protein βcovs binds neu<NUMBER>ac<NUMBER> form sa agglutinates red blood cells rbcs rodents <NUMBER> saoacetylesterase potentiates viral entry protein spreading via mucosal glycans contains carbohydraterecognizing domain crd known lectin glycanbinding domain gbd mediates virus attachment sas host cells ha indicates compared glycoprotein minor ha glycoprotein mainly attaches cell surface protein murine hepatitis virus mhv enveloped cov binds sa<NUMBER>acetylester sa<NUMBER>oacetylester carcinoembryonic antigen cell adhesion molecule <NUMBER>a ceacam known cd<NUMBER>a key receptor <NUMBER> murine covs hes acquired horizontal gene transfer bind c<NUMBER>oac neu<NUMBER>ac however murine cov hes cannot bind c<NUMBER>oac neu<NUMBER>ac original mouse mhv binds c<NUMBER>oac neu<NUMBER>ac mhv sstrain evolutionarily acquired ability bind c<NUMBER>oac neu<NUMBER>ac <NUMBER> terms structure c<NUMBER> n c<NUMBER> oac neu<NUMBER>acaccomodating hydrophobic pocket shifted c<NUMBER> n c<NUMBER>oac neu<NUMBER>acaccomodating pocket <NUMBER> type specific <NUMBER>oacetylated sas <NUMBER>oacsas type ii specific <NUMBER>oacsas sabinding shift indicates quasisynchronous adaptations sarecognition sites lectin esterase domains type monomers βcov lineage bimodular enzyme–lectin domain similar cellular glycancarbohydratemodifying proteins originally homologs found various viruses including toroviruses orthomyxoviruses influenza virus cd isavirus well exceptional case βcov lineage among covs gene transmitted βcov lineage progenitor via horizontal gene transfer <NUMBER>oacsia–recognizing hef shown influenza virus cd acquisition expansion occurred crossspecies transmission evolution phenomenon reflects viral evolutionary adaptation host sacontaining glycans therefore cov receptor switching precedes virus evolution driven sacontaining glycan diversity hosts instance bcov prefers <NUMBER>dioacsas also target bovine torovirus outstanding case switching event occurred murine covs βcov lineage type switch toward oacsa recognition specificity murine covs two different murine cov subtypes virus group exist one subtype possessing typical <NUMBER>oacsa type attachment factor exclusively <NUMBER>oacsa type ii attachment virus group <NUMBER> first coronaviral proteins identified porcine hemagglutinating encephalomyelitis virus phev bcov hcovoc<NUMBER> bear sa<NUMBER>oacetylesterases similar hef <NUMBER> rat cov rcov sa<NUMBER>oacetylesterases converting neu<NUMBER>ac<NUMBER> neu<NUMBER>ac <NUMBER> murine covs prefer <NUMBER>oacsas others <NUMBER>oacsas hcovoc<NUMBER> bcov prefer α<NUMBER>sa <NUMBER>oacetylation saoacetyleseterases glycoproteins bcov hcovoc<NUMBER> neu<NUMBER>ac<NUMBER>recognizing lectins agglutinate murine rat chicken erythrocytes due enriched <NUMBER>oacsa species <NUMBER> bcov hcovoc<NUMBER> adapted sa receptor determinants <NUMBER>oacsa receptors <NUMBER> second receptor binding glycoprotein neu<NUMBER>ac<NUMBER> receptor essential entry cells bcovinfection prevented prior treatment cells na enzyme viral saoacetylesterases blocking roles glycoprotein sadependent entry host cells αcovs tgev haactivity attributed sarecognizing activity α<NUMBER>neugc <NUMBER> sabinding site present nterminal region sglycoprotein tgev tgev two types enteric respiratory tropism respiratory tgev porcine aminopeptidase n papnbinding domain sabinding domain nucleotide <NUMBER> gene essential enteric tropism s<NUMBER>a mutation glycoprotein confers enteric respiratory tropism shift addition <NUMBER>nucleotide insertional mutation nucleotide <NUMBER> yields y<NUMBER>t<NUMBER>insnd shift glycoprotein causes enhanced enteric tract tropism tgev interacts sa species mucinlike glycoprotein mgp highly glycosylated protein sadependent manner mucinsecreting goblet cells <NUMBER> mgp sabinding allows virus entry via mucus layer intestinal enterocytes different tgev glycoprotein porcine cov hemagglutination activity due deletion sabinding site glycoprotein <NUMBER> loss sabinding activity correlated nonenteropathogenicity sas function hamediated entry determinants tgev causing enteropathogenic outcome virus sarecognition activity also responsible virus amplification cells sabinding activitydeficient tgev propagate cells papn known cd<NUMBER> receptor <NUMBER> sabinding activity potentiates infection crucial intestinal infection βcov mediates viral attachment oacsas function relies combined cbd rde domains βcovs target <NUMBER>oacsas type certain strains switched alternatively targeting <NUMBER>oacsas type ii example saacetylesterase enzyme bcovs hcovoc<NUMBER> known hemagglutinizing activities type sa<NUMBER>oacetylesterase <NUMBER> saacetylesterase surface glycoprotein bcov threedimensional structure bcov similar viral esterases <NUMBER> gene found βcov genus acetylesterase murine covs differs substrate binding specificity bcov hcovoc<NUMBER> specific oacetyl residue release sa c<NUMBER> murine covs prefer esterize <NUMBER>oacetylneuac <NUMBER> βcov acetylesterase destroys receptors specificity similar influenza viruses acetylesterase activity inhibited diisopropyl fluorophosphate agent decreases viral infection levels <NUMBER> deduced sa acetylesterase hcovoc<NUMBER> <NUMBER> <NUMBER>oacsa species receptor binding determinant erythrocytes entry cells <NUMBER> bcov protein dual activity acetylesterase ha <NUMBER> bcov widely agglutinates erythrocytes purified agglutinates neu<NUMBER>ac<NUMBER>enriched erythrocytes rats mice bcov hcovoc<NUMBER> agglutinate chicken erythrocytes purified cannot contrast protein purified glycoprotein agglutinate chicken erythrocytes <NUMBER> indicating major ha protein acts major sabinding protein however role oacsas certain essential receptors sabinding activity may essential protein glycoprotein <NUMBER> γcovs ibv strains known poultry respiratory infectious pathogens agglutinate erythrocytes ibv prefers recognize α<NUMBER>neuac sa functions host entry receptor infection <NUMBER> glycosylation ibv m<NUMBER> s<NUMBER> protein rbd crucial interaction chicken trachea tissue rbd nglycosylation confers receptor specificity enables virus replication heavy glycosylated m<NUMBER> rbd <NUMBER> glycosylation sites nglycosylation ibv determines receptor specificity however host receptor yet found na treatment reduces binding soluble kidney tracheal epithelial cells ibv protein recognizes epithelial cells sadependent manner sabinding ability ibv necessary infection tracheal epithelial cells lung respiratory epithelial cells <NUMBER> sabinding site located s<NUMBER> ibv protein although ibvspecific protein receptor known contrast bcov hcovoc<NUMBER> ibv lacks rde sa binding ibv likely essential viruses tgev torovirus belongs family coronaviridae toroviruses grouped torovirinae subfamily torovirus genus known toroviruses infect four species hosts constituting bovine equine porcine human toroviruses mildly infect swine cattle protein similar βcov protein <NUMBER> protein class membrane glycoprotein forms homodimers mw <NUMBER> kda rde protein reversibly binds glycans <NUMBER> binding sas acetylesterase activity disrupts sa binding hemagglutinates mouse erythrocytes cleaves acetylester linkage glycans acetylated synthetic substrate pnitrophenyl acetate pnpa <NUMBER> similar cov torovirus acetylesterase type cleaves oacetyl group sa c<NUMBER> position using neu<NUMBER>ac<NUMBER> nacetyl<NUMBER>oneuac <NUMBER> however torovirus exhibits restricted specificity neu<NUMBER>ac<NUMBER> substrate neu<NUMBER>ac<NUMBER> substrate unique sabinding site generated single amino acid difference porcine thr<NUMBER> bovine ser<NUMBER> <NUMBER> glycoprotein sarscov<NUMBER> initiates infection host cells molecular basis cov attachment sugarglycan receptors important issue demonstrated recent cryoem defining structure covoc<NUMBER> glycoprotein trimer complexed <NUMBER>oacetylated sa <NUMBER> cryoem structures trimeric ectodomain glycoprotein observed using forms complexed neu<NUMBER>ac neu<NUMBER>gc sialyl–lewisx slex α<NUMBER>sialylnacetyllactosamine α<NUMBER>slacnac α<NUMBER>slacnac respectively receptorbinding site commonly conserved cov glycoproteins attach <NUMBER>oacsa species similar ligandbinding pockets cov hes influenza virus cd hef glycoproteins indicating conserved recognizing structures <NUMBER> glycoprotein<NUMBER>oacetylsa interaction resembles ligandbinding pockets cov hes influenza virus cd fusion glycoproteins hcovoc<NUMBER> bcov recognize <NUMBER>oacsa glycoproteins engage <NUMBER>oacetylsas <NUMBER>oacetyl sas binding site hcovoc<NUMBER> glycoprotein related β<NUMBER> cov glycoproteins however sabinding sites <NUMBER>oacetyl sialyl receptors merscov glycoprotein hcovoc<NUMBER> glycoprotein different <NUMBER> thus covs use two different entry attachment receptors therefore glycoproteins covs distinct influenza virus bind neu<NUMBER>ac species conserved binding sites ligandbinding sites bcov enzyme influenza hef enzyme cov glycoprotein evolved <NUMBER>oacsa binding hydrogen bonding <NUMBER>oacetyl carbonyl group hydrophobic pocket formation <NUMBER>oacetyl methyl group <NUMBER> however influenza ha cannot bind <NUMBER>oacetylsas bind neugcs <NUMBER> hcovoc<NUMBER> glycoprotein hcovhku<NUMBER> glycoprotein bcov glycoprotein phev glycoprotein therefore share ligandbinding specificity influenza cd hef enzyme although functionally similar influenza virus ab ha whereas cov influenza virus ab na rde activities cov hes functionally similar influenza virus cd hef glycoproteins cov glycoprotein recognizes <NUMBER>oacsa sugar acts rde enzyme saoacetylesterase activity release virions infected host cells example hcovoc<NUMBER> also similar rde <NUMBER> influenza c viruses hef glycoproteins act similarly cov <NUMBER> influenza virus rde na releases virions host cells however merscov similar enzyme thus mercov binding sa receptors mediated energetically reversible interactions lipid rafts increased sa receptors <NUMBER> thus enhancing dipeptidyl peptidase <NUMBER> dpp<NUMBER> carcinoembryonic antigenrelated cell adhesion molecule <NUMBER> ceacam<NUMBER> recognition power viral entry <NUMBER> membraneassociated <NUMBER>kda glucoseregulated protein grp<NUMBER> <NUMBER> merscov glycoprotein hemagglutinate human erythrocytes mediates virus entry human respiratory epithelial cells merscov glycoprotein attachment observed <NUMBER>oacetylated <NUMBER>nglycolyl sas observed α<NUMBER>sa linkage α<NUMBER>sa linkages sabinding sites merscov glycoprotein hcovoc<NUMBER> glycoprotein conserved <NUMBER> although engage α<NUMBER>sas avian host cell surface <NUMBER> merscov recognizes α<NUMBER>sa lesser extent α<NUMBER>sas sulfated slex binding preference thus glycoproteins may independently evolved sa recognition acquisition sabinding ability merscov seems evolutionarily recent event hku<NUMBER> s<NUMBER> hku<NUMBER> s<NUMBER> cannot hemagglutinate human erythrocytes <NUMBER> indicating flexible evolutionary exchange allowing crossspecies transmission towards host cell tropism covs conclusion cov recognition <NUMBER>oacsas infection based conserved sequence engagement sarelated carbohydrate ligands across covs orthomyxoviruses sarscov<NUMBER> needs ace<NUMBER> entry host proteases human ace<NUMBER> help viral entry removement barrier enter human cells unknown receptors human ace<NUMBER> known role sarscov<NUMBER> entry receptor sarscov receptor enzyme ace<NUMBER> reninangiotensin system ras associated cov entry lungs ace<NUMBER> mediates sars<NUMBER> entry host cells via glycoprotein interaction ace<NUMBER> receptor ace<NUMBER> levels plasma membrane correlate virus infectivity ace<NUMBER> expression present tissues lung epithelium highly expressed respiratory epithelial cells type iii lung alveolar epithelial cells <NUMBER> host receptor linked classification covs merscov βcov recognize ace<NUMBER> receptor contrast αcov hcovnl<NUMBER> recognizes ace<NUMBER> receptor ace<NUMBER> membraneanchored carboxypeptidase <NUMBER> amino acid residues captoprilinsensitive contains <NUMBER> amino acid residues signal peptide nterminal region type membraneanchored domain cterminal region extracellular nterminal domain heavy nglycans nterminal sarscovbinding carboxypeptidase site short cterminal cytoplasmic tail ace<NUMBER> gene located chromosome xp<NUMBER> two ace<NUMBER> forms known membranebound form soluble form ace cleaves angiotensin ang substrate ang ii ang ii recognizes ang ii receptor type <NUMBER> at<NUMBER>r contributing systemic local vasoconstriction fibrosis salt retention vascular organs ace<NUMBER> opposite function ace ace<NUMBER> close homolog human ace ace<NUMBER> activity ang ii <NUMBER>fold higher ang ang<NUMBER> ang<NUMBER> recognize g proteincoupled receptor gpcr mas activate vasorelaxation cardioprotection antioxidative action antiinflammation antiang iisignaling therefore ace<NUMBER>ang<NUMBER> ang<NUMBER> axis target candidate cardiovascular diseases ace<NUMBER> shows similar binding structures ncov sarscov three proteins ace ang ii at<NUMBER>r contribute progression lung injury humans ace<NUMBER> removes single amino acid residue ang ii yield vasodilator named ang <NUMBER>ang <NUMBER> ace<NUMBER> cleaves angi ang <NUMBER>–ang <NUMBER> ang ii ang<NUMBER> ang<NUMBER> biggest difference ace<NUMBER> ace ace<NUMBER> noninhibitory property ace inhibitors pulmonary ace<NUMBER> potentially candidate target covinvolved inflammatory pathogenesis ace inhibitors ang iiat<NUMBER> blockers dosed ace<NUMBER> expression increased however currently conclusive evidence inhibitors help sarscov sarscov<NUMBER> entry rather sarscov infection reduces ace<NUMBER> expression therefore sarscov<NUMBER> host tropism related ace<NUMBER> expression ace<NUMBER> levels ang iiang <NUMBER>–<NUMBER> levels regulate pathogenic progression ace<NUMBER> expression upregulated gene polymorphisms ace inhibitors angiotensin ii receptor blockers sartans disintegrin metallopeptidase domain adam family znmetalloproteinases belongs membrane proteins wellknown adam<NUMBER> tnfαconverting enzyme tace called sheddase tnfα adam sheddase family members include adam<NUMBER> adam<NUMBER> adam<NUMBER> adam<NUMBER> mediates ace<NUMBER> shedding sarscov glycoprotein activates cellular tace consequently facilitates virus entry soluble ace<NUMBER> nterminal carboxypeptidase domain form derived original ace<NUMBER> form adam<NUMBER> metalloprotease membrane <NUMBER> adam<NUMBER> indeed enzyme convert membrane type protnfα soluble tnfα functional proinflammatory cytokine therefore adam<NUMBER> inhibition indicates antiinflammatory response adam<NUMBER> inhibitors promising candidates tnfαinduced inflammatory diseases short cterminal domain ace<NUMBER> removed adam<NUMBER> tmprss<NUMBER> however tmprss<NUMBER> cleaves ace<NUMBER> competitively adam<NUMBER> metalloprotease sarss proteinace<NUMBER> binding leads adam<NUMBER>tnfαconverting enzyme tacecleavage ace<NUMBER> facilitating extracellular ace<NUMBER> shedding consequent sarscov entry host cells <NUMBER> tmprss<NUMBER> cleavage allows sarscov entry host cells endocytosis fusion soluble ace<NUMBER> also recognizes virus prevents sarscov<NUMBER> infection sarscov<NUMBER> infection requires membrane ace<NUMBER> tmprss<NUMBER> ace<NUMBER>–b<NUMBER>at<NUMBER> complex binds glycoprotein sarscov<NUMBER> intestinal membrane ace<NUMBER> lung tmprss<NUMBER>shedded ace<NUMBER> act alternative entry sites sarscov<NUMBER> sarscov<NUMBER> infects lungs intestine via tmprss<NUMBER>cleaved ace<NUMBER> tmprss<NUMBER> engaged sarscov<NUMBER> entry ace<NUMBER> downregulation tmprss<NUMBER> inhibition would lead covid<NUMBER> prevention although ace<NUMBER> expressed type type ii lung alveolar epithelial cells sarscov sarscov<NUMBER> target type ii epithelial cells due ace<NUMBER>–tmprss<NUMBER> interaction therefore supplementation ace<NUMBER> soluble ace<NUMBER> ang<NUMBER> ang<NUMBER> way reduce sarscov<NUMBER>related symptoms tmprss<NUMBER>cleaved ace<NUMBER> involved sarscov merscov infections sarscov<NUMBER> uses ace<NUMBER> cell entry tmprss<NUMBER> priming glycoprotein figure <NUMBER> infection h<NUMBER>n<NUMBER> influenza h<NUMBER>n<NUMBER> influenza subtype viruses also mediated tmprss<NUMBER>cleaved ace<NUMBER> implies tmprss<NUMBER> targeted strategic antiviral therapy <NUMBER> transmembrane protease serine <NUMBER> termed tmprss<NUMBER> type ii tm ser protease ttsp also cleaves ace<NUMBER> human tmprss<NUMBER> gene located chromosome <NUMBER> comprises androgen receptor elements ares upstream <NUMBER>′flanking region <NUMBER> tmprss<NUMBER> expression regulated androgendependent manner tmprss<NUMBER> gene encodes <NUMBER> amino acids original form cleaved major membrane form minor soluble form tmprss<NUMBER> activates protease activated receptor <NUMBER> par<NUMBER> activated par<NUMBER> upregulates matrix metalloproteinase<NUMBER> mmp<NUMBER> mmp<NUMBER> tmprss<NUMBER>activated hepatocyte growth factor hgf induces cmet receptor signaling tmprss<NUMBER> activates sarscov merscov sarscov glycoprotein cleaved hostborne tmprss<NUMBER> human airway trypsinlike protease hat tm protease serine <NUMBER> mspl serine protease desc<NUMBER> desc<NUMBER> furin factor xa endosomal cathepsin lb sarscov enter cells upon cleavage protease tmprss<NUMBER> endosomal cathepsin lb <NUMBER> virus protein precursor cleaved host proteases spikes cleaved endosomal cathepsin golgi plasma membrane tmprss<NUMBER> step assembly attachment release serine protease inhibitor camostat effectively blocks lethal sarscov infection mice however serine protease cathepsin inhibitors effective thus tmprss<NUMBER> suggested acting protease sarscov entry host cells cathepsin ciscleavage liberates sarscov glycoprotein fragments extracellular supernatant transcleavage activates sarscov glycoprotein target cells potentiating efficient sarscov glycoproteindriven viral fusion tmprss<NUMBER>activated sarscov facilitates enveloped virus entry cells tmprss<NUMBER> important sarscov entry infection <NUMBER> fact sars merscov infections potentiated tmprss<NUMBER> indicates tmprss<NUMBER> promising target therapeutic agents example several ser protease inhibitors camostat mesylate inhibit tmprss<NUMBER>–ace<NUMBER>involved sarscov<NUMBER> entry camostat serine protease inhibitor reduces influenza virus titers cell culture camostattreated tmprss<NUMBER> inhibition calu<NUMBER> cells greatly reduces sarscov viral titers improves survival rate sarscov infected mice treatment <NUMBER>μm camostat blocks merscov entry african green monkey kidney verotmprss<NUMBER> cells blocks viral rna synthesis calu<NUMBER> cells upon merscov infection aprotinin polypeptide <NUMBER> amino acid residues isolated bovine lungs another serine protease inhibitor nafamostat inhibits merscov entry infection tmprss<NUMBER> inhibition <NUMBER> nafamostat mesylate blocks tmprss<NUMBER>–ace<NUMBER>involved sarscov<NUMBER> envelope–pm fusion prevents sarscov<NUMBER> entry <NUMBER> nafamostat mesylate inhibits viral entry thrombosis covid<NUMBER> patients similarly fdaapproved mucolytic cough suppressant bromhexine hydrochloride bhh inhibits tmprss<NUMBER> ic<NUMBER> <NUMBER> μm hence blocks infection cov influenza virus mprss<NUMBER> host factor plays pivotal role sarscov merscov infections fdaapproved tmprss<NUMBER> inhibitors yet development tmprss<NUMBER> mediates efficient viral entry replication promising target new therapeutics cov infection ser exopeptidase dpp<NUMBER>human cd<NUMBER> pdb <NUMBER>l<NUMBER> type ii tm ectopeptidase functions host cell receptor merscov rbd structure characterized crystallography approaches merscov glycoprotein–dpp<NUMBER> complex dpp<NUMBER> single type ii tm glycoprotein small cytoplasmic tail nterminal region present homodimeric form dpp<NUMBER> cleaves xproline dipeptides nterminal region glycoprotein recognizes sa species dpp<NUMBER> attachment entry receptors respectively merscov s<NUMBER> nterminal domain attaches dpp<NUMBER> host receptor <NUMBER> s<NUMBER> cterminal domain merscov anchors cellular pm enter merscov glycoprotein cleaved sequence s<NUMBER> s<NUMBER> domains <NUMBER> another cleavage site s<NUMBER>′ present s<NUMBER> domain mers cov glycoprotein sialyl receptors expressed camel nasal respiratory epithelial cells human lung alveolar epithelial cells express dpp<NUMBER> binding capacities hindered sa <NUMBER>oacetyl group sa <NUMBER>nglycolyl group <NUMBER> entry host cells needs binding glycoproteins ceacam receptor forming sproteinmediated membrane fusion trimeric glycoprotein bears three s<NUMBER> receptor heads three s<NUMBER> heads virus bind three receptor molecules host cell cholesterol indirectly involved membrane fusion ceacam engagement “lipid raft” microdomains increasing multiple protein interaction receptors triggering membrane fusion <NUMBER> enveloped cov mhv binds ceacams cholesteroldepleted cells bhk cell cultures ntd s<NUMBER> recognizes ceacam<NUMBER> merscov another ceacam<NUMBER> isoform attachment factor virus entry <NUMBER> cov s<NUMBER> ntd similar tertiary structure human galactoserecognizing galectins mhv s<NUMBER> ntd binds murine ceacam<NUMBER>a bcov s<NUMBER> ntd binds sugar <NUMBER> ceacam<NUMBER>a cell adhesion protein cam mrna alternatively spliced cryoem structure mhv complexed ceacam<NUMBER>a elucidated <NUMBER> thus hcovs evolutionarily combined galectin gene hosts s<NUMBER> glycoprotein gene bcov s<NUMBER> protein present without gene recombination contains sugarrecognizing lectin capacity mhv s<NUMBER> protein also evolutionarily acquired murine ceacam<NUMBER>arecognizing activity <NUMBER> therefore covs evolution adapt host receptor interaction infect crossspecies hosts <NUMBER> host side escape lethal pressure cov infections hosts also evolved acquire sabinding proteins siglecs inhibit activate innate immune cells raft nonraft ceacams involved virus–cell membrane fusion event formation ceacamassociated mhv particles ceacaminduced mhv fusion possible gpianchored ceacams binding ceacam proteins however mhv bind gpi tmanchored ceacams addition soluble ceacams also mediate glycoproteindriven fusion <NUMBER> implies membrane anchors intrinsically necessary fact ceacams present different tissuespecific isoforms <NUMBER> nevertheless gpianchored ceacams effective mhv infection tmanchored ceacams soluble ceacam receptors bind viral glycoproteins induce conformational shifts acceptable glycoproteininvolved membrane fusions <NUMBER> example soluble ceacam forms interacts s<NUMBER> fragments <NUMBER> alters s<NUMBER>–s<NUMBER> association stability <NUMBER> s<NUMBER> oxidation confirmation <NUMBER> proteins structurally shifted prior membrane fusion crosslinking viruses cells integral hydrophobic peptides s<NUMBER> chain embedded membranes via membrane hydrophobic cholesterols merscov glycoprotein also recognizes <NUMBER>kda glucose–regulated protein grp<NUMBER> heat shock <NUMBER> kda protein <NUMBER> hspa<NUMBER> known binding immunoglobulin protein bip byun<NUMBER> encoded hspa<NUMBER> gene humans hsp<NUMBER>a erresident unfolded protein response upr protein stressed cell status viral infection increase expression translocation hspa<NUMBER> pm form membrane protein complex grp<NUMBER> modulates merscov entry presence dpp<NUMBER> host cell receptor additionally lineage βcov bat cov hku<NUMBER> bcovhku<NUMBER> also bind grp<NUMBER> <NUMBER> cell surface receptor grp<NUMBER> predicted another covid<NUMBER> receptor glycoprotein binding site <NUMBER> prediction made using combined technology molecular modeling docking structural bioinformatics grp<NUMBER> bip chaperone protein located er lumen <NUMBER> known erbound enzymes include activating transcription factor <NUMBER> atf<NUMBER> inositolrequiring enzyme <NUMBER> ire<NUMBER> protein kinase rna pkrlike er kinase perk <NUMBER> depending threshold unfolded protein accumulation grp<NUMBER> releases ire<NUMBER> atf<NUMBER> perk activated resulting translation inhibition refolding stressoverexpressed grp<NUMBER> avoid er retention translocated membrane grp<NUMBER> translocated cell pm recognize viruses substratebinding domain sbd virus entry cell figure <NUMBER> sequence structural alignments protein–protein docking rbd cov spike protein recognizes grp<NUMBER> sbdβ host cell receptor predicted region iii c<NUMBER>–c<NUMBER> region iv c<NUMBER>–c<NUMBER> glycoprotein grp<NUMBER> highly potential binding sites region iv grp<NUMBER> bindingdriving force nine amino acid residues molecularly targeted designation simulation covid<NUMBER>specific drugs process mechanism underlying cell surface hspa<NUMBER> grp<NUMBER> exposure exploited used pathogen entry pathogenic entry host cells observed multiple infections including pathogenic human viruses human papillomavirus ebola virus zika virus hcovs—as well fungal rhizopus oryzae <NUMBER> therefore natural products inhibit cellsurface hspa<NUMBER> recognition viral glycoprotein among six hcovs αcov hcov<NUMBER>e protein recognizes hapn known cd<NUMBER> membrane alanyl aminopeptidase ec <NUMBER> porcine epidemic diarrhea coronavirus virus pedv binds protein receptor apn human pig neuac species coreceptor apart hapn tgev pedv bind sa species <NUMBER> although sa recognition tgev essential first step entry cycle hcov<NUMBER>e recognizes hapn known cd<NUMBER> entry receptor hapn pdb <NUMBER>fyq cd<NUMBER> ec <NUMBER> zndependent metalloprotease mw <NUMBER> kda <NUMBER> amino acids cd<NUMBER> type ii tm protein short cytoplasmic domain nterminal region long extracellular region ctd ctd pentapeptide sequence specific zinc–mmps apn binding domain located ctd pedv s<NUMBER> amino acid <NUMBER>–<NUMBER> residues sabinding domain found nterminal region pedv s<NUMBER> amino acid <NUMBER>–<NUMBER> residues <NUMBER> cd<NUMBER> also receptor hcov<NUMBER>e human cytomegalovirus porcine cov tgev feline infectious peritonitis virus fipv feline enteric virus fecv canineinfectious covs <NUMBER> homodimeric cd<NUMBER> digests luminal peptides hapnencoding anpep gene dominant component proximal tubular epithelial cells small intestinal cells macrophages granulocytes synaptic membranes gene defective leukemia lymphoma transformed <NUMBER> porcine human apn exhibit <NUMBER> protein identity fipv fecv group hcov<NUMBER>e tgev thus porcine apn also attachment site pig tgev additional second receptor hcov<NUMBER>e first binds cd<NUMBER> consequently clusters cd<NUMBER> caveolaeassociated lipid rafts <NUMBER> glycan interaction hcovnl<NUMBER> mhv utilize heparan sulfate proteoglycans hspgs attachment enhancers <NUMBER> viruses recognize hspgs attachment molecules spike proteindeficient virions protein recognizes hspg proteins generally bind viral cellular receptor however protein also acts receptor early step hcovnl<NUMBER> infection membrane protein hcovnl<NUMBER> recognizes attachment site hspgs hcovnl<NUMBER> protein binds hspg initial attachment virus host cells thereafter proteins cooperate virus entrance host cells <NUMBER> hspgs glycosaminoglycan gagcarrying proteins frequently used secondary receptor viral entry hspgs composed covalentbonded hs chains gag form hs gag linkage structure tetrasaccharide exhibits gluaβ<NUMBER>glcnacα<NUMBER>galβ<NUMBER>galβ<NUMBER>xylβoserine glycosyltransferases involved hs gag synthesis include glcatii glucuronosyltransferase glcnactii nacetylglucosaminyltransferase ii heparan sulfate synthesis figure <NUMBER> gag used docking sites virus interaction host cell surface gags contain negatively charged n osulfated sugars <NUMBER> biosynthetic pathway biologic roles early embryogenic morphogenesis vulval morphogenesis hs chondroitin sulfate gag elucidated caenorhabditis elegans <NUMBER> negative charges mediate interaction gags ligands electrostatic forces interaction hspg ligands potentiates many virus infectious cycles examples adenoassociated virus human cell lymphotropic virus type <NUMBER> human papilloma virus <NUMBER> herpes viruses hepatitis b c viruses kaposi’s sarcomaassociated herpesvirus human papilloma viruses merkel cell polyoma virus recognize hspgs <NUMBER> hspgs increase virulence upon interaction viral factors required viral attachment replication although hcovhku<NUMBER> utilizes oacetylsas attachment sites hcovhku<NUMBER> protein also interacts mhci c hlac additional attachment molecule <NUMBER> sarscov uses ctype lectins dcsign dclsign additional secondary receptors glycans glycoprotein recognized dclsign virus attachment entry seven glycosylation sites glycoprotein found essential dclsigndriven virus entry <NUMBER> tetraspanin cd<NUMBER> tetraspanin cd<NUMBER> associates dpp<NUMBER> type ii tm serine protease ttsp member tmprss<NUMBER> covactivating protease form cell surface complex <NUMBER> cd<NUMBER>–dpp<NUMBER>–tmprss<NUMBER> complex permits merscov pseudovirus entrance host cells tetraspanins four tm spanning regions linked one large one small loop extracellular region tetraspanins form virus entry baselines open cov entry routes help viral entry host cells merscov interacts dpp<NUMBER> receptors via rbd receptor involvement causes cleavage using proteases previously described tmprss<NUMBER> association tetraspanin cd<NUMBER> dpp<NUMBER>–tmprss<NUMBER> complex triggers glycoprotein merscovs enter cells via endocytosis cathepsins cleave proteins <NUMBER> sas predominant surface determinants pathogen attachment adherence entry host cells eleven representative vertebrate virus families utilize sas initial entry receptors attachment factors interaction virus sacontaining glycans complex virus sabinding lectins inherently low affinity viruses acquire enzymes catalyze virion elution regional depletion binding receptors <NUMBER> tm glycoprotein recognizes oligosaccharide receptors using cryoem technology observed structures glycoprotein trimers cov oc<NUMBER> complexed <NUMBER>oacetylated sa glycoprotein demonstrated mediate virus adhesion entry host cells cov proteins show conservation binding <NUMBER>oacetylsas merscov also recognizes <NUMBER>carbon sugar sa species merscov s<NUMBER>a binds sa species example saα<NUMBER> saα<NUMBER>linkages expressed human erythrocytes mucins preferentially targeted merscov s<NUMBER>a binding hence blocked sa modification <NUMBER>nneugc <NUMBER> <NUMBER>oneuac species <NUMBER> example impairment ace<NUMBER> receptor glycosylation influence sglycoproteinace<NUMBER> interaction however sarscov<NUMBER> virus entry respiratory epithelial host cells downregulated <NUMBER> changes ace<NUMBER> nglycans apparently influence interaction sarscov glycoprotein instead impair viral glycoproteinmediated membrane fusion receptor glycan structures decide entry human viruses changes ace<NUMBER> receptor sialylation influences interaction affinity virus ligands host receptor interspecies individual genetic variations drift mutation may occur sarscovs explains currently emerging differences cov responses within population humans hand aspect virus ligand glycoprotein decorates viral surfaces therefore target vaccination design virus internalization requires potential glycosylation viral glycoproteins among three viral envelope components major glycoproteins e nascent glycosylated glycoprotein consists short glycosylated ectodomain nterminal region glycoprotein expressed hemagglutinating encephalomyelitis virus ha recognizes nacetyl<NUMBER>oneuac binding receptor expressed erythrocyte surfaces <NUMBER> example bcovs attach surface receptor nacetyl<NUMBER>oneuac <NUMBER>oacetylated sas host cells tgev pedv currently known similar class covs pedv infects multiple hosts including bat pig human monkey bats considered evolutionary origin pedv glycoprotein sarscov<NUMBER> utilizes different glycosylation patterns recognize receptors glycosylation sites minimal rbd exhibits similar sites covs trimeric sarscov<NUMBER> glycoprotein also highly glycosylated <NUMBER> nglycans oglycans <NUMBER> glycosylation glycoproteins leads immune evasion merscov batspecific covhku<NUMBER> glycosylation linked zoonotic infection fusionbased entry <NUMBER> clq clqoh investigation worldwide treat covid<NUMBER> figure <NUMBER> clq derivative clqoh block cov replication amplification spread vitro culture via inhibition ace<NUMBER> receptor glycosylation hcovs interaction glycoprotein gangliosides initially occur first entry step replication cycle virus clq clqoh alternative drugs ra several autoimmune diseases <NUMBER> years although antimalaria prophylaxis drugs clqoh aminoquinoline less toxicity clq clqoh bears nhydroxyethyl side chain increases solubility compared clq <NUMBER> clqoh modulates activated immune cells via downregulation tlr signaling il<NUMBER> production <NUMBER> clinical trials also consideration efficacy safety drugs regarding action mechanisms clq clqohmediated inhibition ace<NUMBER> terminal glycosylation considered vitro vero e<NUMBER> cells clq significantly inhibits sarscov spread interfering ace<NUMBER> function acting entry postentry steps sarscov<NUMBER> replication infection binding affinity ace<NUMBER> glycoprotein simulated lowered treatment clqoh clq clq may modify binding affinity ace<NUMBER> glycoprotein alterations ace<NUMBER> glycosylation modification clqoh ec<NUMBER> <NUMBER> μm clq ec<NUMBER> <NUMBER> μm inhibit sarscov<NUMBER> <NUMBER> using computer simulation techniques clq clqoh suggested recognize enzymatic active site udpglcnac <NUMBER>epimerase known essential enzyme sa biosynthesis <NUMBER> blocking sialylation host cells mechanism underlying glycosylation inhibition may support antiviral properties clq clqoh interactions clq clqoh ndpsaccharide mutases glycosyltransferases <NUMBER> clq reported inhibit quinone reductase <NUMBER> <NUMBER> known catalytic mimetic structural neighbor udpglcnac <NUMBER>epimerases <NUMBER> clq clqoh inhibits sa synthesis inhibitory properties may support antiviral activity clq clqoh sarscovs sarscov receptor ace<NUMBER> contains sa species fact clq exhibits vitro antisarscov<NUMBER> activity via defective glycosylation viral ace<NUMBER> vero cells <NUMBER> addition interference clq clqoh sa synthesis may broadly applicable antiviral hcovs orthomyxoviruses also utilize sas entry molecules <NUMBER> however detailed mechanisms elucidated clq treatment efficacy covid<NUMBER> patients however conclusively determined lipid rafts also viral attachment sites viruses ibv dengue virus ebola virus hepatitis c virus hiv human herpes virus <NUMBER> measles virus newcastle disease virus poliovirus west nile virus footandmouth disease virus simian virus <NUMBER> rotavirus influenza virus marburg virus also use lipid rafts virus entry <NUMBER> avian cov ibv structural proteins ibv virus colocalized pm lipid rafts embedded ganglioside gm<NUMBER> hcov<NUMBER>e entry prevented cholesterol depleted conditions hcov<NUMBER>e clusters caveolaeassociated lipid rafts <NUMBER> caveolae caveolin<NUMBER> <NUMBER> <NUMBER> crosslinked <NUMBER> control molecular distribution rafts caveolae regulatory mechanism proteincd<NUMBER> crosslinking occurs via cd<NUMBER>caveolin<NUMBER> sequestering hcov<NUMBER>e particles similarly exhibit longitudinal distribution property hcov<NUMBER>ecolocalized caveolin<NUMBER> undergoes next step virus infection caveolin<NUMBER> knockdown inhibited hcov<NUMBER>e endocytosis entry thus caveolin<NUMBER> essential hcov<NUMBER>e infection tgev also endocytoses clathrinmediated mechanism mdck cells <NUMBER> viruses including hcovoc<NUMBER> also use entry receptor sequestered crosslinked caveolae <NUMBER> sarscov first entry step host cells needs ace<NUMBER> intact lipid rafts glycoprotein <NUMBER> ace<NUMBER> associated caveolin<NUMBER> gm<NUMBER> membrane rafts depending celltype specific localization <NUMBER> raft integrity cholesterol ace<NUMBER> necessary sarscov pseudovirus entry vero e<NUMBER> cells sarscovmicrodomainbased entry ctype lectin cd<NUMBER> l lsign also form lipid rafts acts sarscov receptor <NUMBER> information cov entry pathways important therapeutic designation sarscovtargeting drugs example agents disrupt lipidraft localization ace<NUMBER> receptor clq binds sas gangliosides lipid rafts high affinity therefore clq clqoh prevents glycoprotein–ganglioside binding clq clqoh binding sa consequently prevents glycoprotein binding host receptors nterminal region sarscov<NUMBER> glycoprotein interacts gangliosides gangliosidebinding site gbs gangliosidebinding domain gbd present ntd glycoprotein sarscov<NUMBER> using molecular modeling simulation technology clq suggested recognize sas gangliosides human type neu<NUMBER>ac binds clq clqoh thus sas binding targets clq clqoh clq clqoh two specific recognition sites polar sugar residues ganglioside gm<NUMBER> first site found tip sugar residues gm<NUMBER> interaction energy −<NUMBER> kjmol clq rings face galnac residue gm<NUMBER> second site large region sugarceramide junction sugar residues several amino acid residues protein ntd phe<NUMBER> asn<NUMBER> arg<NUMBER> recognize ganglioside gm<NUMBER> glycoprotein ntdgm<NUMBER> complex suggested form trimolecular complex two molecules ganglioside gm<NUMBER> anchored ntd protein <NUMBER> ace<NUMBER>binding rbd suggested potential gbs located differential site glycoprotein ntd protein sequence interfacing surface ntd consensus gbds <NUMBER> amino acids gly pro andor ser residues found gbd motifs <NUMBER>–<NUMBER> amino acids ntd gangliosideattachment interface gbd conserved throughout viral isolates worldwide covid<NUMBER> patients gbd potentially increases viral attachment ability pm lipid rafts contact host ace<NUMBER> protein <NUMBER> interaction clqoh <NUMBER>oacetylneuac also similar <NUMBER>oacetylneuacclq interaction clqoh oh group enhances interaction clq sa via hydrogen bond <NUMBER> conditions clq clqoh derivative treatment glycoprotein cannot bind gangliosides silico studies used uncover action mechanism clq clqoh prevent binding glycoprotein gangliosides clqsa complex formed mixed surface balls positioning negative charged cooh group neu<NUMBER>ac one two cationic charges clq <NUMBER> covs preferentially bind <NUMBER>oacetylneuac <NUMBER> differentiating viral properties clq interacts gm<NUMBER> sugar part nterminal domain protein loses viral attachment capacity cell receptors <NUMBER> protein ntd clqclqoh maintain position gm<NUMBER> binding consequently preventing gm<NUMBER> binding protein drug time ntd clqclqoh simultaneously recognize gm<NUMBER> asn<NUMBER> forms hydrogen bond galnac residue whereas aromatic phe<NUMBER> stacks glc residue gm<NUMBER> therefore antiviral activities clq clqoh block interaction sarscov<NUMBER> glycoprotein gangliosides host cell surfaces lipid composition host cell pm also potential target preventive therapeutic drugs viruses sarscov<NUMBER>caused covid<NUMBER> pandemic global public health issue <NUMBER>st century order coordinate efforts mitigate public health consequences spreading outbreak disease international community exchanging independent information knowledge scientists epidemiologists exchange covid<NUMBER> information highlight interdisciplinary approaches pandemic outbreak issue raised interest pathology epidemiology disease current covid<NUMBER> pandemic resulted establishment covid action platform world economic forum wef perform evidencebased cuttingedge research analyze fastevolving pandemic virus outbreak data network vodan gofair data alliance also pursues apply best remedy pandemic infection aspect basic biology βcovs recognize <NUMBER>oacetyl sas certain viruses switched binding <NUMBER>oacetyl sa originally found viruses toroviruses orthomyxoviruses influenza cd isavirus exceptional βcov lineage one bear among covs virus entry replication inhibitors need urgently developed computationfused artificial intelligence accelerates therapeutic agent development sarscov<NUMBER> genome shows <NUMBER> similarity previous sarscov sarstargeting agents commonly treated related sarscov<NUMBER> patients better understanding entry pathway sarscov<NUMBER> importance carbohydrates including sas cell virus surfaces emphasized coronavirus sarscov<NUMBER> responsible pandemic started wuhan china latter part <NUMBER> spread <NUMBER> countries areas territories according <NUMBER> <NUMBER> april <NUMBER>th <NUMBER> continues spread infecting approximately <NUMBER> causing death approximately <NUMBER> people daily although young people usually develop mild symptoms cause severe lower respiratory disease affecting mostly elderly individuals comorbidities cardiovascular problems preexisting respiratory disease diabetes hypertension cancer <NUMBER> sarscov<NUMBER> belongs βcov genera coronavirinae subfamily order nidovirals <NUMBER> compared sars merscoronavirus strains caused two recent epidemics <NUMBER> <NUMBER> respectivelyit mostly resembles sarscov<NUMBER> <NUMBER> <NUMBER> sequence identity mechanism host cell entrance via angiotensinconverting enzyme<NUMBER> ace<NUMBER> surface protein cell <NUMBER> far cleavage recognition motifs concerned sarscov<NUMBER> main protease cleaves viral polyprotein less <NUMBER> sites recognizing sequence leugln ↓ seralagly <NUMBER> hiv<NUMBER> protease recognizes nine cleavage sites polyprotein substrate sequence differences keep feature cleavage commonly phe pro alternatively cleaves amino acids hydrophobic aromatic side chains tyrmetleuphe ↓ prophetyralaleumet <NUMBER> hcv protease cleaves polyprotein substrate four sites recognizing gluaspgluaspxxxcys ↓ ser general motif <NUMBER> human organism protease dpp<NUMBER> preferentially cleaves x ↓ pro x ↓ ala sites <NUMBER> whereas thrombin preferentially cleaves glyalavalileproarg ↓ seralaglythrnotedxnotedargnote motif <NUMBER> coagulation factor xa cleaves arg recognizing motif valproileglnaspglupheglyarg ↓ serleu <NUMBER> renin recognizes sequence ilehisprophehisleu↓ <NUMBER> angiotensinconverting enzyme ace recognizes angiotensin sequence aspargvaltyrilehisprophe ↓ hisleu <NUMBER> similarities proteases catalytic amino acids active site nature amino acids substrate may indication efficient inhibition proteases inhibitors however nature surrounding amino acids active site <NUMBER>d structure active center also great importance present study <NUMBER>d structure sarscov<NUMBER> main protease compared <NUMBER>d structures proteases drug targets approved inhibitors addition number approved inhibitors proteases evaluated docking analysis ability inhibit sarscov<NUMBER> main protease interacting active site enzyme since <NUMBER>d structure active site enzyme crucial catalytic activity proceeded comparison sarscov<NUMBER> main protease mpro hiv<NUMBER> protease hcv protease ns<NUMBER> protein human proteases dpp<NUMBER> thrombin factor xa renin ace constitute known drug targets approved inhibitors significant <NUMBER>d similarity found sarscov<NUMBER> hcv protease p <NUMBER> × <NUMBER> −<NUMBER> well sarscov<NUMBER> protease αthrombin p <NUMBER> × <NUMBER> −<NUMBER> interestingly protein parts increased structural alignment included catalytic area enzyme lowest similarity observed case angiotensinconverting enzyme coagulation factor xa figures <NUMBER> <NUMBER> structural similarity sarscov<NUMBER> protease selected proteases combination existence amino acids certain positions substrate cleavage site ser p<NUMBER> position recognition sequence hcv protease thrombin promising features effort identify effective sarscov<NUMBER> protease inhibitors among approved drugs selected proteases investigate possibility proceeded docking analysis randomly selected approved ontrial inhibitors selected proteases table <NUMBER> exception random selection made hiv<NUMBER> inhibitors lopinavir ritonavir selected already proposed treatment sarscov<NUMBER> rest drugs selected antihcv drugs telaprevir boceprevir dpp<NUMBER> inhibitor sitagliptin renin inhibitor alisliren ace inhibitor captopril thrombin direct inhibitors argatroban dabigatran coagulation factor xa inhibitor rivaroxaban docking analysis performed using sarscov<NUMBER> structure <NUMBER>lu<NUMBER> results promising compounds exception ace renin inhibitors captopril aliskiren calculated free binding energy −<NUMBER> −<NUMBER> kcal mol −<NUMBER> respectively table <NUMBER> according previous experience literature free binding energy higher −<NUMBER> kcal mol −<NUMBER> indication compound inactive <NUMBER> <NUMBER> best results obtained hcv protease inhibitors telaprevir boceprevir free binding energies −<NUMBER> −<NUMBER> kcal mol −<NUMBER> respectively followed thrombin inhibitor argatropan dpp<NUMBER> inhibitor sitagliptin free binding energies −<NUMBER> −<NUMBER> kcal mol −<NUMBER> respectively hiv<NUMBER> protease inhibitors ritonavir lopinavir showed little lower predicted activity free binding energies −<NUMBER> −<NUMBER> kcal mol −<NUMBER> respectively docking analysis whole enzyme indicated enzyme active site second preferred binding site lopinavir ritonavir boceprevir according observation expected inhibitory action compounds lower predicted based binding energy active site <NUMBER> rivaroxamban dabigatran also expected active calculated free binding energies −<NUMBER> −<NUMBER> kcal mol −<NUMBER> respectively since evaluation randomly selected hcv protease dpp<NUMBER> αthrombin coagulation factor xa inhibitors showed promising results proceeded evaluation extended sample approved drugs categories including number drugs currently phase iii clinical trial table <NUMBER> table <NUMBER> better estimation probable inhibitory effect selected compounds second protein structure sarscov<NUMBER> protease also used pdb id <NUMBER>m<NUMBER>n whole enzyme including protease subunits selected process comparison reasons estimated binding energy compounds initial targets also calculated reasons promising sarscov<NUMBER> candidate inhibitors estimated binding energy hiv<NUMBER> <NUMBER>rvj protease structure calculated docking analysis sarscov<NUMBER> protease structures gave similar results interestingly <NUMBER> <NUMBER> compounds selected evaluation exhibited lower estimated binding energy initial inhibitor <NUMBER>m<NUMBER>n structure −<NUMBER> kcal mol −<NUMBER> <NUMBER> n<NUMBER> inhibitor −<NUMBER> kcal mol −<NUMBER> <NUMBER> docking compounds target proteases designed showed generally higher binding probability lower estimated binding energy initial targets compared sarscov<NUMBER> protease active compounds showed comparable results two targets example faldaprevir exhibited estimated binding energy −<NUMBER> kcal mol −<NUMBER> sarscov<NUMBER> protease −<NUMBER> kcal mol −<NUMBER> hcv protease teneligliptin showed −<NUMBER> kcal mol −<NUMBER> new protease −<NUMBER> kcal mol −<NUMBER> initial target table <NUMBER> estimated binding energies approved undertrial iii protease inhibitors structure sarscov<NUMBER> main protease structures pdb code <NUMBER>lu<NUMBER> pdb code <NUMBER>m<NUMBER>n initial protease target hcv protease structure <NUMBER>wf<NUMBER> dpp<NUMBER> structure <NUMBER>ffw athrombin structure <NUMBER>dwe factor xa structure <NUMBER>bti hiv<NUMBER> protease structure <NUMBER>rvj according estimated free binding energies evaluated drugs could act sarscov<NUMBER> protease inhibitors among hcv protease inhibitors faldaprevir exhibited lowest free binding energy teneligliptin gemigliptin promising drugs among dpp<NUMBER> inhibitors group anticoagulants inogartan argatroban first randomly selected compounds promising among athrombin inhibitors edoxaban among factor xa inhibitors docking analysis whole enzyme indicated enzyme active site first preferred binding site hcv protease dpp<NUMBER> inhibitors presented table <NUMBER> third preferred site inogatran second edoxaban consequently expected inhibitory action inogatran edoxaban lower predicted based relative binding energy active site conclusion faldaprevir teneligliptin gemigliptin compounds expected exhibit highest activity sarscov<NUMBER> main protease sarscov<NUMBER> protease preferentially cleaves substrate gln follows leu ser ala gly amino acid leugln ↓ seralagly gln amino acid p<NUMBER> position substrate amino acid relatively long side chain leading polar amide group hydrogen donoracceptor possibility shown studies complexes mpro enzyme substrate analogues <NUMBER> gln placed vicinity cys<NUMBER> subsite s<NUMBER> active center surrounded side chains amino acids asn<NUMBER> glu<NUMBER> his<NUMBER> his<NUMBER> main chains phe<NUMBER> leu<NUMBER> p<NUMBER> amino acid leu relatively long hydrophobic bulky aromatic side chain side chain leu inserted s<NUMBER> subsite consists side chains amino acids his<NUMBER> met<NUMBER> tyr<NUMBER> met<NUMBER> placed vicinity asp<NUMBER> p<NUMBER> amino acid peptide interacts amino acids met<NUMBER> leu<NUMBER> phe<NUMBER> gln<NUMBER> main chain gln<NUMBER> case substrate analogue n<NUMBER> addition polar hydrophobic interactions hydrogen bond hb formed his<NUMBER> side chain lactam ring serves mimetic gln amino acid natural substrate <NUMBER> second hb formed h closest lactam ring nh group backbone ligand co main chain his<NUMBER> enzyme nh group backbone leu amino acid ligand interacts co backbone gln<NUMBER> enzyme lactam ring mimetic gln amino acid substrate also present structure aketomide inhibitors designed zang et al <NUMBER> case h nh group lactam ring forms two hydrogen bonds co main chain phe<NUMBER> carboxylate glu<NUMBER> co oxygen lactam moiety forms hydrogen bond imidazole his<NUMBER> active compound series p<NUMBER> leu natural substrate replaced cyclopropane pyridon ring p<NUMBER> position participates complex stabilization hydrogen bonds side chain gln<NUMBER> nh main chain glu<NUMBER> two substrates constitute peptidomimetics peptide bonds amino acid mimetic moieties cases catalytic amino acid cys<NUMBER> forms covalent bond ligand approved drugs proposed sarscov<NUMBER> protease inhibitors according silico studies peptidomimetics according docking analysis various groups may placed s<NUMBER> subsite <NUMBER>methoxy<NUMBER>methylquinoline moiety simeprevir <NUMBER> oxadiazole group raltegravir adopts curved form within binding pocket <NUMBER> interaction thr<NUMBER> thr<NUMBER> ser<NUMBER> also seems play important role complex stabilization many compounds including raltegravir ribavirin <NUMBER> inhibitors used study contain classic peptide bonds share peptide substrates characteristic many polar hda groups gemigliptin tetrahydropyridine ring <NUMBER>amino<NUMBER>oxobutyl bridge placed s<NUMBER> subsite glu<NUMBER> cys<NUMBER> hydrogen bond co group backbone glu<NUMBER> nh <NUMBER> group <NUMBER>amino<NUMBER>oxobutyl bridge contributes complex stabilization cys<NUMBER> participates hydrophobic interactions carbons bicyclic moiety figure <NUMBER> trifluoromethyl pyrimidine moiety interacts his<NUMBER> s<NUMBER> subsite stabilizes complex halogen bond formation f atoms pi interactions pyrimidine ring halogen bonds also formed f atoms fluoropiperidinone ring amino acids val<NUMBER> arg<NUMBER> thr<NUMBER> linagliptin n piperidine ring participates hydrogen bond interactions co group main chain glu<NUMBER> s<NUMBER> subsite nh <NUMBER> substituent ring forms hb pro<NUMBER> his<NUMBER> s<NUMBER> subsite participates complex stabilization polar interaction n atom methylquinazoline hydrophobic pi interactions carbons moiety met<NUMBER> also forms hydrophobic interactions additional stabilization achieved interaction met<NUMBER> dihydropurine moiety figure <NUMBER> faldaprevir cyclopentyl carbamate moiety participates hydrogen bond formation asn<NUMBER> s<NUMBER> subsite hydrogen bonds also formed <NUMBER>ethenylcyclopropane<NUMBER>carboxylic acid group amino acids thr<NUMBER> ser<NUMBER> figure <NUMBER> case melagatran curved conformation adopted catalytic amino acid cys<NUMBER> forms hydrophobic interactions cyclohexan asn<NUMBER> s<NUMBER> subsite strongly contributes complex stabilization via polar interaction n atom aminoacetyl acid group s<NUMBER> subsite nh group side chain his<NUMBER> participates hydrogen interaction methyl carbamoyl bridge met<NUMBER> involved hydrophobic interactions phenyl ring molecule addition oh group nearby ser<NUMBER> participates hydrogen bond formation nh <NUMBER> benzimidamide group figure <NUMBER> betrixaban chloropyridin moiety placed s<NUMBER> subsite interacting via halogen bonds amino acids glu<NUMBER> phe<NUMBER> leu<NUMBER> via hydrophobic interactions cys<NUMBER> addition hydrogen bond formed cys<NUMBER> n amide bridge connecting chloropyridin<NUMBER>yl methoxybenzyl rings molecule his<NUMBER> s<NUMBER> subsite forms pi interactions carbons methoxyphenyl ring nndimethylbenzimidamide moiety placed area s<NUMBER> subsite strongly contributes complex stabilization via hydrophobic interaction met<NUMBER> phenyl ring well hydrogen bond formation amino acids arg<NUMBER> thr<NUMBER> gln<NUMBER> n nndimethylbenzimidamide moiety figure <NUMBER> general great variety groups placed s<NUMBER> s<NUMBER> subsites enzyme concluded results literature <NUMBER> <NUMBER> <NUMBER> amino acids involved complex stabilization natural substrate peptide analogues <NUMBER> <NUMBER> participate interactions studied compounds well however substantial interaction his<NUMBER> peptidomimetic complexes observed interaction pattern potent compounds different structures may offer possibility interaction crucial amino acids sarscov<NUMBER> active site contributing complex stability however right distances polar hda hydrophobicaromatic moieties constitute important features structure according docking analysis active molecules long enough interact simultaneously amino acids surrounding glu<NUMBER> cys<NUMBER> amino acids vicinity thr<NUMBER> his<NUMBER> contain several hydrophobic aromatic moieties well hydrogen bond donoracceptor groups capable hydrogen bond formation polar interactions enzyme amino acids involved hydrogen bond formation glu<NUMBER> pro<NUMBER> gln<NUMBER> arg<NUMBER> thr<NUMBER> thr<NUMBER> thr<NUMBER> his<NUMBER> cys<NUMBER> ser<NUMBER> asn<NUMBER> gly<NUMBER> cys<NUMBER> his<NUMBER> thr<NUMBER> glu<NUMBER> figures <NUMBER> apart polar hydrophobic interactions least two hydrogen bonds formed case active compounds interactions phe<NUMBER> also involved complex stabilization argatroban promising compounds categories contain multiple hydrophobic moieties well polarhydrogen donoracceptor moieties active molecules categories gliptines previrs relatively long molecules adopt linear conformations hydrophobic moieties distances approximately <NUMBER> å <NUMBER> å <NUMBER> å <NUMBER> å present potent compounds met<NUMBER> his<NUMBER> cys<NUMBER> cys<NUMBER> leu<NUMBER> mpro active site mainly involved hydrophobic pi interactions maximum distance approximately <NUMBER> å figures <NUMBER> polar hydrogen donoracceptor moieties present multiple distances distance <NUMBER> å common active compounds glu<NUMBER> <NUMBER> distance approximately <NUMBER> å participate hydrogen bond polar interactions potent gliptins figures <NUMBER> <NUMBER> ser<NUMBER> thr<NUMBER> asn<NUMBER> distance approximately <NUMBER> å participate hydrogen bond formation faldaprevir sarscov<NUMBER> protease amino acids involved hydrophobic polar interactions distributed active sites although pi interactions mostly observed region his<NUMBER> distances approximately <NUMBER> å <NUMBER> å <NUMBER> å <NUMBER> å observed amino acids participating polar hydrophobic interactions amino acids hydrophobic polarhydrogen donor acceptor properties exist similar distances active sites initial target compounds dpp<NUMBER> hcv protease respectively example case gliptins initial target dpp<NUMBER> great number tyrosine amino acids present active site shown case teneligliptin figure <NUMBER> amino acids tyr<NUMBER> phe<NUMBER> tyr<NUMBER> tyr<NUMBER> ty<NUMBER> tyr<NUMBER> involved hydrophobic pi interactions distances among varying <NUMBER> å <NUMBER> å amino acids arg<NUMBER> glu<NUMBER> glu<NUMBER> ser<NUMBER> tyr<NUMBER> asn<NUMBER> involved polar interactions hydrogen bond formation hydrophobic interactions originate amino acids oriented moiety active site amino acids participating polar interaction placed moiety distances <NUMBER> <NUMBER> å observed amino acids active site participating polar hydrophobic interactions length molecules great number polar hydrophobic groups flexibility molecules appropriate distances characteristic groups seem favor binding gliptins mpro active site higher binding energy estimated smaller molecule alogliptin figure <NUMBER> case thrombin inhibitors number hydrogen bonds hydrophobic interactions mainly stabilize complex his<NUMBER> ser<NUMBER> met<NUMBER> participate hydrogen bond formation melagatran mpro enzyme leu<NUMBER> his<NUMBER> met<NUMBER> cys<NUMBER> involved hydrophobic interactions although interactions lead substantially low estimated binding energy compound significantly higher hydrogen bonds pi bonds polar hydrophobic interactions may responsible much better prediction results binding initial protease target ala<NUMBER> ala<NUMBER> gly<NUMBER> cys<NUMBER> cys<NUMBER> trp<NUMBER> <NUMBER> leu<NUMBER> seem involved binding thrombin evaluated compounds approved drugs currently market exception four compounds phase iii trial table <NUMBER> several compounds among promising ones characterized welltolerated side effects danoprevir sovaprevir hcv protease inhibitors teneligliptin gemigliptin also trelagliptin evogliptin gosogliptin among dpp<NUMBER> inhibitors inogatran melagatran αthrombin inhibitors dpp<NUMBER> inhibitors developed treatment diabetes type ii well αthrombin factor xa inhibitors used anticoagulants may appropriate patients suffer problems however may worth consideration patients already treated type ii diabetes anticoagulants moreover higher platelet count increased coagulation features observed covid<NUMBER> patients severe pneumonia compared patients non sarscov<NUMBER>induced pneumonia furthermore according recent results anticoagulant treatment heparin administration reduced mortality covid<NUMBER> patients severe pneumonia markedly elevated ddimers <NUMBER> general results considered promising evaluated drugs could useful scientists working field vitro evaluation also within future targets recombinant sarscov<NUMBER> protease becomes available market <NUMBER>d alignment performed <NUMBER>d structure sarscov docking analysis carried molecular docking server using autodock <NUMBER> <NUMBER> previously described <NUMBER> lamarckian genetic algorithm lga solis wets local search method <NUMBER> used docking simulation docking rotatable torsions released autodock parameter setand distancedependent dielectric functions used calculation van der waals electrostatic terms respectively<NUMBER> different runs set terminate maximum <NUMBER> energy evaluations performed docking experiment population size set <NUMBER> translational step <NUMBER> å quaternion torsion steps <NUMBER> applied search docking analysis hcv protease hiv<NUMBER> protease presented table <NUMBER> performed using autodock<NUMBER> via ligandscout among values calculated program estimated free binding energy indicator probability compounds form stable complex selected enzyme target consequently probability effective enzyme inhibitors protein structures chosen protein data bank docking center docking box chosen docking analysis follows docking analysis sarscov<NUMBER> main protease enzyme structure <NUMBER>lu<NUMBER> enzyme complex competitive inhibitor n<NUMBER> active compounds docking repeated extending docking box cover whole enzyme ensure compound preferentially bind sites enzyme instead active site <NUMBER> better estimation probable inhibitory effect selected compounds second protein structure sarscov<NUMBER> protease complexed inhibitor <NUMBER>trihydroxy<NUMBER>phenyl<NUMBER>hchromen<NUMBER>one also used pdb id <NUMBER>m<NUMBER>n structure subunits included pdb file whole enzyme constructed two identical subunits used use two subunit form preferred could enable evaluation probable interference second subunit binding inhibitors since glu<NUMBER> commonly participates complex stabilization interacts ser<NUMBER> protein chain docking center set x −<NUMBER> −<NUMBER> z <NUMBER> docking box set x <NUMBER> <NUMBER> z <NUMBER> comparison reasons estimated binding energy compounds initial targets also calculated structures chosen hcv structure <NUMBER>wf<NUMBER> complex asunaprevir center promising sarscov<NUMBER> candidate inhibitors estimated binding energy hiv<NUMBER> protease <NUMBER>rvj structure crystallized complex amprenavir evaluated center x −<NUMBER> <NUMBER> z <NUMBER> box x <NUMBER> <NUMBER> z <NUMBER> cases enzyme preparation inhibitor initial enzyme complex abstracted ph set <NUMBER> ligand preparation evaluation docking method initial ligand docked enzyme position compared initial position complex examples similarity two positions shown figure <NUMBER> stomach ache abnormal results blood tests measure liver function anemia <NUMBER> otamixaban ended phase iii sanofi figure <NUMBER> docking initial ligand <NUMBER>trihydroxy<NUMBER>phenyl<NUMBER>hchromen<NUMBER>one <NUMBER>m<NUMBER>n complex sarscov<NUMBER> protease structure <NUMBER>m<NUMBER>n initial ligand sitagliptin <NUMBER>ffw structure dpp<NUMBER> position docked ligand green close initial ligand magenta <NUMBER>d structure alignment sarscov<NUMBER> main protease hiv<NUMBER> hcv viral proteases well human proteases dpp<NUMBER> thrombin coagulation factor xa renin ace showed greater similarity hcv protease thrombin finding combination fact two proteases preferentially cleave ser like sarscov<NUMBER> protease enhances possibility finding effective sarscov<NUMBER> inhibitors among approved antihcv protease antithrombin inhibitors docking analysis <NUMBER> approved phase iii trial protease inhibitors sarscov<NUMBER> protease revealed several drugs may act sarscov<NUMBER> protease inhibitors within classes hcv protease dpp<NUMBER> αthrombin coagulation factor xa inhibitors twenty five exhibited estimated binding energy lower reference inhibitor n<NUMBER> twenty one lower −<NUMBER> kcal mol −<NUMBER> several promising compounds approved drugs characterized well tolerated subjects compared lopinavir ritonavir evaluated compounds showed better results characterized lower predicted free binding energy high preference binding active site compared sites enzyme promising silico results encourage evaluation vitro vivo antiviral activity dpp<NUMBER> inhibitors developed treatment type ii diabetes well αthrombin factor xa inhibitors used anticoagulants may appropriate patients suffer problems may useful patients need treatment worth mentioning diabetic patients belong highrisk group virus anticoagulant therapy proposed covid<NUMBER> patients severe pneumonia authors declare conflict interest rnadependent rna polymerase dpp<NUMBER> dipeptidyl peptidase<NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> since initiation pandemic caused globally hundreds thousands deaths <NUMBER> majority people covid<NUMBER> won’t require hospitalization asymptomatic mild symptoms need clinical features may evolve acute respiratory distress syndrome ards cardiac injury major risk factors developing severe symptoms age sex prevalence males well obesity diabetes hypertension respiratory cardiovascular diseases <NUMBER> covid<NUMBER> specific drugs available <NUMBER> better understanding underlying covid<NUMBER> pathobiology required molecular level sarscov<NUMBER> entry target cells facilitated spike protein coronavirus sarscov<NUMBER> infection starts binding zinc metallopeptidase angiotensinconverting enzyme <NUMBER> ace<NUMBER> enables viral attachment surface target cells additional step refers protein priming transmembrane protease serine <NUMBER> tmprss<NUMBER> <NUMBER> fig <NUMBER> reportedly furin protease also likely involved sarscov<NUMBER> infection process <NUMBER> processes similar used sarscov transmissibility <NUMBER> notably sarscov endosomal cysteine proteases cathepsins bl ctsb ctsl also needed viral cell entry <NUMBER> ammonium chloride treatment strongly inhibited sarscov<NUMBER> cell entry tmprss<NUMBER> <NUMBER>t cells suggesting sarscov<NUMBER> likely use either tmprss<NUMBER> ctsbl cell infection <NUMBER> tmprss<NUMBER> expression lung tissues may determinant viral tropism pathogenicity initial site sarscov<NUMBER> infection <NUMBER> sarscov <NUMBER> may reduce viral control humoral immune response notably common sarscov sarscov<NUMBER> infection enhanced tmprss<NUMBER> <NUMBER> ace<NUMBER> critical component reninangiotensin system ras plays key role maintaining blood pressure homeostasis well fluid salt balance <NUMBER> components system mainly include renin angiotensinogen agt angiotensin ii angii angiotensin converting enzyme ace angiotensin ii type <NUMBER> receptor at<NUMBER>r angiotensin ii type <NUMBER> receptor at<NUMBER>r fig <NUMBER> angii generated angi ace key effector peptide system causing vasoconstriction ras overactivation implicated among others induction progression hypertension atherosclerosis diabetes heart failure renovascular disorders pulmonary hypertension fibrosis pneumonia sepsis <NUMBER> ace<NUMBER> highly homologous ace metalloprotease functions negative regulator agt system reduces angii levels producing sorter ang<NUMBER> ang<NUMBER> peptides activate antiinflammatory vasodilationpromoting receptor mas masr fig <NUMBER> <NUMBER> recombinant ace<NUMBER> protects mice severe acute lung failure loss ace<NUMBER> expression likely involved increased vascular permeability one hallmarks ards pathogenesis <NUMBER> ace<NUMBER> also links amino acid malnutrition intestinal inflammation key regulator dietary amino acid homeostasis innate immunity gut microbial ecology <NUMBER> overall balance aceangiiat<NUMBER>r counterregulatory ace<NUMBER>ang<NUMBER>–<NUMBER>masr axes critical physiological regulation neural cardiovascular blood pressure kidney functions <NUMBER> although ace<NUMBER> expression seems correlate susceptibility sarscov infection cell assays downregulated sarscov <NUMBER> relationship ace<NUMBER> expression levels susceptibly sarscov<NUMBER> infection remains elusive also clear whether sarscov<NUMBER> infection interferes ace<NUMBER> expression nonetheless logical assume high ace<NUMBER> expression levels andor simultaneous coexpression ace<NUMBER> tmprss<NUMBER> ctsbl proteins sarscov<NUMBER> targeted tissuescells may lead higher risk sarscov<NUMBER> infection get insights issue mapped ace<NUMBER> tmprss<NUMBER> ctsb ctsl genes corresponding proteins expression human tissues pathology well response sarscov<NUMBER> used therapeutic treatments analyzing expression datasets geo arrayexpress protein atlas databases findings provide rational explanation clinical features covid<NUMBER> gene expression profiling metaanalysis study ace<NUMBER> ace<NUMBER> entrez id <NUMBER> ensembl ensg<NUMBER> tmprss<NUMBER> tmprss<NUMBER> entrez id <NUMBER> ensembl ensg<NUMBER> genes related microarray datasets retrieved ncbi arrayexpress databases selection datasets ncbi arrayexpress based terms homo sapiens organism ace<NUMBER> gene symbol tmprss<NUMBER> gene symbol respectively along additional data filtering updown genes differential expression search filter geo profiles ncbi ncbi arrayexpress databases also searched currently investigated therapeutic approaches covid<NUMBER> eg interferonbeta ifnβ remdesivir lopinavir ritonavir chloroquinehydroxychloroquine number immunosuppressants terms ace<NUMBER> gene symbol tmprss<NUMBER> gene symbol records collected database search include <NUMBER> ace<NUMBER> <NUMBER> tmprss<NUMBER> <NUMBER> ifnβ <NUMBER> chloroquine <NUMBER> hydroxychloroquine entries following removal duplicate entries ncbi array express databases unique datasets n<NUMBER> collected additional datasets excluded eliminating nongeo entries n<NUMBER> n<NUMBER> insufficient data specifically datasets excluded nongeo entries low number samples per statecondition provided thus requirements geo<NUMBER>r tool met gene expression analysis <NUMBER> selected datasets performed using ncbi provided geo<NUMBER>r tool aiming identify differential expression genes interest ie ace<NUMBER> tmprss<NUMBER> ctsb ctsl across different experimental conditions statistically significant cases pvalue <NUMBER> chosen visualization see prisma flowchart fig s<NUMBER> <NUMBER> additional information expression levels ace<NUMBER> tmprss<NUMBER> ctsb ctsl genes proteins across human tissues recorded pathologies gathered human protein atlas database finally terms ace<NUMBER> tmprss<NUMBER> ctsb ctsl searched kegg pathways found pathwaysmolecules used screen drugbank drugs various phases development modulate identified kegg pathways differential regulation sarscov<NUMBER> spike protein receptor ace<NUMBER> priming protease tmprss<NUMBER> genes geo arrayexpress databases given sarscov<NUMBER> infection rate human cells likely depends expression levels receptor ace<NUMBER> priming protease tmprss<NUMBER> initially performed expression profiling metaanalysis geo arrayexpress microarrays databases found ace<NUMBER> gene significantly less expressed venous vs arterial endothelial cells biopsies patients nephrosclerosis hypoxiarelated glomerulopathy well various biological settings following treatment lipopolysaccharides tumor necrosis factor tnf interleukins <NUMBER> il<NUMBER> <NUMBER> il<NUMBER> fig <NUMBER> a<NUMBER> table s<NUMBER> tmprss<NUMBER> gene among others suppressed tnf hepatitis antigen hbsag influenza h<NUMBER>n<NUMBER> virus hypoxia methotrexate serum response factor estradiol primary endothelial receptor lox<NUMBER> oxidized ldl oxidized ldl arc nucleoside analog anticancer activity sangivamycin nucleoside analogue potent inhibitor protein kinase c bet inhibitor ibet<NUMBER> well following tgfβactivated kinase <NUMBER> tak<NUMBER> knock mycophenolic acid bicalutamide antiandrogen treatment prostate castration fig <NUMBER>b<NUMBER> table s<NUMBER> tmprss<NUMBER> gene also found significantly downregulated many tumors tumor cells hand ace<NUMBER> gene expression among others see fig <NUMBER>a<NUMBER> table s<NUMBER> induced obesity stomach infection helicobacter pylori interferons ifnα ifnγ also upregulated following treatment retinoic acid p<NUMBER> steroid coactivator protein src<NUMBER> egfserum fgfr stimulation knock rnf<NUMBER> atypical e<NUMBER> ligase hepatocyte nuclear factor <NUMBER>beta expression tmprss<NUMBER> gene among others see fig <NUMBER>b<NUMBER> table s<NUMBER> elevated androgens androgen receptor ar activationoverexpression ar agonists cigarette smoke extract rectal suction specimens cystic fibrosis patients nasal lavage samples obtained asthmatic children acute picornavirusinduced exacerbation following rhinovirus infection well juvenile rheumatoid arthritis diabetes barretts esophagus notably ace<NUMBER> tmprss<NUMBER> genes showed trend similar regulation geo arrayexpress experiments fig s<NUMBER> tables s<NUMBER> s<NUMBER> search geo arrayexpress databases showed ace<NUMBER> gene highly expressed thymus lung kidney pancreas heart fig <NUMBER>a<NUMBER> table s<NUMBER> tmprss<NUMBER> gene overexpressed bladder kidney well tissues gastrointestinal respiratory tract fig <NUMBER>b<NUMBER> table s<NUMBER> thus ace<NUMBER> tmprss<NUMBER> genes widely expressed human tissues induced proinflammatory conditions androgens comparative analysis ace<NUMBER> tmprss<NUMBER> ctsb ctsl genes corresponding proteins expression patterns depicted protein atlas collected data ace<NUMBER> tmprss<NUMBER> ctsb ctsl genes proteins expression data protein atlas database ctsb ctsl genes general homogeneously expressed higher levels compared ace<NUMBER> tmprss<NUMBER> across different tissues fig <NUMBER> table s<NUMBER> ace<NUMBER> tmprss<NUMBER> genes low expression levels found brain blood tissues well cell lines studied contrary high ace<NUMBER> tmprss<NUMBER> genes coexpression found kidney gallbladder colon duodenum small intestine salivary thyroid glands also ace<NUMBER> gene highly expressed heart testis similarly according protein atlas database ace<NUMBER> protein expressed adrenal gland testis high levels gastrointestinal tract tmprss<NUMBER> highly expressed kidney gastrointestinal tract fig s<NUMBER> table s<NUMBER> notable observation analyses tendency positive correlation ace<NUMBER> tmprss<NUMBER> genes expression patterns fig <NUMBER>b thus intervention modulates either ace<NUMBER> tmprss<NUMBER> expression would likely also affect nontargeted gene regulation ace<NUMBER> tmprss<NUMBER> ctsb ctsl genes following treatment ifn<NUMBER>β chloroquine hydroxychloroquine screening kegg pathways drugbank identification possible anti covid<NUMBER> treatments given number combinational therapeutic schemes <NUMBER> currently prioritized covid<NUMBER> treatment also performed focused search geo arrayexpress databases drugs ace<NUMBER> tmprss ctsbl genes findings shown fig <NUMBER> see also tables s<NUMBER>–s<NUMBER> refer experiments containing information ifnβ chloroquine hydroxychloroquine interestingly ifnβ significantly induced ace<NUMBER> gene expression bronchial epithelial cells fig <NUMBER>a table s<NUMBER> hand chloroquine administration hivinfected patients tended nonsignificant induce ctbs gene expression likely due negative feedback loop aiming restore physiological cathepsins activity fig <NUMBER>b table s<NUMBER> finally hydroxychloroquine suppressed ace<NUMBER> tmprss<NUMBER> genes expression induced ctsb ctsl genes expression pbmc cells systemic lupus erythematosus patients fig <NUMBER>c table s<NUMBER> analyzed kegg pathways modulated ace<NUMBER> tmprss<NUMBER> ctsbl found ace<NUMBER> involved reninangiotensin system protein digestion tmprss<NUMBER> transcriptional misregulation cancer prostate cancer influenza ctsbl renin secretion antigen processingpresentation autophagy lysosome phagosome apoptosis nodlike receptor signaling pathway proteoglycans cancer rheumatoid arthritis fluid shear stress atherosclerosis table s<NUMBER> modules pathways used probe drugbank order identify drugs experimental trials approved target components pathways also searched clathrinmediated endocytosis actin tubulinpolymerization inhibitors tables s<NUMBER>–s<NUMBER> see also fig <NUMBER> number potentially usable drugs include antiandrogens ar inhibitors vasodilators tnf blockers interleukins’ activity modulators tables s<NUMBER>–s<NUMBER> findings indicate major cellular components ie ace<NUMBER> tmprss<NUMBER> ctsbl enable sarscov<NUMBER> infection human cells widely expressed human tissues enriched kidney heart well tissues gastrointestinal respiratory tract minimal expression ace<NUMBER> tmprss<NUMBER> genes levels brain blood cells data accordance recent similar approaches focused solely ace<NUMBER> gene <NUMBER> regarding lung primary site infection recently found ace<NUMBER> tmprss<NUMBER> genes primarily expressed bronchial transient secretory cells <NUMBER> also found sarscov<NUMBER> entry factors highly expressed nasal epithelial cells <NUMBER> enrichment sarscov<NUMBER> infectionrelated cellular components gastrointestinal tract explain diarrhoea sarscov<NUMBER> sustained isolation stool major symptom covid<NUMBER> <NUMBER> suggest intestine may represent major entry site virus due consumption contaminated food considering ace<NUMBER> expression correlates sarscov close relative sarscov<NUMBER> infection rate cells <NUMBER> likely even patients underlying morbidities major human organs potentially vulnerable covid<NUMBER> addition tissuesorgans enrichment ace<NUMBER> tmprss<NUMBER> ctsbl genes expression also found ace<NUMBER> likely counterbalancing antiinflammatory response tmprss<NUMBER> genes induced various proinflammatory conditions including obesity barretts esophagus stomach infection helicobacter pylori diabetes autoimmune diseases oxidized ldl several morbidities already recognized risk factors severe disease death <NUMBER> others indicate novel possible risk factors severe covid<NUMBER> notably particular biological settings assayed genes induced exhaustive likely moderate exercise well cigarette smoke growth factors viruses’ infections interferons see also found strong positive regulation androgens largely explaining increased sensitivity men covid<NUMBER> <NUMBER> highrisk covid<NUMBER> conditions like hypertension respiratory disease cardiovascular disease aceangiiat<NUMBER>r axis overactive likely ace<NUMBER> expression thus sarscov<NUMBER> available binding sites increases patients treated drugs suppress aceangiiat<NUMBER>r eg at<NUMBER>r blockers <NUMBER> hypertensive patient infected sarscov<NUMBER> high risk simply aceangiiat<NUMBER>r overactive partly suppressed at<NUMBER>r blockers ace<NUMBER> overexpressed infection sarscov<NUMBER> likely eliminates ace<NUMBER>ang<NUMBER>–<NUMBER>masr regulatory axis fig <NUMBER> leading sudden exaggeration aceangiiat<NUMBER>r activity causing thus ards systemic level among others kidney cardiac failure fig <NUMBER> indeed sarscov infection mice downregulates ace<NUMBER> protein ace contributing severe lung injury <NUMBER> also loss ace<NUMBER> expression locally increased angii production triggers leakage pulmonary blood vessels at<NUMBER>r stimulation ards <NUMBER> interestingly model nanoparticlesmediated lung injury due direct binding ace<NUMBER> led suppression ace<NUMBER> activity expression levels administration losartan at<NUMBER>r antagonist ameliorate nanoparticlesinduced lung injury <NUMBER> since ace<NUMBER> tmprss<NUMBER> ctsbl genes widely expressed human tissues eg heart kidney leakage pulmonary blood vessels ards fig <NUMBER> would likely allow virus spreading circulation enabling direct infection organs decreased ace<NUMBER>ang<NUMBER>–<NUMBER>masr activity systemic failure although likely detectable viremia ie infectious virus plasma asymptomatic infection prior clinical disease <NUMBER> sarscov<NUMBER> rna detected blood donations patients mild symptoms <NUMBER> detectable sarscov<NUMBER> viral rna blood strong indicator clinical severity <NUMBER> overall since aging another risk factor covid<NUMBER> correlates increased ace<NUMBER>ace<NUMBER> ratio rat model <NUMBER> high risk covid<NUMBER> patients even hypertensive patients prophylactic measure likely receive additional ras inhibitors decrease systemic damage risk given delicate balance aceangiiat<NUMBER>r ace<NUMBER>ang<NUMBER>–<NUMBER>masr regulatory axes along aforementioned morbidities induced due disruption balance favor aceangiiat<NUMBER>r activation development effective covid<NUMBER> therapeutics seems particularly puzzling specifically covid<NUMBER> twophase disease namely infection spreading life cycle virus fig <NUMBER> ❶ ❾ respiratory likely gastrointestinal tracts b ards induction lead systemic failure fig <NUMBER> ❶ ❹ thus seemingly virus uncontrolled response patient’s immune system promote lethality effective treatments thus probe life cycle sideeffects induced sarscov<NUMBER> current investigation clinical trials therapeutics covid<NUMBER> include azithromycin bacterial protein synthesis inhibitor chloroquinehydroxychloroquine lysosomotropic agents inhibiting activity endosomallysosomal compartments lopinavirlavipiravirremdesivir antiviral drugs τocilizumab humanized monoclonal antibody il<NUMBER> receptor <NUMBER> alternatives andor additional combinatorial approaches searched kegg pathways ace<NUMBER> tmprss<NUMBER> ctsb ctsl terms figs s<NUMBER>–s<NUMBER> drugbank agents various phases development tables s<NUMBER>–s<NUMBER> target modules found pathways additional information clathrinmediated endocytosis well actin tubulin polymerization inhibitors shown tables s<NUMBER>–s<NUMBER> targeting virus life cycle magic bullet development effective vaccine cell lines express ace<NUMBER> see fig <NUMBER>a<NUMBER> table s<NUMBER> facilitate viral replication may efficient largescale vaccine production another approach soluble ace<NUMBER> eg rhace<NUMBER> apn<NUMBER> gsk<NUMBER> likely used neutralize virus competitive binding also rescue cellular ace<NUMBER> activity towards blocking sarscov<NUMBER> binding ace<NUMBER> reducing available binding sites ace<NUMBER> downregulation possible approaches may involve antibodies small molecules target ace<NUMBER> eg ssaa<NUMBER>e<NUMBER> blocks early interactions sarscov ace<NUMBER> <NUMBER> b tnf androgen ar inhibitors see tables s<NUMBER>–s<NUMBER> found interventions strongly suppress ace<NUMBER> tmprss<NUMBER> genes expression yet given anticipated toxic effects systemic lossof ace<NUMBER> activity whatever intervention transient constant monitoring clinical output alternative likely safer compared ace<NUMBER> inhibition approach would usage tmprss<NUMBER> specific inhibitors tmrpss<NUMBER> druggable camostat mesylate partially blocked sarscov<NUMBER> entry caco<NUMBER> verotmprss<NUMBER> cells <NUMBER> additional benefits tmrpss<NUMBER> inhibition would reduced viral tropism initial site sarscov<NUMBER> infection enhanced humoral immune responses see next steps targeted sarscov<NUMBER> life cycle include membrane fusion clathrinmediated endocytosis clathrinmediated endocytosis inhibitor ikarugamycin <NUMBER> dynamin inhibitor dynasore analogs <NUMBER> actin depolymerizing drug latrunculin b <NUMBER> tested preclinical models also ssaa<NUMBER>e<NUMBER> prevents fusion viral membrane host cellular membrane sarscov infection model <NUMBER> intracellularly novel sarscov<NUMBER> specific antiviral drugs target sarscov<NUMBER> main protease due essential role processing polyproteins translated viral rna <NUMBER> alternatively existing antiviral tested according molecular docking studies bind tightly rna dependent rna polymerase <NUMBER> intracellular components virus life cycle targeted include tubulin andor ctsbl fig <NUMBER> former colchicine tubulin polymerization inhibitor <NUMBER> promising least patients ards <NUMBER> drug latter chloroquine hydroxychloroquine already used covid<NUMBER> <NUMBER> yet spite promising clinical data obtained chloroquinehydroxychloroquine could also relate reduced renin production fig s<NUMBER> lysosomotropic agents inhibit activity endosomallysosomal compartments nonspecifically thus existing ctsbl specific inhibitors endogenous origin function regulators cathepsin b activity cell cystatins <NUMBER> also considered notably cathepsins bl activity increases significantly age <NUMBER> associated arterial stiffening atherosclerotic vascular disease <NUMBER> observations support notion age cardiac dysfunction risk factors covid<NUMBER> dark side inhibiting acidic cellular endosomal compartments ctsbl functional involvement mhc class ii antigen ag presentation fig <NUMBER> <NUMBER> thus usage chloroquinehydroxychloroquine ctsbl specific inhibitors even excessive contamination endosomal compartments virus could suppress mhc class ii antigen ag presentation functional output along presence olinked glycans surface virus <NUMBER> could result immunoevasion case clearance virus may proceed via proteasomemediated mhci related ag presentation fig <NUMBER> <NUMBER> activity specific immune cells eg nk cells proteasome downregulated aging <NUMBER> less responsive ifnγ <NUMBER> would result reduced ag presentation mhc molecules consequently reduced immune responses fig <NUMBER> elderly context drugs andor small molecules activate proteasome could provide useful additive therapeutics covid<NUMBER> previous highthroughput screenings identification natural products modulating proteostatic pathways revealed promising candidates exert antioxidant activity parallel combinatorial action ctsbl inhibitors proteasome activators unpublished data relation phase <NUMBER> disease ie ards induction cytokine storm lead systemic failure <NUMBER> along downregulation ace<NUMBER> due sarscov<NUMBER> infection propose use ang<NUMBER> peptide nonpeptide analogs could bypass loss ace<NUMBER> reactivate antiinflammatoryvasodilatory masr signaling pathway fig <NUMBER> support ang<NUMBER> protects endothelial cells high glucoseinduced injury inflammation <NUMBER> improves action insulin <NUMBER> shown protective action heart failure <NUMBER> stroke <NUMBER> due likely covid<NUMBER> infectionmediated overactivation prooxidative aceangiiat<NUMBER>r axis promote endothelial dysfunction due dysbalanced nitric oxide reactive oxygen species ratios vessel wall <NUMBER> use drugs activate antioxidant cellular defenses act radicals scavengers could additional prophylactic intervention finally regarding covid<NUMBER> induced cytokine storm ie uncontrolled systemic inﬂammatory response resulting release large amounts proinﬂammatory cytokines <NUMBER> idea inhibiting key proinflammatory cytokines eg il<NUMBER> receptor tocilizumab makes sense <NUMBER> obviously however excessive inhibition immune system corticosteroids avoided <NUMBER> findings interferons especially ifnβ ifnγ induce ace<NUMBER> gene figs <NUMBER>a <NUMBER>α tables s<NUMBER> s<NUMBER> indicate therapeutic activationp could upregulate bindings sites hence infection rates virus targeted tissues thus regulation ace<NUMBER> tmprss<NUMBER> ctsbl genes immune system key effector molecules studied details conclusion data indicate possible novel highrisk groups covid<NUMBER> also provide rich resource future investigations covid<NUMBER> pathogenesis b possible combinatorial therapeutic approaches ipt supervised study interpreted data wrote paper eg gb kv collected analyzed data authors edited manuscript authors declare conflict interest confirmed sarscov<NUMBER> virus like coronaviruses enters lung cells binding angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> important element ras main function enzyme expressed various human tissues <NUMBER> appears maintenance balance vasoconstricting system proinflammatory proliferative profibrotic oxidant effects antagonizing effects degradation decreased production angiotensin ii formation angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> seems main mechanism ace<NUMBER> regulates angiotensin ii direct degradation effect angiotensin ii estimated <NUMBER> times greater effect angiotensin <NUMBER> recent years various studies published ace<NUMBER>s possible beneficial effects cardiovascular system kidneys lungs <NUMBER> <NUMBER> <NUMBER> <NUMBER> linked angiotensin iisuppressing effect imai et al <NUMBER> found angiotensin ii worsened respiratory distress different experimental models poor course improved angiotensin ii receptor type <NUMBER> at<NUMBER> blockade also found course worsened event reduction ace<NUMBER> expression coronavirus infections argued unfavorable course due part drop angiotensin ii regulation enzyme line gurwitz <NUMBER> authors <NUMBER> suggested angiotensin ii receptor blockers arbs could beneficial effect course lung disease sarscov<NUMBER> infection either directly due capacity increase ace<NUMBER> levels counteracting decrease levels caused virus blocking at<NUMBER> receptors thus impeding action possible excess angiotensin ii harmful effects lungs reported cases pneumonia due sarscov<NUMBER> virus <NUMBER> avian influenza virus <NUMBER> experimental study rats ferrario et al <NUMBER> found conflicting data effects lisinopril ace inhibitor losartan arb mrna expression ace<NUMBER> activity enzyme observing increase mrna expression ace<NUMBER> although losartan lisinopril increases activity based study fact patients higher cardiovascular risk infected sarscov<NUMBER> virus seem follow worse course sommerstein gräni suggested treatment ace inhibitors could unfavorable effect circumstances <NUMBER> contrast studies conducted humans found association use ace inhibitors arbs levels ace<NUMBER> <NUMBER> line imai et al <NUMBER> worse course infection sarscov<NUMBER> virus patients higher cardiovascular risk hypertensive diabetic elderly patients well greater cardiac morbidity <NUMBER> could also interpreted due higher levels angiotensin ii consequently higher levels ace<NUMBER> degrade thus reduce harmful effects lungs also supporting idea presence excess angiotensin ii process fact patients sarscov<NUMBER> infection patients survived sarscov<NUMBER> infection higher incidence hypertension cardiovascular problems glucose metabolism disorders <NUMBER> according hypothesis blocking angiotensin ii production ace inhibitors could alternative decreasing levels inflammatory potential lungs consequently decreasing ace<NUMBER> expression would render virus less infectious early phases disease contacts would decrease receptors available sarscov<NUMBER> virus enter cells experimental studies found ace<NUMBER> knockout mice infected viruses <NUMBER> also suggested ace inhibitors could partly alter structure enzyme due similarity ace would also impede binding virus <NUMBER> respect severe cases data contradictory reported drop ace<NUMBER> activity caused virus could increase lung injury although circumstances possible benefit ace<NUMBER> could due fact increases angiotensin ii degradation would elevated defect regulation increase renin activity stimulated hypoxia conditions seen <NUMBER> patients sarscov<NUMBER> infection characterized devastating acute inflammation predominant pulmonary expression pneumonia hypoxia severe respiratory distress probably tied different expressions interferon patterns cytokines unknown molecular mechanisms would explain different clinical presentations independent patient age <NUMBER> interesting note differences individuals terms structure ace accompanying effects different studies shown pharmacogenomic significance three variants endothelial nitric oxide synthases enos regard ace inhibition responses genetic variability enos genes genes contribute activation could affect ace inhibitor response one studies focused patients hypertension treated enalapril ace inhibitor <NUMBER> beneficial effects ace inhibition lungs demonstrated various studies experimentally enalapril found exert antiinflammatory effect animal model induced pulmonary toxicity <NUMBER> perindopril another ace inhibitor found effect lung impairment secondary sepsis <NUMBER> clinically metaanalysis found ace inhibitors possess protective effect respect pneumonia risk <NUMBER> clinical effect ace inhibitors arbs patients covid<NUMBER> require hospital admission evaluated study progress kings college hospital princess royal university hospital london <NUMBER> preliminary results find worse course patients treated ace inhibitors compared patients taking drugs even noted seem follow favorable course regarding arbs yet possible draw conclusions given limited number cases analyzed regardless specific treatment options antivirals direct ace<NUMBER> blockade treatment recombinant ace<NUMBER> attempt saturate capacity binding virus vaccines others <NUMBER> option proposed considered wellknown accessible safe treatment administered proper management monitoring could aid reducing spread effects infection initial phase would necessary authors remarked <NUMBER> analyze soon possible epidemiological data available infected patients respect course history taking antihypertensive drugs time would appropriate propose randomized prospective studies initial infections one arms includes treatment considered suitable case also ace inhibitor strict clinical management patients line already started researchers necessary continue conducting research aimed improving knowledge correlation angiotensin ii levels ace<NUMBER> activity different tissues lung heart kidney tissuessince seems degree activity components ras may vary organ accordance plasma levels addition must clarified whether possible beneficial effect reported higher ace<NUMBER> levels due greater degradation angiotensin ii increased angiotensin <NUMBER> action metabolic pathways also believe important soon possible results regulated systematized studies effects blockade angiotensin ii components ras j u r n l p r e p r f sarscov<NUMBER> infection since lack scientific evidence regard resulting proliferation scientific literature highly conflicting opinions possible effects drugs interfere system based experimental studies many limitations mentioned subjective interpretations <NUMBER> <NUMBER> indeed even formal believe hasty proposals actions contrary positioning scientific associations european medicines agency use medicines patients covid<NUMBER> <NUMBER> none angiotensina <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> angiotensina ii <NUMBER> figure <NUMBER> diagram reninangiotensin system ace angiotensinconverting enzyme ace<NUMBER> angiotensinconverting enzyme <NUMBER> arb at<NUMBER> receptor blocker at<NUMBER> angiotensin ii receptor type <NUMBER> at<NUMBER> angiotensin ii receptor type <NUMBER> mas mitochondrial assembly receptor gr<NUMBER> global epidemic three coronaviruses emerged century far <NUMBER> <NUMBER> current studies indicate coronavirus similar sarscov although three coronaviruses sarscov merscov sarscov<NUMBER> identified highly pathogenic human population effective antiviral treatment therefore current studies focused rapid development vaccines antiviral drugs prevent treat coronavirus infection one attractive antiviral drug targets sarscov encoded cysteine protease papainlike protease plpro <NUMBER> enzyme recognizes tetrapeptide lxgg motif found inbetween viral proteins nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> <NUMBER> <NUMBER> hydrolysis peptide bond carboxyl side glycine p<NUMBER> position leads release nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> proteins essential viral replication vitro studies shown sarscovplpro harbors two proteolytic activities removal ubiquitin ub ubiquitinlike protein isg<NUMBER> interferoninduced gene <NUMBER> cellular proteins <NUMBER> <NUMBER> <NUMBER> ubiquitinated isgylated substrates efficiently hydrolyzed sarscovplpro small substrates containing cterminal lrgg motif <NUMBER> <NUMBER> results indicated complex mechanism substrate recognition interaction s<NUMBER>s<NUMBER> pockets enzyme tetrapeptide fragment studies revealed sarscovplpro possess two distinct ub binding subsites sub<NUMBER> sub<NUMBER> recognize lys<NUMBER>linked polyub chains polyubiquitin chain editing andor deubiquitination polyubiquitinated proteins <NUMBER> <NUMBER> <NUMBER> due deubiquitinating deisgylating activities sarscov plpro enzyme performs significant role innate immune response viral infection <NUMBER> <NUMBER> sarscovplpro involved inhibiting production cytokines chemokines <NUMBER> responsible activation host innate immune response viral infection <NUMBER> <NUMBER> <NUMBER> reasons enzyme important molecular target design sarscov antiviral drugs despite substantial research efforts development sarscov inhibitors efficacy data compounds clinical trials missing <NUMBER> <NUMBER> <NUMBER> nevertheless hypothesize information gained past years sarscovplpro could immediately translated timely study sarscov<NUMBER>plpro accelerate new antivirals development drug retargeting approaches optimal method check level similarity binding site architecture two enzymes positional scanning technology recently developed novel chemical approach called hycosul hybrid combinatorial substrate library dissect broad substrate specificity proteolytic enzymes <NUMBER> application approach sarscov<NUMBER>plpro facilitated development irreversible inhibitors vir<NUMBER> vir<NUMBER> harboring high degree selectivity sars plpro variants versus proteases crystal structures vir<NUMBER> vir<NUMBER> complex sarscov<NUMBER>plpro reveal inhibitory mechanisms provide structural basis observed substrate specificity profiles also examined processing ub ubl sarscov<NUMBER> plpro found harbors deisgylating activities similar sarscov<NUMBER>plpro ability hydrolyze k<NUMBER>linked ub chains significantly diminished altogether work revealed molecular rules governing plpro substrate specificity provides framework development inhibitors potential therapeutic value drug repositioning reveals intriguing differences biochemical functions sarscov<NUMBER> <NUMBER> plpro may contribute differences biology sarscov<NUMBER> plpro recognizes tetrapeptide lxgg motif found inbetween viral proteins nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> figure <NUMBER>a <NUMBER> <NUMBER> hydrolysis peptide bond carboxyl side glycine p<NUMBER> position leads release nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> proteins essential viral replication sarscov<NUMBER> plpro also harbors deubiquitinating deisgylating activities recognizes conserved lrgg motif cterminus proteins figure <NUMBER>a previous studies sarscov<NUMBER> plpro substrate preferences using combinatorial substrate library containing natural amino acids revealed protease recognizes lxgg motif p<NUMBER>p<NUMBER> positions broad substrate specificity p<NUMBER> position <NUMBER> results suggest detailed mapping binding pocket architecture facilitate design new active substrates well optimal peptide sequences inhibitor development efforts achieve goal developed defined combinatorial substrate library hycosul containing wide variety nonproteinogenic amino acids <NUMBER> since tetrapeptide fluorogenic substrates efficiently hydrolyzed enzymes exhibiting deubiquitinating activity designed synthesized p<NUMBER> defined library general structure aclrxgacc x <NUMBER> natural <NUMBER> unnatural amino acids hybrid combinatorial substrate library three positions fixed one position contains equimolar mixture <NUMBER> amino acids mix p<NUMBER> sublibrary acmixp<NUMBER>glyglyacc p<NUMBER> sublibrary acp<NUMBER>mixglyglyacc p<NUMBER> p<NUMBER>a natural unnatural amino acid <NUMBER> design libraries tailored peptide scaffold toward dubs could reach highest possible concentration individual fluorogenic substrates sublibrary assay table s<NUMBER> supplemental information enzymes recognize acidic residues damino acids exception darg dhphe dlys dphg s<NUMBER> pocket sarscov sarscov<NUMBER>plpro accommodate hydrophobic residues among natural amino acids practically leucine tolerated best hit sarscov<NUMBER>plpro figure <NUMBER>b sarscovplpro recognized two unnatural residues better leucine p<NUMBER> position htyr htyrme bulky amino acids also accepted ≥ <NUMBER> hphe abubth phe<NUMBER>i cysbzl cysmebzl cys<NUMBER>meobzl hserbzl dht figure <NUMBER>b validate libraryscreening data designed optimal tetrapeptide fluorogenic substrates find optimal sequences recognized sarscov sarscov<NUMBER>plpro analyzed sars plpro substrate specificity profile p<NUMBER>p<NUMBER> positions selected preferred amino acids p<NUMBER> gly p<NUMBER> dap pheguan p<NUMBER> htyr hphe abubth figure <NUMBER>e kinetic analysis revealed designed substrates better recognized sarscov<NUMBER> plpro achtyrdapglyglyacc almost <NUMBER> times efficiently cleaved endogenous aclrggacc case sarscov<NUMBER>plpro find significant difference aclrggacc tested substrates figure <NUMBER>c important notice substitution arg p<NUMBER> position relatively small dap affect binding s<NUMBER> pocket yields good substrates figure <NUMBER>c thus data obtained combinatorial screening well translate individual substrates demonstrate high level similarity two investigated enzymes next wanted see incorporation unnatural amino acids p<NUMBER> p<NUMBER> positions peptide sequence result selective tetrapeptide substrates tested substrates four enzymes exhibit deubiquitinating activity sarscovplpro sarscov<NUMBER>plpro merscovplpro human dub uchl<NUMBER> found none substrates unnatural amino acids sequence significantly recognized <NUMBER>µm either merscov<NUMBER> plpro <NUMBER> µm human dub uchl<NUMBER> <NUMBER> µm figure <NUMBER>d line previous data aclrggacc recognized four enzymes figure <NUMBER>d analyze selectivity peptide sequences unnatural amino acids converted two substrates achtyrdapglyglyacc acabubthdapglyglyacc inhibitors exchanging fluorescent tag reactive group vinylmethyl ester vme vme group selected due broad reactivity toward dubs inhibitor selectivity determined tetrapeptide sequence results kinetic analysis sarscovplpro sarscov<NUMBER>plpro inhibitors reflected substrate hydrolysis figure <NUMBER>a b selective inhibitor toward enzymes acabubthdapglyglyvme hereafter referred vir<NUMBER> importantly compounds exhibit high selectivity sarsplpro variants robustly inhibit sarscovplpro sarscov<NUMBER>plpro activities contrast practically inhibition human uchl<NUMBER> slight inhibition mersplpro observed figure <NUMBER>a b incubation hela lysates ubvme yields crosslinking profile unaltered titrations vir<NUMBER> vir<NUMBER> figure <NUMBER>c since major crosslinking target ubvme known human dub enzymes data suggests vir<NUMBER> <NUMBER> vir<NUMBER> crossreact human dubs important finding search selective antiviral molecule minimal crossreactivity human dubs next set determine crystal structures sarscov<NUMBER>plpro complex vir<NUMBER> vir<NUMBER> order gain insights molecular mechanism molecules inhibit sarscov<NUMBER>plpro activity well basis observed substrate selectivity profile catalytic cysteine <NUMBER> cov<NUMBER>plpro engages michael addition bcarbon vinyl group vme warheads vir<NUMBER> vir<NUMBER> resulting formation covalent thioether linkage figure <NUMBER>d largescale crosslinking reactions yielded cov<NUMBER>plprovir<NUMBER> cov<NUMBER> plprovir<NUMBER> complexes yield purity sufficient growth diffraction quality crystals structure cov<NUMBER>plpro complex vir<NUMBER> figure <NUMBER>e determined molecular replacement using recently determined structure apo cov<NUMBER> plpro pdb <NUMBER>w<NUMBER>c resolved <NUMBER> å resolution rrfree values <NUMBER> table s<NUMBER> structure used molecular replacement search model determination structure cov<NUMBER>plpro complex vir<NUMBER> figure <NUMBER>f cov<NUMBER> plprovir<NUMBER> structure resolved <NUMBER> å resolution refined rrfree values <NUMBER> table s<NUMBER> figures <NUMBER>a b analysis cov<NUMBER>plprovir<NUMBER> cov<NUMBER>plprovir<NUMBER> complexes reveals similar network interacting residues <NUMBER> å <NUMBER> total <NUMBER> å <NUMBER> solvent accessible area vir<NUMBER> <NUMBER> å <NUMBER> total <NUMBER> å <NUMBER> solvent accessible area vir<NUMBER> buried upon complex formation exception p<NUMBER> positions vir<NUMBER> vir<NUMBER> engage largely hydrophobic interactions cov<NUMBER>plpro majority interactions p<NUMBER>p<NUMBER> positions inhibitors mediated polar interactions hydrogen bonds figures <NUMBER>a b p<NUMBER> position vir<NUMBER> glyvme covalently linked via thioether bond catalytic cys<NUMBER> cov<NUMBER>plpro engages backbonebackbone hydrogen bond gly<NUMBER> figure <NUMBER>a p<NUMBER> vir<NUMBER> position gly engages two backbonebackbone hydrogen bonds gly<NUMBER> van der waals contacts leu<NUMBER> tyr<NUMBER> cov<NUMBER>plpro p<NUMBER> dap vir<NUMBER> participates backbonebackbone hydrogen bond gly<NUMBER> figure <NUMBER>a network backbonebackbone hydrogen bonds participated p<NUMBER>p<NUMBER> positions vir<NUMBER> fully conserved vir<NUMBER> figure <NUMBER>b contrast methylester group glyvme warhead vir<NUMBER> engages hydrogen bond his<NUMBER> catalytic triad cov<NUMBER>plpro corresponding methylester vir<NUMBER> participates hydrogen bonds trp<NUMBER> asn<NUMBER> side chains proposed contribute oxyanion hole stabilization figures <NUMBER>a b trp<NUMBER> adopts different conformation poorly ordered vir<NUMBER> complex figure <NUMBER>a terms structures correlate observed substrate selectivity profiles described p<NUMBER> dependence gly result residues b<NUMBER>b<NUMBER> a<NUMBER>a<NUMBER> loops cov<NUMBER>plpro notably leu<NUMBER> tyr <NUMBER> cys<NUMBER> gly<NUMBER> tyr<NUMBER> clamping top p<NUMBER> position leaving room side chain atoms r position figures <NUMBER>ac preference positive hydrophobic residues selection acidic residues p<NUMBER> position likely result broader pocket proximity acidic carbonyl oxygens tyr<NUMBER> gln<NUMBER> leu<NUMBER> side chain asp<NUMBER> well hydrophobic side chains leu<NUMBER> tyr<NUMBER> figures <NUMBER>ac p<NUMBER> position strong preference bulky hydrophobic residues explained hydrophobic nature p<NUMBER> binding pocket largely formed residues met<NUMBER> pro<NUMBER> pro<NUMBER> tyr<NUMBER> tyr<NUMBER> figures <NUMBER>a b notably deep broad nature s<NUMBER> pocket sarscov<NUMBER>plpro exploited abubth htyr sidechains p<NUMBER> vir<NUMBER> vir<NUMBER> noted project towards different ends s<NUMBER> pocket engage distinct networks contacts figure <NUMBER>c said remain regions deepest parts pocket particularly acidic patch formed asp<NUMBER> tyr<NUMBER> thr<NUMBER> could potentially exploited development potent inhibitors studies carried sarscov<NUMBER> plpro revealed enzyme ubiquitin binding domain efficiently process full ubiquitin fluorogenic substrates <NUMBER> wanted see also case sarscov<NUMBER>plpro end used ubiquitin activitybased probe abp labeling enzymes abp biotin used detection tag vme irreversible warhead crosslinks catalytic cysteines test sensitivity performed sdspage analysis followed nitrocellulose membrane transfer visualization fluorescent streptavidin figure <NUMBER>a observed significant labeling proteases biotinubvme concentration twice higher enzyme concentration <NUMBER> nm however sarscov<NUMBER> plpro efficiently labeled compared sarscov<NUMBER> plpro next decided explore ub ublike protein ubl substrate specificity sarscov<NUMBER> plpro testing reactivity panel ububl abps plpro recognition isg<NUMBER> monoub poor ability recognize k<NUMBER>linked k<NUMBER>linked diub figure <NUMBER>b expected preincubation sarscov<NUMBER> plpro vir<NUMBER> completely blocked ability react probes figure <NUMBER>b apparent lack reactivity k<NUMBER>linked diubpa probe increased processing isg<NUMBER> ctd vps relative monoubpa surprising since sarscov<NUMBER> plpro demonstrated robustly process k<NUMBER>linked polyub chains preference ub isg<NUMBER> <NUMBER> <NUMBER> thoroughly examine differences performed comparison kinetics sarscov<NUMBER> cov<NUMBER> plpro processing lrggacc ubacc isg<NUMBER>amc fluorogenic substrates results experiment show sarscov<NUMBER> plpro processes ubacc <NUMBER>fold less efficiently compared sarscov<NUMBER> plpro sarscov<NUMBER> plpro processes isg<NUMBER>amc <NUMBER>fold efficiently ubacc figure <NUMBER>c sarscov<NUMBER> plpro like sarscov<NUMBER> plpro robustly processes k<NUMBER> tetraub compared k<NUMBER> tetraub figure <NUMBER>d crosslinks abp ubvs similarly sarscov<NUMBER> plpro mers plpro human dub usp<NUMBER>cd figure <NUMBER>e yet sidebyside comparison sarscov<NUMBER> plpro demonstrates significantly diminished ability process k<NUMBER> tetraub compared sarscov<NUMBER> plpro figure <NUMBER>f unexpected finding others shown sarscov<NUMBER> plpro displays preference recognition k<NUMBER> diub linkages isg<NUMBER> <NUMBER> <NUMBER> expected shown mers plpro usp<NUMBER>cd efficiently processes types ub chains significantly diminished ability sarscov<NUMBER> plpro process k<NUMBER> polyub chains compared sarscov<NUMBER> plpro surprising considering high overall similarity enzymes <NUMBER> identity <NUMBER> similarity figure <NUMBER>d try reconcile apparent contradiction compared sarscov<NUMBER> plpro structures previously reported structure sarscov<NUMBER>plpro complex k<NUMBER> diub figure <NUMBER>g <NUMBER> structure revealed three key interfaces <NUMBER> catalytic site accommodates cterminus ub l<NUMBER> r<NUMBER> g<NUMBER> g<NUMBER> constituting s<NUMBER>s<NUMBER> residues <NUMBER> binding site s<NUMBER> ub ub nterminal cleavage site k<NUMBER> polyub chain <NUMBER> binding site s<NUMBER> ub nterminal s<NUMBER> ub figure <NUMBER>g comparative analysis catalytic sites sarscov<NUMBER> <NUMBER> plpro shows <NUMBER> conservation residues involved contacts s<NUMBER>s<NUMBER> positions s<NUMBER> ub vir<NUMBER> vir<NUMBER> figure <NUMBER>d unsurprisingly similar structure region figure <NUMBER>g ub s<NUMBER> site harbors variability catalytic site overall amino acid conservation still high <NUMBER> identity <NUMBER> similarity figure <NUMBER>d structures align well region figure <NUMBER>g contrast catalytic s<NUMBER> ub sites s<NUMBER> ub site sarscov<NUMBER> plpro harbors much less conservation amino acid level <NUMBER> identity <NUMBER> similarity compared sarscov<NUMBER> plpro figure <NUMBER>d several structural differences regions important molecular recognition s<NUMBER> ub figure <NUMBER>g key interaction surface interface formed ile<NUMBER> hydrophobic patch formed leu<NUMBER> ile<NUMBER> val<NUMBER> sarscov<NUMBER> plprok<NUMBER> diub structure ile<NUMBER> patch s<NUMBER> ub engages network hydrophobic contacts leu<NUMBER> figure <NUMBER>g interestingly residue changed threonine sarscov<NUMBER> would unable engage similar network contacts s<NUMBER> ub leucine much sarscov<NUMBER> structure proximity s<NUMBER> ub site adopts slightly different structure including <NUMBER> å translation thr<NUMBER> sarscov<NUMBER> plpro relative leu<NUMBER> sarscov<NUMBER> plpro notable amino acid changes s<NUMBER>v e<NUMBER>p figure <NUMBER>g lastly glu<NUMBER> sarscov<NUMBER> plpro engages hydrogen bonds thr<NUMBER> lys<NUMBER> s<NUMBER> ub figure <NUMBER>g residue changed aspartate sarscov<NUMBER> plpro conservative change shorter aspartate side chain unable engage similar set contacts figure <NUMBER>g based analysis posit diminished ability sarscov<NUMBER> plpro process k<NUMBER> polyub largely due aforementioned differences s<NUMBER> ub binding site consistent hypothesis mutation leu<NUMBER> sarscov<NUMBER> plpro serine resulted fivefold reduction binding k<NUMBER> diub apparent effect monoub <NUMBER> combination changes sarscov<NUMBER> plpro e<NUMBER>d appears cumulative effect several relatively minor changes sarscov<NUMBER> <NUMBER> plpro s<NUMBER> binding site altogether significant effect ability process k<NUMBER> polyub whether changes also account apparent preference sarscov<NUMBER> plpro isg<NUMBER> ub whether intriguing differences function sarscov<NUMBER> <NUMBER> plpro effect biology viruses remains seen outbreak current coronavirus pandemic leading covid<NUMBER> disease dramatically accelerated research effective drugs vaccine treat disease genome severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> consists <NUMBER> nucleotides encode <NUMBER> proteins two proteases first sarscov<NUMBER>mpro used virus process protein maturation structure already described recently <NUMBER> results retargeting <NUMBER> drugs leading structures resulted selection several candidates studies <NUMBER> date information activity second protease namely sarscov<NUMBER>plpro hypothesizing enzyme similarly sarscovplpro addition participating process virus protein maturation also performs additional function help virus evasion host innate immune responses controlling deubiquitination deisgylation process thus sarscov<NUMBER>plpro also excellent candidate drug blocking virus replication also inhibiting dysregulation signaling cascades infected cells <NUMBER> knowledge substrate preferences equally important understanding structure protein enables rational design inhibitors research drug retargeting research decided examine sarscov<NUMBER>plpro substrate preferences positions p<NUMBER>p<NUMBER> compare directly wellknown sars virus <NUMBER> protein sarscovplpro purpose used positional scanning technology using natural unnatural amino acids hycosul library screening revealed enzymes recognize gly p<NUMBER> possess broad p<NUMBER> rather narrow substrate specificity p<NUMBER> position moreover direct analysis preferences enzymes demonstrate architecture s<NUMBER>s<NUMBER> pockets almost identical recognize natural unnatural amino acids practically similar way differences activity given amino acid two enzymes observed positions small amino acids recognized one enzyme also confirmed analysis amino acids building s<NUMBER>s<NUMBER> pockets enzymes identical figure <NUMBER>b s<NUMBER> critically important information aspect using information research inhibitors retargeting drugs conducted past sarscovplpro immediate application sarscov<NUMBER>plpro analysis kinetic parameters tetrapeptide substrates enzymes shows high degree similarity terms kcatkm values proving catalytic yields enzymes also similar importantly sequences containing unnatural amino acids p<NUMBER>p<NUMBER> positions recognized sarsplpro mersplpro human dub uchl<NUMBER> next leveraged information gained regarding molecular rules governing substrate selectivity sarscov<NUMBER>plpro develop covalent inhibitors vir<NUMBER> vir<NUMBER> inhibitors proved active selectively inhibited sarscov<NUMBER> <NUMBER> plpro exhibited much weaker activity towards mersplpro practically activity towards human uchl<NUMBER> excellent information terms conducting research towards search peptide antiviral compounds targeted enzyme importantly crystal structures vir<NUMBER> vir<NUMBER> complex sarscov<NUMBER>plpro reveals inhibitory mechanisms provides structural basis observed substrate specificity profiles unexpected finding p<NUMBER> amino acids vir<NUMBER> vir<NUMBER> occupy opposite sides broad s<NUMBER> pocket sarscov<NUMBER> plpro additional regions pocket unengaged either inhibitor raise possibility structures inform future drug discovery efforts aimed generating potent inhibitors lastly decided examine processing ub ubl variants sarscov<NUMBER> <NUMBER> plpro found sarscov<NUMBER>plpro harbors deisgylating activities similar sarscov<NUMBER>plpro ability hydrolyze k<NUMBER>linked ub chains significantly diminished unexpected result considering high sequence identity sarscov<NUMBER> <NUMBER> plpro however structure analysis revealed subtle structural sequence variations s<NUMBER> ub binding site sarscov<NUMBER> plpro posit collectively diminish ability s<NUMBER> ub k<NUMBER> polyub bind subsequently processed analysis enzyme kinetics ubacc substrate indicates efficiently processed enzyme difference tetrapeptide substrate ubiquitin ten times case sarscov<NUMBER> plpro difference around sixty times figure <NUMBER>c indicates differences enzymes aspect interaction exosite binding region related amino acids identity similarity given role ub isg<NUMBER> conjugation evasion host innate immune responses whether intriguing differences function sarscov<NUMBER> <NUMBER> plpro effect biology viruses remains seen topic future studies collectively work revealed molecular rules governing plpro substrate specificity reveals high level sequence structural similarity sarscov<NUMBER> <NUMBER> plpro substrate binding pocket findings signal previously discovered information sarscov<NUMBER> plpro immediately applied search effective antiviral molecules well retargeting known drugs inhibition sarscov<NUMBER> plpro structures novel inhibitors vir<NUMBER> vir<NUMBER> complex sarscov<NUMBER> plpro provides framework rational development inhibitors improved potency altogether data also gives hope design drug act panselective inhibitor sarscovplpro sarscov<NUMBER>plpro may universal value emerging coronaviruses near future puumala virus puuv infection causes <NUMBER> cases hemorrhagic fever europe annually influence hemostatic balance extensively infection might lead hemorrhage recent study showed increased risk myocardial infarction shortly puuv infection mechanism hantavirus influences coagulation system remains unknown therefore aimed elucidate mechanisms explaining alterations seen primary secondary hemostasis puuv infection using low passage puuv isolates infect primary human umbilical vein endothelial cells huvecs able show alterations regulation primaryand secondary hemostasis release fibrinolysis regulators main finding activation secondary hemostasis due increased tissue factor tf expression leading increased thrombin generation functional assay furthermore showed infection platelets adhered huvec subsequently specifically puuv virus particles infection huvec puuv result increased von willebrand factor produced plasminogen activator inhibitor type<NUMBER> pai<NUMBER> compared controls pai<NUMBER> produced model formed complexes vitronectin first report reveals potential mechanism behind procoagulant changes puuv patients could result increased thrombin generation due increased tf expression endothelial cells infection furthermore provide insight contribution endothelial cell responses regarding hemostasis puuv pathogenesis puumala virus puuv hantavirus carried chronically infected bank voles causative agent estimated <NUMBER> cases yearly viral hemorrhagic fever europe vapalahti et al <NUMBER> vaheri et al <NUMBER>a hantaviruses rodentborne negative stranded rna viruses belonging bunyaviridae family may cause two types disease humans goeijenbier et al <NUMBER> europe asia hantavirus infection causes hemorrhagic fever renal syndrome hfrs characterized renal failure bleeding complications north south america hantavirus infection causes hantavirus cardiopulmonary syndrome hcps patients present severe acute respiratory distress sargianou et al <NUMBER> changing ecological factors determine fluctuations hantavirus epidemiology resulting sudden increases incidence instance increased food availability prolonged virus survival decreased biodiversity reusken heyman <NUMBER> recent epidemiological studies reported overall incidence increase puuv infections europe heyman vaheri <NUMBER> although puuv infections low case fatality rate <NUMBER> literature virus often described least virulent pathogenic viruses within hantavirus genus puuv infections cause severe disease healthy adults may require long recovery period lasting <NUMBER> year schmaljohn hjelle <NUMBER> furthermore several reports described cases severe hemorrhagic complications like pituitary gland hemorrhage hematemesis gastrointestinal bleedings eckerle et al <NUMBER> antonen et al <NUMBER> contrast bleeding complications recent study sweden reported increased risk acute myocardial infarction shortly puuv infection connollyandersen et al <NUMBER> given high incidence northern europe acute myocardial infarction complication puuv infection could major impact endemic areas light bleeding thrombotic events might complicate puuv infections hypothesized endothelial cells also target cells hantaviruses major regulators coagulation inflammation play central role pathogenesis disease zhou et al <NUMBER> hantavirus infection drastic alterations coagulation system observed laine et al <NUMBER> clinical studies focusing primary secondary hemostasis hantavirus disease showed thrombocytopenia hfrs hcps decreased plasma activity coagulation factors ii v viii ix x acute hfrs patients prolongation prothrombin activated partial thromboplastin time increased thrombin generation ddimer levels decrease adamts<NUMBER> activity acute puuv patients lee <NUMBER> mackow gavrilovskaya <NUMBER> laine et al <NUMBER> mustonen et al <NUMBER> ability infect endothelial cells hantaviruses demonstrated vitro vivo yanagihara silverman <NUMBER> pensiero et al <NUMBER> toro et al <NUMBER> although infection lead cytopathic changes several studies observed endothelial cell dysfunction hantavirus infection yanagihara silverman <NUMBER> pensiero et al <NUMBER> mackow gavrilovskaya <NUMBER> ranging increased clinical markers stressed endothelium vivo sicam<NUMBER> vwf circulating endothelial cells han et al <NUMBER> krautkramer et al <NUMBER> increased permeability decreased huvec integrin ligand migration vitro geimonen et al <NUMBER> taylor et al <NUMBER> integrin ανβ<NUMBER> experimentally proven receptor hantavirus infection abundantly present surface endothelial cells gavrilovskaya et al <NUMBER> song et al <NUMBER> infection pathogenic hantaviruses suggested result loss function ανβ<NUMBER> integrin wang et al <NUMBER> also increased ανβ<NUMBER> expression cultured endothelial cells platelets observed liu et al <NUMBER> furthermore gavrilovskaya et al <NUMBER> studied adherence quiescent platelets sin nombre hantaan virus infected endothelial cells seems result virus binding ανβ<NUMBER> integrin present platelets gavrilovskaya et al <NUMBER> abnormalities primary thrombocytopenia secondary hemostasis increase thrombin generation raised ddimer levels induced puuv infected patients mechanism oldworld hantaviruses cause hemorrhage andor renal failure remain largely elusive vaheri et al <NUMBER>b lack specific treatment effective vaccine makes understanding pathophysiology hantavirus infection important medical need especially recently discovered association puuv cardiovascular disease connollyandersen et al <NUMBER> therefore used integrated approach study changes primary secondary hemostasis using vitro endothelial cell model veroe<NUMBER> cells american type culture collection usa grown dulbeccos modified eagle medium dmem containing <NUMBER> fetal bovine serum fbs lonza netherlands <NUMBER> uml penicillinstreptomycin solution <NUMBER> hepes buffer <NUMBER> sodium bicarbonate gibco life sciences usa human umbilical vein endothelial cells huvecs harvested umbilical veins kindly provided erasmus mc birth center briefly umbilical cords stored sterile <NUMBER> ml pbs supplemented gentamycin <NUMBER> μgml leo pharmaceutical denmark veins rinsed pbs containing <NUMBER> uml heparin leo pharmaceutical subsequently cells detached <NUMBER> collagenase solution c<NUMBER> sigma aldrich usa cell suspension collected sterile <NUMBER> ml tube followed two times centrifugation <NUMBER> min <NUMBER> g cell pellet resuspended huvec medium human endothelialsfm medium invitrogen life sciences usa containing <NUMBER> human serum lonza <NUMBER> filtrated fbs lonza penicilinstreptomycin <NUMBER> uml <NUMBER> ngml fibroblast growth factor peprotech usa <NUMBER> ngml endothelial cell growth factor peprotech huvec cell suspensions cultured flasks precoated <NUMBER> μgml fibronectin roche netherlands cells passage four one specific donor used study identity endothelial cells confirmed flow cytometry using ulex europeus lectin anticd<NUMBER> von willebrand factor vwf staining immunoblot made use following antibodies conjugates polyclonal rabbit antivwf hrp labeled polyclonal goat antirabbit igg polyclonal rabbit antimouse dako netherlands fitc labeled monoclonal anticd<NUMBER> sigma aldrich usa polyclonal rabbit anticd<NUMBER> perbio science netherlands polyclonal rabbit anticd<NUMBER> dako polyclonal rabbit antipuuv nucleoprotein bei resources usa monoclonal antipuuv glycoprotein hy test finland monoclonal antiανβ<NUMBER> integrin abcam uk monoclonal antivitronectin novus bio usa polyclonal rabbitanti pai<NUMBER> bio connect netherlands polyclonal rabbit antitissue factor tf bio connect human serum recovered puuv case described goeijenbier et al <NUMBER> retrieved informed consent ethical board approval antibodies conjugate diluted dilution buffer consisted pbs <NUMBER> bovine serum albumin <NUMBER> nacl <NUMBER> normal goat serum lungs myodes glareolus konnevesi finland infected puuv homogenized dmem <NUMBER> wv <NUMBER> μl added onto <NUMBER> monolayer veroe<NUMBER> cells incubated <NUMBER> min <NUMBER> • c <NUMBER> co <NUMBER> supernatant discarded cells washed three times incubated fresh veroe<NUMBER> medium additional <NUMBER> days virus stocks passage four created centrifugation <NUMBER> min <NUMBER> g supernatant create cell free virus stock virus titer determined using immune peroxidase reaction ipox tcid <NUMBER> calculated using karber formula kärber <NUMBER> infectious virus inactivated using betapropiolactone bpl sigma aldrich usa <NUMBER> vv <NUMBER> • c <NUMBER> h subsequently bpl inactivated <NUMBER> h <NUMBER> • c virus stocks stored −<NUMBER> • use experiments conducted biosafety instructions required regarding work live puuv vesicular stomatitis virus vsv strain indiana propagated also veroe<NUMBER> cells kindly provided dr bart haagmans erasmus mc human umbilical vein endothelial cell seeded <NUMBER>well<NUMBER> × <NUMBER> <NUMBER> cells <NUMBER>well plates <NUMBER> × <NUMBER> <NUMBER> cells corning usa depending experiment confluent monolayers infected multiplicity infection moi <NUMBER> <NUMBER> infectious inactivated bplinactivated virus normal medium control <NUMBER> min <NUMBER> • c <NUMBER> co <NUMBER> incubation supernatant discarded cells washed three times rpmi <NUMBER> gibco life sciences fresh medium added described earlier vwf plasminogen activator inhibitor type<NUMBER> pai<NUMBER> quantification medium contain fcs supplemented <NUMBER> sterile filtered bovine serum albumin bsa sigma aldrich usa avoid addition fetal calf vwf pai<NUMBER> zoellner et al <NUMBER> quantify percentage infected cells used house developed ipox procedure huvec washed three times pbs cells fixed absolute −<NUMBER> • c methanol incubated −<NUMBER> • c <NUMBER> min fixation methanol discarded cells incubated <NUMBER> min <NUMBER> • c <NUMBER> μl <NUMBER> h <NUMBER> <NUMBER> pbs block endogenous peroxidases subsequently cells washed three times pbs incubated <NUMBER> min polyclonal rabbit antipuuv nucleoprotein antibody <NUMBER> cells washed pbs <NUMBER> tween followed incubation hrplabeled goat antirabbit igg conjugate <NUMBER> color development achieved addition <NUMBER>amino<NUMBER>ethylcarbazole aec substrate aec dissolved dimethylformamide buffered acetate buffer ph <NUMBER> percentage infected cells determined manual counting quantification viral replication used standard line house generated puuv rna runoff transcripts described westnile virus lim et al <NUMBER> briefly rna runoff transcripts generated using segment amplified panhantavirus degenerative pcr primers johansson et al <NUMBER> pcr products separated <NUMBER> agarose gel bands correct size collected dna gel extraction using minelute gel extraction kit protocol qiagen usa dna fragments cloned pcr<NUMBER> vector using topo ta cloning kit life technologies one shot top<NUMBER> chemically competent escherichia coli transformed recombinant vector qiagen according manufacturers protocol least five colonies collected analyses plasmid dna purified using minelute dna purification kit qiagen plasmid dna linearized restriction digestion noti negative strand rna psti positive strand rna runoff transcripts vitro transcripts synthesized using t<NUMBER> rna polymerase negative strand t<NUMBER> rna polymerase positive strand megascript t<NUMBER> t<NUMBER> transcription kits life technologies followed dnase treatment ambion turbo dnafree tm life technologies according manufacturers manual amount rna stock determined using nanodrop serially diluted copy numbers standards calculated using rna concentration sequence length help online calculator httpendmemocombiodnacopynumphp study interaction puuv platelets platelets collected according protocol described gavrilovskaya et al <NUMBER> minor modifications briefly blood collected <NUMBER> end concentration sodium citrate tubes bdplymouth uk supplemented <NUMBER> μm prostaglandin e<NUMBER> cayman chemical usa block platelet activation plateletrich plasma prp prepared centrifugation <NUMBER> min <NUMBER> × g <NUMBER> • c subsequently platelets pelleted <NUMBER> min <NUMBER> × g <NUMBER> • c platelets washed twice resuspended modified hepes buffer <NUMBER> mm hepes <NUMBER> mm nacl <NUMBER> albumin <NUMBER> μm prostaglandin e<NUMBER> ph <NUMBER> counted hematocytometer platelets <NUMBER> <NUMBER> per ml incubated infected huvec <NUMBER> wells plate puuv bpl inactivated puuv mock control <NUMBER> min <NUMBER> • c incubation monolayers washed three times rpmi cells fixed formalin fixation formalin discarded cells incubated <NUMBER> min <NUMBER> • c<NUMBER> co <NUMBER> pbs <NUMBER> h <NUMBER> <NUMBER> three washing steps cells incubated rabbit polyclonal antihuman cd<NUMBER>a antibody <NUMBER> following steps described earlier ipox incubation hrplabeled goat antirabbit conjugate <NUMBER> tmb added wells substrate reaction <NUMBER> min reaction stopped addition <NUMBER> sulphuric acid optical density od measured <NUMBER> nm using tecan elisa reader cd<NUMBER>a expression od calculated subtracting blanc od value wells incubated without platelets detection antibody conjugate rabbit polyclonal anticd<NUMBER> <NUMBER> served isotype control test changes cd<NUMBER>a expression related direct binding puuv platelets mechanism shown hantaan andes virus infection gavrilovskaya et al <NUMBER> pull assay designed end first coated elisa plates puuv control virus vsv <NUMBER> μl <NUMBER> <NUMBER> virus particles dmem <NUMBER> • c overnight followed platelet incubation <NUMBER> <NUMBER> platelets subsequently cells washed five times pbs bound platelets quantified using platelet detection antibody anticd<NUMBER>a <NUMBER> dilution buffer followed conjugate substrate reaction cd<NUMBER>a expression calculated subtraction od measured wells without platelet incubations blanco correct direct aspecific anticd<NUMBER>a antibody binding puuv anticd<NUMBER> used isotype control subsequently elisa plates coated mouse monoclonal antipuuv glycoproteinor isotype control antibody igg<NUMBER> corona virus <NUMBER> pbs <NUMBER> • c overnight followed incubation puuv capture virus followed platelet incubation detection antibody conjugate substrate reaction thirdly confirm platelet puuv binding elisa plates coated antiplatelet antibody <NUMBER> pbs <NUMBER> • c overnight followed incubation fresh isolated platelets eventually incubation step puuv vsv followed hantavirus detection antibody mouse mab antipuuvglycoprotein <NUMBER> washing substrate reaction achieved conjugate addition tmb reaction steps final step studied potential blocking platelet binding puuv particles addition blocking step polyclonal human anti puuv serum puuv coated plates plates coated <NUMBER> days old virus free veroe<NUMBER> medium incubated polyclonal puuv serum <NUMBER> case described goeijenbier et al <NUMBER> puuv igg negative control human serum healthy volunteer also <NUMBER> following platelet binding steps cd<NUMBER> detection earlier experiments infection <NUMBER>well plate supernatants <NUMBER> μl subsequently removed cells lysed three washing steps using <NUMBER> min incubation <NUMBER> μl pbs <NUMBER> tritonx<NUMBER> followed centrifugation <NUMBER> min <NUMBER> × g cellfree supernatants supernatant cell lysates measured using pai<NUMBER> antigen vwf elisa kits according manufacturers instructions zymugen hyphen biomed france human umbilical vein endothelial cell <NUMBER> wells plates fixed <NUMBER> formalin incubated rabbit polyclonal antitf antibody <NUMBER> followed incubation respective conjugate <NUMBER> washing tmb added substrate reaction reaction stopped <NUMBER> min addition <NUMBER> sulphuric acid od <NUMBER> nm value measured tecan elisa reader cell lysates prepared described section von willebrand factor plasminogen activator inhibitor type<NUMBER> quantification elisa plates coated mixture <NUMBER> μl cell lysate <NUMBER> μl pbs night <NUMBER> • c together standard curve recombinant tf innovin siemens healthcare diagnostics germany blocking wells incubated rabbit polyclonal antitf antibody <NUMBER> followed incubation respective conjugate <NUMBER> washing tmb added substrate reaction reaction stopped <NUMBER> min addition <NUMBER> sulphuric acid od <NUMBER> nm value measured tecan elisa reader thrombin generation plateletpoor plasma ppp measured directly huvec surface <NUMBER> well plate recalcification <NUMBER> μl pooled citrated plasma healthy donors added monolayer infected uninfected cells summary cells washed three times rpmi <NUMBER> μl freshly thawed plasma added monolayer together <NUMBER> μl hepes buffer <NUMBER> mm hepes <NUMBER> mm nacl <NUMBER> albumin plate serial dilution recombinant tf innovin siemens healthcare diagnostics germany absence cells finally <NUMBER> μl hepes calcium <NUMBER> mm hepes <NUMBER> mm nacl <NUMBER> albumin <NUMBER> mm cacl<NUMBER> added plasma directly recalcification od <NUMBER> nm value measured using tecan elisa reader kinetic cycle measuring every <NUMBER> <NUMBER> h thrombin generation time defined time halfmaximal od vitronectin pai<NUMBER> complex levels elisa plates coated antivitronectin antibody <NUMBER> pbs <NUMBER> • c overnight incubated supernatant puuv infected noninfected huvec followed incubation polyclonal antipai<NUMBER> antibody <NUMBER> subsequent conjugatesubstrate reaction pbs incubation used blanc control anticd<NUMBER> antibody <NUMBER> incubation isotype control statistical analyses performed using graphpad prism <NUMBER> windows comparing two groups made use students ttest mannwhitney u depending distribution data comparison multiple groups nonparametric kruskalwallis test used dunns multiple comparison test oneway anova tukeys multiple comparisons test depending distribution data p ≤ <NUMBER> considered significant prevent puuv vitro loss virulence virus stocks four passages prepared freshly isolated huvec infected moi <NUMBER> <NUMBER> puuv infected replicated huvec summarized figure <NUMBER> noninfected cells figures <NUMBER>ab showed red peroxidase staining confirming specificity puuvstaining <NUMBER> h post infection low moi infection <NUMBER> onward figure <NUMBER>c frontiers microbiology wwwfrontiersinorg small percentage ±<NUMBER> cells infected strongly increased <NUMBER> h figure <NUMBER>d resulting <NUMBER> infected stained cells twentyfour hours infection moi <NUMBER> <NUMBER> cells infected figure <NUMBER>e increased <NUMBER> <NUMBER> h figure <NUMBER>f comparable kinetics seen viral rna copy numbers determined end viral rna numbers estimated supernatant figure <NUMBER>g cell lysate figure <NUMBER>h mois number viral rna increased significantly <NUMBER>log <NUMBER> h kruskalwallis p <NUMBER> supernatant well cell lysate confirming active viral replication viral replication reached plateau <NUMBER> h post infection furthermore westernblot analysis cell lysate puuv nucleoprotein confirmed infection huvec figure <NUMBER>i viral copy numbers supernatant cell lysate huvec incubated bpl inactivated virus served control nonreplicating virus consistently rna copy numbers increase time indicating efficient inactivation virus bpl treatment efficient inactivation confirmed negative ipox staining huvec incubated bpl inactivated puuv data shown gavrilovskaya et al <NUMBER> reported potential hantaan andes virus bind quiescent platelets via ανβ<NUMBER> integrin since observation much importance understanding alterations primary hemostasis role disease mechanisms hfrs decided confirm mechanism puuv using different approach first assessed ability quiescent platelets bind puuv infected huvec figure <NUMBER> binding platelets determined measuring intensity cd<NUMBER>a platelet glycoprotein iib heterodimeric integral membrane protein present platelets megakaryocytes cd<NUMBER>a expression significantly higher huvec monolayer infection moi <NUMBER> <NUMBER> compared control detection cd<NUMBER>a expression differ platelets added huvec monolayers suggesting nonspecific anticd<NUMBER>a binding infected cells furthermore difference od values isotype control anticd<NUMBER> used detect platelets based cd<NUMBER>a expression statistically significant differences measured infected wells wells incubated virus free veroe<NUMBER> medium negative control <NUMBER> h post infection one way anova moi <NUMBER> vs neg p <NUMBER> moi <NUMBER> vs neg p <NUMBER> <NUMBER> h infection difference cd<NUMBER>a expression also significant moi <NUMBER> infected wells bpl inactivated virus control one way anova moi <NUMBER> vs neg p <NUMBER> moi <NUMBER> vs bpl p <NUMBER> moi <NUMBER> vs neg p <NUMBER> taken together data indicate platelets bind cultures incubated puuv huvec incubated bpl show trend increased platelet cd<NUMBER>a expression figure <NUMBER> statistically significant measured vwf antigen cell free supernatant vwf expression surface infected huvec increased vwf production may general inflammatory response endothelial cells could evoked result puuv infection however time points platelet binding increased huvecs infected puuv showed alteration vwf activity determined elisa neither supernatant cell lysate data shown compared bpl negative control next looked whether platelets could bind directly puuv particles purpose performed inhouse developed platelet pull downassay using quiescent platelets end several experiments conducted demonstrate specificity binding figure <NUMBER> shows results binding platelets viruscoated elisa plates figure <NUMBER>a platelets frontiers microbiology wwwfrontiersinorg figure <NUMBER> puumala virus platelets bind pull assay platelets adhere better puuv virus particles compared vesicular stomatitis virus vsv mannwhitney u p <NUMBER> virus captured puuv glycoprotein antibody b platelets able bind captured virus contrast wells coated igg<NUMBER> control antibody anticoronavirus glycoprotein mannwhitney u p <NUMBER> resulting capture puuv incubation process controlling potential factors present virus stock medium platelets bound plates coated anticd<NUMBER>a antibody c puuv particles able bind platelets based significant increase puuv detection od compared wells incubated vsv particles thus puuv present mannwhitney u p <NUMBER> binding puuv platelets could blocked addition blocking step human antipuuv serum show decreased cd<NUMBER> expression compared puuv coated wells incubated puuv negative control serum experiments difference od measured isotype control antibody used data representative three independent experiments p <NUMBER> p ≤ <NUMBER> mannwhitney u p <NUMBER> adhered plates directly coated puuv compared plates coated virus control vsv cultured conditions puuv subsequently control binding platelets directly puuv particles due another factor present veroe<NUMBER> supernatant made use sandwich elisa principle puuv incubated elisa plates wells coated monoclonal igg<NUMBER> specific glycoprotein puuv igg<NUMBER> control antibody approach significantly platelets bound wells puuv captured compared wells puuv capture mannwhitney u p <NUMBER> figure <NUMBER>b confirm direct binding platelets puuv platelets captured anticd<NUMBER> coated elisa plates incubated virus followed detection puuv specific antibody control binding puuv detection antibody captured platelets control wells incubated vsv puuv detection significantly higher wells incubated puuv compared vsv mannwhitney u p <NUMBER> figure <NUMBER>c experiments collectively suggest platelets specifically bind puuv finally show figure <NUMBER>d binding platelets puuv particles could blocked addition blocking step human serum recovered puuv case wells coated puuv incubated human serum proven puuv neutralizing igg antibodies significantly less platelets adhered wells compared wells incubated puuv negative human control serum figure <NUMBER>d p <NUMBER> anticd<NUMBER> expression wells blocking step comparable negative control consisted whiskers minimum maximum moi <NUMBER> infection resulted shortened tgt <NUMBER> h post infection one way anova p <NUMBER> mean tissue factor tf concentration calculated tgt standard curve increased ninefold moi <NUMBER> infection one way anova <NUMBER> <NUMBER> h p <NUMBER> moi <NUMBER> infection increased tf concentration threefold <NUMBER> h one way anova p <NUMBER> e f bars represent se mean data representative three independent experiments p <NUMBER> p <NUMBER> p ≤ <NUMBER> plates coated <NUMBER> days old vero e<NUMBER> virus free medium binding neutralizing igg antibodies confirmed incubation goatanti human hrp labeled conjugate subsequent tmb reaction test hypothesis whether increased thrombin generation observed acute puuv patients result increased tf expression endothelial cells incubated huvec infected puuv moi <NUMBER> virus free <NUMBER> days old vero e<NUMBER> medium control polyclonal antitf antibody approach showed tf expression significantly increased almost twofold increase od value <NUMBER> h post infection figure <NUMBER>a mannwhitney u p <NUMBER> cells infected puuv also showed increased tf concentration cell lysates puuv infected wells compared lysates control wells figure <NUMBER>b mock bpl subsequently wanted prove increase tf expression endothelial cell surface biological significance would led increased thrombin generation thrombin generation quantified directly infected endothelial cells incubating normal plasma cells initiating coagulation addition calcium ions infected cells induced plasma clotting faster due increased thrombin generation figures <NUMBER>cd using calibration curve purified tf absence endothelial cells quantified huvec tf production virus infection incubation virus free medium control tf concentration showed statistically significant increase moi <NUMBER> <NUMBER> h compared negative control huvec infected moi <NUMBER> one way anova p <NUMBER> <NUMBER> h post infection compared negative control one way anova p <NUMBER> moi <NUMBER> infection led higher levels tf huvec surface <NUMBER> h post infection one way anova p <NUMBER> compared mock increased levels pai<NUMBER> pai<NUMBER>vitronectin complexes huvec supernatant infection puuv important proteins regulation fibrinolysis show close interactions pathogenic hantavirus receptor ανβ<NUMBER> integrin instance vitronectin stabilizer pai<NUMBER> activity plasma largely regulated receptor mackow gavrilovskaya <NUMBER> florova et al <NUMBER> study potential changes regulators fibrinolysis first measured pai<NUMBER> levels cellfree supernatant supernatant cell lysate <NUMBER>well plates infected puuv control infections total pai<NUMBER> antigen combination levels supernatant cell lysate significantly increased <NUMBER> h post infection kruskalwallis p <NUMBER> moi <NUMBER> figure <NUMBER>a subsequently tested model pai<NUMBER> would bind vitronectin since binding associated increasedprolonged pai<NUMBER> activity seiffert loskutoff <NUMBER> interaction altered infection elisa plates coated monoclonal antibody vitronectin incubated supernatant experiments pooled control moi <NUMBER> infected wells followed incubation pai<NUMBER> antibody suggested formation pai<NUMBER> vitronectin complexes due increase od compared incubation pbs mean expression medium <NUMBER> mod ±<NUMBER> vs <NUMBER> mod ±<NUMBER> p <NUMBER> supernatants tested separately puuv vs mock levels pai<NUMBER> vitronectin complexes increased puuv infection mannwhitney u p <NUMBER> figure <NUMBER>b present study addresses platelet binding puuv infected cells activation secondary hemostasis endothelial cell puuv infection lack valid accessible animal model oldworld hantavirus infection remain dependent ex vivo cell culture models address questions regarding virulence pathogenesis vaheri et al <NUMBER>b taking account recently found association puuv infection cardiovascular disease connollyandersen et al <NUMBER> hemorrhagic complications may occur infection interaction puuv coagulation system especially warrants attention since puuv tends rapidly lose virulence upon vitro cell passages use low passaged isolates vital importance nemirov et al <NUMBER> therefore put lot emphasis obtaining low passage puuv isolates optimisation hemostatic assays right biosafety regulations using primary cell cultures based hemostatic changes seen several clinical studies northern europe decided study specific parts coagulation system vitro started studying effects puuv infection formation platelet plug major event primary hemostasis binding platelets puuv infected cells could explain thrombocytopenia acute puuv patients since would result wasting loss platelets adhered cells gavrilovskaya et al <NUMBER> laine et al <NUMBER> especially make notice ability hantaviruses infect megakaryocytes thereby lead decreased production platelets addition loss platelets adhered infected cells liang et al <NUMBER> lutteke et al <NUMBER> model seems puuv infection increases binding platelets surface huvec compared control cells figure <NUMBER> assumed increased cd<NUMBER>a expression observed first experiments result increased number platelets huvec theoretically increased cd<NUMBER>a detection could also due increased expression cd<NUMBER>a platelets <NUMBER> min incubation infected huvec rather actual increase platelet numbers cannot rule based experiments blocked extrinsic platelet activation prostaglandin treatment making platelet activation less likely furthermore line studies performed pathogenic hantaviruses gavrilovskaya et al <NUMBER> tested specific binding platelets puuv particles judged results platelet pull experiments figure <NUMBER> seemed specific binding virus platelets could reversed addition puuv neutralizing antibodies experiments controlled aspecific binding antibodies isotype control experiments factors present virus culture medium <NUMBER> days old veroe<NUMBER> medium control binding platelet detection antibody directly puuv expected increased platelet binding cooccur increased vwf production general inflammatory response infection however observation vwf concentration change puuv infection suggested vwfindependent mechanism platelet binding hfrs results earlier studies showed increased vwf concentration hospitalized puuv patients laine et al <NUMBER> one keep mind overall plasma vwf level patient represents state total endothelial cell layer infected cells case model furthermore studying acute response endothelial cells first <NUMBER> h infection time point puuv patients generally considered hospitalized tested increase vwf three conditions control bpl puuv time huvec model could result increased number cells sign vitro stress activation endothelial cells since seems highly unlikely cells still multiply formation full monolayer present time infection believe also noninfected cells show certain level activation culture gavrilovskaya et al <NUMBER> first study interaction hantaviruses andes hantaan platelets concluded specific binding hantaan andes virus particle particles ανβ<NUMBER> integrins present endothelial cells platelets interestingly experiment showed trend increased number platelets bound bplinactivated virus treated cultures suggesting active replication unnecessary inactivated virus bound cell surface might also bind integrins present platelets however hypothesis merely based statistical trend observed wells cells incubated bpl inactivated virus interpretation data one take mind made use moi <NUMBER> bpl <NUMBER> h bpl inactivated virus replicate therefore timepoint <NUMBER> <NUMBER> bpl control likely comparable moi <NUMBER> infection could well case increasing moi bpl infection comparable result moi <NUMBER> infection would observed puumala virus infections huvec directly increased expression tf cell surface cell lysate compared controls resulted drastic activation secondary hemostasis cell model puuv infection data direct clotting assay cell monolayer gives interesting insights potential mechanism behind increased thrombin generation seen acute puuv patients laine et al <NUMBER> laine et al <NUMBER> clear procoagulant state result increased expression tf surface puuv infected cells resulted enhanced thrombin generation increased thrombin generation decreased thrombin time overall increase prothrombin fragments <NUMBER> <NUMBER> antithrombin protein c laine et al <NUMBER> laine et al <NUMBER> observed acute puuv patients could well result direct infection endothelial cells concomitant increased production tf whether increase tf general defense response virus actually benefits tf seen certain herpesvirus infections pryzdial et al <NUMBER> remains unknown however excess tf production infection could lead increased clotting eventually consumptive coagulopathy even dic severe condition seen small percentage puuv patients laine et al <NUMBER> could one factors contributing hemorrhagic complications seen hfrs especially since increased tf expression proven play important role pathogenesis viral hemorrhagic fevers like marburg ebola geisbert et al <NUMBER>ab since alterations pai<NUMBER> levels related renal disturbances comparable seen hantavirus disease gong et al <NUMBER> malgorzewicz et al <NUMBER> functional polymorphisms pai<NUMBER> related severe disease acute puuv patients laine et al <NUMBER> also studied pai<NUMBER> regulators pai<NUMBER> activity infection puuv increases pai<NUMBER> production would vivo lead decreased fibrinolysis ανβ<NUMBER> integrin receptor plays important role pai<NUMBER>vitronectin complex formation zhou et al <NUMBER> increased ανβ<NUMBER> expression puuv infection combined competitive binding hantavirus vitronectin ανβ<NUMBER> could hypothetically lead alterations pai<NUMBER> halflife stability increased level vitronectinpai<NUMBER> complexes supernatant puuv infected cells strengthens hypothesis considering increase pai<NUMBER> vitronectin could result renal impairment even cause nephritislike response pledges evaluation interaction ανβ<NUMBER> integrin pai<NUMBER> vitronectin hantaviruses angiotensin converting enzyme ace dicarboxypeptidase cleaves angiotensin ang form angiotensin ang ii enzymatically active homologue angiotensin converting enzyme <NUMBER> ace<NUMBER> contrast degrades ang ii form ang<NUMBER> well substrates <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> limited information whether organspecific ace<NUMBER> expression altered ace decreased genetic models ace absent ace<NUMBER> acts indeed negative regulator reninangiotensin system ras regulating angiotensin ii levels ace<NUMBER> decrease ace decreases conversely ace<NUMBER> activity increase ace activity increases mode physiologic regulation however altered pathophysiologic conditions instance known kidneys diabetic mice ace<NUMBER> ace change opposite direction <NUMBER> <NUMBER> <NUMBER> <NUMBER> renal cortex diabetic dbdb <NUMBER> <NUMBER> stz mice <NUMBER> ace decreased whereas ace<NUMBER> increased note within glomeruli dbdb mice <NUMBER> ace ace<NUMBER> also altered opposite manner high ace low ace<NUMBER> contrary seen proximal tubules <NUMBER> <NUMBER> finding diabetic mice generally confirmed kidney biopsies patients diabetic kidney disease <NUMBER> examine whether deficiency kidney ace results expected physiologic decrease kidney ace<NUMBER> expression used two different genetic models ace ablation captopril telmisartan moreover used pharmacologically inhibit ace activity block at<NUMBER> receptor respectively recent recognition ace<NUMBER> main receptor facilitates coronavirus entry cells <NUMBER> raised concerns treatment reninangiotensin system blockers ras might increase risk developing severe fatal severe acute respiratory syndrome coronavirus<NUMBER> infection <NUMBER> relevant certain groups patients including hypertension heart disease diabetes mellitus clearly elderly risk covid<NUMBER> many patients treated ras blockers <NUMBER> <NUMBER> <NUMBER> concerns came previous studies showing angiotensin ii type <NUMBER> receptor blockers ace inhibitors upregulate ace<NUMBER> certain experimental conditions <NUMBER> <NUMBER> <NUMBER> <NUMBER> evidence regard always consistent differs among diverse ras blockers animal species differing organs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reasoned issue investigated assessing ace<NUMBER> expression using membrane membranes prepared target organs protein resides polarized epithelia like lungs kidneys intestine ace<NUMBER> full length form anchored apical plasma membrane <NUMBER> kidney abundant ace<NUMBER> apical border proximal tubule colocalizes ace <NUMBER> lungs contrast low level ace<NUMBER> expression metabolism angiotensin ii formation angiotensin <NUMBER> depends enzymes ace<NUMBER> namely pop <NUMBER> determine whether deficiency kidney ace alters kidney ace<NUMBER> expression used two different genetic models ace ablation mimic clinical setting patients receiving ras blockers exposed current covid <NUMBER> pandemic captopril telmisartan administered <NUMBER> weeks pharmacologically inhibit ace activity at<NUMBER> receptor respectively studies conducted review approval institutional animal care use committee northwestern university organs two genetic models ace kidney ablation ace<NUMBER> ace <NUMBER> generously provided drs hong xiao kenneth bernstein ace<NUMBER> mice somatic ace promoter replaced kidney androgenregulated protein promoter mice essentially nonfunctional <NUMBER> absence exogenous androgens levels kidney ace less <NUMBER> normal ace detected organs model overtly hypotensive <NUMBER> effect localized kidney ace deficiency kidney ace<NUMBER> levels examined ace<NUMBER> mouse model lacking ace kidney vascular endothelium <NUMBER>fold normal cardiac ace levels <NUMBER> addition ace<NUMBER> mice significant levels ace activity lung plasma blood <NUMBER> animal model kidney represents major change wildtype mice organ normally expresses substantial amount ace activity vascular endothelium proximal tubular epithelium <NUMBER> ace<NUMBER> mice near normal blood pressure exhibit gross abnormalities kidney function <NUMBER> ace models used study mixed c<NUMBER> background <NUMBER> <NUMBER> examine effect pharmacological ace inhibition ace<NUMBER> two groups <NUMBER> weeks old c<NUMBER>blksj mice assigned drink either tap water n<NUMBER> tap water ace inhibitor captopril n<NUMBER> dose <NUMBER> mgkg <NUMBER> day <NUMBER> <NUMBER> days two experimental groups <NUMBER> weeks old c<NUMBER>blksj mice randomly assigned drink either tap water vehicle n<NUMBER> tap water angiotensin ii receptor antagonist telmisartan boehringer ingelheim dose <NUMBER> mgkg <NUMBER> day <NUMBER> n<NUMBER> <NUMBER> days captopril telmisartan administration mice weighted daily fluid intake per mouse recorded estimate concentration compound needed added drinking water drug administration water consumption body weights also controlled make appropriate adjustments rna isolated kidney cortex trizol reagent gibco invitrogen quantitative realtime pcr performed using taqman gold rtpcr kit abi prism <NUMBER> applied biosystems sequencedetection system primers probes ace designed using primer express software applied biosystems sequences forward reverse primer probe ace ace<NUMBER> glyceraldehyde<NUMBER>phosphate dehydrogenase g<NUMBER>pdh described <NUMBER> reverse transcription carried <NUMBER> min <NUMBER>°c ace ace<NUMBER> mrna levels samples normalized g<NUMBER>pdh contents experiments carried triplicate data point total cell lysates tissues kidney cortex lungs homogenized buffer consisting mmoll <NUMBER> hepes ph <NUMBER> <NUMBER> nacl <NUMBER> triton x<NUMBER> <NUMBER> zncl<NUMBER> <NUMBER> phenylmethylsulphonyl fluoride clarified centrifugation <NUMBER>g <NUMBER> min membrane fraction isolation previously employed protocol used <NUMBER> without edta addition measuring protein concentration tissue samples diluted buffer <NUMBER> mmoll <NUMBER>morpholineethanesulfonic acid <NUMBER> mmoll nacl <NUMBER> µmoll zncl<NUMBER> <NUMBER> tritonx<NUMBER> ph <NUMBER> containing edtafree tablets plates read using fluorescence plate reader flx<NUMBER> biotek instruments excitation wavelength <NUMBER> nm emission wavelength <NUMBER> nm reactions performed ambient temperature microtiter plates <NUMBER> µl total volume <NUMBER> <NUMBER> total cell lysates isolated membrane preparations kidney cortices lungs isolated specified subjected western blot analysis previously described <NUMBER> detection ace nitrocellulose membranes incubated mouse monoclonal antibody <NUMBER>c<NUMBER> kind gift dr sergei danilov ace<NUMBER> protein detected using affinity purified rabbit antiace<NUMBER> antibody obtained described signals western blots quantified densitometry eagle eye stratagene corrected gapdh total cell lysates βactin membrane fraction loading control data expressed relative control vehicle wildtype animal groups assigning value <NUMBER> control baseline mean data reported mean ± standard error se significance defined p <NUMBER> comparisons two independent means ttest used ace<NUMBER> mice kidney ace mrna <NUMBER>±<NUMBER> mrna levels wt mice previously reported <NUMBER> total cell lysates ace<NUMBER> mice kidney cortex examined presence ace ace<NUMBER> protein figure <NUMBER> signal ace protein kidneys wt mice detectable single band expected molecular weight <NUMBER> kd ace<NUMBER> mice ace protein barely detectable equivalent <NUMBER>±<NUMBER> wt figure <NUMBER>b ace<NUMBER> mice ace<NUMBER> protein abundance kidney cortex total cell lysates isolated membranes reduced <NUMBER> <NUMBER> wt p<NUMBER> respectively figure <NUMBER>b <NUMBER>c concordant ace<NUMBER> protein expression ace<NUMBER> activity also reduced significantly kidneys ace<NUMBER> mice compared wt controls <NUMBER>±<NUMBER> wt figure <NUMBER>d figure <NUMBER>a whereas clearly present wt kidneys figure <NUMBER>a ace<NUMBER> protein expression isolated kidney membranes ace<NUMBER> significantly reduced <NUMBER>±<NUMBER> wt mice figure <NUMBER>b ace<NUMBER> mice ace<NUMBER> activity likewise lower wildtype difference small statistically significant <NUMBER>±<NUMBER> wt figure <NUMBER>c ace<NUMBER> mrna levels kidney cortex ace<NUMBER> mice different respective wt littermates <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> respectively kidney cortex mice treated captopril telmisartan <NUMBER> days respective vehicle treated controls examined presence ace<NUMBER> mrna protein activity significant changes mrna levels found captopril treated control mice <NUMBER>±<NUMBER> control ace<NUMBER> activity lower isolated membrane captopriltreated mice <NUMBER>±<NUMBER> vehicletreated mice difference reach statistical significance p <NUMBER> ace<NUMBER> protein abundance total lysates captopriltreated mice reduced <NUMBER>±<NUMBER> vehicletreated mice difference reach statistical significance figure <NUMBER>a isolated membranes however decrease ace<NUMBER> protein profound statistically significant <NUMBER>±<NUMBER> vehicletreated mice figure <NUMBER>b corresponding increase cytosolic ace<NUMBER> protein found figure <NUMBER>c confocal microscopy ace<NUMBER> localized apical membrane strongly colocalizes ace previously described site <NUMBER> weak ace<NUMBER> staining seen cytoplasm cells captopril treated mice suggesting internalization protein whereas ace staining remains restricted luminal membrane figure <NUMBER>c ace<NUMBER> protein lysates telmisartantreated mice significantly different vehicletreated mice <NUMBER>±<NUMBER> figure <NUMBER>d whereas isolated membranes significant decrease ace<NUMBER> protein <NUMBER>± <NUMBER> vehicletreated mice p<NUMBER> figure <NUMBER>e lung tissue ace<NUMBER> protein low demonstrated us recently <NUMBER> attempts perform western blots either total lysates isolated membranes produce signal therefore results limited ace<NUMBER> activity although low consistently detectedfigure <NUMBER> captopril treatment significant effect ace<NUMBER> activity either lung lysates figure <NUMBER>a isolated membranes figure <NUMBER>b likewise telmisartan significant effect ace<NUMBER> activity either lung lysates figure <NUMBER>c isolated membranes figure <NUMBER>d findings two different models ace genetic ablation global ace<NUMBER> mice restricted kidney ace<NUMBER> mice shows lack ace protein associated significant reduction kidney ace<NUMBER> protein decrease ace<NUMBER> level protein accompanied reduction kidney ace<NUMBER> mrna confirms ace<NUMBER> regulated post transcriptionally previously reported us<NUMBER> others <NUMBER> finding ace<NUMBER> mrna unchanged ace deficient mice also consistent previous report another genetic model tisaceknockout mice lacks tissue ace possess <NUMBER> normal circulating levels ace <NUMBER> similar results two models kidney ace deficiency tisacemice kidney expression ace<NUMBER> mrna altered ace depletion ace<NUMBER> protein abundance activity however determined previous study <NUMBER> altogether findings suggest changes ace <NUMBER> occur post transcriptionally accompanied changes ace<NUMBER> direction decrease kidney ace apt associated decrease kidney ace<NUMBER> overall directionally observed changes consistent physiologic role ace<NUMBER> terms regulating main substrate angiotensin ii <NUMBER> given intense interest ace<NUMBER> sarscov<NUMBER> receptor next wanted see similar directional change ace<NUMBER> occurs ace inhibitor at<NUMBER> blocker chronically administered reasoned terms assessing ace<NUMBER> sarscov<NUMBER> receptor matters relative abundance fulllength membrane bound ace<NUMBER> protein polarized epithelia like lungs kidneys intestine ace<NUMBER> full length form anchored apical plasma membrane <NUMBER> effect acei arbs ace<NUMBER> protein expression lungs previously studied previous studies kidney organs gave variable results <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> show captopril telmisartan decrease kidney ace<NUMBER> protein isolated membranes without significantly affecting protein abundance total cell lysates figure <NUMBER> captopril particular produced marked decline ace<NUMBER> protein isolated membranes increasing cytosolic ace<NUMBER> figure <NUMBER>c latter result somewhat unexpected ang ii shown produce internalization ace<NUMBER> cultured cells <NUMBER> discrepancy previous study ace<NUMBER>transfected neuroblastoma cells findings vivo chronic administration captopril apparent us clearly experimental conditions widely different lung tissue expression ace protein low <NUMBER> consistent previous study could detect ace<NUMBER> western analysis lung lysates isolated membranes terms enzymatic ace<NUMBER> activity significant effect either captopril telmisartan figure <NUMBER> within lung tissue ace<NUMBER> protein detectable type ii pneumocytes makes difficult assess impact ras blockers using lung membranes conclusion genetic ablation inhibition ace accompanied reduction ace<NUMBER> protein enzymatic activity transgenic model cardiac ace overexpression kidney ace ablation ace<NUMBER> protein kidney also decreased suggest changes expression one enzyme may elicit similarly directional changes homologue formation degradation ang ii coupled administration ace inhibitor at<NUMBER> receptor blocker decreased ace<NUMBER> protein expression kidney isolated membranes detectable effect ace<NUMBER> activity lung isolated membranes ace<NUMBER> expression low findings altogether suggest two potential target sites sarscov<NUMBER> infection ace<NUMBER> expressed kidney lung apical membrane ras blockers decrease effect ace<NUMBER> expression conclude medications increase ace<NUMBER> expression lung kidney epithelia therefore longer considered pose risk covid<NUMBER> information supports position many medical societies recent publications expressing view ras blockers abandoned covid<NUMBER> patients large number people potentially exposed panel c proximal tubule confocal microscopy showing ace<NUMBER> red ace green merged image yellow ace<NUMBER> apical site arrow ace<NUMBER> staining also seen cytoplasm double arrow captopril treated mice inset shows increase cytosolic ace <NUMBER> protein captopril treated compared vehicle treated mice panel shows ace<NUMBER> protein total cell lysates telmisartantreated mice panel e shows ace<NUMBER> protein isolated membranes telmisartantreated mice p<NUMBER> p<NUMBER> authors recently suggested angiotensinconverting enzyme ace inhibitors angiotensin ii receptor blockers arbs discontinued even temporarily given current pandemic sarscov<NUMBER> virus suggestion based hypothesis aceinhibitors arbs may favor entry diffusion sarscov<NUMBER> virus human cells aceinhibitors arbs may increase expression ace<NUMBER> receptors sites viral entry human organism ace<NUMBER> receptors ubiquitous although extremely abundant cell surface type <NUMBER> pneumocytes type <NUMBER> pneumocytes small cylindrical alveolar cells located close vicinity pulmonary capillaries responsible synthesis alveolar surfactant known facilitate gas exchanges increased expression ace<NUMBER> effect aceinhibitors arbs detected increased production angiotensin<NUMBER> mrna related ace<NUMBER> fear increased expression ace<NUMBER> induced aceinhibitors arbs may ultimately facilitate entry diffusion sarscov<NUMBER> virus however clinical evidence support hypothesis furthermore available data conflicting counterintuitive findings suggest arbs may beneficial harmful indeed studies conducted different laboratories demonstrated ace<NUMBER> receptors show downregulation ie opposite would happen aceinhibitors arbs effect interaction virus animal studies downregulation ace<NUMBER> found prevalent pulmonary areas infected virus surrounding areas studies virusinduced ace<NUMBER> downregulation would lead reduced formation angiotensin<NUMBER> ace<NUMBER> degrades angiotensin ii angiotensin<NUMBER> consequent accumulation angiotensin ii excess angiotensin ii would favor pulmonary edema inflammation phenomenon directly associated angiotensin ii levels along worsening pulmonary function detrimental effects blocked arbs experimental models light considerations reasonable conclude suggestion discontinue aceinhibitors arbs patients aim preventing limiting diffusion sarscov<NUMBER> virus based clinical evidence conversely experimental studies suggest arbs might useful patients limit pulmonary damage inhibition type <NUMBER> angiotensin ii receptors controlled clinical studies area eagerly awaited review discusses facts theories potential impact aceinhibitors arbs setting sarscov<NUMBER> pandemic aceinhibitors angiotensin receptor blockers severe acute respiratory syndrome caused coronavirus k nowledge underlying biology physiology ace<NUMBER> angiotensinconverting enzyme <NUMBER> accumulated last <NUMBER> years since discovery provided major stimulus understanding reninangiotensin system ras <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> distinct roles ranging catalytic activities various substrates functional receptors severe acute respiratory syndrome sars coronaviruses sarscov amino acid transporter <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> functions master regulator ras mainly converting ang angiotensin ang ii ang <NUMBER> ang <NUMBER> respectively <NUMBER> <NUMBER> lossoffunction gainoffunction approaches experimental models human diseases defined critical role ace<NUMBER> heart failure hf systemic pulmonary hypertension ph myocardial infarction mi diabetic cardiovascular complications <NUMBER> gut dysbiosis altered gut permeability emerged important mechanism disease controlled ace<NUMBER> axis vascular lung diseases <NUMBER> <NUMBER> well diabetes mellitus <NUMBER> clinical experimental studies support physiological pathophysiological role ace<NUMBER> cardiovascular disease cvd increasingactivating ace<NUMBER> may elicit protective effects hypertension cvd although yet proven clinically <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently ace<NUMBER> garnered widespread interest cellular receptor sarscov<NUMBER> causative virus coronavirus disease <NUMBER> covid <NUMBER> pandemic emerged wuhan china late <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> offers protection acute lung injury suggesting although facilitates viral entry epithelial surface ace<NUMBER>ang <NUMBER> axis carefully manipulated mitigate sarsinduced tissue injuries represents potential target therapeutic intervention <NUMBER> <NUMBER> experimental models lung disease catalytically active ace<NUMBER> alleviates pulmonary injury vascular damage <NUMBER> <NUMBER> prevent ph decreased lung fibrosis arterial remodeling improved right ventricular performance <NUMBER> due combination direct action lungs via ace<NUMBER>dependent gutlung axis <NUMBER> <NUMBER> <NUMBER> phase ii clinical trials administration ace<NUMBER> shown reduce systemic inflammation shifted ras peptide balance away ang ii toward ang <NUMBER> <NUMBER> <NUMBER> ongoing global efforts focused manipulating ace<NUMBER>ang <NUMBER> axis curtail sarscov<NUMBER> infection affording maximal protective effects lung cardiovascular damage patients review summarize diverse roles ace<NUMBER> highlighting role sarscov<NUMBER> receptor negative regulator ras implications covid<NUMBER> pandemic also provide framework developing novel therapeutic strategies exploring ace<NUMBER> pathway relates cvd covid<NUMBER> following initial seminal discovery renin <NUMBER> tigerstedt bergman ras encompasses complex network enzymes peptides receptors figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> many metallopeptidases cluster small interrelated gene families eg neprilysin nep family unusually human homolog vasoactive zincpeptidase ace angiotensin converting enzyme identified turn century almost simultaneously <NUMBER> <NUMBER> independent approaches searching ace homologs revealed existence close relative ace gene designated aceh<NUMBER> ace<NUMBER> <NUMBER> aceh cloned human lymphoma cdna library identical ace<NUMBER> human hf ventricular cdna library latter emphasizing potential role ace<NUMBER> cardiovascular pathologies expression ace<NUMBER> gene initially established heart kidney testis subsequent studies shown much broader distribution including upper airways lungs gut liver figure <NUMBER>a sequence comparison ace ace<NUMBER> strongly suggested ace<NUMBER> like ace integral transmembrane protein ectoenzyme transmembrane anchor close cterminus type membrane protein close evolutionary relationship existed ace ace<NUMBER> genes presumed <NUMBER> proteins would similar substrate specificities involvement ras turned important differences occur particularly active site regions enzymes <NUMBER> enzymes counterbalance rather reinforce others actions many subsequent studies next <NUMBER> years revealed interrelationship respective roles ras multiple physiological pathological actions vasoactive peptide metabolism importantly including ang ii also apelin intestinal amino acid transport affecting innate immunity lung function brain amyloid metabolism converting aβ<NUMBER> aβ<NUMBER> substrate ace <NUMBER> <NUMBER> <NUMBER> another unexpected twist ace<NUMBER> biology identification <NUMBER> cellsurface receptor newly identified sarscov led <NUMBER> cases sars almost <NUMBER> deaths <NUMBER> receptor sarscov<NUMBER> currently devastating many countries worldwide <NUMBER> <NUMBER> ace<NUMBER> gene basic biochemistry unlike ace gene located human chromosome <NUMBER> <NUMBER>kb ace<NUMBER> gene located chromosome xp<NUMBER> contains <NUMBER> exons resemble exons ace gene whereas somatic ace contains <NUMBER> active sites ace<NUMBER> possesses single catalytic domain ace ace<NUMBER> act zinc metallopeptidases differing substrate specificities defining distinct counterbalancing roles ras whereas ace cleaves cterminal dipeptide residues susceptible substrates peptidyl dipeptidase ace<NUMBER> acts simple carboxypeptidase able hydrolyze ang forming ang <NUMBER> ang ii ang <NUMBER> figure <NUMBER>b ace<NUMBER> cleave bradykinin distinguishing specificity ace also insensitive conventional ace inhibitors <NUMBER> <NUMBER> cterminal domain ace<NUMBER> similarity ace homolog renal protein collectrin regulates trafficking amino acid transporters cell surface endowing ace<NUMBER> multiple distinctive physiological functions multiplicity physiological roles ace<NUMBER> plays allowed hijacked sarscov<NUMBER> receptor resulting covid<NUMBER> pandemic <NUMBER> <NUMBER> structural studies revealed structures sarscov much recently sarscov<NUMBER> complex ace<NUMBER> figure <NUMBER>b <NUMBER> <NUMBER> case sarscov<NUMBER> major spike glycoprotein s<NUMBER> binds nterminal region ace<NUMBER> knowledge biology physiology ace<NUMBER> accumulated last <NUMBER> years since discovery provide major stimulus understanding key steps sarscov<NUMBER> infection ultimate prevention march <NUMBER> <NUMBER> world health organization declared outbreak sarscov<NUMBER> global pandemic reporting community scale transmissions occurring every continent outside antarctica since outbreak escalated well one million cases caused <NUMBER> <NUMBER> deaths worldwide start april <NUMBER> however emergence sarscov <NUMBER> coronaviruses conventionally viewed inconsequential pathogens circulating nature throughout various host intermediate species occasionally infected humans causing mild upper respiratory tract infections symptoms common cold <NUMBER> <NUMBER> <NUMBER> better understand renin first component ras discovered following finding extracts rabbit kidney produced pressor effects tigerstedt bergman <NUMBER> constriction renal artery found lead hypertension htn thus driving discovery hypertensin angiotonin later termed angiotensin goldblatt et al <NUMBER> page helmer <NUMBER> ang angiotensin subsequently purified <NUMBER> forms resolved ang ang ii therefore existence converting enzyme predicted ace subsequently isolated characterized skeggs et al <NUMBER> severity global health risks posed sarscov<NUMBER> optimize treatment infected patients must recognize role ace<NUMBER> sarscov<NUMBER> pathogenesis addition respiratory involvement multiorgan dysfunction occurs response sarscov<NUMBER> infections <NUMBER> <NUMBER> <NUMBER> respiratory symptoms predominant acute cardiac kidney injuries arrhythmias gut liver function abnormalities documented infected patients suggesting myocardial renal enteric hepatic damage covid<NUMBER> similarly sarscov also resulted systemic manifestations damages heart gastrointestinal liver kidney tissues <NUMBER> <NUMBER> ace<NUMBER> receptor sarscov<NUMBER> sarscov<NUMBER> differs original sarscov <NUMBER> amino acid substitutions translates differences five six vital amino acids receptorbinding domain viral spike protein surface expressed human ace<NUMBER> <NUMBER> viral sproteins well established significant determinant host tropism represents key target therapeutic vaccine development additionally host cell proteases important sarscov<NUMBER> entry infection cells sproteins ace<NUMBER> proteolytically modified process binding affinity sarscov<NUMBER> ace<NUMBER> seems stronger sarscov alterations several amino acid residues allowing enhanced hydrophobic interactions salt bridge formations may explain considerably larger global influence covid<NUMBER> initial sars <NUMBER> <NUMBER> moreover sarscov<NUMBER> evolved utilize wide array host proteases including cathepsin l cathepsin b trypsin factor x elastase furin tmprss<NUMBER> transmembrane protease serine <NUMBER> sprotein priming facilitating cell entry following receptor binding <NUMBER> far tmprss<NUMBER> cathepsin lb mediates sprotein priming sarscov<NUMBER> camostat mesylate serine protease inhibitor combined cathepsin lb inhibitor e<NUMBER>d blocked sarscov<NUMBER> entry <NUMBER> entry sarscov sarscov<NUMBER> cells facilitated interaction viral sprotein extracellular domains transmembrane ace<NUMBER> proteins followed subsequent downregulation surface ace<NUMBER> expression figure <NUMBER> <NUMBER> ace<NUMBER>derived peptides small molecule inhibitors ace<NUMBER> antibody single chain antibody fragment ace<NUMBER> postmortem autopsy heart tissues <NUMBER> patients succumbed sarscov <NUMBER> heart samples detectable viral sarscov genome characterized increased myocardial fibrosis inflammation reduced myocardial ace<NUMBER> expression <NUMBER> patients also much aggressive illness associated earlier mortality additionally bilateral pleural effusions frequently observed autopsy sarscov patients supporting evidence cardiac involvement individuals preexisting diabetes mellitus hypertension lung disease particular risk covid<NUMBER> infection <NUMBER> <NUMBER> likely due dysregulated ras occurs conditions <NUMBER> <NUMBER> significance sarscov<NUMBER> infection cardiovascular system reflected incidences acute myocardial injury elevated high sensitivity troponin levels andor new ecgechocardiogram abnormalities arrhythmias cardiac arrest sepsis septic shock viral myocarditis hf elevated ntprobnp levels systolic dysfunction cardiac magnetic resonance imaging <NUMBER> <NUMBER> <NUMBER> <NUMBER> abnormalities laboratory tests including elevation ddimers reflective increased thrombosis risk may lead acute coronary syndrome sustained increased inflammatory cytokines levels throughout clinical course suggest ongoing systemic tissue inflammation patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> gut dysbiosis possible link disease progression covid<NUMBER> patients ubiquitous expression ace<NUMBER> throughout luminal surface gastrointestinal tract prevalently enterocytes may serve secondary site enteric sarscov<NUMBER> infection figure <NUMBER>a leaky gastrointestinal ace<NUMBER>mediated cardiovascular protection lost following endocytosis enzyme along severe acute respiratory syndromecoronavirus sarscov<NUMBER> viral particles ang ii angiotensin ii levels elevate increased activity angiotensin <NUMBER> receptors <NUMBER> r cost ace<NUMBER> ang <NUMBER> driven pathways leading adverse fibrosis hypertrophy increased reactive oxygen species ros vasoconstriction gut dysbiosis adam<NUMBER> disintegrin metalloproteinase <NUMBER>mediated proteolytic cleavage ace<NUMBER> upregulated endocytosed sarscov<NUMBER> spike proteins activation <NUMBER> r elevated ang ii levels also increases adam<NUMBER> activity adam<NUMBER> correspondingly also cleaves primary substrate releasing soluble tnfα tumor necrosis factorα extracellular region autoand paracrine functionality tnfα activation tumor necrosis factor receptor tnfr represents third pathway elevating adam<NUMBER> activity tnfα along systemic cytokines released due sarscov<NUMBER> infection conjunction comorbidities diabetes mellitus hypertension lead cytokine storm tmprss<NUMBER> indicates transmembrane protease serine <NUMBER> conditions experimental models human disease ameliorated worsened either gain loss ace<NUMBER> respectively <NUMBER> <NUMBER> patients covid<NUMBER> also suffer gastrointestinal discomfort diarrhea may arise earlier respiratory conditions concurrent detection viral rna feces seen previous coronavirus outbreaks <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover common comorbidities cvd including diabetes mellitus obesity known affect integrity gastrointestinalblood barrier result gut dysbiosis bacteremia systemic inflammation figure <NUMBER> development gastrointestinal leakage gut dysbiosis correspondingly linked onset ph gutlung axis closely related hyperactivation aceang iiat <NUMBER> r angiotensin ii type <NUMBER> receptor axis ace<NUMBER> loss <NUMBER> <NUMBER> continued viral production host enterocytes perpetuates situation deteriorates conditions gutlung axis <NUMBER> <NUMBER> evidence supports sarscov<NUMBER> infection potentially leads degeneration gutblood barrier leading systemic spread bacteria endotoxins microbial metabolites likely affecting hosts response covid<NUMBER> infection cumulating multisystem dysfunction septic shock <NUMBER> <NUMBER> <NUMBER> enteric involvement associated worsening patient outcomes documented initial sarscov outbreak early <NUMBER>s fecal viral rna detected <NUMBER> patients viral shedding gastrointestinal tract associated aggressive clinical course <NUMBER> <NUMBER> separate study sarscov particles detected within cytoplasm surface microvilli apical enterocytes ileum colon <NUMBER> patients covid<NUMBER> sarscov<NUMBER> detected feces suggesting fecaloral transmission <NUMBER> gastrointestinal tract sarscov possibly sarscov<NUMBER> patients acts staging ground sustained viral replication concurrent disruption enteric ace<NUMBER> axis adverse outcomes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition direct impact virus microbiome predisposing disease states diabetes mellitus <NUMBER> pulmonary disease adverse effects gut microbiome <NUMBER> may worsened sarscov<NUMBER> infection ang iidependent hypertension animal models <NUMBER> humans associated gut dysbiosis increased gut leakiness gut wall pathology <NUMBER> <NUMBER> <NUMBER> <NUMBER> broad support observations pulmonary diseases including ph copd asthma <NUMBER> <NUMBER> type <NUMBER> diabetes mellitus dysbiosis characterized decreased microbial richness diversity altered representation bacterial metabolic pathways modifications composition firmicutes f bacteroidetes b <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> disruption biomedical models shown us gut dysbiosis quite prevalent change microbial profiles alter systemic pathways exacerbating diabetes mellitus hypertension recently showed ace<NUMBER> deficiency magnifies diabetes mellitusinduced dysbiosis <NUMBER> characterized increase peptidoglycanproducing bacteria loss gut barrier integrity ace<NUMBER> −y akita mice also identified new role bone marrow cells gut ace<NUMBER> −y akita akita mice disrupted gut barrier associated reduced levels circulating angiogenic cells hematopoietic cells reparative function giving exogenous circulating angiogenic cells wildtype mice corrected gut barrier dysfunction ace<NUMBER> −y akita akita mice thus decreased enteric ace<NUMBER> expression sarscov<NUMBER> infection may similarly reduce circulating angiogenic cells compromise integrity endothelium gut epithelium leading dysbiosis examination required validate link whether direct indirect effect viral infection <NUMBER> link ace<NUMBER> adam<NUMBER> inflammation proteolytic cleavage ace<NUMBER> adam<NUMBER> tnfα tumor necrosis factorα cytokine implicated chronic inflammation extracellular domain shedding activation driven membranebound protease coined tace tnfαconverting enzyme also known adam<NUMBER> disintegrin metalloproteinase <NUMBER> <NUMBER> adam<NUMBER> type transmembrane protein belonging adamalysin subfamily zndependent metalloproteases <NUMBER> following discovery adam<NUMBER> cleaves tnfα substrate specificity enzyme expanded include various cytokines receptors many contribute initiating exacerbating inflammation <NUMBER> <NUMBER> importantly adam<NUMBER> also found mediate proteolysis ectodomain shedding ace<NUMBER> <NUMBER> enhanced ace<NUMBER> shedding resulting ras overactivation subsequent adam<NUMBER> upregulation drives pathogenesis hf atrial fibrillation coronary artery disease thoracic aortic aneurysm <NUMBER> <NUMBER> <NUMBER> <NUMBER> ang iimediated activation <NUMBER> r triggers signaling cascade culminates activation p<NUMBER> mapk mitogenactivated protein kinase adam<NUMBER> phosphorylation napdh oxidase <NUMBER>induced reactive oxygen species formation <NUMBER> <NUMBER> phosphorylation enhances catalytic activity adam<NUMBER> thus increasing ace<NUMBER> shedding resulting loss ace<NUMBER> membrane impaired conversion ang ii ang <NUMBER> leading rasmediated detrimental effects positive feedback cycle <NUMBER> <NUMBER> importantly depletion ace<NUMBER> cell surface critical pathological outcome sarscov<NUMBER> infection sarscov<NUMBER> endocytosed cells complex ace<NUMBER> thus initial detrimental effects viral infection begins loss ace<NUMBER>mediated tissue protection <NUMBER> adam<NUMBER> activity upregulated upon binding sarscov ace<NUMBER> facilitates viral entry knockdown adam<NUMBER> sirna severely attenuated sarscov cellular entry <NUMBER> molecular mechanisms sarscov another human coronavirus causes mild respiratory symptoms hnl<NUMBER>cov compared interestingly although hnl<NUMBER>cov also utilizes ace<NUMBER> receptor cellular entry induce adam<NUMBER> activation ace<NUMBER> ectodomain shedding <NUMBER> <NUMBER> therefore study elucidates unique role adam<NUMBER> mediated shedding ace<NUMBER> sarscov infectivity may inform disparity severity coronavirus subtypes furthermore loss membrane ace<NUMBER> promotes ang ii accumulation also activates adam<NUMBER> activity thus perpetuating membrane shedding ace<NUMBER> ras overactivation inflammation <NUMBER> modulatory effects ang iiat <NUMBER> r ang <NUMBER>masr axes make ace<NUMBER> plausible target preventing treating chronic inflammation inflammatory diseases highlighted recent covid<NUMBER> pandemic <NUMBER> patients covid<NUMBER> develop pneumonia acceleration injury susceptible patients multiple organ failure <NUMBER> driven part inflammatory cytokine storm notable cause death patients critically ill <NUMBER> <NUMBER> immune system activated due factors sarscov<NUMBER> infection imbalance th<NUMBER>treg cell function overactivation immune cells secrete large number proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> imbalance ras system loss ace<NUMBER> patients covid<NUMBER> contributing factors tissue systemic inflammation <NUMBER> <NUMBER> lipopolysaccharideinduced acute lung injury decreased expression ace<NUMBER> precipitated inflammatory injury upregulated expression renin ang ii ace at<NUMBER> receptors <NUMBER> injection rhace<NUMBER> lung function pathological injury improved attenuation inflammation <NUMBER> addition rhace<NUMBER> beneficial improves acute lung injury caused sarscov acid inhalation sepsis <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> knockout ko mice showed severe acute respiratory distress syndrome ardsacute lung injury pathology increased vascular permeability increased pulmonary edema neutrophil accumulation deterioration lung function compared normal wt control mice <NUMBER> ace deficiency partially rescued severe phenotype mice single mutation ace<NUMBER> acute lung injury deletion ace gene <NUMBER> suggesting balance ace<NUMBER>ace levels key lung injurylung protection inflammatory storm arbs at<NUMBER>r blockers induce ace<NUMBER> ang <NUMBER> mas expression line reduction proinflammatory cytokines induction il<NUMBER> antiinflammatory cytokine <NUMBER> showed ace<NUMBER> ko hypertensive mice exhibited enhancement proinflammatory cytokines il<NUMBER>β il<NUMBER> tnfα chemokine cc motif ligand <NUMBER> administration rhace<NUMBER> rescued ang iiinduced tlymphocytemediated inflammation <NUMBER> <NUMBER> blockade mas receptor dala<NUMBER>ang <NUMBER> a<NUMBER> completely inhibited ang <NUMBER> mediated antiinflammatory effects ave <NUMBER> agonist ang <NUMBER> receptors mimicked actions ang<NUMBER> <NUMBER> negative regulator ras discovery ace<NUMBER> resulted paradigmchanging concept aspects ras ace<NUMBER> monocarboxypeptidase converts ang nonapeptide ang <NUMBER> ang ii heptapeptide ang <NUMBER> figure <NUMBER>a distinct enzymatic pathway degradation ang ang ii negatively regulates ras activation mitigates deleterious actions mediated ang ii <NUMBER> r <NUMBER> particular significance pathological conditions ras overstimulated ang <NUMBER> biologically active peptide whose vast array effects opposite attributed ang ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore ace<NUMBER> antagonize aceindependent formation ang ii mast cell chymase <NUMBER> <NUMBER> <NUMBER> endogenous orphan receptor mas receptor masr identified ang <NUMBER> receptor a<NUMBER> masr antagonist shown inhibit majority ang <NUMBER> effects <NUMBER> ang <NUMBER> also shown beneficial biological effects via <NUMBER> r result cardioprotection <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus ace<NUMBER>ang <NUMBER>masr axis emerged physiological antagonist counterregulates activated ras <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cardioprotective effects ace<NUMBER> taken together attributed <NUMBER> degradation ang ang <NUMBER> whereby limiting action ace substrate <NUMBER> reducing ang ii detrimental effects degradation peptide <NUMBER> formation ang <NUMBER> exercises cardioprotective effects formation ang <NUMBER> important mechanism ace<NUMBER> mediated protection antagonism ang <NUMBER> using a<NUMBER> prevented beneficial effects rhace<NUMBER> murine model systolic dysfunction <NUMBER> diminished ace<NUMBER> activity results activation ang iiat<NUMBER>r axis contributing increased progression cvd elevated ace<NUMBER> level activity result formation ang <NUMBER> ang <NUMBER> leading protection cvd figure <NUMBER>a apelin family peptides act apelin receptors mediating protection cvd <NUMBER> <NUMBER> xlinked apln gene encodes <NUMBER> amino acids preproapelin subsequently cleaved endopeptidases various bioactive peptides <NUMBER> <NUMBER> amino acids length cvd including hf hypertension characterized apelin deficient state human myocardium plasma <NUMBER> <NUMBER> <NUMBER> apelin ko mice exhibit increased infarct size systolic dysfunction following coronary ligation reduced myocardial contractility concomitant increased susceptibility hf pressureoverload models <NUMBER> <NUMBER> reduced myocardial ace<NUMBER> mrna ace<NUMBER> protein levels apelin ko mice rescued infusion apelin<NUMBER> suggest crucial regulatory role apelin ace<NUMBER> gene expression <NUMBER> apelin signaling apelin receptors specifically increased ace<NUMBER> promoter activity leading increase ace<NUMBER> mrna protein <NUMBER> <NUMBER> <NUMBER> effects consistent ability pyrapelin<NUMBER> peptide negatively regulate ang iimediated superoxide production myocardial hypertrophy dysfunction fibrosis <NUMBER> analogs apelin<NUMBER> preventing abdominal aortic rupture lowdensity lipoprotein receptor ko models induced ang ii infusion <NUMBER> however ace<NUMBER> monocarboxypeptidase activity cleaves inactivates bioactive apelin peptides apelin<NUMBER> apelin<NUMBER> negative feedback mechanism heart vasculature figure <NUMBER>b <NUMBER> <NUMBER> due short halflife endogenous apelin peptides plasma synthetic apelin peptide analogs resistant ace<NUMBER> degradation retaining binding capability endogenous apelin receptors elicit protection cardiovascular system explored potential new therapies <NUMBER> <NUMBER> ace<NUMBER> chaperone protein amino acid transporter b <NUMBER> at<NUMBER> slc<NUMBER>a<NUMBER> b <NUMBER> at<NUMBER> highly expressed intestines kidneys function absorption neutral amino acids <NUMBER> ace<NUMBER>b<NUMBER>at<NUMBER> complex assembled dimer heterodimers collectrinlike domain ace<NUMBER> mediating homodimerization <NUMBER> ace<NUMBER> rasindependent function regulating intestinal amino acid homeostasis expression antimicrobial peptides gut microbiome <NUMBER> ace<NUMBER> necessary expression hartnup transporter intestine differential functional association mutant b<NUMBER>at<NUMBER> transporters ace<NUMBER> intestine regulates phenotypic heterogeneity human hartnup disorder <NUMBER> cardiovascular disease leading cause death worldwide major public health concern heart disease characterized activation several signaling pathways associated pathological hypertrophy maladaptive ventricular remodeling heart ace<NUMBER> localized cardiomyocytes cardiac fibroblasts epicardial adipose tissue coronary vascular endothelium <NUMBER> <NUMBER> <NUMBER> ang <NUMBER>masr also present cardiomyocytes cardiac fibroblasts endothelial vascular smooth muscle cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> genetic ace<NUMBER> deletion resulted exacerbation ang iimediated cardiorenal fibrosis oxidative stress heart kidney hypertensive mice administration rhace<NUMBER> recombinant human ace<NUMBER> remarkably rescued ang iiinduced hypertension pathological hypertrophy oxidant injury cardiac dysfunction <NUMBER> <NUMBER> various ace<NUMBER> polymorphisms linked cvd <NUMBER> postmi remodeling coronary artery disease common causes hf <NUMBER> <NUMBER> notably mi increases ace<NUMBER> mrna expression human mice rat hearts <NUMBER> <NUMBER> whereas genetic ace<NUMBER> deletion results worsening miinduced cardiac dysfunction infarct size mmp matrix metalloproteinase<NUMBER>mmp<NUMBER> activation extracellular matrix disruption <NUMBER> <NUMBER> loss ace<NUMBER> leads increased neutrophilic infiltration infarct periinfarct regions resulting upregulation inflammatory cytokines interferonγ il interleukin<NUMBER> chemokine mcp<NUMBER> monocyte chemoattractant protein<NUMBER> well increased phosphorylation erk<NUMBER> extracellular signalregulated kinase <NUMBER> jnk<NUMBER> signaling pathways changes blocked figure <NUMBER> ace<NUMBER> angiotensin converting enzyme <NUMBER> role reninangiotensin system peptide cascade interaction apelinergic peptide system angiotensinogen processed renin ang angiotensin cleaved ace mast cell chymase ang ii ang ii go affect cardiovascular system predominantly angiotensin type <NUMBER> receptor <NUMBER> r via angiotensin type <NUMBER> receptor <NUMBER> r alternatively ang ii degraded carboxypeptidase ace<NUMBER> pcp prolyl carboxypeptidase ang <NUMBER> angiotensin <NUMBER> ang <NUMBER> mediates protective effects throughout tissues host mas receptor masr ang <NUMBER> formed activity ace<NUMBER> ang forming ang <NUMBER> cleaved either ace nep neprilysin b stimulation apelin receptor apelin peptides leads cardiovascular protective effects disrupting ang ii signaling sequestration <NUMBER> r receptor heterodimerization apelin inactivated ace<NUMBER> cleavage cterminal phenylalanine stimulation apelin receptor promotes ace<NUMBER> mrna transcription presenting apelins role positive regulator ace<NUMBER> ros indicates reactive oxygen species arb ultimately resulting improvement myocardial function <NUMBER> contrast overexpression ace<NUMBER> action ang <NUMBER> ameliorates miinduced cardiac remodeling <NUMBER> <NUMBER> importantly heterozygote loss ace<NUMBER> seen explanted human hearts patients dilated cardiomyopathy sufficient increase susceptibility heart disease <NUMBER> hf preserved ejection fraction proinflammatory state closely linked obesityrelated cardiac microvascular dysfunction approved therapies <NUMBER> <NUMBER> <NUMBER> epicardial adipose tissue primary source inflammatory cytokines could detrimental effects heart <NUMBER> loss ace<NUMBER> increases macrophage polarization proinflammatory m<NUMBER>phenotype alternatively activated cd<NUMBER>c epicardial adipose tissue patients hf preserved ejection fraction decreases polarization antiinflammatory m<NUMBER>phenotype macrophages worsening hf preserved ejection fraction response dietinduced obesity <NUMBER> importantly ang <NUMBER> decreased macrophage polarization epicardial adipose tissue preserved cardiac function obese ace<NUMBER> ko mice <NUMBER> <NUMBER> ang <NUMBER> potent antiinflammatory effects adipose tissue obese type <NUMBER> diabetic mice protects diabetic cardiomyopathy nephropathy <NUMBER> <NUMBER> <NUMBER> ace<NUMBER>ang <NUMBER> axis also promotes browning adipose tissue leading improved metabolic effects weight loss confer benefits cardiovascular system <NUMBER> <NUMBER> blockade deleterious arm ras mainstay therapeutic management hypertensive individuals increase ace<NUMBER> vasoprotective axis ras ace inhibitors angiotensin receptor blockers arbs clearly reinforces view see section pharmacological antagonists ras ace<NUMBER> expression furthermore increased ace<NUMBER> expression protects hypertension ace<NUMBER> deficiency exacerbates hypertension renal ace<NUMBER> expression inversely related blood pressure experimental models hypertension <NUMBER> spontaneously hypertensive rat strokeprone spontaneously hypertensive rat renal ace<NUMBER> mrna levels reduced compared normotensive wistarkyoto rats <NUMBER> studies support essential role ace<NUMBER> maintaining healthy blood pressure lentiviral overexpression ace<NUMBER> results increased expression antihypertensive components ras attenuates elevated blood pressure <NUMBER> <NUMBER> pretreatment rhace<NUMBER> prevented hypertension induced ang ii decreased plasma ang ii increasing plasma ang <NUMBER> levels <NUMBER> ace<NUMBER> adam<NUMBER> selectively knocked neurons acn revealed reduction inhibitory inputs acn presympathetic neurons relevant blood pressure regulation mice ace<NUMBER> selectively knocked sim<NUMBER> neurons mice exhibited blunted blood pressure elevation preserved ace<NUMBER> activity development saltsensitive hypertension <NUMBER> metalloproteinase adam<NUMBER> responsible mediating ace<NUMBER> shedding cell membranebound domain promoted ang ii release ace<NUMBER> soluble form plasma <NUMBER> <NUMBER> <NUMBER> impairing brain ace<NUMBER> compensatory activity thus contributing development neurogenic hypertension <NUMBER> genetic ace<NUMBER> deficiency associated upregulation putative mediators atherogenesis enhances responsiveness proinflammatory stimuli suggestive key role ace<NUMBER> suppressing vascular inflammation atherosclerotic disease <NUMBER> addition ace<NUMBER> inhibition blocks neuropeptide catestatinmediated protective effects development atherosclerosis apoe −− mice fed highfat diet <NUMBER> counterregulatory role ace<NUMBER>ang <NUMBER> masr axis ras well characterized progression diabetic complications including cardiovascular kidney disease <NUMBER> <NUMBER> <NUMBER> support importance ace<NUMBER> diabetes mellitus comes impact diabetic complications wherein diabetes mellitusinduced vascular dysfunction strongly associated shift ras axis toward profibrotic proinflammatory arm ras reduction protective arm figure <NUMBER> loss protective effects ras related regulation tissue circulating levels ang ii sequelae context diabetes mellitus <NUMBER> <NUMBER> alterations within ras considered pivotal development diabetic micro macrovascular complications <NUMBER> <NUMBER> blockade proinflammatory profibrotic arms ras provides significant renoprotection experimental models diabetes mellitus patients loss ace<NUMBER> worsens diabetic kidney injury <NUMBER> rhace<NUMBER> therapeutic animal model diabetic nephropathy <NUMBER> experimental alport syndrome <NUMBER> ace inhibitors t<NUMBER>d angiotensin receptor blockade losartan irbesartan t<NUMBER>d retard progression nephropathy <NUMBER> diabetic renal tubules ace<NUMBER> gene expression decreased ≈<NUMBER> would reduce ang <NUMBER> formation allow ang ii accumulation hence directly increasing expression tgfβ ctgf connective tissue growth factor leading tubulointerstitial fibrosis <NUMBER> ras blockade retards renal damage ace inhibitor therapy mentioned resulting compensatory increase ace<NUMBER> leading renoprotection <NUMBER> therefore support loss ace<NUMBER> contributing vascular complications diabetes mellitus comes strong clinical experimental evidence <NUMBER> retinopathy common complication diabetes mellitus one leading causes blindness workingage adults linked activation oxidative stress profibrotic proinflammatory arm ras effectively curtailed ace<NUMBER>ang <NUMBER> axis experimental models <NUMBER> <NUMBER> increased secretion proinflammatory cytokines bone marrow mesenchymal stem cells skews hematopoiesis toward generation increased number myelomonocytic cells <NUMBER> target tissues diabetic complications secrete ccl<NUMBER> response high glucoseinduced stress <NUMBER> facilitating homing ccr<NUMBER> cells regions promoting development vascular complications <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition increase myeloidosis diabetics complications reduced bone marrowderived vascular reparative cells circulating angiogenic cells cd<NUMBER> cells <NUMBER> levels ace<NUMBER> mrna also significant predictor presence microvascular disease diabetic patients <NUMBER> diabetic individuals remained free retinopathy despite <NUMBER> years poor glycemic control higher mrna levels genes vasoprotective axis ace<NUMBER>mas compared age sex glycemiamatched diabetics retinopathy <NUMBER> dysfunctional cd<NUMBER> cells diabetic individuals activation protective arm ras exposing cells ang<NUMBER> corrected dysfunction restoring bioavailable reducing reactive oxygen species ang<NUMBER> gene modification cd<NUMBER> cells restored vivo vasoreparative function cells mouse retinal ischemiareperfusion injury model <NUMBER> moreover intraocular administration aavace<NUMBER> ang<NUMBER> reduced diabetes mellitusinduced retinal vascular leakage inflammation thus preventing retinopathy <NUMBER> patients diabetes mellitus dysregulated ras may influence vulnerability sarscov<NUMBER> guan et al examined <NUMBER> individuals confirmed covid <NUMBER> individuals <NUMBER> severe disease <NUMBER> diabetics <NUMBER> zhang et al studied <NUMBER> patients hospitalized due severity covid<NUMBER> infection individuals <NUMBER> diabetes mellitus interesting speculate diabetics may risk sarscov<NUMBER> infection general population may due reduced ace<NUMBER> levels typically observed vasculature diabetic individuals diabetic animal models <NUMBER> indeed loss ace<NUMBER> associated marked gut dysbiosis worsened model type <NUMBER> diabetes mellitus <NUMBER> lung epithelial cells express high levels ace<NUMBER> positively correlates airway epithelial differentiation <NUMBER> <NUMBER> <NUMBER> involvement ace<NUMBER> ards triggered multiple diseases including sarscov sarscov<NUMBER> established multiple animal models <NUMBER> <NUMBER> ace<NUMBER> ko mice exhibit severe pathology ards <NUMBER> <NUMBER> additional ace deficiency treatment ar<NUMBER>r blockers ace<NUMBER> ko mice rescues ards implicating benefit ace<NUMBER> critical balance protective versus proinflammatory fibrotic axes ras <NUMBER> findings consistent evidence beneficial effect rhace<NUMBER> pulmonary blood flow oxygenation pig model lipopolysaccharideinduced ards <NUMBER> agerelated loss ace<NUMBER> lungs correlates increased mortality worsened phenotype elderly patients covid<NUMBER> <NUMBER> ace<NUMBER> implicated acute lung injury inducing imbalance ras evidence includes acute lung injury <NUMBER> decrease pulmonary ace<NUMBER> increase ang ii levels occurs <NUMBER> supplementation ace<NUMBER> inhibition ang ii improves outcomes <NUMBER> lack decrease pulmonary ace<NUMBER> aggravates viralinduced acute lung injury ace<NUMBER> also involved ph fibrosis <NUMBER> increasing ace<NUMBER> activity using rhace<NUMBER> reduced bleomycininduced inflammation fibrosis resulting improved lung function exercise capacity <NUMBER> ace<NUMBER> activator dize protects animals ph fibrosis <NUMBER> moreover oral feeding bioencapsulated form ace<NUMBER> protects arrests progression ph <NUMBER> validation protective effect comes small human study showed ph characterized reduced ace<NUMBER> activity supplementation individuals rhace<NUMBER> improved pulmonary hemodynamics reduced oxidative inflammatory markers <NUMBER> collectively studies unequivocally establish conceptual framework ace<NUMBER> central player normal pulmonary function imbalance leads pulmonary diseases pathological neurohormonal activation ras drives development progression cvd current pharmacotherapies aim achieve multilevel ras inhibition distinct modes action although ace<NUMBER> direct cellular target therapies ace<NUMBER> gene transcription translation ultimately catalytic activities modified due intricate nature ras blocking aceang iiat <NUMBER> r axis limiting formation actions ang ii potentiates effects ace<NUMBER> endogenous ras counterregulator arbs consistently increased ace<NUMBER> mrna expression protein levels catalytic activities heart kidneys thoracic aorta translation protein levels activity differs experimental models tissues ace inhibitors table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> combination lisinopril losartan treatment normotensive lewis rats abolished increase ace<NUMBER> mrna levels observed individually retained losartan induced rise ace<NUMBER> activity heart <NUMBER> moreover lisinopril normotensive lewis rats increased ace<NUMBER> mrna without affecting ace<NUMBER> activity heart opposite observed kidneys <NUMBER> <NUMBER> findings could attributed tissuespecific regulation ace<NUMBER> higher ace<NUMBER> protein levels reported heart ace<NUMBER> activity higher kidneys spraguedawley rats adding complexity tissue ras <NUMBER> type <NUMBER> diabetic akita angiotensinogentransgenic mice dual ras blockade perindopril losartan normalized diseasemediated reduction kidney ace<NUMBER> mrna expression protein levels <NUMBER> findings suggest accumulation ang ii pathological conditions contributes modulatory effects ras blockade ace<NUMBER> ang ii regulate ace<NUMBER> expression <NUMBER> r healthy hearts kidneys characterized high levels ace<NUMBER> mrna protein expression moderate expression ace <NUMBER> ras overactivation cvd increases at<NUMBER>r stimulation ang ii promoting erk<NUMBER> p<NUMBER> mapk signaling pathways downregulate ace<NUMBER> upregulating ace expression <NUMBER> activation p<NUMBER> mapk upregulates adam<NUMBER> activity though posttranslational phosphorylation cytoplasmic domain results shedding surface ace<NUMBER> positive feedback loop could explain observed effects arbs increasing ace<NUMBER> protein levels activity <NUMBER> <NUMBER> <NUMBER> mechanisms behind augmentation ace<NUMBER> mrna levels ace inhibitors arbs require characterization moreover mineralocorticoid receptor antagonists increased ace<NUMBER> mrna expression activity samples patients chronic hf wildtype mice rats varying degrees among different tissues heart rat hypertensive disease model table <NUMBER> <NUMBER> <NUMBER> spironolactone nonselective mineralocorticoid receptor antagonist prevented increase ace <NUMBER> r mrna levels associated increase <NUMBER> r density aldosterone signaling cardiomyocytes <NUMBER> <NUMBER> activation mineralocorticoid receptors also stimulates overlapping downstream signaling pathways <NUMBER> r including erk<NUMBER> p<NUMBER> mapk pathways mentioned <NUMBER> <NUMBER> blocking signaling pathways contributes observed effect mineralocorticoid receptor antagonist ace<NUMBER> gene expression surface protein levels activity promoting ace<NUMBER>ang <NUMBER>mas signaling rhace<NUMBER> ang <NUMBER> receptors agonist ave <NUMBER> salutary therapeutic effects cvd lung disease diverse etiologies <NUMBER> ang <NUMBER> receptors agonist ave <NUMBER> shown exert cardiorenal pulmonary protective effects <NUMBER> treatment rhace<NUMBER> improved symptoms acute lung injury cvd kidney injury various preclinical models <NUMBER> <NUMBER> <NUMBER> <NUMBER> maintaining ace<NUMBER> levels patients predisposed common cvd states diabetes mellitus hypertension obesity wards advancement comorbidities instances patient contracts sarscov<NUMBER> maintaining level ace<NUMBER>ang<NUMBER> masr negative counterregulation rhace<NUMBER> functionally sequesters circulating viral particles prevent sprotein interactions endogenous ace<NUMBER> simultaneously regulating systemic ras may provide therapeutic benefits covid<NUMBER> moving phase ii clinical trials europe <NUMBER> potential limitation rhace<NUMBER> restricted penetrance activity tissue ras owning large molecular size pharmacological ras blockade agents arbs particular capable modulating systemic tissue ras simultaneously increasing ace<NUMBER> expression activity experimental models direct implications ras inhibition patients covid<NUMBER> hypertension remain elusive clinical evidence desperately needed determine relative benefits risks associated usage medications <NUMBER> nonetheless introducing arbs patients already infected sarscov<NUMBER> may effective therapeutic option addressing viralmediated ras imbalance currently investigation several clinical trials wwwclinicaltrialgov number nct<NUMBER> nct<NUMBER> nct<NUMBER> <NUMBER> <NUMBER> <NUMBER> potential ace<NUMBER> therapy also facilitated using probiotic species lactobacillus paracasei lp engineered express recombinant ace indicates angiotensinconverting enzyme ras reninangiotensin system proteins mice treated recombinant lp expressing secreted ace<NUMBER> fusion nontoxic subunit b cholera toxin acts carrier facilitate transmucosal transport showed increased ace<NUMBER> activities serum tissues reduced diabetic retinopathy <NUMBER> results provide proof concept using bioengineered probiotic species live vectors delivery human ace<NUMBER> enhanced tissue bioavailability treating diabetic complications could potentially repurposed treating cvd covid<NUMBER> infection since discovery ace<NUMBER> <NUMBER> tremendous progress made elucidating biochemical actions fundamental role cvd recently sarscov<NUMBER> receptor ace<NUMBER> dominant mechanism negative regulation ras metabolizing ang ii beneficial peptide ang <NUMBER> important biochemical physiological property harnessed potential therapy patients hf activation ras axis due binding sarscov<NUMBER> ace<NUMBER> leading direct loss ace<NUMBER> indirectly via proteolytic processing shedding partly drives systemic manifestations covid<NUMBER> careful targeting ras axes needed patients optimize clinical outcomes including use at<NUMBER> receptor blockers arb disease <NUMBER> · reninangiotensin system · severe acute respiratory syndrome coronavirus <NUMBER> late december <NUMBER> several clusters pneumonia cases unknown aetiology reported city wuhan peoples republic china investigation respiratory samples cases identified novel coronavirus cov causative agent <NUMBER> <NUMBER> nucleotide sequence analysis viral rna genome revealed closely related betacoronavirus responsible outbreak severe acute respiratory syndrome sars asia pacific canada <NUMBER> <NUMBER> china new virus designated sarscov<NUMBER> rapidly spread throughout world total <NUMBER> confirmed cases <NUMBER> deaths <NUMBER> may <NUMBER> <NUMBER> figures likely gross underestimation actual impact sarscov<NUMBER> due limited virological testing underreporting primary routes sarscov<NUMBER> transmission respiratory droplets direct contact approximately <NUMBER> sarscov<NUMBER> infections relatively mild flulike symptoms even asymptomatic <NUMBER> cases result severe disease socalled covid<NUMBER> characterised pneumonia dyspnoea while<NUMBER> sarscov<NUMBER>infected individuals experience critical illness ie acute respiratory distress syndrome ards septic shock multiorgan failure require intensive care like original sarscov host cell penetration sarscov<NUMBER> relies interaction viral spike protein angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> ace<NUMBER> monocarboxypeptidase present surface wide variety different cell types including epithelial cells lining respiratory tract cardiac fibroblasts cardiomyocytes endothelial cells vascular smooth muscle cells vsmcs <NUMBER> <NUMBER> lungs ace<NUMBER> expression mainly found fig <NUMBER> overview major ace ace<NUMBER> substrates products gproteincoupled receptors gpcrs activated products biological consequences stimulation gpcrs mode action ace inhibitors acei angiotensin ii type<NUMBER> receptor blockers arb besides ace ace<NUMBER> proteolytic enzymes also involved processing reninangiotensin system components eg angii also generated angi chymase chy secreted mast cells ang<NUMBER> produced angi neprilysin also known neutral endopeptidase nep <NUMBER> <NUMBER> alveolar macrophages surfactantproducing type ii pneumocytes lesser extent bronchial tracheal epithelial cells <NUMBER> ace<NUMBER> paralogue angiotensinconverting enzyme ace enzymes zn <NUMBER> dependent transmembrane proteins involved production vasoactive peptides <NUMBER> <NUMBER> however ace ace<NUMBER> generally opposite effects thus functioning counterregulatory factors within reninangiotensin system ras ace converts angiotensin angiangiotensin<NUMBER> angiotensin ii angiiangiotensin<NUMBER> fig <NUMBER> binding angii angii type<NUMBER> receptor at<NUMBER>r proinflammatory prooxidative proapoptotic profibrotic effects increases vascular tone leakage fig <NUMBER> involved pathophysiology many different tissues organs <NUMBER> stimulation at<NUMBER>r surface vsmcs angii results activation signalling pathways promote vsmc contraction excessive angiiat<NUMBER>r signalling also induces proliferation migration growth vsmcs promotes vascular remodelling contributes initiation progression atherosclerosis inducing endothelial dysfunction <NUMBER> activation at<NUMBER>rs cardiac myocytes induces cellular hypertrophy binding angii at<NUMBER>rs surface cardiac fibroblasts results cardiac fibrosis stimulating synthesis extracellular matrix proteins including collagen type iii inducing proliferation migration cardiac fibroblasts <NUMBER> unbalanced at<NUMBER>r signalling lungs associated airway inflammation bronchial hyperresponsiveness fibrosis pulmonary hypertension angii also important driving force inflammatory cascade alveolar epithelial injury associated ards <NUMBER> <NUMBER> apart binding at<NUMBER>r angii also bind ang ii type<NUMBER> receptor at<NUMBER>r fig <NUMBER> stimulation receptor effects largely opposite induced angiiat<NUMBER>r signalling pathophysiological conditions angiiat<NUMBER>r signalling generally dominant angiiat<NUMBER>r signalling ace<NUMBER> cleave angi generate angiotensin<NUMBER> ang<NUMBER> angii produce angiotensin<NUMBER> ang<NUMBER> fig <NUMBER> conversion angii ang<NUMBER> ace<NUMBER> reduces detrimental angiiat<NUMBER>r signalling also generates ligand mas receptor masr activation opposes effects at<NUMBER>r stimulation angii fig <NUMBER> recently ang<NUMBER> shown also exert beneficial effects binding at<NUMBER>r inducing βarrestinbiased signalling receptor <NUMBER> ang<NUMBER> another ace<NUMBER> reaction product involved counterbalancing angiiat<NUMBER>r signalling stimulating at<NUMBER>r signalling fig <NUMBER> sarscov<NUMBER> uptake receptormediated endocytosis directly indirectly lowers ace<NUMBER> surface expression reduces conversion angii ang<NUMBER> hence causes misbalance activities aceangiiat<NUMBER>r ace<NUMBER>ang<NUMBER>masr axes together sarscov<NUMBER>induced cell death inflammation thromboembolism responsible severe lung injury seen critically ill covid<NUMBER> patients disintegrin metalloprotease <NUMBER> adam<NUMBER> ace secretase membranebound proteases involved production enzymatic cleavage soluble ace<NUMBER> ace respectively angiiat<NUMBER>r signalling increases adam<NUMBER> expression leading reduction surface ace<NUMBER> levels due sace shedding recognition adverse effects unopposed angiiat<NUMBER>r signalling led development ace inhibitors aceis at<NUMBER>r blockers arbs shown fig <NUMBER> aceis inhibit production angi thereby indirectly prevent harmful at<NUMBER>r signalling analysis plasma vasoactive peptide levels shown moderate decrease angii large increase ang<NUMBER> eg generated angi neprilysin following acei treatment <NUMBER> thus aceis suppress detrimental angiiat<NUMBER>r signalling also promote beneficial ang<NUMBER> signalling arbs hand block angii production selectively competitively inhibit binding angii at<NUMBER>r fig <NUMBER> blood plasma patients receiving arbs contains strongly elevated angii moderately increased ang<NUMBER> levels <NUMBER> due wellestablished antihypertensive antioxidative antiinflammatory antifibrotic antihypertrophic effects aceis arbs found widespread use clinical practice consequence large percentage cardiovascular patients including suffering systolic heart failure hfref receive aceis arbs lower blood pressure reducing systemic vascular resistance slow adverse cardiac remodelling europe aceis part firstline treatment asymptomatic hfref patients unless contraindicated tolerated <NUMBER> latter case aceis commonly replaced arbs united states either aceis arbs recommended firstline pharmacological treatment hfref <NUMBER> european society cardiology guidelines recommend use at<NUMBER>rneprilysin inhibitors arnis instead aceis arbs patients remain symptomatic spite optimal treatment aceisarbs betaadrenergic receptor antagonists mineralocorticoid receptor blockers guidelines american college cardiology american heart association recommend prescription arnis chronic symptomatic nyha class ii iii hfref patients tolerate aceis arbs reduce morbidity mortality replacement aceisarbs arnis supported recent metaanalysis showing arnis superior aceis arbs mediating reverse cardiac remodelling hfref patients <NUMBER> analogy happens sarscov widely assumed infection airway epithelial cells results strong reduction ace<NUMBER> expression plasma membrane affect ace surface levels <NUMBER> study arb losartan attenuated sarscov sproteininduced lung injury mouse model moreover serum angii levels significantly elevated covid<NUMBER> patients exhibit linear positive correlation viral load lung injury determined oxygenation index <NUMBER> led hypothesis hypothesis <NUMBER> sarscov<NUMBER>mediated downregulation ace<NUMBER> disturbs balance aceangiiat<NUMBER>r ace<NUMBER>ang<NUMBER> masr signalling lungs thereby contributes development ards covid<NUMBER> patients fig <NUMBER> aceis arbs may beneficial effect course covid<NUMBER> reducing ace angiiat<NUMBER>r signalling thereby restoring local balance activities aceangiiat<NUMBER>r ace<NUMBER>ang<NUMBER>masr axes fig <NUMBER> support idea comes study henry et al showing favourable effects acei treatment hospitalisation patients noncoronaviral pneumonia <NUMBER> also several research groups demonstrated aceis arbs <NUMBER> attenuate lung injury caused experimental ards <NUMBER> reduce pulmonary arterial hypertension <NUMBER> <NUMBER> number scientists <NUMBER> raised opposite idea hypothesis <NUMBER> acei arb pharmacotherapy may aggravate sarscov<NUMBER>induced lung disease increasing ace<NUMBER> surface expression airway epithelial cells fig <NUMBER> several animal studies indicated increase ace<NUMBER> expression following treatment aceis arbs although especially aceis decreases alterations ace<NUMBER> expression also reported reviewed <NUMBER> information effect antihypertensive drugs humans limited analysis duodenal biopsies collectively data show consistent upregulation ace<NUMBER> arbs aces <NUMBER> various tissues however whether ace<NUMBER> expression upregulated either drugs primary target cells sarscov<NUMBER> human lungs yet known hypotheses presented mutually exclusive patients aceisarbs infection sarscov<NUMBER> aceiarbmediated upregulation ace<NUMBER> airway epithelium could increase risk becoming infected sarscov<NUMBER> may facilitate initial virus propagationspread patients receive aceisarbs infected sarscov<NUMBER> drugs could mitigate extent lung injury inhibiting detrimental angiiat<NUMBER>r signalling hence restoring balance beneficial ang<NUMBER>masr signalling recently number observational studies performed investigate influence acei arb pharmacotherapy sarscov<NUMBER> infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> none studies showed use antihypertensivecardioprotective drugs associated increased risk <NUMBER> sarscov<NUMBER> infection <NUMBER> severe covid<NUMBER> <NUMBER> sarscov<NUMBER>related inhospital death conversely smallscale study <NUMBER> patients bean colleagues lower rate death transfer critical care unit within <NUMBER> days found patients aceinhibitor <NUMBER> likewise study mehra coworkers involving <NUMBER> covid<NUMBER> patients use aceis associated better survival <NUMBER> moreover smallscale studies meng et al <NUMBER> zhang et al <NUMBER> favourable effects aceisarbs respectively severity disease allcause mortality observed although studies arrives conclusion namely acearb pharmacotherapy unlikely harmful covid<NUMBER> patients may even beneficial effects smallscale studies high risk chance associations observational studies always possibility confounding weaknesses eg use different virological tests within one study lack information continuation acearb treatment hospitalisation bias resulting selective virological testing randomised controlled trials required definitively answer question whether ras inhibitors bloodpressurelowering drugs eg arnis beta blockers calcium channel blockers thiazide diuretics harmful covid<NUMBER> patients ideally trials also investigate effect different combinations antihypertensive drugs timing antihypertensive drug administration course covid<NUMBER> special interest effect arnis covid<NUMBER> drugs cause large rise plasma angii levels increase concentration ang<NUMBER> blood plasma <NUMBER> apart exploring possible benefit chemical reninangiotensinaldosterone system inhibitors covid<NUMBER> patients another promising approach might consist treatment covid<NUMBER> human recombinant soluble ace<NUMBER> biological drug could inhibit virus entry host cells competing binding protein membranebound ace<NUMBER> time increase ang<NUMBER> levels expense angii conflict interest aaf de vries declares competing interests open access article licensed creative commons attribution <NUMBER> international license permits use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesby<NUMBER> reninangiotensin system ras plays key role maintaining blood pressure homeostasis well fluid salt balance mammals skeggs et al <NUMBER> inagami <NUMBER> weinberg et al <NUMBER> turner hooper <NUMBER> abnormal activation ras associated pathogenesis cardiovascular renal diseases hypertension myocardial infarction heart failure ferrario <NUMBER> nicholls et al <NUMBER> fleming et al <NUMBER> protease renin cleaves angiotensinogen generate angiotensin ang angiotensinconverting enzyme ace critical protease cleaves ang generate ang ii key regulator ras exerts biological functions two gproteincoupled receptors ang ii receptor type <NUMBER> receptor at<NUMBER>r ang ii receptor type <NUMBER> receptor at<NUMBER>r skeggs et al <NUMBER> corvol et al <NUMBER> although exist alternative ang iigenerating enzymes cathepsins chymase belova <NUMBER> miyazaki takai <NUMBER> thought ace key possibly sole enzyme regulation ang ii production ras skeggs et al <NUMBER> turner hooper <NUMBER> <NUMBER> homologue ace angiotensinconverting enzyme <NUMBER> ace<NUMBER> discovered donoghue et al <NUMBER> tipnis et al <NUMBER> accumulated evidences indicate ace<NUMBER> negatively regulates activated reninangiotensin system degrading ang ii heptapeptide ang <NUMBER> several studies support counterregulatory role ang <NUMBER> opposing many at<NUMBER> receptormediated actions especially vasoconstriction cellular proliferation santos et al <NUMBER> ferrario <NUMBER> thus ang <NUMBER> become key component ras system due beneficial effects cardiovascular system addition capacity generate ang<NUMBER> ace<NUMBER> multifunctional enzyme beneficial effects may result ability act vasoactive peptides vickers et al <NUMBER> intriguingly peptidaseindependent actions ace<NUMBER> recently elucidated particular ace<NUMBER> identified essential receptor sars coronavirus infections well protective molecule lethal lung failure sars li et al <NUMBER> kuba et al <NUMBER> interestingly sars receptor function ace<NUMBER> independent catalytic activities ang ii degradation whereas ace<NUMBER>mediated ang ii degradation still important lung protection sars pathogenesis furthermore ace<NUMBER> homolog collectrin identified essential molecules required expression neutral amino acid transporters cell surface epithelial cells collectrin might also role insulin secretion pancreatic βcells andor growth islet cells review discuss classical functions ace<NUMBER> regulating reninangiotensin system peptidase activity new peptidaseindependent functions ace termed hypertensinconverting enzyme initially isolated <NUMBER> skeggs et al <NUMBER> human ace gene located chromosome <NUMBER> encodes <NUMBER> kda protein two homologous domains domain active zincbinding motif hisgluxxhis hexxh motif found many peptidases skeggs et al <NUMBER> soubrier et al <NUMBER> fig <NUMBER> ace typei transmembrane glycoprotein anchored plasma membrane single carboxyterminal transmembrane domain humans two distinct ace isoenzymes described abundant somatic form found endothelial surface lungs brushborder membranes kidneys intestine placenta choroid plexus germinal form ace found testis turner hooper <NUMBER> ace isoforms membranebound protein cell surface function ectoenzymes hydrolyze circulating peptides ace cleaved cell surface thereby act soluble enzyme however biological significance soluble ace remains unclear ace<NUMBER> consists <NUMBER> amino acids type transmembrane glycoprotein single extracellular catalytic domain human ace<NUMBER> gene cloned mapped x chromosome crackower et al <NUMBER> like ace ace<NUMBER> two domains aminoterminal catalytic domain carboxyterminal domain fig <NUMBER> catalytic domain one active sitethe zinc metallopeptidase domainand shows <NUMBER> sequence identity amino domain ace donoghue et al <NUMBER> tipnis et al <NUMBER> turner hooper <NUMBER> ace<NUMBER>s carboxyterminal domain shows <NUMBER> sequence identity collectrin fig <NUMBER> noncatalytic protein recently shown critical role amino acid reabsorption kidney danilczyk et al <NUMBER> malakauskas et al <NUMBER> verrey et al <NUMBER> pancreatic beta cell proliferation akpinar et al <NUMBER> possibly insulin exocytosis fukui et al <NUMBER> early studies observed tissue localization ace<NUMBER> predominantly heart kidneys testes lower level wide variety tissues particularly colon lung tipnis et al <NUMBER> later studies also indicated significance ace<NUMBER> organs like liver intestines komatsu et al <NUMBER> hamming et al <NUMBER> heart ace<NUMBER> expressed endothelium tipnis et al <NUMBER> wells cardiomyocytes kidney ace<NUMBER> distributes luminal surface tubular epithelial cells donoghue et al <NUMBER> tipnis et al <NUMBER> testes adult leydig cells douglas et al <NUMBER> ace<NUMBER> localization mapped apical surface epithelial cells contrast ace appears evenly distributed apical basolateral membranes polarized cells moreover efficacy sarscov infection <NUMBER>fold increased virus applied apical surface ace<NUMBER>expressing cells vitro tseng et al <NUMBER> ace ace<NUMBER> belong m<NUMBER> family clan metalloproteases active site domains exposed extracellular surface facilitating metabolism circulating peptides ace ace<NUMBER> catalyze reactions utilizing zinc coordinated conserved histidines within active site facilitate nucleophilic attack carbonyl bond substrate water molecule forming noncovalently bound intermediate addition two histidines located within hexxh motif glutamate residue involved coordinating zinc ion located <NUMBER> amino acids cterminally hexxh motif ace ace<NUMBER> donoghue et al <NUMBER> tipnis et al <NUMBER> structural analyses native ace<NUMBER> compared inhibitor mln <NUMBER>bound ace<NUMBER> dales et al <NUMBER> revealed large hingebending motion catalytic subdomains ii peptidase domain exhibit opentoclose transitions fig <NUMBER> movement induced binding inhibitor repositions key residues catalysis towler et al <NUMBER> despite similarities ace ace<NUMBER> function differently ace releases cterminal dipeptide substrate dipeptidylpeptidase whereas ace<NUMBER> cleaves single amino acid monocarboxypeptidase donoghue et al <NUMBER> tipnis et al <NUMBER> ace<NUMBER> catalyzes peptides substrate preference hydrolysis proline hydrophobic basic cterminal residue vickers et al <NUMBER> ace converts ang potent vasoconstrictor ang ii corvol et al <NUMBER> ace<NUMBER> cleaves ang generate presumably inactive ang <NUMBER> peptide donoghue et al <NUMBER> tipnis et al <NUMBER> converted vasodilator peptide ang <NUMBER> ace peptidases donoghue et al <NUMBER> importantly ace<NUMBER> directly metabolizes ang ii generate ang <NUMBER> higher efficiency protein type integral protein signal peptide depicted gray transmembrane domain shown black zincbinding motif hemgh repeats two times ace ace<NUMBER> located within homology region denoted yellow box regions homology ace<NUMBER> collectrin denoted green numbers refer amino acids human protein converting ang ang <NUMBER> vickers et al <NUMBER> resolution ace<NUMBER> crystal structure revealed substrate specificity differences result smaller binding pocket ace<NUMBER> due arginine<NUMBER> making saltbridge cterminus substrate whereas ace residue substituted smaller glutamine residue towler et al <NUMBER> although already known ang <NUMBER>forming enzymes neprilysin yamamoto et al <NUMBER> prolyl endopeptidase <NUMBER> nozaki et al <NUMBER> thimet oligopeptidase chappell et al <NUMBER> identification ace<NUMBER> added support biological significance ang <NUMBER> donoghue et al <NUMBER> tipnis et al <NUMBER> vickers et al <NUMBER> peptide shown interact gproteincoupled receptor mas mediate vasoprotective effects santos et al <NUMBER> keidar et al <NUMBER> raizada ferreira <NUMBER> alenina et al <NUMBER> ace<NUMBER> also acts cterminus peptides apelin<NUMBER> apelin<NUMBER> cleaves amino acid high catalytic efficiency vitro vickers et al <NUMBER> apelin synthesized <NUMBER> aminoacid preprohormone processed <NUMBER> amino acid peptide apelin<NUMBER> proteolytic cleavage generates apelin<NUMBER> tatemoto et al <NUMBER> lee et al <NUMBER> systemic administration apelin<NUMBER> prompts hypotension rats mice tatemoto et al <NUMBER> ishida et al <NUMBER> interestingly modification cterminal residue apelin<NUMBER> f<NUMBER>a lost hypotensive action antagonized effect wild type apelin<NUMBER> lee et al <NUMBER> implicating putative roles ace<NUMBER> metabolism apelin peptides requirement chloride ions hydrolysis ang ace long recognized skeggs et al <NUMBER> similarly ace<NUMBER> activity also regulated chloride ions vickers et al <NUMBER> however presence chloride ions increases hydrolysis ang ace<NUMBER> inhibits cleavage vasoconstrictor ang ii guy et al <NUMBER> proposed chloride binding induces subtle changes conformation active site either facilitate hinder substrate binding ehlers riordan <NUMBER> increase cl − <NUMBER> mm physiological concentration human plasma increases ang decreases ang ii cleavage ace<NUMBER> increases ang cleavage ace rushworth et al <NUMBER> would effect increasing localized concentration vasoconstrictor ang ii kidney ace ace<NUMBER> high levels expression extracellular chloride ion levels fluctuate broad range ace inhibitors captopril lisinopril affect activity ace<NUMBER> donoghue et al <NUMBER> tipnis et al <NUMBER> whereas ace<NUMBER> activity inhibited dipeptide prophe guy et al <NUMBER> specific ace<NUMBER> inhibitors peptide analogues dx<NUMBER> huang et al <NUMBER> mln <NUMBER> ss<NUMBER>carboxy<NUMBER>dichlorobenzyl<NUMBER>himidazol<NUMBER>ylethylamino<NUMBER>methylpentanoicacid developed dales et al <NUMBER> mln <NUMBER> first rationally designed inhibitor ace<NUMBER> based cterminal dipeptide ang hisleu high potency k <NUMBER> nm specificity counterregulatory axis ras ace<NUMBER> prompted researchers investigate impact ace<NUMBER> delivery cardiovascular diseases animal models katovich et al <NUMBER> ace<NUMBER> treatment means gene therapy recombinant protein indeed improved hypertension atherosclerosis kidney diseases diezfreire et al <NUMBER> dong et al <NUMBER> lovren et al <NUMBER> oudit et al <NUMBER> silico conformationbased drug screening identified two compounds ace<NUMBER> activator xanthenone resorcinolnaphthalein moderately enhance ace<NUMBER> activity hernandez prada et al <NUMBER> however clear specific compounds although ace<NUMBER> functions peptidase catalyze ang ii cleavage recent studies demonstrate transmembrane domain ace<NUMBER> also biological functions <NUMBER> epidemics sars threatened world ace<NUMBER> identified functional receptor causative pathogen sars coronavirus fig <NUMBER> li et al <NUMBER> kuba et al <NUMBER> cells expressing catalytic inactive mutants ace<NUMBER> still permissive sarscov infection indicating peptidase actions ace<NUMBER> necessary sars entry host cells consistent biological result structural analyses demonstrated sars spike protein contacts tip subdomain ace<NUMBER> catalytic domain affect subdomain ii occludes peptidase active site fig <NUMBER> li et al <NUMBER> upon ligation sarscov ace<NUMBER> ectodomain ace<NUMBER> cleaved transmembrane domain internalized virus particlehost cell fusions fig <NUMBER> inoue et al <NUMBER> haga et al <NUMBER> wang et al <NUMBER> thus although detailed mechanisms still elusive transmembrane domain ace<NUMBER> fig <NUMBER> schematic diagram role ace<NUMBER> reninangiotensin system angiotensin ang drvyihpfhl serves substrate ace dipeptidyl carboxypeptidase converted angiotensin ii ang ii drvyihpf main active peptide classical ras ace<NUMBER> catalyzes inactivates angiotensin ii produces vasodilator peptide angiotensin <NUMBER> ang <NUMBER> drvyihpf binds mas receptor andor degraded inactive peptides red arrowheads indicate ace cleavage site blue arrowheads show ace<NUMBER> cleavage sites noted ace<NUMBER> unspecific protease cleave multiple additional substrates apelin implicated traffic sarscovreceptor complex cell membrane cytoplasm sarscov infections expression analyses rat kidneys isolated collectrin upregulated gene regenerating collecting ducts collectrin shares <NUMBER> identity cterminal end ace<NUMBER> however unlike ace<NUMBER> collectrin lacks active carboxypeptidase catalytic domains fig <NUMBER> initial report documented collectrin localized cytoplasm collecting duct epithelial cells studies indicated predominant localization collectrin brush borders proximal tubular epithelial cells danilczyk et al <NUMBER> danilczyk et al also serendipitously identified collectrin essential regulator neutral amino acid transporters genetargeting studies mice excess amounts neutral amino acids tyrosine phenylalanine appeared urine collectrin knockout mice biochemical studies indicated collectrin binds b <NUMBER> at<NUMBER> neutral amino acid transporters plays critical roles proper expression transporters cell surface required amino acid reabsorption proximal tubules kidney danilczyk et al <NUMBER> malakauskas et al <NUMBER> despite structural similarity ace<NUMBER> bind amino acid transporters kidneys intestines ace<NUMBER> highly expressed amino acids absorbed gut ace<NUMBER> bind b <NUMBER> at<NUMBER> amino acid transporter contributes absorption neutral amino acids importantly peptidase activity ace<NUMBER> necessary pairing amino acid transporter ace<NUMBER> originally cloned using cdna library human failing heart ventricle donoghue et al <NUMBER> ace<NUMBER> mrna levels changing dynamically depending physiological pathological conditions zisman et al <NUMBER> kuba et al <NUMBER> koitka et al <NUMBER> oudit et al <NUMBER> although transcriptional regulation ace<NUMBER> still elusive accumulating evidences indicated inhibition ras ace inhibitors at<NUMBER> receptor blockers upregulates ace<NUMBER> mrna expression ishiyama et al <NUMBER> ferrario et al <NUMBER> instance downregulation ace<NUMBER> mrna levels rat proteinuric renal injury model reversed pharmacological inhibition nfκb transcription factor operates downstream ang ii receptor cytokine signaling takase et al <NUMBER> inhibition mineralcorticoids aldosterone increased ace<NUMBER> mrna macrophages likely suppression oxidative stress associated ang ii andor nfκb signaling keidar et al <NUMBER> consistently interferonγ interleukin<NUMBER> downregulate expression ace<NUMBER> mrna levels epithelial cells de lang et al <NUMBER> thus inflammatory signals including ang ii cytokines nfκb likely suppress ace<NUMBER> transcription early studies observed upregulation hypoxiainducible genes hearts ace<NUMBER> knockout mice crackower et al <NUMBER> tissue local hypoxia increases ace<NUMBER> expression human rat myocardial infarction burrell et al <NUMBER> although another model rat myocardial infarction changes ace<NUMBER> mrna levels observed ishiyama et al <NUMBER> ace<NUMBER> overexpression counteracts inhibits hypoxiainduced collagen production cardiac fibroblasts grobe et al <NUMBER> pulmonary smooth muscle cells subjected hypoxia ace<NUMBER> mrna levels increased early stages hypoxia decreased nearbaseline levels later stages hif<NUMBER>α accumulation zhang et al <NUMBER> thus regulation ace<NUMBER> expression hypoxia still elusive may context cellsorgandependent alltrans retinoic acid also shown elevate ace<NUMBER> mrna levels spontaneously hypertensive rats zhong et al <NUMBER> hepatocyte nuclear factor <NUMBER>β hnf<NUMBER>β tcf<NUMBER> tissuespecific transcription factor whose mutation humans leads renal cysts genital malformations pancreas atrophy maturity onset diabetes young mody<NUMBER> cell lines ace<NUMBER> identified direct target gene hnf<NUMBER>β hnf<NUMBER>α tcf<NUMBER> multiple hnf<NUMBER>β binding sites ace<NUMBER> promoter regions senkel et al <NUMBER> ace<NUMBER> homologue collectrin located close ace<NUMBER> locus x chromosome also target gene hnf<NUMBER> transcription factors hnf<NUMBER>α pancreatic β cells fukui et al <NUMBER> hnf<NUMBER>β kidney epithelial cells thus one speculate ace<NUMBER> collectrin gene expression coordinately regulated hnf<NUMBER> transcription factors ace<NUMBER> identified sars receptor li et al <NUMBER> reported ace<NUMBER> intact molecule andor transmembrane domain internalized together sarscov upon infection since endocytosis essential establishment virus entry blau holmes <NUMBER> inoue et al <NUMBER> internalization take place fig <NUMBER> posttranslational modifications ace<NUMBER> internalization shedding sars coronavirus sarscov binds internalizes ace<NUMBER> cellular entry clathrindependent manner membrane fusion mediated via activation spike proteases trypsin furin viral rnas released cytoplasm establishing sars infection transmembrane proteinase adam<NUMBER> cleaves extracellular juxtamembrane region ace<NUMBER> releasing catalytically active ectodomain extracellular milieu whether ace<NUMBER> cleavage contributes sars pathogenesis known yet fig <NUMBER> interaction ace<NUMBER> b <NUMBER> at<NUMBER> amino acid transporter ace<NUMBER> interacts b <NUMBER> at<NUMBER> amino acid transporter slc<NUMBER>a<NUMBER> required polarized surface expression transporter gut epithelial cells whether ace<NUMBER> cleavage contributes supplying neutral amino acids b <NUMBER> at<NUMBER> known yet even recombinant sars spike protein sarscov surface ligand receptor binding interacts ace<NUMBER> wang et al <NUMBER> clathrindependent independent entry sarscov target cells proposed inoue et al <NUMBER> wang et al <NUMBER> however role cytoplasmic tail ace<NUMBER> controversial instance deletion cytoplasmic tail ace<NUMBER> affect sarscov entry inoue et al <NUMBER> whereas attenuated sarscov entry another study haga et al <NUMBER> similar ace parkin et al <NUMBER> ace<NUMBER> subject juxtamembrane cleavage events shedding releases catalytically active ectodomain process stimulated phorbol ester ionomycin endotoxin il<NUMBER>β tnfα shedding mediated promiscuous sheddase adam<NUMBER> tace tnfα converting enzyme fig <NUMBER> jia et al <NUMBER> adam<NUMBER>null cells reduced ace<NUMBER> shedding iwata et al <NUMBER> moreover calmodulinbinding sites identified cytoplasmic tail ace<NUMBER> lambert et al <NUMBER> inhibition calmodulin increased release ace<NUMBER> ectodomain culture supernatants lambert et al <NUMBER> lai et al <NUMBER> although physiological role ace<NUMBER> ectodomain shedding remains elusive roles circulating ace<NUMBER> remnant cterminal domain yet identified shedding seems involved sarscov cellular entry replication adam<NUMBER> inhibitor suppresses sarscov replication vitro glowacka et al <NUMBER> haga et al <NUMBER> <NUMBER> ace<NUMBER> negative regulator ras cardiovascular system ace<NUMBER> gene mapped quantitative trait locus qtl x chromosome three different rat models hypertension hypertensive rats show reduced ace<NUMBER> transcripts protein expression heart kidney crackower et al <NUMBER> consistently transgenic ace<NUMBER> overexpression vessels shrsp rats reduces blood pressure improves endothelial function neuronal overexpression ace<NUMBER> also attenuates hypertension yamazato et al <NUMBER> feng et al <NUMBER> humans several studies shown strong association ace<NUMBER> polymorphisms hypertension female chinese patients metabolic syndrome zhong et al <NUMBER> essential hypertension yi et al <NUMBER> fan et al <NUMBER> niu et al <NUMBER> thus together biochemical data ace<NUMBER> degrades ang ii generate ang <NUMBER> ace<NUMBER> plays profound role controlling blood pressure however genetic inactivation ace<NUMBER> using homologous recombination results apparent alterations blood pressure basal levels crackower et al <NUMBER> another ace<NUMBER> knockout mouse line blood pressure significantly increased following ang ii infusions sharp contrast spontaneous hypotension observed ace knockout mice krege et al <NUMBER> suggesting addition ang ii system ace<NUMBER> might regulate blood pressure peptide systems bradykinin andor apelin nevertheless exogenous supplementation ace<NUMBER> gene transfer decreased blood pressure shr hypertensive rats recombinant ace<NUMBER> treatment attenuated ang iiinduced hypertension specifically wysocki et al <NUMBER> thus ace<NUMBER> negative regulator ras blood pressure control addition hypertension ace<NUMBER> gene delivery also shown beneficial effects atherosclerosis animal models suggesting ace<NUMBER> confers endothelial protection dong et al <NUMBER> lovren et al <NUMBER> heart major organ abundantly expresses ace<NUMBER> many literatures shown importance heart failure ace<NUMBER> null mice displayed impaired cardiac contractility associated aging andor cardiac pressure overload several different ace<NUMBER> knockout mouse lines crackower et al <NUMBER> yamamoto et al <NUMBER> nakamura et al <NUMBER> heart contractility impairment correlated elevated cardiac plasma ang ii levels double knockout mice ace ace<NUMBER> genes treatment at<NUMBER> receptor blockers reversed cardiac phenotype ace<NUMBER> knockout mice crackower et al <NUMBER> yamamoto et al <NUMBER> nakamura et al <NUMBER> similarly myocardial infarction loss ace<NUMBER> accelerates maladaptive left ventricular remodeling kassiri et al <NUMBER> mechanistically agedependent cardiomyopathy ace<NUMBER> knockout mice likely mediated ang iiinduced oxidative stress inflammation at<NUMBER> receptor downstream pi<NUMBER>k phosphatidylinositol<NUMBER>kinase signaling note one study reported knockout mouse line show alterations cardiac function although mice investigated conditions cardiac like pressure overload gurley coffman <NUMBER> however differences resolved appear dependent modifier genes different mouse background thus ace ace<NUMBER> balance ang ii levels contribute maintaining heart functions at<NUMBER> receptor addition counterbalancing ang ii ace involvement ang <NUMBER> apelin actions ace<NUMBER> controlling heart function postulated increasing evidences shown beneficial effects ang <NUMBER>mas receptor axis pathological settings heart treatment ang <NUMBER> peptide shown improve myocardial performance cardiac remodeling even survival rodent heart failure models including ischemiareperfusion injury myocardial infarction hypertensioninduced cardiomyopathy ferreira et al <NUMBER> santos et al <NUMBER> nonpeptide ave<NUMBER> selective ligand mas receptor actions similar cardioprotective effects ang <NUMBER> peptide knockout mice mas receptor displayed reduced heart contractility alenina et al <NUMBER> although accumulating literatures ace<NUMBER>ang <NUMBER>mas axis correlative studies ace<NUMBER> relationships ang <NUMBER>mas system still miss direct evidence linking functional causal relationships ace<NUMBER> ang <NUMBER>mas system instance whether ang <NUMBER> peptide mas agonist rescue ace<NUMBER> knockout mouse heart phenotypes even challenged connection ace<NUMBER> ang <NUMBER>mas system still elusive addition ang ii ace<NUMBER> also acts peptides apelin<NUMBER> apelin<NUMBER> high catalytic efficiency vitro vickers et al <NUMBER> apelin<NUMBER> apelin<NUMBER> overlapped cterminus fragments <NUMBER> aminoacid apelin preprohormone generated proteolytic cleavage tatemoto et al <NUMBER> lee et al <NUMBER> although systemic administration apelin peptides prompts hypotension rats mice tatemoto et al <NUMBER> ishida et al <NUMBER> apelin knockout mice apj apelin receptor knockout mice showed little alterations blood pressure baseline interestingly apelin knockout mice showed agingor stressassociated cardiac contractility defects similar heart phenotype ace<NUMBER> knockout mice implicating potential vivo interaction ace<NUMBER> apelin kuba et al <NUMBER> nevertheless direct evidences vivo catalysis apelin peptides ace<NUMBER> studies awaited humans ace<NUMBER> gene polymorphisms associate parameters left ventricular hypertrophy men lieb et al <NUMBER> soluble ace<NUMBER> activity increased patients myocardial dysfunction correlates disease severity epelman et al <NUMBER> implicating physiological roles ace<NUMBER> patients therapeutic applications ace<NUMBER> using transgenic overexpression ace<NUMBER> hearts phenotypes controversial one study showed cardiac overexpression ace<NUMBER> protects heart ischemiainduced heart failure der sarkissian et al <NUMBER> whereas others overexpression ace<NUMBER> beneficial leading fatal arrhythmia severe fibrosis donoghue et al <NUMBER> masson et al <NUMBER> latter harmful effects may due artifacts transgenic gene overexpression since utilizing recombinant ace<NUMBER> protein therapeutic models recently shown beneficial various disease models oudit et al <NUMBER> treml et al <NUMBER> wysocki et al <NUMBER> neuronal control heart function ace<NUMBER> brains also demonstrated injections ace<NUMBER> inhibitor mln<NUMBER> nucleus tractus solitarii reduced baroreceptor reflex reflex bradycardia rats diz et al <NUMBER> xia lazartigues <NUMBER> suggesting role ace<NUMBER> ras controlling baroreceptor reflex kidney ace<NUMBER> abundantly expressed crackower et al <NUMBER> activity ace<NUMBER> even higher kidney cortex heart tissue ace<NUMBER> emerged protective molecule kidney diseases context negative regulation ras soler et al <NUMBER> oudit et al <NUMBER> instance deletion ace<NUMBER> leads lateonset nephrotic glomerulosclerosis spontaneously oudit et al <NUMBER> accelerates diabetic kidney injury akita diabetic mice wong et al <NUMBER> streptozocininduced diabetic mice line results pharmacological ablation ace<NUMBER> mln<NUMBER> resulted increased albuminuria glomerular pathology kidneys dbdb diabetic mice streptozocininduced diabetic mice soler et al <NUMBER> phenotypes least part dependent ang ii signaling rescued at<NUMBER> receptor blockade soler et al <NUMBER> thus data definitely indicate ace<NUMBER> physiologically renoprotective hypertensive shr rats onset hypertension tubular expression ace<NUMBER> kidneys downregulated compared control rats diabetic nephropathy experimental models shown alter glomerular tubular expressions ace<NUMBER> longterm diabetic rat model renal ace<NUMBER> expression decreased tikellis et al <NUMBER> whereas early increase ace<NUMBER> expression activity kidneys diabetic dbdb ye et al <NUMBER> wysocki et al <NUMBER> akita wong et al <NUMBER> mice highest expression ace<NUMBER> mrna found renal proximal tubules significantly reduced tubules diabetic rats tikellis et al <NUMBER> thus reduced ace<NUMBER> expression might contribute pathogenesis progression kidney diseases tikellis et al <NUMBER> mizuiri et al <NUMBER> reich et al <NUMBER> renal expression ace<NUMBER> may play profound role controlling local ras rather regulating systemic blood pressure therefore ace<NUMBER> counterbalances ace function negatively regulates ang ii levels thereby controls local kidney homeostasis <NUMBER> ace<NUMBER> sars receptor ace<NUMBER> respiratory system acute respiratory distress syndrome ards severe form acute lung injury affects approximately one million individuals worldwideyear mortality rate least <NUMBER> hudson et al <NUMBER> ware <NUMBER> ards triggered multiple diseases sepsis aspiration trauma acute pancreatitis pneumonias following infections sars coronavirus avian human influenza viruses previous studies ace insertiondeletion id polymorphism correlation severity ards humans marshall et al <NUMBER> jerng et al <NUMBER> ace inhibitor treatments rodent ards models raiden et al <NUMBER> suggested ras could role ardsacute lung injury intriguingly despite normal lung structures functions ace<NUMBER> knockout mice exhibited severe pathology ardsacute lung injury compared wild type control mice enhanced vascular permeability increased lung edema neutrophil accumulation worsened lung function at<NUMBER> blocker treatment additional ace gene deficiency ace<NUMBER> knockout background rescues severe phenotype ace<NUMBER> single mutant mice acute lung injury importantly treatment catalytically active enzymatically inactive recombinant ace<NUMBER> protein improved symptoms acute lung injury wild type mice well ace<NUMBER> knockout mice furthermore recent study large animals sepsis ards models recombinant ace<NUMBER> protein significantly improved respiratory failure increased oxygen levels ards pigs treml et al <NUMBER> thus animal models acute lung injury ace ang ii at<NUMBER> receptor function lung injurypromoting factors negative regulation ang ii levels ace<NUMBER> protects lung injury moreover lung injury models like bleomycininduced lung fibrosis monocrotalineinduced pulmonary hypertension ace<NUMBER> recently shown protect chronic lung injuries fibrosis pulmonary vasoconstriction yamazato et al <NUMBER> results suggest ace<NUMBER> may serve entirely novel therapeutic chronic lung diseases well acute lung injury efficacy recombinant ace<NUMBER> protein at<NUMBER> receptor blockers lung diseases tested clinical settings several months <NUMBER> newly identified illness termed severe acute respiratory syndrome sars spread rapidly world international cooperative teams swiftly isolated novel coronavirus sars pathogen sarscov determined sarscov genome sequence marra et al <NUMBER> rota et al <NUMBER> surprisingly ace<NUMBER> identified functional receptor vitro using coimmunoprecipitation techniques li et al <NUMBER> subsequently mouse sars infection model ace<NUMBER> knockout mice ace<NUMBER> indeed identified essential receptor sars infections vivo interaction sarscov ace<NUMBER> initiated via trimers sars spike protein extends hydrophobic pocket ace<NUMBER> catalytic domain li et al <NUMBER> ace<NUMBER>spike interaction leads endocytosis virus particles internalization ace<NUMBER> induces fusion virus host cells establishes sarscov infection however process require affect peptidase activity ace<NUMBER> since cells expressing enzymatically inactive ace<NUMBER> still infected sarscov ace<NUMBER> substrates still accessible catalytic pocket ace<NUMBER> sars spike protein bound furthermore structure sars spikebound ace<NUMBER> catalytically active site ace<NUMBER> blocked sars spike protein li et al <NUMBER> therefore ace<NUMBER> functions sars receptor independently peptidase activity one mystery sarscov contrast coronaviruses infections trigger severe lung disease high mortality accumulating evidence indicates severe sars infections dependent burden viral replication well immunopathologic consequences host response lau peiris <NUMBER> perlman dandekar <NUMBER> addition aberrant activation immune system studies implicated direct involvement ace<NUMBER> sars pathogenesis intriguingly sarscov infection challenge recombinant sarsspike protein triggered marked downregulation ace<NUMBER> expression lungs cell culture thus sarscovinfected spike proteintreated mice resemble ace<NUMBER> knockout mice similar ace<NUMBER> mutant mice spiketreated wild type mice show markedly severe pathology acute lung injury therefore downregulation sars receptor ace<NUMBER> expression sarscov infection activates reninangiotensin system contributes pathogenesis severe ardsacute lung injury sars one clinical features sars patients progressive rapid deterioration lung function obvious loss lung repair capacity viral load declined peiris et al <NUMBER> although many studies demonstrated sars receptor ace<NUMBER>expressing cells alveolar type<NUMBER> type<NUMBER> pneumocytes vascular endothelial cells couple recent studies suggested lung epithelial stem progenitor cells also important sars infection mouse oct<NUMBER> lung epithelial progenitor cells arise vitro cultures enzymereleased cells neonatal lung tissues express ace<NUMBER> target cells sarscov infection vitro support active virus replication leading destruction ling et al <NUMBER> detailed expression analyses mouse lungs revealed highest expression ace<NUMBER> late embryonic days e<NUMBER> declines birth wiener et al <NUMBER> supporting role ace<NUMBER> progenitor cells sarsinfected human patient lungs cd<NUMBER> oct<NUMBER> lung progenitor cells also positive sarscov antigens using immunohistochemistry mature pneumocytes appear negative sarscov antigens interestingly rabbit atherosclerosis models colocalization ace<NUMBER> cd<NUMBER> oct<NUMBER> cells also observed atherosclerotic plaques zulli et al <NUMBER> however noted ace<NUMBER> expression downregulated sars infection transcriptional posttranslational level glowacka et al <NUMBER> inoue et al <NUMBER> haga et al <NUMBER> wang et al <NUMBER> therefore one would actually expect low ace<NUMBER>immunoreactivity sarscov infected cells nevertheless observations suggest potential role ace<NUMBER> lung stem progenitor cells addition type<NUMBER>type<NUMBER> pneumocytes continued destruction lung tissues apparent loss capacity lung repair sarscov infections studies however required homology searches shown ace<NUMBER> chimeric protein emerged duplication two genes homology ace catalytic domain homology collectrin transmembrane cterminal domain collectrin gene gene name transmembrane protein <NUMBER> tmem<NUMBER> located immediate proximity ace<NUMBER> locus x chromosome genes share similar transcription factor binding sites collectrin shown expressed βcells pancreas transcriptional control hepatocyte nuclear factor <NUMBER> hnf<NUMBER> function implicated insulin exocytosis βcell proliferation akpinar et al <NUMBER> fukui et al <NUMBER> surprisingly using genetargeting studies collectrin physiological vivo function collectrin turned critical binding partner amino acid transporters collectrin physically associates numerous apical amino acid transporters kidney controls expression transport functions danilczyk et al <NUMBER> consequence collectrin mutant mice exhibit marked defect reabsorption amino acids proximal tubules kidneys biochemically collectrin binds b <NUMBER> at<NUMBER>family amino acid transporters controls polarized expression transporters cell surface danilczyk et al <NUMBER> malakauskas et al <NUMBER> due high homology transmembrane collectrin ace<NUMBER> also anticipated play role amino acid reabsorption kidneys however case rather ace<NUMBER> binds b <NUMBER> at<NUMBER> amino acid transporter intestine kidney kowalczuk et al <NUMBER> camargo et al <NUMBER> ace<NUMBER> knockout mice luminal expression b <NUMBER> at<NUMBER> intestine completely lost suggesting ace<NUMBER> essential expression b <NUMBER> at<NUMBER> cell surface intestine thus ace<NUMBER> collectrin binding partners b <NUMBER> at<NUMBER> contribute absorption neutral amino acids intestine kidney respectively although reasons tissuespecific bindings b <NUMBER> at<NUMBER> ace<NUMBER> collectrin unknown hartnup disorder hereditary familial disease characterized pellagralike lightsensitive rash cerebellar ataxia emotional instability amino aciduria baron et al <NUMBER> gene mutations b <NUMBER> at<NUMBER> slc<NUMBER>a<NUMBER> neutral amino acid transporter identified one cause hartnups disorder kleta et al <NUMBER> seow et al <NUMBER> despite crucial roles ace<NUMBER> collectrin expression amino acid transporter gene mutations ace<NUMBER> collectrin identified hartnups disease among human hartnup mutations b <NUMBER> at<NUMBER> a<NUMBER>t r<NUMBER>q missense mutants shown vitro defective activation transport function ace<NUMBER> collectrin vitro xenopus oocyte expression system b <NUMBER> at<NUMBER> mutants alone show similar levels amino acid uptake wildtype one although transport rates low seow et al <NUMBER> camargo et al <NUMBER> however mutants coexpressed ace<NUMBER> transport function activated binding partners coexpression ace<NUMBER> b <NUMBER> at<NUMBER> dramatically activates transport functions thus mutations hartnup disorder patients interfering interaction b <NUMBER> at<NUMBER> ace<NUMBER> may explain disease individuals hand ace<NUMBER> knockout mice reported phenotypes recapitulating hartnup disorder also hartnup patients instance compound heterozygous a<NUMBER>t original hartnup mutation ivs<NUMBER>tng showed seizures symptoms like pellagra ataxic gaits therefore physiological significance impaired activation mutants ace<NUMBER> yet elusive analyses role mutations would needed studies ace<NUMBER> knockout mice gene transfer administration recombinant ace<NUMBER> protein demonstrated ace<NUMBER> vivo negative regulator systemic local effects ras systems peptidase activity carboxypeptidase activity ace<NUMBER> appears limit availability ang ii generates counterregulatory vasodilator peptides ang <NUMBER> may even act peptide systems apelin dynorphin importantly ace<NUMBER> also identified key sars receptor plays protective role sarsmediated ards findings providing opportunity develop potential novel medicine treatment ards often lethal condition develop emerging infectious lung diseases avian influenza h<NUMBER>n<NUMBER> swine flu h<NUMBER>n<NUMBER> course studying ace<NUMBER> function also made entirely unexpected finding ace<NUMBER> collectrin essential expression amino acid transporters gut kidney respectively discovery functional characterization ace<NUMBER> shown ras system far complex system tightly connected peptide systems even amino acid transport functions understanding complexity molecular crosstalks broaden knowledge evolution biology cardiovascular systems also offer chance develop new refined therapeutic strategies various diseases covid<NUMBER> coronavirus disease <NUMBER> pandemic caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> infecting one million killing <NUMBER> people worldwide april <NUMBER> fueled enormous interest mechanisms whereby new coronavirus causes acute respiratory distress syndrome ards multiorgan failure estimated <NUMBER> infection rate undocumented cases covid<NUMBER> patients high lethality infections along enormous socioeconomic impact emphasize importance fully understanding mechanisms developing effective treatment strategies early <NUMBER> reports full rna sequence sarscov<NUMBER> virus highlighted remarkable similarity sarscov virus responsible global outbreak killed <NUMBER> people <NUMBER> xu et al <NUMBER> zhou et al <NUMBER> processes whereby sarscov virus infects lung cells already identified held sarscov<NUMBER> uses identical mechanisms discoveries allowed unprecedented acceleration knowledge acid sequence spike protein envelope viruses use infect mammalian cells <NUMBER> amino acid residue difference sarscov sarscov<NUMBER> protein share almost identical <NUMBER>d structure receptor binding domain xu et al <NUMBER> moreover binds ace<NUMBER> even higher affinity sarscov wrapp et al <NUMBER> may explain virulence predilection lungs upon binding ace<NUMBER> sarscov sarscov<NUMBER> activate transmembrane serine protease<NUMBER> tmprss<NUMBER> highly expressed lungs fusion envelope cell membrane virus penetrates cells figure <NUMBER> panel heurich et al <NUMBER> hoffmann et al <NUMBER> note sarscov<NUMBER> entry prevented sars convalescent sera containing neutralizing antibodies tmprss<NUMBER> inhibitors camostat hoffmann et al <NUMBER> nafamostat mesylate approved japan clinical use indications yamamoto et al <NUMBER> seminal discoveries suggested several potential therapeutic strategies prevent sarscov<NUMBER> entry pulmonary cells figure <NUMBER> panel role ace<NUMBER> ace<NUMBER> infections caused sarscov sarscov<NUMBER> similarities ace<NUMBER> target aceis ace<NUMBER> target sarscov sarscov<NUMBER> obviously essential question physicians using aceis angiotensinreceptor blockers arbs frequently prescribed multitude patients ace<NUMBER> ace<NUMBER> cleave angiotensin peptides figure <NUMBER> panel b however differ markedly ace<NUMBER> cleaves dipeptide hisleu angiotensin thus generating angiotensin ang ii causes vasoand bronchoconstriction increases vascular permeability inflammation fibrosis thereby promotes development ards lung failure patients infected sarscov sarscov<NUMBER> yang et al <NUMBER> figure <NUMBER> panel b compelling evidence animal models ards lung fibrosis asthma chronic obstructive lung disease indicate effects essential ards develop aceis arbs block diseasepropagating effect ang ii dhawale et al <NUMBER> imai et al <NUMBER> kaparianos argyropoulou <NUMBER> ace<NUMBER> expressed abundantly apical basolateral side polarized alveolar epithelial cells jia et al <NUMBER> shares <NUMBER> amino acid sequence homology ace<NUMBER> harmer et al <NUMBER> cleaves one amino acid residue leu phe ang ang ii respectively generate ang <NUMBER> ang<NUMBER> figure <NUMBER> panel b importantly ang<NUMBER> counteracts <NUMBER> rmediated aforementioned detrimental effects induced ang ii lungs accordingly genetic deletion ace<NUMBER> worsens experimental ards ang<NUMBER> aceis arbs administration improve wö stenvan asperen et al <NUMBER> thus blunting ace<NUMBER>ang iiat <NUMBER> r axis enhancing ace<NUMBER>ang iiat <NUMBER> r ace<NUMBER>ang<NUMBER>at <NUMBER> r ace<NUMBER>ang<NUMBER>masr receptor axes figure <NUMBER> panel b likely protects ards triggered infectious pathogens including coronaviruses dhawale et al <NUMBER> imai et al <NUMBER> kaparianos argyropoulou <NUMBER> meng et al <NUMBER> ace<NUMBER> identified sarscov<NUMBER> receptor hoffmann et al <NUMBER> yan et al <NUMBER> unexpectedly almost immediately contended treatment aceis arbs would harmful covid<NUMBER> patients hypothesis quickly spread public causing confusion fear patients taking drugs started asking doctors discontinue medications replace antihypertensive drugs classes confusion caused medical community public due publication two commentaries containing simple hypotheses absence supporting evidence one commentary ace<NUMBER> suggested secreted higher amounts patients cardiovascular disease healthy individuals another also stated ace<NUMBER> levels increased use aceis albeit evidence occurring lungs mechanisms covid<NUMBER> sarscov<NUMBER> virus infects lower airway cells modalities increase circulating soluble ace<NUMBER> therapeutic use binding endothelial type <NUMBER> alveolar epithelial cells express ace<NUMBER> high levels virus activates proteases tmprss<NUMBER> allows fusion virus envelope cell membrane facilitating virus enter infect cell note type <NUMBER> alveolar epithelial cells well equipped molecular machinery allows rapid replication viruses thus enhancing pulmonary spreading infection infected sarscov<NUMBER> lung cells downregulates expression ace<NUMBER> therefore lungs remain exposed unprotected detrimental actions angiotensin ii acting via <NUMBER> r increasing circulating soluble ace<NUMBER> levels represents potential new therapeutic principle treat sarscov<NUMBER> infection achieved using different strategies either increasing adam<NUMBER>dependent shedding ace<NUMBER> facilitating removal tissue strategy intravenous administration recombinant soluble ace<NUMBER> capture thereby inactivate sarscov<NUMBER> plasma preventing entering cell strategy b b reninangiotensin system pathophysiology sarscov<NUMBER>associated ards ang ii via <NUMBER> r promotes inflammation vasoconstriction cell proliferation vascular leakage eventually pulmonary fibrosis effects counteracted ace<NUMBER> dependent formation ang<NUMBER> activating <NUMBER> r masr mrgd formation ang<NUMBER> activating <NUMBER> r potential beneficial effects aceis arbs entail rescuing downregulated ace<NUMBER>ang iiat <NUMBER> r ace<NUMBER>ang<NUMBER>at <NUMBER> r ace<NUMBER>ang<NUMBER>masr pathways lungs capturing virus circulation thus impeding binding lung cells preventing damage lungs abbreviations used ace<NUMBER> angiotensin converting enzyme<NUMBER> ace<NUMBER> angiotensin converting enzyme<NUMBER> aceis angiotensin converting enyzme inhibitors arbs angiotensin <NUMBER> receptor blockers <NUMBER> r angiotensin ii type <NUMBER> receptor <NUMBER> r angiotensin ii type <NUMBER> receptor nep neutral endopeptidaseneprilysin mrgprd gproteincoupled receptor mrgd rhace<NUMBER> recombinant soluble human ace<NUMBER> soluble rbd ace<NUMBER> soluble receptorbinding domain ace<NUMBER> tmprss<NUMBER> transmembrane serine protease<NUMBER> exists hypothetical phenomena put forward suggest enhanced susceptibility sarscov<NUMBER> infection thus warn patients taking drugs correspondence lancet respiratory medicine suggested patients cardiac diseases hypertension andor diabetes treated ace<NUMBER>increasing drugs would higher risk severe sarscov<NUMBER> infection treatment aceis arbs would raise ace<NUMBER> fang et al <NUMBER> support contention authors quoted review article however report evidence li et al <NUMBER> contrary search literature revealed data would support notion exist fact evidence ace<NUMBER> upregulation applies heart likely compensatory phenomenon underlying conditions example myocardial infarction burrell et al <NUMBER> ishiyama et al <NUMBER> ocaranza et al <NUMBER> rather drug treatment per se moreover neither commentary authors considered fact increased plasma levels ace<NUMBER> generated delivering soluble forms rhace<NUMBER> andor increasing shedding ace<NUMBER> cell membrane capture protein sarscov<NUMBER> sarscov plasma thus preventing virus binding lung cells two strategies suggested protect sarscov<NUMBER> infection lungs kruse <NUMBER> zhang et al <NUMBER> figure <NUMBER> panel nonetheless publication simple hypotheses unsubstantiated data spread fast public news portals scientific societies including european society hypertension esh italian society cardiology italian society arterial hypertension required release statements confirm evidence aceis arbs could jeopardize covid<NUMBER> patients need recommend discontinuing treatment date italy country highest number sarscov<NUMBER>positive individuals european union highest official number deaths world march <NUMBER> th <NUMBER> joint statement presidents hfsaaccaha bozkurt et al <NUMBER> followed one european medicines agency <NUMBER> several experts opinion articles reported affirmed evidence support discontinuing aceis arbs danser et al <NUMBER> greene et al <NUMBER> perico et al <NUMBER> notion also shared editors new england journal medicine rubin et al <NUMBER> view neutral recommendations could even understatement fact two large metaanalysis casecontrol study involving <NUMBER> patients several highrisk categories patients including stroke survivors shinohara origasa <NUMBER> asian population caldeira et al <NUMBER> liu et al <NUMBER> also patients parkinsons disease aceis superior antihypertensive agents pneumonia prevention experimental data obtained sarscov virus also show drugs protective rather harmful lead proposition specifically enhancing protective arm reninangiotensin system novel therapeutic strategy pulmonary diseases tan et al <NUMBER> moreover abrupt withdrawal raas inhibitors highrisk patients including stage <NUMBER> arterial hypertension heart failure myocardial infarction may result clinical instability adverse health outcomes pointed recently vaduganathan et al <NUMBER> <NUMBER> rmediated detrimental effects ang ii demonstrated several models ards sarscovinduced acute respiratory failure kuba et al <NUMBER> kuba et al <NUMBER> moreover vasodilatory antiinflammatory antiproliferative antifibrotic effects activation ace<NUMBER>ang<NUMBER>at <NUMBER> r ace<NUMBER>ang<NUMBER>masr pathways counterbalances harmful effects ace<NUMBER>ang iiat <NUMBER> r pathway lungs reduced ratio ace<NUMBER>ace<NUMBER> documented ards furthermore experimentally ards lung fibrosis prevented administration ang<NUMBER> cao et al <NUMBER> arbs wö stenvan asperen et al <NUMBER> indicating ace<NUMBER> activation limits pulmonary disease progression implies aceis arbs unlikely detrimental covid<NUMBER> patients likely protective whether applies drugs block mineralocorticoid receptor antagonize aldosterone another downstream mediator ace<NUMBER>ang iiat <NUMBER> r pathway remains unknown endothelial lung type <NUMBER> alveolar epithelial cells sarscov<NUMBER> downregulates ace<NUMBER> thereby ace<NUMBER>ang<NUMBER>masr pathway imai et al <NUMBER> would also suggest aceis arbs beneficial blunting ace<NUMBER>ang iiat <NUMBER> r pathway counterbalancing downregulation ace<NUMBER> figure <NUMBER> administration recombinant soluble human ace<NUMBER> rhace<NUMBER> capture sarscov<NUMBER> bloodstream may prevent binding lung cells enhance ace<NUMBER> activity lung tissue figure <NUMBER> panel could beneficial covid<NUMBER> patients ards possibly even late stage infection patients intensive care requiring assisted ventilation along lines <NUMBER> pilot trial patients ards conducted ten us intensive care units supports value strategy rhace<NUMBER> increased levels ang<NUMBER> alveolar surfactant protein levels tended lower concentrations proinflammatory cytokine interleukin<NUMBER> khan et al <NUMBER> summary disbalance ace<NUMBER>ang iiat <NUMBER> r ace<NUMBER>ang iiat <NUMBER> r ace<NUMBER>ang<NUMBER>at <NUMBER> r ace<NUMBER>ang<NUMBER>masr pathways contributes pathogenesis ards acute lung failure likely also relevant covid<NUMBER> patients therefore seems reasonable conclude rebalancing system blunting deleterious effects ang ii using aceis arbs enhancing ace<NUMBER> axis valuable strategy minimize harmful effects sarscov<NUMBER> lungs majority patients cardiovascular diseases mainly hypertension heart failure ischemic heart disease aceis arbs risk becoming infected infected sarscov<NUMBER> need mechanical ventilation evidence deleterious effects acei arbs fact discontinuing lifesaving medications potentially harmful competing interests matthias barton senior editor elife authors declare competing interests exist funders role study design data collection interpretation decision submit work publication gian paolo rossi conceptualization supervision methodology writing original draft viola sanga resources data curation matthias barton supervision writing validation 